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IMPACT OF WEST NILE VIRUS ON THE NATURAL HISTORY OF ST. LOUIS 
ENCEPHALITIS VIRUS IN FLORIDA 
 
Christy L. Ottendorfer 
 
ABSTRACT 
 
 The emergence of West Nile virus (WNV) has raised important questions about 
the capacity of the public health infrastructure to implement surveillance and control 
programs for WNV and other emerging or re-emerging arboviruses in the United States. 
Florida’s mild climate supports year round enzootic transmission of WNV, St. Louis 
encephalitis virus (SLEV), and Eastern Equine Encephalitis virus (EEEV).  It is unknown 
what effect the establishment of WNV (in 2001) will have on SLEV transmission in 
Florida, where these closely related flaviviruses share amplifying hosts, habitats, and 
vectors.  
 An Arbovirus Isolation Network was formed to obtain and characterize arbovirus 
strains collected from a large population of naturally exposed birds, including sentinel 
chickens and wild birds admitted to rehabilitation centers in Florida. Weekly sentinel 
seroconversion data was used to target sampling of chicken flocks at 37 active sites (17 
WNV, 7 EEEV, and 13 SLEV) in eight counties from 224 birds during 2005-2006. 
Sampling of wild birds occurred following admittance at rehabilitation centers in 2006, 
based on symptoms and known amplifying host species (n=64), but virus was not 
detected. We report the isolation of St. Louis encephalitis virus, West Nile virus and 
detection of Eastern Equine Encephalitis viral RNA from cloacal swabs of naturally 
exposed adult sentinel chickens. We also report the first known dual infection and 
 xxi
isolation of St. Louis encephalitis and West Nile viruses from one chicken. In addition, a 
novel flavivirus strain was detected in two chickens. Early season transmission of WNV 
appears to limit subsequent infection and amplification of SLEV late in the year. 
 Phylogenetic analysis revealed that the introduction (and re-introduction) of South 
American (Brazil) SLEV occurred in 1972 and 2006 in Florida. These strains represent 
the first reported isolation of South American strains of SLEV in the United States, with 
placement in Lineage VA and VB, as proposed by Kramer and Chandler (2001).  
Arbovirus isolation remains an effective tool for surveillance programs and a targeted 
strategy is most cost-effective to capture arboviruses in their natural settings for 
molecular epidemiology analysis that can elucidate genetic variations impacting 
virulence, mosquito infectivity, and disease potential of these pathogens.  
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CHAPTER 1 
 
INTRODUCTION 
 
 An arthropod-borne virus (arbovirus) is a virus that requires a hematophagous 
(blood-sucking) arthropod vector for transmission to vertebrate hosts to maintain its life 
cycle (Gubler, 2001). Arboviruses are globally distributed, but are primarily found in 
tropical areas where the climate can support year-round transmission by cold-blooded 
arthropods (Gubler, 2002). The past 20 years has witnessed changing epidemiological 
trends resulting in dramatically increased global epidemic arboviral activity. Population 
growth, new irrigation systems, deforestation, and uncontrolled urbanization in tropical 
developing countries have contributed to the emergence/resurgence of arboviral diseases 
(Gubler, 2001). 
 During this time, viruses once thought to be controlled or not of major public 
health significance caused epidemic disease in many regions of the world.  For example, 
West Nile virus (WNV) was introduced into North America in 1999 with epidemics and 
epizootics of severe neurologic disease in humans, horses, and birds- an apparent shift 
from relatively less pathogenic strains found previously in the eastern hemisphere 
(Gubler, 2002). From 1999 to 2006, there were 23,975 cases of WNV illness reported to 
the Centers for Disease Control and Prevention (CDC), with 962 fatalities in the US 
(CDC, 2007e). This recent emergence of a new, more virulent strain of WNV with 
greater epidemic potential has raised important questions about the capacity of the public 
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health infrastructure to implement surveillance, prevention, and control programs not 
only for WNV, but also in the event other arboviruses emerge or re-emerge with greater 
virulence characteristics or higher epidemic potential (Gubler, 2002). 
 WNV is maintained in an enzootic transmission cycle between birds and Culicine 
mosquitoes, with humans and horses as incidental (dead-end) hosts (Blackmore et al., 
2003). In the temperate zone, transmission occurs during the warmer months with peak 
activity from July-October (O’Leary et al., 2004). The main competent bird reservoirs in 
the temperate United States (US) are corvid species, house sparrows, house finches, and 
grackles (Komar, 2003). The spread of WNV throughout the United States and to 
Canada, Latin America, and the Caribbean is due to the migration patterns of these bird 
reservoirs (Hayes, 2001; Gubler, 2007). West Nile virus continues to spread slowly 
southward through Central and South America, with recent isolates of the virus in 
Mexico and Argentina (Gubler, 2007).  North American WNV isolates were initially 
characterized by widespread mortality in resident bird populations, a distinctive 
characteristic that appears to have decreased in recent years with the emergence of the 
WN02 North American dominant genotype of the virus (United States Geological Survey 
[USGS], 2007). In contrast, South American WNV strains have not been found to cause 
significant morbidity or mortality in birds, equines, or humans (Kramer and Shi, 2007; 
Gubler, 2007). 
Like WNV, St. Louis encephalitis virus (SLEV) is a member of the family 
Flaviviridae and is vectored by Culex species mosquitoes.  These closely related viruses 
share many antigenic, genetic and ecologic characteristics (Chambers et al., 1990). SLEV 
has been found in both North and South America. The human case fatality ratio depends 
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upon geographic location, but in general, South American strains of SLEV also appear to 
be more attenuated (similar to WNV) in comparison to North American strains (Diaz et 
al., 2006).  In the United States, SLEV has intermittent epidemic transmission with up to 
3,000 cases per year (average 128), and a case fatality rate of 5% (CDC, 2007j).  
Interestingly, SLEV has recently been isolated from humans in South America, where it 
caused an outbreak of encephalitis in both Argentina and Brazil (2003 and 2005) 
[Spinsanti et al., 2003; Diaz et al., 2006; Rocco et al., 2005; dos Santos et al., 2006]. In 
contrast to WNV, enzootic SLEV transmission is very silent in nature with no reports of 
avian mortality (CDC, 2007j).   
 The mild climate of Florida supports year round enzootic transmission of SLEV, 
with most human cases occurring in the late summer and early fall months (Blackmore et 
al., 2003). Outbreaks of SLEV over the last forty years led to the establishment of an 
arboviral surveillance program in Florida (Bigler B, 1999). SLEV epidemics are sporadic, 
often cycling every 10 years, due to complex interactions between environmental factors, 
vector abundance, and avian amplifying hosts. The last large outbreak of SLEV in 
Florida occurred in 1990-1991 resulting in 11 deaths and 223 laboratory confirmed cases. 
These epidemics not only have significant public health impacts, but also adversely affect 
communities through curtailed evening recreational activities and tourism in Florida due 
to emergency response measures and widespread publicity (Day, 2001).  
 In 2001, West Nile virus was first detected in Florida. 199 cases of WNV illness 
were reported to the CDC from 2001 through 2006, with 11 fatalities (CDC, 2007e). Case 
numbers and enhanced surveillance data for WNV in the last five years supports the 
concern that WNV has firmly established enzootic transmission foci within the state. In 
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2002, surveillance programs detected extensive WNV activity, but did not detect SLEV 
transmission activity in the state (Stark and Kazanis, 2002). A single human case was 
reported in 2002 (CDC, 2007l).  SLEV reappeared at low levels in 2003 and every year 
since then (Stark and Kazanis: 2003, 2004, 2005, & 2006).  Despite frequent detection of 
both viruses in bird/mosquito populations and reported clinical cases (USGS, 2007; CDC, 
2007e & l), a review of the literature indicates that St. Louis encephalitis virus has not 
been reported isolated from a region after several years of concurrent WNV transmission 
activity.   
 SLEV is an important public health concern, especially in the southern states, 
where transmission of the virus commonly occurs.  Despite the presence of active 
surveillance and mosquito control programs in many regions, sporadic human cases of 
the disease occur every year in the United States (Chandler and Nordoff, 1999).  The 
introduction of WNV into SLEV-endemic regions has created the need for improved 
detection methods and prevention strategies across the United States.   
Problem Statement 
 Since its unexpected appearance in New York City in 1999, WNV has spread 
across North America and into Canada, the Caribbean, Latin and Central America. The 
largest epidemics of neuroinvasive WNV disease occurred in the United States in 2002 
and 2003, far exceeding WNV case numbers in the eastern hemisphere (Hayes and 
Gubler, 2006).  SLEV, a closely related flavivirus family member, is also maintained in 
an enzootic transmission cycle between birds and Culex sp. mosquitoes in North and 
South America. WNV and SLEV infections often present with similar clinical profiles 
 5
(sudden onset of fever, headache, and myalgia), and have similar prevention measures 
(Johnson et al., 2005).  
 The expansion of WNV into the western hemisphere has prompted a surge in 
research to elucidate the natural history of WNV. Extensive studies have investigated 
virus characteristics that influence pathogenicity (Davis et al, 2005; Hayes et al, 2005b; 
Kuno and Chang, 2005; Deardorff et al, 2006; Samuel and Diamond, 2006), clinical 
features (Kuno, 2001; Klee et al, 2004; Hayes and Gubler, 2006; Kramer and Shi, 2007), 
and epidemiology of the disease (Hayes et al, 2005a). There have also been several 
ecological studies on WNV reviewed by Komar (2003), including biologic and abiotic 
factors such as vector competence (Sardelis et al, 2001; Reisen, Fang and Martinez, 
2005), mosquito feeding behaviors (Kilpatrick et al, 2006), avian amplifying hosts and 
mortality (Komar et al, 2003; Langevin et al, 2005; LaDeau, Kilpatrick and Marra, 
2007), wetting and temperature conditions (Shaman, Day and Stieglitz, 2005; Reisen, 
Fang and Martinez, 2006), spatial-temporal distribution (Davis et al, 2003; Kuno and 
Chang, 2005), and how the virus overwinters in northern climates (Reisen et al, 2006). 
Yet, the potential influence of WNV or its impact on SLEV has largely been ignored in 
these studies.   
 From 1960-1975, the arbovirus field experienced its “heyday”.  During this time, 
several arboviruses were discovered and many regions of the world had fully functional 
arbovirus laboratories with high levels of governmental and institutional support.  These 
laboratories often supported epidemiological investigations, as well as research and 
training opportunities for those interested in the isolation and characterization of viruses 
from arthropods, vertebrate animals and clinical specimens. However, as time passed, a 
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lack of funding and increased regulations on the use and exchange of infectious 
arboviruses often restricted their study to high-security laboratories. As such, virus 
isolation techniques were not feasible for most facilities and have became less important 
as molecular methods were discovered that could rapidly identify virus strains, without 
handling infectious virus.  Unfortunately, this paradigm shift has limited the information 
that can be gained about novel viruses when they are not isolated (e.g. many strains of 
hantavirus) as phenotypic information cannot be assessed (Calisher et al, 2001). 
 During the 1960s and 1970s, field studies were conducted throughout Florida by 
the Epidemiology Research Center (ERC) to improve the knowledge of the natural 
history of arboviruses in response to epidemics of SLEV.  These studies were 
instrumental in identifying mosquito vectors and avian amplifying hosts for arboviruses 
in Florida, including isolation of several arboviruses (Dow et al, 1964; Lewis, Jennings 
and Schneider, 1964; Bond et al, 1966; Jennings, Allen and Lewis, 1966; Jennings et al, 
1967; Jennings et al, 1970; Sather et al, 1970; Bigler et al, 1974 & 1975). However, these 
studies were terminated because of a lack of funding and have not been repeated on as 
large of a scale. These investigations were also conducted prior to the development of 
molecular diagnostic techniques, such as polymerase chain reaction (PCR) and nucleotide 
sequencing for identification of viruses.  Consequently, a sample of these historical 
SLEV isolates will now be included in the current study for molecular characterization 
and comparison to currently circulating arboviruses.   
 It is unknown what effect the establishment of WNV endemicity will have on 
SLEV transmission in Florida.  Florida has a unique climate and ecosystem that is unlike 
most of the continental United States.  It has distinct regions, such that the northern part 
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of Florida approximates the habitat found in the southeastern US, whereas the southern 
part of the state is more tropical in nature. WNV transmission activity has been detected 
throughout the state, whereas SLEV transmission activity predominates in the southern 
region (subtropical) [Day and Curtis, 1993; Day and Stark, 2000; Day, 2001; Shaman, 
Day and Stieglitz, 2004 & 2005].  A recent study in Texas indicates that SLEV and WNV 
are able to coexist in the same region (Lillibridge et al., 2004), which is also supported by 
Department of Health surveillance data in Florida (Stark and Kazanis: 2003, 2004, 2005, 
& 2006).  However, the authors only cultured SLEV in the first month of concurrent 
WNV transmission from mosquitoes in Texas (Lillibridge et al., 2004).   
 In Florida, SLEV has not been isolated in culture after the introduction of WNV, 
despite the operation of the largest arboviral surveillance program in the United States. 
Will the viruses peacefully co-exist or will one virus dominate the other as they both 
compete for shared mosquito vectors, habitat and amplifying hosts? These concerns 
motivated the inception of this project to perform virus isolation studies and capture 
arboviruses in their natural settings. Genetic and phenotypic studies of these viruses, 
especially St. Louis encephalitis virus, are critically necessary because they can identify 
variations in a virus that may impact its virulence, mosquito infectivity, and disease 
potential.   
 As such, this research study will enhance existing collaborations between the 
Florida Department of Health and participating counties within the state, as well as 
develop new partnerships with wildlife rehabilitation centers, the University of South 
Florida and the University of Florida.  These agencies will, for the first time, utilize the 
Florida Sentinel Chicken Program or sample wild bird species to obtain and characterize 
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arbovirus isolates. This project was funded in part by the Southeastern Centers for 
Emerging Biologic Threats (Grant # U38/CCU423095).   
Specific Aims 
 The objective of this project is to investigate the impact on the natural history of 
St. Louis encephalitis virus following the emergence of West Nile virus in Florida.  This 
study was designed to serve five major purposes:  
1)   Establish a network to enhance arbovirus surveillance (with virus isolation) in   
Florida,  
2)   Evaluate a targeted strategy for collection and processing of samples,  
3)   Identify and characterize arbovirus isolates,  
4)   Compare current flavivirus isolates to strains collected prior to the   
introduction of WNV in Florida, and  
5)   Evaluate the effectiveness of virus isolation/detection (cell culture/PCR 
methods) as a surveillance tool in Florida. 
Aim Statements 
Aim One 
Develop and implement a network for the isolation/detection of arboviruses in Florida 
Research Strategies: 
A. Evaluate current surveillance methods for the detection of arboviruses 
B. Identify existing arbovirus surveillance resources at the state and local level 
1. Arboviral Surveillance Network (Sentinel Chicken Program) 
2. Wildlife Rehabilitation Centers 
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C. Optimize methods for use by the virus isolation/detection network 
1. Optimize testing methods for the detection/isolation of arboviruses 
2. Optimize targeted sampling strategy for network agencies 
3. Establish protocol and sampling criteria for use by the agencies to collect 
specimens  
Aim Two 
Evaluate a targeted strategy for the collection and processing of submitted samples 
Research Strategies: 
A. Monitor weekly arbovirus surveillance data for arbovirus transmission activity 
1. Implement targeted sampling strategy by network partners of sentinel 
chicken sites based on sentinel seroconversions 
B. Evaluate targeted sampling strategy of sentinel chickens at sites with confirmed 
arbovirus activity (arbovirus transmission “hot zones”)  
C. Evaluate the use of current serological testing methods (HAI, MAC-ELISA, 
PRNT) for early targeting of active arbovirus transmission sites 
D. Evaluate targeted sampling of wild birds admitted to rehabilitation centers (with 
presumptive symptoms of arbovirus infection)  
E. Evaluate effectiveness of sample collection from sentinel chickens for virus 
isolation/detection 
1. Initiation or continuation of swabbing by county agencies immediately 
following presumptive or confirmed seroconversions at sentinel “hot 
zones”  
2. Cloacal swabs collected 1 day/week vs. 2 days/week  
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F. Evaluate effectiveness of retrospective processing of samples from confirmed 
positive sentinel chickens for the isolation of arboviruses for surveillance 
Aim Three 
Identification and Characterization of Arbovirus Isolates 
Research Strategies: 
A. Evaluate sample collection methods for arbovirus isolation from naturally 
exposed birds 
1. Effectiveness of sample type for isolation of arboviruses  
i. Blood 
ii. Fecal (cloacal swab) 
B. Evaluate effectiveness of current molecular tests (real time TaqMan RT-PCR) 
used for detection of arboviruses 
C. Describe arboviruses isolated 
1. Genotypic characteristics 
2. Phenotypic characteristics (in cell culture) 
D. Describe the primary immune response following natural arbovirus infection in 
adult chickens   
1. Impact of strain (breed) and age of chicken on antibody response 
2. Compare primary immune response in naturally infected chickens to 
reports of artificially infected birds in laboratory studies  
Aim Four 
Compare current flavivirus isolates to strains collected prior to the introduction of WNV 
in Florida 
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Research Strategies: 
A. Evaluate phylogenetic analysis of recent and historical isolates of SLEV and 
WNV 
1. Phylogeny of SLEV 
2. Phylogeny of WNV 
B. Describe changes (mutations) found between current SLEV isolates versus SLEV 
strains collected prior to the introduction of WNV in Florida 
1. Genotypic characteristics 
2. Phenotypic characteristics (in cell culture) 
C. Evaluate use of nucleotide sequence information for molecular epidemiology 
studies of SLEV in Florida 
1. North American strains 
2. South American strains 
D. Evaluate impact of mutations in the envelope region of SLEV on molecular 
detection of the virus 
1. What impact does this have on public health surveillance for the virus? 
2. What molecular methods should be used to identify and confirm atypical 
SLEV strains? 
E. Summarize impact of WNV on the natural history of SLEV in Florida 
1. Evaluate seasonal timing of WNV transmission activity and its impact on 
SLEV transmission activity in Florida 
i. Inhibition of SLEV transmission activity and/or the isolation of 
SLEV with early season transmission of WNV 
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2. Impact on current surveillance methods  
i. Molecular methods 
ii. Serological methods 
Aim Five 
Evaluate the effectiveness of virus isolation/detection (cell culture/PCR methods) as a 
surveillance tool in Florida 
Research Strategies: 
A. Evaluate the effectiveness of virus isolation and/or molecular detection assays 
compared to serological assays for public health surveillance of arbovirus 
transmission activity (from blood and fecal samples) 
B. Impact of retrospective processing of samples on further characterization of 
flavivirus natural infection in chickens 
C. Recommendations for serological and virus isolation surveillance methods to 
identify transmission activity and arbovirus strains 
D. Summarize impact of WNV on the natural history of SLEV in Florida  
Implications of this Study 
 This study’s findings will further elucidate the natural history and molecular 
epidemiology of WNV and SLEV, which is necessary to improve prevention strategies 
needed to protect the public health from these pathogenic arboviruses.  The wide 
geographic range, migration of avian amplifying hosts, and presence of susceptible 
vectors also allows for the emergence of these viruses into new territories which can 
adversely impact global health. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
Arthropod-borne viruses (arboviruses) 
 An arthropod-borne virus (arbovirus) is a virus that requires a hematophagous 
(blood-sucking) arthropod vector for transmission into vertebrate hosts to maintain its life 
cycle (Gubler, 2001). Most arboviruses are zoonoses with vertebrate hosts other than 
humans as their primary reservoir. Vertebrate infection can occur after an infected 
arthropod takes a blood meal, and arthropod infections occur after feeding on viremic 
(presence of virus in the bloodstream) hosts. Usually the virus cycles silently between the 
primary arthropod vector and primary vertebrate host until an ecologic change occurs that 
allow the virus to escape this focus (Centers for Disease Control & Prevention [CDC], 
2003).  
 The most common amplifying hosts are birds and rodents and the most important 
arthropod vectors are mosquitoes and ticks for arboviral diseases of public health 
consequence, although exceptions to this rule exist.  For instance, dengue virus has 
adapted completely to humans and is maintained in a mosquito-human-mosquito 
transmission cycle in urban centers of the tropics and sub-tropics (Gubler, 2002). In 
South America and East Africa, yellow fever virus cycles in both urban and jungle 
environments, where the sylvatic cycle is maintained in wild monkeys (Burke and 
Monath, 2001; CDC, 2007a). Important ecological parameters that govern these cycles 
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include temperature, rainfall, and humidity which influence geographic distribution of the 
vectors and hosts (Gubler, 2002).  Figure 2-1 presents the global geographic distribution 
of the major arboviral encephalitides. 
Although arboviruses are globally distributed, they are primarily found in tropical 
areas where the climate can support year-round transmission by cold-blooded arthropods 
(Gubler, 2002). The past 20 years has witnessed changing epidemiological trends 
resulting in dramatically increased global epidemic arboviral activity. Population growth, 
new irrigation systems, deforestation, and uncontrolled urbanization in tropical 
developing countries have especially contributed to the emergence/resurgence of 
arboviral diseases (Gubler, 2001). During this time, viruses once thought to be controlled 
or not of major public health significance caused epidemic disease in many regions of the 
world. For example, dengue virus expanded globally resulting in larger and more 
frequent epidemics. West Nile virus (WNV) was introduced into North America in 1999 
with epidemics and epizootics of severe neurologic disease in humans, horses, and birds. 
The resurgence or emergence of these pathogens necessitates a reassessment of the public 
health infrastructure and its ability to implement surveillance, prevention, and control 
programs for medically important arboviruses (Gubler, 2002).   
Classification 
 Currently, there are over 534 viruses registered in the International Catalogue of 
Arboviruses (Karabatsos, 1985). Only 134 of these registered viruses have caused 
documented disease in humans (Karabatsos, 1985). Arboviruses are taxonomically 
diverse and belong to eight virus families and fourteen genera. The arboviruses that are 
medically important for humans belong to three virus families: the Bunyaviridae,  
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Figure 2-1 Global distribution of the major arboviral encephalitides.   
Arboviruses have established enzootic or endemic foci on every continent, 
where the virus cycles between primary avian or rodent hosts and primary 
arthropod vectors. In 1999, West Nile virus emerged in the western 
hemisphere in New York City, effectively escaping its previous restriction 
to the eastern hemisphere. 
 
 
Figure appears courtesy of the Centers for Disease Control & Prevention (CDC, 2005a) 
Adapted by author to show the emergence of WN in the western hemisphere. 
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Flaviviridae, and Togaviridae (Gubler & Roehrig, 1998).  The Bunyaviridae and  
Togaviridae families will briefly be described, emphasizing the viruses vectored by 
arthropods. The Flaviviridae family will be covered in greater detail in the next section. 
Bunyaviridae (genus Bunyavirus) 
 Recognized as the largest and most diverse arboviral family, the Bunyaviridae has 
at least 248 identified viruses belonging to five genera (Gubler, 2001), including the 
Bunyavirus, Phlebovirus, Nairovirus, Tospovirus, and Hantavirus genera (CDC, 2004a).  
The Bunyaviridae are single stranded negative-sense RNA viruses, where all genera 
include viruses transmitted by arthropods, with the exception of hantavirus, which is 
rodent-borne (CDC, 2004a).  First classified as California serogroup arboviruses, the 
Bunyavirus genus has at least 167 arbovirus members found on five continents. 
California encephalitis virus (CEV), La Crosse virus (LACV), Jamestown Canyon virus 
(JCV), and Snowshoe hare virus (SSHV) are the medically important arboviruses found 
in North America (Calisher, 1994; Schmaljohn and Hooper, 2001).  
 For example, LACV is a mosquito-borne pathogen that maintains an enzootic life 
cycle with the tree-hole mosquito, Aedes triseriatus that feeds on Eastern gray squirrels 
and chipmunks, which serve as amplifying hosts for LACV. Mosquito LACV infection is 
lifelong and mosquitoes can become dually infected with other bunyaviruses allowing for 
development of intra-genus reassortants (Bennett et al, 2007).  LACV has been identified 
in several Midwestern and Mid-Atlantic states, with an average of 75 cases of LAC 
encephalitis reported to the CDC each year (CDC, 2005b). While California serogroup 
arboviruses (other than LACV or CEV) have previously been isolated in Florida (Lewis 
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et al, 1965; Quick et al, 1965; Bigler et al, 1975), they are not significant human 
pathogens in the state. 
Togaviridae (genus Alphavirus) 
 The Togaviridae family was restructured in 1984 (Karabatsos, 1985) and now 
contains only two genera, Alphavirus and Rubivirus.  Rubella virus is the sole member of 
the Rubivirus genus and is more commonly known as German measles, which is 
transmitted person-to-person (Schlesinger and Schlesinger, 2001; Chantler, Wolinsky and 
Tingle, 2001). In contrast, the genus Alphavirus includes 28 viruses (Gubler, 2001) and 
were initially classified as serologic Group A arboviruses (Casals and Brown, 1954).  The 
alphaviruses are all transmitted by arthropods, are restricted geographically in 
distribution, and share a common replication strategy. The pathogenic alphaviruses can 
be divided into two groups, those causing human diseases characterized by encephalitis, 
usually found in the New World (e.g.Eastern Equine Encephalitis virus [EEEV]), and 
viruses that cause arthritis and rash, found primarily in the Old World (e.g. Chikungunya 
virus) [Griffin, 2001].  The emergence of West Nile virus in the western hemisphere has 
raised concerns that Chikungunya virus may be introduced into the United States by 
infected travelers returning from Africa, India, or Asia, where the virus has caused 
epidemics. A recent study found that infected travelers had high titers of Chikungunya 
viremia, sufficient to potentially infect Aedes aegypti and Aedes albopictus mosquitoes 
and could facilitate local transmission in the United States (Lanciotti et al, 2007). 
 Alphaviruses can be transmitted by a wide range of mosquito species, but each 
virus typically has a preferred mosquito vector for the enzootic cycle that uses either 
birds or mammals as primary amplifying hosts (Scott and Weaver, 1989). Viruses which 
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use avian amplifying hosts, such as EEE complex viruses in North America, may be more 
efficiently dispersed over wide geographic regions, enhancing gene flow, and thus far 
have remained highly conserved. On the other hand, viruses which utilize mammalian 
enzootic hosts, such as Venezuelan equine encephalitis virus (VEEV) and strains of 
EEEV which amplify in rodent hosts in the tropics, have a smaller range of dispersal due 
to limited mobility of the host, which has resulted in genotypic evolution within multiple 
geographic foci in South America (Cilnis et al, 1996; Weaver et al, 1997). 
 Recombination between alphaviruses has been difficult to achieve in vitro, but is 
estimated to have occurred naturally thousands of years ago when a Sindbis-like virus 
and EEEV recombined to form the Western Equine Encephalitis complex viruses 
(Western Equine Encephalitis virus (WEEV), Highlands J virus (HJV), and Fort Morgan 
virus). In Florida, surveillance programs have found that EEEV and HJV are enzootic 
throughout the region, with EEEV an important human pathogen (Bigler et al, 1976; 
Stark and Kazanis, 2004, 2005, 2006). 
Flaviviridae (genus Flavivirus)  
 The Flaviviridae family (from the Latin flavus or “yellow” referring to the 
prototype yellow fever virus) has three genera, including the Flavivirus, Pestivirus, and 
Hepacivirus.  Pestiviruses are animal pathogens (e.g. bovine viral diarrhea virus) and the 
human pathogen hepatitis C virus is the only member of the hepaciviruses (Lindenbach 
and Rice, 2001). The genus Flavivirus includes about 70 viruses (Gubler, 2001; King et 
al, 2007), which were originally classified as serologic Group B arboviruses (Casals and 
Brown, 1954).  Forty of these flaviviruses are significant human pathogens, including 
Japanese encephalitis virus (JEV), the 4 serotypes of dengue virus (DENV 1-4), yellow 
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fever virus (YFV), tick-borne encephalitis virus (TBEV), St. Louis encephalitis virus 
(SLEV) and West Nile virus (WNV) [Lindenbach and Rice, 2001].  These viruses are 
arthropod-borne and transmitted to vertebrates through infected mosquitoes or ticks 
(Chambers et al, 1990).  Yellow fever virus was the first flavivirus isolated (1927), the 
first filterable agent proven to cause human disease and the first virus proven to be 
transmissible by an arthropod vector (Burke and Monath, 2001). 
 Flaviviruses can be categorized into antigenic complexes and subcomplexes 
based on serological criteria or into clusters, clades and species based on molecular 
phylogenetics (Lindenbach and Rice, 2001).  The Japanese Encephalitis (JE) antigenic 
serocomplex includes 10 arboviruses, including the medically important flaviviruses in 
the Americas.  The American pathogenic JE viruses with mosquito vectors include St. 
Louis encephalitis virus, West Nile virus and Rocio virus. JE serocomplex viruses 
demonstrate extensive antigenic cross-reactivity with family members, often 
complicating diagnosis of disease (Chambers et al, 1990). However, only SLEV and 
WNV are enzootic to the United States (Kramer and Chandler, 2001). Table 2-1 lists the 
medically important viruses of the Flavivirus genus, including geographic distribution, 
primary vertebrate hosts and associated clinical syndromes. 
Virus Life Cycle 
 Flaviviruses are able to enter cells via interactions between the viral surface 
glycoprotein and several cellular receptors. The immune response may enhance viral 
uptake into cells if viral particles are opsonized with non-neutralizing antibodies and bind 
to cells expressing Fc receptors (antibody-dependent enhancement) [Lindenbach and 
Rice, 2003].  The virus enters a cell by receptor-mediated endocytosis, mediated by the  
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Table 2-1 Medically Important Vector-borne Flaviviruses 
Flaviviruses pose a significant risk to the health of millions of people around that world that live in regions with 
endemic, enzootic, or epidemic transmission of these arboviruses.  This table summarizes characteristics of each virus, 
including the clinical disease frequently associated with infection, the vector and primary vertebrate host integral to the 
transmission cycle, and geographic distribution. 
 
 
Medically Important Vector-borne Flaviviruses 
 
Virus Vector Vertebrate Host Human Disease Geographic Distribution 
 
Dengue 1-4 
Yellow fever 
Japanese encephalitis 
West Nile 
St. Louis encephalitis 
Rocio 
Murray Valley encephalitis 
Kyasanar Forest disease 
Omsk hemorrhagic fever 
Tick-borne encephalitis 
 
 
Mosquitoes 
Mosquitoes 
Mosquitoes 
Mosquitoes 
Mosquitoes 
Mosquitoes 
Mosquitoes 
Ticks 
Ticks 
Ticks 
 
Humans, primates 
Humans, primates 
Birds, pigs 
Birds 
Birds 
Birds 
Birds 
Primates, rodents, camels 
Rodents 
Birds, rodents 
 
FI, HF 
FI, HF 
FI, ME 
FI, ME 
FI, ME 
FI, ME 
FI, ME 
FI, HF, ME 
FI, HF,  
FI, ME  
 
Worldwide (tropics) 
Africa, South America 
Asia, Pacific 
Africa, Asia, Europe, Americas 
Americas 
South America 
Australia 
India, Saudi Arabia 
Asia 
Asia, Europe, North America 
   FI – Febrile illness, HF- hemorrhagic fever, ME – Meningoencephalitis 
 
Table adapted from Gubler, 2007 
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virion envelope protein and plasma membrane receptors (Chambers et al, 1990) and is 
internalized into clathrin-coated pits (Lindenbach and Rice, 2003). Low pH induces 
fusion of the virus and host cellular membrane to release the virus nucleocapsid. 
Nucleocapsid uncoating occurs in the host cytoplasm for release of the viral genome. 
Transcription and translation of the viral genome produces proteins that lead to 
replication of the virus and assembly of new viral particles (Lindenbach and Rice, 2003). 
The flavivirus life cycle is illustrated in Figure 2-2. 
Molecular Biology 
 Flaviviruses are small, lipid-enveloped RNA viruses approximately 50 nm in 
diameter with a 30 nm core containing a single positive-strand genomic RNA. Flavivirus 
virions contain a nucleocapsid (30 nm core) surrounded by a host membrane derived lipid 
bilayer. This lipid surface contains the viral envelope (E) and membrane (M) “spike” 
proteins (Chambers et al, 1990).  The major antigenic determinant is the E glycoprotein, 
which mediates binding and fusion of virus entry into a cell.  The M protein is a 
proteolytic fragment of the precursor membrane (prM) protein and is produced during 
maturation of nascent viral particles. Removal of the lipid envelope (with nonionic 
detergents) exposes the nucleocapsid, which contain capsid (C) proteins and the genomic 
RNA (Lindenbach and Rice, 2003). 
Genome Structure 
 The genome consists of single-stranded positive sense RNA of approximately 
11,000 nucleotides. This genomic RNA is infectious and appears to be the only virus-
specific mRNA molecule in infected cells (Chambers et al, 1990). Flaviviral genomic 
RNAs have type I caps (m7GpppAmpN2) at their 5’ ends and are not 3’ polyadenylated  
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Figure 2-2 Life cycle of Flaviviruses.  
Flaviviruses enter a cell through receptor-mediated endocytosis, where 
uncoating of the nucleocapsid occurs in the cytoplasm.  This releases the 
viral genome, which allows translation of the polyprotein followed by 
replication of the viral genome, virus assembly and maturation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Used with permission (Lindenbach and Rice, 2001) 
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(unlike cellular mRNAs). Positive strand RNA viruses do not make subgenomic mRNAs.   
Instead, the genomic RNA is used directly as mRNA for the translation of both structural 
and nonstructural proteins followed by replication of the RNA genome (Ball, 2001). 
Figure 2-3 diagrams the replication scheme used by single stranded positive-sense RNA 
flaviviruses. 
The most notable feature of the flaviviral genome is the presence of a single long 
open reading frame (ORF) of more than 10 kilobases (kb). Flanking the long ORF are 5’- 
and 3’-noncoding (untranslated) regions of approximately 100 bases and 400-700 bases, 
respectively. Translation of the long ORF produces a large polyprotein which is cleaved 
both co- and post-translationally into 10 proteins, divided into 3 structural and 7 
nonstructural elements. Figure 2-4 illustrates the genome structure, with the structural 
genes located at the 5’ end and the nonstructural genes at the 3’ end of the genome in 
order 5’-(C-prM-E-NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5)-3’ (Chambers et al, 1990; 
Lindenbach and Rice, 2003).   
 Structural Elements 
Three structural proteins are encoded by the N-terminal region of the flaviviral 
ORF (approximately 25% of the genome beginning at the 5’ end) and include the 
precursor/membrane [prM(M)] , capsid (C), and envelope (E) proteins. Membrane 
proteins are responsible for the maturation of immature viral particles into infectious 
forms (Lindenbach and Rice, 2001). The glycoprotein precursor of the M protein, prM 
has chaperone-like properties and is needed for proper folding of the envelope protein. In 
the secretory pathway, immature virus particles are converted into mature virions with 
cleavage of the prM protein into pr and M fragments by Golgi apparatus furin or furin-  
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Figure 2-3 Replication Scheme of Single Stranded Positive Sense RNA Viruses 
 The flavivirus genome is a single stranded positive sense RNA, which is 
infectious. A positive sense ssRNA genome is infectious because once it is 
uncoated in the cell (Step 1), the virus delivers the genomic RNA to 
cellular ribosomes and initiates the infection cycle with translation. The 
genomic RNA is utilized directly as the mRNA for translation of both 
structural and nonstructural proteins (Steps 2 & 3).  The nonstructural 
proteins catalyze replication with a virus RNA dependent RNA 
polymerase (Step 4) and the synthesis of antigenomic RNA (Step 5).  
Replication creates more genomic RNA for further translation of proteins 
(Steps 6 & 7) and for assembly with structural proteins to produce progeny 
virus (Step 8) [Ball LA, 2001]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    
 
Figure adapted from Ball (2001) 
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Figure 2-4 Flavivirus Genome Organization 
The flavivirus genome consists of single-stranded positive sense RNA of 
approximately 11,000 nucleotides, with a single long open reading frame 
(ORF). The structural genes are encoded at the 5’ end of the genome for 
the capsid (C), membrane (M), and envelope (E). Seven nonstructural 
genes are located downstream of the structural genes for NS1, NSA/B, 
NS3, NS4A/B, and NS5.  The ORF is flanked by noncoding (NC) regions 
at the 5’ and 3’ ends. 
 
 
Figure adapted from Chambers, Hahn, Galler, & Rice (1990) 
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like enzymes. Thus, the pr fragment is believed to stabilize E and prevent it from  
rearranging in the early secretory pathway. After cleavage, pr is secreted and the M 
protein is found in mature virions (Lindenbach and Rice, 2003). 
The capsid protein is highly basic with charged residues that mediate RNA 
interaction, with a signal peptide C-terminal hydrophobic anchor for translocation of the 
prM to the endoplasmic reticulum (ER). This hydrophobic anchor is cleaved from the 
mature capsid protein by viral serine proteases (Lindenbach and Rice, 2003). Mature C 
proteins are then integrated to form structural nucleocapsids (Lindenbach and Rice, 
2001). 
 The envelope (E) protein is the major structural and surface protein of the 
flaviviral virion, which mediates binding and membrane fusion (Chambers et al, 1990; 
Lindenbach and Rice, 2003).  The envelope protein is also the main target for 
neutralizing antibodies (Chambers et al, 1990). The envelope region is highly conserved, 
although it has been suggested that viral mutations in this region may impact virus 
biology and host immune response to the virus (Twiddy and Holmes, 2003). As such, the 
envelope region has been intensively studied for phylogenetic and molecular 
epidemiology purposes to identify alterations in flaviviral envelope proteins that could 
impact disease potential. Consequently, the majority of flavivirus published gene 
sequences in GenBank are E gene sequences (Twiddy and Holmes, 2003). 
 Nonstructural Elements 
 Seven nonstructural proteins are encoded by the long ORF of the flaviviral 
genome (the remaining 75% of the genome), including NS1, NS2A & NS2B, NS3, NS4A 
& NS4B and NS5.  While they are not structural elements, these proteins still have 
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important functions for replication, translation and packaging of the virion, and 
attenuation of host antiviral responses (Samuel and Diamond, 2006). It should be noted 
that a complete understanding of many of these processes is still unknown (Chambers et 
al, 1990; Lindenbach and Rice, 2003).    
 The NS1 protein is retained in cells, but also has cell-surface and extracellular 
forms (Lindenbach and Rice, 2003). Antibodies to this protein are elicited in flaviviral 
infections, which also have significant complement fixing activity (Chambers et al, 
1990).  NS1 is also important for RNA replication, virus production and has cofactor 
activity for the viral replicase (Samuel and Diamond, 2006).  NS2A is membrane 
associated and cleaved from NS1 to become an important determinant for infectious 
particle production, as it interacts with NS3 for virion assembly and may coordinate the 
shift from RNA packaging to RNA replication with NS3, NS5 and the 3’ UTR. NS2B is a 
small, membrane-associated protein that is a necessary cofactor for the serine protease in 
NS3, and the two proteins form a complex (NS2B-NS3) [Lindenbach and Rice, 2003].  
 NS3 is the second largest viral protein and is highly conserved among flaviviruses 
(Chambers et al, 1990).  NS3 is a multifunctional protein with enzymatic activities that 
are involved in RNA replication and polyprotein processing (strategy that allows for 
synthesis of multiple protein products from a single RNA genome) [Lindenbach and 
Rice, 2003]. The N-terminal region of NS3 has been determined to be a serine protease 
(in conjugation with NS2B) that cleaves most of the nonstructural proteins for 
polyprotein processing.  In addition, the C-terminal region of NS3 has been implicated in 
RNA replication with significant homology to RNA helicases (enzymes responsible for 
unwinding RNA duplexes).  The C-terminal region also encodes RNA triphosphatase 
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(RTPase) activity that may be involved in dephosphorylating genomic RNA at the 5’end 
prior to cap addition.  NS4A and NS4B are small hydrophobic proteins with unknown 
functions, although both may play some role in RNA replication (Lindenbach and Rice, 
2003). 
 The NS5 protein is the largest and most highly conserved flaviviral protein 
(Chambers et al, 1990) and is important to RNA replication of the virus. At the N-
terminus, NS5 has homology to S-adenosyl-methionine (SAM)-dependent 
methyltransferases.  This SAM-methyltransferase activity indicates that NS5 is involved 
in formation of the 5’ cap. Deletions in SAM binding regions have been proven lethal for 
virus replication (Lindenbach and Rice, 2003).  In contrast, the C-terminal region of NS5 
has polymerase activity with significant homology to RNA-dependent RNA polymerases. 
NS5 has been shown to function as the RNA-dependent RNA polymerase (RdRp), which 
is critical for RNA replication (Lindenbach and Rice, 2003). 
Phylogeny and Evolution 
 Phylogeny can be defined as the evolutionary relationship between organisms, 
where each organism’s phylogeny reflects the evolutionary branch that led up to the 
organism and has taxonomic significance. One advantage of the use of nucleotide 
sequence data in virus taxonomy is that phylogeny can more readily be inferred (Mayo 
and Pringle, 1998). Previously, arboviruses were classified into groups based on their 
antigenic characteristics in hemagglutination inhibition assays (Casals and Brown, 1954) 
and cross-neutralization tests (de Madrid and Porterfield, 1974). Over the last 20 years, 
significant advances in biomedical technology have produced more sophisticated, 
discriminatory molecular methods and instruments (e.g. polymerase chain reaction, real-
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time thermal cyclers and nucleotide sequencers) for the typing of microorganisms.  As a 
result, the classification of arboviruses is now routinely based on phylogeny from 
nucleotide sequence analysis rather than traditional antigenic techniques for phenotypic 
characterization to identify new strains or to re-classify previous isolates (Calisher et al, 
2001).  
 Phenotypic characterization is important to assess relative fitness of a newly 
isolated virus (in vertebrates and arthropods) and its disease potential, yet these 
“classical” methods are difficult to standardize, less sensitive to variants, as well as less 
sophisticated, slower and less specific than molecular techniques. Plus, it is usually 
necessary to isolate and handle the infectious agent. However, these classical techniques 
have become obsolete in many virology laboratories due to the tremendous diagnostic 
power of molecular techniques (Calisher et al, 2001).  Rapid genotypic characterization is 
possible from the nucleic acid only and has provided researchers with insight into 
arbovirus replication, important elements for virion assembly and processing of the 
genome, and molecular targets for vaccine development and drug discovery (Lindenbach 
and Rice, 2003). 
 Prior to 1984, flaviviruses were classified as members of the Togaviridae based 
on traditional antigenic methods (Karabatsos, 1985).  Phylogenetic analysis of flaviviral 
genes and studies of viral structure and replication found that flaviviruses were an 
evolutionary distinct group from the Togaviridae.  Consequently, these viruses were 
reclassified in 1984 as a separate family, the Flaviviridae (Karabatsos, 1985). Molecular 
phylogenetics has allowed for the classification of yellow fever virus, which lacks close 
relatives (Burke and Monath, 2001). 
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 In 1998, an extensive molecular phylogenetic study of the Flavivirus genus was 
conducted by the CDC to establish the genetic relationship among these arboviruses as 
compared to the existing serological classification method (Kuno et al, 1998).  The study 
was motivated by the discovery of new arboviruses that were not defined or serologically 
classified, yet were described as flaviviruses in the literature. In addition, classification 
through molecular phylogeny could be used for viruses that cannot be grouped by 
serology (i.e. yellow fever virus) [Kuno et al, 1998].  
 A total of 71 viruses were typed based on a 1 kb portion of the NS5 gene. An 
unrooted neighbor-joining phylogram identified a monophyletic tree with 14 flaviviral 
clades (group of viruses with 69% or higher pairwise nucleotide sequence identity), with 
3 clusters separated into:  1) mosquito-borne viruses, 2) tick-borne viruses and 3) no 
known vector viruses (cluster definition: bootstrap support greater than 95% and host-
vector association).  An updated smaller version of this phylogram (n=35) is shown in 
Figure 2-5 (Kuno and Chang, 2005). The CDC study created objective criteria for the 
classification of flaviviruses based on the NS5 gene, which agree with previous flaviviral 
phylograms based on the envelope gene. The authors noted that phylograms based on 
short sequences (<300 bases) can be different from those created with longer sequences, 
and caution should be used when interpreting such phylograms (Kuno et al, 1998).  
 RNA viruses have the capacity for rapid evolution due to their short replication 
times, high mutation rates (RNA polymerases lack proof-reading ability) and large 
population sizes in comparison to DNA viruses (Drake and Holland, 1999).  However, 
rapid rates of evolution have not been observed in arboviruses (Weaver et al, 1992; Cilnis 
et al, 1996; Jenkins et al, 2002). Evolutionary pressures on flaviviruses are predominately  
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Figure 2-5 Phylogeny of the Flavivirus Genus 
Phylogram of flaviviruses (n=35) generated using a neighbor-joining 
inference method (MEGA). The number at each node indicates % branch 
support by bootstrap sampling with 500 replicates. Phylogram is based on 
the complete RNA-dependent RNA polymerase domain of the NS5 gene.   
The mosquito-borne flaviviruses emphasized in this review include WNV, 
SLEV, DENV 1-4, YFV, and JEV. 
 
 
 
Used with permission, Kuno and Chang (2005) 
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applied by arthropod and avian environments, which have been hypothesized to limit 
rapid evolution by alternate cycles of viral replication in arthropod vectors and vertebrate  
hosts. This implies that compromises in replicative ability are made by virus populations 
in both vertebrate and arthropod hosts (Weaver et al, 1992 & 1994).   
 Homologous recombination is a process of physical rearrangement that can occur 
between two DNA strands to create genetic diversity and may confer evolutionary 
advantages to an organism. Recently, RNA recombination has also been demonstrated in 
a few RNA viruses, including polio virus and Western Equine Encephalitis virus (WEEV 
a recombination of EEEV and Sinbis virus). These findings bely the traditional 
assumption that evolution in arboviruses is clonal with diversity generated through the 
accumulation of mutational changes over time. Subsequently, homologous recombination 
was demonstrated in the Flaviviridae for all four serotypes of dengue virus (Holmes et al, 
1999; Tolou et al, 2001) and St. Louis encephalitis virus (recombination between 
Argentina and United States strains of SLEV) [Twiddy and Holmes, 2003]. Note: the 
recombination identified for SLEV may be a spurious result due to the removal of the 
envelope sequence from the GenBank database (personal communication, L. Kramer). 
The impact of recombination on the evolution of virus taxa will largely depend on the 
level of difference between the viruses that undergo a recombination event. Currently, 
recombination in flaviviruses has been identified only in very closely related viruses, 
leading to low level sequence divergence (Calisher and Gould, 2003). 
 Genetic diversity can also be generated through mutation.  There are two basic 
categories of mutation, base substitution and deletion/insertion mutations.  Base 
substitution mutations result in the replacement of one nucleotide with a different 
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nucleotide in a nucleic acid sequence.  Deletion or insertion mutations involve the 
deletion or insertion of one or more nucleotides in a nucleic acid sequence. Both types of 
mutation can occur in coding (impact amino acid sequence of a protein) or non-coding 
regions of the genome.  In a coding region, base substitution mutations may be silent (no 
change in amino acid sequence), missense (replacement of wild type amino acid with 
another residue), or nonsense (resulting in premature termination of translation during 
protein synthesis). Similarly, deletion or insertion of multiples of three nucleotides results 
in removal or addition of one or more amino acids in a protein sequence. Deletions or 
insertions not in multiples of three can result in a translational reading frame shift.  In 
general, frameshift or nonsense mutations may inactivate a gene whereas missense 
mutations may result in subtle phenotypic differences (Condit, 2001). 
Phylogenetic studies are an important tool to elucidate the evolution of viruses 
and are especially valuable to identify the origin and spread of emerging or re-emerging 
diseases (Gaunt et al, 2001). In the family Flaviviridae, most phylogenetic studies imply 
that flaviviruses originated in Africa and then spread to other continents. One example is 
the trans-Atlantic dispersal of yellow fever virus that likely coincided with transportation 
of mosquitoes and people from Africa to the Americas on slave ships (Gould et al, 1997; 
Gould et al, 2003).  It has been estimated that flaviviruses diverged from an ancestral 
virus sometime in the past 5,000 to 10,000 years (Zanotto et al, 1996b), such that the 
evolution of this genus likely followed the ending of the last ice age and accompanied the 
development of human civilization and farming practices (Gould et al, 2003). 
Additional studies indicate that the evolution of flaviviruses is largely driven by 
arthropod vectors.  Two theories of evolution are widely hypothesized: 1) the mosquito 
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and tick-borne viruses evolved from a common ancestor, with the “no known vector” 
viruses entering into arthropod transmission cycles.  However, a few flaviviruses are 
competently transmitted by both vectors (e.g. WNV, SLEV and YFV have been found in 
ticks). And, non-vector viruses cannot be cultured in mosquito cell lines. As such, 
another theory has been proposed: 2) flaviviruses may have instead evolved from the “no 
known vector” to tick-borne and then into the mosquito-borne group (Burke and Monath, 
2001). Estimates of the relative degree of amino acid divergence between tick-borne and 
mosquito-borne flaviviruses concluded that mosquito-borne flaviviruses evolved 2.5 
times faster than tick-born viruses. Physiologically, these results can be explained by the 
life cycles for ticks versus mosquitoes, where ticks have a long life span and few blood 
meals as compared to the short life span and multiple blood meals of mosquitoes (Zanotto 
et al, 1995).  As a result, further research is needed to elucidate the evolution of 
flaviviruses and identify which group (“no known vector”, tick-borne or mosquito-borne) 
is the most divergent (Gould et al, 2003). 
A combination of constraints, including arthropod vectors, vertebrate hosts and 
ecology plus human activity, has determined the evolution, dispersal patterns, and 
epidemiological characteristics of flaviviruses. For instance, flavivirus phylogenetic 
relationships have been shown to correlate to biogeography (Old World vs. New World), 
disease association (encephalitic vs. hemorrhagic illness) and arthropod vectors 
(mosquito-borne clade further subdivided into Aedes sp. and Culex sp. clades) (Gaunt et 
al, 2001).  Therefore, phylogenetic analysis will continue to provide insight into virus 
taxonomy and further improve our knowledge of virus relationships, as well as the origin 
and spread of diseases of major public health significance. 
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Important Biologic Characteristics 
 Hemagglutination can be described as the clumping together of erythrocytes 
(RBCs) to form interlocking matrices due to the binding of agglutinin (protein) molecules 
on the surface of each cell. Flaviviruses have the ability to hemagglutinate avian RBCs, 
especially goose and chicken erythrocytes, which continues to be a valuable method for 
virus quantification, and for measuring antiviral antibody by the inhibition of 
hemagglutination (HAI) test (Clarke and Casals, 1958).  
Flaviviruses produce cytopathic effects and form plaques in a variety of cell 
cultures, including vertebrate, reptilian and arthropod derived types. In contrast to 
alphaviruses, flaviviruses replicate slowly in most vertebrate cell lines, where SLEV has 
an 11 hour latent period and reaches peak titer at 28 hours (in BHK-21 cells) [Burke and 
Monath, 2001].   
Pathogenesis and Pathologic Changes 
 Three pathogenic patterns have been described in flaviviral encephalitis: 1) fatal 
encephalitis (preceded by early viremia, extensive extraneural replication); 2) subclinical 
encephalitis (preceded by low viremia, late infection of the brain, and viral clearance); 
and 3) inapparent infection (trace viremia, limited extraneural replication, no 
neuroinvasion). The course of infection and prognosis is influenced by both virus and 
host factors. Virus strains may differ in virulence and neuroinvasiveness, or both.  Host 
factors that impact pathogenesis include age, sex, immunocompromised status, and 
genetic susceptibility (Burke and Monath, 2001). 
Flaviviruses are commonly injected into the host through the bite of an infected 
mosquito and cross-infection can occur from adjacently feeding mosquitoes, which may 
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increase transmission to the host.  Mosquito saliva reduces the local immune response 
and promotes the success of viral infection. Additional transmission routes have been 
reported for West Nile virus, and include transplacental and breast milk transmission, 
blood transfusion and organ transplantation associated infections, as well as urinary 
excretion of the virus (human) and experimental oral transmission (birds) (King et al, 
2007).  
Flaviviruses are pleiotropic and infect a wide range of cell types (King et al, 
2007).  After inoculation into the skin, virus may be taken up and infect Langerhans cells 
in the skin (e.g. dengue virus). Langerhans cells could then transport the virus and infect 
lymph nodes draining the inoculation site. Virus replication in lymph nodes allows the 
virus to be carried throughout the lymphatics to the thoracic duct and into the 
bloodstream. A substantial plasma viremia (existence of virus in the bloodstream) seeds 
extraneural tissues, including skeletal and smooth muscle, connective tissue, 
myocardium, and endocrine and exocrine glands. These tissues support additional virus 
replication and release of virus into the bloodstream (Burke and Monath, 2001). 
 The exact mechanism by which encephalitic flaviviruses enter the central nervous 
system (CNS) is unclear. High viremia, development of brain infection and appearance of 
viral antigen in nervous tissue leads to the conclusion of hematogenous spread into the 
CNS.  Artificial disruption of the blood-brain barrier (by underlying infection) may also 
lead to encephalitis and neuroinvasion, although olfactory neuronal infection has also 
been suggested as a route of neuroinvasion. Once the virus gains entry to the CNS, it 
spreads rapidly (Burke and Monath, 2001).  
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 Pathologic changes in the CNS of humans with flaviviral encephalitis include 
neuronal and glial damage, inflammation, nodule formation, and cerebral interstitial 
edema.  After recovery from acute encephalitis, residual neurologic deficits may range up 
to 12 through 67 years post infection (Japanese encephalitis virus) [Burke and Monath, 
2001].  
Antigenic Characteristics 
 Flaviviruses can be grouped based on antigenic classification schemes derived 
from hemagglutination inhibition (HAI) and neutralization assays.  Currently, flaviviruses 
can be separated into eight antigenic complexes, including Modoc, Rio Bravo, TBE, 
Dengue, JE, Tyuleniy, Ntaya and Uganda S.  The envelope protein is the viral 
hemagglutinin and primary target for neutralizing antibodies.  In addition, monoclonal 
antibodies have identified differences at the epitope level that link these antigenic 
complexes (Burke and Monath, 2001).  Recent classification schemes of flaviviruses 
based on phylogenetic analyses strongly parallel earlier relationships identified in 
flaviviral family members based on antigenic methods (Calisher and Gould, 2003). 
The nonstructural protein NS1 is expressed on the surface of infected cells and 
secreted.  This antigen has been shown to elicit an immune response; however, antibodies 
to NS1 are non-neutralizing and do not react with the virion.  Despite these somewhat 
contradictory findings, NS1 antibodies have a protective effect such that passive transfer 
of these antibodies can experimentally protect animals from infection with dengue and 
yellow fever viruses.  Studies suggest that the protective role of NS1 may be a function of 
its recognition by the immune system and subsequent destruction of infected cells (Burke 
and Monath, 2001). 
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Immune Response 
 E protein, NS1, and NS3 are the most immunogenic proteins during a flavivirus 
infection (Hill et al., 1993). Envelope proteins are the major surface proteins considered 
to be an important factor in receptor binding and membrane fusion with host cells. The E 
protein stimulates neutralizing antibody response and changes in this protein have been 
shown to affect WNV virulence (Hayes and Gubler, 2006).  Active immunization with 
NS1 has been protective for animals challenged with homologous flaviviruses (Chambers 
et al, 1990). 
 Adaptive cellular and humoral immune responses induced by arboviral infection 
are important in recovery from infection. Virus-specific immunoglobulin M (IgM) 
antibodies are produced very early in the course of disease, usually detectable in serum 
within 3 to 4 days of infection, and are the targeted molecules for diagnosis of infection. 
IgM antibodies are generally not long lasting, often diminishing within 14 to 30 days, and 
their presence denotes a recent infection (Olson et al, 1991; Martin, 2000). Yet, IgM 
antibodies have been detected in sera after 12 months for WNV encephalitis patients that 
have survived infection (36%). Thus, detectable IgM may sometimes reflect a past 
infection (Hayes et al, 2005b). Conversely, immunoglobulin G (IgG) antibodies are first 
detectable in serum 7 to 14 days after infection (Calisher et al, 1986c; Olson et al, 1991), 
but can remain at high levels for years, especially after secondary exposure to the same, 
or closely related, infectious agent (Figure 2-6). 
 Appearance of antibody correlates with declining viremia as well as neutralization 
of virus infectivity. The humoral antibody response not only provides protection from 
flaviviral disease, but also allows for early serologic antibody testing to diagnose the  
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Figure 2-6 Theoretical Primary and Secondary Antibody Response after 
Exposure to an Infectious Agent 
Within 3-4 days, IgM antibodies are quickly produced but decline as IgG 
antibodies rise, which can remain elevated for months to years.  Secondary 
exposure to the same antigen rapidly results in high levels of IgG. 
        
 
 
 
 
 
 
 
 
Figure adapted from Immune Response by Dr. Thomas Terry. Available from 
URL: http://sp.uconn.edu/~bi102vc/102f01/terry/immunity.html 
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infection (Lindenbach and Rice, 2001). This immune response prevents reinfection with 
the same virus strain in most mammalian hosts, and may promote herd immunity in a 
population (Kuno and Chang, 2005).  A live-attenuated virus vaccine (17-D strain) is 
available for yellow fever virus for humans. In addition, inactivated virus vaccines are 
available for Japanese encephalitis and tick-borne encephalitis viruses (Lindenbach and 
Rice, 2001). For WNV, two vaccines are available to immunize horses: an inactivated 
virus vaccine and a recombinant vaccine to express WNV antigens (using canarypox 
virus).  Currently, several WNV vaccine candidates are in animal and clinical studies for 
development of a human vaccine (Hayes et al, 2005a).  
 
West Nile Virus 
Discovery 
 In 1937, West Nile virus was first isolated from the blood of a febrile woman 
participating in a malaria study in the West Nile region of Uganda (Smithburn et al, 
1940). Thirteen years later, WNV isolates were obtained from the blood of three 
apparently healthy children in Egypt (Melnick et al, 1951). Since the 1950s, hundreds of 
WNV isolates have been obtained over a wide geographic region and from humans, 
birds, and mosquitoes (Hayes, 2001). Researchers have shown that WNV is antigenically 
related to two other arboviruses known to cause encephalitis, St. Louis encephalitis virus 
(SLEV) and Japanese encephalitis (JE) virus (Smithburn, 1942).  In 1999, WNV 
dramatically expanded its geographic range (previously limited to the Old World or 
Eastern Hemisphere) to include the New World with its emergence in North America in 
New York City (Davis et al, 2005). 
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Phylogeny & Evolution 
 West Nile virus can be grouped into two distinct genetic lineages (I and II) on the 
basis of signature amino acid substitutions or deletions in the envelope protein (Brinton, 
2002).  Lineage I strains are found in Africa, Europe, Asia, Australia, and the Americas.  
All outbreaks of human and equine disease have been associated with WNV lineage I 
strains, whereas lineage II strains are not associated with clinical disease (Hayes et al, 
2005a).  Lineage II strains have only been isolated in sub-Saharan Africa and 
Madagascar, where they cause endemic enzootic infections (Brinton, 2002). 
 Lineage I strains are further subdivided into three clades: 1a, 1b (Kunjin), and 1c 
(Indian) [Lanciotti et al, 2002]. The isolates in clade 1a include the strains from the 
United States that are highly virulent, whereas other lineage I clades (and lineage II) 
comprise both virulent and attenuated strains.  These differences in pathogenicity are not 
clearly understood, but may be related to nucleotides coding for specific regions in the 
prM, E, or nonstructural proteins. WNV strains in the United States are closely related to 
isolates obtained in Israel during 1998 (99.7% nucleotide sequence homology) and 
indicate that the US strains originated in the Middle East (Hayes et al, 2005a).  The North 
American strain of the virus isolated in New York is more virulent in American crows 
than strains from Kenya and Australia (where Kunjin virus has been identified as a 
subtype of WNV) [Langevin et al, 2005]. 
 In the United States, phylogenetic analysis reveals that WNV was successfully 
introduced only once (into New York City, NY99 strain) and has remained highly 
conserved in its spread across the continent (Kramer et al, 2007). However, two genetic 
variants of the North American strain have recently emerged.  Both variants were isolated 
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in Texas in 2002, where the major variant differed from the NY99 strain by 0.18% in the 
nucleotide sequence and the minor variant by 0.35% of nucleotides (Hayes et al, 2005a).  
This second genotype of WNV is referred to as WN02, since it was recognized as a 
significant entity that year (Snapinn et al, 2007). In 2003, attenuated strains of this 
genotype were isolated from birds in Texas and Mexico characterized by smaller plaque 
sizes and reduced neuroinvasiveness (as compared to the NY99 strain). These studies 
provide the first evidence of phenotypic variation of WNV in the Western Hemisphere 
(Hayes et al, 2005a).  
Natural History 
 The natural history of a virus can be defined as the multiple factors that influence 
the viral life cycle.  The natural history of an arbovirus is especially complex, as several 
conditions influence virus success including vector and avian abundance/competence to 
complete the amplification cycle, ecological niches and rainfall/drought conditions 
(Monath, 1979). Some of these conditions are poorly understood, such as the exact 
mechanism(s) for arboviral persistence between epidemic years and recrudescence of the 
virus each spring in colder climates. In addition, the sporadic nature of arbovirus 
transmission and unknown factors that “switch” an enzootic cycle into an epidemic 
continue to challenge researchers to further elucidate the natural history of these viruses. 
An improved understanding of arboviral natural history will enhance public health 
prevention strategies and prediction of disease outbreaks (CDC, 1993). 
Amplification Cycle 
 The flaviviral amplification cycle is similar for WNV and SLEV in North 
America. These arboviral encephalitides are zoonotic and maintained in complex life 
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cycles involving a primary vertebrate host (avian) and a primary arthropod vector 
(mosquito). Vertebrate infection can occur after an infected arthropod takes a blood meal, 
and arthropod infections occur after feeding on viremic (presence of virus in the 
bloodstream) hosts. Usually the virus cycles silently between the primary arthropod 
vector and the primary vertebrate host until an ecologic change occurs that allow the 
virus to escape this focus (Gubler, 2002). These cycles remain undetected until humans 
encroach on a natural focus, or the virus escapes this focus via another vector, vertebrate 
host or as the result of ecologic change. Humans and domestic animals may develop 
clinical illness but usually are incidental or "dead-end" hosts as they do not produce 
significant viremia to infect mosquito vectors and continue the cycle (CDC, 2004b).  
Figure 2-7 illustrates the amplification and transmission cycle of arboviruses, including 
WNV and SLEV. 
Vectors 
WNV has established enzootic foci in nature, with amplification cycles between 
adult blood-feeding mosquitoes and bird reservoir hosts. Infectious mosquitoes carry 
virus particles in their salivary glands and infect susceptible bird species during blood-
meal feeding (CDC, 2007b).  Several mosquito species have been shown to be competent 
vectors for WNV including Aedes, Anopheles, Mansonia, and Minomyia species in 
Africa, Asia and the United States; however Culex species mosquitoes are the most 
competent for infection (Brinton, 2002). Culicine mosquitoes have been implicated as 
both the enzootic and/or epizootic vectors of WNV (Gubler, 2007). In general, flavivirus 
infection of the vector does not appear to damage the mosquito or have a deleterious 
effect on mosquito offspring (Burke and Monath, 2001). 
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Figure 2-7 Arbovirus Transmission Cycle 
West Nile virus and St. Louis encephalitis virus share a similar 
amplification and transmission cycle.  Both viruses are vectored by 
Culicine mosquitoes, share avian amplifying host species, and are 
impacted by abiotic conditions (rain, temperature) that influence host 
dynamics. 
 
 
Figure appears courtesy of the Centers for Disease Control & Prevention (CDC, 2007c) 
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In Egypt, early field studies conducted from 1952-1954 implicated Culicine 
mosquitoes as important WNV vectors, including virus isolates from pools of Culex 
antennatus, Culex univittatus, and Culex pipiens.  Additional studies in South Africa and 
Israel in the 1960s further supported the role of the Culex univittatus complex as the 
major vectors of WNV in the eastern hemisphere (Hayes, 2001).  Since those early 
studies, WNV has been isolated from more than 40 mosquito species in the eastern 
hemisphere (Gould and Fikrig, 2004). In the three epidemics of WNV between 1996 and 
2000, Culex pipiens mosquitoes were implicated as the major vector for the first time, 
including the Romanian and North American epidemics (Hayes, 2001).  
Mosquitoes in the Culex pipiens complex have been observed to feed mainly on 
birds, although some members of the complex primarily bite humans or other mammals 
(Kuno and Chang, 2005). Since the 1999 introduction of WNV, 62 mosquito species with 
diverse ecologies and behaviors infected with WNV have been identified in the United 
States (CDC, 2007d), although it is believed that less than 10 of these species are the 
principal vectors of WNV (Hayes et al, 2005b). In the US, Culex species are the most 
important maintenance vectors in the avian cycle, with other species serving as the bridge 
vectors from birds to incidental hosts in mid to late summer (Gould and Fikrig, 2004). 
Culex nigripalpus, Culex salinarius, Culex restuans, Culex pipiens and Culex 
quinquefasciatus are the principal vectors involved in bird to human transmission of the 
virus, which may result in disease (Rey et al, 2006).  In Florida, Culex nigripalpus has 
been identified in the majority of WNV positive mosquito pools collected by state 
agencies (Stark and Kazanis, 2002-2006) and is considered to be the primary vector. 
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West Nile virus has also been isolated occasionally from ticks but their role in the 
transmission and ecology of the virus remains unknown (Hayes, 2001). 
 Amplifying Hosts 
Vertebrate hosts for the virus to amplify in are also critical to maintenance of the 
enzootic cycle. Primary amplifying hosts for WNV in North America are corvids (crows, 
jays and magpies), house sparrows, house finches, and grackles (Komar et al, 2003).  
Competent bird reservoirs will sustain an infectious viremia (virus circulating in the 
bloodstream) for 1 to 4 days after exposure, after which these hosts develop life-long 
immunity. Infected vertebrate hosts must develop high viremia titers (in excess of 105 
plaque forming units [PFU]/ml) for a mosquito to acquire the virus from the blood (Burke 
and Monath, 2001).  
In laboratory studies, migratory Passeriformes (perching birds/songbirds), 
Strigiformes (owls), Falconiformes (hawks), and Charadriiformes (shorebirds) developed 
sufficient viremia to infect feeding mosquitoes. Certain passerine species including 
corvids, grackles, house sparrows and house finches were highly infectious to mosquitoes 
but had high mortality rates (>40%) [Komar et al, 2003; Hayes et al, 2005b]. Field 
studies conducted in different geographical areas corroborated the importance of birds in 
the transmission cycle of WNV based on the presence of high antibody rates in birds 
(Hayes, 2001).  
The spread of WNV throughout the United States into Canada, the Caribbean, 
Central and South America is due to the migration patterns of these bird reservoirs 
(Rappole and Hubalek, 2003; Gubler, 2007).  In the United States, the westward 
movement of the virus in 2001, 2002, 2003 and 2004 is correlated to the Atlantic, 
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Mississippi, Central, and Pacific flyways of migratory birds (Gubler, 2007). After WNV 
spread throughout the northeast, it appeared in Florida in 2001 bypassing several mid-
Atlantic states, a pattern that can be explained from these migratory patterns (Deardorff et 
al, 2006). Further migration of these bird reservoirs south spread WNV into the 
Caribbean, Mexico and Central America from 2001-2003 (Gubler, 2007).  The first 
evidence of activity in South America occurred in 2004 (Colombia and Trinidad) and 
then caused equine deaths in 2006 (Argentina) [Morales et al, 2006; Gubler, 2007]. 
Alligators may also serve as a reservoir for WNV in the southeastern United 
States (Klenk et al, 2004; Jacobson et al, 2005; Bowen and Nemeth, 2007). In addition, 
the lake frog appears to serve as a reservoir of infection in Russia. WNV has also been 
isolated from rodents in Nigeria and a bat in India, but most mammals do not appear to 
generate the high titered viremias necessary to contribute to the transmission cycle 
(Hayes et al, 2005b).   
 Incidental Hosts 
Humans, horses, and other mammals are not preferred reservoir hosts and do not 
contribute to WNV amplification; only low levels of virus circulate in the bloodstream. 
They are incidental hosts, a dead-end for the transmission cycle since mosquitoes will not 
be infected upon taking a blood meal from these hosts (CDC, 2005c).  In the eastern 
hemisphere, WNV infections in these mammals are truly incidental, where outbreaks of 
disease are infrequent and infections result in asymptomatic or mild illness in humans, 
horses and birds; rarely resulting in death or neurologic disease (Gubler, 2007).  
However, the introduction of WNV into the western hemisphere has resulted in 
significant morbidity and mortality associated with “incidental” host infections, 
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especially in humans and horses. From 1999 to 2006, there were 23,975 human cases of 
WNV illness reported, with 962 fatalities in North America (4% mortality rate) [CDC, 
2007e]. Approximately 44% of all confirmed cases were caused by WNV neuroinvasive 
disease (Kramer et al, 2007).  Conversely, it is important to note that severe neurologic 
disease and fatalities are rare in humans, horses and birds south of the North American 
border in the Caribbean, Mexico, Central and South America (Gubler, 2007). 
Equines are significantly affected by WNV disease in North America. Horses are 
at higher risk for infection with arboviruses because of higher exposure levels; they 
remain outdoors and attract hordes of biting mosquitoes (CDC, 2005c) and if infected, 
may develop WNV encephalitis characterized by weakness, paralysis and recumbency 
(Morales et al, 2006). In 2002, a large epizootic occurred in horses with 14,571 cases 
reported to the CDC in North America. Fortunately, the number of equine cases has 
declined dramatically since 2003 and 2004 due to the widespread use of an equine 
vaccine for WNV (Gubler, 2007). Case fatality rates range from 30 to 40% in 
unvaccinated horses (Gubler, 2007; CDC, 2007b). Equine arboviral encephalitis cases are 
valuable surveillance tools, since morbidity in horses typically precedes bridging of the 
virus into human populations (CDC, 2005c; Blackmore et al, 2003). 
 For the first time in the natural history of WNV, fatal infections were identified in 
mammals other than humans and horses during the epidemic/epizootic in the northeastern 
United States. Fatal WNV infections were diagnosed and reported to the CDC in a bat, 
cat, chipmunk, rabbit, squirrel, and skunk (Hayes, 2001).  WNV has also been detected in 
over 30 species of wild vertebrate hosts including alligators, bears, wolves, cattle, llamas, 
sheep, reindeer, elephants, rhinoceros, camels, seals and penguins in the US (Gould and 
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Fikrig, 2004; Weaver and Barrett, 2004; Gubler, 2007). These findings indicate the 
tremendous host range of WNV in the western hemisphere, where it is highly 
“promiscuous” as compared to its host range in the eastern hemisphere and may result 
from a new geographical range with non-immune hosts (Weaver and Barrett, 2004). 
Ecology & Habitat 
 Important ecological parameters govern the amplification and transmission cycles 
of arboviruses and include habitat, temperature and rainfall.  These factors also influence 
geographic distribution of the vectors and hosts (Gubler, 2002). 
 Geographic Location 
 Until 1999, there were no Old World extant Culicine mosquito-associated viruses 
in the New World (Gould et al, 2003). As a result, West Nile virus has become one of the 
most widespread flaviviruses in the world and its geographic range continues to steadily 
increase (Rappole et al, 2000; Gubler, 2007). West Nile virus is widely distributed 
throughout Africa, Europe, the Middle East, west and central Asia, Oceania (WNV 
subtype Kunjin), and most recently, in North and South America (CDC, 2007f). 
 The ecology of WNV is closely tied to its mosquito vectors as the virus cycles 
between bird and mosquito hosts.  Consequently, regions that maintain or contain 
favorable habitats for Culicine mosquito vectors are predisposed to enzootic transmission 
and epidemics of WNV based on the feeding behavior and preferences of these vectors 
(Kilpatrick et al, 2006).  Outbreaks of WNV in the United States have highlighted the 
importance of favorable mosquito habitats to the transmission of disease. For example, 
cases in the New York 1999 epidemic were clustered in an area with higher vegetation 
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cover; in 2002, human cases in Chicago occurred in areas with more vegetation, older 
homes, and lower human population density (Hayes et al, 2005b). 
  Ecologic niches with the appropriate habitat for these viruses may be artificially 
created from human influence in certain geographic regions.  For example, in the Nile 
delta, WNV transmission intensity is greater in the southern vs. the northern region due to 
the greater amount of irrigated land under cultivation in the southern region (Hayes, 
2001). Extensive irrigation systems have also been instrumental to Culex tarsalis 
vectored transmission of WNV in California and the southwest, where it affords 
extensive breeding grounds for the mosquitoes (Hayes, 2005b). In addition, epidemics in 
Israel (1960s) were restricted to two geographic sites previously covered by swamps that 
had been converted to fish ponds, but still retained earlier ecological characteristics 
(Hayes, 2001).   
However, the importance of avian hosts in the transmission cycle cannot be 
discounted, especially as migratory birds have effectively dispersed WNV throughout the 
Americas. Natural geographic features that foster habitat for birds also contribute to 
WNV activity as shown by epidemics in Romania, Russia, and NYC in the late 1990s.  
All three transmission sites were adjacent to large rivers, which provided a favorable 
wetland habitat for both resident and migratory birds (Hayes, 2001).  
In contrast to WNV infections reported in North America, very few human or 
animal cases of severe neurologic disease or death due to WNV have been reported in 
tropical regions (Caribbean, Mexico, Central and South America) despite the abundance 
of Culicine mosquito vectors, passerine bird species, and habitat that support other 
epizootic/epidemic flaviviral transmission cycles (Gubler, 2007). It has been suggested 
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that the extensive prevalence of other flaviviruses (especially dengue viruses) confers 
protective immunity to humans, whereas enzootic SLEV, Rocio and Ilheus viruses 
(among others) may confer protective immunity to bird and small mammal amplifying 
hosts, thus preventing infection with WNV.  Geographic location may also impact this 
apparent attenuation of West Nile disease in the tropics, as found for JEV and SLEV 
which typically only cause neuroinvasive epidemic disease in the temperate regions of 
their geographic distribution despite widespread transmission in the tropics. In fact, this 
geographic dichotomy has also been described for WNV infection in the Old World 
(Gubler, 2007). 
 Transmission Season 
 In the eastern hemisphere, several characteristics of WNV transmission were first 
elucidated during the 1950s (Hayes, 2001).  Serosurvey studies in the southern part of the 
Nile delta region of Egypt found that WNV transmission activity was most intense during 
the summer (June through September), peaking in July. In contrast, along the northern 
rim of the Nile delta near the Mediterranean coast, transmission intensity was much lower 
and maybe related to a smaller human population density and lower density of the 
primary mosquito vector (Hayes, 2001). Transmission is clearly influenced by both 
vector and host abundance. 
In the western hemisphere, the transmission season is longer and WNV activity 
peaks at a different time.  In the United States, human cases of WNV usually occur from 
May to December, with onset in August and September in 85% of cases (Gould and 
Fikrig, 2004).  In temperate regions, outbreaks of WNV occur during late summer or 
early fall (July through October) coinciding with the arrival of high numbers of migratory 
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birds and mosquitoes (Rappole et al, 2000). However, in Florida and other Gulf Coast 
states, WNV can be transmitted year-round due to the mild climate that supports 
continuous mosquito activity (Blackmore et al, 2003).  
Recent evidence indicates that mosquito feeding behaviors appears to modulate 
the WNV transmission season. In northeastern and north-central regions of North 
America, Culex pipiens mosquitoes demonstrate a late summer shift in feeding behavior 
from their preferred avian hosts (American robins) to humans, which may explain the late 
summer timing and intensity of human WNV epidemics (Cx pipiens is the dominant 
enzootic and bridge vector in the northeast).  In addition, these feeding shifts intensify 
WNV transmission and epidemics in central and western regions of the US following 
dispersal and migration of American robins and other avian competent hosts following 
their breeding.  In the southeast, Cx. nigripalpus also shifts its feeding behavior on birds 
in the spring to mammals and humans later in the summer. Consequently, these shifts in 
mosquito feeding behavior are a geographically widespread phenomenom that may 
intensify epidemics of avian zoonotic viruses such as WNV and SLEV (Kilpatrick et al, 
2006). 
 The transmission season of WNV is also linked to geographic location, as warmer 
climates appear to lengthen the annual transmission period of the virus as WNV spread 
south throughout the United States.  Onset of human illness has been described as early 
as April and as late as December (Hayes et al, 2005b), which creates a lengthy 
transmission season. In Florida, a widespread epidemic of WNV with hundreds or 
thousands of human cases has not yet occurred (Shaman et al, 2005).  However, recorded 
transmission cycles indicate focal and sporadic activity of WNV, with rare outbreaks of 
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human cases (Blackmore et al, 2003).  This transmission pattern is very similar to 
reported transmission patterns of SLEV in the same region, with one important 
difference. Sporadic and focal outbreaks of WNV appear to result in more human cases 
than similar outbreaks historically associated with SLEV (Shaman et al, 2005).   
 Contribution of Climatic Conditions 
 Climatic conditions are directly related to arboviral transmission intensity and 
epidemics of disease, especially temperature and rainfall conditions that impact biology 
of the mosquito vector. Temperature is an important parameter that influences vector 
competence and transmission of arboviruses by mosquitoes.  Once a mosquito ingests an 
infectious blood meal, the time from ingestion until the mosquito is capable of 
transmitting the virus is termed the extrinsic incubation period (EIP).  The mosquito host 
temperature approaches ambient conditions and studies have shown that fluctuations in 
environmental temperature impact the duration of extrinsic incubation periods and 
replication of arboviruses (Reisen, Fang and Martinez, 2006).   
WNV is widely distributed throughout temperate and tropical regions of the 
world, indicating that it must be transmissible under a variety of temperature conditions.  
Unlike a lineage II WNV strain from South Africa, the North American NY99 strain 
required warmer temperatures for efficient transmission. In the United States, enzootic 
WNV activity began soon after ambient environmental temperatures increased, resulting 
in a shorter duration of the EIP and virus transmission likely occurred after only one or 
two blood meals by the female mosquitoes. In addition, summer temperature deviations 
from a 30-year mean in the United States indicate that WNV always dispersed into new 
areas in years with above-normal temperatures and amplification in the following year 
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occurred during summers with normal or elevated temperatures. Subsequent cooler 
summers correlated with decreased or delayed WNV activity, especially at northern 
latitudes. Outbreaks of WNV in Louisiana and Arizona did not correlate with higher 
summer temperatures, likely because average summer temperatures are already sufficient 
for transmission (Reisen, Fang and Martinez, 2006). 
Climatic rainfall and drought patterns have been correlated to mosquito infection 
rates and abundance to promote arbovirus transmission (Shaman et al: 2002, 2003a & b, 
2004a & b, 2005a). Prior to the 1990s, the largest known epidemic of WNV in the eastern 
hemisphere occurred in South Africa in 1974.  The South African epidemic followed 
unusually heavy rains in a normally arid region, where this rainfall contributed to an 
increase in mosquito densities (Cx. univittatus in this situation) and compounded with 
high temperatures during summer months created the perfect conditions for an outbreak 
of disease (Hayes, 2001). 
Further evidence of the contribution of climatic conditions can be shown from the 
first epidemics reported from large cities in the 1990s (in Romania, Russia and New 
York), which may have been triggered by drought conditions where these urban 
environments had below average rainfall in the summer of the epidemic (Hayes, 2001). 
In southern Florida, modeling of human WNV cases and WNV transmission to sentinel 
chickens was associated with land surface wetness conditions (water table depth).  Low 
water table depth (WTD) occurred in drought conditions, whereas high WTD occurred 
after wetting (rainfall).  This study found that dry conditions followed by wetting led to 
subsequent WNV activity.  The authors proposed that drought brings Cx. nigripalpus 
mosquitoes and wild birds into close contact, which facilitates epizootic WNV 
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amplification in the spring (Shaman et al, 2005).  In other regions, dry conditions could 
increase the number of favorable breeding sites for Cx. pipiens which lay eggs in stagnant 
or polluted water sources (Hayes, 2001).   
In conclusion, the natural history of West Nile virus is influenced by multiple 
parameters governing the bird-mosquito-bird amplification cycle, which are impacted by 
the ecology and habitat of these hosts. Together, these factors implicate a complex virus 
life cycle that will be difficult to completely eradicate, but improved understanding of 
these conditions will enhance transmission forecasting and prevention strategies to 
minimize human WNV disease. 
Clinical Disease 
Human  
The incubation period of WNV ranges from 1 to 6 days (Burke and Monath, 
2001).  WNV infection is characterized by an acute onset of fever, headache, malaise, 
fatigue, weakness, muscle pain, and difficulty concentrating. Symptomatic illness 
develops 2-14 days after virus infection in humans (Gubler, 2007). However, 
approximately 80% of WNV infections are asymptomatic, 20% result in self limiting 
West Nile virus fever (WNF), and <1% result in neuroinvasive disease (Hayes et al, 
2005b).  Neuroinvasive cases include encephalitis, meningitis, and polio-like flaccid 
paralysis with case fatality rates of 4-15% (Gubler, 2007).  The risk of WNV encephalitis 
increases with age and is higher among organ transplant recipients (Hayes et al, 2005b).  
The main risk factor for death is advanced age (>70 years old) as shown by a case fatality 
rate ranging from 15-29% (Gould and Fikrig, 2004). 
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Patients that recover from WNV neuroinvasive disease often have a poor 
prognosis and may experience long-lasting or permanent neurologic sequelae (Gubler, 
2007). Patients with polio-like flaccid paralysis may have some improvement in limb 
strength, but many do not recover (Leis et al, 2002; Marciniak et al, 2004). The case 
fatality rate for WNV neuroinvasive disease is approximately 9% (O’Leary et al, 2004).  
One follow-up study found that for patients that sought medical attention for WNF 
(n=98), fatigue and muscle weakness lasted for approximately one month after onset, as 
well as difficulty concentrating, neck pain and stiffness. The median time for full 
recovery in these patients was 60 days, and 79% of these patients missed work or school 
because of their illness (Watson et al, 2004).  
 Since 2002, it has been noted that human-to-human transmission of WNV can 
also occur through blood transfusion, organ transplantations, and intrauterine infection 
and through breast milk (Gould and Fikrig, 2004). 
Avian 
The importance of wild birds to West Nile virus transmission was first established 
in Egypt from 1952-1954 in a village-based study on ecology. Serosurveys (a 
surveillance technique used to assess the prevalence of disease through detection of 
agent-specific antibodies in a population) on six of the Nile delta region’s most common 
bird species found neutralizing antibody rates between 48% and 100% to WNV.  In 
addition, the hooded crow population had a seropositive prevalence rate of 40% during 
the late spring that increased to 87% in summer and winter.  These findings were 
supported forty years later following the Romanian epidemic of 1996, where a serosurvey 
detected high antibody rates (41%) to WNV in domestic birds.  Additional experimental 
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studies in South Africa found that most wild birds were susceptible to WNV and 
developed high titered viremias, but did not result in bird mortality (Hayes, 2001). The 
first avian deaths from natural WNV infections were reported in 1998 in domestic 
goslings and white storks in Israel. This Middle Eastern 1998 goose strain of WNV is 
nearly identical to the New York 1999 strain (Komar et al, 2003). As a result, the intense 
epizootic of WNV in the United States has had a significant impact on native North 
American wild bird species, with thousands of reported deaths (United States Geological 
Survey, 2007; LaDeau, Kilpatrick and Marra, 2007).  
In the United States, West Nile virus has been detected in dead birds of at least 
317 different species (CDCg, reported to Arbonet as of 4/19/07), although most fatal 
infections occur in crows (Komar et al, 2003). Birds, particularly crows and jays, infected 
with WN virus may die or become ill, but most infected birds do survive in natural 
settings (CDC, 2007g). Experimental studies performed by Komar et al. (2003) 
investigated the role of 25 different species of wild birds in transmission of the New York 
1999 strain of WNV.  The authors found that viremias were higher and longer in duration 
in passerine and charadriiform bird species than in other orders.  Passerine bird species 
were also implicated as competent reservoirs for WNV (Komar et al, 2003). 
Signs of illness in these experimentally infected wild birds included lethargy, 
unusual posture, ruffled feathers, inability to hold head upright, ataxia (Komar et al, 
2003), anorexia or weight loss, shaking and convulsion (Brault et al, 2004). For most of 
the birds, clinical symptoms were followed by death within 24 hours. In addition, this 
study demonstrated that oral transmission and direct contact transmission of WNV is 
possible from infected meals or cage mates, respectively. Both types of transmission 
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induced viremia and neutralizing antibody production in the infected birds. The mode of 
direct contact transmission is still unknown (Komar et al, 2003). 
A previous study has shown that WNV viremia and cloacal shedding is limited in 
adult chickens (17, 20 or 60 weeks old), with low titers of virus recovered between 2-6 
days post-inoculation (DPI). After needle or mosquito inoculation of WNV, 
experimentally infected chickens were viremic between two to three DPI and shed WNV 
from the cloaca between two to six days.  All 60 week old chickens (n=5) inoculated by 
mosquito shed virus from the cloaca as compared to 17 week old birds, where only 18% 
shed (2 of 11 chickens). Neutralizing antibody titers to WNV developed within two 
weeks of infection (Langevin et al, 2001).  In contrast, one study conducted in young 
chickens (7 weeks old) found that needle-inoculated hens developed higher titers of 
viremia (105 pfu/ml), with WNV detected in blood plasma up to eight DPI and 
neutralizing antibodies detected as early as five DPI. Cloacal swabs detected fecal 
shedding of WNV only on days 4 and 5 after infection (Senne et al, 2000).  
These findings were experimentally replicated in wild birds, such that most birds 
shed WNV in the feces (71% of 24 species) and wild species excreted higher titers of 
virus than shown for chickens. Thus, it is possible that oral or cloacal shedding of WNV 
in naturally infected birds may spread the virus (mechanism for contact transmission) or 
pose a risk to animal handlers (Komar et al, 2003).  Kipp et al. (2006) confirmed that 
high titered shedding of WNV in the feces of wild birds could present a risk for fecal-oral 
transmission in crows, as well as direct transmission to birds and animal handlers that 
come into contact with contaminated feces.  
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Finally, experimental WNV infection of wild birds resulted in disseminated 
infection, such that all 11 organs tested had virus including the brain, heart, spleen, liver 
(lowest titer), kidney, eye, ovary, and skin.  Interestingly, the highest titer of virus was 
recovered from skin samples which may improve transmission of the virus to mosquitoes 
or ticks that feed on the skin. Persistent infections of the ovaries may also allow 
transovarial transmission of the virus to progeny (Komar et al, 2003). 
Epidemiology 
 Prior to the introduction of WNV to the United States, the largest known human 
epidemic of WNV occurred in Cape Providence, South Africa in 1974 with 3,000 clinical 
cases (Brinton, 2002).  WNV is endemic in Africa and Asia (and likely now in the United 
States, as well), with outbreaks occurring every few years during the late summer and fall 
months. Significant epidemics were reported in Israel in the 1950s and the Rhone delta 
region of France in 1962 (Hayes, 1989). In the late 1990s, epidemics of WNV in humans 
and horses have been much more frequent including these outbreaks in recent years: 
Romania and Morocco (1996), Tunisia (1997), Italy (1998), Russia and the United States 
(1999), and Israel, France, and the United States (2000) [Brinton, 2002]. 
 Early epidemiological studies conducted in Egypt and the Sudan during the 1950s 
revealed that WNV human infections were extremely common. In the Nile delta, 
serosurveys discovered that 22% of children and 61% of adults were immune in this 
endemic region (Burke and Monath, 2001). Remarkably, 50% of four year olds and 90% 
of adults aged 20 had neutralizing antibodies to WNV in surveys conducted in 1952-1954  
in Egypt (Hayes, 2001). However, in areas where people have low immunity to WNV, 
epidemic disease can cause very high attack rates. For example, summertime epidemics 
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in Israel during the 1950s resulted in hundreds of cases and attack rates greater than 60%. 
A similar situation occurred during the 1974 South African epidemic, with an attack rate 
of 55% in the Cape Province population (Burke and Monath, 2001). 
West Nile virus was first detected in North America in 1999 during an outbreak of 
encephalitis in New York City (Hayes and Gubler, 2006). At first mistaken for St. Louis 
encephalitis virus (SLEV), researchers identified WNV by its high mortality in birds and 
appeared to be a highly virulent strain of WNV introduced from Israel (Lanciotti et al, 
1999). Epidemiologic evidence suggested that the virus was introduced in the spring or 
early summer of 1999 by infected humans/birds/mosquitoes arriving from Israel, as Tel 
Aviv also experienced epidemic WNV infections at that time, although this hypothesis 
may never definitively be proven (Giladi et al, 2001).  Since 1999, WNV rapidly spread 
across North America and into Canada, the Caribbean, and Latin and South America. The 
largest epidemics of neuroinvasive WNV disease ever reported occurred in the United 
States in 2002 and 2003 (Hayes and Gubler, 2006). West Nile virus has emerged as a 
major public  health threat and rapidly impacted humans, horses, and birds throughout the 
western hemisphere.  
Molecular Epidemiology 
Molecular epidemiology has been defined as a science that investigates the 
contribution of potential genetic and environmental risk factors, identified at the 
molecular level, to the etiology, distribution and prevention of disease (Dorman, 1998).  
Since the emergence of WNV in North America, molecular epidemiology studies have 
been useful in tracing the geographic and temporal spread of the virus (Davis et al, 2003; 
Estrada-Franco et al, 2003; Ebel et al, 2004).  Analysis of the complete and partial 
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genome sequences from viruses isolated in the northeast at the beginning of the epidemic 
(1999 and 2000) has provided a genetic baseline for future comparative studies.  The 
complete genetic characterization of the NY99 strain of WNV has allowed for the 
identification of novel mutations in genomes of WNV isolates made in different parts of 
the country and Mexico. These differences can then be used to infer phylogenetic 
relationships among isolates and characterize the evolution of WNV in the western 
hemisphere (Davis et al, 2005).  
Molecular epidemiology studies on North American strains of WNV have 
provided important clues to the pathogenicity of the virus. The first genotype of WNV 
associated with the North American outbreak was isolated in New York City (NY99 
strain). However, this strain was found to be nearly identical to WNV isolated from Israel 
and was not a novel United States strain, i.e. originating in the Middle East (Lanciotti et 
al, 1999). In 2002, a second genotype of the virus was isolated in Texas. This strain was 
recognized as a significant entity, designated WN02, and is considered the North 
American genotype of WNV (not the NY99 isolate).  WN02 is closely related to NY99, 
but belongs to a distinct phylogenetic lineage and seems to have displaced the NY99 
strain as the dominant North American genotype (Davis et al, 2005).   
Interestingly, isolates of WNV made after 2002 demonstrate the highest degree of 
nucleotide and amino acid sequence divergence from the progenitor NY99 strain. These 
mutations may be significant as they coincided with the largest recorded epidemic of 
arboviral encephalitis in North America and the vast geographic expansion of the virus.  
Several fixed mutations have been found since 2002 in Georgia, Texas and Indiana 
isolates, and are present in all isolates from western states. These nucleotide mutations 
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may reflect the rapid westward progression of WNV from 2002 through 2004 (Davis et 
al, 2005). A single conserved amino acid substitution (V159A) in the envelope gene is 
shared by strains isolated since 2002 and also found in eastern hemisphere strains of 
WNV (Davis et al, 2005). The majority of the nucleotide mutations are silent but amino 
acid substitutions have been identified, which result in phenotypic variation within the 
North American WNV population (Beasley et al, 2004; Davis et al, 2004; Ebel et al, 
2004; Davis et al, 2005).  
A recent study indicates that the WN02 variant has an epidemic doubling time of 
one month, as compared to five months for the NY99 strain, through analysis of 
nucleotide substitution rates, population growth, and time of origin (Bayesian Markov 
chain Monte Carlo method) [Snapinn et al, 2007].  In addition, the period of highest 
growth for WN02 coincides with the peak in human cases in 2002-2003 reported to the 
CDC. Snappin et al. (2007) propose that WN02 has increased mosquito transmission 
efficacy, which is responsible for the displacement of NY99 as the dominant North 
American genotype. This hypothesis is supported by experimental data that found Cx. 
pipiens mosquitoes transmitted WN02 two days earlier in the extrinsic incubation period 
compared to NY99, with significant increases in vectorial capacity of WN02 infected 
mosquitoes (Ebel et al, 2004). However, these population growth studies of North 
American WNV isolates concluded that the WN02 genotype is no longer growing and 
has likely reached peak prevalence in North America (Snappin et al, 2007). 
Although North American WNV isolates were characterized by widespread 
mortality in resident birds upon introduction of the virus to a naive population, South 
American WNV strains have not been found to cause significant morbidity or mortality 
 63
in birds, humans or horses (Kramer and Shi, 2007; Gubler, 2007).  A potential attenuating 
mutation identified in a WNV isolate from Tabasco state in southern Mexico is an E-156 
Ser → Pro glycosylation negative variant (glycosylation of the E protein plays an 
important role in flavivirus assembly in mammalian cell culture) [Estrada-Franco et al, 
2003; Beasley et al, 2004]. However, analysis of isolates from near the US-Mexican 
border are more closely related to Texas strains and do not encode mutations at the E 
glycosylation motif (Beasley et al, 2004; Deardorff et al, 2006). A molecular 
epidemiology study of Mexican isolates indicate that this glycosylation negative WNV 
variant appears to be limited to southern Mexico, as strains found in northern Mexico 
contain the glycosylated motif typical of United States WNV strains (Deardorff et al, 
2006).  Consequently, more research is needed to identify additional attenuating 
mechanisms of virulence in Central and South America. 
Perhaps the answer to this puzzling question does not rely on attenuation of the 
viral genotype or phenotype in the tropical Americas; rather demographic factors or 
surveillance for WNV may account for the relatively few cases reported in the Caribbean, 
Central and South America. For example, the incidence of human WNV encephalitis is 
much higher on the United States (California) side than on the Mexican (Baja California 
and Sonora) side of the common border. One potential explanation for this discrepancy 
could be differences in disease diagnosis, surveillance and reporting in Mexico 
(Deardorff et al, 2006).  
However, a second hypothesis for the decreased incidence of severe disease may 
involve cross-reactive flavivirus antibodies that provide protection for animal and human 
populations. Several endemic flaviviruses circulate in the Caribbean, Central and South 
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America, including dengue, SLEV, yellow fever, Ilheus, and Rocio to name a few.  
Experimental evidence has shown that heterotypic flavivirus antibody can modulate 
clinical illness and reduce virus loads (Bond, 1969; Bond and Hammon, 1970; Vaughn et 
al, 2000).  As such, widespread flaviviral antibody among bird, domestic animal and 
human populations in tropical America may modulate viremia and clinical illness in 
WNV infections and potentially reduce transmission. In addition, intrinsic or extrinsic 
host and environmental factors may select less virulent genetic variants of WNV. 
Heterotypic flavivirus antibody, development of innate immunity due to frequent 
exposure to several flaviviruses, warmer ambient temperatures, different species of 
mosquito vectors, and secondary vertebrate hosts are factors that may influence selection 
of less virulent strains of WNV (Gubler, 2007).    
Economic Burden 
The emergence of West Nile virus in the western hemisphere has had a significant 
impact on regional economies that have experienced or that are still experiencing 
epidemic/epizootic WNV activity. It is unknown what long-term impact this disease will 
have on avian biology as well as that of other endemic arboviruses in the United States, 
but it is believed that WNV may continue to cause a higher incidence of human illness 
than all other endemic arboviruses combined in the US (Zohrabian et al, 2004; Gubler, 
2007). For instance, it has been estimated that for 1 clinically apparent infection of WNV, 
there are 150 human cases that are infected with WNV but that do not seek medical 
treatment. Consequently, during the largest outbreak of WNV in 2003, it has been 
estimated that 1.5 million people were infected (Peleman, 2004). 
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Few studies on the short or long-term economic burden of arboviruses have been 
conducted in the United States (Zohrabian et al, 2004). Although WNV results in fewer 
apparent clinical cases and deaths in the United States then influenza (i.e. >36,000 
deaths/year) [CDC, 2007h], it has highlighted the importance and necessity of public 
health agencies for the detection and prevention of WNV.  Many of these agencies 
effectively prevent arbovirus transmission through mosquito abatement and medical 
alerts, which often have lower operating costs than those associated with the 
hospitalization and life-long debilitation of a single neuroinvasive or encephalitic 
arbovirus case.  
A long-term economic impact study in Massachusetts of eastern equine 
encephalitis virus, which has a similar range of clinical illness as WNV, found that the 
economic cost for transiently affected patients (with full recovery) averaged $21,000 per 
case (in 1995 dollars), mostly for direct medical services. However, for a person with 
residual sequelae the average lifetime cost of EEEV infection approached $3 million, 
including loss of potential income earned (Villari et al, 1995). These figures have likely 
increased over the last decade as medical costs have increased. In contrast, massive aerial 
applications of ultra-low volume (ULV) malathion for insecticidal interventions that are 
very effective at preventing outbreaks of EEEV infection, cost between a quarter ($0.7 
million) to one half ($1.4 million) less than the expense of a single residually affected 
child (Villari et al, 1995). Vector control technologies have also improved in the last 
decade allowing for targeted pesticide applications based on surveillance data which is 
much more cost-effective. 
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One study on the short-term economic impact of an epidemic of WNV in 
Louisiana in 2002 (Zohrabian et al, 2004) agreed with the EEEV model above, but 
resulted in lower cost estimates because it did not evaluate long-term costs associated 
with WNV sequelae. The authors estimated that the total short-term costs of the 2002 
WNV epidemic in Louisiana were $20.14 million. The median acute-care inpatient 
medical cost per patient was $8,274, with a range of $623 - $164,688 (Zohrabian et al, 
2004).  A later study by Zohrabian, Hayes and Peterson (2006) derived the cost per case 
of neuroinvasive WNV illness (with full recovery) as $27,500, a figure closer to the 
findings for EEEV above. The cost of mosquito surveillance and abatement programs, 
including reimbursement requests from emergency preparedness funds to handle the 
epidemic, was $8.3 million for the 2002 epidemic in Louisiana. The central state public 
health agency expenses were estimated at $866,000, with $586,000 for operating costs, 
$134,000 for laboratory expenses, and $166,000 for veterinary and entomologic services 
(Zohrabian et al, 2004). 
Zohrabian et al. (2004) extrapolated their findings for the 2002 epidemic in 
Louisiana to estimate the magnitude of the WNV epidemic nationwide that year.  They 
found that short-term costs for inpatient treatment were $57.5 million, outpatient 
treatment costs were $5.6 million, and non-medical associated expenses were $76.7 
million, totaling $139.8 million for 4,156 cases (2,942 CNS cases). This total did not 
include the costs of mosquito abatement and prevention (Zohrabian et al, 2004).  Even 
though clinically apparent arboviral infections in the United States are relatively rare, the 
severe sequelae and potential need for life-long institutionalized care for survivors of 
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encephalitis or neuroinvasive disease may make expensive preventive programs much 
more cost-effective over time for a community. 
Finally, the economic burden of WNV may be ameliorated by the successful 
development and implementation of a human vaccine for the disease.  A cost-
effectiveness study for the development of a WNV vaccine from the societal perspective 
found that the average “savings” per case of WNV illness prevented by a vaccine would 
be approximately $36,000 (range from $20,000 - $59,000).  In this model, vaccination of 
a hypothetical population of 100 million people would cost approximately $8.7 billion (as 
determined by baseline costs of the vaccine and its administration, as averaged from the 
costs of yellow fever, JEV, and Lyme disease vaccines).  These findings suggest that a 
universal vaccination program to prevent WNV disease would not result in societal 
monetary savings unless the incidence of the disease substantially increases or the cost is 
less than $12 per person vaccinated (Zohrabian, Hayes, and Peterson, 2006). 
Public Health Implications 
In the absence of a human vaccine, public health prevention and protection from 
WNV must rely on surveillance and vector-control programs to minimize risk of disease 
(CDC, 2003Aa). Unlike regions in the eastern hemisphere where WNV has established 
endemic foci, recent outbreaks in the United States, Europe and the Middle East are 
characterized by low prevalence of WNV infection in the human population. WNV 
appears to cause infection in less than 5% of these affected populations, including 
asymptomatic infections. Consequently, WNV remains a public health concern as these 
low levels of infection are unable to decrease the frequency of epidemics, modulate 
severity, or provide protective herd immunity (principle where a large proportion of a 
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population is immunized to a disease, resulting in fewer susceptible individuals and 
community-wide protection from outbreaks) to the disease (Hayes et al, 2005a). 
In the United States, WNV has demonstrated the danger an emerging vector-
borne disease can have on a naïve environment, with widespread avian mortality, wide 
host ranges, and thousands of clinically apparent human cases with millions of human 
infections estimated (Zohrabian, Hayes, and Peterson, 2006).  As such, WNV is a 
significant threat to public health in North America, where it has likely established 
enzootic foci in many states. Infections can be severe with permanent neurologic damage 
in a low percentage of survivors, 4% case fatality rates (Gubler, 2007), and incredible 
economic costs to communities (Zohrabian et al, 2004).  
It is unlikely that WNV will be eliminated from the Western Hemisphere, as 
WNV will persist in many different ecologic systems due to its broad vector and host 
ranges. The public health infrastructure for vector-borne and zoonotic diseases must 
improve to face this and other potential emerging threats (Gubler, 2007). Early detection 
of arboviral activity is crucial for timely implementation of risk-reduction strategies, such 
as vector-control practices, medical alerts, and educational campaigns to promote use of 
repellents and avoid insect bites (CDC, 1993). Critical areas in need of improvement 
include epidemiologic, vector control, and laboratory infrastructures for vector-borne 
diseases to enhance prevention and control strategies for arboviruses (Gubler, 2007).  
 
St. Louis Encephalitis Virus 
 Prior to the outbreak of WNV in New York City, St. Louis encephalitis virus (SLEV) 
was the most important agent of epidemic viral encephalitis in North America and the only 
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mosquito-borne human pathogen in the family Flaviviridae found on this continent. SLEV 
activity is restricted to the western hemisphere, in North and South America (Tsai & Monath, 
1987; Hunt et al, 2002). 
Discovery 
 In 1932, St. Louis encephalitis virus (SLEV) was first recognized as a human 
pathogen following an outbreak in Paris, Illinois (Burke and Monath, 2001).  The 
following year, a large human epidemic characterized by central nervous system 
infections occurred in St. Louis (origin of the virus name) and Kansas City, Missouri.  
The causative agent was isolated from human brain tissue after inoculation into mice and 
monkeys; Culex pipiens mosquitoes were implicated as the vector on epidemiologic 
grounds.  This mosquito species was later confirmed (after more than 20 years) as the 
principal vector in the east-central United States.  In the 1940s, SLEV was recognized in 
Pacific Coast states and isolated from Culex tarsalis mosquitoes.  In Florida, a third 
transmission cycle involving Culex nigripalpus mosquitoes was implicated during 
outbreaks in 1959 and 1961.  Numerous outbreaks of SLEV have occurred in the western 
United States, Texas, Florida, and the Ohio-Mississippi Valley since its discovery in 
1933 (Burke and Monath, 2001).  Distribution of SLEV by state is shown in Figure 2-8, 
including the cumulative number of human cases from 1964-2006 (CDC, 2007i).   
Phylogeny and Evolution 
 Unlike West Nile virus, there is no generally accepted classification of SLEV 
subtypes. Previously, oligonucleotide fingerprinting (ONF) analysis and virulence 
markers of 43 SLEV isolates suggested four unique genotypes of the virus in the United 
States, with two additional genotypes found in South America. These isolates were 
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grouped into clusters as follows by Trent et al, 1980; Monath et al, 1980a & b; Bowen et 
al, 1980:  
1) Central and Atlantic US,  
2) Florida epidemic,  
3) Florida enzootic,  
4) Western US,  
5) Central and South America [mixed virulence], and  
6) South America [low virulence].   
At that time, phylogeny could not readily be inferred until developments in molecular 
genetics over a decade later allowed for improved understanding of SLEV genetics and 
distribution (Reisen, 2003). 
A recent classification scheme proposed by Kramer and Chandler (2001) has 
improved genotypic characterization and elucidated the phylogenetic relationships that 
exist among strains of St. Louis encephalitis virus. Phylogenetic analysis of the entire 
envelope region (~1700 nucleotides) of SLEV indicates that isolates (n=62) studied from 
North and South America form a monophyletic group, with most isolates clustering 
according to geographic region. Two major groups of SLEV occur in the United States, 
which appears to also be the case in South and Central America.  Parsimony and 
neighbor-joining tree analyses have identified seven lineages of SLEV designated I-VII  
 (Kramer and Chandler, 2001).  Overall, these lineages appear to have some overlap with 
the original ONF classification schemes developed nearly 30 years ago (Reisen, 2003). 
Lineage I and II viruses predominately contain North American strains (with a 
few South American isolates).  Lineage I strains are found in the western United States  
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Figure 2-8 Distribution of Human Cases of St. Louis encephalitis virus in the 
United States (1964-2006) 
 Map of the United States that illustrates the total number of SLEV human 
cases per state reported to the Centers for Disease Control and Prevention 
from 1964 through 2006.  Texas leads the nation with the largest number 
of reported cases (n=1015), followed by Illinois (n=697) and then Florida 
(n=380). 
 
 
Figure appears courtesy of the Centers for Disease Control and Prevention (CDC,2007i) 
 
 
 
 
 
 
 72
with two clusters: IA and IB.  Lineage II has the largest number of strains and is grouped 
into six clusters (IIA – IIF).  Interestingly, at least one Florida strain has been grouped 
into most of these clusters (IIA – IID). Lineage IIE contains the prototypical SLEV  
strains Hubbard and Parton isolated in St. Louis, Missouri in 1933 and 1937, 
respectively.  The sixth group IIF contains one isolate from Guatemala in 1969 (Kramer 
and Chandler, 2001), which has also been identified as a putative recombinant in the 
envelope region between Argentinean (Lineage III) and Tennessee (Lineage IIB) strains 
of SLEV by Twiddy and Holmes (2003).  Note: this envelope sequence has been 
removed from the GenBank database (personal communication, L. Kramer). The 
remaining lineages (III-VII) of SLEV consist of strains isolated in South America 
[Kramer and Chandler, 2001].  The seven lineages have been summarized in Table 2-2. 
 A maximum of 10% nucleotide differences in the envelope region was shown for 
62 strains of SLEV. An earlier study by Kramer et al. (1997) also found that some SLEV 
strains (in California) remained almost unchanged within regional foci, in some cases for 
periods longer than 25 years. Evidently, SLEV persists with little change for consecutive 
years but may become extinct over time, allowing for the possible evolution or 
introduction of new genotypes in California (Kramer et al, 1997). This relative genetic 
homogeneity over time supports the hypothesis of local transmission and maintenance of 
SLEV in a particular geographic region. Yet, both of these studies identified that SLEV 
strains can be transported between regions within and outside of the United States 
(Reisen, 2003).   
 The most divergent lineages (ancestral) of SLEV were found in Argentina, 
whereas the least divergent were isolated in North America by analysis of the E gene 
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Table 2-2 St. Louis Encephalitis Virus Classification Scheme  
 
Lineage Cluster Strain Location Year Host 
E22924 Kern Co., CA 1970 Cx. tarsalis 
Bfs4772 Kern Co., CA 1963 Cx. tarsalis 
A 
Bfs1750 Kern Co., CA 1953 Cx. tarsalis 
PV7-3389 El Paso Co., TX 1987 Cx. quinquefas. 
PVO-620 Dallas, TX 1989 Cx. quinquefas. 
Coav750 Riverside Co., CA 1998 Cx. tarsalis 
Iv 824 Imperial Co., CA 1978 Cx. tarsalis 
Soue135 Los Angeles, CA 1985 Cx. stigmatos. 
P17797 Dallas, TX 1966 Human 
72V1165 Chaves Co., NM 1972 Cx. tarsalis 
68V1587 Hale Co., TX 1968 Cx. inornata 
TD6-4G Dallas, TX 1966 Cx. pipiens 
I 
B 
72V4749 Washington Co.,CO 1972 Cx. tarsalis 
II L695121.05 South Florida 1969 Cx. nigripalpus 
 69M1143 Polk Co., FL 1969 Procyon lotor 
 Kent904 Calvert City, KY 1956 Colaptes auratus 
 Tex16017 Texas ? unknown 
 TexU1193 Texas ? unknown 
 TexM6 Texas ? unknown 
 Texas1955 Rio Grande Valley,TX 1955 Human 
 
A 
SpAn9398 Sao Paulo, Brazil 1968 Akodon sp 
 83V4953 Houston, TX 1983 Cx. quinquefas. 
 PV1-2419 Corpus Christi, TX 1991 Cx. quinquefas. 
 98V3181 Houston, TX 1998 Cx. quinquefas. 
 TNM4711K Memphis, TN 1974 Cx. pipiens 
 
B 
GHA-3 Tampa Bay, FL 1962 Human 
 C Imp1311 Imperial Co., CA 1991 Cx. tarsalis 
  Chlv587 Riverside Co., CA 1992 Cx. quinquefas. 
  Chlv374 Riverside Co., CA 1991 Cx. tarsalis 
  Imp917 Imperial Co., CA 1988 Cx. tarsalis 
  Kern217 Kern Co., CA 1989 Cx. tarsalis 
  75v14868 Memphis, TN 1975 Cx. pipiens 
  MSI-7 Mississippi 1975 Passer domesticus 
  75256PG-3 Maryland 1975 Cx. pipiens 
  VP34 Prince Georges City, MD 1977 Cx. pipiens 
  FortWash Maryland 1977 Cx. pipiens 
  FL79-411 Florida 1979 Cx. nigripalpus 
 D P15 Tampa Bay, FL 1962 Cx. nigripalpus 
  TBH-28 Tampa Bay, FL 1962 Human 
 
 
 
 65V310 
PanAn902604 
Mexico 
Panama 
1965 
1973 
Butorides virescens
Cormorant 
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Table 2-2 St. Louis Encephalitis Virus Classification Scheme, Continued 
 
Table adapted from lineages proposed by Kramer & Chandler, 2001. 
 
 
 
 
 
 
 
 
 
Lineage Cluster Strain Location Year Host 
II E Hubbard St. Louis, MO 1937 Human 
  Parton St. Louis, MO 1933 Human 
 F Gmo94 Guatemala 1969 Cx. nigripalpus 
III  79V2533 Sante Fe, Argentina 1979 Cx. spp 
IV  Gml902612 Panama 1973 Haemag. equinus 
  PanAn902745 Panama 1973 Haemag. lucifer 
  Gml902984 Panama 1977 Mansonia dyari 
  Gml902981 Panama 1977 Mansonia dyari 
  Gml900968 Panama ? unknown 
V A BeAn242587 Belem, Brazil 1973 Cx. declarator 
  75D90 Peru 1975 Mosquito sp 
  BeAn248398 Brazil ? unknown 
  78V6507 Santa Fe, Argentina 1978 Cx. pipiens 
  BeAn246407 Belem, Brazil 1973 Hylo. poecilonota 
  TR9464 Trinidad 1955 Psorophora ferox 
 B BeAn246262 Belem, Brazil 1972 Opossum 
  BeH203235 Brazil 1971 Human 
  BeAr23379 Belem, Brazil 1960 Sabethes belisarioi 
VI  GML903797 Panama 1983 Sentinel chicken 
VII  CorAn9124 Argentina 1966 Calom. musculinus 
  CorAn9275 Argentina 1967 Mus musculus 
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 (Kramer and Chandler, 2001). These findings suggest that SLEV first arose (or was 
introduced) and successfully established in South America prior to evolution and 
dispersal into North America. Further evidence of this theory is that all flaviviruses 
associated with Culicine mosquitoes are found in South America, but few of them are  
found in North America. In all likelihood, one theory suggests that several different 
flaviviruses were introduced to South America from the Old World in the last few 
centuries, rather than a single virus diverging into all of the New World flaviviruses 
(Gould et al, 2003). 
Interestingly, no clear differences have been found between isolates from multiple 
host sources, including mosquito, avian, or human suggesting conserved evolution in the 
envelope region despite phenotypic differences associated with geographic origin 
(Kramer and Chandler, 2001).  Evolutionary pressures have likely contributed to the 
segregation of North American genotypes by species of mosquito, as seen with Culex 
tarsalis vectored transmission of Lineage I viruses (formerly genotype III by ONF, as 
shown in a classification scheme proposed by Trent et al, 1980) in the western states 
(especially California) [Burke and Monath, 2001].  
Natural History 
Amplification Cycle  
 In nature, SLEV is maintained in the same mosquito-bird-mosquito cycle as West 
Nile virus (see Figure 2-7), with periodic amplification by peridomestic birds and Culex 
species mosquitoes. Unlike WNV, the St. Louis encephalitis virus cycle is silent in nature 
and does not cause disease (morbidity or mortality) in wild birds (McLean et al, 2001; 
CDC, 2007j).  An amplification cycle is necessary to achieve mosquito infection rates 
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sufficient to allow “spillover” of the virus from the enzootic/epizootic cycle into the 
human population to cause an epidemic (Shaman et al, 2004). 
 Vectors 
In the eastern and mid-western United States, principal mosquito vectors of SLEV 
are Culex pipiens and Culex quinquefasciatus complexes, which lay eggs in polluted 
water and gain high population densities in urban-suburban environments (Monath, 
1979). In contrast, frequent human exposures occur in rural areas in western states due to 
Culex tarsalis activity as it breeds in irrigated or flooded arid regions with a widespread 
distribution. In Florida, the principal epidemic vector is the tropical mosquito Culex 
nigripalpus, which is commonly found in central and southern counties in the state. The 
majority of human cases in the US have occurred in regions with Cx. pipiens and Cx. 
nigripalpus transmission cycles (Monath, 1979; Burke and Monath, 2001).  
Culex pipiens is known as the northern house mosquito, whereas Culex 
quinquefasciatus is considered the southern equivalent, and it is often difficult to 
distinguish between the two species. Cx. pipiens complex mosquitoes are important in 
urban epidemics of SLEV, especially in the Midwest and Texas. Cx. pipiens female 
mosquitoes primarily feed on birds, whereas Cx. quinquefasciatus females prefer avian 
blood but readily also feed on mammals (CDC, 1993).  
Culex nigripalpus ranges northward from northern South America and can be 
found in southeastern states. Cx. nigripalpus is an opportunistic feeder on mammals and 
birds, with a seasonal shift of host feeding practices demonstrated in Florida.  Peak 
abundance usually occurs between August to December, and Cx. nigripalpus has 8 to 10 
generations per year, with up to 15 broods in Florida (CDC, 1993). 
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Culex tarsalis is the primary enzootic and epidemic vector of SLEV (and WEEV) 
in agricultural areas in western states. Unlike other Culicine species, Cx. tarsalis is an 
avid biter of humans and feeds readily on people outside during dusk and dawn hours in 
summer months. Cx. tarsalis females may  travel up to 10 miles in two nights and may 
spread up to 25 miles from breeding sites, leading to widespread transmission (CDC, 
1993).  
Culex restuans has also been implicated as an efficient vector of SLEV in the 
laboratory and SLEV has been isolated in field collected mosquito pools.  This species 
feeds primarily on birds, has early season abundance in the spring and breeds throughout 
the summer in cooler regions.  However, its role as either an epizootic or enzootic vector 
is uncertain (CDC, 1993).  
In Central and South America, the transmission cycle for SLEV is not well 
defined, and other mosquito genera may be involved.  In this region, SLEV has been 
isolated from 11 different genera, including Mansonia, Haemagogus, Sabethes, as well as 
Culicine species of mosquitoes (Reisen, 2003).  
 Amplifying Hosts 
Vertebrate hosts for the virus to amplify in are also critical to maintenance of the 
enzootic cycle. Primary reservoir hosts for SLEV include the avian orders Passeriformes 
(perching birds/songbirds) and Columbiformes (pigeons and doves). In North America, 
house sparrows, house finches, mourning doves, pigeons, blue jays, robins, and cardinals 
are competent bird reservoirs for SLEV (CDC, 1993). Generally, infection with SLEV 
does not result in morbidity or mortality in amplifying wild bird species (CDC, 2007j). 
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Birds involved in the urban transmission cycles of SLEV throughout the eastern 
and central regions are peridomestic species, where Culex pipiens mosquitoes are also 
abundant.  House sparrows and pigeons that live in close proximity to the human 
population are the primary avian amplifying hosts in these environments.  Conversely, 
the mourning dove, blue jay and cardinal (as well as the house sparrow and pigeon) have 
been found to be important amplifying hosts in Florida, where the primary vector is 
Culex nigripalpus (CDC, 1993).   
In Florida, resident juvenile and nestling wild birds are primary vertebrate 
amplifying hosts for SLEV because young birds have reduced mobility, poorly developed 
immune systems, and sparse feather coverage to enable blood-feeding by mosquitoes 
(Day and Stark, 1999).  It is possible that SLEV transmission cycles may also include 
mammals, such as the raccoon, armadillo and cotton rat in some regions of the state 
(CDC, 1993; Day et al, 1995). 
In Central and South America, SLEV has been isolated from a wide variety of 
wild bird genera, including egrets, herons, and cormorants. In this region, wild birds may 
not be the primary amplifying hosts in tropical America as many tropical mosquito 
species frequently feed on mammals. Evidence of SLEV infection has been found in a 
variety of forest mammals (Reisen, 2003). Coupled with distinct genetic differences 
between North and South American strains of SLEV (Kramer and Chandler, 2001), these 
findings indicate that there may be important differences in the ecology and 
epidemiology of SLEV amplification and transmission in tropical America (Reisen, 
2003).  
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Incidental Hosts 
Mammals in North America generally do not develop high titers of SLEV and do 
not contribute to the amplification cycle.  As such, they are considered “dead-end” hosts. 
Humans, horses, and other mammals are not preferred reservoir hosts and do not 
contribute to SLEV amplification; only low levels of virus circulate in the bloodstream 
(CDC, 2005j).   
In North America, human SLEV infections are reported annually (Calisher, 1994; 
CDC, 2007j). From 1964 to 2006, 4658 SLEV encephalitis cases were identified in the 
United States (7% mortality rate). However, less than 1% of all SLEV infections are 
clinically apparent and the vast majority of infections remain undiagnosed (CDC, 2007k). 
Conversely, it is important to note that severe encephalitic disease and fatalities are very 
rare in humans in the Caribbean, Mexico, Central and South America, similar to recent 
findings for West Nile virus (Gubler, 2007). 
 Unlike WNV, SLEV is not pathogenic for equines (Monath, 1979).  Horses are 
frequently infected in nature without known clinical pathology, but are susceptible to 
lethal encephalitis after intracerebral inoculation of SLEV in experimental studies (Burke 
and Monath, 2001).  SLEV has been isolated, or neutralizing antibodies detected, in other 
mammals, including bats, bears, moose, and nonhuman primates. The exact role of these 
animals to maintenance or amplification of the virus has not been shown; they are more 
likely to have minimal contribution to persistence of SLEV (Sulkin, Sims and Allen, 
1966; Allen, Taylor and Sulkin, 1970; Trainer and Hoff, 1971; Dunbar, Cunningham and 
Roof, 1998).  In Florida, neutralizing antibodies to SLEV have been detected in a cotton 
mouse, opossums, raccoons, horses and dogs.  SLEV was also isolated from one raccoon 
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during these wild vertebrate studies; however, the exact role of these hosts in the SLEV 
amplification and transmission cycle is unknown (Bigler et al, 1975). 
Ecology & Habitat 
 Geographic Location 
SLEV is widely distributed from Argentina to Canada (Calisher, 1994). SLEV has 
been isolated in the United States, Central and South America, and the Caribbean islands.  
There is no evidence that SLEV exists naturally outside of the western hemisphere (Luby, 
Sulkin and Sanford, 1969). In the United States, SLEV is an endemic (occasionally 
epidemic) disease west of the Mississippi River; whereas in eastern states, it periodically 
reappears in epidemic form. These epidemics primarily occur in the Mississippi-Ohio 
River Valley, eastern Texas and central Florida (Monath, 1979; Calisher, 1994).  In the 
United States, SLEV human cases occur annually (Calisher, 1994), whereas only a small 
number of cases have occurred in South America with no large outbreaks of the virus 
(Kramer and Chandler, 2001).   
The ecology of SLEV is closely tied to its mosquito vectors as the virus cycles 
between bird and mosquito hosts.  As described on page 71, four genetic lineages of 
SLEV were previously defined based on oligonucleotide fingerprinting patterns that 
correlated with avian and mosquito transmission cycles in North America: 1) central and 
Atlantic states including the Mississippi flyway (Cx. quinquefasciatus or Cx. pipiens 
cycles), 2 & 3) Florida epidemic and enzootic strains (associated with Cx. nigripalpus 
cycles), and 4) western states’ strains (Cx. tarsalis cycles). This distribution suggests that 
SLEV is maintained in each region in local reservoir hosts or vectors and the virus may 
have become adapted to the mosquito species (Calisher, 1994). Recent phylogenetic 
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analysis supports the relationship between Culex tarsalis cycles in the western United 
States (Kramer and Chandler, 2001).  
 Consequently, geographic regions that maintain or contain favorable habitats for 
Culicine mosquito vectors and wild bird hosts are predisposed to enzootic transmission 
and epidemics of SLEV based on the feeding behavior and preferences of these vectors 
(CDC, 1993).  Outbreaks of SLEV in the United States have highlighted the importance 
of favorable mosquito habitats to the transmission of disease. For example, cases in the 
St. Louis 1933 epidemic were clustered among residents living in lower income housing 
located near inadequate open drainage/sewer ditches that produced large Culex sp. 
mosquito populations (Lumsden, 1958).  In contrast, Culicine mosquitoes were more 
abundant in extensively irrigated and landscaped upper socioeconomic level 
neighborhoods as compared to lower income neighborhoods with minimal landscaping in 
California (Reisen, 2003). An epidemic in Philadelphia, Pennsylvania in 1964, cases 
were clustered near the Delaware River and an outbreak in Corpus Christi, Texas in 1966, 
human cases were related to residence in areas of the city which had open storm sewers 
(Luby, Sulkin and Sanford, 1969). 
 Culicine mosquito larval habitats vary depending on the species and benefit from 
both natural and man-made habitats.  Cx. nigripalpus larval habitats consist of near-
permanent bodies of water (i.e. ditches, catch basins and grassy pools) and occasionally 
larvae may be found in artificial containers (i.e. tires, wading pools).  Cx. nigripalpus 
mosquitoes are primarily restricted to forest habitats.  Adults congregate in areas of dense 
vegetation, such as cypress or oak hammocks, during the day.  In contrast, Cx. pipiens 
larvae are found in water with high organic content, but may also be found in clean water 
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sources. During dry seasons, Cx. pipiens population densities rise as organic 
concentrations increase due to water evaporation. Larval habitats include roadside 
ditches, ponds, construction sites, as well as artificial containers including tires, 
abandoned swimming pools, and tin cans. During the day, adults prefer to rest in dark, 
damp shelters (storm sewers, cellars, culverts).  Cx. quinquefasciatus larval habitats are 
similar to those described for Cx. pipiens (CDC, 1993).  
  Ecologic niches with the appropriate habitat for these viruses may be artificially 
created from human influence in certain geographic regions. The expanded development 
of suburban environments across North America has contributed to an increase in 
populations of peridomestic bird species, such as house sparrows, blue jays, robins, and 
cardinals. Extensive irrigated farmlands throughout the western states have been 
correlated to increased populations of wild bird species, as well as to Culex tarsalis 
vectored transmission of SLEV (and WEEV), where they afford extensive breeding 
grounds for the mosquitoes. Consequently, modification of natural habitats in these 
regions has provided additional food and shelter for vector mosquitoes and amplifying 
hosts, which increases human risk as all elements for virus transmission are brought 
closer together (CDC, 1993). 
 Seasonal Transmission 
 The seasonal timing of amplification and transmission cycles of SLEV from 
spring through late summer/early fall has been well-documented (Reeves and Hammond, 
1962; Monath et al, 1980; Tsai et al, 1989; Day and Curtis, 1993; Shaman et al, 2004a).  
The disease appears first in July, with peak incidence in August and September (Burke 
and Monath, 2001).  Human cases nearly always occur from mid to late summer and into 
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early fall (Reisen, 2003). In southern latitudes, SLEV transmission activity may occur 
year-round, with onset of illness in humans as late as December (Monath and Tsai, 1987; 
Hayes et al, 2005b). In south Florida, the annual dynamics of SLEV transmission can 
divided into four phases: 1) maintenance in January-March, 2) amplification in April-
June, 3) early transmission in July-September, and 4) late transmission in October-
December (Day and Curtis, 1993). 
 The efficiency and rate of transmission depends heavily on the mosquito host, as 
the majority of the SLEV transmission cycle is spent in the mosquito.  The mosquito 
body temperature roughly parallels ambient environmental conditions (Meyer, Hardy and 
Reisen, 1990), where the duration of the extrinsic incubation period decreases and rate of 
transmission increases with warmer temperatures (Reisen, 2003).  Human cases appear to 
occur relatively late in the transmission season (Monath, 1980) after considerable 
amplification in the primary bird-mosquito cycle results in spillover to the human 
population (Reisen, 2003; Shaman et al, 2004). Cooler weather then slows virus 
replication and initiates mosquito diapause (temporary interruption in development of 
eggs or larvae, associated with a dormant period) in the late fall months in temperate 
regions (Reisen, 2003).   
 Most evidence indicates that maintenance of SLEV occurs in local winter 
reservoirs in North America, with the possibility of reintroduction of the virus from South 
America by migrating birds or bats involved in year-round transmission cycles.  Several 
studies have investigated mosquitoes and wild birds to identify a local reservoir of 
infection; however, the mechanism for maintenance of SLEV during winter months is 
still unclear (Burke and Monath, 2001).  SLEV has been isolated from hibernating adult 
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female Cx. pipiens mosquitoes (Bailey et al, 1978), and vertical transmission 
(transovarial route- an infected female mosquito transmits virus to her progeny) of SLEV 
has been experimentally demonstrated for Cx. pipiens, Cx. restuans and Cx. 
quinquefasciatus (Nayar, Rosen and Knight, 1986).  Venereal transmission (vertically 
infected males sexually transmit virus to females) has also been reported in Culicine 
mosquitoes (Shroyer, 1990).  
Overall, the mechanisms for SLEV persistence and long distance transport have 
not been resolved. Current genetic data has not provided conclusive evidence for the local 
maintenance and emergence of new strains or to the local extinction and annual re-
introduction of similar SLEV genotypes (Reisen, 2003). Although introduction by 
migratory birds has been suggested as a mechanism for initiation of spring transmission, 
this hypothesis has not been substantiated as migrants are rarely positive for virus 
(Calisher et al, 1971) nor have antibody from previous arbovirus infections (Reisen et al, 
2000b). This indicates that they are not a likely source for SLEV introduction (Reisen et 
al, 2003).  Recent evidence for WNV indicates that migratory birds have dispersed the 
virus throughout North America and into South America (Gubler, 2007), but the 
reintroduction of South American WNV strains to North America has not been shown. 
 In Florida, extensive arboviral surveillance studies were conducted from the late 
1950s to 1971, when research activities associated with the Florida Department of Health 
Epidemiology Research Center in Tampa Bay were discontinued (Monath and Tsai, 
1987). Extensive field studies characterized this research period, which was launched to 
investigate SLEV following human outbreaks in the state, and hundreds of arbovirus 
isolates were obtained from mosquitoes and wild vertebrate hosts (Wellings, Lewis and 
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Pierce, 1972).  From 1963 to 1970, only 4 of 697 arbovirus isolates were identified as 
SLEV: 1 isolated from a raccoon in October and 3 isolated from Cx. nigripalpus pools in 
November. These 4 isolates were obtained in 1969 during a sporadic human outbreak of 
SLEV in Polk County (3 human cases), apparently an interepidemic year of SLEV 
transmission. The authors concluded that all virus strains isolated, except SLEV, were 
endemic during that time period (i.e. EEEV, WEEV [HJV], Keystone virus, Tensaw 
virus, etc). As such, SLEV appeared to be an “exotic agent” that was reintroduced into 
Florida during 1969, but failed to survive the severe 1969-1970 winter as no evidence of 
SLEV activity was detected in the following year (Wellings, Lewis and Pierce, 1972).  
Unfortunately, the “heyday” of arbovirology (and funding) waned in the 1970s and the 
mechanism for continued survival or reintroduction of SLEV remains unknown. 
 Contribution of Climatic Conditions 
 Historically, the distribution of North American mosquito-borne encephalitis 
epidemics has been delineated by temperature, with Western Equine Encephalitis virus in 
the north (California) and SLEV predominating as the etiologic agent in southern 
latitudes (Hess, Cherubin and LaMotte, 1963; Reisen, 2003).  Extraordinarily cold 
weather may also impact virus transmission cycles in Florida.  For example, a widespread 
freeze in central Florida during the winter of 1989-1990 altered ecological habitats by 
removing understory vegetation. This may have enhanced mourning dove populations the 
following spring, which contributed to extensive SLEV amplification during the 1990 
epidemic year (Day and Stark, 1999).  
 In addition to temperature, important abiotic factors such as rainfall, humidity and 
drought influence SLEV amplification and transmission cycles in both the mosquito and 
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avian host.  Wetting (precipitation) in the form of winter rainfall and snow pack in the 
west (Wegbreit and Reisen, 2000) or summer rainfall in the east (Day and Curtis, 1989) 
creates oviposition and larval habitats for mosquito species.  In rural mosquito species, 
studies found that Cx. nigripalpus and Cx. tarsalis increase in abundance as rainfall 
creates new habitats, as they can breed in surface pools (Day and Curtis, 1989; Day, 
Curtis and Edman, 1990; Reisen, 2003). In contrast, urban mosquito species such as Cx. 
pipiens increase in abundance when rainfall decreases and municipal drainage systems 
dry up, creating pools, which favors Cx. pipiens that prefers breeding in drainage 
systems.  Rainfall patterns also influence bird survival, nestling success, and number of 
broods per year, as wetting directly impacts plant and insect food availability. These 
factors are important to arboviral transmission, although the full impact of bird survival 
measures may be delayed until the next transmission season (Reisen, 2003). 
 Humidity levels also may influence vector-host seeking behavior and impact 
transmission.  Elevated humidity tends to enhance transmission efficiency, as humid 
environments increase vector survival.  During dry periods, mosquito host-seeking is 
arrested, which allows virus infections in gravid and parous vectors to complete extrinsic 
incubation.  Once rainfall resumes, humidity rises and initiates mosquito host-seeking 
behavior resulting in synchronized transmission events (Reisen, 2003).  Day and Curtis 
(1989) also found that the tropical Cx. nigripalpus vector only blood feeds after humidity 
levels increase following rainfall. 
 One of the most important abiotic factors leading to increased amplification of 
SLEV and outbreaks of disease is drought.  In 1933, a summer drought with low rainfall 
concentrated sewage in creeks surrounding St. Louis, which led to large populations of 
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Cx. pipiens mosquitoes and spread of the disease (Lumsden, 1958).  Researchers 
investigating the 1990 epidemic in Florida also implicate drought as a necessary factor 
for epidemic SLEV activity (Shaman, Day and Steiglitz, 2003 & 2004). The authors 
suggest that three conditions created the 1990 human epidemic in Florida: 1) large 
population of susceptible wild birds, 2) severe springtime drought, and 3) continued 
rainfall and wetting of the land surface in summer and early fall (Shaman, Day and 
Steiglitz, 2004).  The severe springtime drought facilitated amplification of SLEV among 
wild bird and Cx. nigripalpus populations, and summer and fall wetting sustained large 
numbers of infective Cx. nigripalpus mosquitoes. This investigation found that 
antecedent drought is a necessary (although not sufficient) condition for SLEV 
amplification and transmission in Florida, such that drought is associated with spatial-
temporal variability of human cases and SLEV epicenters are identifiable with drought 
and wetting foci (Shaman, Day and Steiglitz, 2004). 
 The mechanism of drought-induced amplification and transmission of SLEV (and 
WNV) has been proposed to relate primarily to mosquito-wild bird interactions in 
Florida. Although Cx. nigripalpus populations increase during very dry conditions 
preceding heavy SLEV transmission, it is believed that drought restricts Cx. nigripalpus 
activity to more humid, densely vegetated hammock habitats. In addition, drought periods 
in southern Florida usually occur during the spring, when nesting wild birds also reside in 
the hammocks. Consequently, drought drives mosquito vectors and amplifying wild bird 
hosts into contact with one another providing an ideal environment for rapid epizootic 
amplification of SLEV. Once water resources increase following summer and fall 
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wetting, infected mosquitoes and wild birds disperse and carry SLEV out of the 
hammocks (Shaman, Day and Steiglitz, 2005). 
Clinical Disease 
Human 
SLEV causes an acute illness in man, with a spectrum of CNS manifestations 
from self-limited fever plus headache to fatal meningoencephalitis (Monath, 1979). 
Primarily, three clinical syndromes have been reported including encephalitis, aseptic 
meningitis, and febrile headache, although most SLEV infections are asymptomatic 
(Calisher, 1994; CDC, 2007j). The disease is generally milder in children than in adults, 
but in those children with the disease, there is a high rate of encephalitis. The elderly are 
at highest risk for severe disease and death (CDC, 2007j), as nearly 90% of elderly SLEV 
patients develop encephalitis (Calisher, 1994).  The overall case fatality rate is 
approximately 7%, but can be significantly influenced by age as shown below (CDC, 2007j).   
The severity of SLEV disease in humans is greatly dependent on age. During 
epidemics, incidence of disease in people older than 60 is generally 5-40 times greater than in 
people less than 10 years old.  Encephalitis is the most severe symptom of SLEV infection, 
and it is also age-dependent.  Frequency of encephalitis increases from 56% for those aged 20 
or younger to 87% for those over 60.  In addition, mortality is 7-24% among those over 50, 
and less than 5% for those under 50 (Shroyer, 1990).   
Since its discovery, SLEV has been responsible for over 1,000 deaths, more than 
10,000 severe clinical illnesses, and over 1 million mild or subclinical infections (Calisher, 
1994).  The ratio of apparent to inapparent infection is 1:806 in children, as compared to 1:85 
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in the elderly (Burke and Monath, 2001). From 1964 to 2006, there have been 4,658 human 
encephalitis cases of SLEV reported in the US (see Figure 2-8) [CDC, 2007l]. 
A period of prolonged convalescence occurs in 30 – 50% of patients, 
characterized by memory loss and headaches, asthenia, irritability, tremulousness, 
sleeplessness, and depression lasting up to 3 years.  Approximately 20% of these cases 
have long-term sequelae or persistence of these symptoms, including gait and speech 
disturbances, tremors, and sensorimotor impairment.  Old age and severity of acute 
illness predispose patients to these types of sequelae (Burke and Monath, 2001). 
However, in endemic areas where the human population has high rates of acquired 
immunity, illness peaked in children and was low in older residents (Reeves and Hammon, 
1962).  In Florida, cross-protective disease protection may have modulated or moderated 
SLEV infections, where incidence of encephalitic disease was significantly lower in patients 
previously infected with dengue virus (protective immunity) during an epidemic of SLEV 
(Bond and Hammon, 1970).  Interestingly, humans are frequently infected with SLEV in 
California but clinical disease is rare, which may be influenced by genotype of the infecting 
strain (Reisen and Charles, 1997).  
SLEV isolation from CSF or serum is very unusual, although it has been 
recovered from fatal cases in the following tissues: brain, liver, kidney, spleen, and lung. 
IgM antibodies appear in sera with the first 4 days after onset, peak at 7 to 14 days, and 
decline afterward. In 25% of patients, IgM antibody may persist for up to one year 
(Burke and Monath, 2001). Antibodies are generally present at the time of onset of 
symptoms due to the relatively long incubation period (4 to 21 days) of SLEV. As such, 
viremia is believed to be short in duration (Calisher, 1994).  
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Avian 
Enzootic SLEV transmission is silent in nature with no reports of avian mortality, 
unlike the high rates of avian mortality associated with WNV in the western hemisphere 
(Komar, 2001; Edison et al, 2001; Lanciotti and Kerst, 2001).  Several studies have evaluated 
viremia and/or serological responses to SLEV infection in wild and domestic birds (McLean 
and Bowen, 1980; McLean et al, 1983; Reisen et al, 1994, 2000, 2001, & 2003; Day and 
Stark, 1999; Reisen, 2003; Fang and Reisen, 2006; Reisen and Hahn, 2007).  Overall, acute 
SLEV infection in most birds is characterized by a low titered, short-lived viremia detected 
between 1 to 5 days post-infection that does not produce clinical illness (McLean and Bowen, 
1980; Reisen et al, 1994; Fang and Reisen, 2006; Reisen and Hahn, 2007).  As a result, 
diagnosis of bird (and animal) infections by virus isolation from field populations is 
extremely difficult and occurs infrequently (Reisen, 2003). 
In California, Reisen et al. (2003) found that only 6 out of 22 wild bird species 
developed sufficient viremia after experimental inoculation with SLEV to become competent 
host species.  These findings may, in part, be explained by the low viremogenic capacity of 
SLEV strains associated with Cx. tarsalis in the west, as compared to isolates from Cx. 
pipiens mosquitoes in eastern states (Bowen et al, 1980).  Consequently, the strain of SLEV 
inoculated, as well as the bird species and age at time of infection result in markedly different 
viremic responses in avian hosts (highest titers between 2-4 DPI) [Bowen et al, 1980].  In 
general, immature birds produce a higher viremia than adults in response to SLEV infection 
(Reisen, 2003) and SLEV isolations have been more successful from nestling birds, where 
viremias are typically higher (McLean and Bowen, 1980). 
Regardless of viremic response, most birds develop detectable antibody titers to 
SLEV (Calisher et al, 1986c) and produce an IgM response to infection (Calisher et al, 
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1986c; Reisen et al, 1994 & 2003).  This characteristic response has been exploited for 
decades as a reliable indicator of arboviral transmission activity in sentinel chicken programs 
throughout the United States (Komar, 2001). For example, adult chickens develop high 
antibody titers when infected with SLEV and are useful as sentinels (Day, 1989; Reisen et al, 
1994 & 2000; Day and Stark, 1999; Blackmore et al, 2003).  Importantly, mature chickens 
rarely produce detectable viremias and therefore are not competent hosts capable of infecting 
mosquito vectors (Reisen et al, 1994; Langevin et al, 2001).  In 1977, sentinel chicken 
seroconversions to SLEV were noted one month before the first human case in Florida to 
provide an early warning of epizootic activity, whereas wild bird seroconversions appeared 
late (Monath, 1979).  
 The recent introduction of West Nile virus into North America renewed interest in 
St. Louis encephalitis virus, as prior to 1999, the geographic distributions of SLEV and 
WNV did not overlap.  The rapid spread of WNV across the United States and its 
establishment in regions historically endemic for SLEV, including Florida, California and 
Texas, raised questions about the ability of both viruses to coexist during the same and 
subsequent transmission seasons (Lillibridge et al, 2004).  Initial evidence suggests that 
SLEV activity disappears for a few years before rebounding to low levels following the 
introduction of WNV, such as has been reported in Texas (Lillibridge et al, 2004) and 
Florida (Stark and Kazanis, 2002-2006). In California, WNV spread to the southern part 
of the state in 2003 during active SLEV transmission, but as with Florida and Texas, 
SLEV disappeared in 2004-2005 (Fang and Reisen, 2006).   
Consequently, the impact of acquired immunity to one virus in avian hosts may 
limit or prevent subsequent infection (and amplification) by another closely related virus, 
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such as appears to be the case for WNV transmission followed by SLEV.  A recent study 
tested this hypothesis by infecting house finches with either SLEV or WNV, followed by 
challenge six weeks later with either the homologous (same) or heterologous (different) 
virus (e.g. WNV/WNV, SLEV/WNV, etc).  Initial infection with West Nile virus resulted 
in sterilizing immunity in house finches against both viruses upon challenge.  In contrast, 
previous infection with SLEV only provided protection against subsequent challenge 
with a homologous virus, i.e. preventing a second SLEV viremia. When the original 
SLEV birds were challenged with the heterologous virus instead, WNV was still able to 
infect these birds and significant viremias developed (range from 102.7-6.4 pfu/ml) capable 
of infecting mosquitoes.  As a result, WNV infections appear to prevent subsequent 
SLEV infections in wild birds and may impact arboviral amplification and transmission 
cycles where these viruses coexist.  Conversely, previous infection with SLEV in house 
finches does not induce sterilizing immunity that would prevent subsequent WNV 
infection and development of high titered WNV viremias (Fang and Reisen, 2006). 
Geographic Strain Differences of SLEV 
Early oligonucleotide fingerprinting (ONF) studies indicate that enzootic strains 
of SLEV vary from isolates collected during epidemics. ONF identified 6 groupings of 
SLEV from different geographic locations (Trent et al, 1980 & 1981), where virulence 
and neuroinvasiveness of disease in mice and monkeys correlated with ONF patterns and 
geographic origin of SLEV isolates (Trent et al, 1980; Monath et al, 1980).  These 
studies classified SLEV strains based on 1) high virulence, 80-100% mortality rates; 2) 
intermediate virulence, variable mortality rates; and 3) low virulence, no or minimal 
mortality for entire dose range. In North America, the authors concluded that 90% of 
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SLEV strains isolated in epidemic years were highly virulent (n=27), with the remaining 
10% of intermediate virulence (n=3).  In contrast, isolates obtained during non-epidemic 
years were of low or intermediate virulence (n=14), with only 29% virulent for mice 
(n=4). In Florida, six strains isolated during epidemic years (in 1962 and 1977) were of 
high virulence, as compared to two avirulent strains isolated in an interepidemic year 
(1969) [Monath et al, 1980]. 
 Similar to North America, strains isolated throughout the Caribbean, Central and 
South America could be grouped into high, intermediate, and low virulence categories.  
Unlike the majority of isolates studied from the United States, these strains were 
considered endemic (or enzootic) since they were either associated with sporadic human 
cases or were obtained in absence of human clinical illness during field studies.  Despite 
low levels or absent human cases, 52% of strains were highly virulent (n=12) whereas 
48% were completely or partially attenuated in mice (n=11). In general, attenuated strains 
occurred more frequently in the southern part of South America (Monath et al, 1980). A 
companion paper to this mouse study investigated the virulence of many of these North 
and South American SLEV strains in two species of avian hosts, nestling and adult house 
sparrows (Passer domesticus) and 3-week old chickens (Gallus gallus) [Bowen et al, 
1980]. Bowen et al. (1980) found that variations in virulence by geographic region in 
mice correlated well to viremogenic capacity of SLEV in birds (also high, intermediate, 
and low). 
Epidemiology 
In the United States, national surveillance for SLEV began in 1955. Since the 1960s, 
epidemics of SLEV have occurred approximately every 10 years and epidemic attack rates 
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range from 1 to 800 per 100,000 population (Calisher, 1994). In eastern states, 
serosurveys conducted during epidemics in urban areas indicate a 6% incidence of SLEV 
infection. A survey conducted in both rural and urban Indiana residents found an overall 
seroprevalence of 3.6% to SLEV, with an estimated annual infection rate of 0.32% 
(Burke and Monath, 2001). In California, surveys have detected a range of 
seroprevalence rates (<1% to 11%) throughout the state. In sum, these low 
seroprevalence rates indicate that there would be minimal protection in the North 
American population by acquired immunity to SLEV in the event of an epidemic (Reisen, 
2003). 
The epidemiology of SLEV differs dramatically in the United States.  In western 
states, SLEV transmission is an endemic (occasionally epidemic) disease transmitted by 
Cx. tarsalis mosquitoes that affects the non-immune childhood population.  In contrast, 
SLEV transmission in eastern states is characterized by explosive epidemics. SLEV is 
absent or at low levels during interepidemic periods, with no accumulation of immunity 
with age. The disease primarily affects elderly populations and is transmitted by Cx. 
pipiens, Cx. quinequfasciatus or Cx. nigripalpus mosquitoes (Monath et al, 1980). Other 
risk factors include residence (southern United States), outdoor occupation, and 
socioeconomic status related to the distribution of human SLEV cases.  The decline in 
SLEV cases over time paralleled the increase in television ownership and air 
conditioning, as well as lowered antibody prevalence to SLEV with extensive screened 
housing (Reisen, 2003).  Figure 2-9 illustrates epidemic SLEV activity in the United 
States from human encephalitis cases reported to the CDC since 1964 (CDC, 2007l). 
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In Florida, the first indication that SLEV was a threat to the human population 
occurred in 1952 when the virus was isolated from a 30-year-old Miami man (Sanders et al, 
1953). Human SLEV infections have been classified into four frequencies in the state: 1) no 
cases, seen in the majority of years, 2) focal outbreak, less than 10 cases/year in a clearly 
defined geographical region, as seen in 1958, 1969 and 1993, 3) sporadic outbreak, less than 
10 cases/year over a widespread geographical area, as seen in 1979, 1997 and 1999, and 4) 
epidemic, greater than 20 human cases, which may be focal or widespread (Day and Curtis, 
1999). Major SLEV epidemics occurred in 1959, 1961, 1962, 1977 and 1990 (Shroyer, 1991; 
Day and Stark, 2000). Notably, 333 of 377 clinical cases reported in Florida from 1976 
through 2000 occurred during two epidemics, 1977 and 1990 (Reisen, 2003). 
 In Central and South America, SLEV transmission is endemic in humans, as 
shown by high antibody prevalence in serosurveys conducted in Mexico, Brazil, and 
Argentina.  Prior SLEV infection has been estimated at 13.7% in northwestern Mexico 
(Calisher, 1994), approximately 5% in Brazil (Mondini et al, 2007) and ranging from 3- 
50% in Argentina (Sabbatini et al, 1985) based on SLEV specific antibodies detected in 
the population.  However, these seroprevalence studies should be interpreted cautiously 
in South America as diagnostic tests may be influenced by cross-reacting antibodies to 
dengue virus or other endemic flaviviruses and extensive yellow fever vaccination of the 
population (Mondini et al, 2007). A high prevalence of cross-reactive immunity may 
modulate severe symptoms associated with SLEV infection, such that CNS involvement 
is rarely reported. Epidemics of disease are also rare in the region (Monath et al, 1980; 
Calisher, 1994; Spinsanti et al, 2003; Diaz et al, 2006; Mondini et al, 2007; Gubler, 
2007).  
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Figure 2-9 Epidemics of Human SLEV Cases in the United States, 1964-2006 
Periodic epidemics of St. Louis encephalitis virus have occurred over the last twenty years throughout the United 
States. Confirmed and probable human cases of SLEV infections are shown from 1964-2006, as reported to the CDC. 
The most recent outbreaks (greater than 20 encephalitis cases) occurred in Louisiana in 2001 (n=71 cases) and in 
Florida in 1990 (n=223 cases). [Figure adapted from Reisen, 2003] 
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Molecular Epidemiology 
 Previous oligonucleotide fingerprinting studies have shown that SLEV strains 
have genomic variability and can be classified by their geographic origin (Trent et al, 
1980 & 1981).  These experiments used radioactive RNase T1 digestions of the RNA 
genome to produce a “signature” oligonucleotide fingerprint for each SLEV strain 
studied. Although phenotypic strain differences related to geographic origin and 
virulence in mice and birds were found (Trent et al, 1980 & 1981), these early studies 
were unable to identify the location of nucleotide sequence polymorphisms in the viral 
genome (Kramer et al, 1997). 
In contrast, dideoxy-terminator chain sequence analysis allows for the 
identification of individual nucleotide residues and their location within a genome.  This 
principle has been exploited for molecular epidemiology studies of arboviruses (Gaunt et 
al, 2001), as well as for the recent complete sequencing of the human genome (IHGSC, 
2004).  The partial nucleotide sequence of SLEV was first reported by Trent et al. in 
1987, which identified the coding sequence for the structural proteins and three (out of 
seven) nonstructural proteins (NS1, NS2A/B)  and presented a rudimentary evolutionary 
tree with other flavivirus outgroups.  A decade later, a more sophisticated phylogenetic 
analysis of the (partial) envelope region of strains collected in periods of high and low 
activity in California found no consistent differences, but did detect new genotypes of 
SLEV after 1972 that either were introduced to the region or mutated from earlier strains 
(Kramer et al, 1997).  SLEV isolates throughout the Americas were further investigated 
by studying the complete envelope gene: geographic differences that could be grouped 
into seven lineages based on parsimony analysis were detected (Kramer and Chandler, 
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2001). Consequently, this study provided a framework for the molecular epidemiological 
analysis of SLEV strains. It is now possible for the genotype of newly isolated St. Louis 
encephalitis viruses to be rapidly characterized, such that strain origin, virulence 
classification, and epidemic potential can quickly be ascertained based on nucleotide 
sequence. 
 Since the introduction of WNV in the United States, an epidemic of SLEV has not 
occurred following the appearance and widespread transmission of WNV in a state.  Only 
Louisiana experienced an epidemic of SLEV (n=71 cases) in 2001, when WNV was first 
introduced and concurrently circulated in the state.  In Texas, 19 human cases of SLE 
were reported in 2002 (introduction of WNV to the region) and 17 cases in 2003, but 
both years had less than 20 cases indicative of a epidemic.  From 2004 through 2006, a 
total of 26 sporadic human cases of SLEV have occurred throughout the United States, 
with 5 or fewer cases reported from any single state (CDC, 2007l). Thus far, there have 
been no reported isolations of SLEV or phylogenetic analyses on any strains detected 
since the introduction and widespread transmission of WNV in North America. However, 
this is not the case south of the North American border.  
In South America, SLEV strains represent distinct genotypes from those found in 
North America.  Recent phylogenetic analysis indicates that five lineages occur in South 
America, with up to 161 nucleotide differences (Argentina 1966 strain) from all other 
SLEV isolates (Kramer and Chandler, 2001).  Consequently, annual recrudescence of 
transmission in North America is thought not likely to depend on reintroduction from 
migratory birds or bats infected with South America genotypes (Burke and Monath, 
2001). 
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 Recent outbreaks of SLEV in tropical regions have raised concerns that the mild 
illness typically associated with the virus in South America may have become more 
severe. In 2002, SLEV emerged in Cordoba Province, Argentina with one case of human 
encephalitis after a seventeen year absence from the region (Spinsanti et al, 2003).  
Encephalitic cases in Argentina are rare, despite a widespread distribution of SLEV with 
seroprevalence rates from 3 to 50% of the population (Sabattini et al, 1985).  In 2005, an 
outbreak of SLEV in the same province resulted in 47 laboratory confirmed cases, with 9 
fatalities. Field investigations in response to this outbreak isolated SLEV from two 
mosquito pools. These strains were subsequently sequenced (E gene) for molecular 
epidemiology purposes, and matched to Lineage III subtypes, as proposed by Kramer and 
Chandler in 2001.  This correlates with the single Argentinean isolate previously placed 
in that lineage (Diaz et al, 2006). 
Prior to 2005, only two SLEV isolates from humans have been reported in Brazil 
in 1971 and 1978 from the Amazon region.  Each patient had febrile illness and jaundice, 
without CNS symptoms.  Then, in January of 2004, a female patient was hospitalized 
with fever, severe headache, macular rash, and myalgia with an initial clinical diagnosis 
of “probable dengue fever” in Sao Paulo State, Brazil.  SLEV was isolated from serum 
(designated SPH253175), a portion of the NS5 gene was sequenced (~1 kb at the 3’ 
terminus), and shared 93% nucleotide sequence identity with a Mississippi isolate (MSI-
7) from 1975 (Lineage IIC) [Rocco et al, 2005]. However, dos Santos et al. (2006) 
sequenced the complete envelope region of the Sao Paulo isolate and found that it shared 
~100% nucleotide sequence identity with an Argentinean strain (79V-2533), placing it in 
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Lineage III instead (dos Santos et al, 2006). The discrepancy between the NS5 
phylogenetic analysis and that based on the envelope region was not discussed.  
A community outbreak of SLEV also occurred in Sao Paulo State, Brazil in 2006 
(n=6 human cases).  Simultaneously, a large epidemic of dengue virus (DENV-3 
serotype), with more than 15,000 estimated cases, was reported to various health 
agencies. Despite initial misdiagnosis as dengue infections, six patients were later 
confirmed SLEV positive after dengue and yellow fever etiologies were ruled out. 
Interestingly, three of these cases had clinical symptoms of hemorrhagic disease and is 
the first time that hemorrhagic signs have been linked to SLEV infections.  Yet, dengue 
virus is endemic in the region and previous infections with dengue may confound this 
association. A small portion of the NS5 region was sequenced (159 base pairs) and 
indicated 96% homology to an Argentinean SLEV isolate (Mondini et al, 2007).  
Consequently, molecular epidemiology studies of SLEV strains are rapid, sensitive 
methods that can identify geographic origin, genotype, and phenotypic (virulence) 
characteristics of newly isolated viruses. Such studies are in critical demand to further 
improve epidemiologic analysis and public health prevention and response strategies for 
outbreaks of arboviral disease.  
Economic Burden 
One study has directly assessed the economic costs related to an epidemic of St. 
Louis encephalitis virus in Dallas, Texas during 1966.  This outbreak resulted in 172 
confirmed or probable human cases, with 20 deaths. The total costs associated with the 
Dallas epidemic were estimated at $796,500 in 1966 dollars, with $348,500 needed for 
public health control measures (Schwab, 1968).  Over the last forty years, medical and 
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mosquito control expenses have dramatically increased. Zohrabian et al. (2004) adjusted 
these 1966 dollar figures based on consumer price indices to reflect current prices, in 
2002 dollars.  The authors estimated a total adjusted epidemic cost of $5.4 million, with 
$1.9 million spent on vector and epidemic control expenditures. These adjusted findings 
for the Dallas epidemic are a sharp contrast to the total short-term cost estimates ($20.1 
million) associated with the WNV epidemic in Louisiana during 2002, with 329 reported 
cases and 24 deaths (Zohrabian et al, 2004). 
Schwab (1968) also investigated the broader impact of the 1966 epidemic of 
SLEV on the Dallas community.  Convention, school and theater attendance were 
examined, as well as retail sales and highway usage.  Results identified a mild impact on 
the economy, such that convention attendance was lower during August, coinciding with 
the most intensive national publicity about the epidemic and aerial spraying to control the 
vector population. School attendance, retail sales and highway usage were not 
significantly impacted. Residents may have altered their outdoor activities somewhat, as 
evidenced by decreased attendance at outdoor theaters (especially drive-in movie 
theaters).  Authorities also reported numerous calls from out-of-state residents concerned 
about traveling to Dallas, but tourist and convention business was not significantly 
affected (Schwab, 1968).  The 1990-1991 epidemic in Florida resulted in the closing of 
recreational parks at night, such as Walt Disney World, and cancellation of other evening 
activities (Meehan et al, 2000). As in 1966, publicized health warnings in 1990 also 
prompted out-of-state travelers concerned about the epidemic to contact public health 
agencies on the advisability of traveling to central Florida (L.M. Stark, personal 
communication). The extent of economic impact on Florida’s tourism and convention 
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attendance due to arboviral medical alerts and early closing of businesses is unknown, for 
either SLEV or WNV. 
Public Health Implications 
Currently, there is no approved human vaccine for SLEV (or WNV) and specific 
antiviral therapy is not available for treatment of flavivirus infections (Leyssen et al, 2003; 
Kramer and Shi, 2007). It is unlikely that a SLEV vaccine will be developed, as the cost-
benefit ratio is not high due to the traditionally sporadic, low number of cases that occur 
annually (as compared to WNV) [Reisen, 2003].  The main mode of prevention for SLEV 
and WNV is to control the vector population (mosquitoes) through integrated vector control 
management programs and encourage use of personal protection behaviors. A surveillance 
network of federal, state, and local health departments monitors arboviral activity in humans, 
vectors and wildlife hosts (Gubler, 2002).  The recent introduction of WNV into areas 
historically endemic for SLEV in North and South America, where both viruses share 
mosquito vectors, amplifying hosts and habitat, has unknown consequences. As such, it will 
be of utmost importance to continue to closely monitor flaviviral activity in the western 
hemisphere should competition pressures promote rapid evolution of these viruses (Reisen, 
2003; Gubler, 2007).  
Surveillance for Arboviral Activity 
 Surveillance systems serve as an early warning for the transmission of disease and 
aim to limit or prevent human cases. A surveillance program should quantify arbovirus 
activity at a specific time, predict the likely future course of the transmission cycle, as 
well as indicate when control should be implemented to prevent epizootic or epidemic 
viral transmission. An effective surveillance program requires long-term commitment and  
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proactive projects to gather data in epidemic and interepidemic years. This allows for 
baseline (background) levels to be set and can provide the basis for setting thresholds so 
that prompt decision making for vector control and medical alerts can begin when 
increased activity is detected. Due to the complex life cycles of arboviruses, no single 
technique can collect all the data necessary for accurate risk assessment of vector-borne 
diseases. Thus, multiple detection methods are necessary and threshold levels and 
indicator parameters may vary by region and season.  Current year data should also be 
compared with historical data for the same region as well (CDC, 1993). 
 Successful arboviral surveillance programs focus on components of both the 
enzootic cycle and the epizootic cycle. An ideal program should monitor meteorological 
data (rainfall and temperature patterns which promote development of large mosquito 
populations), vector data (field infection rates, density and age structure of Culicine 
species), avian morbidity and mortality (for WNV), and vertebrate host data (high 
flaviviral antibody prevalence in wild passerine birds will prohibit further viral 
amplification). Active or passive surveillance of encephalitis in unvaccinated equine 
cases can also be useful predictors (CDC, 1993; Blackmore et al, 2003). 
 A few states including Alabama, California, Colorado, Delaware, Florida, Utah, 
Louisiana, Maryland, Nebraska, Nevada, North Carolina, Tennessee, and Texas use 
sentinel chicken flocks scattered throughout regions at greatest risk for WNV, SLEV, 
EEEV and/or WEEV infection (CDC, 1993; Komar, 2001).  Where Cx. tarsalis and Cx. 
nigripalpus are the primary mosquito vectors, these programs provide a sensitive and 
cost-effective method to monitor SLEV transmission activity in western states (Reisen et 
al, 2000b; Scott et al, 2001) and in Florida (Day, 1989).  However, sentinel chickens may 
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not be the perfect indicators for all regions, as they were not useful for detecting WNV 
activity in Cx. pipiens complex associated epidemics in New York City (Komar, 2001; 
Cherry et al, 2001). For example, in Houston, Texas, mosquito infection rates instead of 
sentinel chickens are used for WNV and SLEV surveillance (Chandler, Parsons and 
Randle, 2001). Despite this, domestic chickens are still the most widely used sentinel 
animals for detection of arboviruses, but it is likely that one ideal captive avian sentinel 
truly does not exist (CDC, 1993). The primary advantage of captive bird sentinels is that 
time and place of exposure are known. Conversely, sentinels only detect focal 
transmission and multiple flocks must be placed to accurately represent geographic areas 
(CDC, 2003Aa). 
Surveillance in Florida (State and Local Levels) 
 In Florida, arboviral activity is monitored year-round with several surveillance 
activities, which may include screening of mosquito populations, sentinel chickens, wild 
birds and other animal cases, to detect increased transmission activity and to intervene 
and reduce the risk of transmission to humans.  These activities are coordinated through 
interagency cooperation at local and state levels, where different agencies may participate 
or respond at various times during routine surveillance for arboviruses. Evidence of 
increased transmission activity in nature initiates control measures and intensification of 
surveillance. At the state level, the Florida Interagency Arbovirus Partners Group 
recommends policy. The Florida Department of Health (FDOH)-Bureau of Community 
Environmental Health (BCEH) coordinates statewide surveillance, prevention and control 
programs, as well as reports epidemiologic information to participating agencies and 
recommends health alerts.  The Department of Agriculture and Consumer Services 
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(DACS) oversees both entomological and veterinary surveillance activities, and the 
Florida Fish and Wildlife Conservation Commission (FWC) monitors and investigates 
wild bird mortality. Florida is comprised of 67 counties and currently 32 participate in 
arbovirus surveillance activities; county health departments (CHD) and/or mosquito 
control districts perform routine field sampling (sentinel chickens, mosquito pools) for 
arbovirus surveillance. CHD also investigate and report human cases, as well as provide 
community information and education, as needed.  The FDOH Bureau of Laboratories 
(BOL) performs assays for detection of flaviviral (and alphaviral) infections: the 
Jacksonville Virology Laboratory performs clinical serology, whereas the Tampa 
Virology Laboratory (BOL-Tampa) performs serology, molecular and virus isolation 
assays for the detection of arboviruses in clinical and field specimens (FDOH-BCEH, 
2007).  
 For field surveillance activities, this review will discuss only sentinel chicken and 
wild bird surveillance activities in Florida, as they are most pertinent to this project. 
Florida Sentinel Chicken Program 
 Periodic outbreaks of St. Louis encephalitis virus over the last forty years 
(e.g. 1959 to 1962- 315 human cases/55 deaths; 1977- 110 cases/8 deaths; 1990- 223 
cases/11 deaths) led to the formation and continuation of an arboviral surveillance 
program in Florida (Bigler B, 1999). At the heart of this program is the Florida Sentinel 
Chicken Arboviral Surveillance Network, which was established in 1978 (Nelson et al, 
1983). Chickens are chosen as sentinels because they are susceptible to infection and will 
develop antibodies, the infection is mild, and significant viremia does not develop; thus 
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they are non-infectious to handlers, mosquitoes, and other chickens (Langevin et al, 
2001). 
Every year, approximately 30 counties (out of 67) participate in the network and 
place thousands of sentinel chickens at potential arboviral enzootic transmission sites for 
weekly monitoring (administered by mosquito control districts) [FDOH-BCEH, 2007]. 
This statewide surveillance program has shown that sentinel chicken seroconversions 
(development of antibodies) to arboviruses often precede human cases and can serve as 
an early warning system (Blackmore et al, 2003; Butler and Stark, 2005).   
Chicken Serosurveillance Guidelines 
 Six flocks of six chickens each are recommended for each county, where they are 
placed at potential enzootic transmission sites. Sentinel sites are permanently positioned 
in areas free from public access and vandalism, within 2-3 miles of active mosquito 
breeding areas, in both swamps and near residential areas. Chickens are protected from 
the elements and predators, and an additional flock of chickens is recommended to be 
kept in a mosquito-proof building as replacements for chickens removed from flocks due 
to seroconversion or mortality. All chickens are uniquely identified by numbered wing or 
leg bands. Leghorn, Rhode Island Red, or Barred Rock chickens that are 10-12 weeks old 
at onset are recommended. Chickens are bled and baseline antibody levels analyzed prior 
to placement in the field. It is recommended that all chickens in a flock are sampled every 
week (FDOH-BCEH, 2007). 
 Seroconversion (development of antibodies after exposure to an infectious agent) 
rates in sentinel chickens, along with data collected by mosquito control agencies, are 
utilized by public health officials as indicators of the intensity of enzootic transmission 
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activity as a potential predictor of epidemic arboviral transmission in an area and to 
determine control measures needed to prevent clinical disease. The recent emergence of 
West Nile virus (WNV) in Florida mobilized public health agencies statewide and 
reaffirmed the importance of the sentinel chicken program as an early warning system not 
only for endemic diseases, like SLEV and EEEV, but also allows for the detection of new 
or reemerging diseases (Blackmore et al, 2003; FDOH-BCEH, 2007). 
Wildlife Surveillance 
 The Florida Fish and Wildlife Conservation Commission was established in 1999 
for the protection, management, regulation and research of wildlife resources in the state.  
Surveillance for arboviral infections in wild birds is monitored by the FWC through 
investigation of dead bird mortality clusters and through dead bird sightings (reported by 
the public).  These data are especially useful to detect focal areas of intense West Nile 
virus activity, as most other arboviruses are non-pathogenic for wild birds.  Wildlife 
rehabilitation centers are included under the aegis of the FWC, both of which may 
request arboviral testing by the BOL-Tampa for diagnosis of infection in suspected 
animal cases (FWC, 2007). 
Serological Detection Methods 
 It is rare to isolate arboviruses from blood (or cerebrospinal fluid [CSF] from 
humans) taken during the acute phase of infection because the viremic stage is often 
completed prior to onset of illness. Consequently, diagnostic methods primarily are based 
upon detection of antibodies. Serologic detection methods are complex due to close 
antigenic relationships within virus families. After a sample is determined to be a certain 
virus group positive by the screening test, specialized diagnostic tests are required to 
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differentiate between specific viruses, including cross-reactions between WNV and 
SLEV (FDOH-BCEH, 2007). 
Hemagglutination Inhibition (HAI) Test 
 Hemagglutinating antigens from SLEV, WNV, WEEV and dengue virus were 
first demonstrated by Sabin and his associates. These studies indicated that 
hemagglutination was characteristic of most arboviruses, and that hemagglutinins had 
specific requirements for type of erythrocyte and pH (Sabin & Buescher, 1950; Sabin, 
1951; Chanock & Sabin, 1953, 1954a, 1954b; Sweet & Sabin, 1954). Later studies were 
able to use this property to extend the list of arboviruses with HA activity (after sucrose 
acetone and ether-extracted antigen preparation) and show that most of the arboviruses 
fall into three immunologically distinct groups: A, B, and C (Casals and Brown, 1954; 
Casals, 1957). Antiviral antibodies in sera can specifically inhibit the hemagglutination 
reaction such that this test can be utilized for diagnostic purposes (Clarke and Casals, 
1958). 
 Previously one of the most common laboratory techniques used to determine 
arboviral infections, the HAI test now is only used by a few states for this purpose. The 
HAI test may be used for a variety of etiologic agents; it is inexpensive and easy to 
perform, and allows for testing of large numbers of specimens at one time. However, 
when testing a large number of specimens, samples are usually batched and results 
reported once a week. Laboratories (mostly state diagnostic facilities) that use this 
method are typically located far from the surveillance site. The HAI test as used by these 
laboratories is cost-effective, reproducible, and is useful for analyzing hundreds or over a 
thousand specimens (only Florida has this capability) at once. However, results may not 
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be reported for a week and may effect local agencies response time to initiate or intensify 
control measures (Olson et al, 1991). 
 The best source of HA antigens is sucrose-acetone extracted suckling mouse 
brain. Suckling mice are inoculated with virus, and the brain tissue, which contains high 
titers of virus, is harvested. Acetone extraction removes non-specific lipoprotein 
inhibitors of agglutination, and treatment of the test sera with protamine sulfate also 
removes serum inhibitors and broadens the pH range for HA activity. Goose erythrocytes 
are routinely used to remove naturally occurring agglutinins in the sera. The sera are then 
serially diluted and appropriate antigens containing 4-8 units of hemagglutinin are added. 
The serum-virus mixture is incubated overnight to allow for antigen-antibody binding. 
Then, goose RBCs are added to the test sera-antigen mixtures and incubated for 1 hour. 
Inhibition of agglutination is indicated by a button of red cells (Clarke and Casals, 1958). 
 Cross-reactivity within a virus group is common and can complicate interpretation 
of HAI test results. As such, HAI tests are valuable screening assays (with a high 
sensitivity), but a positive test result requires additional confirmatory tests. Both the IgM 
and IgG antibody fractions are involved in the HAI reaction so that a fourfold rise in titer 
between acute and convalescent sera may be diagnostic of recent infection (FDOH-
BCEH, 2007). 
IgM Antibody Capture Enzyme-Linked Immunosorbent Assay (MAC-ELISA) 
 IgM antibodies are efficient agglutinating molecules, excellent complement-
activators, and largest in size. Although they cannot pass through the placenta and are 
inefficient in the neutralization of viruses, IgM antibodies are very important for 
diagnosis of disease etiology as they are typically the first class of immunoglobulins 
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produced following infection. Elevated levels of IgM usually indicate recent exposure to 
antigen or a recent infection (Benjamini et al, 2000).  
 The immunoglobulin M antibody capture enzyme-linked immunosorbent assay 
(MAC-ELISA) has proven to be an excellent technique for measuring IgM antibodies in 
response to viral infection (Duermeyer et al, 1979; Hofmann et al, 1979; Schmitz et al, 
1980; Roggendorf et al, 1981; Burke & Nisalak, 1982; Jamnback et al, 1982; Monath et 
al, 1984; Calisher et al, 1986a; Calisher et al, 1986b; Calisher et al, 1986c; Olson et al, 
1991; Martin et al, 2000; Johnson et al, 2003). This diagnostic method has been 
standardized and allows for a consistent rapid approach for monitoring arboviral disease, 
but is restricted by species type (Martin et al, 2000). The MAC-ELISA is more specific 
than the hemagglutination inhibition test, which can only indicate viral group infection 
(i.e. Alphavirus or Flavivirus) due to extensive cross reactions between family members. 
The presence of virus-specific IgM antibodies in a single serum specimen indicates that it 
is a presumptive positive. This eliminates the need for a convalescent-phase serum to be 
drawn (Martin et al, 2000), which often is difficult to achieve due to improper timing and 
loss to follow-up for humans. Chickens can be lost to follow-up as well; they may escape, 
be lost to predation, or not re-bled (personal observation, sentinel submission sheets). 
 The test is performed as follows: anti-species IgM capture antibody is coated on 
96-well microplates, and the wells are blocked with milk protein to decrease background 
non-specific protein adsorption to the plate. Serum from the animal species is added 
followed by non-infectious viral antigen. The presence of antigen is detected using an 
enzyme-conjugated anti-viral antibody that interacts with a chromogenic substrate to 
generate a colorimetric result (Martin et al, 2000). 
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IgM Antibody Microsphere-based Immunoassay (MIA) 
 The microsphere-based immunoassay (MIA) is a more rapid serological test than 
the ELISA for laboratory diagnosis of many diseases (Kellar et al, 2001). This 
technology merges the concepts of ELISA and flow cytometry, where monoclonal 
antibodies are coupled to beads in a microsphere-based flow cytometric assay as an 
alternative to the microtiter plate-based ELISA (Vignali, 2000).  Advantages of the MIA 
include greater sensitivity than the conventional ELISA and it can often resolve clinical 
samples indeterminate by other assay methods (Vignali, 2000; McHugh et al, 1997). 
 Recently, a MIA was developed to detect IgM antibodies to WNV and SLEV in 
human sera. This duplex method uses a flavivirus group-reactive monoclonal antibody 
coupled to two different bead sets. The use of this monoclonal antibody allows for 
different types of antigen (e.g. WNV or SLEV) that can be attached to unique bead sets. 
Human serum is added and detection of virus specific IgM antibody is done with a single 
primary antibody (Anti-human IgM) that is conjugated to the detection molecule 
phycoerythrin. These duplex MIA results compared favorably to those of the plaque 
reduction neutralization test (PRNT) and MAC-ELISA (Johnson et al, 2005). 
 The BOL-Tampa has developed an experimental technique for the detection of 
IgM antibodies in chicken sera (Haller, 2005) based on the MIA originally developed for 
human sera by Johnson et al. (2005).  This method will be described in greater detail in 
Chapter Three. 
Plaque Reduction Neutralization Test (PRNT) 
 The plaque reduction neutralization test (PRNT) is the gold standard for 
differentiating between closely related etiologic agents. Time consuming, expensive, and 
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laborious, the assay utilizes live infectious agents to challenge suspect sera for the 
presence of specific neutralizing antibodies. This assay may also be used to determine the 
identity of viral isolates. The test is highly sensitive and specific and, for arboviruses, is 
usually performed in African green monkey kidney (Vero) cell cultures. The principle of 
the assay is that specific neutralizing antibodies in serum will block viral infectivity so 
that the virus cannot attach to cells. Any virus that is not neutralized will initiate as a 
plaque, which develops when the infected cell monolayers are maintained under media 
solidified by agarose. To easily visualize the plaques, the media is supplemented with 
neutral red, a vital dye. Plaques characteristically form as colorless, round areas, where 
the cells have been killed by the virus. These appear against a red background of viable 
cells, and can be quantified. If neutralizing antibodies are present, a reduction in the 
number of plaques occurs (Beaty et al, 1989). 
 Serum neutralizing antibody is primarily IgG antibody (FDOH-BCEH, 2007). 
Unlike IgM molecules, IgG antibodies are effective at neutralizing viruses and 
predominate in the blood, lymph, and CSF. The IgG class also has the longest half-life of 
all the immunoglobulin isotypes, as well as agglutinating properties (Benjamini et al, 
2000). Serum neutralizing antibody, especially IgG molecules, may persist for life after 
some viral infections, as seen for SLE and dengue viruses in humans (FDOH-BCEH, 
2007). 
Arbovirus Cell Culture Methods 
The most commonly used virus isolation technique in arbovirology is cell culture.  
Cell culture is the maintenance of animal cells in vitro and provides the most powerful 
host for cultivation and assay of viruses (Condit, 2001). For flaviviruses, cell cultures can 
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be used to replicate and multiply the virus from viral stocks or from unknown specimens 
in mammalian, mosquito and avian cell lines (most commonly used).  They also can be 
grown in rodent, swine, amphibian or reptilian cells; all of which have different growth 
characteristics (Burke and Monath, 2001). In this manner, viruses are now more often 
isolated from in vitro cell cultures, as opposed to in vivo from susceptible animals (mice), 
because of ease of use and the extensive regulations required for experiments on research 
animals.  
From a public health perspective, cell culture is an important tool as it allows for 
the isolation of many different viruses, including some that are not even suspected at the 
time of inoculation. For instance, isolation of novel or emerging viruses may be detected 
in cell culture, but missed with other diagnostic assays that are limited to known or 
suspected pathogens for which diagnostic reagents are available. This is a tremendous 
advantage over nucleic-acid based or immunologic tests, which only detect the specific 
virus to which the diagnostic reagent is directed. However, disadvantages of virus culture 
include the required expertise and specialized facilities for handling infectious agents, 
greater expense, and a longer time needed for detection (Storch, 2001). Yet, virus 
isolation from cell culture or animals remains the “gold standard” for virus detection 
assays (Lanciotti, 2003). 
Virus Growth Characteristics 
 Cytopathic effect (CPE) is the simplest and most widely used criterion for 
detection of virus infection in cell culture.  CPE is the pathology caused to the cell by a 
virus, which may include cell rounding, shrinkage, loss of adherence, lysis or fusion.  
Virus growth in cell culture is distinct for each virus, with characteristic CPE and 
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incubation times needed for maximal growth. Inoculated cell cultures can be examined 
with inverted light microscopes to identify cytopathic effect or inclusion bodies for 
several days to detect positive cultures. Inclusion bodies are intracellular abnormalities 
specific to an infected cell and visible with light microscopy. These inclusion bodies 
typically represent focal points of viral replication and assembly, which may appear 
different for each virus type (Condit, 2001). 
Plaque Assay 
 The plaque assay is the most quantitative, useful, and elegant biologic assay for 
the study of viruses.   This technique was originally developed in the early 1900s (for 
bacteriophage studies) and then adapted to animal viruses in 1953 by Dulbecco and Vogt.  
Plaque assays are quantitative, qualitative, and have enabled cloning of individual genetic 
variants of a virus. In addition, phenotypic differences in viruses can be characterized 
based on plaque morphology, growth properties or cytopathology (Condit, 2001). 
 In general, the plaque assay relies on the principle that a single infectious viral 
particle can infect a single cell (in a cell monolayer).  For diagnostic virology, viral titers 
(concentrations) of unknown samples or virus stocks can be precisely calculated using a 
plaque assay. Serial dilutions of the virus stock or specimen are made and then inoculated 
into separate cell monolayers. After a one hour adsorption period, cells are overlaid with 
media solidified with agarose, which “traps” the virus to that area and does not allow it to 
infect other cells.  Over a period of days, the single virus will give rise to progeny viruses 
that will infect surrounding cells, and after multiple rounds of infection, a plaque will 
form.  A second media-agarose overlay containing neutral red is often used to visualize 
the plaques. Plaques are then counted and the titer (concentration) of infectious virus in 
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the original sample or stock is calculated based on the serial dilution, expressed as plaque 
forming units per milliliter (pfu/ml) [Condit, 2001].  
 Plaque assays can also be used to clone genetically unique virus variants.  These 
virus variants may only form plaques under certain conditions (temperature, drug 
treatment) or the plaques may appear altered in size or shape. Theoretically, since each 
plaque results from a single virus particle, individual genetic variants can be cloned by 
“picking” plaques by removing a small plug of agar and infected cells with a pipet 
(Condit, 2001). 
Molecular Detection Methods 
Due to the expense, expertise, specialized facilities and longer time needed for 
virus growth, cell culture procedures in diagnostic virology have largely been replaced 
with molecular techniques for identification of viruses. Virus isolation studies have 
become less important as rapid molecular methods, especially polymerase chain reaction 
(PCR), were discovered that could identify viruses.  These molecular methods detect 
specific nucleic acid sequences and can be applied for identification of a single virus 
species, or for a group of related viruses (Storch, 2001; Lanciotti, 2003).  
There are two types of nucleic acid in living systems, deoxyribonucleic acid 
(DNA) and ribonucleic acid (RNA), although the majority of viruses have an RNA 
genome. Nucleic acid amplification assays are especially important in diagnostic virology 
for virus species that grow slowly in culture or those that are difficult or impossible to 
cultivate. Molecular techniques only require a small volume of sample (Storch, 2001) and 
flaviviral nucleic acids can be extracted from a variety of bodily fluids (CSF, blood, 
serum, urine) and tissues (brain, heart, lung, kidney, etc) [Lanciotti, 2003; FDOH-BCEH, 
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2007].  All molecular amplification assays involve three basic steps, including nucleic 
acid extraction/purification from specimens, amplification of the nucleic acid, and 
detection of the amplified product (Lanciotti, 2003).  
The prototype of targeted amplification assays is PCR, which was developed in 
conjunction with the discovery of thermostable DNA polymerases in the late 1980s 
(Mullis et al, 1987; Saiki et al, 1988).  Briefly, PCR utilizes short oligonucleotide primers 
and a thermostable DNA polymerase (e.g. Taq polymerase) to amplify a segment of 
target DNA, typically 100-1000 base pairs in size.  The PCR reaction includes at least 
three steps, denaturation, primer annealing and extension, which require different 
temperatures. These steps are cycled 25 to 40 times to generate the PCR product, or 
amplicon. A thermal cycler is the instrument used to control the progression of the cycle 
steps and the temperature of the reaction. The analytical sensitivity of PCR is 
tremendous, as it can amplify very low copy numbers of the target DNA in a sample, 
often between 1 to 10 copies. Contamination of the reaction may occur due to the highly 
sensitive nature of PCR, which may result in false-positives. As such, it is important to 
carefully follow established procedures, physically separate the laboratory into areas for 
sample prep, PCR amplification, or detection, and to include negative extraction and no 
template controls with every PCR run to verify contamination has not occurred (Storch, 
2001). This technique has revolutionized the field of viral diagnostics (Lanciotti, 2003). 
For RNA viruses, it is not possible to perform PCR directly on the ribonucleic 
acid, as Taq polymerase only uses DNA as a template.  Consequently, detection of viral 
RNA sequences requires a reverse-transcriptase (RT) step prior to PCR to convert the 
RNA into complementary DNA (cDNA) that will be used as the template (Storch, 2001).  
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Since flaviviruses have RNA genomes, an RT step is required in both end point PCR and 
real-time PCR techniques for species detection and sequence analysis. 
End Point RT-PCR 
 A reverse transcriptase step prior to PCR requires additional cycling times and 
temperatures for the reverse transcription of the viral (plus sense) genomic RNA into 
single stranded DNA (cDNA).  Taq polymerase in the PCR reaction then converts the 
cDNA into double-stranded DNA (dsDNA) and amplifies the dsDNA.  Consequently, 
reverse transcriptase polymerase chain reaction (RT-PCR) occurs in either a one or two-
step process for the conversion of RNA into DNA and subsequent amplification of the 
dsDNA. In one step RT-PCR, the RT and PCR reactions are combined in the same tube.  
This is often accomplished by mixing reverse transcriptase and Taq polymerase enzymes 
with common reagents to carry out both the RT and DNA polymerase reactions 
(Lanciotti, 2003), where the thermal cycler controls both RT and PCR conditions (Storch, 
2001). In two step RT-PCR, the reverse transcriptase reaction is carried out separately 
from the PCR reaction, and after the cDNA template is created, a portion of it is added to 
another tube for the PCR reaction and conversion into dsDNA (Lanciotti, 2003). After 
the RT-PCR reaction is complete, the end-point is visualized/detected by gel 
electrophoresis and ethidium bromide staining (Storch, 2001). 
Real-Time RT-PCR 
 Real-time polymerase chain reaction is revolutionizing traditional gel-based, end-
point PCR methodologies. The improved process combines PCR amplification and 
confirmation in a single step, so that results are detected during the PCR cycling steps 
rather than later running the PCR products on a gel for visualization (Storch, 2001; 
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Lanciotti et al, 2000). Real time PCR technology allows for detection of amplification 
during early stages of the reaction versus gel-based systems that require end-point 
detection (gels).  In addition, real time PCR assays have improved precision, are very 
sensitive and specific, have high throughput, and rapid turn around of results, which does 
not rely on product size discrimination (which may only differ by a few base pairs 
between strains of virus) in end-point platforms (Applied Biosystems, 2001; Lanciotti, 
2003). Real time PCR assays also have the advantage of detecting products during 
logarithmic and linear phases, which correlates to starting template and can be quantified.  
In comparison, the plateau stage (end point) for traditional PCR may have the same 
plateau despite different starting templates, and is where the products may begin to 
degrade (Applied Biosystems, 2001). 
 For example, TaqMan® is real-time PCR chemistry that is commonly used for the 
identification of infectious diseases.  An advantage of this system over other real-time 
PCR platforms (e.g. Light Cycler with SYBR Green platform, SmartCycler with 
multiplex platform) is that 96 samples can be analyzed at once. The RT and PCR 
amplification reactions are identical to those already described above for end-point PCR, 
except the reaction master mix also includes a specific oligonucleotide probe that is dual-
labeled (Lanciotti, 2003).  Briefly, the TaqMan® system is designed with 2 specific 
primers and 1 probe (Applied Biosystems, 2001).  The probe anneals to a specific 
sequence in between the forward and reverse primers on the template and has two types 
of fluorophores, reporter (R) at the 5’end and quencher (Q) at the 3’ end. Before Taq 
polymerase acts, the probe is attached or unattached to the template, and the quencher 
reduces the fluorescence from the reporter fluorophore through Fluorescence Resonance 
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Energy Transfer (FRET). Once the TaqMan® probe is bound to the template after 
denaturation and the reaction cools, the primers anneal to the DNA. Taq polymerase then 
adds nucleotides and removes the probe from the template, separating the quencher from 
the reporter, allowing the reporter to release its energy. The emitted light is then 
quantified with a computer to generate CT values (cycle threshold where emitted light 
from sample reaches fluorescent intensity above background) [Storch, 2001; Pierce, 
2003]. 
 TaqMan® chemistry has been developed for detection of WN and SLE viral RNA 
for surveillance programs and diagnosis of clinical cases in the United States (Lanciotti et 
al, 2000; Lanciotti and Kerst, 2001), as it offers increased sensitivity, higher throughput, 
quantification, and increased reproducibility as compared to traditional, end-point RT-
PCR (Morris, Robertson and Gallagher, 1996; Martell et al, 1999).  Lanciotti et al. 
(2000) developed a TaqMan® RT-PCR assay that was able to detect 0.1 plaque forming 
units of WNV (compared to 1 PFU for traditional PCR) and was much more sensitive for 
testing mosquito pools, where it detected 1 to 10 PFU of WNV, as compared to the 
traditional RT-PCR assay that could only detect >100 PFU in a sample. In addition, the 
two TaqMan® primer/probe sets accurately identified all WNV strains tested in the study 
(NY99, Romania, Italy, Egypt, Kenya, Kunjin), with no false-positive results from 
serologically related flaviviruses or other arboviruses (Lanciotti et al, 2000).  Similar 
results were obtained with the two TaqMan® primer/probe sets developed for SLEV, 
which detected SLEV strains from the United States and South America, with no false-
positive results from other arboviruses (Lanciotti and Kerst, 2001). For both WNV and 
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SLEV TaqMan® RT-PCR assays, CT values < 37 were considered positive (Lanciotti et 
al, 2000; Lanciotti and Kerst, 2001).  
Nucleotide Sequencing 
Nucleotide sequencing of PCR products (amplicons) provides valuable 
information about the identity of the virus and can be used for phylogenetic analysis, 
molecular epidemiology, and presence of mutations in the viral genome (Storch, 2001).  
The nucleotide sequence represents the primary structure of a DNA molecule or strand, 
with the capacity to carry genetic information. The possible letters in a nucleotide 
sequence represent the four nucleotide subunits of a DNA strand, the adenine (A), 
cytosine (C), guanine (G) and thymine (T) bases that are covalently linked to the sugar 
phosphate backbone. A nucleotide sequence may be either coding or noncoding, and is 
dependent on the region of the genome analyzed (Innis et al, 1988). Consequently, for 
viruses with genomic RNA, the dsDNA amplicon generated from the RT-PCR reaction is 
analyzed, not the RNA.  
The Sanger chain-termination method utilizes dye-terminators incorporated into 
an enzyme-mediated amplification reaction, where dideoxynucleotides insert into the 
nascent (elongating) DNA strand terminate DNA strand extension, resulting in DNA 
fragments of varying length (Sanger and Coulson, 1975).  Labeling these chain 
terminators is called dye-terminator sequencing, where incorporation of bases with dye-
terminators effectively halts polymerization in the PCR-like reaction. Linear products of 
varying sizes (ranging from 1 to n, where n is the length of the amplicon) are obtained. 
This product is ethanol precipitated, reconstituted and loaded onto a sequencing 
instrument where it is passed through a poly-acrylamide gel and separated based on size. 
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A laser within the instrument detects the wavelength of each dye and makes a “base call” 
based on the covalent linkage associated with each dye to a specific base [black = G, red 
= T, blue = C, green = A].  The computer software computes the sequence, based on user-
supplied parameters, and the final nucleotide sequence for each amplicon is displayed.  
Nucleic acid sequence analysis offers the clearest, least ambiguous picture of 
amplified DNA products (Lanciotti, 2003) and has improved phylogenetic analyses and 
molecular epidemiology studies on viruses, where it can be used to identify strains, 
mutations, and virulence markers in the genome (Storch, 2001; Kramer and Chandler, 
2001).  Figure 2-10 summarizes the molecular amplification and detection methods 
described in this brief review. 
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Figure 2-10 Molecular Amplification & Detection Methods for RNA Arboviruses 
Diagram provides an overview of the molecular methods for the 
amplification and detection of RNA arboviruses. This is a three step 
process: 1) extraction of the nucleic acid (i.e. RNA) from a variety of 
sample types; 2) amplification of the RNA with RT-PCR in one of two 
methods, end-point or real-time; 3) detection of the RT-PCR product.  For 
end-point RT-PCR, the amplicons are visualized on an agarose gel stained 
with ethidium bromide (EtBr).  For real-time RT-PCR, detection occurs 
simultaneously with amplification of the PCR reaction and is recorded by 
the instrument. 
 
 
Molecular Amplification and Detection Methods for RNA Arboviruses:  
A 3 Step Process 
 
        
 
Figure adapted from Lanciotti, 2003 
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Surveillance Case Definition for Arboviral Disease 
In Florida, WNV, SLEV and EEEV are reportable human diseases. As a result, 
physicians and county health departments provide case information to the Bureau of 
Community Environmental Health for data analysis and dissemination. The wide range of 
clinical illness in humans infected with these arboviruses complicates the case description 
and requires laboratory diagnosis to confirm a case (FDOH-BCEH, 2007). 
Clinical Description 
 A spectrum of illness in humans may result from arboviral infections including 
asymptomatic infections to CNS disease of variable severity. Arboviral encephalitis is 
characterized by such symptoms as fever, headache, and altered mental status ranging 
from confusion to coma (CDC, 2004c).  Consequently, diagnosis with either 
neuroinvasive or non-neuroinvasive disease from an arboviral infection requires specific 
case findings that are not explained by a more likely clinical explanation (FDOH-BCEH, 
2007). 
Neuroinvasive Disease  
Neuroinvasive disease is reported if the patient has presence of fever and at least 
one of the following symptoms: 1) acutely altered mental status (such as stupor, 
disorientation, or coma); or 2) acute signs of central or peripheral neurologic dysfunction 
(for example, paralysis, nerve palsies, sensory deficits, abnormal reflexes, or generalized 
convulsions); or 3) pleocytosis (increased white blood cell count in CSF) associated with 
symptoms clinically compatible with meningitis (headache or stiff neck), as documented 
by a physician and in the absence of a more likely clinical explanation.  Rarely, WNV 
poliomyelitis (paralysis) has also been reported (CDC, 2004b; FDOH-BCEH, 2007). 
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Non-neuroinvasive Disease  
Similar to neuroinvasive disease, non-neuroinvasive disease is only considered in 
the absence of a more likely explanation for illness. The patient must have, at minimum, 
presence of a documented fever (measured by either patient or clinician) and the absence 
of neuroinvasive disease. Involvement of non-neurological organs (heart, pancreas, liver) 
should be documented using standard clinical and laboratory criteria (FDOH-BCEH, 
2007).  For WNV, thousands of cases of non-neuroinvasive West Nile fever have been 
reported. Clinical features of West Nile fever include fever, headache, and/or 
occasionally the following symptoms: swollen lymph glands, skin rash on the trunk of the 
body, or eye pain (CDC, 2004c). 
Neuroinvasive and non-neuroinvasive cases are then classified as either probable 
or confirmed arboviral infections based upon laboratory diagnosis (CDC, 1993). 
Laboratory Criteria for Diagnosis 
Results of diagnostic assays are used in conjunction with clinical findings to 
classify suspected arboviral infections either as confirmed or probable cases. Several 
diagnostic tests are performed to investigate each clinical case, where two methods are 
commonly used for confirmation of an arboviral infection. Serological methods test for 
the presence of virus-specific antibodies in the blood, whereas molecular methods detect 
virus-specific genomic sequences in a variety of samples. Isolation of the virus also 
confirms an infection (FDOH-BCEH, 2007). 
Serological Methods 
 For humans, a fourfold or greater rise in virus-specific serum antibody titer; virus-
specific IgM antibodies detected by antibody capture enzyme immunoassay; or detection 
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of virus specific serum IgG antibodies in the same or convalescent specimen by HAI or 
PRNT are utilized to confirm an arboviral infection (CDC, 1993; FDOH-BCEH, 2007). 
For chickens, demonstration of virus-specific IgM antibodies by MAC-ELISA or 
detection of virus-specific serum IgG antibodies by PRNT is confirmation of arboviral 
infection (FDOH-BCEH, 2007).  
Molecular Methods 
 The detection of arbovirus-specific genomic sequences in blood, tissue or CSF 
confirms an arboviral infection.  Traditional and real-time RT-PCR assays are frequently 
used by public health laboratories to test clinical, animal and mosquito samples for 
arboviruses (Lanciotti et al, 2000; Lanciotti and Kerst, 2001).  The CDC recommends 
several criteria for laboratory diagnosis of WNV using molecular methods. A positive 
RT-PCR test for WN viral RNA must be validated by one of the following methods: 1) a 
repeated positive test with different primers; 2) a positive PCR result using another 
system (e.g. TaqMan®);  or 3) virus isolation (CDC, 2003A).  Consequently, the Florida 
Department of Health has modeled its molecular protocols for WNV and SLEV detection 
based on these recommendations, such that suspected human cases and field (animal, 
mosquito) samples must first screen positive with one TaqMan® primer/probe set 
targeted to a specific region of the genome (Ct value <37).  Samples that screen positive 
must then be confirmed with another TaqMan® primer/probe set specific for a different 
region of the viral genome, and virus isolation attempted (Lanciotti et al, 2000; Lanciotti 
and Kerst, 2001).  Cell cultures that display characteristic cytopathic effect are then 
confirmed by real-time RT-PCR assays to identify isolation of the infecting agent. 
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Surveillance: A Team Approach 
 Surveillance systems are most effective when data is shared and feedback 
strategies are built into the program, so that results can trigger a change in action. 
For example, the Florida Arbovirus Response Plan is designed for control measures that 
must be activated when surveillance detects arboviral activity in an area. At Response 
Level 2, where wide-spread detection in sentinel flocks, wild birds, or mosquitoes occurs, 
a Department of Health (DOH) declared medical alert will be considered for affected 
counties. Additional sentinel chickens may be placed to increase surveillance activities 
and the Department of Agriculture and Consumer Services (DACS) can issue a mosquito 
declaration, with increased vector control measures, such as aerial adulticiding. Sentinel 
chicken surveillance data are summarized and reported weekly by the Florida Department 
of Health, Bureau of Laboratories (BOL). The state Bureau of Community and 
Environmental Health summarizes the data on a weekly basis and provides the 
information to interagency partners, DOH County Health Departments, and the CDC. 
Consequently, coordination between multiple state agencies, local county health 
departments and mosquito control districts is crucial for implementation and success of 
an arboviral surveillance program (FDOH-BCEH, 2007).  Successful arboviral 
surveillance programs should integrate data from all aspects of the arbovirus life cycle, 
including avian, mosquito, and incidental host infections, as well as important abiotic 
factors, such as rainfall and temperature (Reisen, 2003; Gubler 2007).  
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CHAPTER 3 
 
RESEARCH METHODS 
 
Study Design 
 
 Field studies for the detection or isolation of arboviruses from naturally exposed 
animals or arthropod vectors are often cost-prohibitive with several logistical problems 
(e.g. large geographic area, sporadic transmission activity, large host population, short 
viremic period in the host). Consequently, this study proposed to perform targeted 
sampling on a large population of caged chickens located in active arboviral transmission 
areas (based on serological surveillance data), rather than rely on samples passively 
submitted from all regions.  Additionally, wild birds admitted to rehabilitation centers 
were also sampled, based on “patient” symptoms. 
 In 2004, initial pilot experiments were conducted to test the study design, field 
protocol, and to optimize laboratory reagents for virus detection and isolation.  The active 
study period occurred during the 2005 and 2006 calendar years for the targeted collection 
of samples to detect or isolate arboviruses from naturally exposed birds. All samples were 
collected from sentinel chickens permanently located in several counties or from birds 
admitted to wildlife rehabilitation centers throughout Florida. 
Virus Strains 
 Reference virus strains were obtained from the archived collection maintained by 
the Florida Department of Health, Bureau of Laboratories, Tampa (BOL-Tampa), the 
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Division of Vector-Borne Infectious Diseases, CDC, Fort Collins, Colorado, or purchased 
from the American Type Culture Collection (ATCC).  Three control viruses were used 
throughout the study period, one strain for SLEV and two strains of WNV.  St. Louis 
encephalitis virus (strain TBH-28) was isolated in Florida and archived; West Nile virus 
strains were obtained either from the CDC (Egypt 101 strain) or from ATCC (NY99, 
strain 385-99, Cat. No. VR-1507). These viruses were used to optimize molecular 
extraction, amplification, and detection assays, as well as for positive controls in RT-PCR 
and plaque assays.   
St. Louis encephalitis virus strains chosen from the archive for sequence analysis 
were representative of isolates made in each of the last 5 decades (1950s, 1960s, 1970s, 
1980s, and 1990s) in Florida. Genetic sequences of these strains have not previously been 
published, except for strain TBH-28 (1962) [Kramer and Chandler, 2001].  In addition, 
two Brazilian strains and two Trinidad strains of SLEV were acquired by the 
Epidemiology Research Center (ERC) prior to 1972.  These strains were chosen from the 
BOL-Tampa (previously the ERC) archive for sequence analysis to represent South 
American strains of St. Louis encephalitis virus.  West Nile virus strains were also 
included in the study: the emergent North American strain (NY99, strain 385-99) and an 
Old World strain (Egypt 101) used as positive controls, as well as six strains isolated in 
Florida from 2001 (two strains), 2002 (two strains) and 2005 (two strain). 
A list of these control and reference viruses, including their strain designation, 
source, passage history and geographic location is presented in Table 3-1 (WNV strains) 
and Table 3-2 (SLEV strains).    
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Table 3-1 Eight WNV Reference Strains Sequenced for Phylogenetic Analysis 
Eight strains of West Nile virus were sequenced for phylogenetic analysis. Six of these strains were isolated (cultured) 
in Florida, including 3 WNV strains from different avian species following death from natural infection. A strain 
isolated from an alligator was also included in the study following death from WNV (natural exposure at an alligator 
farm). Two mosquito pool WNV isolates were also studied from 2002. Two control strains were analyzed and used as 
positive controls in RT-PCR and sequencing assays, including Egypt101 obtained from the CDC, Fort Collins, and 
strain 385-99 (NY) purchased from ATCC.  
 
 
STRAIN 
 
DESIGNATION 
 
LOCATION 
 
YEAR 
 
HOST 
 
PASSAGE 
 
Eg101* 
385-99* 
FL01-I401 
FL01-I403 
FL02-M1215 
FL02-M1220 
FL05-I189 
FL05-I242 
 
 
WNEgypt 
WNNY99 
FL01a 
FL01b 
FL02a 
FL02b 
FL05a 
FL05b 
 
 
Egypt 
New York City, NY 
Madison Co., FL 
Suwanee Co., FL 
St. John’s Co., FL 
St. John’s Co., FL 
Clermont, FL 
Dixie Co., FL 
 
 
1952 
1999 
2001 
2001 
2002 
2002 
2005 
2005 
 
 
Human 
Snowy owl 
Crow 
Blue Jay 
Oc. taeniorhynchus 
Oc. taeniorhynchus 
Alligator 
Crow 
 
 
SM2, Vero 3 
Vero 5 
Vero 1 
Vero 1 
Vero 1 
Vero 1 
Vero 1 
Vero 1 
 
*WNV strain used as positive control. 
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Table 3-2 Fourteen SLEV Reference Strains Sequenced for Phylogenetic Analysis 
Ten strains of St. Louis encephalitis virus collected during the last 5 decades in Florida were sequenced for 
phylogenetic analysis. After 1972, archived Florida SLEV strains were collected by Dr. Jonathan Day (University of 
Florida) and submitted to the BOL-Tampa for virus detection and culture.  South American strains of SLEV were 
acquired by the BOL-Tampa (formerly the Epidemiology Research Center) prior to 1972.  One control strain (TBH-28) 
was analyzed and used as a positive control in RT-PCR and sequencing assays. This strain also represents a Florida 
isolate of SLEV made in 1960s. 
  
STRAIN DESIGNATION LOCATION YEAR HOST PASSAGE 
 
Miami 
TBH-28* 
F72-M022 
86-100309 
86-100802 
1A-059 
3-594 
3A-038 
3-582 
CXN GR8 
 
TRVL 21647 
TRVL 43174 
BeAn 70092 
BeAn 156204 
 
 
FL52 
TBH-28 
FL72 
FL85a 
FL85b 
FL89 
FL90a 
FL90b 
FL90c 
FL90d 
 
TR58 
TR62 
BR64 
BR69 
 
Miami, FL 
Tampa Bay, FL 
Walnut Hill, FL 
Indian River Co., FL 
Indian River Co., FL 
Indian River Co., FL 
Indian River Co., FL 
Indian River Co., FL 
Indian River Co., FL 
Indian River Co., FL 
 
Trinidad 
Trinidad 
Belem, Brazil 
Belem, Brazil 
 
1952 
1962 
1972 
1985 
1985 
1989 
1990 
1990 
1990 
1990 
 
1958 
1962 
1964 
1969 
 
Human 
Human 
Opossum (D. marsupialis) 
Cx. nigripalpus 
Cx. nigripalpus 
Northern cardinal 
Common grackle 
Mourning dove 
Common grackle 
Cx. nigripalpus 
 
Cx. coronator 
Cx. nigripalpus 
Kingfisher (C. inda) 
Chicken 
 
SM1, Vero 
SM11, Vero 2 
SM3, Vero 
SM1 
SM2 
SM2 
SM1 
SM1 
SM1 
SM2 
 
SM3 
SM4 
?, SM1 
M2, Vero 1 
*SLEV strain used as positive control and representative strain of the 1960s. 
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Pilot Field Study 
 
 One small field study was conducted in Hillsborough County, where a total of 
eighteen cloacal swabs were collected from sentinel chickens at three sites experiencing 
arboviral transmission activity (based on results of weekly BOL-Tampa serological 
assays). Molecular and tissue culture assays were performed on each swab, but no virus 
was detected or isolated from these chickens.  In addition, four of the chickens sampled 
were confirmed positive for antibodies to WNV and these findings indicated that it may 
be unlikely for successful arbovirus isolation after a chicken has developed antibody 
(seroconverted). The results from this initial field study guided the design of a targeted 
sampling strategy used by the collaborating agencies when collecting specimens from the 
sentinel chickens to minimize waste of resources.  
Pilot Laboratory Studies 
 
 Preliminary studies were performed to standardize and improve efficacy of 
arbovirus recovery from swab culturettes. Experiments were performed to standardize 
nucleic acid extraction methods and real-time (TaqMan) RT-PCR detection thresholds. 
Swab culturettes (Becton Dickinson, Cat. No. 261514) were inoculated with 0.1 ml ten-
fold serial dilutions of St. Louis encephalitis virus (SLE TBH) [100 through 10-4] and 
then processed in 1 ml biologic field diluent (BFD) [see Appendix A for BFD reagent 
formulas] for cell culture plaque assays and RNA extraction/detection. However, the 
manufacturer discontinued production of these swab culturettes after 2005. In 2006, 
replacement swab culturettes (Becton Dickinson, Cat. No. 220221), which contain 3 ml 
of media (proprietary), were also validated. These swabs were inoculated with 0.3 ml ten-
fold serial dilutions of St. Louis encephalitis virus (SLE TBH) [100 through 10-5] in 3 ml 
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culture media to approximate the previous swab conditions.  Swabs were processed as 
described later in this chapter.   
Four types of Qiagen nucleic acid extraction kits [QIAamp Viral RNA Mini Kit, 
Cat. No. 52906; QIAamp MinElute Virus Spin Kit, Cat. No. 57704; QIAamp RNA Blood 
Mini Kit, Cat. No. 52304; and RNeasy Mini Kit, Cat. No. 74104] were tested to optimize 
viral RNA detection from whole blood samples; lysis buffers varied between kits (AVL, 
AL, EL, RLT, respectively). Four spiked dilutions of fresh goose blood (collected from 
geese maintained by BOL-Tampa for the hemagglutination inhibition assay) were tested.  
Four ten-fold serial dilutions were prepared, each dilution contained 0.9 ml anti-
coagulated whole goose blood spiked with 0.1 ml of SLEV TBH [10-1 through 10-4].  
Nucleic acid was extracted following manufacturer’s instructions for each kit.  
RT-PCR assays were performed, as described later this chapter. Results indicated that the 
“cell-free” kits (QIAamp Viral RNA Mini Kit and QIAamp MinElute Virus Spin Kit) 
specifically designed for virus nucleic acid extraction produced the highest yield; not the 
whole blood kit or RNeasy Mini Kit.  Table 3-3 summarizes the RT-PCR results for each 
extraction kit.  
The QIAamp Viral RNA Mini kit was chosen for use in the study.  This type of 
kit had previously been validated at the BOL-Tampa for nucleic acid extraction from 
cloacal swabs (Brennan, 2003), and it was also used for nucleic acid extraction from 
whole blood samples in this study.  AVL lysis buffer with carrier RNA (10 µg/ml) added 
[Qiagen, Cat. No. 19073] was aliquoted (0.56 ml) into 1.5 ml microcentrifuge tubes 
(Fisher, Cat. No. 02-681-320), and shipped on ice packs overnight to participating 
counties for blood specimen collection.  
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Table 3-3 Evaluation of Nucleic Acid Extraction Kits 
Four Qiagen nucleic acid extraction kits were tested to optimize the 
extraction procedure for the detection of SLEV from whole blood 
samples.  Whole goose blood was spiked with St. Louis encephalitis virus. 
Blood dilutions were then lysed with the appropriate volumes of blood and 
lysis buffer, and extracted, following manufacturer’s instructions for each 
kit. Real time RT-PCR (TaqMan) was performed for each dilution, tested 
in replicate, with the SLE A primer/probe set.  CT values for each dilution 
were averaged and are shown in table.  
 
SLEV Dilutions 
QIAGEN Kit 
10-1 10-2 10-3 10-4 Negative 
 
Viral RNA Mini 20.9 24.72 26.96 31.52 undet 
 
MinElute Virus 26.64 29.19 39.06 40.83 undet 
 
Whole Blood 30.95 34.18 36.12 40.82 undet 
 
RNeasy Mini 35.93 undet undet undet undet 
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study network. Table 3-4 provides a list of the collaborating agencies.  Field studies were 
conducted on both domestic fowl (sentinel chickens) and wild birds to simulate the rural  
and urban transmission cycles of arboviruses (refer to Chapter 2, p. 77-79). In 2005 and 
2006, sentinel chickens were sampled for the detection of viral RNA/isolation of 
arboviruses from blood (2005 only) and cloacal swabs (2005-2006).  In 2006, wild birds 
admitted to collaborating rehabilitation centers and studied by the Florida Fish and 
Wildlife Conservation Commission (FWC) were sampled for the detection of viral 
RNA/isolation of arboviruses from cloacal swabs.   
Sentinel Chicken Surveillance Program 
 Participants in the Florida Arboviral Surveillance Network include county health 
departments and county mosquito control districts. These agencies maintain sentinel 
chicken flocks at potential arboviral enzootic transmission sites throughout the state. In 
2005 and 2006, sentinel chickens detected flaviviral and alphaviral activity. County 
agencies in the traditional SLEV belt (central and southern counties) typically support 
sentinel chicken surveillance programs and were requested to participate in the study 
based on historical reported human cases and SLEV transmission patterns in Florida 
(Figure 3-1).  
Sentinel Chickens   
Young female white Leghorn, Barred Rock, Rhode Island Red or Minorcan 
chickens were recommended for sentinel surveillance, however, other breeds are used by 
some agencies. Chickens were purchased by county agencies either from local chicken 
farmers or from other vendors, including Zephyr Eggs, Hillandale Farms, or Clyde 
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Table 3-4 Florida Agencies and Collaborating Partners in the Field Study 
Network  
 
 
Collaborating Agencies in the Arbovirus Isolation/Detection Field Study Network 
 
State Agencies 
 
Florida Department of Health, Bureau of Community & Environmental Health (FDOH-
BCEH) 
Florida Department of Health, Bureau of Laboratories- Tampa (BOL-Tampa) 
Florida Fish and Wildlife Conservation Commission (FWC) 
Florida Department of Agriculture and Consumer Services (DACS) 
University of South Florida (USF) 
University of Florida (UF) 
 
County Agencies* 
 
Charlotte County MCD 
Collier County MCD 
Hillsborough County MCD 
Lee County MCD 
Manatee County MCD 
Orange County MCD 
Pasco County MCD 
Pinellas County MCD 
Sarasota County MCD 
Volusia County MCD 
 
 
Wildlife Rehabilitation Centers 
 
Florida Wildlife Care Center (Gainesville) 
Audubon Center for Birds of Prey (Orlando) 
Wildlife Inc, Education & Rehabilitation (Bradenton) 
Pelican Harbor Seabird Station, Inc (Miami) 
Marathon Wild Bird Center (Marathon) 
*Mosquito Control District (MCD) 
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Figure 3-1 Historical SLEV Transmission Belt in Florida 
Distribution of reported human cases of St. Louis encephalitis virus in 
Florida (1987-2006).  The majority of cases were reported from central 
and southern counties, the traditional SLEV belt, where ecologic factors 
and habitat support amplification and transmission of SLEV. 
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Mizell, Inc (FDOH-BCEH, 2007). After 16 weeks of age, chickens were placed in the 
field in potential enzootic arboviral transmission sites (as determined by mosquito control 
agencies).  Prior to field-placement, chickens were bled and tested in the 
hemagglutination inhibition (HAI) assay for the presence of arboviral antibodies to rule 
out previous infection (FDOH-BCEH, 2007).  
Monitoring Sites and Sample Collection 
Sampling of sentinel chicken flocks is a routine part of arbovirus surveillance in 
Florida conducted by local county health departments and/or mosquito control districts.  
These agencies utilize sentinel chickens to recognize areas of increased arbovirus 
transmission in order to target mosquito control/abatement strategies and to estimate risk 
of human infection (FDOH-BCEH, 2007). 
In 2005, 3,801 adult sentinel chickens were maintained at 279 potential enzootic 
transmission sites in 31 Florida counties. During the second year of the study (2006), 
2,901 adult sentinel chickens were maintained at 275 potential enzootic transmission sites 
in 34 Florida counties. Blood was collected from each chicken (1.5 ml to 2.0 ml) up to 4 
times per month, with weekly sampling during peak transmission months (July through 
December) as previously described (Blackmore et al, 2003).  Clotted blood was 
centrifuged at 1200 x g for 15 minutes to separate serum and sent to the BOL-Tampa for 
analysis.   
Serological Methods 
At the Florida Department of Health, Bureau of Laboratories-Tampa (BOL-
Tampa), as many as four types of serological diagnostic assays were routinely performed 
on the chicken sera to identify arboviral infections: the hemagglutination inhibition (HAI) 
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antibody test, the IgM-capture enzyme-linked immunosorbent assay (MAC-ELISA), 
IgM-capture microsphere-based immunoassay (MIA), and the plaque reduction 
neutralization test (PRNT).  Serum samples were screened for the presence of antibody to 
alphavirus and flavivirus group antigens with the HAI antibody test, where serum 
samples were treated with protamine sulfate (Holden et al, 1966), acetone extracted and 
assayed by the method of Clarke and Casals (1958) in microtiter plates. Hemagglutining 
antigens (SLEV TBH 28; EEEV D64-837) were prepared from suckling mouse brains by 
sucrose-acetone-extraction (Schmidt, 1979) and betapropriolactone-inactivation (Sever et 
al, 1964).  
Sentinel chickens that were HAI flavivirus or alphavirus positive for the first time 
were confirmed as WNV, SLEV, or EEEV positive with the MAC-ELISA, as in previous 
studies (Calisher et al, 1986c; Martin et al, 2000). Chicken sera that were IgM negative 
or equivocal were further assayed in the PRNT test for WNV and SLEV or EEEV and 
HJV. PRNT assays were performed at BioSafety Level 3, using previously described 
methods (Schmidt, 1979; Beaty, Calisher and Shope, 1989; Voakes, 2004). HAI, MAC-
ELISA, and PRNT antigens/viruses are listed in Appendix AI.   
A microsphere-based immunoassay (MIA) for the detection of IgM antibodies in 
chicken sera was developed and standardized in the BOL-Tampa for WNV and SLEV 
(Haller, 2005) based on a procedure developed for human sera at the CDC (Johnson et al, 
2005).  Briefly, sera samples, primary and secondary antibody, and antigen/bead set 
mixtures were diluted to working concentrations and added to filter plates designed for 
the MIA (Millipore, Cat. No. MABVN1250). Sera, including positive and negative 
controls, were diluted 1:400 in MIA running buffer (PBS 1% BSA) [Sigma, Cat. No. 
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P3688]. Primary antibody, goat anti-chicken IgM serum lyophilized (MP Biomedicals, 
Cat. No. 64395) was diluted to 2 μg/ml in MIA running buffer. Secondary antibody, 
porcine anti-goat IgG-phycoerythrin (PE) (R&D Systems, Cat. No. F0106) was diluted to 
1 μg/ml in MIA running buffer. Coupled bead sets (Cat. No. 32 & 57/6B6C-1 Bead Sets) 
were purchased from Radix Biosolutions, Georgetown, TX.  Positive WNV recombinant 
antigen (Cat. No. M120-270) and negative antigen (Cat. No. M130-270) was purchased 
from Hennessy Research Associates, Shawnee, KS.  Positive SLEV (TBH-28) suckling 
mouse brain antigen (M29797) and normal control suckling mouse brain antigen (VB2115) 
was obtained from CDC, Fort Collins, CO. Coupled antigen/6B6C-1 bead set mixtures 
(bead set 32/WNV+Ag, bead set 32/WNV-Ag, bead set 57/SLEV+Ag, bead set 
57/SLEV-Ag) were also diluted in MIA running buffer (1:10) and MIA performed as 
previously described (Haller, 2005).  The BOL-Tampa testing algorithm for sentinel 
chicken sera is shown in Figure 3-2.  
Wild Birds 
 The natural mosquito-bird-mosquito cycle of arbovirus amplification primarily 
occurs in wild avian hosts that develop high titered viremias (as opposed to domestic 
fowl). As such, this study requested partners that routinely work with a variety of wild 
avian species for arbovirus detection/isolation in the primary vertebrate amplifying host.   
Florida Fish and Wildlife Conservation Commission (FWC) 
The FWC is a state agency that investigates clusters of wild bird deaths for the 
detection of avian pathogens, including arboviruses.  In 2006, the FWC agreed to 
collaborate on this project. FWC veterinarians collected cloacal swab samples from 23 
birds, as part of routine diagnostic procedures to investigate these fatal cases.  
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Figure 3-2 BOL-Tampa Diagnostic Testing Algorithm for Detection of Arbovirus 
Antibodies in Sentinel Chicken Sera 
Sentinel chicken sera were first screened in the HAI antibody test with  
flavivirus and alphavirus group antigens. Positive sera were confirmed 
using the MAC-ELISA with WNV, SLEV, or EEEV antigens. MAC-
ELISA negative or equivocal sera were tested in the PRNT for WNV and 
SLEV or EEEV and HJV.  In 2006, HAI flavivirus group positive samples 
were also tested in the MIA with WNV and SLEV antigens/bead sets. 
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Wildlife Rehabilitation Centers 
In March 2006, wildlife rehabilitation centers were contacted by email through  
the Florida Wildlife Rehabilitators Association (FWRA) and requested to collaborate in 
the study.  Wildlife rehabilitation centers routinely perform medical examinations and 
diagnosis of injured, orphaned or diseased wildlife, including birds.  These agencies also 
provide treatment for these animals, including medication, physical therapy, feeding, 
husbandry, and pre-release conditioning, with the ultimate goal of releasing each into its 
natural habitat.  However, most of the animals received at rehabilitation centers are sick 
or injured not because of natural causes, but because of accidental or intentional human 
intervention (FWRA, 2007).  
Five wildlife rehabilitation centers agreed to participate in the study (see Table 3-
5). Three of the five centers specialized in wild bird rehabilitation, including seabirds and 
birds of prey. Previous studies have found that these wild bird species can be infected 
with arboviruses (Spalding et al, 1994; Nemeth et al, 2007).  In this study, 64 birds were 
sampled during routine medical exams performed upon admission to each center. 
Sites, Symptoms and Sample Collection 
 The collaborating wildlife rehabilitation centers were located throughout the state 
of Florida (see Table 3-4 for locations).  Since many birds “admitted” to rehab centers are 
not injured or ill because of natural causes (e.g. arboviral infection), sample collection 
criteria were established to minimize waste of resources.  Criteria used for triage of birds 
for admission to this study included: 1) species (known amplifying hosts) [Komar et al, 
2003]; 2) symptoms indicative of arboviral infection (e.g. lethargy, shaking and 
convulsions, anorexia, weight loss, etc) [Komar et al, 2003; Brault et al, 2004]; and 3) 
 142
recent admission (swab cloaca within 1-2 days of admission).  Complete Sample 
Collection Criteria for Wild Birds are shown in Appendix B. 
Targeted Sampling Strategy (Sentinel Chickens) 
Elevated arboviral activity (especially flaviviral) was detected in sentinel chicken 
flocks in both 2005 and 2006. County agencies with confirmed arboviral transmission 
sites based on sentinel surveillance test results (HAI, MAC-ELISA, MIA) were 
immediately contacted and requested to participate in this study. Arbovirus transmission 
activity was detected at several sites in each participating county; and two to six sites per 
county were sampled weekly.   
At the positive sites targeted for arboviral detection/isolation, all sentinel chickens 
that had not yet seroconverted in a flock (site) were sampled for up to two months 
following the initial sentinel seroconversion.  Cloacal swabs and blood samples were 
collected from each bird during the weekly scheduled bleeding of the flocks (2005); 
however, blood sampling was discontinued and only cloacal swabs were collected in 
2006. Cloacal swabs were collected twice each week (2-3 days apart), county personnel 
and resources permitting.  In general, most counties swabbed the sentinels once a week. 
Complete Sample Collection Criteria for Sentinel Chickens are listed in Appendix B. 
Targeted Sentinel Sampling Sites (2005) 
In 2005, sentinel sites were targeted in Manatee, Orange and Sarasota counties 
based on weekly seroconversion test results (HAI, MAC-ELISA, PRNT). Table 3-5 lists 
sentinel chicken sites located in each county and type of arbovirus transmission activity 
(WNV, SLEV, EEEV, and/or HJV) detected by sentinel chicken seroconversions at each  
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Table 3-5 County Sentinel Chicken Sites & Arbovirus Transmission (2005)  
Counties maintained sentinel chicken flocks located at sites scattered 
throughout each county. Sentinel chicken seroconversions (development 
of virus-specific antibodies) indicated the presence of arbovirus 
transmission activity (WNV, SLEV, EEEV, and/or HJV) in the area. 
  
Sentinel Chicken Sites and Arbovirus Transmission Activity (2005) 
 
County All Sites WNV+ SLEV+ EEEV+ HJV+ 
 
Manatee 001 
002 
003 
006 
007 
008 
009 
010 
011 
012 
013 
014 
015 
 
001 
002 
003 
006 
008 
010 
011 
012 
013 
014 
 
015 
002 
003 
008 
 
Not Detected 
 
Orange 
 
001 
002 
003 
004 
005 
006 
007 
008 
Not Detected Not Detected 
001 
004 
005 
006 
007 
008 
004 
006 
 
Sarasota 
 
001 
002 
003 
004 
005 
006 
007 
008 
009 
010 
011 
 
002 
003 
004 
005 
007 
009 
010 
011 
 
008 006 
 
Not Detected 
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location. Figures 3-3 (Manatee County), 3-4 (Orange County) and 3-5 (Sarasota County) 
indicate the location of the sentinel chicken flocks (sites) and confirmed arbovirus 
activity detected at each site. 
Targeted Sentinel Sampling Sites (2006) 
In 2006, sentinel sites were targeted in Orange and Sarasota counties based on 
confirmed weekly seroconversion data (HAI, MAC-ELISA, PRNT) and on experimental 
MIA results for Lee, Pasco, and Volusia counties. Table 3-6 lists the sentinel chicken 
sites located in each county and the type of arbovirus transmission activity (WNV, 
SLEV, EEEV, and/or HJV) detected by confirmed sentinel chicken seroconversions at 
each location; experimental MIA data not shown. Figures 3-6 (Lee County), 3-7 
(Orange), 3-8 (Pasco), 3-9 (Sarasota) and 3-10 (Volusia) indicate the location of the 
sentinel chicken flocks (sites) and confirmed arbovirus activity detected at each site. 
Field Sample Collection 
Blood and Cloacal Swabs 
In the field, two drops of blood (~0.2 ml) from the specimen collected as part of 
routine sentinel surveillance were added to each of two pre-labeled sterile 1.5 ml 
microcentrifuge tubes containing:  1) 0.56 ml lysis buffer plus carrier RNA (10 µg/ml) 
and 2) 1 ml of Biology Field Diluent (BFD) for each sentinel chicken sampled. Blood 
samples were briefly mixed. Blood samples were collected in 2005 only. 
For sentinel chickens and wild birds, swabs of the cloacae were taken with viral 
culturettes (Becton Dickinson, Cat. No. 261514 in 2005 or Cat. No. 220221 in 2006), 
such that the cotton applicator tips were thoroughly wetted. All specimens were placed in  
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Figure 3-3 Manatee County Sentinel Chicken Sites and Arbovirus Activity (2005) 
Sentinel chicken sites are shown as triangle shapes (    ) on the map.  Sites that experienced arbovirus activity (EEE, 
SLE, or WN) during 2005 are shown on the map (* = WNV, circled triangles = SLEV, and square boxes = EEEV 
activity).  SLEV was detected at Site 015. Two sites (002, 003) had both WNV and EEEV confirmed transmission in 
those regions in 2005. 
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Figure 3-4 Orange County Sentinel Chicken Sites and Arbovirus Activity (2005) 
Sentinel chicken sites are shown as triangle shapes (    ) on the map.  Sites that experienced arbovirus activity (EEE, 
SLE, or WN) during 2005 are shown on the map (* = WNV, circled triangles = SLEV, and square boxes = EEEV 
activity).  The majority of sites experienced confirmed EEEV activity, with three sites with both WNV and EEEV 
transmission in 2005.  
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Figure 3-5 Sarasota County Sentinel Chicken Sites and Arbovirus Activity (2005) 
Sentinel chicken sites are shown as triangle shapes (    ) on the map.  Sites that experienced arbovirus activity (EEE, 
SLE, or WN) during 2005 are shown on the map (* = WNV, circled triangles = SLEV, and square boxes = EEEV 
activity).  SLEV activity was detected at one site (008) in the northwestern region of the county in 2005. 
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Table 3-6 County Sentinel Chicken Sites & Arbovirus Transmission (2006)  
Counties maintained sentinel chicken flocks located at sites scattered 
throughout each county. Confirmed sentinel chicken seroconversions 
(development of virus-specific antibodies) indicated the presence of 
arbovirus transmission activity (WNV, SLEV, EEEV, and/or HJV) in the 
area. 
 
 
Sentinel Chicken Sites and Arbovirus Transmission Activity (2006) 
 
County All Sites WNV+ SLEV+ EEEV+ HJV+ 
 
Lee 
 
001 
002 
003 
004 
005 
006 
007 
008 
009 
010 
011 
012 
013 
014 
015 
016 
017 
018 
002 
002 
003 
005 
008 
010 
013 
014 
Not Detected Not Detected 
 
Orange 
 
001 
002 
004 
005 
006 
007 
008 
000HP 
Not Detected Not Detected 
001 
004 
006 
Not Detected 
 
Pasco 
 
001 
002 
003 
004 
005 
006 
007 
001 Not Detected Not Detected Not Detected 
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Table 3-6 County Sentinel Chicken Sites & Arbovirus Transmission (2006), 
Continued  
Counties maintained sentinel chicken flocks located at sites scattered 
throughout each county. Confirmed sentinel chicken seroconversions 
(development of virus-specific antibodies) indicated the presence of 
arbovirus transmission activity (WNV, SLEV, EEEV, and/or HJV) in the 
area. 
 
 
Sentinel Chicken Sites and Arbovirus Transmission Activity, Continued (2006) 
 
County All Sites WNV+ SLEV+ EEEV+ HJV+ 
 
Sarasota 
 
001 
002 
003 
004 
005 
006 
007 
008 
009 
010 
011 
005 
001 
004 
006 
007 
 
Not Detected 
 
Not Detected 
 
 
Volusia 
 
001 
002 
003 
004 
005 
006 
007 
008 
009 
010 
011 
012 
013 
014 
015 
016 
010 Not Detected 
004 
010 
014 
003 
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Figure 3-6 Lee County Sentinel Chicken Sites and Arbovirus Activity (2006) 
Sentinel chicken sites are shown as triangle shapes (    ) on the map.  Sites that experienced arbovirus activity (EEE, 
SLE, or WN) during 2006 are shown on the map (* = WNV, circled triangles = SLEV, and square boxes = EEEV 
activity).  SLEV was detected at seven sites. One site (002) had both WNV and SLEV confirmed transmission at that 
location in 2006.  
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Figure 3-7 Orange County Sentinel Chicken Sites and Arbovirus Activity (2006) 
Sentinel chicken sites are shown as triangle shapes (    ) on the map.  Sites that experienced arbovirus activity (EEE, 
SLE, or WN) during 2006 are shown on the map (* = WNV, circled triangles = SLEV, and square boxes = EEEV 
activity).  Several sites had confirmed EEEV transmission in 2006. 
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Figure 3-8 Pasco County Sentinel Chicken Sites and Arbovirus Activity (2006) 
Sentinel chicken sites are shown as triangle shapes (    ) on the map.  Sites that experienced arbovirus activity (EEE, 
SLE, or WN) during 2006 are shown on the map (* = WNV, circled triangles = SLEV, and square boxes = EEEV 
activity).  A single site (001) had confirmed WNV transmission in 2006.  
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Figure 3-9 Sarasota County Sentinel Chicken Sites and Arbovirus Activity (2006) 
Sentinel chicken sites are shown as triangle shapes (    ) on the map.  Sites that experienced arbovirus activity (EEE, 
SLE, or WN) during 2006 are shown on the map (* = WNV, circled triangles = SLEV, and square boxes = EEEV 
activity).  Four sites (001, 004, 006, 007) had SLEV transmission in 2006. 
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Figure 3-10 Volusia County Sentinel Chicken Sites and Arbovirus Activity (2006) 
Sentinel chicken sites are shown as triangle shapes (    ) on the map.  Sites that experienced arbovirus activity (EEE, 
SLE, or WN) during 2006 are shown on the map (* = WNV, circled triangles = SLEV, and square boxes = EEEV 
activity).  Three sites (004, 010, 014) had EEEV transmission in 2006.  Site 010 also had confirmed EEEV activity. 
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coolers on ice packs during sample collection and transport from the sites, and then 
stored at -70°C until shipment to the Florida Department of Health, BOL-Tampa 
laboratory for testing. Samples were shipped to the laboratory with dry ice overnight. 
To conserve resources, samples were processed retrospectively based on weekly 
seroconversion data for each chicken, that is, samples were processed if seroconversion 
was detected after collection date.  All blood samples and cloacal swabs were processed 
in a Biosafety cabinet in accordance with laboratory biosafety 2 procedures and 
regulations. 
Field Sample Processing 
Blood Processing 
Viral RNA was extracted from blood samples in 0.56 ml lysis buffer with 
QIAamp Viral RNA Mini spin column kits (Qiagen, Cat. No. 52906) following the 
manufacturer’s instructions.  Blood samples placed in 1 ml of BFD were rapidly thawed 
in a 37°C water bath, vortexed for 30 seconds, and centrifuged in a microcentrifuge at 
4,000 x g for 4 minutes, 4°C.  A 0.2 ml aliquot of the BFD sample was transferred into a 
sterile 1.5 ml centrifuge tube and stored at -70°C for plaque assays.  The remainder of the 
BFD sample (0.8 ml) was directly inoculated into Vero cell culture as described below. 
Cloacal Swab Processing 
The two types of viral culturettes used in this study required different processing 
procedures.  In 2005, viral culturettes (Becton Dickinson, Cat. No. 261514) were 
processed as following: sterile 12x75mm glass tubes were labeled and 1 ml of Biology 
Field Diluent (BFD) was added.  Cellulose acetate syringe filters, 0.2 um pore size 
(Nalgene Cat. No. 0974061A), were pretreated with inactivated fetal calf serum (FCS).  
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Swabs were rapidly thawed at 37°C and placed in an ice bath for processing.  Each swab 
was immersed in 1 ml of BFD and agitated for approximately 1 minute to release virus 
and particulate from the swab.  The BFD was then passed through a pretreated cellulose 
filter into a sterile 5 ml tube (Falcon, Cat. No. 352063) to remove bacteria and fecal 
material. A 0.14 ml aliquot of the filtrate was removed, added to 0.56 ml AVL lysis 
buffer in a sterile 1.5 ml centrifuge tube, vortexed and stored at 4°C for RNA extraction. 
An additional 0.2 ml aliquot was transferred into a sterile 1.5 ml centrifuge tube and 
stored at -70°C for plaque assays.  The remainder of the swab sample (0.7 ml) was frozen 
at -70°C until inoculation onto Vero cell culture.    
In 2006, viral culturettes (Becton Dickinson, Cat. No. 220221) were processed 
with a different procedure, as swabs were immersed in 3 ml media in each culturette. 
These culturettes also contained small glass beads that assist the release of virus and 
particulate from the swab when vortexed for 15 seconds. Cellulose acetate syringe filters, 
0.2 um pore size, were pretreated with inactivated FCS.  Swabs were rapidly thawed at 
37°C and placed in an ice bath for processing.  Swabs were vortexed for 15 seconds to 
release virus and particulate from the swab.  A 0.14 ml aliquot of the culture media was 
removed, added to 0.56 ml AVL lysis buffer in a sterile 1.5 ml centrifuge tube, vortexed 
and stored at 4°C for RNA extraction by QIAamp Viral RNA Mini kits.  Alternatively, a 
0.4 ml aliquot of the culture media was removed, added to 0.45 ml AVL lysis buffer in a 
sterile 1.5 ml centrifuge tube, vortexed and stored at 4°C for RNA extraction with the 
Qiagen M48 Biorobot (Cat. No. 9000708). Next, 1.5 ml of the sample was passed 
through a pretreated cellulose filter into a sterile 5 ml tube to remove bacteria and fecal 
material. A 0.2 ml aliquot of the filtrate was transferred into a sterile 1.5 ml centrifuge 
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tube and stored at -70°C for plaque assays.  The remainder of the swab filtrate (~1.3 ml) 
was frozen at -70°C until inoculation onto Vero cell culture. 
Vero Cell Culture and Plaque Assays 
 African Green Monkey Kidney (Vero) cells (ATCC, Cat. No. CCL-81, passage 
130-140) were seeded into tissue culture six-well plates (Falcon, Cat. No. 35520), grown 
in 3 ml/well outgrowth media. Media reagents and catalog numbers are provided in 
Appendix A. Plates were incubated at 37°C, 4% CO2 until the cells were approximately 
90% confluent (4 days). These plates were used for the PRNT (Schmidt, 1979; Beaty, 
Calisher and Shope, 1989; Voakes, 2004) and for virus plaque assays (see below). Tissue 
culture 25 cm2 flasks (Nalgene Nunc International, Cat. No. 156340) were concurrently 
seeded with Vero cells in 10 ml outgrowth media and incubated at 37°C until confluent 
(4 days). 
The PRNT is a quantitative assay that requires precision in pipetting and must be 
performed under stringent biosafety requirements (Beaty et al, 1989). A protocol 
developed 30 years ago at the CDC is still in use today, with minor modifications 
(Lindsey et al, 1976). Briefly, a virus stock is titrated so that the challenge virus contains 
approximately 200 PFU/0.1 mL (plaque forming unit). Test sera are inactivated (56°C for 
30 min) to destroy endogenous complement and are serially diluted two-fold in Serum 
Virus Diluent (SVD) [see Appendix 1 for vendors, reagents and recipes for cell culture 
medias] and then combined with an equal volume of challenge virus diluted in the same 
media plus labile serum factor (Beaty et al, 1989; Chappell et al, 1971). The serum-virus 
mixtures are incubated overnight at 4°C before 100 µl of this mixture (containing 100 
PFU) is inoculated onto Vero cells in six-well plates. After a one hour adsorption period, 
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cells are overlaid with media solidified with agarose. Timing of the second overlay with 
the vital dye is virus specific and depends on the incubation period for each virus. 
Plaques are counted and serum antibody titers are determined based on specified plaque 
reduction levels, commonly 80, 90, or 95% (Beaty et al, 1989).  
 Prior to inoculation, cell monolayers in 25cm2 flasks were washed with 6 ml of 
Earle’s Balanced Salts (EBSS) (Sigma, Cat. No. E-6132).  A micropipette was used to 
inoculate approximately 0.8 ml of the processed BFD blood and/or cloacal swab sample 
onto the Vero cell monolayer in 25cm2 flasks.  The processed blood and/or cloacal swab 
filtrates were removed from -70°C and rapidly thawed at 37°C immediately prior to 
inoculation. Samples were inoculated onto the Vero cell monolayer in 25cm2 flasks using 
a sterile 1 ml pipet. The flasks were rocked at 37°C for 2 hours and fed with 10 ml liquid 
maintenance media (see Appendix A).  Cultures were incubated at 37°C and cell 
monolayers were examined daily by microscope for evidence of cytopathology (cpe) for 
fourteen days.  Flavivirus positive samples exhibited characteristic cpe between 5 to 8 
days post-infection, including round, suspended clusters or single cells as the cells 
detached from the monolayer (Schmidt, 1979).  Positive cultures were confirmed by RT-
PCR methods (see below) for the identification of the infectious agent.  
Once a positive cell culture had been identified by molecular assay (e.g. WNV, 
SLEV, EEEV), viral plaque assays were performed on the stored (reserved) samples of 
swab filtrate (0.2 ml) or blood filtrate (0.2 ml) to quantify the amount of virus present in 
the swab and/or blood samples.  Viral plaque assays were executed in six-well plates with 
a method previously described (Lindsey, Calisher and Mathews, 1976), as modified by 
Beaty, Calisher and Shope (1989) for six well plates.  Briefly, 0.2 ml aliquots of the 
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filtered cloacal swab sample and BFD blood sample were rapidly thawed at 37°C. A 0.1 
ml portion of each sample was serially diluted to 10-5 in serum virus diluent (SVD) 
[reagents found in Appendix A].  Media was aspirated from the Vero cell monolayer 
leaving approximately 0.05 ml of media per well.  Plates were inoculated with 0.1ml of 
each sample dilution, one dilution per well.  An undiluted 0.1 ml portion of the sample 
was also inoculated into one well.  Plates were incubated for 1 hour in a 37°C, 4% CO2 
incubator, and were rocked every 10 minutes.  Media agarose overlays were performed as 
described (Beaty, Calisher and Shope, 1989), with second neutral red overlays performed 
at different virus incubation periods (WNV 3 DPI, SLEV 7 DPI, and EEEV 2 DPI).  
After the addition of a neutral red second overlay, plates were incubated at 37°C 
overnight, then inspected on a light box and plaques counted on two consecutive days. 
Media-agarose overlay reagents are provided in Appendix A. 
Neutralization assays were also conducted on positive cloacal swab virus isolates 
to verify the infectious agent. WNV-specific polyclonal antibodies (Cat. No. 0069) and 
SLEV-specific polyclonal antibodies (Cat. No. 0055) were obtained from the CDC, Fort 
Collins for use in the PRNT.  These antibodies were diluted in SVD (1:10), heat 
inactivated at 56°C for 30 minutes, serially titrated and challenged with an equal volume 
of control virus (SLEV TBH 28 or WNV Eg101) containing ~200 pfu/0.1 ml. These 
virus-antibody mixtures were incubated overnight at 4°C and then inoculated into Vero 
6-well plates for plaque reduction neutralization assays to determine the 95% 
neutralization end-point of each antibody. Serial dilutions (10-1 to 10-6) of cloacal swab 
virus isolates (passaged once in Vero cells) were challenged with the appropriate 
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concentration of polyclonal antibody (1:100 for WNV, 1:20 for SLEV) and plaque assays 
performed, as described above.  
 Individual plaques (clones) for all cloacal swab virus isolates were “picked” from 
6-well Vero plates and suspended into 1 ml of SVD.  A portion of the SVD (0.14 ml) was 
removed, added to 0.56 ml AVL lysis buffer in a sterile 1.5 ml centrifuge tube, vortexed 
and stored at 4°C for RNA extraction.  The remainder of the SVD (0.8 ml) was added to 
25cm2 Vero flasks.  The flasks were rocked at 37°C for 2 hours, and then fed with 10 ml 
maintenance media (Appendix A). Cultures were incubated at 37°C and cell monolayers 
were examined daily by microscope for evidence of cytopathology (cpe) for fourteen 
days.  After RNA extraction of the 0.14 ml aliquots, clones were confirmed with real-
time (TaqMan) RT-PCR assays.  Figure 3-11 illustrates the complete testing algorithm 
for cloacal swabs. 
Nucleic Acid Extraction 
 Viral RNA was extracted from blood samples and cloacal swab samples with 
QIAamp Viral RNA Mini spin column kits (Qiagen, Cat. No. 52906) or a BioRobot M48 
(Qiagen, Cat. No. 9000708) with MagAttract Virus Mini M48 kits (Qiagen, Cat. No. 
955336). A 0.14 ml or 0.4 ml aliquot from each sample was added to 0.56 ml or 0.45 ml  
AVL lysis buffer, respectively.  All samples were processed according to manufacturer’s 
instructions and RNA was eluted from the membrane in 0.06 ml elution buffer (QIAamp 
Viral RNA Mini Kits) or from magnetic beads in 0.1 ml elution buffer (MagAttract Viral 
RNA M48 Kits) into sterile 1.5 ml centrifuge tubes.  The RNA samples were stored at     
-70°C until amplification and detection by real-time or end-point RT-PCR.   
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Figure 3-11 Diagnostic Algorithm for the Isolation and Detection of Arboviruses 
from Cloacal Swabs  
Cloacal swabs were processed for both cell culture (left side of flowchart) 
and molecular assays (right side of flowchart). Inoculation of a portion of 
the sample into cell culture allows for the growth and isolation of 
arboviruses, which can be identified using molecular RT-PCR assays.  
Each sample was also lysed for RNA extraction followed by RT-PCR 
amplification/detection tests, using a panel of arbovirus-specific primer 
sets. Positive samples were confirmed through nucleotide sequencing. 
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Viral RNA was extracted from positive Vero cell cultures (passage 1) with 
QIAamp Viral RNA Mini spin column kits.  A 0.14 ml aliquot from each culture was 
added to 0.56 ml AVL lysis buffer (AVL).  All samples were processed according to 
manufacturer’s instructions and RNA was eluted from the membrane in 0.06 ml elution 
buffer into sterile 1.5 ml centrifuge tubes.  The RNA samples were stored at -70°C until 
amplification and detection by real-time and end point RT-PCR.  Figure 3-12 illustrates 
the nucleic acid extraction procedure with these two methods (Viral RNA Mini Spin kits 
or MagAttract Viral RNA M48 kits), followed by amplification/detection, in a flow chart. 
Nucleic Acid Amplification and Detection 
 RNA was amplified in a one-step reverse transcriptase-polymerase chain reaction 
(RT-PCR) procedure for both real-time and end-point reactions. Oligonucleotide primers 
were obtained from Operon (Alameada, CA) as lyophilized powders and were re-
hydrated in 1 ml (primers) or 0.1 ml (probes) RNase/DNase free water upon receipt. 100 
μM (real-time primers), 200 μM (end-point primers) and 25 μM (real-time probes) 
working dilutions were prepared, aliquoted in 20 µl volumes and stored at -20°C to 
eliminate excessive freeze/thaws of stock solution.  Primer sets and probes are shown in 
Table 3-7 (WNV), Table 3-8 (SLEV), and Table 3-9 (universal flavivirus), as described 
in previous studies (citations provided below).  Target regions on the flaviviral RNA 
genome and amplicon product sizes are indicated in Figures 3-13 (WNV), Figure 3-14 
(SLEV) and Figure 3-15 (flavivirus). 
Real-Time Reverse Transcriptase-Polymerase Chain Reaction 
Arboviral RNA was amplified and detected using TaqMan technology on ABI 
Prism7000 or 7500 Sequence Detectors (Applied Biosystems, Foster City, CA), in 2005  
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Figure 3-12 Molecular Diagnostic Testing Algorithm for Detection of Arboviruses  
Virus nucleic acids were extracted from samples with Qiagen’s Viral RNA 
Mini Spin kits or BioRobot M48. Samples were screened in real-time RT-
PCR (TaqMan) assays, with a specific primer set (“A”) for WNV, SLEV, 
or EEEV. Positive samples were confirmed with a second virus-specific 
primer set (“B”) in real-time RT-PCR and/or end-point RT-PCR assays. 
End-point RT-PCR products were excised from an 1% agarose-EtBr gel, 
cleaned and prepared for nucleotide sequencing. 
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 or 2006, respectively.  West Nile virus (Lanciotti et al, 2000) [see Table 3-7], St. Louis 
encephalitis virus (Lanciotti and Kerst, 2001) [see Table 3-8], and Eastern equine 
encephalitis virus (Lambert, Martin and Lanciotti, 2003) specific TaqMan primer-probe 
sequences were used as previously described.  Two primer-probe sets (targeting different 
regions of the viral genome) were used for each virus. “A” primer/probe sets were used to 
screen samples and “B” primer/probe sets confirmed positive samples for each virus 
(WNV, SLEV or EEEV) per CDC recommendations (CDC, 2003A). Positive, negative 
extraction and amplification controls were included with each run. Figure 3-12 illustrates 
the molecular diagnostic testing algorithm used by the BOL-Tampa. 
One-step TaqMan RT-PCR master mix (Applied Biosystems, Cat. No. 4309169) 
was prepared for each primer/probe set on ice.  RT-PCR master mix reagent volumes 
varied depending on whether the ABI Prism 7000 or 7500 Sequence Detector was used 
(see Appendix AV for real time RT-PCR master mix components and cycling profiles). 
In a 96-well plate (Applied Biosystems, Cat. No. 4302109), 45 µl of RT-PCR master mix 
and 5 µl of sample RNA were combined for a total reaction volume of 50 µl for the ABI 
7000 system. However, the ABI 7000 system was only used in 2005.  Alternatively, 20 µl 
of RT-PCR master mix and 5 µl of sample RNA were combined for a total reaction 
volume of 25 µl in a 96-well plate (Applied Biosystems, Cat. No. 4346906) for use in the 
ABI 7500 system (instrument used during 2006). The plate was loaded into the 
appropriate ABI sequence detector for temperature cycling and detection. Samples were 
considered positive for WNV, SLEV, or EEEV if they exhibited CT counts at 40 or below 
and a valid multicomponent split with both “A” and “B” primer/probe sets. However,  
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Table 3-7 WNV Oligonucleotide Primers and Probes used in Real Time (TaqMan) and End Point RT-PCR Assaysª  
The TaqMan primer/probe set WN3’NC was named “WNA” at the BOL-Tampa and used to screen all samples 
for detection of WNV.  Positive samples were confirmed with the “WNB” primer/probe set (WNENV).  End 
point RT-PCR was conducted on TaqMan-positive samples to generate a larger amplicon for sequencing 
(WN233-640c was named “WNAE”). 
 
 
Real Time and End Point RT-PCR Primers & Probes for WNV 
Primer Sequence (5’ → 3’) Genome Positionb Platform Name & Reference Product Size 
 
WN3’NC - F 
WN3’NC - R 
WN3’NC - P 
 
WNENV - F 
WNENV - R  
WNENV - P 
 
WN233 - F 
WN640c - R 
 
CAG-ACC-ACG-CTA-CGG-CG 
CTA-GGG-CCG-CGT-GGG 
CTG-CGG-AGA-GTG-CAG-TCT-GCG-AT-BHQ 
 
TCA-GCG-ATC-TCT-CCA-CCA-AAG 
GGG-TCA-GCA-CGT-TTG-TCA-TTG 
TGC-CCG-ACC-ATG-GGA-GAA-GCT-C-BHQ 
 
TTG-TGT-TGG-CTC-TCT-TGG-CGT-TCT-T 
CAG-CCG-ACA-GCA-CTG-GAC-ATT-CAT-A 
 
10668-10684 
10770-10756 
10691-10714 
 
1160-1180 
1209-1229 
1186-1208 
 
233-257 
640-616 
 
TaqMan 
RT-PCR 
 
 
TaqMan 
RT-PCR 
 
 
End Point 
RT-PCR 
 
 
 
WNA 
 
 
 
WNB 
 
 
 
WNAE 
 
 
103 bp 
 
 
 
70 bp 
 
 
 
408 bp 
 F = forward (sense) primer, R = reverse (anti-sense) primer, P = probe.    
ªPrimer sequences published by Lanciotti et al (2000).  Probes adapted with black hole quenchers (BHQ) to enhance sensitivity 
(Lanciotti, personal communication, 2007).   
bWest Nile virus-specific genome positions are according to WNV NY99 sequence in GenBank (Accession Number AF196835). 
 
 
 166
Figure 3-13 Amplicons Generated by WNV Primers for RT-PCR and Sequencing 
 Location of amplicons on the flavivirus genome. Primers anneal to the flanking sides and lines represent three 
expected amplicons generated from WNV real-time and end point RT-PCR assays. End point RT-PCR products 
(WNAE primer set) were sequenced.  F = forward (sense) primer, R = reverse (anti-sense) primer, P = probe.    
 
 
5'NC PrM/M E NS1 NS2A/B NS3 NS4A/B
PrM/M       E
WNB-F
WNB-P
WNB-RWNAE-R
NS5C 3'NC
70 bp
Name Genome Position
WNAE-F
408 bp
C
WNA-F
3'NC
WNA-P
WNA-R
103 bp
NS5
WNBE-F
WNBE-R
312 bp
 WNA-F              10668
 WNA-R              10770
 WNA-P              10691
 WNB-F                1160
 WNB-R                1209
 WNB-P                1186
 WNAE-F                233
 WNAE-R               640
 WNBE-F       9483
 WNBE-R       9794
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Table 3-8 SLEV Oligonucleotide Primers and Probes used in Real Time (TaqMan) and End Point RT-PCR Assays 
TaqMan primer/probe set SLE834/905c was named “SLEA” at the BOL-Tampa and used to screen all samples for 
detection of SLEV.  Positive samples were confirmed with the “SLEB” primer/probe set (SLE2420/2487c).  End point 
RT-PCR was conducted on TaqMan-positive samples to generate a larger amplicon for sequencing (SLE727/1119c was 
named “SLEC”; envelope region of 1700 bp was sequenced with primers F880 through B2586). 
 
 
Real Time and End Point RT-PCR Primers & Probes for SLEV 
Primer Sequence (5’ → 3’) Genome Positionª Platform Name & Reference 
Product 
Size 
 
SLE834 – F b 
SLE905c – R   
SLE857 – P  
 
SLE2420 – F  b 
SLE2487c – R   
SLE2444 – P   
 
SLE727 – F b 
SLE1119c – R  
 
F880 – F c 
F1390 – F 
B1629 – R 
F1990 – F 
B1993 – R   
B2586 – R  
 
GAA-AAC-TGG-GTT-CTG-CGC-A 
GGT-GCT-GCC-TAG-CAT-CCA-TCC 
TGG-ATA-TGC-CCT-AGT-TGC-GCT-GGC-BHQ 
 
CTG-GCT-GTC-GGA-GGG-ATT-CT 
TAG-GTC-AAT-TGC-ACA-TCC-CG 
TCT-GGC-GAC-CAG-CGT-GCA-AGC-CG-BHQ 
 
GTA-GCC-GAC-GGT-CAA-TCT-CTG-TGC 
ACT-CGG-TAG-CCT-CCA-TCT-TCA-TCA 
 
CGA-TTG-GAT-GGA-TGC-TAG-GTA-G 
GTG-CAT-GGT-TCA-ACG-GAC-TCT-AC 
GGT-TCA-AGT-CGT-GAA-ACC-AGT-C 
CTG-CAA-ACC-TCA-TGG-ATT-TGA-CAC-C 
GCA-GTC-ACG-GAG-ATG-GGA-ACT-CGG-C 
CAG-TTG-GAG-TCA-GAG-GGA-AAT-ACT-T 
 
834-852 
905-889 
857-880 
 
2420-2439 
2487-2468 
2444-2466 
 
727-750 
1119-1096 
 
880-901 
1390-1411 
1629-1608 
1990-2014 
1993-1969 
2586-2562 
 
TaqMan 
RT-PCR 
 
 
TaqMan 
RT-PCR 
 
 
End Point 
RT-PCR 
 
End Point 
RT-PCR 
+ 
Direct 
Internal 
Sequencing 
 
SLEA 
 
 
 
SLEB  
 
 
 
SLEC 
 
 
F880 
F1390 
B1629 
F1990 
B1993 
B2586 
 
72 bp 
 
 
 
68 bp 
 
 
 
393 bp 
 
 
 
 
750 bp 
 
 
1700 bp 
 F = forward (sense) primer, R = reverse (anti-sense) primer, P = probe.  
ªSt. Louis encephalitis virus-specific genome positions are according to SLEV MSI-7 sequence in GenBank (Accession Number M16614). 
   bPrimer sequences published by Lanciotti and Kerst (2001).  Probes adapted with black hole quenchers (BHQ) [Lanciotti, personal commun, 2007].  
cRT-PCR and sequencing primers published by Kramer and Chandler (2001). 
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Figure 3-14 Amplicons Generated by SLEV Primers for RT-PCR and Sequencing 
 Location of amplicons on the flavivirus genome. Primers anneal to the flanking sides and lines represent five 
expected amplicons generated from SLEV real-time and end point RT-PCR assays. End point RT-PCR products 
(SLEC, F880 through B2586 primer sets) were sequenced. F = forward (sense) primer, R = reverse (anti-sense) 
primer, P = probe.    
 
 
5'NC C E NS1 NS2A/B NS3
F880-F B1390-F
NS4A/BPrM/M 3'NCNS5
SLEA-R
SLEA -F
SLEC-R
72 bp
B1629-R
393 bp
SLE C-F
NS1E
750 bp
     PrM                                      M
B1993-R
F1990-F
SLEA-P SLEB-P
SLEB-R
SLEB-F
68 bp
B2586-R
1700 bp
Genome Position
 SLEA-F                    834
 SLEA-R                    905
 SLEA-P                    857
 SLEB-F                  2420
 SLEB-R                 2487
 SLEB-P                 2444
 SLEC-F                   727
 SLEC-R                1119
 F880-F                    880
 F1390-F                1390
 B1629-R               1629
 F1990-F                1990
 B1993-R               1993
 B2586-R               2586
Name
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Table 3-9 Flavivirus Oligonucleotide Primers and Probes used in End Point RT-PCR Assays 
End point RT-PCR was conducted on TaqMan-positive samples (WNV and SLEV) to generate a larger 
amplicon for sequencing.  A portion of the NS5 region was amplified with the FU1/cFD3 primer set (named 
“NS5” at the BOL-Tampa), which generated a product size of ~1 kb for both WNV and SLEV.  The YF1/YF2 
primer set (named “YF”) targeted the 3’UTR with an overlap in the NS5 gene and generated different sized 
products, 700 bp or 600 bp, for WNV and SLEV, respectively.  
 
 
End Point RT-PCR Primers for Flaviviruses 
 
Primer Sequence (5’ → 3’) Genome Positionc, d Platform 
Name & 
Reference Product Size 
 
FU1 – F ª 
cFD3 – R   
 
YF1 – F b 
YF2 – R    
 
TAC-AAC-ATG-ATG-GGA-AAG-AGA-GAG-AA 
AGC-ATG-TCT-TCC-GTG-GTC-ATC-CA 
 
GGT-CTC-CTC-TAA-CCT-CTA-G 
GAG-TGG-ATG-ACC-ACG-GAA-GAC-ATG-C 
 
8993-9018 
10077-10055 
 
10052-10070 
10709-10685 
 
End Point 
RT-PCR 
 
End Point 
RT-PCR 
 
NS5 
 
 
YF 
 
1 kb 
(WN & SLE) 
 
WN: 700 bp
SLE: 600 bp 
  
 F = forward (sense) primer, R = reverse (anti-sense) primer.  
ªPrimer sequences published by Kuno et al (1998).   
bPrimer sequences published by Tanaka (1993). 
c FU1/cFD3 primer genome positions are according to YF virus sequence in GenBank (Accession Number  K0274). 
dYF1/YF2 primer genome positions are according to YF 17D vaccine strain (taxa: 11090). 
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Figure 3-15 Amplicons Generated by Universal Flavivirus Primers for RT-PCR and Sequencing 
 Location of amplicons on the flavivirus genome. Primers anneal to the flanking sides and lines represent two 
expected amplicons generated from universal flavivirus end point RT-PCR assays. End point RT-PCR products 
(NS5 and YF primer sets) were sequenced.  F = forward (sense) primer, R = reverse (anti-sense) primer, P = 
probe.    
 
 
5'NC C PrM/M E NS1 NS2A/B NS3 3'NCNS5NS4A/B
YF2-R
NS5 3'NC
FU1-F
cFD3-R  
YF1-F
Genome Position
 FU1-F                 8993
 cFD3-R              10077
 YF1-F                 10052
 YF2-R                 10709
Name
1000 bp
~700 bp
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positive samples with a single TaqMan primer/probe set were further tested with end 
point RT-PCR primer sets (see below) for confirmation. 
End Point Reverse Transcriptase-Polymerase Chain Reaction  
 Several previously published primer sets were used in end point RT-PCR 
reactions to amplify and sequence SLEV, including the complete envelope (Kramer and 
Chandler, 2001) and partial membrane (Lanciotti and Kerst, 2001) regions (see Table 3-
9).  For WNV, a portion of the capsid region was amplified and sequenced with primer 
set WN233-640c published by Lanciotti et al (2000) [see Table 3-8].  Universal flavivirus 
primer sets were used to generate amplicons for sequencing both SLEV and WNV strains 
(see Table 3-10). These included a primer set (FU1/cFD3) targeting the partial NS5 
region (Kuno et al, 1998) and another set (YF1/YF2) that targets the 3’ UTR, with a 
slight overlap in the NS5 region (Tanaka, 1993).   
Arboviral RNA was amplified for subsequent nucleotide sequencing using the 
SuperScript III One-Step RT-PCR System with Platinum Taq High Fidelity polymerase 
(Invitrogen, Cat. No. 12574-035).  This system allowed for amplification of longer 
templates with improved fidelity due to the Platinum Taq high fidelity enzyme mix, 
which includes a proof-reading enzyme with 3’ to 5’ exonuclease activity to repair base 
mismatches. RT-PCR master mix was prepared for each primer set on ice following the 
manufacturer’s instructions. In 0.2 ml thin walled PCR tubes (Molecular BioProducts, 
Cat. No. 3412), 48 µl of RT-PCR master mix and 2 µl of sample RNA were combined for 
a total reaction volume of 50 µl.  Thermal cycling was performed in a GeneAmp PCR 
System 9700 thermal cycler (Applied Biosystems, Foster City, CA). Positive and 
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negative controls were included with each run.  See Appendix AV for end point RT-PCR 
master mix components and cycling conditions.  
Detection of End Point RT-PCR Products 
 All end point RT-PCR products were visualized via gel electrophoresis, with 1% 
agarose gels (0.435g NuSieve agar [Cambrex, Cat. No. 50090], 0.215g SeaKem agar 
[Cambrex, Cat. No. 50004], 65ml 1X TAE [Fisher, Cat. No. BP13324, 50X solution], 8 
µl 1% ethidium bromide [Fisher, Cat. No. BP1302-10]).  Electrophoresis was conducted 
at 120mV for approximately forty five minutes with 10 µl lane marker (Promega: 1 kb 
ladder, Cat. No. G316A; 10 kb ladder, Cat. No. G754A). 
Sample Preparation for Nucleotide Sequencing 
 Bands of the correct amplicon size were excised from the gels with scalpels. 
Bands were placed in 1.5ml microfuge tubes and weighed using an analytical balance 
(Mettler, Cat. No. AE260). These amplification products were then “cleaned” with 
QIAquick Gel Excision kits (Qiagen, Cat. No. 28706) following the manufacturer’s 
instructions.  Nucleic acid was eluted in 0.1 ml Buffer EB (included in kit).  “Cleaned” 
products (5µl) were analyzed on a second 1% agarose gel along with 2µl and 4µl lane 
marker in order to provide a rough estimate of dsDNA concentration. Approximately 5ng 
to 20ng of dsDNA template was added to the sequencing reaction for each sample. 
Sequencing reactions were performed in replicate for each sample. 
Nucleotide Sequencing 
Sequencing reactions were performed with DTCS Quick Start kits (Beckman-
Coulter, Cat. No. 608126). Twenty microliter sequencing reactions were prepared in 96-
well plates (Beckman-Coulter, Cat. No. 609801) and thermal cycling was performed in a 
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GeneAmp PCR System 9700 thermal cycler (Applied Biosystems, Foster City, CA). 
Master mix and cycle parameters for sequencing are shown in Appendix AV.  A reaction 
“stop solution” consisting of glycogen (supplied in kit at 20mg/ml), 100mM EDTA 
(Sigma, Cat. No. E-7889, 0.5 M solution), and 3M Sodium Acetate (Sigma, Cat. No. S-
7899) was combined in a 1:2:2 ratio. 5 µl of this “stop solution” was added to all wells to 
ensure termination of sequencing PCR product extension. Well contents were then 
ethanol-precipitated to remove salts. One wash was performed with cold 95% ethanol 
(stored @ -20°C) prior to centrifugation at 6,000 x g for 5 minutes. Two additional 
washes with cold 70% ethanol (stored @ -20°C ) were followed by two centrifugations at 
6,000 x g for 3 minutes. Samples were allowed to air-dry for 10 minutes and then 40 µl 
SLS solution (supplied in kit) was added to each well. After 10 minutes incubation at 
room temperature, plates were vortexed lightly and each well was overlayed with mineral 
oil (included in kit). Nucleotide sequencing of RT-PCR amplicons was performed with a 
Beckman-Coulter® (Fullerton, CA) CEQ8000 Automated Sequence Analysis System 
(Cat. No. 285501), in accordance with the manufacturer’s protocol. Plates were added to 
instrument and run was initiated. Method LFR (long fragment read) was used for all runs. 
Additional sequencing reactions for the complete envelope and NS5 regions of 
historical SLEV isolates were performed by the H. Lee Moffitt Cancer Center molecular 
biology core facility.  Complete genome maps of FLS545 and FLS569 isolates 
(excluding 5’ and 3’ non-coding regions) were assembled at the University of Alabama at 
Birmingham (UAB), with nucleotide sequencing reactions performed at the UAB 
molecular genetics core facility. 
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Sequence Analysis 
The basic local alignment search tool (BLAST) was used to identify virus 
subtypes. BLAST utilizes a freely available sequence database at the following URL: 
http://www.ncbi.nlm.nih.gov/BLAST. Briefly, this program compares user submitted 
sequence data (nucleotide, BLASTn, or protein, BLASTp) against an extensive database 
commonly referred to as GenBank. Sequences obtained were queried against GenBank 
and evaluated for accuracy. Sequences for isolates evaluated for the first time in this 
study were submitted to GenBank and provided unique identifiers, known as Accession 
Numbers. 
Sequence data was exported to the SeqmanII module of the Lasergene software 
suite, version 5.08 (DNAStar, Madison, WI) as “.scf” files. These files contain raw 
sequence data and the analyzed “base calls” data for each sequencing reaction. Contigs 
were assembled in the SeqmanII module, which are consensus sequences derived from 
bi-directional sequencing using both the forward (sense) and reverse (anti-sense) primers. 
This provides a level of quality control and allows for better coverage of the amplicon 
region. Assembled contigs were saved as “.seq” files for use in all modules of Lasergene. 
In addition, large amplicons (greater than 700bp) were assembled with overlapping 
fragments to generate a consensus sequence in both the forward and reverse directions. 
Overlapping fragments were necessary to generate a complete contig for the 1633 bases 
analyzed in the SLEV envelope region.  
Contigs were converted to GCG format (.msf files) using Megalign (DNAStar) 
and exported for use in the multiple sequence alignment program MEGA 4.0.1.  Multiple 
sequence alignments were performed in MEGA4.0.1 using the ClustalW 1.6 method. 
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Clustal W 1.6 was also used in the MEGA (molecular evolutionary genetic analysis) 
module, a free software program (version 4.0.1) downloaded from URL: 
http://www.megasoftware.net/ (Tamura et al, 2007).  ClustalW is a progressive pair-wise 
alignment algorithm, which aligns homologous bases and inserts gaps where homology is 
not present. 
Phylogenetic Analysis 
Multiple sequence alignments were used to create phylogenetic trees. The 
Megalign module automatically constructs a phylogenetic tree when an alignment is 
produced. In addition, MEGA (molecular evolutionary genetic analysis) was downloaded 
from URL: http://www.megasoftware.net/.  This free software program allows the user to 
specify preferences (feature not available in the MegAlign module). Additional complete 
flavivirus sequences were downloaded from GenBank for use as outgroups. Phylogenetic 
trees were computed in MEGA4.0.1 to infer the evolutionary relationships of SLEV and 
WNV strains. Neighbor-joining, maximum parsimony, and unweighted paired group 
means arithmetic (UPGMA) methods were used to construct trees, with 1000 bootstrap 
replicates performed for each tree method. The consensus tree was chosen. Neighbor-
joining and maximum parsimony trees were used, where a constant rate of evolution is 
not assumed unlike the UPGMA (Unweighted paired group mean arithmetic) tree 
method. Phylogenetic trees from these methods were evaluated for accuracy of branch 
points and phyletic clusters.  
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CHAPTER FOUR 
 
RESULTS 
 
 In Florida, St. Louis encephalitis virus has not been isolated in culture since the 
introduction of West Nile virus. It is unknown what impact the establishment of WNV 
endemicity will have on the natural history of SLEV.  Consequently, this study proposed 
to isolate arboviruses, especially St. Louis encephalitis virus, from naturally exposed 
birds with a targeted sampling strategy.  The project investigated potential strain 
differences in current circulating isolates as compared to a historical archive of flavivirus 
isolates.  A network was established for the isolation and/or molecular detection (RT-
PCR) of arboviruses in Florida from sentinel chickens and wild birds. 
Network for Isolation/Detection of Arboviruses in Florida 
 The largest arboviral surveillance program in the United States operates year-
round in Florida.  However, Florida’s surveillance program rarely attempts arbovirus 
isolation from specimens (e.g. sera) collected from live subjects, with the exception of 
clinical (human) cases where cerebral spinal fluid is collected during acute infection. 
Instead, this program utilizes multiple other strategies for the early identification of 
arbovirus transmission activity, including routine serological testing of sentinel chicken 
sera for virus-specific antibodies and molecular detection/virus isolation assays of dead 
mosquito pools, bird and mammalian tissues to identify the etiological agent.  In 2004, 
these routine surveillance techniques were assessed following the introduction of WNV 
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to New York (1999) and to Florida (2001) in order to determine an optimal sampling 
strategy for the detection/isolation of SLEV.  
Evaluation of Arbovirus Surveillance Methods  
 A method that anchors the state’s arbovirus surveillance program is the Florida 
Sentinel Chicken Arboviral Surveillance Network, which was established in 1978 
(Nelson et al, 1983). This statewide surveillance program has shown that sentinel chicken 
seroconversions (development of antibodies) to arboviruses often precede human cases 
and can serve as an early warning system (Blackmore et al, 2003; Butler and Stark, 
2005).  Figure 4-1 illustrates the rate (number positive birds divided by total number of 
susceptible birds x 100 =  %) of sentinel chicken flavivirus seroconversions from 1988 to 
2006 (figure appears courtesy of Stark and Kazanis, 2006). The rate of SLEV 
seroconversions dramatically declined following the introduction of WNV in Florida 
(2001).   
Although low levels of SLEV were detected by sentinel chickens in 2001 (n=7) 
during the first year of WNV transmission activity, SLEV was not detected by the 
sentinels in 2002.  SLEV sentinel chicken seroconversions reappeared in 2003 (n=10) 
and 2004 (n=12) at much lower levels than in 1999 (n=193) and 2000 (n=144) prior to 
the introduction of WNV.  Figure 4-2A illustrates this decline in number of SLEV 
positive sentinel chickens, as well as the rate (%) of SLEV and WNV seroconversions 
(1999-2004) [data summarized from Laboratory Reports 1997-2006 and Annual Reports 
2002-2006, available at the FDOH-BECH website at URL: 
http://www.doh.state.fl.us/environment/community/arboviral/survey-info.htm].   
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 A second surveillance tool for the detection and/or isolation of arboviruses 
involves testing of pools of trapped mosquitoes (1-50 mosquitoes per pool).  Mosquitoes 
were collected, anesthetized, speciated, and pooled by county mosquito control districts 
(MCD) and then submitted to the laboratory on dry ice for diagnostic purposes. During 
2001-2004, the BOL-Tampa performed molecular assays for the detection of arboviral 
RNA on 13,496 traditional mosquito pools, as well as inoculation of homogenized,  
filtered mosquito pools for virus isolation in cell cultures. Nucleic acid was extracted 
from each pool and screened for flavivirus-specific RNA in a real time RT-PCR assay 
(TaqMan). Alternatively, mosquito control districts performed extraction and RT-PCR 
assays of collected mosquito pools “in-house”, depending on personnel, resource and 
equipment availability. Positive mosquito pool results were reported by the BOL-Tampa 
or mosquito control districts to the FDOH-BCEH by agencies in the state that performed 
virology molecular detection assays (FDOH-BCEH, 2007).   
Unlike sentinel chicken seroconversions, assays for the detection of flaviviruses in 
mosquito pools have not been as sensitive in Florida with few positives reported by the 
BOL-Tampa, especially in years with few seroconversions (Stark and Kazanis, 2001-
2007).  SLEV has rarely been detected in mosquito pools since the introduction of WNV, 
with zero positive pools in 2001, 2003, and 2004.  In 2002, the only SLEV positive 
mosquito pools detected in the state were extracted and assayed by Lee County Mosquito 
Control District (n=2) following the introduction of WNV (FDOH-BCEH, 2002). 
Interestingly, sentinel chicken seroconversions to SLEV were not detected in flocks 
located in Lee County or elsewhere in the state during 2002 (Stark and Kazanis, 2002).  
Figure 4-2 B shows the number of positive mosquito pools for SLEV and WNV (1999- 
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Sentinel Chicken Seroconversions to Flavivirus 
1988-2006
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Figure 4-1 Rate of Sentinel Chicken Seroconversions to Flaviviruses (1988-2006) 
In Florida, sentinel chickens are used to detect arbovirus activity throughout the state. The rate of sentinel chicken 
seroconversions to flaviviruses are shown below, with fluctuating rates of WNV (yellow) and SLEV (red) over time.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure appears courtesy of Lillian Stark, where it is available for open access at the FDOH-BCEH website at URL: 
http://www.doh.state.fl.us/environment/community/arboviral/survey-info.htm (Annual Laboratory Reports, 2006)
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2004) reported to FDOH-BCEH (Stark and Kazanis, 1999-2004; Mosquito-Borne 
Disease Summaries 2002-2004 available from URL: 
http://www.doh.state.fl.us/environment/community/arboviral/survey-info.htm). 
 Another component of Florida’s arbovirus surveillance program is the 
detection/isolation of virus from tissues collected from dead birds and mammals. This 
surveillance technique was routinely performed at the BOL-Tampa, where specimens 
submitted to the laboratory were tested for the presence of arbovirus RNA (TaqMan RT-
PCR) and cultured in Vero cells for virus isolation. Tissues from 15,586 dead 
birds/mammals were tested by the BOL-Tampa for arbovirus detection/isolation during 
2000-2004. SLEV was not detected or isolated in these samples. Figure 4-2 C illustrates 
the number of positive dead birds/mammals for SLEV and WNV.  
Identification of Existing Arbovirus Surveillance Resources 
 In Florida, several resources exist at local and state levels for surveillance of 
arboviruses, including West Nile virus and St. Louis encephalitis virus transmission 
activity. Three methods were evaluated to identify a system (live domestic birds, dead 
wild birds/mammals and mosquitoes) that could be targeted for the isolation/detection of 
SLEV.  The number of sentinel chickens that seroconverted (developed antibodies) to 
SLEV [n=10 in 2003, n=12 in 2004] was higher than the number of positive mosquito 
pools [n=2 in 2002] or positive dead birds/mammals [n=0 during 2001-2004], following 
the introduction of WNV. Consequently, the sentinel chicken program was chosen to 
implement a targeted sampling strategy for the isolation of St. Louis encephalitis virus. 
During the study period, 14 county agencies with active sentinel chicken 
programs in central and southern regions of the state were recruited. These local agencies  
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Figure 4-2 Comparison of Arbovirus Surveillance Methods for the Detection of 
SLEV, as compared to WNV, from 1999-2004.  
 A) Sentinel chicken seroconversions to SLEV declined following the 
introduction of WNV in 2001 (# chickens on the first y axis). Low levels 
of SLEV sentinel seroconversions resumed in 2003 and 2004 (rate on 
second y axis). B) WNV was detected in 86 mosquito pools during 2001-
2004; SLEV was identified in 2 pools during 2002.  C) SLEV was not 
detected in dead bird/mammalian tissues, despite the detection of more 
than 2000 WNV infections in the same time period. 
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were selected based on historical SLEV transmission patterns in Florida (traditional SLE 
belt, see Figure 3-1).  The University of Florida (IFAS, FMEL) was contacted for 
inclusion in this project, as this agency submitted sentinel chicken sera during 2006. 
In 2006, wildlife rehabilitation centers affiliated with the Florida Wildlife 
Rehabilitation Association (FWRA) were also recruited using the FWRA listserv 
directory of its members. In addition, the Florida Fish and Wildlife Conservation 
Commission (FWC) was contacted to collect cloacal swabs from wild bird mortality 
events, when the agency investigated clusters of dead birds throughout the state.  
Agencies and rehab centers were contacted with a description of the study by 
email and/or telephone and requested to collaborate with the Florida Department of 
Health, Bureau of Laboratories- Tampa for the isolation of arboviruses from naturally 
exposed birds. Shipping and laboratory testing of collected samples was offered at no 
cost to each agency.  
Optimization of Methods for Network 
In 2004 and 2006, testing methods were optimized at the BOL-Tampa for the 
detection/isolation of arboviruses from blood (see Methods for details) and viral 
culturette swabs.  The QIAamp Viral RNA Mini kit had previously been validated at the 
BOL-Tampa for nucleic acid extraction from cloacal swabs (Brennan, 2003) and was 
validated in 2004 for blood samples. At the initiation of this study, the cloacal swab 
processing protocol was assessed to quantify recovery of virus by RT-PCR (TaqMan) and 
plaque assays after processing a swab. This information was used to determine virus 
detection thresholds in cloacal samples and for quantification (titer) of arbovirus 
shedding in the feces.  In 2004, swab culturettes (Becton Dickinson, Cat. No. 261514) 
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were inoculated with 0.1 ml ten-fold serial dilutions of St. Louis encephalitis virus (SLE 
TBH) [100 through 10-4] and then processed in 1 ml biologic field diluent (BFD). The 
protocol did not require modifications, as the amount of recovered virus closely matched 
the expected quantity of SLEV inoculated onto each swab (titered by plaque forming 
assays). It was also determined that the dilution containing 2 PFU/0.1 ml SLEV was not 
recovered or detected using this swab extraction protocol.  Figure 4-3 illustrates the 
relationship between the TaqMan CT value and the titer of virus recovered (PFU/0.1 ml) 
following processing of a swab. Expected plaque forming units are also shown for each 
dilution. 
In 2006, replacement swab culturettes (Becton Dickinson, Cat. No. 220221) were 
validated (following manufacturer’s discontinuation of the initial swabs (Cat # 261514) 
used for the project). These swabs were inoculated with 0.3 ml ten-fold serial dilutions of 
St. Louis encephalitis virus (SLE TBH) [100 through 10-5] in 3 ml culture media. Unlike 
in 2004, the amount of recovered SLEV was much lower than the expected quantity of 
virus inoculated onto each swab (measured by plaque forming assays). This experiment 
was repeated and the average of the results (CT values within 0.15) is reported. The SLEV 
dilution containing 2 PFU/0.1 ml was detected (CT value 36.95), but not recovered by 
culture, using this swab extraction protocol.   
In addition, this swab type was inoculated with 0.3 ml ten-fold serial dilutions of 
West Nile virus (NY99) [100 through 10-5].  For WNV, the amount of recovered virus 
closely matched the expected quantity of WNV inoculated onto each swab and the 10-5 
dilution containing 13 PFU/0.1 ml WNV was detected (CT value 39.58). Figures 4-4 and 
4-5 illustrate the relationships between the RT-PCR (TaqMan) CT value and the  
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Figure 4-3 SLEV Recovery From Spiked Swab Culturettes (Cat. No. 261514) 
The expected and recovered titers of SLEV from spiked cloacal swabs 
were determined by plaque assays in Vero cells, measured in plaque 
forming units (PFU/0.1 ml) [logarithmic scale]. The amount of SLEV 
recovered following the processing protocol closely matched the titer of 
each virus dilution spiked onto a swab.  The data table provides the 
averaged result of replicates performed for each dilution used to generate 
the graph. 
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Figure 4-4 SLEV Recovery From Spiked Swab Culturettes (Cat. No. 220221) 
The recovered titers of SLEV were much lower than the expected quantity 
of virus inoculated onto each swab, determined by plaque assays in Vero 
cells and measured in plaque forming units (PFU/0.1 ml) [logarithmic 
scale]. However, the improved transport media in this swab type enhanced 
detection of SLEV to 2 PFU/0.1ml, but not recovery at the highest 
dilution. RT-PCR (TaqMan) and plaque assays were performed for each 
dilution, tested in replicate. The data table provides the averaged result of 
replicates performed for each dilution used to generate the graph. 
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Figure 4-5 WNV Recovery From Spiked Swab Culturettes (Cat. No. 220221) 
The expected and recovered titers of WNV from spiked cloacal swabs 
were determined by plaque assays in Vero cells and measured in plaque 
forming units (PFU/0.1 ml) [logarithmic scale] .The amount of WNV 
recovered following the processing protocol closely matched the titer of 
each virus dilution spiked onto a swab.  RT-PCR (TaqMan) and plaque 
assays were performed for each dilution, tested in replicate. The data table 
provides the averaged result of replicates performed for each dilution used 
to generate the graph. 
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titer of virus recovered (PFU/0.1 ml) following swab processing for SLEV and WNV, 
respectively. Expected plaque forming units are also shown for each dilution.   
Optimization of Targeted Sampling Strategy for Network Agencies 
 In 2004, a small pilot field study was conducted in Hillsborough County to design 
a targeted sampling strategy for use by network agencies. Weekly sentinel chicken 
surveillance results identified extensive WNV seroconversions (flavivirus positive in the 
HAI assay and confirmed WNV by MAC-ELISA) in sentinel chicken flocks located in 
Hillsborough County during June (19 confirmed positive birds).  During the last two 
weeks of June, WNV activity was confirmed at 3 sites in Hillsborough County with a 
total of 7 confirmed positive birds (weekly sentinel chicken seroconversion results can be 
found at the FDOH-BECH website for arbovirus activity in the state, available at URL: 
http://www.doh.state.fl.us/environment/community/arboviral/Weekly-Summary.html). 
These sites were then targeted in the last week of the month (4 confirmed positive birds) 
to pilot the protocol for collection of cloacal swabs prior to widespread implementation in 
the surveillance network.  
Cloacal swabs were collected at these targeted sites one day following 
confirmation in the MAC-ELISA; however, the chickens were initially sampled seven 
days (positive sera specimens) prior to these test results. Swabs were collected from 14 
chickens that had not seroconverted at these sites, as well as from four confirmed positive 
chickens, for a total of 18 swabs.  No virus was detected or isolated for all swabs.  
Protocol and Sampling Criteria for Specimen Collection 
The pilot field study in Hillsborough County provided a guideline for a targeted 
protocol and sampling criteria for specimen collection from sentinel chickens. The BOL-
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Tampa determined “hot zones” of arbovirus transmission activity based on weekly HAI 
and MAC-ELISA test data, and requested that county agencies collect additional samples 
at these positive sites. The pilot study indicated that it was unlikely that West Nile virus  
could be detected or isolated on cloacal swabs seven days after the initial positive blood 
(serum) collection date, or from birds that recently seroconverted. As a result, this 
strategy requested targeted county agencies to immediately implement sample collection 
at sites where sentinel chickens seroconverted with high flavivirus or alphavirus antibody 
titers (1:40 and >40) in the HAI assay. Chickens that had not seroconverted were 
sampled. In addition, sites with chickens that were weakly positive or reactive in the HAI 
assay were confirmed in the MAC-ELISA prior to targeting of that site. SLEV-specific 
targeted sampling of sentinel chicken flocks was first confirmed by MAC-ELISA or 
PRNT, due to its low prevalence. 
Thus, recommended sentinel chicken sampling strategies were guided by weekly 
HAI test results and/or confirmation by MAC-ELISA of positive birds, on a case by case 
basis.  Targeted agencies collected samples from positive chicken flocks for up to two 
months upon request by the BOL-Tampa. Sampling was terminated by a targeted agency 
after a decline in new sentinel seroconversions over a period of one month, or at the 
agency’s discretion at any time.  
For wild birds in rehabilitation centers, a separate protocol and sampling criteria 
was established as they are not routinely bled for arbovirus serological testing by the 
BOL-Tampa. Wildlife rehabilitation centers receive injured or ill birds from a variety of 
sources and locations in the region where a center provides care. As a result, a specific 
site cannot be targeted for swab collection.  Instead, birds were triaged and swabbed 
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based on patient symptoms at admission. Symptoms indicative of encephalitis (shaking, 
weakness, inability to hold head upright, etc) were provided to participating centers to 
screen admitted birds for inclusion in the study. In addition, each center that participated 
in the study was requested to swab these triaged bird one time, as soon as possible 
following admission. The complete protocols and sampling criteria for the collection of 
cloacal swabs from sentinel chickens and wild birds are available in Appendix C.  
Targeted Strategy for Collection and Processing of Submitted Samples 
 A targeted strategy for the collection of blood samples and cloacal swabs for the 
detection/isolation of arboviruses at active transmission sites was conducted from June 
2005 to December 2006 by participating agencies with sentinel chicken programs. Three 
(out of four) counties participated in the study during 2005, and five (out of five) counties 
participated in the study during 2006.   The collection of blood samples for RT-PCR and 
cell culture testing was discontinued after 2005; only cloacal swabs were collected in 
2006.  The targeted strategy was expanded to include wild birds in 2006 (March through 
December). Both sentinel and wild birds were located outdoors, such that the detection of 
an arbovirus infection occurred from a natural exposure to the virus. 
 Weekly Surveillance Results of Arbovirus Transmission Activity (2005-2006) 
 In 2005, the HAI assay was performed on 47,535 sentinel chicken sera samples 
from birds (n=3801) located at 279 sites throughout the state.  HAI positive samples were 
confirmed in either the IgM antibody capture-enzyme linked immunosorbent assay 
(MAC-ELISA) or the plaque reduction neutralization test (PRNT) for WNV, SLEV, 
EEEV and HJV. During 2005, transmission of all 4 viruses occurred to the sentinel 
chickens resulting in 869 confirmed seroconversions. 
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The HAI assay was performed on 47,132 sentinel chicken sera from birds 
(n=2901) located at 277 sites in 2006. As in 2005, HAI positive samples were confirmed 
by MAC-ELISA or PRNT.  During 2006, transmission of WNV, SLEV, EEEV, and HJV 
occurred to sentinel chickens resulting in 155 confirmed seroconversions. Weekly 
arbovirus surveillance results reported for the sentinel chickens can be found at 
http://www.doh.state.fl.us/environment/community/arboviral/Weekly-Summary.html, for 
2005 and 2006.  
Sentinel chicken seroconversions occurred during every month in both years (see 
rate of arbovirus transmission by region for EEEV [Figure 4-6], WNV [Figure 4-7] and 
SLEV [Figure 4-8]). Table 4-1 lists the total number of sentinel chicken seroconversions 
by arbovirus for 2005 and 2006.  Maps of Florida with the cumulative totals and location 
of confirmed sentinel chicken arbovirus seroconversions are located in Appendix E 
(2005) and Appendix F (2006) [open access, available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-arboviral.html]. 
Implementation of Targeted Sampling Strategy (2005) 
The targeted sampling project was implemented in June 2005. Flaviviral activity 
(WNV) was present in several counties with sentinel chicken programs during the early 
summer months (May-July). However, these agencies opted not to participate in the 
targeted program (4 out of 14) when initially recruited. One partner (Pinellas County) 
was unable to participate upon request, due to intensive vector control efforts needed to 
limit a human outbreak of WNV in the region. Consequently, one county with alphavirus 
activity was first able to accommodate a request by the BOL-Tampa to target sentinel 
chicken flocks.  
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Figure 4-6 Rate of EEEV Sentinel Chicken Seroconversions in Florida (2005-
2006) 
The rate of sentinel seroconversions to EEEV was higher in the north, 
panhandle, and central regions of the state in 2005 than in 2006. In 
addition, statewide EEEV activity (black circle) was elevated for most 
months of the year in 2005 over the average historical mean (black line). 
 
 
Figures appear courtesy of Lillian Stark (Stark and Kazanis, 2006). 
 192
Figure 4-7 Rate of WNV Sentinel Chicken Seroconversions in Florida (2005-
2006) 
  The rate of sentinel seroconversions to WNV was higher in the north,  
  central, and panhandle regions of the state in 2005 than in 2006. However, 
  sentinel seroconversions to WNV were dramatically reduced for all  
  regions in 2006, as compared to 2005. 
 
 
Figures appear courtesy of Lillian Stark (Stark and Kazanis, 2006). 
 193
Figure 4-8 Rate of SLEV Sentinel Chicken Seroconversions in Florida (2005-
2006) 
The rate of sentinel seroconversions to SLEV was much lower in 2005 
(five seroconversions total) than in 2006.  In addition, SLEV activity was 
elevated from August to December compared to the same period in 2005 
and averaged close to the historical mean (black line) in Florida.   
 
 
Figures appear courtesy of Lillian Stark (Stark and Kazanis, 2006). 
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Table 4-1 Confirmed Sentinel Chicken Arbovirus Seroconversions (2005-2006) 
During 2005-2006, sera were collected from sentinel chickens and 
submitted to the BOL-Tampa for arboserology testing. In 2005, 414 
chickens developed antibodies (seroconversion) to WNV and 5 birds 
seroconverted to SLEV, as confirmed by MAC-ELISA or PRNT. In 
contrast, the number of chickens that seroconverted to SLEV in 2006 was 
greater than number of sentinel birds with confirmed WNV infections. 
This increased SLEV transmission activity to sentinel chickens occurred 
for the first time since the introduction of WNV to Florida in 2001.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# Arbovirus Confirmed Sentinel Chicken Seroconversions 
 Year # Chickens 
WNV SLEV EEEV HJV 
 
2005 
 
3,801 414 5 342 108 
 
2006 
 
2,901 30 40 79 6 
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Targeted Sampling of Orange County (2005) 
One mosquito control district in Orange County collected blood and cloacal swab 
samples from the first week of July through August 2005, following extensive alphaviral 
transmission activity in the county. Six sites were targeted, where 303 swabs were 
collected from 41 birds. Three sentinels were confirmed antibody positive for EEEV 
(Sites 004, 007), 3 birds seroconverted to HJV and one bird was alphavirus antibody 
positive (Sites 004, 006) over this time period. However, only one of these three positive 
sites was targeted for swab collection at the same time of these seroconversions (Site 004 
in August). From July to August, no sentinels seroconverted at three other targeted sites 
(001, 005, 008) following the initial transmission activity.  One chicken at Site 008 later 
seroconverted to EEEV (in November), but targeting of that site was discontinued in 
August.  
EEE viral RNA was detected on four swabs collected from Site 004 in August. 
For Bird 846, two swabs collected at -8 and -6 days preceding the development of 
detectable HAI alphavirus antibodies had EEEV specific RNA identified on the swab. 
EEE viral RNA was also detected on two swabs collected from Bird 870. However, Bird 
870 did not seroconvert, as tested by the HAI assay.  Virus was not isolated (cultured) 
from these processed swab or blood samples (CT values 33.5 ≥ 34). In total, 102 cloacal 
swabs and 100 blood samples were processed for this county. Confirmed 
seroconversions, site names, and detection of EEEV from targeted samples are plotted on 
a timeline (Figure 4-9), including start and stop dates of targeted sampling of these 
flocks.  
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Figure 4-9 Targeted Sampling of Sentinel Chicken Sites in Orange County (2005) 
From July to August 2005, confirmed arbovirus sentinel seroconversions (rectangles) triggered targeted sampling of 
sites (triangles). Chickens that had not yet seroconverted at six targeted sites (gray triangles below timeline) were 
swabbed for virus isolation/detection assays. EEEV viral RNA (diamond shapes) was confirmed by TaqMan RT-PCR 
on 4 swabs collected from two chickens at Site 004 in August. However, virus was not isolated (cultured) from these 
swabs (NVI). One of these chickens (Bird 846) later developed low titers of cross-reactive alphaviral antibody. 
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Serology Results 
The mosquito control district in Orange County was especially effective at swabbing 
targeted flocks twice a week.  However, frequent swabbing of the targeted flocks did not 
appear to improve recovery of infectious EEEV from cloacal swabs, as evidenced by 
detection of viral RNA only on swabs collected 2 days apart from a bird that 
seroconverted 6 days later.  Despite this finding, collection of cloacal swabs at Site 004 
twice a week resulted in detection of the arboviral infection 8 days prior to the initial 
serum sample taken for serology testing. HAI positive test results were then reported on 
this sentinel 16 days after the first swab collected on August 17 (with EEE viral RNA), 
due to additional testing in the PRNT to confirm infection. Specific serology results are 
provided in Figure 4-10, which illustrates the development of the primary immune 
response following natural EEEV infection in this adult chicken. Note: the exact date of 
infection is unknown.  
Implementation of Retrospective Targeted Strategy for Sample Processing 
Based on the sporadic arbovirus transmission activity in Orange County, a 
targeted retrospective processing strategy was implemented by the BOL-Tampa for 
processing, virus isolation and molecular detection assays to prioritize collected samples. 
The first 30 targeted samples (cloacal swabs and blood) collected from active 
transmission sites were processed as quickly as possible upon receipt at the laboratory, 
usually within two weeks.  If virus was not detected in the first 30 swabs, the 
retrospective processing strategy described below was implemented.  
Cloacal swabs and blood samples from targeted sites were processed only after a 
sentinel had seroconverted in the HAI assay.  Swabs collected within two weeks of the 
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Figure 4-10 Development of the Primary Immune Response Following Natural 
Eastern Equine Encephalitis Virus Infection in a Sentinel Chicken 
Serum samples were collected from Bird 846 (Site 004) and submitted to 
the BOL-Tampa for arbovirus screening in the HAI assay. Alphavirus-
group antibody (titer 1:10, pink dotted line) was first detected in samples 
submitted after August 25. EEE viral RNA was detected on cloacal swabs 
collected on August 17 & 19 (TaqMan CT values, red line). Serum 
collected on August 25 was tested for EEEV-specific IgM antibodies in 
the MAC-ELISA (P/N value 0.97, blue line).  However, the last serum 
sample collected on September 8 had cross-reactive total antibody titers 
(IgM + IgG) to both EEEV and HJV in the PRNT. Serological testing was 
unable to distinguish EEEV from HJV due to cross-reactive antibody in 
these samples; the chicken was reported alphavirus positive. 
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seroconversion were tested for the entire flock, such that collection dates one week prior 
to and following the positive serum sample were tested. This strategy was implemented 
for all other programs that submitted samples in 2005, and then limited initially to 10 
samples in 2006 to conserve laboratory resources. Figures 4-11 and 4-12 indicate the total 
number of cloacal swabs received by the BOL-Tampa for each agency and the subset of 
samples processed for molecular and cell culture assays in 2005 and 2006, respectively. 
Targeted Sampling of Manatee County (2005) 
 In August 2005, the first confirmed sentinel seroconversion to St. Louis 
encephalitis virus in the state occurred in Manatee County. Targeted sampling of the 
chicken flock at Site 015 began within 1 day of the confirmed MAC-ELISA test result 
and continued for 12 days.  However, St. Louis encephalitis virus was not detected or 
isolated from swabs or blood samples collected from this chicken or in the flock at Site 
015.  In addition, no other sentinels seroconverted to SLEV in Manatee County for the 
remainder of 2005. 
A total of 10 sites were targeted from August through November, where 216 
swabs were collected from 63 birds.  Over this time period, 28 sentinels had confirmed 
arbovirus seroconversions.  However, only 14 birds seroconverted to WNV (out of 28) 
where cloacal swabs and blood was collected and preserved for virus detection/isolation 
studies. Consequently, following a targeted processing strategy at the BOL-Tampa 119 
swabs and 100 blood samples were processed for molecular detection and cell culture 
assays at these sites. The EEEV positive site (003) was not actively sampled when two 
out of six (33.3%) sentinels in that flock seroconverted.  Confirmed seroconversions, site  
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Figure 4-11 Targeted Laboratory Sample Processing Strategy (2005) 
A targeted processing strategy was also conducted for sample extraction, 
molecular detection assays and inoculation of cell cultures at the BOL-
Tampa. Sporadic transmission activity of arboviruses and low prevalence 
of SLEV (2005) resulted in several sites that were targeted, but no 
chickens in the flocks seroconverted.  Samples were stored at -70°C and 
processed only if chickens with seroconversions at targeted sites were 
detected by the HAI assay.  Then, samples from a positive flock (with 
collection of cloacal swab and blood at active sites) were tested from one 
week prior and following confirmed sentinel seroconversions. A total of 
259 swabs were tested (out of 623) in 2005.  
 
303
102
119
38
216
104
0
50
100
150
200
250
300
350
Orange Manatee Sarasota
County
N
um
be
r 
of
 S
w
ab
s
Total
Processed
 
 
 
 
 
 
 
n = 63 n = 25 n = 41 
 201
Figure 4-12 Targeted Laboratory Sample Processing Strategy (2006) 
A targeted processing strategy was also conducted for sample extraction, 
molecular detection assays and inoculation of cell cultures at the BOL-
Tampa. Sporadic transmission activity of arboviruses and low prevalence 
of SLEV (2006) resulted in several sites that were targeted, but no 
chickens in the flocks seroconverted.  Samples were stored at -70°C and 
processed only if chickens with seroconversions at targeted sites were 
detected by the HAI assay.  Then, samples from a positive flock (with 
collection of cloacal swab at active sites) were tested from one week prior 
and following confirmed sentinel seroconversions. A total of 529 swabs 
were tested (out of 1338) in 2006. 
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names and detection of arboviruses from targeted samples are plotted on a timeline 
(Figure 4-13), including start and stop dates of targeted sampling of these flocks.   
West Nile virus was detected (confirmed by TaqMan RT-PCR) and cultured from 
the swab of one chicken (Bird 1773, aged 64 weeks) located at Site 001 on the first day 
of targeted sampling at that site. The WNV isolate was designated FLM38. Plaque assays 
conducted on the processed swab diluent identified 3 PFU/0.1 ml infectious West Nile 
virus shed in the feces.  Whole blood collected from the sentinel at the same time was 
added to lysis buffer and BFD, but were negative by TaqMan RT-PCR and cell culture 
assays, respectively.  
However, a separate serum sample collected on the same date as the cloacal swab 
confirmed positive for IgM antibodies to WNV in the MAC-ELISA (P/N 6.2) for Bird 
1773. Interestingly, this serum sample did not screen positive for flaviviral-specific 
antibodies in the HAI assay (titer <10).  As a result, the BOL-Tampa requested that 
Manatee County remove the bird from the flock (due to confirmed infection), but still 
continue to submit sera from this chicken until it developed detectable antibodies in the 
HAI assay.  The bird developed detectable antibody titer (1:10) in the HAI test twenty-
eight days following isolation of WNV from a cloacal swab collected on September 12. 
Figure 4-14 illustrates the development of the primary immune response following 
natural WNV infection in this adult chicken, aged 64 weeks. Note: the exact date of 
infection is unknown.  
WN viral RNA was also detected in cloacal swabs collected from two other birds, 
located at separate sites (002 and 015). Neither of these birds developed antibodies 
toWNV, as detected by the HAI assay. Virus was not isolated (cultured) from these  
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Figure 4-13 Targeted Sampling of Sentinel Chicken Sites in Manatee County (2005) 
From August to November 2005, confirmed arbovirus sentinel seroconversions (rectangles) triggered additional 
sampling of sites (triangles). Chickens that had not yet seroconverted at ten targeted sites (gray triangles) were swabbed 
for virus isolation/detection assays. West Nile viral RNA (diamond shapes) was detected on three cloacal swabs from 3 
separate sentinels (Sites 001, 002, 015), but only cultured from one chicken (Bird 1773) that also seroconverted. Virus 
isolate was designated FLM38 and was sequenced for phylogenetic analysis at this site. 
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processed swab or blood samples. However, CT values for the detected WN viral RNA 
were high (greater than 35, WNA primer set). 
Targeted Sampling of Sarasota County (2005) 
In September 2005, the second and third sentinel chickens seroconverted to St. 
Louis encephalitis virus in Sarasota County.  Both birds were located at Site 008 and sera 
samples collected on September 19 were submitted for arboserology testing by the BOL-
Tampa.  Positive seroconversions in the HAI assay (both titers ≥ 40) on September 23 
were confirmed by MAC-ELISA on September 27.  Targeted sampling of the chicken 
flock began 3 days later at Site 008.  Cloacal swabs were only collected at this site for 21 
days. SLEV was not detected or isolated from processed samples (total of 38 swabs 
only). SLEV activity was not detected again by sentinel chicken flocks located in 
Sarasota County.  
A total of four sentinel sites in Sarasota County were targeted from September 
through November, where 104 swabs were collected from 25 birds. Nine sentinels had 
confirmed WNV seroconversions (Sites 004, 008, 009, 010) over this time period. 
However, these seroconversions did not occur where cloacal swabs were collected for 
virus detection/isolation studies. One chicken (Bird 137-P) seroconverted to WNV 4 days 
after targeted sampling of Site 009 was terminated. Cloacal samples were negative for 
that flock on the previous collection date by RT-PCR and cell culture assays. Confirmed 
seroconversions and site names are plotted on a timeline (Figure 4-15), including start 
and stop dates of targeted sampling of these flocks.  No arbovirus was detected or 
isolated from samples processed for Sarasota County in 2005 despite prompt collection 
by the agency upon notification of confirmed seroconversions by the BOL-Tampa. In  
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Figure 4-14 Development of the Primary Immune Response Following Natural 
West Nile Virus Infection in a Sentinel Chicken 
Day 0 indicates the time of sample collection from a West Nile virus 
infected chicken; not necessarily the first day of infection.  IgM antibodies 
were present at Day 0, peaked at Day 7, and remained elevated for 28 days 
post isolation of the virus (blue) as detected by the IgM ELISA (P/N 
values). In a separate assay, IgG antibodies were first detected by the 
hemagglutination inhibition assay 28 days post viral isolation (pink, dotted 
line). Virus shed in the feces (3 PFU/0.1 ml) was detected on Day 0 only 
(triangle).  Viremia was not detected at Day O and a cloacal swab taken 4 
days post-isolation was also negative (data not shown).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Development of the Primary Immune Response Following 
Natural West Nile Virus Infection in a Sentinel Chicken 
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Figure 4-15 Targeted Sampling of Sentinel Chicken Sites in Sarasota County (2005) 
From September to November 2005, confirmed arbovirus sentinel seroconversions (rectangles) triggered additional 
sampling of sites (triangles). Chickens that had not yet seroconverted at 4 targeted sites (gray triangles) were swabbed 
for virus isolation/detection assays. Targeted sampling of these sites did not appear to coincide with flavivirus 
transmission activity.  
 207
addition, cloacal swabs were often collected twice in one week but the targeted timing of 
“active” arbovirus transmission sites was not effective. 
In summary, targeted sampling of active arbovirus transmission sites occurred in 
three counties during 2005. In addition, arboviruses detected on sentinel chicken 
cloacal swabs included two detections of West Nile virus (FLM42-2, FLM50) and one 
cultured isolate of West Nile virus (FLM38) in Manatee County. Eastern Equine 
Encephalitis viral RNA was detected on four cloacal swabs from two chickens (FLR80, 
FLR84, FLR86, FLR90) in Orange County. Virus isolation attempts on these positive 
EEE samples were negative. No virus was detected or isolated from targeted sites in 
Sarasota County in 2005. 
Targeted Sampling of Lee County (2006) 
 In August 2006, three sentinel chickens seroconverted to St. Louis encephalitis 
virus in Lee County and were the first SLE positive sentinels in the state that year.  These 
chickens were located at separate sites (002, 010 and 014) and had cross-reactive 
antibody profiles to WNV and SLEV in the MAC-ELISA that required further 
confirmation in the plaque reduction neutralization assay to confirm SLEV 
seroconversion.  As a result of the additional PRNT testing needed, final confirmation of 
these birds was delayed by two weeks (a total of 22 days since original collection of the 
sera).  Table 4-2 lists the serology results for these first confirmed SLEV positive sentinel 
chickens. 
Unlike many other sentinel chicken programs in Florida, Lee County does not 
bleed each flock in the region every week. Instead, most sites are rotated and each flock 
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Table 4-2 Serology Results for Three Sentinel Chicken SLEV Seroconversions 
in Lee County (2006) 
Serum samples were collected from three chickens (Birds 360, 422, and 
439) and submitted to the BOL-Tampa for arbovirus screening in the HAI 
assay. Flavivirus-group antibody was detected in these samples (titers 
1:10, 1:20 and 1:20, respectively). These samples were tested in the MAC-
ELISA for WNV and SLEV, where P/N values greater than 2.0 were 
considered positive. However, the sera were cross-reactive to both WNV 
and SLEV in this assay and further confirmation was required in the 
PRNT.  PRNT titers confirmed that the sentinels developed antibodies to 
St. Louis encephalitis virus (1:10, 1:10 and 1:20, respectively). 
 
 
Arboserology Test Results for First Confirmed SLEV  
Positive Chicken Sera Collected in Lee County (2006) 
 
 
Sentinel Chicken Band Number 
 
Assay Type 
 
Bird 360 
 
Bird 422 
 
Bird 439 
 
HAI 1:10 1:20 1:20 
 WN SLE WN SLE WN SLE 
 
MAC-ELISA*  
 
PRNT 
2.6 
 
<10 
2.0 
 
1:10 
3.7 
 
<10 
2.5 
 
1:10 
2.4 
 
<10 
2.0 
 
1:20 
 
*MAC-ELISA P/N values.
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sampled every two weeks to suit the agency’s need.  Consequently, the first targeted 
sampling of these positive sites occurred only at Site 002 on September 11.  This targeted 
sampling started five days after the confirmed SLEV seroconversions were reported, 
when the next sera samples were scheduled for collection.  Cloacal swabs were then 
collected at this site for 14 days.  Site 016 was also targeted based on its location and 
mosquito abundance in traps collected at the site (data not shown, personal 
communication by J. Burgess, LCMCD).  Consequently, two sentinel sites were targeted 
for two weeks in September, where 22 swabs were collected from nine birds. Virus was 
not detected or isolated from these samples.   
After this time period, targeted sampling was terminated due to no new arbovirus 
sentinel chicken seroconversions in the county. Targeted sampling of the chicken flocks 
was not reinitiated despite new SLEV seroconversions starting on October 10 
andcontinuing through December 12, 2006.  The lengthy lag time necessary to confirm 
cross-reactive flavivirus infections and the bi-weekly sampling strategy used by the 
county limited effective targeting of the sites by the BOL-Tampa. Figure 4-16 provides a 
timeline of confirmed seroconversions and site names in Lee County, including start and 
stop dates of targeted sampling of these flocks. 
Targeted Sampling of Orange County (2006) 
In 2006, targeted sampling of sentinel chicken flocks by one mosquito control 
district in Orange County was based on two methods. Early season transmission of EEEV 
had been detected at Site 003 in February.  Then, EEEV activity was detected in flocks 
maintained by a neighboring mosquito control district in Orange County in June (data not 
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shown).  As a result, the BOL-Tampa requested for Orange County to target three of its 
sentinel chicken flocks based on early transmission and neighboring activity in 2006. 
Orange County sampled the sentinel flock at Site 003 and chickens at two other 
sites (006 and 008) based on historical alphaviral activity during the previous 
transmission season.  Targeted sampling was only performed for a period of ten days.  
During this time, three birds seroconverted to EEEV at non-targeted sites, including Birds 
868, 917 at Site 001, and Bird 871 at Site 004. Six days following termination of targeted 
sampling at Site 006, Bird 891 seroconverted to EEEV at this location with historical 
alphavirus transmission activity during 2005.   
Consequently, three sentinel sites were targeted in July, where 36 swabs were 
collected from 18 birds. Virus was not detected or isolated from processed samples 
(n=12).  Figure 4-17 provides a timeline of confirmed seroconversions and site names in 
Orange County, including start and stop dates of targeted sampling of these flocks. 
Targeted Sampling of Pasco County (2006) 
 During 2006, the BOL-Tampa continued to validate a microsphere-bead 
immunoassay (MIA) for the detection of WNV or SLEV-specific IgM antibodies in 
chicken sera (Haller, 2005). Presumptive positive samples to WNV in the MIA were 
confirmed by MAC-ELISA and used to target one site (006) in Pasco County during July 
2006. Targeted sites were also chosen based on two previous sentinel seroconversions (at 
Sites 003, 006) in Pasco County, as well as the location of one site near Pasco County 
Mosquito Control headquarters (Site 004).  A total of 248 cloacal swabs were collected 
from 16 birds located at three sites during July 16 through November 6, 2006.  
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Figure 4-16 Targeted Sampling of Sentinel Chicken Sites in Lee County (2006) 
In September 2006, confirmed arbovirus sentinel seroconversions (rectangles) triggered additional sampling of sites 
(triangles). Chickens that had not yet seroconverted at 2 targeted sites (gray triangles below the timeline) were swabbed 
for virus isolation/detection assays based on sentinel seroconversions (Site 002) and mosquito abundance (Site 016, 
data not shown). Targeted sampling of these sites did not appear to coincide with flavivirus transmission activity in 
September.  SLEV transmission activity dramatically increased on October; however, these sites were not targeted. 
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Figure 4-17 Targeted Sampling of Sentinel Chicken Sites in Orange County (2006) 
In July 2006, confirmed arbovirus sentinel seroconversions (rectangles) triggered additional sampling of sites 
(triangles). Chickens that had not yet seroconverted at 3 targeted sites (gray triangles below the timeline) were swabbed 
for virus isolation/detection assays. Targeted sites were chosen based on one EEEV sentinel seroconversion (Site 003) 
and transmission activity at a neighboring mosquito control district. Confirmed alphaviral activity in the previous 
transmission season of 2005 was used to target Sites 006 and 008. Targeted sampling of these sites for 10 days did not 
coincide with alphavirus transmission activity in July. However, one sentinel (Bird 831) seroconverted to EEEV within 
one week of the termination of targeted sampling at a site (006) with historical EEEV activity. 
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 Targeted sampling of these sites did not coincide with flavivirus transmission 
activity in Pasco County over a four month time period. After June 6, no additional 
sentinel chickens seroconverted in the region for the remainder of the year.  
Consequently, only 20 (out of 248) swabs were processed for this agency. No virus was 
detected or isolated in these processed samples. Figure 4-18 provides a timeline of 
confirmed seroconversions and site names in Pasco County, including start and stop dates 
of targeted sampling of these flocks. 
Targeted Sampling of Volusia County (2006) 
 For Volusia County, the BOL-Tampa also used presumptive positive chicken 
seroconversions in the microsphere-bead immunoassay (MIA) for the detection of WNV 
or SLEV-specific IgM antibodies in chicken sera to target active transmission sites. Three 
chickens were positive by MIA for SLEV-specific antibodies at two sites on June 6 (Sites 
006 and 011).  Site 002 had one WNV presumptive positive seroconversion on the same 
date. These results were confirmed in the MIA the next week on June 16, but did not 
confirm by MAC-ELISA. Volusia County targeted the presumptive SLE positive sites on 
the next scheduled bleeding of the flocks (June 23) for the weekly sera submission to the 
BOL-Tampa for serology testing. 
Two additional sites were included for targeted sampling based on early season 
transmission of alphaviruses.  One chicken seroconversion to HJV occurred in January at 
Site 003, whereas one sentinel seroconverted to EEEV at Site 014 in March. A total of 
four sites were sampled in Volusia County, where 119 cloacal swabs were collected from 
16 birds over a one month period (June 23 through July 24).  
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Figure 4-18 Targeted Sampling of Sentinel Chicken Sites in Pasco County (2006) 
In 2006, confirmed and presumptive arbovirus sentinel seroconversions (rectangles and circle, respectively) triggered 
additional sampling of sites (triangles). Chickens that had not yet seroconverted at 3 targeted sites (gray triangles below 
the timeline) were swabbed for virus isolation/detection assays. Targeted sites were chosen based on two sentinel 
seroconversions (Sites 003, 006) and location near Pasco County Mosquito Control headquarters (Site 004). 
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Targeted sample collection was discontinued after July, when no new 
seroconversions were detected in chicken flocks located in Volusia County.  Sampling of 
these sites with early season data or presumptive MIA test results did not accurately 
predict flavivirus or alphavirus transmission activity as assessed by assay of cloacal 
swabs. A single sentinel chicken seroconverted to WNV in October (well after targeted 
sampling was discontinued).  Consequently, 48 (out of 119) swabs were processed for 
this agency. No virus was detected or isolated in these processed samples. Figure 4-19 
provides a timeline of presumptive and confirmed seroconversions and site names in 
Volusia County, including start and stop dates of targeted sampling of these flocks. 
Targeted Sampling of Sarasota County (2006) 
Serology Results 
 The BOL-Tampa requested the mosquito control district in Sarasota County to 
initiate targeted sample collection following presumptive flavivirus positive MIA results 
on chicken sera collected from four sites (003, 005, 006, and 007) in June 2006.  At three 
sites, one chicken each developed antibodies to SLEV as detected and confirmed by the 
MIA on June 16.  Although none of these birds screened flavivirus antibody positive in 
the HAI assay, two of these chickens (Sites 005, 007) were confirmed by MAC-ELISA 
for presence of flaviviral-specific antibodies (cross-reactive to both WNV and SLEV). In 
addition, Site 003 had one chicken that was detected by MIA as a presumptive WNV 
positive (although not confirmed by MAC-ELISA).   
Sarasota County collected cloacal swabs from chicken flocks located at Sites 003 
and 005, within three days of confirmed MIA results.  Site 007 was not targeted, as this 
site was not on the weekly routing for the trained personnel that collected cloacal swabs.
 216
Figure 4-19 Targeted Sampling of Sentinel Chicken Sites in Volusia County (2006) 
In 2006, presumptive arbovirus sentinel seroconversions (circles) triggered additional sampling of sites (triangles). 
Chickens that had not yet seroconverted at 4 targeted sites (gray triangles below the timeline) were swabbed for virus 
isolation/detection assays. Targeted sites were chosen based on three presumptive sentinel seroconversions to SLEV 
(Sites 006, 011). Confirmed early season alphaviral activity in January and March was used to target Sites 003 and 
014. Targeted sampling of these sites for one month did not coincide with flavivirus or alphavirus transmission activity. 
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In July and August, Site 002 and Site 006 (previously MIA+ for SLE) were added 
for targeted sample collection at the agency’s discretion in each month respectively.  
Cloacal swabs were collected from targeted sites continuously from June through 
December 2006. The county sentinel chicken program was discontinued for the winter 
months after December 12. Swabs were collected again on December 18 from the flock 
at Site 002 upon request by the BOL-Tampa, due to a late confirmed seroconversion at 
that site. 
The first confirmed sentinel chicken SLEV seroconversion in the county was 
located at Site 004 (Bird 8-00-W). Serum from this bird was collected on August 28 and 
a reactive (weak positive) in the HAI assay reported on September 1, with SLEV 
confirmed results in the MAC-ELISA reported on September 6.  The second sera 
collected from this bird developed higher HAI antibody titers (≥40) and a P/N value of 
9.4 in the second MAC-ELISA (data not shown).  These findings indicate that Bird 8-
000-W was recently exposed to St. Louis encephalitis virus.   
Confirmed SLEV transmission activity remained quiescent for approximately 1 
month in the region, until Bird 9-003-R at Site 001 seroconverted on September 25.  
Similar to Bird 8-000-W, this bird also was reactive in the HAI test and was confirmed 
SLEV positive by MAC-ELISA. The third confirmed seroconversion (Bird 8-004-G) was 
located at Site 004. A serum sampled collected on October 3 had a slightly elevated 
antibody titer (1:10) in the HAI assay and was confirmed SLEV by MAC-ELISA.   
Table 4-3 provides the serology test results on the three sera collected from these sentinel 
chicken in Sarasota County, 2006. 
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Table 4-3 Serology Results for First Confirmed SLEV Positive Chicken Sera 
Collected in Sarasota County (2006) 
Serum samples were collected from three chickens (Birds 8-000-W, 9-
003-R, and 8-004-G) and submitted to the BOL-Tampa for arbovirus 
screening in the HAI assay. Weak flavivirus-group antibody was detected 
in these samples (titers R, R and 1:10, respectively). These samples were 
tested in the MAC-ELISA for WNV and SLEV, where P/N values greater 
than 2.0 were considered positive. However, the sera were cross-reactive 
to both WNV and SLEV in this assay, but suggestive of SLEV infection. 
PRNT was performed on a serum sample from the third sentinel chicken 
and confirmed that the sentinel developed antibodies to St. Louis 
encephalitis virus (antibody titer ≥40). 
 
 
Arboserology Test Results for the First Confirmed SLEV  
Positive Chicken Sera Collected in Sarasota County (2006) 
 
 
Sentinel Chicken Band Number 
 
Assay Type 
 
Bird 8-000-W 
 
Bird 9-003-R 
 
Bird 8-004-G 
 
HAI┼ R R 1:10 
 WN SLE WN SLE WN SLE 
 
MAC-ELISA  
 
PRNT* 
2.6 
 
NT 
4.3 
 
NT 
2.0 
 
NT 
2.89 
 
NT 
1.9 
 
<10 
6.1 
 
≥40 
 
┼R = Reactive (weak positive result). 
*NT = Not Tested. 
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Preliminary HAI test results were reported for all sera collected on October 3 to 
each submitting agency at the end of the week (October 6).  Bird 8-004-G located at Site 
004 was the second chicken in the flock to seroconvert to SLEV.  Based on this 
information, Sarasota County targeted this site for collection of cloacal swabs at the next 
scheduled sample date (October 9) and continued swabbing through December.   
Site 001 was also targeted in a similar manner; Sarasota County did not wait for 
confirmed MAC-ELISA results prior to cloacal swab collection at a flavivirus positive 
site.  A serum sample collected from Bird 9-001-Y (Site 001) on October 16 tested HAI 
flavivirus antibody positive (titer ≥40) and was reported on October 20. Targeted sample 
collection of Site 001 began on October 23 and the flock was continuously swabbed 
through December.  Figure 4-20 provides a timeline of presumptive and confirmed 
seroconversions and site names in Sarasota County, including start and stop dates of 
targeted sampling of these flocks. 
As a result, 913 cloacal swabs were collected from 36 birds. The BOL-Tampa 
processed 427 swabs for molecular detection and cell culture assays. A total of seven 
chickens seroconverted to SLEV from August 28 to December 04, 2006. An additional 
bird was flavivirus-antibody reactive in the HAI assay on December 12, but did not 
confirm in the MAC-ELISA or PRNT.  However, six (out of eight) of these chickens 
were not targeted for cloacal swab collection at the time of seroconversion. The other two 
chickens that seroconverted to SLEV were located in targeted flocks, and virus was 
isolated in culture from cloacal swabs for both birds. Virus was also isolated from three 
birds (band numbers 8-005-B, 9-000-W, and 9-004-G) that failed to seroconvert; virus  
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Figure 4-20 Targeted Sampling of Sentinel Chicken Sites in Sarasota County (2006) 
From June to December 2006, presumptive (circles) and confirmed arbovirus sentinel seroconversions (rectangles) 
triggered additional sampling of sites (triangles). Chickens that had not yet seroconverted at six targeted sites (gray 
triangles below timeline) were swabbed for virus isolation/detection assays. SLEV, WNV, and novel flavivirus strains 
were detected and/or isolated from Sites 001, 004 and 005.  Isolates were sequenced for phylogenetic analysis (except 
FLS853). 
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was only cultured for bird 8-005-B. The antibody profiles for these chickens are detailed 
below for sera submitted to the BOL-Tampa for serological testing.  
Bird 8-003-R (Site 004) 
St. Louis encephalitis virus and West Nile virus was isolated from one chicken 
(Bird 8-003-R) that seroconverted to SLEV, as confirmed by MAC-ELISA and PRNT.  
The band number, site number, and collection dates were compared to submitted 
paperwork and information label on each swab, and verified by the agency for this 
sentinel chicken (personal communication, N. Osborn, SCMCD). Since this bird required 
additional testing for confirmation (PRNT), the chicken was swabbed four times over the 
course of 14 days (October 9 – October 23) before it was removed from the field. Three 
HAI positive sera samples were also collected from this chicken on October 9, 16, and 
23. Figure 4-21 compares the test results for three antibody assays (HAI, MAC-ELISA, 
and MIA) performed on these serum samples for SLEV-specific antibodies.  
Interestingly, virus was isolated from cloacal swabs at two of the three time 
points, despite elevated antibody titers in the sera. Detailed assay values for Bird 8-003-R 
have been provided for each serology test in Appendix G.  Notably, no other sentinel 
chicken seroconversions to WNV were detected in Sarasota County in 2006 (following a 
single WNV seroconversion at Site 005 on April 10). However, the MIA test identified 
WNV-specific antibodies in one sentinel in June 2006 at Site 003, but this was a 
presumptive positive that failed to confirm in other assays. 
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Figure 4-21 Comparison of SLEV Serology Test Results for Bird 8-003-R 
A)  Comparison of HAI and MAC-ELISA methods for the detection of 
flavivirus total antibody (HAI assay, squares, dotted line) [second y axis] 
or SLEV-specific IgM antibody (MAC-ELISA, circles) [first y axis]. Total 
flavivirus-specific antibody remained elevated in sera collected at 3 time 
points following arbovirus isolation on Day 0.  SLEV-specific IgM 
antibody was the highest at Day 0 (P/N 3.9) and declined over time. B) 
Comparison of MAC-ELISA [first y axis] and MIA [second y axis] 
methods for the detection of SLEV-specific IgM antibody. Both the MAC-
ELISA (circles) and MIA screening (triangles) assays detected IgM 
antibodies to SLEV on all three time points that declined over the course 
of infection.  
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Evaluation of SLEV-WNV Coinfection 
The isolation of West Nile virus and St. Louis encephalitis virus from the same 
chicken was unexpected. The exact date of infection is unknown, but a serum sample 
collected from the bird on October 3 was negative (Day -6). This site was not targeted 
until a week later, so a cloacal swab was not taken at that early time point. FLS502 
(WNV) was isolated on October 9 (Day 0). FLS545 (WNV) was isolated from a swab 
collected from this bird on October 16 (Day 7) and FLS569 (SLEV) was isolated from a 
third swab collected on October 18 (Day 9). These samples were confirmed by real-time 
(TaqMan) RT-PCR [see Table 4-8 later in this section], gel-based RT-PCR (Figures 4-30, 
4-31), and sequencing of the PCR products. A matching serum sample was not collected 
on Day 9, as cloacal swabs were collected twice a week and sera once a week. A final 
swab (FLS593) and serum sample was collected on October 23 (Day 14). However, virus 
was not detected or isolated from FLS593.  Figure 4-22 illustrates the development of the 
primary immune response following natural SLEV & WNV infection (based on SLEV 
antibody response) in this adult chicken, aged 52 weeks. Note: the exact date of infection 
is unknown. 
Each serum sample was tested in the MAC-ELISA for the detection of IgM-
specific antibodies to SLEV and WNV. Plaque assays were also conducted to titer the 
quantity of infectious virus shed in the feces at each time point. Figure 4-23 compares 
MAC-ELISA IgM antibody results for SLEV and WNV (P/N values) from Day -6 to Day 
cross-reactive WNV IgM antibodies detected in the MAC-ELISA (P/N values < 2.0 for 
all sera).   
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Figure 4-22 Development of the Primary Immune Response Following Natural St. 
Louis Encephalitis Virus & West Nile Virus Infection in a Sentinel 
Chicken 
Day 0 indicates the time of first sample collection from Bird 8-003-R; not 
necessarily the first day of infection.  IgM antibodies (blue line) to SLEV 
were present at Day 0 and declined through Day 14, as detected by the 
IgM ELISA (P/N values, blue line) [first y axis]. In a separate assay, total 
flavivirus antibodies (IgG + IgM) were first detected by the 
hemagglutination inhibition assay (pink dashed line) on the same day as 
the initial WNV isolation [first y axis]. West Nile virus shed in the feces 
was detected on Day 0 and Day 7, whereas St. Louis encephalitis virus 
shed in the feces on Day 9 (triangles) [second y axis].  A cloacal swab 
taken 5 days post-isolation of SLEV was negative for virus (no virus 
detected, NVD) on Day 14.  
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Figure 4-23 Comparison of SLEV and WNV IgM Antibody Development and 
Estimate of Infectious Virus Shed in the Feces of Bird 8-003-R 
MAC-ELISA IgM antibody results (P/N values) for SLEV (red bars) and 
WNV (gray bars) are shown for Bird 8-003-R from Day -6 to Day 14 [first 
y axis]. Virus plaque forming units detected on each swab (PFU/0.1 ml) 
are shown for WNV (gray line) and SLEV (dotted red line) [second y 
axis]. These assays confirmed that Bird 8-003-R seroconverted to St. 
Louis encephalitis virus, with no cross-reactive WNV IgM antibodies 
detected in the MAC-ELISA (P/N values < 2.0 for all sera).  In addition, 
the titer of infectious West Nile virus was much higher (816 pfu/0.1ml) on 
the first day of cloacal swabbing (Day 0) than the titer shed in the feces 7 
days later (36 pfu/0.1ml). St. Louis encephalitis virus was primarily shed 
in the feces (32 pfu/0.1ml) on Day 9. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  FLS502    FLS545       FLS569                FLS593 
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Virus Neutralization Assays 
Neutralization assays were also conducted on these isolates to investigate possible 
co-infection of SLEV on the WNV swabs (FLS502 and FLS545) and/or WNV mixed on 
the SLEV swab (FLS569).  The West Nile virus isolates formed large plaques within 3 
days and may have inadvertently blocked growth of SLEV due to the shorter incubation 
period of West Nile virus (3 days vs. 5-7 days). WNV-specific polyclonal antibodies 
(Cat. No. 0069) and SLEV-specific polyclonal antibodies (Cat. No. 0055)were obtained 
from the CDC, Fort Collins for use in the PRNT.  Serial dilutions (10-1 to 10-6) of cloacal 
swab virus isolates (FLS502, FLS545, and FLS569 passaged once in Vero cells) were 
challenged with the appropriate concentration of polyclonal antibody (1:100 for WNV 
isolates, 1:20 for SLEV) [concentration determined by 95% plaque reduction of control 
viruses] .  
Figure 4-24 illustrates the phenotype in Vero cells of FLS502 (WNV), FLS545 
(WNV) and FLS569 (SLEV) wild type plaques compared to variant plaques that formed 
after virus-specific polyclonal antibody challenge (e.g. SLEV polyclonal antibody used to 
challenge FLS569).  At least 20 individual plaques (clones) were “picked” for each strain 
challenged with antibody, suspended into 1 ml of SVD, and 140 µl transferred to lysis 
buffer for RNA extraction. Clones were confirmed SLEV and/or WNV (with real-time 
(TaqMan) RT-PCR assays. Real-time RT-PCR results are listed in Table 4-4 for 5 
representative clones picked for each strain. None of the clones picked from FLS502 or 
FLS545 were confirmed as SLEV alone, although some of the clones were cross-reactive 
to both WNV & SLEV by TaqMan RT-PCR. In addition, FLS569 did not have confirmed 
WNV plaques 
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Figure 4-24 Comparison of Plaque Phenotype of Arbovirus Isolates Before and After Polyclonal Antibody Challenge  
 West Nile virus strains FLS502 and FLS545 were challenged with polyclonal WN antibody to neutralize infection so 
that plaque clones could be picked to determine co-infection with SLEV.  FLS569 was challenged with polyclonal SLE 
antibody to neutralize SLEV infection for the identification of West Nile virus in a single swab.  
 
FLS502 FLS502 +WN Ab FLS545 FLS545 + WN Ab 
  
FLS569 FLS569 +SLE Ab WN+ NY99 Negative Control 
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Table 4-4 Real-Time RT-PCR (TaqMan) Results for Arbovirus Clones Picked 
After Homologous Antibody Challenge 
Real-time RT-PCR assays were run for the detection of virus strains. West 
Nile virus was detected using two primer-probe sets specific to the virus 
(designated WNA & WNB, see Table 3-7). Two primer-probe sets 
designed to specifically target SLEV (designated SLEA & SLEB, see 
Table 3-8) were used to detect St. Louis encephalitis virus strains. 
Samples were screened with the “A” primer sets. If the homologous 
isolate only was detected (e.g. clones 1c,14c,20c,31c identified WNA but 
not SLEA), the B primer sets were not tested on that clone. Positive “A” 
clones to a heterologous virus (e.g. clones 2c,7c,9c,11c,12c,13c that were 
detected by SLEA) were confirmed with the “B” primer sets. CT values ≤ 
40 were considered positive, as “picked” clones were diluted and then 
extracted with only a small portion of the sample assayed (samples were 
confirmed positive by virus isolation in cell culture). 
 
Real-Time RT-PCR (TaqMan) Results for WNV & SLEV 
Arbovirus Strain Clone # WNA (CT) 
WNB 
(CT) 
SLEA 
(CT) 
SLEB 
(CT) 
#1c 20.99 NT Undet NT 
#2c 21.45 18.99 36.64 Undet 
#7c 21.79 19.50 33.99 34.19 
#9c 19.32 17.90 35.59 34.69 
FLS502 
+ WN Ab 
#31c 21.20 NT Undet NT 
#11c 19.83 17.46 37.25 Undet 
#12c 21.58 18.86 37.49 Undet 
#13c 19.41 18.24 36.47 32.98 
#14c 21.30 NT Undet NT 
FLS545 
+WN Ab 
#20c 23.87 NT Undet NT 
#55c Undet 39.31 Undet Undet 
#56c Undet 39.53 Undet Undet 
#58c 36.36 32.18 36.07 Undet 
#65c NT NT 31.29 30.01 
FLS569 
+ SLE Ab 
#66c NT NT 27.66 25.64 
 
*NT = Not Tested; Undet = viral RNA not detected, CT > 45 cycles. 
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after neutralization with SLEV polyclonal antibodies. Instead, most clones were 
confirmed SLEV (14 of 20) or were cross-reactive to both WNV & SLEV by TaqMan 
RT-PCR (6 of 20) [see Table 4-4]. 
Bird 9-005-B (Site 001) 
St. Louis encephalitis virus was isolated from one chicken (Bird 9-005-B) that 
seroconverted to SLEV antibody positive, as confirmed by MAC-ELISA and PRNT 
assays. The virus was not detected on a swab collected on the same date as 
seroconversion (October 23). However, St. Louis encephalitis virus was isolated in 
culture on October 30, when the chicken was re-sampled following seroconversion. The 
bird was removed from the field after this date due to confirmation of infection (SLEV-
specific IgM antibodies) in the MAC-ELISA. Consequently, only two antibody positive 
sera samples were collected from this chicken on October 23 and 30.   
Despite high total flavivirus antibody titers in the serum, SLEV was isolated 
(cultured) seven days following seroconversion. High SLEV-specific IgM levels (P/N 
17.0) may have prevented virus isolation in the feces on date of seroconversion (October 
23).  Figure 4-25 compares the test results for three antibody assays (HAI, MAC-ELISA, 
and MIA) performed on these sera samples. Detailed test result data for Bird 9-005-B has 
been provided for each serology assay in Appendix G. 
Plaque assays were also conducted on processed swab (S-650) media to titer the 
quantity of infectious virus shed in the feces. However, no plaques formed from this 
cloacal swab (titer less than 2 PFU/0.1 ml). This assay was repeated twice and no plaques 
were identified. However, addition of 1 ml of processed swab eluate to Vero cells 
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Figure 4-25 Comparison of Serology Test Results for Bird 9-005-B  
A)  Comparison of HAI and MAC-ELISA methods for the detection of 
flavivirus total antibody (HAI assay, dotted line) or SLEV-specific IgM 
antibody (MAC-ELISA, solid blue line). Total flavivirus-specific antibody 
remained elevated in sera collected at one time point following arbovirus 
isolation on Day 0 [second y axis].  SLEV-specific IgM antibody was the 
highest at Day 0 (P/N 17.0) and declined over time [first y axis]. B) 
Comparison of MAC-ELISA and MIA methods for the detection of 
SLEV-specific IgM antibody. MAC-ELISA (blue line) [first y axis] and 
MIA screening (red line) [second y axis] assays detected SLEV IgM 
antibodies on two time points, which also declined over time. An MIA 
confirmation assay (serum sample tested with both positive and negative 
antigens) was not performed. 
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in a 25cm2 flask resulted in culture of the virus.  The passaged virus strain FLS650 was 
assayed for the ability to form plaques (see Arbovirus Growth Characteristics, described 
later in this chapter).  Although plaque forming units were too low for detection on the 
cloacal swab elution media in the plaque assay, SLE viral RNA was detected directly 
from extracted swab material (CT = 37.53, SLEA primer-probe set).  Figure 4-26 
illustrates the development of the primary immune response following natural SLEV 
infection in this adult chicken. Note: the exact date of infection is unknown.  
Bird 8-005-B (Site 004)  
West Nile virus was also isolated from one chicken that failed to seroconvert in 
the HAI assay (Bird 8-005-B, Site 004). Sera samples for this bird had unfortunately not 
been saved for retrospective testing and the BOL-Tampa was unable to further evaluate 
this chicken’s antibody profile (seroconversion) in the MAC-ELISA, MIA or PRNT 
assays.  West Nile virus was isolated from another chicken (Bird 8-003-R, discussed 
previously) at this site, which also was not detected by these serology assays (confirmed 
SLEV antibody response instead). 
Bird 7-005-B (Site 005) & Birds 9-005-B, 9-000-W (Site 001) 
Novel flavivirus strains were detected in two different chickens at two sites. Two 
cloacal swabs from one bird (9-000-W) tested positive by RT-PCR for this virus, despite 
a space of 20 days between sample collections. None of these novel flavivirus-positive  
chickens seroconverted and/or generated antibodies detectable by the current HAI assay 
(SLEV-group antigen).   
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Figure 4-26 Development of the Primary Immune Response Following Natural St. 
Louis Encephalitis Virus Infection in a Sentinel Chicken 
Day 0 indicates the time of seroconversion from a St. Louis encephalitis 
virus infected chicken; not the first day of infection.  IgM antibodies were 
present at Day 0 and then declined over the next seven days, as detected 
by the IgM ELISA (P/N values, blue line) [second y axis]. In two separate 
assays, IgG antibodies were first detected by the hemagglutination 
inhibition assay on Day 0 and remained elevated over the 2 time points 
(pink dashed line) [first y axis]. Total antibody (IgG + IgM) titer (≥40) 
measured by the PRNT was also first detected on Day 0 (green) [first y 
axis]. No further serum samples were confirmed in the PRNT. Virus shed 
in the feces was detected by real time RT-PCR (TaqMan CT value, red) 
[second y axis], but the swab eluate had less than 1 PFU/0.1ml infectious 
virus in plaque assays.   
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Targeted Sampling of Wild Birds 
 From April to December 2006, five wildlife rehabilitation centers submitted 64 
cloacal swabs from admitted birds targeted for arbovirus evaluation. The Florida Fish and 
Wildlife Conservation Commission (FWC) also submitted 23 swabs collected from dead 
birds. A total of 87 swabs were submitted from 36 different bird species (see Appendix 
H) to the BOL-Tampa for virus detection and isolation assays. Birds were targeted for 
cloacal swab collection based on species (known amplifying host) and/or symptoms 
indicative of arboviral infection in live birds [Komar et al, 2003; Brault et al, 2004].  All 
wild bird cloacal swabs were processed and extracted for virus isolation and molecular 
detection assays. Despite triage of birds based on these criteria, no virus was isolated or 
detected. 
Arbovirus Isolation and Detection 
During 2005-2006, a targeted sampling strategy for the isolation or detection of 
arboviruses from naturally exposed birds was implemented in several counties throughout 
Florida. Blood samples (2005 only) and cloacal swabs were collected from chickens 
located at potential “hot zones” of arbovirus activity, based on weekly serological 
surveillance results (antibody positive in the HAI and/or MAC-ELISA tests). Table 4-5 
summarizes the arboviruses isolated or detected from targeted sentinel chickens during 
2005-2006.  Wild bird species were swabbed during medical exams or after death, based 
on the species of bird and/or triage of symptoms. Virus was not isolated or detected from 
these wild birds. 
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Table 4-5 Arboviruses Detected/Isolated During a Targeted Sampling Strategy 
of Sentinel Chicken Flocks (2005-2006) 
  
 aNC viruses were detected by RT-PCR, but did not replicate in Vero cells. 
 
 
 
Arbovirus Strains Detected & Isolated from Adult Sentinel Chickens (2005-2006) 
STRAIN DESIGNATED LOCATION YEAR HOST PASSAGEa 
West Nile Virus 
 
FL05-M038 
FL05-M042.2 
FL05-M050 
FL06-S502 
FL06-S504 
FL06-S545 
 
 
FLM38 
FLM42-2 
FLM50 
FLS502 
FLS504 
FLS545 
 
 
Manatee Co., FL 
Manatee Co., FL 
Manatee Co., FL 
Sarasota Co., FL 
Sarasota Co., FL 
Sarasota Co., FL 
 
 
2005 
2005 
2005 
2006 
2006 
2006 
 
 
Chicken 
Chicken 
Chicken 
Chicken 
Chicken 
Chicken 
 
 
Vero 1 
NCNC 
Vero 1 
Vero 1 
Vero 1 
 
St. Louis Encephalitis Virus 
 
FL06-S569 
FL06-S650 
 
 
FLS569 
FLS650 
 
 
Sarasota Co., FL 
Sarasota Co., FL 
 
 
2006 
2006 
 
 
Chicken 
Chicken 
 
 
Vero 1 
Vero 1 
 
Novel Flavivirus  
 
FL06-S649 
FL06-S694 
FL06-S853 
 
FLS649 
FLS694 
FLS853 
Sarasota Co., FL 
Sarasota Co., FL 
Sarasota Co., FL 
2006 
2006 
2006 
Chicken 
 Chicken 
 Chicken 
 NC 
 NC 
 NC 
Eastern Equine Encephalitis Virus 
 
FL05-R80 
FL05-R84 
FL05-R86 
FL05-R90 
 
FLR80 
FLR84 
FLR86 
FLR90 
 
Orange Co., FL 
Orange Co., FL 
Orange Co., FL 
Orange Co., FL 
 
2005 
2005 
2005 
2005 
 
Chicken 
Chicken 
Chicken 
Chicken 
 
NC 
NC 
NC 
NC 
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Blood Samples 
In 2005, blood samples were collected and placed on ice packs for virus 
detection/isolation assays from targeted sentinel chickens.  Whole blood samples from 
chickens collected in Orange County were extracted and screened with Eastern equine 
encephalitis virus specific TaqMan primer-probe sequences (Lambert, Martin and 
Lanciotti, 2003).  Blood samples collected in Manatee County were screened with both 
West Nile virus (Lanciotti et al, 2000) and St. Louis encephalitis virus (Lanciotti and 
Kerst, 2001) specific TaqMan primer-probe sequences, used as previously described.  A 
total of 200 blood samples were tested (n=100 from each county), including five samples 
collected from birds (different sites in two counties) on the same date that virus was 
isolated from a corresponding cloacal swab. No virus was detected or isolated from these 
processed blood samples, as tested by real-time RT-PCR (TaqMan) with the above 
primer-probe sets. 
Cloacal Swabs 
In 2005, three counties participated in the Arbovirus Isolation/Detection Network 
and implemented a targeted strategy for the collection of samples from sentinel chicken 
flocks. A total of 129 birds were sampled in Manatee, Orange and Sarasota counties. 623 
cloacal swabs were collected. A retrospective processing strategy was used by the BOL-
Tampa to assay a subset of these samples, where 259 swabs were processed and extracted 
for virus isolation and molecular detection assays.  Arboviruses (two EEEV and three 
WNV) were detected in five chickens (out of 129 sampled).   
In 2006, five counties participated in the Arbovirus Isolation/Detection Network. 
A total of 95 chickens were sampled in Lee, Orange, Pasco, Sarasota and Volusia 
 236
counties, where 1338 cloacal swabs were collected. The BOL-Tampa retrospectively 
processed 529 swabs for virus isolation and molecular detection assays. Arboviruses (two 
SLEV, two WNV, and three novel flaviviruses) were isolated and/or detected in six 
chickens from one county (Sarasota).   
Arbovirus Characterization 
Real-Time RT-PCR (TaqMan)  
In Orange County, EEE viral RNA only was detected in two birds (four isolates 
were identified, as each bird was swabbed twice).  However, the aims of the study were 
to characterize flavivirus isolates and these EEEV strains were not further analyzed. 
WNV was detected and isolated from one bird in Manatee County (FLM38). Two 
additional isolates were identified by the detection of WN viral RNA on cloacal swabs 
from Manatee County chickens (three WN positive of 119 tested).  These swabs were 
collected and processed from August to November 2005 by the BOL-Tampa. Real-time 
RT-PCR results are listed in Table 4-6 for arboviruses isolated/detected in Orange and 
Manatee counties during 2005. 
In 2006, three isolates were made from one chicken (Bird 8-003-R), including two 
West Nile virus strains isolated prior to a St. Louis encephalitis virus strain cultured from 
the last swab collected. West Nile virus was also isolated from another chicken located at 
the same site (004).  
One cloacal swab processed in December 2006 from Bird 7-005-B (Site 005) 
replicated in Vero cell culture (“1+” cpe at 4 DPI, “3” cpe at 5 DPI). The culture was 
passed again in Vero cells (“3+” cpe at 7 DPI) to improve viral titer. However, both the 
swab and cultures for this bird were negative on screening by real-time RT-PCR for 
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WNV, SLEV, and EEEV (data not shown for EEEV).  This FLS281 isolate was later 
identified as Newcastle virus in March 2008 with the SLEC end-point primer set [data 
not shown].   
A novel flavivirus strain (FLS853) was detected by real-time RT-PCR with WNV 
and SLEV primers in February 2007, but did not replicate (produce cytopathic effect) in 
Vero cells.  This isolated viral RNA was interesting as more than 100 of the WNV 
positive samples tested by the BOL-Tampa since the introduction of WNV to Florida did 
not cross-react with the SLEV-specific primer-probe sets developed by the CDC 
(Lanciotti et al, 2000; Lanciotti and Kerst, 2001), when run in parallel. In addition, the 
CDC had validated these primer sets prior to publication and reported that these two 
strains did not cross-react in real-time RT-PCR (TaqMan) assays with the primer sets, as 
supported by BOL-Tampa results.   
A total of 381 cloacal swabs were processed at the BOL-Tampa from August 
2006 through April 2007.  In September 2007, 46 swabs collected in Sarasota County 
were retrospectively processed based on positive RT-PCR results (FLS853) from Site 
001. A second SLEV isolate was made from Bird 9-005-B (strain FLS650).  Two novel 
flavivirus strains (FLS649 and FLS694) were also detected in two chickens at this site.  
TaqMan real-time RT-PCR results are listed in Table 4-7 for arboviruses 
isolated/detected from sentinel chicken cloacal swabs collected during 2006. 
End-Point RT-PCR  
 
 Traditional gel-based (end-point) RT-PCR assays were either performed directly 
on RNA extracts of cloacal swab material and/or Vero cell cultures to confirm real-time 
RT-PCR detection of most strains isolated in 2005-2006.  End-point primers specific for  
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Table 4-6 Real-Time RT-PCR (TaqMan) Results for Arboviruses Isolated from Sentinel Chickens in 2005 
Real-time RT-PCR assays were run in duplicate for the detection of virus strains. Arboviruses were detected using two 
primer-probe sets specific to each virus (designated EEEA & EEEB for EEEV; designated WNA & WNB for WNV; 
and designated SLEA & SLEB for SLEV). Samples were screened with the “A” primer sets. Samples that confirmed 
with the “B” primer sets were considered true positives. CT values were averaged and values ≤ 40 were considered 
positive, as virus titers in cloacal swabs were low.  
 
 
Real-Time RT-PCR (TaqMan) Results for EEEV, WNV & SLEV 
 
2005 
Virus Strains 
EEEA 
(CT) 
EEEB 
(CT) 
WNA 
(CT) 
WNB 
(CT) 
SLEA 
(CT) 
SLEB 
(CT) 
FLR80 33.95 33.41 Undet Undet NT NT 
FLR84 33.57 36.96 Undet Undet NT NT 
FLR86 33.68 36.54 Undet Undet NT NT 
FLR90 33.90 33.57 Undet Undet NT NT 
FLM38 Undet Undet 34.50 34.56 Undet Undet 
FLM42.2 Undet Undet 35.30 37.28 Undet Undet 
FLM50 Undet Undet 36.32 34.65 Undet Undet 
 *NT = Not Tested to conserve RNA template volume; Undet = viral RNA not detected, CT > 45 cycles. 
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Table 4-7 Real-Time RT-PCR (TaqMan) Results for Arboviruses Isolated from 
Sentinel Chickens in 2006 
Real-time RT-PCR assays were run in duplicate for the detection of virus 
strains. West Nile virus was detected using two primer-probe sets specific 
to the virus (designated WNA & WNB). Two primer-probe sets designed 
to specifically target SLEV (designated SLEA & SLEB) were used to 
detect St. Louis encephalitis virus strains. Samples were screened with the 
“A” primer sets. Samples that confirmed with the “B” primer sets were 
considered true positives. CT values were averaged and values ≤ 40 were 
considered positive, as virus titers in cloacal swabs were low.   
 
 
Real-Time RT-PCR (TaqMan) Results for WNV & SLEV 
 
2006 
Virus Strains 
WNA 
(CT) 
WNB 
(CT) 
SLEA 
(CT) 
SLEB 
(CT) 
 
FLS281 Undet Undet Undet Undet 
 
FLS502 25.00 26.4 Undet Undet 
 
FLS504 33.55 34.95 Undet Undet 
 
FLS545 33.27 34.88 Undet Undet 
 
FLS569 Undet Undet 23.76 15.85 
 
FLS650 Undet Undet 35.53 34.48 
 
FLS649 Undet NT 38.37 38.24 
 
FLS694 37.77┼ 31.26┼ 36.20 38.01 
 
FLS853 36.5 36.49 36.01 Undet 
 
*NT = Not tested to conserve RNA template volume; Undet = viral RNA not detected,  
 CT > 45 cycles, ┼Assayed cell culture supernatant (with negative cpe). Note: FLS649 cell 
culture supernatant not assayed.
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WNV (Table 3-7) and SLEV  (Table 3-8) were used to assay each new arbovirus strain 
detected by TaqMan RT-PCR, as well as two universal primer sets for identification of 
most arthropod-borne flaviviruses.  In addition, reference strains of St. Louis encephalitis 
virus and West Nile virus archived at the BOL-Tampa were assayed with gel-based 
primer sets for sequence and phylogenetic comparison to recent isolates (Table 3-1, also 
see Tables 4-9 and 4-10 later in this section).  
Two gel-based primer sets each were used for confirmation of real-time results 
(CT  ≤ 40) for St. Louis encephalitis virus (complete envelope & SLEC, Table 3-8), West 
Nile virus (WNAE & WNBE, Table 3-7), and/or flavivirus group (partial NS5, 3’NC 
regions, Table 3-9). PCR products were electrophoresed and amplicons of the appropriate 
size were excised from the gel and purified for sequence analysis.  
SLEV Envelope Region 
 The largest PCR product generated for analysis in this study was the complete 
envelope region (~1700bp).  The F880/B2586 primer set was used to specifically detect 
and amplify the SLEV envelope for phylogenetic analysis, as previously described by  
Kramer and Chandler (2001). Four internal primers (two sense and two anti-sense) were 
used to overlap segments for sequencing of both directions along the genome.  
In addition, a 5’ partial envelope region (750bp) was amplified with the forward 
(F880) and one internal anti-sense primer (B1629) for rapid sequence analysis of a 
smaller region (however, only sequence analysis of the complete region was used for this 
study). Gel electrophoresis of these PCR products identified a single band for both North 
American and South American strains of SLEV with the envelope primer sets (Figure 4-
27). These SLEV envelope primer sets also did not cross-react with West Nile virus. 
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Figure 4-27 Gel Electrophoresis of SLEV Isolates (Envelope Region) 
  RT-PCR was performed with F880/B2586 primers to amplify the   
  complete envelope region of SLEV isolates for sequencing. In addition,  
  a partial portion of the envelope gene was amplified with F880/B1629  
  primers (5’ end). Both PCR products were run on 1.0% agarose gels and  
  resulted in single bands (complete envelope product size 1.7 kb, partial  
  product 750bp) for both North and South American strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Lane 1: Marker (10 kb ladder) 
  Lane 2: Blank 
  Lane 3: FL85a [partial envelope] 
  Lane 4: NTC 
  Lane 5: SLE+ (TBH-28) [complete envelope, lanes 5-13] 
  Lane 6: FLS569 
  Lane 7: FL52 
  Lane 8: TR62 
  Lane 9: BR69 
  Lane 10: FL90d 
  Lane 11: FL90b 
  Lane 12: FL72 
  Lane 13:  FL85a 
  Lane 14: NTC 
 
 
 
 
 1   2   3   4   5   6   7   8   9  10 11 12 13 14 
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SLEV M/E Region 
The SLEC primer set (SLE727/SLE1119c) [Lanciotti and Kerst, 2001] was also 
used for phylogenetic analysis of the Membrane (M)/Envelope (E) region of recent SLEV 
isolates compared to a selected subset of reference strains (FL52, TBH-28, FL72, FL85a, 
BR69 and TR62) [Figure 4-28]. Unlike the SLEV complete envelope primers, this primer 
set detected West Nile virus but resulted in an amplicon of the incorrect size (~700bp) 
[data not shown].  
WNV Capsid/prM Region 
 A small portion of the West Nile virus capsid and precursor membrane region was 
amplified by the WNAE primer set (WN233/WN640c) [Lanciotti et al, 2000]. Real-time 
TaqMan RT-PCR results were confirmed West Nile virus positive with this primer set. 
Multiple sequence and phylogenetic analysis of this region was evaluated for all cultured 
isolates of WNV, as well as used to characterize novel flavivirus strains (Figure 4-29). 
Flavivirus NS5 Region 
The Fu1/cfd3 primer set (Kuno et al, 1998) was used to amplify the NS5 (RNA 
dependent RNA polymerase) region of the flavivirus genome. This universal primer set 
detected both WNV and SLEV; sequencing of the PCR products (Figure 4-30) was used 
to generate a multiple sequence alignment and phylogeny of both virus species   An 
additional experimental primer set developed by the CDC (personal communication, RS 
Lanciotti) and sequences provided to the BOL-Tampa for gel-based confirmation of 
WNV (also cross-reactive with SLEV) detected a 300 bp region of the NS5 gene 
(downstream at the 3’end) [Figure4-31]. However, this primer set did not amplify the 
Florida WNV isolates well for  
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Figure 4-28 Gel Electrophoresis of FLS569 & SLEV Reference Strains (SLEC:  
M/E Region) 
RT-PCR was performed with SLE727/SLE1119c primers to amplify the 
M/E region of St. Louis encephalitis virus.  PCR products were run in 
duplicate on 1.0% agarose gels. A single band was produced (400bp) for 
both North and South American strains. 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
Lanes 1, 15:     Marker (1 kb ladder) 
Lanes 2, 4, 6, 9, 12, 16, 19, 22, 25:   Blank 
  Lane 3:     SLE + (TBH-28) 
  Lane 5:     FLS569   
  Lanes 7, 8:     FL52 
  Lanes 10, 11:     TR62 
  Lanes 13, 14:     BR69 
  Lanes 17, 18:     FL90d 
  Lanes 20, 21:     FL90b    
  Lanes 23, 24:     FL72 
  Lanes 26, 27:     FL85a 
  Lane 28:      NTC 
 
15 16 17 18 19 20 21 22 23 24 25 26 27 28 
 1   2   3   4   5   6   7   8   9  10 11 12 13 14 
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Figure 4-29 Gel Electrophoresis of FLM38 & WNV Reference Strains (WNAE:  
Capsid/prM Region) 
RT-PCR was performed with WN233/WN640c primers to amplify the 
capsid/prM region of West Nile virus. Visualization of PCR products was 
run on 1.0% agarose gels. A single band was produced (408bp) for both 
recent and archived strains of West Nile virus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Lanes 1, 14, 15, 28:     Marker (1 kb ladder) 
  Lane 2:      WN + (NY99) 
  Lanes 3, 5, 7, 9, 11, 13, 17, 19, 21, 23, 25, 27: Blank 
  Lane 4:      WN + (Eg101)  
  Lane 6:      FLWN01a 
  Lane 8:      FLWN01b 
  Lane 10:      FLWN02a 
  Lane 12:      FLWN02b 
  Lane 16:      FLM38  
  Lane 18:      FLWN05a 
  Lane 20:      FLWN05b 
  Lane 22:      FLCxs231 
  Lane 24:      FLCxn280  
  Lane 26:      NTC 
 
15 16 17 18 19 20 21 22 23 24 25 26 27 28 
 1  2   3   4   5   6   7   8   9  10 11 12 13 14 
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Figure 4-30 Gel Electrophoresis of FLS502, FLS545 & FLS569 (NS5 Region) 
RT-PCR was performed with FU1/cFD3 primers to amplify the partial 
internal NS5 region of flaviviruses.  PCR products were run in duplicate 
on 1.0% agarose gels. A distinct triple banding pattern (sizes 1 kb, 750 bp, 
and ~300 bp) and was found in this region in FLS569 (SLEV) that was not 
seen for North American SLEV or WNV strains (a single 1 kb band).      
     
                     
 
 
 
 
 
 
 
 
 
 
 
 
Lanes 1, 15:      Marker (1 kb ladder) 
  Lanes 2, 5, 6, 9,10, 13, 16, 18, 19, 22, 23, 26, 27:  Blank 
  Lanes 3, 4:      SLE + (TBH-28) 
  Lanes 7, 8:      FLS569   
  Lanes 11, 12:      FLS502 
  Lanes 14, 28:      Marker (10 kb ladder) 
  Lane 16:      NTC 
  Lane 17:      SLE + (TBH-28) 
  Lanes 20, 21:      FLS545 
  Lanes 24, 25:      WN+ (NY99) 
   
 
15 16 17 18 19 20 21 22 23 24 25 26 27 28 
 1   2   3   4   5   6   7   8   9  10 11 12 13 14 
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Figure 4-31 Gel Electrophoresis of FLS502, FLS545 & FLS569 Isolated from Bird 
8-003-R (WNBE:  3’ NS5 Region) 
RT-PCR was performed with primers to amplify the 3’ region of the NS5 
gene of flaviviruses.  PCR products were run in duplicate on 1.0% agarose 
gels. SLEV strains also amplified with this primer set and resulted in 
several amplicon sizes (including FLS569) that was not seen for WNV 
strains (a single 300bp band).      
           
 
 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lanes 1, 15:      Marker (1 kb ladder) 
  Lanes 2, 5, 6, 9,10, 13, 16, 18, 19, 22, 23, 26, 27:  Blank 
  Lanes 3, 4:      SLE + (TBH-28) 
  Lanes 7, 8:      FLS569   
  Lanes 11, 12:      FLS502 
  Lanes 14, 28:      Marker (10 kb ladder) 
  Lane 16:      NTC 
  Lane 17:      SLE + (TBH-28) 
Lanes 20, 21:      FLS545  
 Lanes 24, 25:      WN+ (NY99) 
 
 
15 16 17 18 19 20 21 22 23 24 25 26 27 28 
  1   2   3   4   5   6   7   8   9  10 11 12 13 14 
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sequencing reactions, so it was only used for additional confirmation of novel flavivirus 
strains. 
Flavivirus 3’NC Region 
The YF1/YF2 primer set amplified the 3’ non-coding region of flaviviruses. A 
subset of SLEV strains (FL52, TBH-28, FL72, FL85a, FL90b, FL90d, FLS569, TR62, 
BR69) were evaluated with this primer set (Figure 4-32).   
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Figure 4-32 Gel Electrophoresis of FLS569 & SLEV Reference Strains (YF: 3’ NC 
Region) 
RT-PCR was performed with YF1/YF2 primers to amplify the 3’NC 
region of flaviviruses. A subset of SLEV strains was sequenced in this 
region for comparison to recent SLEV isolates (FLS569 shown below).      
PCR products were run in replicate on 1.0% agarose gels.  
 
           
 
 
 
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lanes 1, 2:     BR69 
  Lanes 3, 5, 7, 10, 13, 16, 19, 22, 25:   Blank 
  Lane 4:     SLE + (TBH-28) 
  Lane 6:     FLS569   
  Lanes 8, 9:     FL52 
  Lanes 11, 12:     TR62 
  Lanes 14, 15:     Marker (1 kb) 
  Lanes 17, 18:     FL90d 
Lanes 20, 21:     FL90b   
Lanes 23, 24:     FL72 
Lanes 26, 27:     FL85a 
Lane 28:     NTC 
 
 
15 16 17 18 19 20 21 22 23 24 25 26 27 28 
 1   2   3   4   5   6   7   8   9  10 11 12 13 14 
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Sequence Analysis 
 A minimum of two forward and two reverse sequencing reactions were performed 
for each PCR product analyzed. Sequences were uploaded into the DNAStar program 
(SeqManII) to edit base calls and to generate a consensus (contig) sequence for each 
sample. The consensus sequences were entered into the BLASTN tool 
(http://www.ncbi.nlm.nih.gov/) to search the GenBank nucleotide database for 
homologous strains. The top 5 matches (with accession number, max score, query 
coverage, e-value, and max identity score) for each strain and primer set are provided in 
Appendix I for SLEV, Appendix J for WNV, and Appendix K for novel flavivirus strains. 
MEGA4.0.1 was used to generate multiple sequence alignments for each region 
analyzed (ClustalW 1.6 algorithm).  Sequences were trimmed to specific start and stop 
positions to minimize gapped data for SLEV and WNV strains (Table 4-8).  Position 
numbers were based on the complete nucleotide sequence of the Kern217 strain 
(Accession # NC_007580) for SLEV, or the complete sequences of WN NY99 
(Accession # AF196835) and WN Egypt101 (Accession # AF260968) for WNV isolates. 
These alignments were used to generate phylogenetic trees and to identify mismatched 
nucleotide bases and/or predicted translational (amino acid) changes in each strain.  
Multiple sequence alignments (nucleotide and amino acid) for West Nile virus are 
provided in Appendix L (WNAE primer set) and Appendix M (WNBE primer set). 
Nucleotide and translated protein alignments for St. Louis encephalitis virus are provided 
in Appendix N (complete envelope primer set), Appendix O (membrane/envelope, SLEC 
primer set). Flavivirus alignments are provided in Appendix P (NS5, Fu1/cfd3 primer set) 
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Table 4-8 Analyzed Regions of the Virus Genome (Nucleotide Base and Amino Acid Positions) 
Multiple sequence alignments were trimmed to the nucleotide base or amino acid positions provided below, based on 
complete nucleotide sequences of SLEV and WNV. The capsid/prM (WNAE) and 3’NS5 (WNBE) regions were 
analyzed for WNV strains only. Partial membrane/envelope (SLEC), complete envelope, and 3’NC (YF) regions were 
analyzed for SLEV strains only.  Both WNV and SLEV sequences were evaluated in the NS5 region. 
 
Analyzed Regions of the Virus Genome* 
Capsid/prM 
(WNAE) 
Mem/Env 
(SLEC) Envelope NS5 
3’NS5 
(WNBE) 3’NC 
Sequence Position Number (Nucleotide Bases) 
231 - 640 734 - 1082 916 - 2547 
 
9082 – 10087 (WN) 
9072 – 10077 (SLE) 
9505 - 9776 10104 - 10706 
Sequence Position Numbers (Amino Acids) 
78 – 214 246 - 362 308 - 850 3031 – 3364 (SLE) 
3033 – 3366 (WN) 
3169 - 3259 NA 
*Nucleotide base positions and translated amino acid positions are numbered according to the complete nucleotide sequence of 
Kern217 for SLEV, and complete nucleotide sequences of WNNY99 and WNEgypt101 for WNV isolates. 
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and Appendix Q (3’NC, nucleotide alignment only). Standard amino acid abbreviations 
(1 letter symbols) are listed in Appendix S.  
The following flavivirus reference and recent (2005-2006) strains were sequenced 
by the BOL-Tampa. Sequence results were first uploaded into the BLASTN search tool 
in GenBank to identify strains with the closest sequence identity to these isolates. A 
multiple sequence alignment was then performed for each region, including outgroup 
(and SLEV Kern217) sequences downloaded from GenBank, to identify unique 
nucleotide and predicted amino acid differences. Table 4-9 provides a comprehensive list 
of the strains sequenced for this project by the BOL-Tampa, including the strain 
designation, host, collection date, and virus identity. In addition, Table 4-10 provides the 
RT-PCR and sequencing results for each strain.  
St. Louis Encephalitis Virus Strains 
 FL52 
 The 1952 reference strain was isolated from the first recognized human case of 
SLEV in Florida, a Miami resident.  BLASTN search results on the envelope sequence 
identified that FL52 shares 97% sequence identity with strains from Tampa Bay, Florida 
(GHA-3), Mexico (65 V 310), and the prototypical Parton strain (USA, Missouri). The 
NS5 and M/E (SLEC) regions also matched the Tampa Bay (TBH-28), Mexico, and 
Parton strains with 97% identity (Appendix I).  The 3’NC region matched Kern217 
(California), MSI-7 (Mississippi), and South American strains with 96% identity 
(Appendix I). However, these results are likely due to the limited number of SLEV 
strains that have been completely sequenced in this region and submitted to the GenBank 
database. 
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Table 4-9 Recent 2005-2006 and Reference Flavivirus Strains Sequenced 
Thirty flavivirus strains were sequenced in this study, including eight new 
strains isolated from sentinel chickens in Florida. The exact collection date 
for recent strains is shown below, whereas the year of collection for all 
reference strains has been provided. St. Louis encephalitis virus isolates 
are shaded in gray. 
 
STRAIN DESIGNATION HOST COLLECTION DATE 
VIRUS 
IDENTITY
FL05-M038 FLM38 Chicken 1773 09.12.05 WNV 
FL06-S502 FLS502 Chicken 8-003-R 10.09.06 WNV 
FL06-S504 FLS504 Chicken 8-005-B 10.09.06 WNV 
FL06-S545 FLS545 Chicken 8-003-R 10.16.06 WNV 
FL06-S569 FLS569 Chicken 8-003-R 10.18.06 SLEV 
FL06-S649 FLS649 Chicken 9-004 G 10.30.06 FLAVI 
FL06-S650 FLS650 Chicken 9-005-B 10.30.06 SLEV 
FL06-S694 FLS694 Chicken 9-000-W 11.06.06 FLAVI 
Eg101 WNEgypt Human 1952 WNV 
385-99 WNNY99 Snowy Owl 1999 WNV 
FL01-I401 FLWN01a Crow 2001 WNV 
FL01-I403 FLWN01b Blue Jay 2001 WNV 
FL02-M1215 FLWN02a Oc. taeniorhy. 2002 WNV 
FL02-M1220 FLWN02b Oc. taeniorhy. 2002 WNV 
FL05-I189 FLWN05a Alligator 2005 WNV 
FL05-I242 FLWN05b Crow 2005 WNV 
Miami FL52 Human 1952 SLEV 
TBH-28 TBH-28 Human 1962 SLEV 
F72-M022 FL72 Opossum 1972 SLEV 
86-100309 FL85a Cx. nigripalpus 1985 SLEV 
86-100802 FL85b Cx. nigripalpus 1985 SLEV 
1A-059 FL89 Northern cardinal 1989 SLEV 
3-594 FL90a Common grackle 1990 SLEV 
3A-038 FL90b Mourning dove 1990 SLEV 
3-582 FL90c Common grackle 1990 SLEV 
CXN GR8 FL90d Cx. nigripalpus 1990 SLEV 
TRVL 21647 TR58 Cx. coronator 1958 SLEV 
TRVL 43174 TR62 Cx. nigripalpus 1962 SLEV 
BeAn 70092 BR64 Kingfisher  1964 SLEV 
BeAn 156204 BR69 Chicken 1969 SLEV 
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Table 4-10 Primer Sets for Sequencing of Recent 2005-2006 and Reference 
Flavivirus Strains 
 Arbovirus strains were tested with a total of six primer sets for 
sequencing. The complete envelope was sequenced for reference and 
recent SLEV strains, whereas the capsid/prM (WNAE) region was 
sequenced for reference and recent WNV strains. The NS5 region was 
sequenced for both WNV and SLEV strains. 
 
STRAIN DESIGNATION WNAE SLEC ENV NS5 WNBE 3’NC 
FL05-M038 FLM38  NT NT  DNS NT 
FL06-S502 FLS502  X X  DNS NT 
FL06-S504 FLS504  X X   NT 
FL06-S545 FLS545  X X  DNS NT 
FL06-S569 FLS569 DNS    NT  
FL06-S649 FLS649   X X DNS X 
FL06-S650 FLS650 NT    NT NT 
FL06-S694 FLS694   X X  X 
Eg101 WNEgypt  NT X    
385-99 WNNY99  X X    
FL01-I401 FLWN01a  NT NT  NT NT 
FL01-I403 FLWN01b  NT NT  NT NT 
FL02-M1215 FLWN02a  NT NT  NT NT 
FL02-M1220 FLWN02b  NT NT  NT NT 
FL05-I189 FLWN05a  NT NT  NT NT 
FL05-I242 FLWN05b  NT NT  NT NT 
Miami FL52 NT    NT  
TBH-28 TBH-28 X    DNS  
F72-M022 FL72 NT    NT  
86-100309 FL85a NT    NT  
86-100802 FL85b NT NT   NT NT 
1A-059 FL89 NT NT   NT NT 
3-594 FL90a NT NT   NT NT 
3A-038 FL90b NT NT   NT  
3-582 FL90c NT NT   NT NT 
CXN GR8 FL90d NT NT   NT  
TRVL 21647 TR58 NT NT   NT NT 
TRVL 43174 TR62 NT    NT  
BeAn 70092 BR64 NT NT   NT NT 
BeAn 156204 BR69 NT    NT  
Legend:   = sequenced, X = did not amplify, DNS = did not sequence (amplicon failed  
to sequence), NT = not tested. 
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Multiple sequence alignment with other Florida (TBH-28, FL72, FL85a&b, 
FL90a-d) and South American reference strains (TR58, TR62, BR64, BR69) identified 
21 changes in the envelope nucleotide sequence that were unique from other Florida 
SLEV viruses. This resulted in 13 amino acid changes in the translated envelope protein 
(substituted amino acids are located on right side of each arrow in Table 4-11). One 
insertion of an adenine (A) base between positions 1580 and 1581 resulted in the 
insertion of a cysteine in the amino acid sequence (528-529).  
Six nucleotide substitutions were detected in the partial NS5 region, with five 
amino acid changes.  In addition, one nucleotide (C) was inserted between positions 9741 
and 9742 resulting in the insertion of a glutamine (Q between positions 3250 and 3251) 
in the protein sequence. One nucleotide difference was found in the membrane/envelope 
(SLEC) region, a synonymous mutation resulting in one amino acid substitution 
(asparagine). Finally, 3 nucleotide differences were noted in the 3’NC region 
(untranslated) [Table 4-11]. These alignments are provided for all SLEV strains in 
Appendices N-Q. 
TBH-28 
Tampa Bay 28 is a commonly used reference strain of SLEV. For the purpose of 
this study, it was included as a representative Florida SLEV isolate collected in the 
1960s. BLASTN search results on the envelope region sequenced by the BOL-Tampa 
identified that TBH-28 shares 99% sequence identity with strains from Tampa Bay 
(TBH-28) and Pinellas (P-15) county, Florida (as expected for the positive control strain). 
The Mexico strain (65 V 310) shares 98% identity with TBH-28 in the envelope region.   
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Table 4-11 Nucleotide and Amino Acid Changes Identified in SLEV Strains from Florida (1952-1990) 
Multiple sequence alignments identified unique nucleotide and amino acid changes in a comparison of reference SLEV 
strains (FL & South America) and the Kern217 (California) strain (complete sequence).  
 
Envelope Region NS5 Region SLEC Region 3’NC Region
SLEV 
Strain # 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
 
FL52 
 
1006, 1100, 1147, 
1200, 1203, 1214,  
1388, 1413, 1551, 
1552, 1776, 1816, 
2044,  2082, 2134, 
2162, 2232, 2254, 
2393, 2425 
 
Ai (1580-1581) 
369 (* → R) 
402 (K → R) 
403 (L→R) 
407 (K → E) 
473 (H → R) 
519 (S → F) 
683 (F → L) 
713 (T → A) 
722 (E → G) 
753 (I → V) 
799 (R → H) 
810 (V → I) 
Yi (528-529) 
9074, 9164, 
9230 9315, 
9320, 9490 
 
 
Ci (9741-9742) 
 
3028 (G →E) 
3058 (T →I) 
3080 (S→F) 
3110 (K→R) 
3166 (R→K) 
 
Q i (3250-
3251) 
 
1006 
No unique 
translated 
differences 
10353 
10522 
10629 
 
TBH-28 
 
1135, 1146,  1458, 
1506, 1713, 1734, 
1953, 2007, 2157, 
2322, 2442 
381 (E →K) 
384 (T →M) 
488 (L →P) 
504 (A →V) 
9093, 9197, 
9905 
3034 (E→D) 
3069 (L→S) 
No unique 
nucleotide 
differences 
No unique 
translated 
differences 
10137 
10405 
10427 
10580 
T i (10658-
10659) 
 
FL72 
 
923, 954, 1128, 
1322, 1425, 1522, 
2055, 2091,   
2319┼, 2490 
310 (S →F) 
320 (R →Q) 
378  (L →P) 
403 (L →P) 
443 (H → Y) 
477 (I → T) 
522 (R → S) 
9104, 9215, 
9368, 9378, 
9629, 9641, 
9890, 9914 
3038(T→I) 
3075 (R→K) 
3126 (L→S) 
3213 (G→E) 
3217 (L→P) 
897, 954 301 (* → W) 320 (R → Q) 
10188 
10323┼ 
10532 
iInserted nucleotide base/amino acid at the position number. *Termination (stop codon).   ┼Matched Kern217 (California). 
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Table 4-11 Nucleotide and Amino Acid Changes Identified in SLEV Strains from Florida (1952-1990), Continued 
Bolded residues are shared in FL “epidemic” strains (1989-1990), but are unique from the other SLEV strains analyzed 
(except where noted for Kern217).  
Envelope Region NS5 Region SLEC Region 3’NC Region 
SLEV 
Strain # 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
 
FL85  
(a & b) 
 
No unique 
nucleotide 
differences 
No unique 
translated 
differences 
9086, 9926ª 3032(E→A) 864ª   290 (M→T) ª 
 
(FL85a) 
10165, 10257, 
10325, 10400, 
10417, 10431, 
10675 
 
 
FL89 
1068 b, 1092, 1239, 
1335, 1461,  1493 c,  
1800, 1899, 1986, 
2010, 2076, 2196, 
2313, 2433, 2460 
366 (S →L) 
415 (A →V) 
447 (R →K) 
489 (D →G) 
9188, 9254,  
9296, 9387, 
9446, 9653┼, 
9710, 9752, 
9863, 9875, 
9956, 10037, 
10040, 10055 
3066 (M→T) 
3088 (Q→R) 
3102 (P→L) 
3132 (I→S) 
3152 (T→I) 
3221 (V→A) 
3240 (P→L) 
NT NT NT 
 
 
FL90 
a, b, c & d 
1068 b, 1092, 1239, 
1335, 1461,  1493 c,  
1800, 1899, 1986, 
2010, 2076, 2196, 
2313, 2433, 2460 
358 (H →R)b 
470 (R →Q)ª 
500 (R→W) c 
366 (S →L) 
415 (A →V) 
447 (R →K) 
489 (D →G) 
9188, 9254,  
9296, 9387,  
9654┼, 9701,  
9710, 9752, 
9863, 9875, 
9956, 10040, 
10055 
3066 (M→T) 
3088 (Q→R) 
3102 (P→L) 
3132 (I→S) 
3221 (V→A) 
3237 (T→I) 
3240 (P→L) 
NT NT 
(FL90b & d) 
10176, 10242, 
10252, 10435 
ªFL85a or FL90a only. bFL90a, c, d only. cFL90c only. ┼Matched Kern217 (California).  *Termination codon. NT = not tested
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Similar results were found with the NS5 (additional match to MSI-7 strain at 97% 
identity) and partial membrane/envelope (SLEC) regions [Appendix I].  
Multiple sequence alignment with other reference strains indicates that TBH-28 
has 11 unique nucleotide differences (Table 4-11) but only four amino acid changes in 
the predicted translated protein. Alignment of the NS5 region identified three unique 
nucleotide differences, with two translational differences.  No unique differences were 
found in the partial membrane/envelope region (SLEC), as compared to the reference 
strains in this study. Five nucleotide differences were noted in the 3’NC region, including 
the insertion of thymine between positions 10658 and 10659 [Table 4-11]. 
FL72 
The FL72 strain of SLEV was isolated from the blood of an adult, female 
opossum in 1972 from the Florida panhandle (Walnut Hill, Escambia County).  BLASTN 
search results on the envelope region sequenced by the BOL-Tampa identified that FL72 
shares 97 - 98% sequence identity with strains from South America (Brazil: 
BeAn246262, BeAr 23379 and BeH203235), as well as 96% identity with one strain 
from Peru (75 D 90). Similar results were found with the NS5 and partial 
membrane/envelope (SLEC) regions, with an additional match to a Trinidad strain 
(TRVL 9464) at 96% identity (Appendix I).  
Multiple sequence alignment with SLEV reference strains identified ten 
nucleotide base differences in the envelope region, resulting in seven translational 
changes (see Table 4-11).  Alignment of the NS5 region identified eight unique 
nucleotide differences, with five amino acid substitutions. In addition, two nucleotide 
changes were detected in the M/E region, with two amino acid substitutions. Three 
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nucleotide differences were noted in the 3’NC region, where one of these substitutions 
was shared by the Kern217 strain of SLEV [Table 4-11]. 
FL85 (a & b) 
During 1985 through 1997, archived SLEV isolates at the BOL-Tampa were 
collected in Indian River County, Florida, which experienced the most recent large 
outbreaks of SLEV in the state.  FL85 (a & b) strains were collected during an 
interepidemic year from Culex nigripalpus pools. BLASTN search results on the 
envelope sequence identified that FL85 a & b share 99% sequence identity with the 
Mexico strain (65 V 310), as well as 98% identity with strains from Tampa Bay (TBH-28 
and GHA-3). Similar results were found with the NS5 (additional match to MSI-7 strain 
at 97% identity) and partial membrane/envelope (SLEC) regions [Appendix I].  
Multiple sequence alignment with SLEV reference strains identified no unique 
nucleotide or amino acid differences in the envelope region for FL85a & b.  Alignment of 
the NS5 region identified two nucleotide differences in FL85a, with only one change 
noted in FL85b (position 9086). The single change shared by FL85a & b resulted in one 
amino acid substitution (glutamic acid to alanine at position 3032). In addition, one 
nucleotide change was detected in the M/E region (SLEC primers) in FL85a, with one 
amino acid change. Seven nucleotide differences were also noted in the 3’NC region 
(untranslated) for FL85a, but were non-coding [Table 4-11]. FL85b was not assayed with 
the SLEC or YF primer sets (Table 4-10). 
FL89 
SLEV strain FL89 was isolated from the blood of a northern cardinal in Indian 
River County, Florida in 1989.  BLASTN search results on the envelope sequence 
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identified that FL89 shares 98% sequence identity with USA strain (V 2380-42), 
Guatemala strain (78 A 28), and Tennessee strain (TNM 4-711).  Guatemala strain (GMO 
94) and Tampa Bay strain (GHA-3) were also in the top five matches, with 97% sequence 
identity.  Similar results were found with the NS5 region (additional match to Mexico 65 
V 310 strain @ 97% identity); this region did not include a Tampa Bay isolate in the top 
5 matches [Appendix I].  
Multiple sequence alignment with SLEV reference strains identified 15 mutations 
in the envelope region, the majority of which were silent and did not alter the protein 
sequence. However, four amino acid substitutions were noted (positions 366, 415, 447, 
and 489), which were all shared with 1990 strains of SLEV.  In addition, 14 nucleotide 
differences were detected upon alignment of the NS5 region, with seven changes to the 
amino acid sequence of the NS5 protein (see Table 4-11 for amino acid changes). Only 
one amino acid substitution was not found in the 1990 strains (isoleucine, 3152). This 
strain was not tested with the SLEC (M/E region) or YF1/YF2 (3’NC region) primer sets, 
due to limited sequence diversity noted for FL52, TBH-28, FL72, FL85a, as well as to 
conserve resources (Table 4-10). 
FL90 (a, b, c & d) 
These isolates were collected in 1990 during an epidemic of SLEV in Florida 
from the blood of three birds (two common grackles, one mourning dove) (FL90 a, b & 
c) and from a pool of Culex nigripalpus mosquitoes (FL90d). BLASTN search results on 
the envelope sequence identified that strains FL90a-d share 98% sequence homology 
with USA strain (V 2380-42), Guatemala strain (78 A 28), and Texas strains (83V4953, 
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PVI-2419, 98V3181).  The top two matches (USA V 2380-42, Guatemala 78 A 28) were 
identical for these strains in the NS5 region [Appendix I].  
Unique nucleotide mismatches were identified for “epidemic” strains of SLEV 
(isolated during 1989-1990) in the envelope and NS5 regions, as compared to other 
Florida SLEV strains. Multiple sequence alignment with these reference strains identified 
15 nucleotide base changes in the envelope region, which resulted in a total of six amino 
acid substitutions in the protein sequence (some changes not shared by all 1990 strains, 
see Table 4-11).  FL90c had an amino acid substitution at position 500, from arginine to 
tryptophan (R→W).  Thirteen nucleotide differences were detected upon alignment of the 
partial NS5 region, with seven amino acid substitutions (see Table 4-11 for specific 
amino acid changes, right side of arrow). These strains were not tested with the SLEC 
primers (M/E region) due to limited sequence diversity, as shown for FL52, TBH-28, 
FL72 and FL85a (Table 4-12). The 3’NC region of FL90b and FL90d were sequenced, 
and identified 4 nucleotide base changes at the same positions for both strains [Tables 4-
10, 4-11].  
TR58 
TR58 is one of four South American strains included in the study for comparison 
to Florida’s isolates of St. Louis encephalitis virus. In 1958, the TR58 strain of SLEV 
was isolated from Culex coronator mosquitoes collected in the Vega de Oropouche area 
of Trinidad (Aitken et al, 1964).  BLASTN search results on the envelope sequence 
identified that TR58 shared 96 - 97% sequence identity with strains from Trinidad 
(TRVL 9464), Brazil (BeAr 23379, BeAn246262, BeAn 247377), and Peru (75 D 90).  
The same matches were found with the NS5 region (Appendix I). Multiple sequence 
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alignment of these regions identified several nucleotide and amino acid changes that were 
shared by South American strains of SLEV (Table 4-12). 
TR62 
In 1962, the TR62 strain of SLEV was isolated from Culex nigripalpus 
mosquitoes collected in the Bush Bush Forest in Trinidad (Aitken et al, 1964). BLASTN 
search results on the envelope sequence identified that TR62 shared 95 - 96% sequence 
identity with strains from Trinidad (TRVL 9464), Brazil (BeAr 23379, BeAn246262, 
BeAn 247377), and Peru (75 D 90).  The same matches were found with the NS5 and 
M/E (SLEC) regions (Appendix I). Multiple sequence alignment of these regions 
identified several nucleotide base and amino acid changes that were shared by South 
American strains of SLEV (Table 4-12). 
BR64 
St. Louis encephalitis virus strain BR64 was isolated in blood collected from a 
Chloroceryle inda (wild bird species) near Belem, Brazil in 1964 [personal 
communication to F. Wellings (ERC) from G. Sather (University of Pittsburg, 1971).  
BLASTN search results on the envelope sequence identified that BR64 shares 96 - 97% 
sequence identity with strains from Brazil (BeAr 23379, BeAn246262, BeAn 247377), 
Trinidad (TRVL 9464), and Peru (75 D 90).  The same matches were found with the NS5 
region (Appendix I). Multiple sequence alignment of these regions identified several base 
and amino acid changes that were shared by South American strains of SLEV (Table 4-
12).
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Table  4-12 Nucleotide and Amino Acid Changes Identified in SLEV Strains from Florida & South America 
Multiple sequence alignments identified residues shared by Florida “South American” strains (FL72, FLS569, FLS650) 
and four strains isolated in South America (Trinidad, TR58, 62 and Brazil, BR64, 69).  
 
Envelope Region NS5 Region SLEC Region┼ 
SLEV  
Strain # 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
 
 
 
FL72 
FLS569 
FLS650 
 
TR58 
TR62 
BR64 
BR69 
 
943, 951, 966, 969,  996, 
1002, 1004, 1044, 1084, 
1113, 1116, 1125, 1143, 
1185, 1215, 1260, 1296, 
1314, 1329, 1354, 1359, 
1437, 1485, 1557, 1575, 
1578, 1605, 1623, 1624, 
1692, 1698, 1719, 1731, 
1743, 1759, 1798, 1818, 
1824, 1887, 1909, 2139, 
2142, 2193, 2208, 2226, 
2247, 2253, 2265, 2277, 
2307, 2310, 2353, 2371, 
2427, 2439, 2448, 2451, 
2466, 2535, 2541 
319 (L → P) 
334 (L→S) 
336 (R → K) 
337 (E → G) 
350 (G→ E) 
373 (L → P) 
374 (P → R) 
377 (P→ L) 
383 (V → A) 
397 (A → V) 
407 (K → R) 
422 (A→ V) 
434 (G→ E) 
440 (Q→ R) 
455 (E→ G) 
481 (R→ K)  
497 (R→ H) 
512 (I→ T) 
521 (R→ Q) 
522 (R→ K) 
523 (I→ T) 
527 (S→ L) 
528 (L→ Q) 
9080, 9098 
9111, 9137, 
9149, 9185, 
9186, 9251, 
9269, 9299, 
9341, 9350, 
9377, 9387, 
9389, 9392, 
9493, 9563, 
9583, 9626, 
9647, 9674, 
9677, 9713, 
9725, 9731, 
9743, 9761, 
9782, 9797, 
9806, 9884, 
9977, 1004, 
10022, 10031, 
10052, 10064 
 
 
 
3030 (L →P) 
3036 (F →S) 
3041 (W →*) 
3049 (K →R) 
3053 (S →F) 
3093 (T →M) 
3103 (G →A) 
3117 (R →K) 
3120 (K →M) 
3129 (Q →R) 
3151 (P →L) 
3167 (W →*) 
3191 (W →*) 
3198 (R →*) 
3219 (D →G) 
3228 (T →M) 
3229 (T→I) 
3241 (L →P) 
3245 (F→S) 
3247 (I→T) 
 
765 
900 
943 
951 
969 
1002 
1005 
1044 
1056 
 
 
257 (I→ T) 
275  (N→S) 
302  (V→A) 
319  (L→P) 
325  (T→I) 
336  (R→K) 
337  (E→G) 
350 (G→E) 
354 (L→S) 
 
 
*Termination codon. ┼SLEC region only sequenced for FL72, FLS569, FLS650, TR62, BR69.
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BR69 
In 1969, SLEV strain BR69 was isolated in blood collected from a sentinel 
chicken near Belem, Brazil [personal communication to F. Wellings (ERC) from G. 
Sather (University of Pittsburg), 1971].  BLASTN search results on the envelope 
sequence identified that BR69 shares 96% sequence identity with strains from Brazil 
(BeAr 23379, BeAn246262, BeAn 247377), Trinidad (TRVL 9464), and Peru (75 D 90).  
The same matches were found with the NS5 region and membrane/envelope (SLEC) 
regions (Appendix I). Multiple sequence alignment of these regions identified several 
base and/or amino acid changes that were shared by South American strains of SLEV 
(Table 4-12). 
FLS569  
FLS569 was cultured from a cloacal swab collected from a sentinel chicken in 
Sarasota County, Florida in 2006. Nucleotide sequence analysis of purified PCR products 
targeting the complete envelope, membrane/envelope (SLEC) and partial NS5 regions 
confirmed that FLS569 strain was SLEV (refer to previous Figures 4-27, 4-28, and 4- 30 
in this chapter).  BLASTN search results on the envelope sequence identified that 
FLS569 shares 98% sequence identity with South American strains of SLEV, including 
Brazil (BeAn247377, BeAn242587) and Peru (75 D 90). FLS569 also matched the Coav 
405 strain of SLEV isolated in the Coachella Valley of California in the envelope region. 
Similar results were found with the NS5 and partial membrane/envelope (SLEC) regions, 
with an additional match to a Trinidad strain (TRVL 9464) [Appendix I].  
Multiple sequence alignment also indicated that FLS569 was most closely related 
to South American strains.  However, analysis of the nucleotide alignment of the 
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envelope region identified 14 unique nucleotide changes (Table 4-13) that were not seen 
in archived Florida or South American isolates studied (see Appendix N). Only one 
(#1407) of these mutations was not found in the second SLEV strain (FLS650) later 
isolated from Sarasota county, such that 13 of these mutations were shared between the 
two recent strains. The T → C transition mutation (pyrimidine to pyrimidine) at position 
1281 was shared by the Kern217 (California) strain of SLEV. These nucleotide base 
changes coded for eight predicted amino acid changes to the translated protein sequence.  
The partial NS5 region of FLS569 was also sequenced. 19 unique nucleotide base 
changes were observed (note: 18 were shared with FLS650), with 12 predicted amino 
acid substitutions (see Table 4-13 for specific amino acid changes on the right side of 
each arrow). The SLEC primer set (M/E region) was initially used to confirm TaqMan 
RT-PCR results. Sequence analysis of this 400 bp PCR product confirmed that this 
isolate was South American in origin, with nine nucleotide substitutions in the M/E 
region of the virus (one transition mutation [C→T] at position 735 was shared by 
Kern217).  These nucleotide substititutions resulted in eight amino acid substititutions to 
the protein coding sequence. In addition, a portion of the 3’NC region was sequenced for 
this strain, which identified five nucleotide base changes (see Table 4-13).  
FLS650  
FLS650 was confirmed SLEV positive by sequencing three regions of the virus 
(envelope, M/E and NS5). BLASTN search results were identical to those reported above 
for FLS569 (Appendix I).  In addition, multiple sequence alignment identified 13 (out of 
14) nucleotide substitutions in the envelope region and 18 of 20 mutations in the NS5
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Table 4-13 Nucleotide and Amino Acid Changes Identified in SLEV Strains Isolated from Sentinel Chickens in Florida 
Multiple sequence alignments of the envelope and NS5 regions identified unique nucleotide and amino acid changes in 
a comparison of recent SLEV isolates (FLS569 & FLS650) to reference strains (FL, California [Kern217], and South 
American (TR58, TR62, BR64, BR69). Mutations in the nucleotide coding sequence often resulted in amino acid 
substitutions (new amino acid located on right side of each arrow). Bolded residues are shared in the recent Florida 
isolates, but are unique from other strains of SLEV analyzed (except for two nucleotide mismatches that were also 
found in Kern217).  
 
Envelope Region NS5 Region 
SLEV  
Strain # 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
 
FLS569 
 
 
993, 999, 1026, 1098, 
1281┼, 1407, 1500, 
1665, 1797, 1932, 
2103, 2328, 2394, 2439 
333 (T → I) 
335 (S→L) 
344 (L → S) 
364 (W → *) 
429 (V → A) 
471 (T → I) 
472 (P → L) 
502 (T→I) 
9092, 9326, 9458, 9470, 
9496, 9522, 9527, 9530, 
9545, 9564, 9614, 9707, 
9722, 9749, 9851, 9899, 
9983, 9992, 10019 
3034 (E→G),  3112 (K→R) 
3156 (S→F),   3160 (T→I) 
3168 (S→L),  3176 (P→ F)  
3179 (P→ L), 3180 (F→C) 
3186 (A→V), 3208 (R→Q)  
3239 (L→S),  3244 (T→I) 
 
FLS650 993, 999, 1026, 1098, 
1281┼, 1410┼, 1500, 
1665, 1797, 1932, 
2103, 2328, 2394, 2439 
333 (T → I) 
335 (S→L) 
344 (L → S) 
429 (V → A) 
472 (P → L) 
502 (T→I) 
9092, 9182, 9326, 9458, 
9496, 9522, 9527, 9530, 
9545, 9564, 9614, 9707, 
9722, 9749, 9851, 9899, 
9983, 9992, 10019, 10061 
3034 (E→G),  3064 (T→I) 
3112 (K→R),  3156 (S→F) 
3168 (S→L),  3176 (P→ F)  
3179 (P→ L), 3180 (F→C) 
3186 (A→V), 3208 (R→Q)  
3239 (L→S),  3244 (T→I) 
┼Matched Kern217 (California).   
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Table 4-13 Nucleotide and Amino Acid Changes Identified in SLEV Strains Isolated from Sentinel Chickens in Florida, 
Continued 
Multiple sequence alignments of the membrane/envelope (SLEC Region) and 3’non-coding regions identified unique 
nucleotide changes in a comparison of recent SLEV isolates (FLS569 & FLS650) to reference strains (FL, California 
[Kern217], and South America). Mutations in the nucleotide coding sequence (consensus amino acid on left side of 
arrow) often resulted in amino acid substitutions (new amino acid located on right side of each arrow), early 
termination (* on right side of arrow) &/or continuation of translation instead of termination (* on left side of arrow). 
Bolded residues are shared in these recent Florida isolates, but are unique from other strains of SLEV analyzed (except 
for two nucleotide mismatches that were also found in Kern217). 
 
SLEC Region 3’NC Region 
SLEV  
Strain # 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Pos.#/AA) 
 
FLS569 
 
 
735┼, 744, 807, 
834, 846, 876,  
993, 999, 1026 
247 (D→G)  
250 (S →F)┼ 
280 (S →L) 
284 (F→S) 
294 (R→H) 
333 (T→I) 
335 (S →L) 
344 (L→S) 
10209, 
10227, 10397, 
10620, 10712 
Untranslated 
region 
 
FLS650 
807, 834, 846, 876, 
993, 999, 1026 
280 (S →L) 
284 (F→S) 
294 (R→H) 
333 (T→I) 
335 (S →L) 
344 (L→S) 
NT NT 
   ┼Matched Kern217 (California).  
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region (with predicted amino acid changes) that were identical to those detected in 
FLS569. However, seven nucleotide changes were noted in the SLEC region, with six 
substitutions to the translated sequence. The 3’NC region was not sequenced for this 
strain [Table 4-13].  
West Nile Virus Strains (2001-2006) 
FLWN01a  
In 2001, FLWN01a was isolated from a wild bird (Corvidae, Corvus spp., crow) 
following natural exposure and death during the first year that WNV was introduced to 
Florida. The bird was collected in the northern region of the state (Madison County). 
BLASTN search results on the capsid/prM sequence indicated that FLWN01a shares 
99% sequence identity with West Nile virus strains isolated in Texas (TVP 8533) in 
2002, Oklahoma and Florida in 2003, and New York in 2000. The NS5 region had 98% 
sequence homology to New York strains of the virus (385-99, 3356K VP2) [Appendix J].  
Multiple sequence alignment identified four base changes in the capsid/prM 
nucleotide sequence that were different from Florida strains isolated from sentinel 
chickens during 2005-2006. Four of the changes were shared by strains isolated in 2001, 
2002, and 2005 (positions 300, 348, 459 and 483). The cytosine at position 483 is 
conserved in the NY99 strain of the virus (Beasley et al, 2004). These were silent 
mutations, in that the translated protein coding sequence was not altered for FLWN01a. 
In contrast, multiple sequence alignment on the NS5 gene revealed two nucleotide base 
changes, including one amino acid substitution (tryptophan to glycine at position 3054) 
[Table 4-14]. 
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FLWN01b  
West Nile virus strain FLWN01b was also isolated from a wild bird (Corvidae, 
Cyanocitta cristata, blue jay) following natural exposure to the virus and subsequent 
death in Suwanee County.  BLASTN search results on the capsid/prM sequence indicated 
that FLWN01b shares 99% sequence identity with West Nile virus strains from the 
United States, including strains isolated in Iowa (crow envelope protein) in 2003, New 
York (3356K VP2) in 2000, as well as Arizona from 2004-2005 (BSL-2004-2005, human 
blood donor samples). In contrast, the NS5 region has 96% sequence homology to WNV 
strains isolated in Florida (FL232, 03-113FL), as well as to NY99 (385-99) [Appendix J]. 
FLWN01b had the highest number of nucleotide mutations and amino acid 
substitutions out of the six Florida strains studied (in the NS5 region). Multiple sequence 
alignment with reference strains indicated three nucleotide base changes in the 
capsid/prM region, a transition mutation (T → C) at position 428. This resulted in the 
substitution of threonine for isoleucine at position 144 of the predicted translated protein 
(Table 4-14).  
Unlike the capsid region, the NS5 region had 12 unique nucleotide changes, 
including one inserted base. Eight of these were transversion mutations (purine to 
pyrimidine, for example, A↔T), with only four transition mutations (T↔C and A↔G). 
These nucleotide base changes resulted in eight amino acid substitutions, including the 
insertion of tyrosine between positions 3231 and 3232 (Table 4-14).   
FLWN02 (a & b) 
In 2002, FLWN02 (a & b) were isolated from mosquito pools (Ochlerotatus 
taeniorhynchus) collected in St. John’s county in the northern region of the state.  
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Table 4-14 Nucleotide and Amino Acid Changes Identified in WNV Strains from Florida (2001-2005) 
Multiple sequence alignments of the capsid/prM (WNAE) and NS5 (Ful/cfd3) regions identified unique nucleotide and 
amino acid changes in reference strains of WNV collected in different years in Florida (except where noted).  
Capsid/prM Region NS5 Region 
WNV  
Strain # 
Nucleotide 
(Position #) 
Amino Acid 
(Position#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Position#/AA) 
 
FLWN01a 
 
 300, 348, 459 
483 (C)‡ 
No unique translated 
differences 9103, 9152 
3054 (W→G)   
 
 
FLWN01b 
 
428, 459 
483 (C)‡ 144 (I →T) 
9163, 9164, 9166, 9180, 
9182, 9276, 9297, 9336, 
9706, 9744┼, 9828┼ 
T i (9685-9686)  
3058  (M→L),  3063  (L→*) 
3064  (E→*),   3095  (S→F) 
3102  (A→G),  3115  (K→R) 
Yi (3231-3232), 3238 (D→H) 
 
FLWN02a 
 
300, 348, 459 
483 (C)‡ 
No unique translated 
differences 
No unique nucleotide 
differences 
No unique translated 
differences 
FLWN02b 483 (T) No unique translated differences 9744
┼, 9828┼ No unique translated differences 
FLWN05a 300, 348, 459 483 (C)‡ 
No unique translated 
differences 
9264, 9352┼, 9366, 9420, 
9456, 9468, 9660 
3091 (L→P),  3125 (N→S), 
3155 (S→L),  3159 (S→F), 
3223 (S→L) 
FLWN05b 459 483 (C)‡ 
No unique translated 
differences 9136, 9352
┼, 9704 3048 (S→F) 3238 (P→L) 
‡Conserved position reported in NY99 strain of WNV (Beasley et al, 2004). ┼Position where nucleotide matches WN 
Egypt101, not NY99.  *Termination (stop codon).  iInserted nucleotide base/amino acid at the position number. Bolded 
residues are shared in WN isolates, but are unique from other strains of WNV analyzed. 
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BLASTN search results on the capsid/prM sequence indicated that FLWN02a shares 
99% sequence identity with West Nile virus strains isolated in Texas (TVP 8533), Iowa, 
New York and Arizona. The NS5 region had 99% sequence homology to New York 
strains of the virus (385-99, 3356K VP2) [Appendix J].  
In contrast, FLWN02b closely matched a strain isolated from a human blood 
donor sample collected in Utah (2003) and from WNV isolated from viremic patients in 
Israel during an outbreak in 2000 (99% sequence identity in the capsid/prM region). 
BLASTN results on the NS5 region also matched Florida (FL232, 03-113FL) and New 
York (385-99, 3356K VP2) strains, with 99% homology (Appendix J).  
Multiple sequence alignment identified four silent mutations in the capsid/prM 
region at positions 300, 348, 459, and 483 in strain FLWN02a.  No base changes were 
identified in the NS5 region. In addition, one non-conserved transition mutation was 
identified at position 483 (C→T) in strain FLWN02b. However, no unique amino acid 
substitutions were found for FLWN02a or FLWN02b in the capsid region (Table 4-14).  
Two nucleotide substitutions were noted for FLWN02b in the NS5 region, where 
positions 9744 and 9828 matched FLWN01b and the Egypt101 strain of West Nile virus 
(unlike NY99). However, these nucleotide changes did not affect the amino acid coding 
sequence. 
FLWN05a  
In 2005, FLWN05a was isolated from an alligator following natural WNV 
exposure and death (juvenile, farmed alligator).  BLASTN search results on the 
capsid/prM sequence indicated that FLWN05a shares 99% sequence identity with West 
Nile virus strains from the United States, including Texas (TVP 8533), New York, 
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Florida (FL03-FL2-3), and Arizona isolates. The NS5 region has 98% sequence 
homology to strains isolated from viremic blood donors in New Mexico and Colorado 
during 2004, as well as to WNV isolated from a grackle in Sonora, Mexico in 2005 
(TVP9115) [Appendix J].  
Multiple sequence alignment of the capsid/prM region identified the same four 
silent mutations at positions 300, 348, 459 and 483, as seen for FLWN01a and 
FLWN02a. However, several differences were noted in the NS5 region for FLWN05a, 
where seven unique transition mutations (T↔C and A↔G) resulted in five changes to the 
translated amino acid coding sequence (Table 4-14).  
FLWN05b 
West Nile virus strain FLWN05b was isolated from a wild bird (Corvidae, Corvus 
sp., crow) following natural exposure to the virus and subsequent death in Dixie County, 
Florida (northern region of the state).  BLASTN search results on the capsid/prM 
sequence indicated that FLWN05b shares 99-100% sequence identity with West Nile 
virus strains isolated in Iowa, New York and Arizona, as described above for FLWN01b. 
However, the NS5 region had 98% homology to strains isolated from viremic blood 
donors in North Dakota, Colorado and Texas from 2003-2004, as well as one isolate from 
a cardinal in Louisiana (TWN496) [Appendix J].  
Alignment of the capsid/prM sequences from WNV isolates collected in Florida 
found two differences, at positions 459 and 483, in the nucleotide sequence (as shown 
above for the other Florida strains of WNV), which were silent mutations. However, 
three nucleotide and and two amino acid substitutions were found in the NS5 region for 
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FLWN05b, including a serine to phenylalanine substitution at position 3048 and proline 
to leucine change at position 3238 (Table 4-14). 
FLM38 
In 2005, FLM38 was cultured from a cloacal swab of an adult sentinel chicken 
following natural exposure to WNV in Manatee County, Florida (southern Gulf Coast 
region). BLASTN search results of GenBank found that FLM38 closely matched a strain 
isolated from a human blood donor sample collected in Utah (2003) and WNV isolated 
from viremic patients in Israel during an outbreak in 2000 (99% sequence identity in the 
capsid/prM region). However, this region is conserved and FLM38 was also homologous 
to an Iowa WNV strain (2003) and New York isolate in 2000.  98% sequence identity in 
the NS5 region was found to viremic blood donors, from Florida (in 2003), North Dakota 
(2004), Colorado (2004), and Texas (2003) [Appendix J].  
Results of the multiple sequence alignments for this strain also found a single 
unique nucleotide transition mutation (C →T) in the capsid region, but did not result in a 
change to the amino acid coding sequence. Three base changes were noted in the NS5 
region, but they were silent mutations (Table 4-15).   
FLS502 
In 2006, FLS502 was cultured from a cloacal swab of an adult sentinel chicken 
following natural exposure to WNV (and SLEV) in Sarasota County, Florida (southern 
Gulf Coast region).  BLASTN search of GenBank returned identical results to those 
found for FLM38 above (Utah, Israel, Iowa and New York for capsid/prM region; WNV 
strains detected in blood donors from several states for the NS5 region) [Appendix J]. 
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Table 4-15 Nucleotide and Amino Acid Changes Identified in WNV Strains Isolated from Sentinel Chickens in Florida 
Analysis of multiple sequence alignments of the capsid/prM (WNAE) and NS5 (Ful/cfd3, WNBE) regions identified 
limited unique nucleotide changes in 2005-2006 WNV isolates (FLM38, FLS502, FLS504, FLS545). Reference strains 
included isolates collected in Florida since 2001, as well as WN NY99 and WN Egypt101. Each nucleotide and amino 
acid change was unique from other strains of WNV analyzed (except for 1 nucleotide mismatch also found in WN 
Egypt101). 
 
Capsid/prM Region NS5 Region NS5 (3’) [WNBE] Region 
WNV 
Strain # 
Nucleotide 
(Position #) 
Amino Acid 
(Position#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Position#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Position#/AA) 
 
FLM38 
 
483 (T) 
No unique 
translated 
differences 
9352┼, 9912, 
9966 
No unique 
translated 
differences 
Sequencing 
failed 
Sequencing 
failed 
 
FLS502 483 (T) 
No unique 
translated 
differences 
9352┼, 9912, 
9966 
No unique 
translated 
differences 
Sequencing 
failed 
Sequencing 
failed 
 
FLS504 
 
483 (T) 
No unique 
translated 
differences 
9352┼, 9912, 
9966 
No unique 
translated 
differences 
No unique 
nucleotide 
differences 
No unique 
translated 
differences 
FLS545 
237,  
483 (T), 
591┼ 
81 (L → V) 9352┼, 9912 3248i (R) Sequencing failed 
Sequencing 
failed 
┼Position where nucleotide matches WN Egypt101.  iInserted nucleotide base/amino acid at the position number. Bolded 
residues are shared in strains isolated in Florida from sentinel chickens (2005-2006). 
 274
Results of the multiple sequence alignments for this strain also found a single unique 
nucleotide transition mutation (C →T) in the capsid region, but did not result in a change 
to the amino acid coding sequence. Three base changes were noted in the NS5 region, but 
they were silent mutations (Table 4-15).   
FLS504 
FLS504 was also cultured from a cloacal swab of another sentinel chicken located 
at the same site as FLS502 above, following natural exposure to WNV in Sarasota 
County, Florida.  BLASTN search of GenBank returned identical results to those found 
for FLM38 and FLS502 above (Utah, Israel, Iowa and New York for capsid/prM region; 
WNV strains detected in blood donors from several states for the NS5 region) [Appendix 
J].   
Results of the multiple sequence alignments for this strain also found a single 
unique nucleotide transition mutation (C →T) in the capsid region, but did not result in a 
change to the amino acid coding sequence. Three base changes were noted in the NS5 
region, but they were silent mutations. The WNBE primer set was used to target an 
internal segment of the NS5 region to corroborate sequence homology for this WNV 
isolate. No differences were found. Sequencing reactions for FLM38, FLS502 and 
FLS545 failed with this primer set, when assayed by both the BOL-Tampa and molecular 
biology core at the H. Lee Moffitt Cancer Center. A single contig (consensus) sequence 
could not be produced due to poor quality sequence data of different sizes for the forward 
and reverse primers, due to long runs of repeated bases in the sequence (Table 4-15).  
BLASTN search results on the 3’NS5 region (WNBE) returned 100% sequence 
identity to Oklahoma (OKO3), New York (385-99, 3356K VP2), and Florida (FL03-FL2-
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3) strains of WNV.  A North Dakota strain cultured from blood donors also matched at 
100% (consistent with results found for the larger NS5 region) [Appendix J]. 
FLS545 
In 2006, FLS545 was cultured from a cloacal swab collected from a sentinel 
chicken in Sarasota County seven days following the first isolation of West Nile virus 
(FLS502) from that chicken. SLEV (FLS569) was then isolated from another swab 
collected from this bird 2 days later.  
BLASTN search results on the WNV capsid/prM region identified 99% identity 
to strains previously described for FLM38, FLS502 and FLS504 (WNV strains from 
Utah, Israel, Iowa and New York).  98% homology was also found for the NS5 region, 
which matched WNV strains cultured from blood donors in several states [Appendix J]. 
Unlike previous WNV strains (FLM38, FLS502, FLS504) collected from sentinel 
chickens, two nucleotide and one amino acid substitution was identified in the genome of 
FLS545. Multiple sequence alignment results for this strain identified one unique 
nucleotide difference in the capsid/prM region at position 237.  This transversion 
mutation (thymine to guanine) resulted in the substitution of valine (instead of lysine) at 
position 81 in the translated protein sequence. An additional nucleotide base change was 
found at position 591, but was shared with WN Egypt101, FLS649 and FLS694 (see next 
section). This base difference was not seen for WN NY99 or other WNV strains analyzed 
from Florida (Table 4-15, Appendix L).   
One inserted amino acid (arginine) was noted at position 3248 predicted in the 
portion of the NS5 region analyzed for FLS545 (Table 4-15, Appendix P). 
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Novel Flavivirus Strains  
SLEV Membrane/Envelope Region  
FLS649 
FLS649 was also isolated from Site 001 in Sarasota County, Florida in 2006. This 
strain was detected on a cloacal swab collected the same day as FLS650 (SLEV), but 
from another sentinel chicken located at the same site (Bird 9-004-G). This bird failed to 
seroconvert in the HAI assay following RT-PCR detection (TaqMan) of presumptive 
SLEV viral RNA on a cloacal swab.  Several primer sets were used to confirm the 
TaqMan results. Since FLS649 did not replicate in Vero cells, it was first confirmed 
SLEV positive by sequencing the membrane/envelope region of the virus (non-specific 
banding pattern observed on gel-electrophoresis) [Figure 4-33]. RT-PCR was repeated in 
a second assay and the PCR products sequenced by the BOL-Tampa and by the 
molecular biology core facility at the H. Lee Moffitt Cancer Center.  
BLASTN search results on the membrane/envelope sequence identified 97% 
sequence homology with strains from Tampa Bay (TBH-28 and GHA-3), as well as a 
Mexico strain (65 V 310).  St. Louis encephalitis virus strains from Missouri (Parton) and  
Tennessee (TNM 4-711) were also matched to the FLS649 query sequence at 96% 
identity (Appendix K). 
Unlike SLEV reference strains, the FLS649 strain was not detected by several 
RT-PCR assays used for this project. The complete envelope primers did not amplify the 
viral RNA of FLS649 [Figure 4-34], nor did primer sets used to target the NS5 and 3’NC 
regions [Figure 4-35].  
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Figure 4-33 Gel Electrophoresis of Sentinel Chicken Arbovirus Isolates:  
FLS569, S649, S650, S694 (M/E Region).  
RT-PCR was performed with SLE727/SLE1119c primers (SLEC) to 
amplify the partial M/E region of SLEV. PCR products were run in 
duplicate on 1.0% agarose gels. This region was amplified by all four 
isolates, with different banding patterns. The top band was excised for 
sequence analysis, with the exception of FLS649 (2nd band from top was 
used). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lane 1:   Marker (1 kb ladder) 
Lane 2:   NTC 
Lane 3:   SLE+ (TBH-28) 
Lanes 4, 6, 9, 12:  Blank 
Lane 5:  FLS569 
Lanes 7, 8:  FLS649 
Lanes 10, 11:  FLS650 
Lanes 13, 14:  FLS694 
 
 
 
 
 
 
 
 1   2   3   4   5   6   7   8   9  10 11 12 13 14 
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Figure 4-34 Gel Electrophoresis of Sentinel Chicken Arbovirus Isolates: FLS569, 
S649, S650, S694 (SLE Complete Envelope Region).  
RT-PCR was performed with F880/B2586 primers to amplify the 
complete envelope region of SLEV. This region was successfully 
amplified in two of these viruses, FLS569 (Lane 5) and FLS650 (Lanes 10 
and 11).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Lane 1:   Marker (10 kb ladder) 
Lane 2:   NTC   
Lane 3:   SLE+ (TBH-28) 
Lanes 4, 6, 9, 12:  Blank 
Lane 5:   FLS569  
Lanes 7, 8:   FLS649 
 Lanes 10, 11:   FLS650 
Lanes 13, 14:   FLS694 
 
 
 
 
 
 
 
 
 1   2   3   4   5   6   7   8   9  10 11 12 13 14 
 279
Figure 4-35 Gel Electrophoresis of Sentinel Chicken Arbovirus Isolates,  
FLS569, S649, S650, S694 (Partial NS5 Region, and 3’NC) 
A) RT-PCR was performed with FU1/cFD3 primers to amplify the partial 
NS5 region. PCR products were run in duplicate on 1.0% agarose gels. 
The NS5 region was successfully amplified in two viruses, FLS569 
and FLS650. FLS649 and FLS694 failed to amplify. 
B) The 3’NC region was amplified by RT-PCR with YF1/YF2 primers. 
This region was successfully amplified by one virus, FLS569. 
  
A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Lane 1: Marker (1 kb ladder). Lane 2: NTC. Lane 3: SLE+ (TBH-28). 
  Lanes 4, 6, 9, 12: Blank. Lane 5: FLS569. Lanes 7, 8: FLS649 
  Lanes 10, 11: FLS650. Lanes 13, 14: FLS694. 
 
B)  
 
 
 
 
 
 
 
 
 
 
 
 
 
  Lane 1: Marker (1 kb ladder). Lane 2: SLE+ (TBH-28). Lane 3: WN+  
  (NY99). Lanes 4, 5, 6, 7, 8, 9: Clones. Lane 10: FLS569. Lane 11:  
  FLS649. Lane 12: FLS650. Lane 13: FLS694. Lane 14: NTC. 
 
 1   2   3   4   5   6   7   8   9  10 11 12 13 14 
 1   2   3   4   5   6   7   8   9  10 11 12 13 14 
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However, multiple sequence alignment was performed on the sequenced PCR 
products that targeted the M/E region. Analysis of the alignment identified six nucleotide 
mutations (positions 757, 760, 762, 772, 788, 1050) that were either transition or 
transversion substitutions.  These nucleotide base differences altered the translated amino 
acid sequence at six positions (252, 253, 254, 257, 263, and 351) [Table 4-16]. 
FLS694  
In RT-PCR analysis, FLS694 was most similar to FLS649. Both were isolated 
from Site 001 in Sarasota County, but were collected seven days apart and from two 
different birds. Bird 9-000-W also failed to seroconvert in the HAI assay post-detection 
of viral RNA from a cloacal swab.  Consequently, FLS694 was detected and confirmed 
SLEV positive by sequencing the membrane/envelope region of the virus. RT-PCR 
assays and sequencing of the PCR products were performed as described for FLS649.  
Clear differences were noted in the gel electorphoresis banding pattern, such that multiple 
bands were identified for FLS649 versus double bands observed for FLS694.  FLS650 
resulted in a single band with the SLEC membrane/envelope primer set (Figure 4-33).  
BLASTN search results on the membrane/envelope region were identical to 
FLS649, where the query sequence of FLS694 had 97% homology with strains from 
Tampa Bay (TBH-28 and GHA-3), as well as a Mexico strain (65 V 310).  St. Louis 
encephalitis virus strains from Missouri (Parton) and Tennessee (TNM 4-711) were also 
matched to the FLS694 query sequence at 96% identity (Appendix K).  The complete  
envelope primers did not detect the viral RNA of FLS694. In addition, this genome did 
not amplify with the NS5 primer set or the 3’NC primer set (Figures 4-34 and 4-35).  
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Table 4-16 Nucleotide and Amino Acid Changes Identified in Novel Flavivirus Strains Isolated in Florida 
Analysis of multiple sequence alignments of the capsid/prM (WNAE), membrane/envelope (SLEC) and NS5 (WNBE) 
regions identified unique nucleotide and amino acid changes in 2005-2006 flavivirus isolates (FLS649, FLS694) as 
compared to reference flavivirus strains. Each nucleotide and amino acid change was unique from other strains of 
SLEV or WNV analyzed (except where noted for WN Egypt101, FLS545). Sequencing reactions failed for WNBE 
PCR products of the appropriate size for FLS649, due to long runs of repeated bases in the sequence. 
 
M/E [SLEC] Region Capsid/prM [WNAE] Region NS5 (3’) [WNBE] Region 
Strain # 
Nucleotide 
(Position #) 
Amino Acid 
(Position#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Position#/AA) 
Nucleotide 
(Position #) 
Amino Acid 
(Position#/AA) 
FLS649 757, 760, 762, 772, 788, 1050 
255 (M →I) , 256 (E→G) 
259 (H→Q),  265 (R →S) 
352 (A→G) 
{445, 483, 
504, 513, 528, 
561, 585, 591, 
600, 615}┼ 
137 (K → ?) 
149 (G → ?) 
188 (N → ?) 
198 (G → ?) 
Sequencing 
Failed 
Sequencing 
Failed 
FLS694 834 
 
280 (S →L) 
 
{445, 483, 
504, 513, 528, 
561, 585, 591, 
600, 615}┼, 
619 
104 (G → ?) 
208 (E → K) 
No unique 
nucleotide 
differences 
No unique 
translated 
differences 
┼Positions where nucleotides match WN Egypt101. Bolded residues are shared between the two novel flavivirus strains and 
WN Egypt101, but not by other strains (except position 591 by FLS545). ? = Missing residue.
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A multiple sequence alignment was performed on the sequenced PCR products 
that targeted the M/E region. Analysis of the alignment identified one nucleotide 
mutation (position 834).  This base change was a transition substitution between two 
pyrimidines (cytosine → thymine). Translation of the protein polypeptide was terminated 
(*) at position 279 of the amino acid sequence, instead of addition of arginine (R) at that 
site [Table 4-16, Appendix O]. 
FLS281  
FLS281 was isolated from Bird 7-005-B located at Site 005 in Sarasota County in 
August 2006. Despite replication of virus in cell culture, this bird failed to develop 
detectable flavivirus antibodies in the HAI assay post-isolation of the virus from a cloacal 
swab. In addition, this isolate was not detected by the TaqMan primer-probe sets (Table 
4-9). As a result, this isolate was unidentified in 2006.  
In 2008, further investigation of FLS281 identified the strain as Newcastle virus 
(contagious zoonotic disease transmitted by contaminated bodily secretions, including 
respiratory and fecal, in susceptible bird populations). However, this Newcastle virus 
strain generated a RT-PCR product of the appropriate size (~400bp) with the SLEC 
primer set (data not shown). Initial interpretation of this result identified the virus as 
SLEV, but was disproved by sequence analysis of the RT-PCR product.  BLASTN search 
results on the SLEC “membrane/envelope region” confirmed that FLS281 had 94% 
homology with a dove strain (Italy/2736/00, AY562989.1) of Newcastle virus disease. 
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WNV Capsid/prM Region (WNAE) 
FLS649 
FLS649 was also tested with WNV specific primers to the conserved capsid/prM 
region [Figure 4-36, left side of gel]. These PCR products were excised from the gel, 
cleaned and sequenced by the BOL-Tampa. The assay was repeated and PCR products 
were sequenced by the molecular biology core facility at the H. Lee Moffitt Cancer 
Center. 
BLASTN search results indicated that FLS649 shares 100% sequence identity 
with West Nile virus strains isolated in the Old World from Portugal (PTRoxo), Egypt 
(Eg101) and India (WNI68856B). 99% homology was identified for a strain isolated in  
Romania (96-1030) in the capsid/prM region. Repeated sequencing of this region 
returned the same results. 
A second WNV specific RT-PCR was performed that targeted the 3’ NS5 region 
of the virus (WNBE primer set) [Figure 4-36, right side of gel]. Despite PCR products of 
the appropriate size (300bp), sequencing failed to generate a quality consensus sequence 
for FLS649, due to long runs of repeated bases in the sequence.  The primer set 
(Fu1/cfd3) that targeted a larger region of the NS5 gene did not amplify the viral RNA 
for FLS649. 
Multiple sequence alignment identified nine base changes in the capsid/prM 
nucleotide sequence that were unique compared to other Florida isolates of the virus.   
However, this pattern is identical to Old World strains of WNV at those positions (446, 
505, 514, 529, 562, 586, 592, 601, 616).  These were silent mutations, in that the 
predicted translated protein sequence was not altered (Table 4-16, Appendix L).   
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Figure 4-36 Gel Electrophoresis of Sentinel Chicken Arbovirus Isolates,  
FLS569, S649, S650, S694 (WNAE, WNBE Primers).  
The WNAE capsid/prM region was amplified by RT-PCR with 
WN233/WN640c primers. This region was successfully amplified by 
FLS569, FLS649, and FLS694.  FLS650 did not produce the correct size 
amplicon (400bp) [Lane 5]. The WNBE 3’ NS5 region was amplified with 
WN9483/9794 primers. As for WNAE, this region also failed to amplify 
the correct 300bp product for FLS650 [Lane 12]. FLS569, FLS649 and 
FLS694 were detected with both primer sets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lane 1:   Marker (1 kb ladder) 
Lane 2:   WNAE + (NY99)   
Lane 3:   FLS569 
Lane 4:  FLS649 
Lane 5:   FLS650 
Lane 6:   FLS694 
 Lane 7:   SLE + (TBH-28) 
Lane 8:   NTC 
Lane 9:  WNBE + (NY99) 
Lane 10:   FLS569 
Lane 11:   FLS649 
Lane 12:  FLS650 
Lane 13:  FLS694 
Lane 14:  NTC 
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FLS694 
FLS694 was also tested with WNV specific primers to the conserved capsid/prM 
region [Figure 4-36, left side of gel]. These PCR products were excised from the gel, 
cleaned and sequenced by the BOL-Tampa. The assay was repeated and PCR products 
were sequenced by the molecular biology core facility at the H. Lee Moffitt Cancer 
Center. 
BLASTN search results indicated that FLS694 also shares 100% sequence 
identity with West Nile virus strains isolated in the Old World from Portugal (PTRoxo), 
Egypt (Eg101) and India (WNI68856B). 99% homology was identified for a strain 
isolated in Romania (96-1030) in the capsid/prM region. Repeated sequencing of this 
region returned the same results. 
Multiple sequence alignment identified nine base changes in the capsid/prM 
nucleotide sequence that were unique compared to other Florida isolates of the virus.   
However, this pattern is identical to Old World strains of WNV at those positions (446, 
505, 514, 529, 562, 586, 592, 601, 616).  These were silent mutations, in that the 
translated protein sequence was not altered (Table 4-16, Appendix L).   
NS5 Region (3’) [WNBE] 
FLS694 
A second WNV specific RT-PCR was performed that amplified the 3’ NS5 region 
of the virus (WNBE primer set) for FLS694 [Figure 4-36, right side of gel]. PCR 
products were excised for the gel, cleaned and sequenced. This region was successfully 
sequenced for FLS694, but failed for FLS281, FLS649, FLCxs231, and FLCxn280 (data 
not shown). BLASTN search results were similar to those obtained for FLS504 in this 
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region, which returned 100% sequence identity to Oklahoma (OKO3), New York (385-
99, 3356K VP2), and Florida (FL03-FL2-3) strains of WNV.  100% sequence identity 
was also found for a California WNV strain cultured from a blood donor [Appendix K]. 
Several sequences were downloaded from GenBank to include additional West 
Nile virus (Texas, Mexico, Hungary, and Florida) sequence information in this region for 
multiple sequence alignment with FLS694 and FLS504.  However, no nucleotide or 
amino acid differences were found in this region (Table 4-16). 
 
Phylogenetic Analysis 
Contiguous DNA sequences were assembled (SeqMan II program v.5.08, 
DNAStar) for each PCR product to generate a consensus sequence from the sense 
(forward) and anti-sense (reverse) primers. In addition, large amplicons (greater than 
700bp) were assembled with overlapping fragments to generate a consensus sequence in 
both the forward and reverse directions. Overlapping fragments were necessary to 
generate a complete contig for the 1633 bases analyzed in the SLEV envelope region.  
Contigs were converted to GCG format (.msf files) using Megalign (v. 5.08, DNAStar) 
and exported for use in the multiple sequence alignment program MEGA 4.0.1.  Multiple 
sequence alignments were performed in MEGA4.0.1 using the ClustalW 1.6 method. 
Additional complete flavivirus sequences were downloaded from GenBank for use as 
outgroups. Phylogenetic trees were computed in MEGA4.0.1 to infer the evolutionary 
relationships of SLEV and WNV strains. Neighbor-joining, maximum parsimony, and 
unweighted paired group means arithmetic (UPGMA) methods were used to construct 
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phylogenetic trees, with 1000 bootstrap replicates each. The consensus tree generated for 
each method was chosen.  
The complete sequence of Kern217 was downloaded, aligned and trimmed to the 
appropriate length for each region analyzed to represent a well-characterized strain of 
SLEV in the alignment and subsequent phylogenetic trees. In addition, the complete 
sequences of West Nile virus NY99 and Egypt101 were also downloaded, aligned, 
trimmed, and included as outgroups in the multiple sequence alignment of these 
genomes. Additional outgroup sequences downloaded from GenBank were also aligned 
and trimmed for analysis of the flavivirus NS5 region, WNV capsid/prM and 3’NS5 
regions (Appendix R). 
Envelope Region 
The complete envelope gene extends from base 963 to 2465 on the SLEV genome 
(Kramer and Chandler, 2001). Reference St. Louis encephalitis virus strains and recent 
isolates (listed in Tables 3-2 and 4-4, respectively) were sequenced in this region from 
bases 915 through 2548 (overlaps into the membrane and NS1 gene were included). One 
unique nucleotide difference was found in the overlap region of the membrane gene for 
FL72 (position 954) and FL85a (position 948). A single base change was identified in the 
83 bases of the NS1 overlap for FL72 (position 2490) only.  
The consensus tree for the neighbor-joining method [Figure 4-37] indicates that 
reference strains fall into two separate clades, grouped predominately according to 
geographic origin (North American and South American). Branch bootstrap values were 
below 95% (except for the outgroups), which may infer inaccurate branch topology. The 
maximum parsimony method resulted in a consensus tree with higher bootstrap values, 
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indicating improved topology of the interior branches drawn [Figure 4-38]. The UPGMA 
method produced similar results to the maximum parsimony tree for this region of the 
virus (tree not shown). All three trees separated the reference SLEV strains based on 
geographic origin. 
However, three exceptions to grouping by geographic origin were noted for 
Florida strains (FL72, FLS569 and FLS650). SLEV strain FL72 was collected in the 
Florida panhandle, but grouped with Brazilian and Trinidad reference strains. In addition, 
both neighbor-joining and maximum parsimony algorithms estimated that the SLEV 
strains FLS569 and FLS650 (isolated in the southern region of the state) diverged from 
Brazilian and Trinidad strains (and FL72) to form a separate cluster in the South 
American clade. 
FL89 and FL90a-d strains formed a separate cluster in the North American 
(Florida) clade of SLEV.  These “epidemic” strains were collected during the last large 
outbreak of SLEV in Florida and diverged from Florida strains isolated in 1952, 1962, 
and 1985, as detected in the entire envelope gene (Figures 4-37 and 4-38).  
SLEV Membrane/Envelope Region  
A subset of reference strains was sequenced for comparison to recent circulating 
SLEV strains in the partial membrane/envelope region of the virus from base 728-1112 
(genome position based on complete Kern217 strain, Accession # NC_007580).  
Phylograms on the partial membrane/envelope region included the novel flavivirus strains 
collected from sentinel chickens in Sarasota County (FLS649 and FLS694).   
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Figure 4-37 Phylogenetic Relationships of SLEV Strains (Envelope Region), 
Neighbor-Joining Method 
Phylogram of the complete envelope region was inferred using the 
neighbor-joining method in MEGA4.0.1, where bootstrap analysis was 
performed (1000 replicates). The consensus tree was chosen. Branch 
lengths represent the amount of genetic divergence, with the scale bar 
corresponding to number of base changes per site (maximum composite 
likelihood method).  Bootstrap values are shown on branches. Outgroup 
and Kern217 sequences were downloaded from GenBank (Appendix R). 
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Figure 4-38 Phylogenetic Relationships of SLEV Strains (Envelope Region), 
Maximum Parsimony Method 
Phylogram of the complete envelope region was inferred using the 
maximum parsimony method in MEGA4.0.1, where the consensus tree 
(1000 bootstrap replicates) was chosen. Branch lengths represent the 
amount of genetic divergence, with the scale bar corresponding to number 
of base changes in the entire sequence. Bootstrap values are shown on 
branches. Outgroup and Kern217 sequences were downloaded from 
GenBank (Appendix R). 
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The consensus tree for the neighbor-joining method [Figure 4-39] indicates that SLEV 
reference strains fall into two separate clades, as seen for the complete envelope 
sequence, and grouped predominately according to geographic origin. Unlike FLS569 
and FLS650 that have been characterized as South American (Brazil) in origin, FLS649 
and FLS694 cluster with North American strains of SLEV despite isolation in the same 
time period and location.  However, branch bootstrap values were below 95% (except for 
the outgroups) for both the neighbor-joining and maximum parsimony (Figure 4-40) 
phylogenetic trees, which do not assume a constant rate of evolution.  
In contrast, the UPGMA method produced a consensus tree with high bootstrap 
support values for branch topology (Figure 4-41). This method produced a rooted tree 
and assumed a constant rate of evolution. Minimal sequence divergence was identified in 
Florida strains of SLEV, as depicted by the short branch lengths. 
WNV Capsid/prM Region  
The complete capsid/prM gene extends from base 97 to 2465 on the WNV 
genome (Lanciotti et al, 1999). A fragment of this region was sequenced extending from 
base 232 to 641. Multiple sequence alignment detected one synonymous mutation in two 
strains analyzed in this region, including FLWN01b at base position 429 and FLS545 at 
base position 238.  This highly conserved region of the virus is reflected in the short 
branch lengths drawn for these phylogenetic trees. The limited number of WNV strains 
analyzed in this study formed a monophyletic tree using neighbor-joining, maximum 
parsimony and UPGMA methods, with 1000 bootstrap replicates. However, branch 
bootstrap values were below 95% (except for the outgroups) for the neighbor-joining tree 
(Figure 4-42).  The maximum parsimony and UPGMA phylograms had more robust  
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Figure 4-39 Phylogenetic Relationships of SLEV and Flavivirus Strains (Partial 
Membrane/Envelope Region), Neighbor-Joining Method 
Phylogram of the partial membrane/envelope region (bases 728-112) was 
inferred using the neighbor-joining method in MEGA4.0.1, where the 
consensus tree (1000 bootstrap replicates) was chosen. Branch lengths 
represent the amount of genetic divergence, with the scale bar 
corresponding to number of base changes per site (maximum composite 
likelihood method). Bootstrap values are shown on branches. Outgroup 
and Kern217 sequences were downloaded from GenBank (Appendix R). 
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Figure 4-40 Phylogenetic Relationships of SLEV and Flavivirus Strains (Partial 
Membrane/Envelope Region), Maximum Parsimony Method 
Phylogram of the partial membrane/envelope region (bases 728-112) was 
inferred using the maximum parsimony method in MEGA4.0.1, where the 
consensus tree (1000 bootstrap replicates) was chosen. Branch lengths 
represent the amount of genetic divergence, with the scale bar 
corresponding to number of base changes in the entire sequence. Bootstrap 
values are shown on branches. Outgroup and Kern217 sequences were 
downloaded from GenBank (Appendix R). 
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Figure 4-41 Phylogenetic Relationships of SLEV and Flavivirus Strains (Partial 
Membrane/Envelope Region), UPGMA Method 
Phylogram of the partial membrane/envelope region (bases 728-112) was 
inferred using the unweighted-paired group means arithmetic (UPGMA) 
method in MEGA4.0.1, where the consensus tree (1000 bootstrap 
replicates) was chosen. UPGMA method produced a rooted tree and 
assumed a constant rate of evolution. Branch lengths represent the amount 
of genetic divergence, with the scale bar corresponding to number of base 
changes per site (maximum composite likelihood method). Bootstrap 
values are shown on branches. Outgroup and Kern217 sequences were 
downloaded from GenBank (Appendix R). 
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Figure 4-42 Phylogenetic Relationships of WNV and Flavivirus Strains (Partial 
Capsid/prM Region), Neighbor-joining Method 
Phylogram of the partial capsid/prM region (bases 232-641) was inferred 
using the neighbor-joining method in MEGA4.0.1, where the consensus 
tree (1000 bootstrap replicates) was chosen. Branch lengths represent the 
amount of genetic divergence, with the scale bar corresponding to number 
of base changes per site (maximum composite likelihood method). 
Bootstrap values are shown on branches. Lineage I strains of West Nile 
virus formed a monophyletic group (expected). However, two strains 
isolated in Florida clustered with an Old World strain of the virus (WN 
Egypt101).  Outgroup sequences were downloaded from GenBank 
(Appendix R). 
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bootstrap values for the subtrees (Figure 4-43 and Figure 4-44, respectively). These trees 
indicate minimal sequence divergence of recently isolated strains of WNV as compared 
to WNV NY99 and WNV Egypt101 (both Lineage 1 strains) in the capsid/prM region. 
Unusually, two Florida isolates clustered with the Egypt strain of West Nile virus (Old 
World) instead of grouping with the other North American strains in this region.  
Flavivirus NS5 Region   
NS5 Primer Set (Fu1/cfd3)               
The complete NS5 gene extends from base 7637 to 10395 on the WNV genome 
(Lanciotti et al, 1999). A fragment of this region was sequenced extending from base 
9090 to 10091 (WNV) and from 9080 to 10077 (SLEV). Multiple sequence alignment  
detected several mutations in archived Florida strains of SLEV and WNV, including base 
and amino acid changes noted for the strains isolated in 2006 (one WNV, two SLEV 
strains).  Although this region encodes the RNA-dependent RNA polymerase, greater 
sequence diversity was detected in this non-structural protein than found in the capsid or 
membrane regions of the viruses analyzed in this study.  
Multiple sequence alignment was performed on WNV and SLEV strains 
simultaneously to generate a combined phylogenetic tree for these two arbovirus species. 
The novel flavivirus strains were not included in this analysis, as this region failed to 
amplify with the NS5-specific primer set in RT-PCR assays. The phylogenetic trees were 
calculated with neighbor-joining and maximum parsimony methods, with 1000 bootstrap 
replicates each. The consensus tree was chosen for each method. Branch bootstrap values 
for subtrees were more robust for the maximum parsimony (Figure 4-45) method than for 
the neighbor-joining tree (Figure 4-46). However, both trees branched into two separate  
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Figure 4-43 Phylogenetic Relationships of WNV and Flavivirus Strains (Partial 
Capsid/prM Region), Maximum Parsimony Method 
Phylogram of the partial capsid/prM region (bases 232-641) was inferred 
using the maximum parsimony method in MEGA4.0.1, where the 
consensus tree (1000 bootstrap replicates) was chosen. Branch lengths 
represent the amount of genetic divergence, with the scale bar 
corresponding to number of base changes in the entire sequence. Bootstrap 
values are shown on branches. Lineage I strains of West Nile virus formed 
a monophyletic group (expected). However, two strains isolated in Florida 
clustered with an old world strain of the virus (WN Egypt101).  Outgroup 
sequences were downloaded from GenBank (Appendix R). 
 
 
   
 FLWN02a
 FLWN05a
 FLWN01a
 FLWN01b
 FLWN05b
 WNNY99
 FLS502
 FLM38
 FLWN02b
 FLS504
 FLS545
 FLS649
 FLS694
 WNEgypt
 Kunjin
 MVE
 JE
 Kern217
92
84
51
59
97
100
58
10  
Old World 
WNV 
North 
American  
WNV 
Outgroups 
 298
Figure 4-44 Phylogenetic Relationships of WNV and Flavivirus Strains (Partial 
Capsid/prM Region), UPGMA Method 
Phylogram of the partial capsid/prM region (bases 232-641) was inferred 
using the unweighted-paired group means arithmetic (UPGMA) method in 
MEGA4.0.1, where the consensus tree (1000 bootstrap replicates) was 
chosen. UPGMA method produced a rooted tree and assumed a constant 
rate of evolution. Branch lengths represent the amount of genetic 
divergence, with the scale bar corresponding to number of base changes 
per site (maximum composite likelihood method). Bootstrap values are 
shown on branches. Lineage I strains of West Nile virus formed a 
monophyletic group (expected). However, two strains isolated in Florida 
clustered with an old world strain of the virus (WN Egypt101), with robust 
bootstrap values.  Outgroup sequences were downloaded from GenBank 
(Appendix R). 
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Figure 4-45 Phylogenetic Relationships of SLEV & WNV Strains (NS5 Region), 
Neighbor-Joining Method 
Phylogram of the partial NS5 region for SLEV and WNV isolates was 
inferred using the neighbor-joining method in MEGA4.0.1, where the 
consensus tree (1000 bootstrap replicates) was chosen. Branch lengths 
represent the amount of genetic divergence, with the scale bar 
corresponding to number of base changes per site. Bootstrap values are 
shown on branches. Outgroup and Kern217 sequences were downloaded 
from GenBank (Appendix R). 
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Figure 4-46 Phylogenetic Relationships of SLEV & WNV Strains (NS5 Region), 
Maximum Parsimony Method 
Phylogram of the partial NS5 region for SLEV and WNV isolates was 
inferred using the maximum parsimony method in MEGA4.0.1, where the 
consensus tree (1000 bootstrap replicates) was chosen. Branch lengths 
represent the amount of genetic divergence, with the scale bar 
corresponding to number of base changes in the entire sequence. Bootstrap 
values are shown on branches. Outgroup and Kern217 sequences were 
downloaded from GenBank (Appendix R). 
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groups, such that SLEV isolates clustered in the top region whereas WNV strains 
clustered in the lower half of the tree.  As shown for the complete envelope region of 
SLEV, Florida’s “epidemic” strains clustered into a separate group from reference SLEV 
isolates collected over five decades in Florida. In addition, recent SLEV strains collected 
from sentinel chickens also clustered with South American strains, as seen in the partial 
membrane/envelope (SLEC) and complete envelope regions of the genome. 
A small number of sequence mutations were identified in the NS5 (RNA-
dependent RNA polymerase domain) region of West Nile virus strains collected over a 
five year time span. Consequently, these strains clustered into a single group with little 
sequence variation and shorter branch lengths. 
WNBE Primer Set  
 
A second C-terminal fragment of the NS5 gene was analyzed for detection of 
WNV (and non-specifically amplified SLEV).  Recent West Nile virus and novel 
flavivirus strains isolated from sentinel chickens were assayed with the WNBE primer set 
for amplification of this region. However, this primer pair was not optimal for sequencing 
reactions and most of the strains sequenced with this primer set failed.  
A contig was successfully generated for FLS504 with the forward and reverse 
primers for this region of the virus. In addition, a contig for one of the novel flavivirus 
strains (FLS694) was also assembled for this shorter C-terminal fragment of the NS5 
gene (~300bp).  Interestingly, the larger NS5 gene fragment (~1.0 kb) was not 
successfully amplified by the Fu1/cfd3 primer set for the FLS694 strain. Additional West 
Nile virus complete genome sequences were downloaded from GenBank (Accession 
numbers provided in Appendix R) and imported into MEGA4.0.1.  A ClustalW 1.6 
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multiple sequence alignment was performed with the FLS504 and FLS694 sequences, as 
well as the downloaded WNV sequences, for trimming of complete sequences to the 
appropriate size (Appendix M).   
Phylogenetic trees were constructed using neighbor-joining and maximum 
parsimony methods. The neighbor-joining method produced a consensus tree with the 
North American, Mexican and European (Hungary 2003) strains diverging from the 
Egypt101 strain of WNV, with a poor bootstrap value (82) [Figure 4-47]. However, the 
maximum parsimony method generated a more robust phylogenetic tree, such that the 
bootstrap value for the branch diverging from Egypt101 was 99 [Figure 4-48]. 
Flavivirus 3’Non-coding Region 
The complete 3’Non-coding region of flaviviruses extends from genomic position 
10, 396 through 11,029 (as reported for WNV) [Lanciotti et al, 1999]. A 600bp fragment 
of this region was analyzed for a subset of St. Louis encephalitis virus strains, including 
one recent strain (FLS569) isolated from a sentinel chicken. Phylogenetic trees were 
constructed using neighbor-joining, maximum parsimony and UPGMA methods, with 
1000 bootstrap replicates each. The consensus tree was chosen for each method.  
Neither the neighbor-joining or maximum parsimony (Figure 4-49) methods 
produced phylogenetic trees with robust bootstrap values at the interior branches 
(neighbor-joining tree not shown). However, the UPGMA method produced improved 
bootstrap values for most branches (although still below 95) [Figure 4-50]. 
Topology of these trees was similar to topologies estimated for the complete envelope 
and NS5 regions, in that SLEV strains branch into North and South American groups. In  
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Figure 4-47 Phylogenetic Relationships of WNV and Flavivirus Strains (WNBE: 
Partial NS5 Region), Neighbor-joining Method 
Phylogram of the partial partial NS5 region was inferred using the 
neighbor-joining method in MEGA4.0.1, where the consensus tree (1000 
bootstrap replicates) was chosen. Branch lengths represent the amount of 
genetic divergence, with the scale bar corresponding to number of base 
changes per site (maximum composite likelihood method). The bootstrap 
value is shown on the branch. Four additional complete WNV sequences 
(WNFL03, WNHungary, WNTX02, WNMexico) were downloaded from 
GenBank (Appendix R) for comparison to FLS504 and FLS694. 
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Figure 4-48 Phylogenetic Relationships of WNV and Flavivirus Strains (WNBE: 
Partial NS5 Region), Maximum Parsimony Method 
Phylogram of the partial partial NS5 region was inferred using the 
maximum parsimony method in MEGA4.0.1, where the consensus tree 
(1000 bootstrap replicates) was chosen. Branch lengths represent the 
amount of genetic divergence, with the scale bar corresponding to number 
of base changes in the entire sequence. Four additional complete WNV 
sequences (WNFL03, WNHungary, WNTX02, WNMexico) were 
downloaded from GenBank (Appendix R) for comparison to FLS504 and 
FLS694. 
 
        
 FLS504
 WNNY99
 WNFL03
 WNHungary
 FLS694
 WNTX02
 WNMexico
 WNEgypt
 Kern217
99
10  
 
 
 
 
 
 
 
 305
Figure 4-49 Phylogenetic Relationships of SLEV Strains (Flavivirus 3’NC Region), 
Maximum Parsimony Method 
Phylogram of the 3’non-coding region was inferred using the maximum 
parsimony method in MEGA4.0.1, where the consensus tree (1000 
bootstrap replicates) was chosen. Branch lengths represent the amount of 
genetic divergence, with the scale bar corresponding to number of base 
changes in the entire sequence.  Bootstrap values are shown on the 
branches. Kern217, WNNY99 and WNEgypt complete genome sequences 
were downloaded from GenBank to include in this analysis (Appendix R). 
 
 TBH-28
 FL85a
 Kern217
 FL52
 FL90b
 FL90d
 FLS569
 TR62
 FL72
 BR69
 WNNY99
 WNEgypt
91
77
46
64
27
45
47
99
20  
 
 
 
 
 306
Figure 4-50 Phylogenetic Relationships of SLEV Strains (Flavivirus 3’NC Region, 
UPGMA Method 
Phylogram of the 3’non-coding region was inferred using the UPGMA 
method in MEGA4.0.1, where the consensus tree (1000 bootstrap 
replicates) was chosen. Branch lengths represent the amount of genetic 
divergence, with the scale bar corresponding to number of base changes 
per site (maximum composite likelihood method). Bootstrap values are 
shown on the branches. Kern217, WNNY99 and WNEgypt complete 
genome sequences were downloaded from GenBank to include in this 
)analysis (Appendix R). 
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addition, the SLEV strains isolated in 1990 clustered together for all genomic regions 
analyzed, including this segment of the 3’non-coding region. 
FLS569 Complete Coding Sequence  
The complete nucleotide coding sequence for FLS569 was sequenced and 
assembled at the University of Alabama at Birmingham to investigate potential 
recombination between flaviviruses in this SLEV strain. Recombination was not detected 
when 1000bp sequence fragments were blasted in GenBank (99-100% identity matches  
to Brazilian and Peruvian strains previously described for FLS569).  A phylogenetic tree 
was created using the heuristic search option in PAUP 4.0 (D.Swofford, Sunderland, 
Massachusetts, available at http://paup.csit.fsu.edu/index.html), with 1000 bootstrap 
replicates for the complete coding sequence of FLS569 (Figure 4-51). One WNV strain 
(FLS545) collected from this sentinel chicken two days earlier than FLS569 was also 
sequenced in the coding regions. The FLS545 WNV strain coding sequence was blasted, 
with BLASTN sequence identity matches 100% to North American strains of West Nile 
virus. Recombination was not detected when 1000bp sequence fragments were blasted in 
GenBank for this strain of WNV (data not shown). 
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Figure 4-51 Phylogenetic Relationships of North and South American SLEV 
Strains (Complete Coding Sequences) 
A phylogenetic tree was computed following sequencing of the complete 
coding region of FLS569. Complete coding sequences for North and 
South American strains of SLEV were evaluated (downloaded from 
GenBank, see Appendix R). Phylogeny was inferred using PAUP4.0, 
heuristic search option and 1000 bootstrap replicates. Bootstrap values are 
shown on the branches. FLS569 has been identified as 569Tampa in this 
phylogram. This tree corroborates BLASTN results on FLS569 and 
recommends placement of this strain in Lineage V, as proposed by Kramer 
and Chandler (2001).  
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Arbovirus Growth Characteristics 
Primary Passage (Mouse Brain to Vero Cell Culture) 
From the 1950s to the 1970s, reference strains of St. Louis encephalitis virus were 
passaged in suckling mice and stored at -70ºC at the Florida Department of Health 
Epidemiology Research Center (now known as the Virology section of the FDOH Bureau 
of Laboratories).  These included Florida and South American strains of the virus. For 
this project, aliquots of these reference strains were thawed and virus was extracted from 
the tissue. A two-log dilution (10-2) of the extracted virus sample was prepared and 
inoculated into Vero cell culture to evaluate the in vitro phenotype of selected strains. 
South American SLEV strains adapted quickly to Vero cell culture, with first observed 
cytopathic effect (cpe) at 6 days post-inoculation.  
The FL52 Miami strain of SLEV replicated slowly in culture (1+ cpe at Day 6) 
and was harvested at Day 11 (2+ cpe). FL72 isolate adapted quickly to Vero cell culture 
and was preserved (frozen) seven days post-inoculation (DPI), with 3 cpe observed at this 
time point. TBH-28 had previously been cultured in Vero cells and required 7-9 days to 
replicate in cell culture and/or plaque assays. SLEV strains from the 1980s and collected 
during 1990 were previously cultured in Vero cells.  
However, two strains of SLEV isolated in 1985 from Culex nigripalpus mosquito 
pools (FL85a & FL85b) were difficult to culture again. FL85a produced weak cpe (+/-) 
seven days post-inoculation but this cytopathic effect did not increase through Day 14.  
The FL85a (Vero1) culture was re-passaged and cpe was first observed 10 days following 
second passage (1+ cpe) and preserved on Day 12. In addition, cytopathic effect was not 
detected during the 14 days following initial passage of FL85b. This culture was also 
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passaged again and cpe first observed 10 DPI and frozen on Day 12.  SLEV FL89 also 
was difficult to culture, with the same pattern observed as described above for FL85a 
(except cpe was first noted 7 DPI, Vero2). Table 4-17 summarizes the incubation times 
and cpe value noted for each strain.  
Plaque assays were also performed for a subset of the reference strains by diluting 
an aliquot of the passaged culture (Vero1) 1:100 and 1:1000 and inoculating 0.1 ml into 
6-well Vero culture plates, in duplicate. Neutral red agarose-media overlays were added 
at the appropriate time for each strain, 3 days post-inoculation for South American SLEV 
isolates and 7 DPI for North American isolates (except FL72, FLS569, and FLS650).  
Plaques were then clearly visible on Day 5 and Day 9 for South and North American 
isolates, respectively. Plaque morphology is illustrated in Figure 4-52, where North 
American strains generally formed larger plaques than South American strains that were 
studied. Note: small plaque variants were also seen, especially for FL90d. 
Primary Passage (Cloacal Swab to Vero Cell Culture) 
The pattern of virus replication in cell culture (phenotype) of recent arbovirus 
isolates was characterized in vitro to investigate potential strain differences.  In 2005, 
first passage of FLM38 (WNV) in vitro was tested by inoculation of 1.0 ml filtered 
cloacal swab diluent into Vero cell culture (25cm2 flasks). This first passage of FLM38 
required 3 days to produce a microscopically observable weak cytopathic effect (+/-) and 
5 days post-inoculation to produce 3+ cpe.  Plaque assays were performed on the cloacal 
swab diluent to estimate the titer of virus in the sample. Results from this assay estimated 
3 PFU/0.1ml infectious WNV shed in the feces for this strain.  FLM38 was the only 
arbovirus cultured in 2005 from sentinel chickens. 
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Table 4-17 Incubation Period for SLEV Reference Strains  
 Cloacal swabs were processed and 1.0 ml of diluent was filtered and inoculated into Vero cell cultures. Cultures were 
microscopically examined each day for cytopathic effect (cpe) and incubated for 14 days. South American SLEV 
strains quickly developed cpe, whereas first passage of North American strains needed a longer incubation period. 
 
 
  
*
O
b
s
e
r
v
e
d
 
c
y
t
o
pathic effect for each time point is provided on scale of 0, +/-, 1, 2, 3, 4 (note: plus signs indicate a half-way point 
between each level from 1 to 4, with 4 as the strongest effect).  Cultures were examined microscopically each day to 
detect cpe and cultures were preserved (frozen) when cpe reached 2+ to 4.   
 
 
 
First Observed Cytopathic Effect for SLEV Reference Strains Inoculated into Vero Cell Culture* 
SLEV Reference Strains 
Vero Cell 
Culture 
FL52 TBH-28 FL-72 FL85a FL85b FL89 FL90a TR62 BR69 
Passage 1 6 DPI (1+) 
7 - 9 DPI 
(2+) 
7 DPI 
(3) 
7 DPI 
(+/-) 
14 DPI 
(0) 
7 DPI 
(+/-) 
3 DPI 
(+/-) 
6 DPI 
(+/-) 
7 DPI 
(+/-) 
Passage 2 NA NA NA 10 DPI (1+) 
10 DPI 
(1+) 
7 DPI 
(+/-) NA NA NA 
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Figure 4-52 Comparison of Plaque Phenotype of Reference St. Louis Encephalitis Virus Strains  
 Cell culture media from VERO passage 1 of St. Louis encephalitis virus strains were diluted two logs (10-2), inoculated 
into 6-well Vero culture plates, and incubated for 5-9 days.  SLEV strains FL52, TBH-28, FL90a and FL90d formed 
plaques 9 days post inoculation.  FL72 and South American strains of SLEV formed plaques 5 days post-inoculation. 
 
FL52 TBH-28 FL72 FL90a 
 
FL90d TR62 BR69 Negative Control 
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In 2006, FLS502 (WNV) produced strong cytopathic effect (2+) after 4 days of 
incubation in Vero cell culture on initial passage and was frozen at Day 5 (4 cpe).  Plaque  
assays on the cloacal swab diluent detected 816 PFU/0.1ml shed in the feces. In contrast, 
weak cpe (+/-) was observed for FLS504 and FLS545 after primary passage in Vero cells 
at 4 days post-inoculation, but quickly reached an observed cpe of 4 within 24 hours (Day 
5).  Plaque assays on the processed cloacal swab media for FLS504 detected 6 PFU/0.1ml 
of virus shed in the feces.  WNV was isolated from Bird 8-003-R in Sarasota County 
twice, the FLS502 and FLS545 strains.  The second cloacal swab (FLS545) contained 36 
PFU/0.1ml of virus in the feces seven days following collection of the initial swab 
(FLS502, 816 PFU/0.1ml).  
First passage of FLS569 (SLEV) from the processed cloacal swab in Vero cell 
culture required 11 days to produce weak cytopathic effect (+/-) and the culture was 
frozen after 13 days (2+ cpe).  Plaque forming units were directly detected on the 
processed cloacal swab media (32 PFU/0.1 ml) after ten days. 
FLS650 (SLEV) required a longer incubation period than FLS569 after primary 
inoculation from the cloacal swab into Vero cultures in order to replicate. Cytopathic 
effect was not observed at Days 11 or 14 post-inoculation, but was identified after 17 
days (3 cpe) and the culture was frozen.  Molecular detection of the viral RNA (TaqMan 
RT-PCR) on the cloacal swab prevented this culture from being discarded after 14 days 
(the normal incubation period). In addition, plaque forming units were not detected 
directly from processed cloacal swab media for FLS650 despite a longer incubation 
period (20 days as compared to 10 days) allowed for the plaque assays.  As a result, the 
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amount of virus shed in the feces for this chicken could not be quantified but was 
estimated at less than 2 PFU/0.1 ml (detection limit of the plaque assay).  
Cytopathic effect was not observed for the novel flavivirus strains FLS649 and 
FLS694 following inoculation into Vero cell cultures with processed cloacal swab media 
(14 days). 1.0 ml of the original Vero culture (first passage) was inoculated into a second 
culture and incubated for 14 days, but cytopathic effect was not detected (second 
passage). In addition, plaque assays performed on the processed cloacal swab diluent for 
FLS649 and FLS694 did not produce plaque forming units. Table 4-18 summarizes the 
incubation times for first and second passage of arboviruses isolated from cloacal swabs.  
Secondary Passage (Vero Culture to Vero Culture) 
  Plaque assays were also performed for each recent arbovirus strain collected from 
sentinel chickens by first diluting an aliquot of the passaged culture (Vero1) 1:100 and 
1:1000. These dilutions were inoculated into 6 well Vero culture plates, 0.1 ml per well, 
and performed in replicate. Neutral red agarose-media overlays were added at the 
appropriate time for each strain, 3 days post-inoculation for West Nile and South 
American SLEV isolates and 7 DPI for North American SLEV isolates (TBH-28).  
Plaques were then clearly visible on Day 5 for WNV, as well as for South American 
SLEV strains. TBH-28 plaques were not visible until 9 DPI. Plaque morphology of the 
1:100 dilution for each strain is illustrated in Figure 4-53, where it can be seen that West 
Nile virus formed much larger plaques than SLEV strains isolated from sentinel chickens. 
Although SLEV strain FLS569 formed several large plaques, it also produced 
hundreds of small plaques that scattered across the cell monolayer. In contrast, SLEV 
FLS650 did not produce large plaques; instead hundreds of very small, pin point plaques  
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Table 4-18 Incubation Period & Titer of Arbovirus Strains Isolated from Cloacal Swabs of Sentinel Chickens 
 Cloacal swabs were processed and 1.0 ml of diluent was filtered and inoculated into Vero cell cultures (the inoculum 
was out of 1.0 ml total for FLM38 or out of 3.0 ml for FLS502-FLS694). Cultures were microscopically examined each 
day for cytopathic effect and typically incubated for up to14 days. West Nile virus isolates quickly developed cpe, 
whereas first passage of St. Louis encephalitis virus required up to 17 days post-inoculation. 
 
*Observed cytopathic effect for each time point is provided on scale of 0, +/-, 1, 2, 3, 4 (note: plus signs indicate a half-way 
point between each level from 1 to 4, with 4 as the strongest effect).  Cultures were examined microscopically each day to 
detect cpe and cultures were preserved (frozen) when cpe reached 2+ to 4. ┼Cloacal swabs collected from the same bird.   
First Observed Cytopathic Effect & Virus Titer for Cloacal Swabs Inoculated into Vero Cell Culture* 
WNV SLEV FLAVIVIRUS 
Vero Cell 
Culture 
FLM38 FLS502┼ FLS504 FLS545┼ FLS569┼ FLS650 FLS649 FLS694 
Passage 1 3 DPI (+/-) 
4 DPI 
(2+) 
4 DPI 
(+/-) 
4 DPI 
(+/-) 
11 DPI 
(+/-) 
17 DPI 
(3) 
14 DPI 
(0) 
14 DPI 
(0) 
Passage 2 3 DPI (2+) 
3 DPI 
(2+) 
3 DPI 
(1+) 
3 DPI 
(3+) 
5 DPI 
(2+) 
6 DPI 
(1+) 
14 DPI 
(0) 
14 DPI 
(0) 
Virus Titer on 
Cloacal Swab 
(PFU/0.1 ml) 
3 816 32 36 32 < 2 NA NA 
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Figure 4-53 Comparison of Plaque Phenotype of Sentinel Chicken Arbovirus Strains  
 Cell culture media from VERO passage 1 of West Nile virus strains FLM38, FLS502, FL504 and FLS54 was diluted 
two logs (10-2), inoculated into 6-well Vero culture plates, and incubated for five days.  SLEV strains FLS569 and 
FLS650 (passage 1) were also assayed as above.  SLEV isolated from sentinel chickens was assayed as above and also 
formed plaques five days post-inoculation. 
 
FLM38 (WN) FLS502 (WN) FLS504 (WN) FLS545 (WN) 
FLS569 (SLE) FLS650 (SLE) TBH-28 (SLE+ Control) Negative Control 
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formed after 7 days-post inoculation (Figure 4-53). Ten plaques were measured for each 
virus strain (Vero1) isolated from sentinel chickens for both the wild type and antibody-
neutralized plaque variants. The average plaque size and incubation period for each virus 
strain is included in Table 4-19.  
Novel flavivirus strains (FLS649 and FLS694) did not replicate or produce 
cytopathic effect in Vero cell cultures. Further studies are needed to fully evaluate the 
detection of these flavivirus strains, including inoculation into susceptible hosts to 
investigate host range, virulence potential, and to generate additional viral RNA template 
for complete genome sequencing of these strains. 
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Table 4-19 Plaque Morphology of Arbovirus Strains Isolated from Sentinel 
Chickens (2005-2006) 
Plaque assays were performed on arbovirus isolates collected from 
sentinel chickens. Ten plaques were measured for each virus strain 
(passaged once in Vero cells, “wild type”), with the average size reported 
below. Virus neutralization assays were also performed on four of these 
strains by challenge with the homologous antibody (polyclonal WN 
antibody for FLS502, FLS504, and FLS545; polyclonal SLE antibody for 
FLS569). Smaller plaque sizes were identified for each strain following 
neutralization with polyclonal antibody. Ten plaques (small variants) were 
measured, with the average size reported below.  The incubation periods 
for the plaque assays are shown for each strain, as timed days post-
inoculation (DPI). 
 
 
Plaque Morphology of Arbovirus Strains Isolated from Sentinel Chickens 
 
Strain 
Wild Type 
Vero 1 (mm) 
Small Variants +Ab 
Vero1 (mm) 
Incubation Period 
(DPI) 
 
FLS502┼ 
 
6 1 5 
 
FLS504 
 
5.5 5 5 
 
FLS545┼ 
 
7 5.25 5 
 
FLS569┼ 
 
4.08 0.92 5 
 
FLS650 
 
0.05 NA 7 
 
┼Cloacal swabs collected from the same bird. 
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CHAPTER FIVE 
 
DISCUSSION 
 
 The introduction of West Nile virus to the United States in 1999 demonstrated the 
potential of arboviruses to emerge into new regions, with widespread impact on the 
native human and animal populations (Gubler, 2002; CDC, 2007e). The rapid dispersal 
and establishment of enzootic foci of West Nile virus transmission activity throughout the 
United States (likely Canada, the Caribbean and South America, as well) in the last eight 
years created the need for public health agencies to enhance surveillance and research of 
this serious zoonotic, vector-borne pathogen (Gubler, 2007).   
 Prior to 1999, St. Louis encephalitis virus was the only mosquito-borne human 
pathogen in the family Flaviviridae found on this continent, with intermittent epidemic 
transmission up to 3,000 cases per year (average 128), and a case fatality rate of 5% 
(CDC, 2007j).  However, limited transmission activity of SLEV has also been shown by 
sentinel chicken surveillance for both viruses in Florida (Stark & Kazanis, 2001-2006) 
and throughout the United States (USGS, 2007) since the introduction of West Nile virus.  
The reason for the “disappearance” of SLEV in areas with enzootic foci of WNV 
has not been thoroughly investigated. A complex interplay of abiotic (rainfall, 
temperature, habitat) and biotic (competent vector and host species, virus strain) factors 
contribute to the life cycle and subsequent transmission of these viruses (see Figure 2-7) 
[Day, Curtis and Edman, 1990; Day, 2001; Reisen, 2003; Shaman, Day, Stiegletz, 2005; 
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Reisen, Fang, Martinez, 2006; CDC, 2007b and d]. However, the establishment of a 
closely related flavivirus family member (West Nile virus) in historically endemic areas 
of St. Louis encephalitis virus transmission likely influences their life cycles as they share 
and/or compete for these resources (Reisen, 2003; Lillibridge et al, 2004). This study was 
motivated to elucidate the impact of West Nile virus on the natural history of St. Louis 
encephalitis virus in Florida, where several outbreaks of SLEV led to the establishment 
(and continuation) of one of the largest arboviral surveillance programs in the United 
States (Bigler B, 1999).  
In 2004, as part of this study, an Arbovirus Isolation Network was established to 
collect arbovirus samples from naturally exposed birds at potential “hot zones” of 
transmission activity based on weekly surveillance results for the Sentinel Chicken 
Program. In particular, this project investigated the impact on the St. Louis encephalitis 
viral genome by assessing genotypic and phenotypic characteristics of the virus prior to 
and following the introduction of West Nile virus to Florida in 2001. A molecular 
epidemiology analysis of Florida SLEV strains identified nucleotide base changes 
characteristic of the 1990 epidemic strains that may be useful from a public health 
perspective to evaluate the relative pathogenicity of future circulating strains.  
Aim One 
Evaluation of Arbovirus Isolation Network 
 Earlier studies were unsuccessful in the isolation of SLEV from migratory or 
resident birds and/or mosquitoes (Calisher et al, 1971; Reisen et al, 2000; Reisen et al, 
2003). In fact, diagnosis of animal infection by virus isolation of SLEV is infrequent 
(Reisen, 2003). These findings are supported by surveillance data in Florida. The 
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submission of mosquito pools and dead birds since the introduction of WNV has not 
resulted in the detection or culture of St. Louis encephalitis virus at the BOL-Tampa 
(Stark and Kazanis, 2001-2007). Consequently, a random approach to arbovirus isolation 
is unlikely to succeed due to the low prevalence of SLEV and sporadic transmission of 
arboviruses in Florida. Epidemiological data has been used to target mosquito collections 
during local transmission of malaria (P. vivax) in Palm Beach, Florida, where trapping 
was performed within 1 mile of patient homes. The parasite was not detected in these 
mosquito collections (CDC, 2003b).  This strategy has also been used to collect 
mosquitoes during outbreaks of West Nile virus near patient homes and active sentinel 
chicken sites during 2001-2005 in Florida to detect the virus, with moderate success 
(unpublished data, BOL-Tampa).  
In 2004, a similar strategy was employed in the State of Sao Paulo, Brazil 
following the isolation of SLEV (strain SPH 253175) from one patient’s serum, the first 
human case in more than twenty years reported in the region.  Mosquitoes and wild birds 
were trapped near the patient’s residence and in forested areas in the region from May 18 
through May 22, 2004. Sentinel mice were also set up in the same locations for 3 days. 
All samples collected were SLEV negative. However, the patient’s illness had occurred 
five months earlier in January (Rocco et al, 2005). 
Arbovirus Isolation Network (Sentinel Chicken Program) 
Therefore, a targeted method was designed to collect samples from sentinel 
chickens at “hot zones” of arbovirus (especially SLEV) transmission activity based on 
weekly surveillance data for these viruses. In 2004, local agencies collaborating in the 
Florida Sentinel Chicken Program were invited to participate in the Arbovirus Isolation 
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Network based on their location in the historical SLEV transmission belt in Florida (see 
Figure 3-1). Ten out of fourteen agencies contacted by the Florida Department of Health, 
Bureau of Laboratories, Tampa (BOL-Tampa) agreed to participate in the Arbovirus 
Isolation Network. The effective recruitment of these partners relied on the long-standing 
success of the Florida Sentinel Chicken Program and nearly two decades of collaboration 
with the BOL-Tampa. 
In 2004, one agency (Hillsborough County Mosquito Control District) 
successfully piloted a protocol at 3 targeted sites to optimize sampling criteria and 
collection methods, which guided the design of the targeted protocol for all agencies.  
During 2005-2006, the Arbovirus Isolation Network was effective at targeting sites for 
virus isolation. The BOL-Tampa requested 9 agencies to target sentinel chicken sites 
based on alphavirus and flavivirus surveillance results (HAI, MAC-ELISA, PRNT 
assays). Eight agencies implemented sample collection at targeted sites within one week 
of request, with most collaborators starting sample collection within 2-3 days.  
The only agency that was unable to accommodate the request to target its active 
sentinel chicken sites experienced an outbreak of WNV in its area during July, 2005. Due 
to intensive vector control efforts needed to limit the human outbreak, personnel were 
unable to also target active sites for cloacal swab collection.  Although targeted samples 
in this region may have provided the highest success of arbovirus isolation, personnel to 
perform the collections were not available. For an Arbovirus Isolation Network to 
specifically target sites during an outbreak of WNV or SLEV, additional funding may be 
required to supplement mosquito control personnel for the collection of samples from 
sentinel chickens (as shown in this study). 
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Partner agencies in the Sentinel Chicken Program estimated that the time needed 
to collect cloacal swabs from a targeted site during the weekly collection of serum was 
minimal, approximately 5-10 additional minutes per site [personal communications, E. 
Elbert (OCMCD) and N. Osborn (SCMCD)].  In addition, these agencies monitored the 
chickens every 2-3 days during the week to feed, water, and monitor the health of the 
flock so that collection of swabs twice during a week did not require a special trip.  
Arbovirus Isolation Network (Wild Birds) 
Nevertheless, adult chickens are not believed to develop the high titered viremias 
necessary to infect mosquitoes and do not contribute to the amplification cycle, as 
estimated by previous studies on SLEV and WNV (Reisen et al, 1994; Langevin et al, 
2001; Komar, 2001; Patiris et al, 2008).  In 2006, sampling of wild birds was also 
implemented to attempt SLEV detection/isolation from the primary avian amplifying 
hosts of the virus. Wildlife rehabilitation centers were recruited to the Arbovirus Isolation 
Network based on membership in the Florida Wildlife Rehabilitation Association. Five 
wildlife centers located throughout Florida participated in the study and submitted 
samples from wild bird species (Appendix H) from March through December, 2006. The 
Florida Fish and Wildlife Conservation Commission (FWC) also collected samples from 
wild bird mortality events in the state.  
Wildlife rehabilitation centers also reported minimal time spent for sample 
collection [personal communication, D. Flynt (ACBP)]. Samples were often frozen, 
batched and shipped to the laboratory every few weeks. However, virus was not detected 
or isolated from these samples. These strategies for sample collection from wild bird 
species were either from ill or injured birds, or from fatalities. While these methods have 
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been successful for West Nile virus detection/isolation (Komar et al, 2002; Nemeth et al, 
2007; CDC, 2007g), SLEV has not been reported to cause morbidity or mortality in wild 
bird species (CDC, 2007j). The addition of agencies to the Arbovirus Isolation Network 
that work with live, healthy wild species is recommended in future studies for the specific 
detection of SLEV.  
This Arbovirus Isolation Network focused on a targeted sampling strategy of 
avian species for the detection/isolation of St. Louis encephalitis virus. However, the 
weekly surveillance results that identify arbovirus transmission activity at sentinel 
chicken sites would be especially useful in future studies to also target mosquitoes and 
wild birds at/near these sites for virus isolation. Currently, many mosquito control 
agencies collect mosquitoes at sites when sentinel activity is detected for speciation and 
counts but may not perform or submit pools for molecular detection of the virus. 
Additional investigations to detect/isolate the virus in the vector and primary amplifying 
hosts would require additional funding and coordination between the mosquito control 
district and ornithologists/veterinarians for sample collection from mosquitoes and birds, 
respectively.  
Aim Two 
Evaluation of Targeted Sampling Strategy 
 Previously, SLEV has been isolated from one sentinel chicken in Panama in 1983 
(Kramer and Chandler, 2001) and Belem, Brazil in 1969 [personal communication to F. 
Wellings (ERC) from G. Sather (University of Pittsburg) about the BR69 strain acquired 
by the Epidemiology Research Center in 1971].  Murray Valley encephalitis virus was 
isolated from the blood of sentinel chickens in Australia during 1974 (Campbell and 
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Hore, 1975). In addition, SLEV was isolated from a flock of domestic pigeons in 1962 
near Tampa, Florida (Gainer et al, 1964). However, these collections were not 
systematically targeted (with the exception of samples collected from the flock of pigeons 
following 12 pigeon deaths in 1962). 
Targeted Strategy for Sentinel Chickens 
In Florida, the targeted sampling strategy of sentinel chicken sites for the 
isolation/detection of arboviruses was performed from July 2005 through December 
2006.  Most sampling occurred during peak months of the SLEV transmission season 
(August through November) in Florida. This long-term study (two years) is the first to 
actively target sentinel chicken flocks for the isolation of St. Louis encephalitis virus with 
cloacal swabs. Eight agencies with sentinel chicken programs actively participated and 
collected blood and/or cloacal swabs as part of routine arbovirus surveillance programs. 
 Sentinel chicken serological assay results were used to target sites (range 2-10) 
which limited the collection of swabs from every site in the county. This reduced hands-
on time for animal handlers, waste of resources and effectively investigated sites with 
confirmed arbovirus transmission activity. An additional targeted laboratory strategy was 
employed by the BOL-Tampa to retrospectively assay swabs from sites with sentinel 
seroconversions (see Figures 4-11 and 4-12). Despite targeting of sites with known 
arbovirus transmission activity, virus was not detected/isolated from processed samples 
in five of the eight counties (Table 5-1). The complex arbovirus transmission cycle, 
influence of abiotic factors, and prompt vector-control efforts by these mosquito control 
districts likely resulted in only sporadic arbovirus transmission in many of these counties,   
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Table 5-1 Comparison of the Number of Targeted Sites to the Number of Sites 
with Virus Detected/Isolated, by County 
Eight counties targeted sentinel chicken flocks for the detection/isolation 
of arboviruses at several sites in each region (2005-2006). However, 
sporadic arbovirus transmission activity and vector-control efforts often 
limited continued sentinel chicken seroconversions, such that virus was 
detected/isolated from a subset of targeted sites. The number of cloacal 
swabs processed and confirmed positive by molecular detection assays are 
also shown for each county.  
 
Number of Targeted Sites Compared to Number of Sites with Virus 
Detected/Isolated, by County 
County (Year) Targeted Sites Sites with Virus Detected/Isolated
# Processed 
Cloacal 
Swabs 
# Positive 
Cloacal 
Swabs 
 
Manatee (2005) 
 
10 3 119 3 
 
Orange (2005) 
 
6 1 102 4 
 
Orange (2006) 
 
3 0 36 0 
 
Sarasota (2005) 
 
5 0 38 0 
 
Sarasota (2006) 
 
6 2 427 8 
 
Lee (2006) 
 
2 0 22 0 
 
Pasco (2006) 
 
3 0 20 0 
 
Volusia (2006) 
 
4 0 48 0 
 
 
 327
where no further confirmed sentinel seroconversions occurred during targeted sampling 
(Lee, Pasco, and Volusia counties).  
Further analysis of sentinel chicken seroconversions in these counties revealed 
that 19 birds with confirmed seroconversions were swabbed at targeted sites.  Virus was  
detected/isolated from six of these positive chickens and also from six chickens that 
failed to seroconvert in the HAI assay (Tables 5-2 and 5-3). The majority of chickens that 
seroconverted but arboviruses were not isolated or detected from cloacal swab and blood 
samples occurred in one county. In Manatee County, virus was not detected/isolated for 
thirteen (out of 14) sentinels that seroconverted in Manatee County during targeted 
sampling. The reason for this high number of failed arbovirus isolation attempts was 
likely due to the age of the chickens (see section on the development of primary immune 
response, page 355), rather than the targeted sampling method.  
The use of sentinel chicken serology results was critical to successful arbovirus 
isolation from these sites. HAI, MAC-ELISA and PRNT reported results were compared 
to evaluate the most effective method for targeting of sentinel chicken sites (Table 5-4). 
MAC-ELISA confirmed seroconversions appropriately targeted and resulted in virus 
detection/isolation from two counties, where the reported dates of MAC-ELISA results 
for Manatee and Orange counties initiated targeted sample collection within 2 days.  In 
Manatee County, the single West Nile virus isolation from a confirmed sentinel 
seroconversion occurred on the first date of targeted sampling, which was also the report 
date of a positive MAC-ELISA result on another chicken in the flock.   
In Orange County, targeted sample collection began four days days after HAI 
detected seroconversion to alphavirus was reported in July 2005. The sample was 
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Table 5-2 Comparison of Sentinel Chicken Seroconversions to Birds Targeted for Virus Detection/Isolation (2005) 
During 2005, three counties with arbovirus transmission activity to sentinel chickens (seroconversions) targeted 
selected flocks for virus detection/isolation sampling. The annual total number of sentinel seroconversions is shown for 
each county; however, sampling for virus isolation was not performed year-round. During sampling, a subset of birds 
seroconverted at all sites. The number of birds that seroconverted at targeted sites provided a better measure of 
arbovirus isolation/detection success. Manatee County had 13 chickens seroconvert from whom no virus was 
isolated/detected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
┼Annual total includes both alphavirus and/or flavivirus sentinel chicken seroconversions. 
 
 
 
Sentinel Chicken Seroconversions & Virus Detected/Isolated from Targeted Sites (2005) 
 
County 
 
# Birds 
Seroconverted 
(Annual Total)┼ 
# Birds 
Seroconverted 
During Sampling
(All Sites) 
# Birds 
Seroconverted 
During Sampling 
(Targeted Sites) 
# Birds  
Seroconverted 
Arbovirus 
Detected/Isolated 
 
# Birds  
Sero-negative 
Arbovirus  
Detected/Isolated 
 
Manatee 49 29 14 1 2 
Orange 21 7 1 1 1 
Sarasota 17 8 0 NA 0 
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Table 5-3 Comparison of Sentinel Chicken Seroconversions to Birds Targeted for Virus Detection/Isolation (2006) 
During 2006, five counties with arbovirus transmission activity to sentinel chickens (seroconversions) targeted selected 
flocks for virus detection/isolation sampling. The annual total number of sentinel seroconversions is shown for each 
county; however, virus isolation sampling was not performed year-round. During targeted sampling, a subset of birds 
seroconverted at all sites. The number of birds that seroconverted at targeted sites provided a better measure of 
arbovirus isolation/detection success. Virus was isolated/detected from each bird that seroconverted in Sarasota Co. 
 
 
 
 
 
 
 
 
 
 
┼Annual total includes both alphavirus and/or flavivirus sentinel chicken seroconversions. 
*14 SLEV seroconversions, 1 WNV seroconversion.  Note: 11 birds seroconverted to SLEV after targeted sampling was 
terminated in Lee County. 
 ‡7 SLEV seroconversions (August-December 2006), 1 WNV seroconversion (April 2006).
 
Sentinel Chicken Seroconversions & Virus Detected/Isolated from Targeted Sites (2006) 
County 
 
# Birds 
Seroconverted 
(Annual Total)┼ 
# Birds 
Seroconverted 
During Sampling
(All Sites) 
# Birds 
Seroconverted 
During Sampling 
(Targeted Sites) 
# Birds  
Seroconverted 
Arbovirus 
Detected/Isolated 
 
# Birds  
Sero-negative 
Arbovirus  
Detected/Isolated 
 
Lee 15* 0 0 NA 0 
Orange 5 3 0 NA 0 
Pasco 1 0 0 NA 0 
Sarasota 8‡ 10 4 4 3 
Volusia 7 0 0 NA 0 
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negative for IgM. However, this sample was assayed in the PRNT and later confirmed 
positive (reported 08/02/05). Targeted sample collection continued at Site 004 for one 
month and EEE viral RNA was detected on cloacal swabs on August 17 and 19. In this 
situation, a delay in targeting of the site until confirmation in the PRNT would still have 
resulted in detection of EEEV (due to the relatively short PRNT assay time of 5 days 
compared to 14 days for SLEV) [Table 5-4].   
Unlike these two agencies, Sarasota County did not wait until confirmation in the 
MAC-ELISA or PRNT to initiate targeted sample collection in 2006. At site 004, 
presumptive seroconversions in the HAI assay were reported on October 6 and targeted 
sampling of this flock started 3 days later on October 9. At this site, West Nile virus was 
isolated from Bird 8-003-R twice before confirmed MAC-ELISA results were reported 
on October 18 for a serum sample collected from this chicken on October 9 (Figure 4-
20). Consequently, HAI positive test results were indicative of acute stage arbovirus 
infections in Sarasota County, with virus shedding in the feces (Table 5-4). 
Targeted sampling of sentinel chicken sites based on confirmed SLEV 
seroconversions in the PRNT were unsuccessful. In Lee County, a confirmed 
seroconversion in the PRNT necessitated a delay of more than two weeks since the initial 
serum collection date and was not effective at targeting sites for the detection/isolation of 
arboviruses during the acute stage of infection. Although SLEV transmission was 
detected at several sites located throughout Lee County in 2006 (Figure 3-6), this activity 
was sporadic with positive sentinel seroconversions at different time points (Figure 4-16). 
Timing of sample collection at targeted sites in Lee County was too late and a quiescent 
period of one month resulted in no arbovirus detected/isolated (Table 5-4).  However, a 
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Table 5-4 Dates of Reported Serology Test Results & Start Dates of Targeted 
Sampling 
Serology test results (HAI, MAC-ELISA, and PRNT) were used to initiate 
targeted sample collection at sentinel chicken sites during 2005-2006. The 
reported dates on these assays are compared to the start of targeted sample 
collection for four counties, with and without subsequent virus isolation.  
The first bird (top row) triggered targeted sample collection at one site in 
each county. The second bird (shaded row) was the next bird to 
seroconvert at the site (except for Lee County, the second bird 
seroconverted at another site).  
 
Targeted Sampling Based on Serology Positive Result Dates 
County Bird # 
Serum 
Collect 
Date 
Lab 
Receipt  
Date 
HAI + 
Report 
Date 
MAC-
ELISA+ 
Report 
Date 
PRNT+ 
Report 
Date 
Targeted 
Sampling 
Start 
Date 
Virus 
Isolated/ 
Detected? 
Manatee 1772 09/05/05 09/07/05 09/09/05 09/12/05 NT 09/12/05 NA 
 
 
1773 
 
09/12/05 09/14/05 09/16/05 (HAI -) NT NT 09/12/05 Yes 
Orange 778 07/14/05 07/19/05 7/22/05 07/25/05 ELISA- 08/02/05 07/25/05 NA 
 846 08/25/05 08/30/05 09/02/05 HAI- 
09/06/05 
ELISA- 09/13/05 07/27/05 Yes
┼ 
Sarasota 
 
8-004-G 
 
10/03/06 10/04/06 10/06/06 10/11/06 10/25/06 10/09/06 NA 
 
 
 8-003-R 
 
10/09/06 10/11/06 10/13/06 10/18/06 11/01/06 10/9/06 Yes 
 
Lee 
 
360 08/14/06 08/16/06 08/18/06 08/23/06 09/06/06 09/11/06 NA 
 
 
 
425 10/10/06 10/11/06 10/13/06 10/18/06 NT Stopped 09/26/06 No 
 
┼Detection of virus on cloacal swabs on 08/17/05 preceded first detection of antibody 
development (seroconversion) in the HAI assay for this sentinel chicken. 
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recommendation for future studies in Lee County would request that the agency continue 
(or reinstate) targeted sampling based on positive HAI assay results. 
Overall, the use of sentinel chicken seroconversions for targeted collection of 
samples from active transmission sites was effective for the isolation of arboviruses. 
However, one caveat to the use of this strategy should be noted. Real-time detection of 
arboviral infections (i.e. transmission activity) was not possible for sentinel chickens. 
Instead, an estimated 2-4 day lag time was necessary for the birds to first develop 
antibodies to the virus following infection (Reisen et al, 1994; Langevin et al, 2001). A 
further time delay was required for antibody detection in the HAI screening assay (2-7 
days, depending on sera collection date and date of submission to the laboratory). As a 
result, targeted sampling of “active” sites always occurred following at least one sentinel 
seroconversion and a time lag of 2-9 days.  For some regions, this delay may have 
adversely affected the success of virus isolation attempts where arbovirus transmission 
activity was extremely limited or sporadic (as noted for Pasco and Volusia counties in 
2006, Figures 4-18 and 4-19). In addition, mosquito control agencies may have used the 
seroconversions to target areas for immediate eradication/vector control activities.  
Most agencies routinely collected cloacal swabs only once during the week, at the 
same time as the scheduled bleeding of the flocks. However, Manatee, Orange and 
Sarasota counties intermittently collected cloacal swabs twice a week.  As a result, this 
method improved virus detection/isolation in these counties on first and/or second swabs 
from positive chickens. This method was not strictly necessary for the detection of 
arboviruses (as shown by Sarasota County in 2006), but it provided additional 
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information on the course of natural arbovirus infections in adult chickens (Figures 4-10, 
4-14, 4-22). 
Targeted Strategy for Wild Birds 
 From April to December 2006, a total of 87 cloacal swabs were submitted from 
five wildlife rehabilitation centers and the Florida Fish and Wildlife Conservation 
Commission from 36 different bird species. Despite targeting of certain species (known 
amplifying host) and/or symptoms indicative of arboviral infection in live birds [Komar 
et al, 2003; Brault et al, 2004; Nemeth et al, 2007], arboviruses were not 
detected/isolated.  A previous study on clinic-admitted raptors in Colorado identified 
West Nile virus infections months earlier than other traditional surveillance methods, but 
used both oral swabs and seroconversions to identify the virus in wild bird species 
(Nemeth et al, 2007).   
This study agrees with the work by Nemeth et al (2007) that found that wildlife 
rehabilitation centers in Colorado provided an existing resource outside of the public 
health system for surveillance of arboviruses in wild birds, where nationwide an 
estimated 10,000 birds are admitted to 1,000 centers each year. In addition, participation 
in this study provided Florida rehabilitators with access to the diagnostic services of the 
BOL-Tampa for detection of arbovirus infected birds. As a result, one raptor admitted to 
the Audubon Center for Birds of Prey was diagnosed with EEEV infection based on a 
four-fold rise in neutralizing antibody titers in the PRNT.  Virus isolation was not 
attempted on this bird, due to its admission to the rehabilitation center two weeks after 
first symptoms of infection.  
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For the detection of St. Louis encephalitis virus, one recommendation for future 
studies on wild birds would be for the collection of swabs and sera from a larger sample 
size of birds admitted to these centers, not just those exhibiting symptoms characteristic 
of arbovirus infection or known amplifying host species (n=64).  In addition, agencies 
should be recruited for the study of healthy bird populations, such as wildlife stations that 
routinely band and track migratory birds. One such resource is already available in 
Florida for the surveillance of avian influenza virus in wild bird populations [personal 
communication, D. Wolf (FWC)]. A study to attempt targeted sample collection from 
wild birds located near positive sentinel chicken sites would also be beneficial. However, 
this would require mist net traps and experienced handlers (Reisen et al, 2000b; Reisen et 
al, 2004b).  The impact to the bird and environment would be minimized by release 
following collection of a serum sample and cloacal swab.  
The techniques used in this study for sample collection from wild birds were 
previously proven successful for the isolation of West Nile virus (Langevin et al, 2001; 
Komar et al, 2002; Nemeth et al, 2007).  Targeted sampling during a year with increased 
rates of WNV transmission activity may improve isolation of West Nile virus from 
rehabilitated birds in Florida. SLEV has not been shown to cause significant morbidity or 
mortality in wild avian species (Gainer, 1964; McLean et al, 2001; Reisen, 2003) and the 
detection of SLEV-infected wild birds would require a funding increase to add to existing 
arbovirus surveillance programs in Florida. Nonetheless, blood samples collected from 
wild trapped/released birds was proven successful in Florida during the 1980s and 1990s 
for the isolation of SLEV, including the FL89, FL90a-c strains analyzed in this study.  
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Seasonal Timing of West Nile Virus and St. Louis Encephalitis Virus 
In 2006, the flavivirus transmission season in Florida was unusual due to the 
increased incidence of sentinel chicken seroconversions to SLEV (n=40) than to WNV 
(n=30) for the first time since the introduction of West Nile virus to the state in 2001 
(Stark and Kazanis, 2001-2006). One laboratory study has suggested the impact of 
acquired immunity to one virus in avian hosts may limit or prevent subsequent infection 
(and amplification) by another closely related virus, such as appears to be the case for 
WNV transmission followed by SLEV (Fang and Reisen, 2006). WNV infections 
appeared to prevent subsequent SLEV infections in wild caught house finches and may 
impact arboviral amplification and transmission cycles where these viruses coexist (Fang 
and Reisen, 2006).  
These viruses coexist in Florida and flavivirus amplification and transmission 
cycles have been impacted since 2001 (Figure 4-1). During the study period, seasonal 
timing was shown by rates of sentinel chicken seroconversions to West Nile virus (Figure 
4-7) and St. Louis encephalitis virus (Figure 4-8) in 2005 and 2006. A comparison of 
these rates indicated that WNV transmission activity during May through August in 2005 
was much higher than detected during the same months in 2006. Consequently, limited 
West Nile virus activity appeared to allow late season amplification of SLEV (without 
early season transmission of WNV) during August through December, 2006.  These 
findings support the experimental evidence that found previous West Nile virus infection 
of avian amplifying hosts led to sterilizing immunity, whereby neutralizing antibodies 
prevented a later St. Louis encephalitis virus infection (Fang and Reisen, 2006).  
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 Therefore, the influence of West Nile virus should not be discounted when a 
targeted sampling strategy for SLEV is implemented in the United States. Effective 
surveillance data may alert an agency that the large scale transmission of St. Louis 
encephalitis virus may be unlikely during a calendar year following the early season 
transmission of WNV. This situation was found during this study in 2005, where SLE 
virus not isolated or detected despite targeted sample collection in two counties. 
Additional targeted studies over several years and surveillance studies in naturally 
infected wild bird populations would be recommended to support this finding and to 
further estimate risk of an epidemic/epizootic of SLEV during active West Nile virus 
seasons in Florida. 
Aim Three  
Evaluation of Arbovirus Identification Methods 
This study relied on two methods for the accurate identification of arbovirus 
infections in sentinel chickens, antibody development (seroconversions) and detection of 
the viral genome with RT-PCR. The serology method was based on the detection of 
arbovirus-specific antibodies through testing of chicken sera samples with the HAI, 
MAC-ELISA, and PRNT assays, performed as previously described (Clarke and Casals, 
1958; Holden et al, 1966; Calisher et al, 1986c; Martin et al, 2000; Schmidt, 1979; Beaty, 
Calisher and Shope, 1989; Voakes, 2004).  These assays confirmed WNV, SLEV, EEEV, 
and HJV transmission activity to sentinel chickens during 2005 and 2006 (Table 4-1). 
This information was used to target collection of samples at sentinel chicken sites located 
in three counties in 2005 (Figures 3-3, 3-4 and 3-5) and five counties in 2006 (Figures 3-
6, 3-7, 3-8, 3-9, 3-10).  
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Serology & RT-PCR Assays 
The HAI assay was extremely sensitive for the detection of arbovirus 
transmission activity, and also detected sentinel chicken seroconversions to South 
American strains of SLEV at Sites 001 and 004 in Sarasota County during 2006. 
However, two drawbacks to the use of this assay for the identification of arboviruses 
existed, as performed at the BOL-Tampa. This assay detected antibodies that were 
flavivirus or alphavirus-group specific and could not distinguish between closely related 
arboviruses, such as WNV and SLEV (or EEEV and HJV). As a result, additional 
confirmatory testing (MAC-ELISA or PRNT) was required to identify the etiologic 
agent.   
In addition, sera samples were batched for analysis in this test, as the laboratory 
typically processed up to 1500 chicken sera each week. Results were then reported each 
Friday. Consequently, confirmation of a positive test result in the HAI assay required at 
least 7 days (MAC-ELISA) following the original serum collection date, or up to 22 days 
when additional confirmation (PRNT) was needed. Therefore, the use of confirmed HAI 
results for targeted sample collection at sentinel chicken sites introduced an unavoidable 
time delay, which may have negatively impacted the success of arbovirus isolation in 
some areas (notably Manatee and Lee counties for SLEV targeting).  
A molecular RT-PCR assay was the second method used to screen samples for the 
detection of arboviruses in blood and/or cloacal swabs. The rapid, sensitive real-time RT-
PCR (TaqMan) method was used to screen both field samples and archived reference 
strains of these viruses, performed as previously described (Lanciotti et al, 2000; 
Lanciotti and Kerst, 2001; Lambert, Martin and Lanciotti, 2003).  Samples that screened 
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positive with the “A” primer sets were then confirmed with a second TaqMan assay using 
another (“B”) primer-probe set specific for each virus type. All samples that screened 
positive were further assayed with end-point primer sets for confirmation and sequencing 
(Figure 3-12). 
Real-time RT-PCR effectively detected (and confirmed) WNV, SLEV and EEEV 
in extracted cloacal swab samples. Six strains of the virus (4 WNV+ and 2 SLEV+) were 
detected in cloacal swabs and matching Vero cell culture extracts. Real-time RT-PCR 
also detected arboviral RNA on 9 cloacal swabs (from 6 birds) but these viruses did not 
replicate in cell culture (2 WNV+, 4 EEEV+, and 3 Flavi+) [Table 4-5]. These molecular 
assays also detected and confirmed plaque “clones” picked from a VERO cell culture 
monolayer, inoculated into 1 ml of media, and RNA extracted for both WNV and SLEV 
(Table 4-4).  
Evaluation of Seroconversions 
Sentinel chicken seroconversions have proven to effectively detect arbovirus 
transmission activity prior to human cases in Florida (Blackmore et al, 2003; Butler and 
Stark, 2005). In Florida, sentinel chicken seroconversions (rates, distribution) are 
evaluated and provided on a weekly basis 
(http://www.doh.state.fl.us/environment/community/arboviral/Weekly-Summary.html) 
for partner agencies to assess transmission activity and to implement control measures. 
This information is also summarized yearly by the BOL-Tampa (Stark and Kazanis, 
2001-2007). The current study has also identified that sentinel chicken seroconversions 
(development of antibodies) in the HAI test indicated current or recent shedding of the 
virus in the feces as detected by RT-PCR (Figures 4-10, 4-14, 4-22, 4-23, 4-26). 
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However, the HAI assay failed to detect seroconversions to arbovirus infections in 
some sentinel chickens (n=6) where the viral RNA genome was identified on cloacal 
swabs. RNA extraction and RT-PCR assays were repeated from the starting swab 
material, with similar results, indicating that contamination or switched samples likely 
did not occur in the laboratory. The exact reason for the failure of these birds to 
seroconvert (i.e. escape detection in the HAI assay) is unknown and has not been 
demonstrated experimentally (Reisen et al, 1994; Senne et al, 2000; Langevin et al, 2001; 
Patiris et al, 2008).  
In Manatee County, many sentinel chickens were at least one year in age or older 
(some up to 3 years) [personal communication, D. Kinney (MCMCD)]. Only chickens 
that seroconverted each year were removed from the field and replaced with younger 
birds. Consequently, many chickens were not removed following each season and flocks 
contained birds of mixed ages. WNV was detected on cloacal swabs from chickens at 
Sites 002 (Bird 1714) and 015 (Bird 1695) that did not later seroconvert (Figure 4-13). 
This may be a result of the advanced age and/or an altered immune response in these 
chickens, whereas younger chickens usually seroconverted earlier (as seen for Sarasota 
County with birds aged 52 weeks or 3 months younger). However, previous studies have 
investigated the immune response following inoculation of WNV in adult chickens 
(Langevin et al, 2001; Patiris et al, 2008) and found that all birds developed neutralizing 
antibodies.   
One potential explanation for these findings in Manatee County may result from 
low-titered viremia following infection (note: no virus was detected in blood samples 
collected from these birds) that may have resulted in weak antibody production and/or 
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non-detection in the HAI assay. A previous study of “old” chickens (38 weeks) 
experimentally infected with SLEV found that these birds did not develop a low-titer 
viremia following inoculation, unlike younger birds.  Nonetheless, both old and young 
chickens inoculated with SLEV eventually developed detectable antibody in the HAI 
assay (Reisen et al, 1994). Further animal studies would be necessary to evaluate the 
antibody response following WNV infection in older chickens to elucidate these findings.  
This phenomenon was not restricted to Manatee County. Interestingly, West Nile 
virus was also detected by RT-PCR in two birds from Sarasota County, which did not 
screen antibody-positive in the HAI assay in 2006. Despite the culture of infectious West 
Nile virus (strain FLS504), Bird 8-005-B did not develop detectable HAI antibody at Site 
004. Since swab samples were processed retrospectively, the paired serum sample (HAI 
negative) for the cloacal swab was discarded and further testing (MAC-ELISA, PRNT) 
could not be performed. Later sera samples were drawn but were also negative by HAI 
and MAC-ELISA. It is interesting to note that three plaques (out of four) picked from 
direct inoculation of the cloacal swab (FLS504) eluate confirmed WNV and SLEV 
positive by TaqMan RT-PCR. CT values ranged from 22-24 for WN primer-probe sets 
and 37-40 for SLE primer-probe sets. The other plaque picked only tested positive for 
WNV, with CT values of 23-24 (data not shown) [note: additional plaques formed in 
more concentrated wells but grew too close together to be picked].  The CT values for 
both SLE primer sets were higher (37-40) than noted for FLS502 collected at the same 
time point, so this may be an equivocal result. However, cross-reactions between these 
primer sets have not been noted during routine testing at the BOL-Tampa, or in prior 
publications (Lanciotti et al 2000; Lanciotti and Kerst, 2001). It is unknown if a mixed 
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population of WNV and SLEV in the cloacal swab resulted in these cross-reactions 
(although this possibility was not supported by plaque assays, where only WNV was 
detected).  
West Nile virus (strain FLS502) was isolated from another chicken (Bird 8-003-
R) at this site from the same time point and did not develop WNV-specific antibodies in 
serum collected on October 9 (Figure 4-23).  However, this chicken was also infected 
with SLEV and only developed SLEV-specific antibodies in the HAI or MAC-ELISA 
assays (detected in all serology assays). In addition, no seroconversions to West Nile 
virus were detected in sentinel chickens after April in Sarasota County (2006) [except for 
a presumptive positive for WNV by the MIA test at Site 003 in June, Figure 4-20]. 
Consequently, the isolation of West Nile virus from these chickens was surprising, as the 
virus was only detected by molecular methods (RT-PCR) in October. As in Manatee 
County, the age of these chickens (52 weeks) in Sarasota County may play a role in 
development of the immune response following natural West Nile virus infection.  
Finally, two chickens at Site 001 in Sarasota also failed to produce detectable total 
antibodies (HAI negative) following RT-PCR detection of a novel flavivirus strain on 
cloacal swabs. Unfortunately, serum samples from these birds were not tested in the 
MAC-ELISA or PRNT, as these swabs were processed retrospectively. It is unknown if 
these birds developed detectable WNV or SLEV antibodies in a more specific assay, such 
as the MAC-ELISA. A future study is planned to perform complete genome sequencing 
of these virus strains, which may elucidate these unusual findings.  Virus genotype and/or 
mutations in the envelope gene have been identified that predict virulence and/or 
modulate the production of cross-reactive neutralizing antibodies (Beasley et al, 2002; 
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Beasley et al, 2004; Crill and Chang, 2004; Trainor et al, 2006). Perhaps similar 
mutations in these genomes may be found that produced the clinical picture presented by 
these flavivirus and West Nile virus strains. 
Evaluation of RT-PCR Assays 
Real-Time (TaqMan) RT-PCR 
The TaqMan primer-probe sequences and gel-based primer sets developed for 
WNV and SLEV (Lanciotti et al, 2000 and Lanciotti and Kerst, 2001, respectively) were 
accurate for the detection of Florida strains of these arboviruses. New strains (n=8) 
collected during 2005 and 2006, as well as WNV (n=8) and SLEV (n=14) reference 
strains, were confirmed and sequenced with these gel-based primer sets.  
The WNV primer sets performed as previously reported (Lanciotti et al, 2000), 
such that six reference strains of WNV from Florida were detected in TaqMan RT-PCR 
assays (WNA and WNB primer-probe sets) and confirmed by sequencing the partial 
capsid/envelope region (WNAE primer set) [Table 3-7].  In addition, recent isolates of 
WNV from sentinel chickens (n=4) also were detected by real-time and gel-based RT-
PCR assays. Interestingly, the WNA and WNB primer-probe sets detected the novel 
flavivirus strain FLS694, but did not detect FLS649.  In contrast, the SLEA and SLEB 
primer-probe sets detected both novel flavivirus strains (Table 4-7). 
Conversely, the SLEV real-time primer-probe sets (Lanciotti and Kerst, 2001) did 
not perform as expected for South American reference strains and one Florida isolate 
(FL72) of St. Louis encephalitis virus [Table 5-5].  The SLEA primer-probe set 
(SLE834/SLE905c/SLE857p) targeted the membrane region of the virus and detected all 
of the reference strains (n=14) analyzed in this study. In addition, recent isolates of SLEV 
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from sentinel chickens (n=2) were detected by the SLEA primer-probe set.  However, 
confirmation of South American reference strains failed to detect several strains with the 
SLEB primer-probe set (SLE2420/SLE2487c/SLE2444p) [Table 5-5], especially SLEV 
isolates from Trinidad.  Each of the Florida strains of SLEV confirmed with the SLEB 
set, with the exception of FL72 (strain collected in the panhandle region of the state in 
1972).  Lanciotti and Kerst (2001) only reported the detection of three South American 
strains of SLEV [Guatemala (1969), Panama (1973), and Ecuador (1976)] with these 
TaqMan assays. Trinidad and Brazilian strains were not assayed or experimental results 
were not published, if they were evaluated in this study (Lanciotti and Kerst, 2001).  
Mutations in the St. Louis Encephalitis Virus Envelope Region 
Four additional reference strains from South America were tested (three isolates 
from Trinidad [TRVL strains] and one strain from Brazil) with TaqMan primer sets 
[Table 5-5] to evaluate strain-specific differences in the envelope region of SLEV. The 
four supplemental reference strains also screened positive with the SLEA set (CT values ≤ 
40), with two strains undetected by the SLEB set. However, these strains were not 
studied further or included in phylogenetic analysis of the envelope region due to 
incomplete strain histories (unknown source, passage, or date).  
TaqMan primers and probes are designed to specific conserved regions of the 
virus.  In fact, the oligonucleotide probe has been shown to be especially intolerant of 
nucleotide substitutions at its binding site for the envelope region of West Nile virus.  
A single nucleotide change in the probe region can prevent annealing of the probe 
and detection by the instrument. Viral variants with multiple substitutions may escape  
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Table 5-5 Real-Time RT-PCR (TaqMan) Results for SLEV Reference Strains 
Real-time RT-PCR assays were run in replicate for the detection of virus 
strains. Two primer-probe sets designed to specifically target SLEV 
(designated SLEA & SLEB) were used. Samples were screened with the 
“A” primer sets and confirmed with “B” primer sets. CT values were 
averaged and values ≤ 40 were positive. One Florida strain and several 
South American (Trinidad & Brazil) strains of SLEV were negative with 
the SLEB primer set (shaded boxes). 
 
Reference SLEV Strains SLEA (CT) SLEB (CT) 
FL52 21.60 24.48 
TBH-28 28.20 22.03 
FL72 23.74 43.00 
FL85a 22.43 16.52 
FL85b 24.28 15.12 
FL89 18.50 17.22 
FL90a 25.07 20.83 
FL90b 21.72 18.89 
FL90c 21.86 19.74 
FL90d 21.93 18.80 
TR58 19.14 Undet 
TR62 19.15 Undet 
BR64 21.86 33.86 
BR69 22.26 Undet 
BeAn 208331 17.94 Undet 
TRVL 33228-1 36.53 36.07 
TRVL 21882 18.88 37.42 
TRVL 35928 20.45 Undet 
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detection by TaqMan®, as shown by a 47% false-negative rate for WNV mutants with 
altered probe-binding sites (Papin, Vahrson and Dittmer, 2004).   
 Synthesized mutations to the viral envelope region and subsequent detection of St. 
Louis encephalitis virus strains with TaqMan primer-probe sets has not been 
investigated,nor has a SYBER green-based assay been developed, as shown for WNV 
(Papin, Vahrson and Dittmer, 2004). However, SLEV strain-specific differences have 
been demonstrated in this study for TaqMan detection of North American versus South 
American strains (3’ end of the envelope region). The complete envelope region of 
fourteen reference strains was sequenced and aligned (Appendix N). This region was also 
trimmed to the 68 base pairs amplified by the SLEB real-time TaqMan primer-probe set 
(Figure 5-1) and analyzed. Several conserved nucleotide substitutions were noted for 
South American strains (compared to a single mutation in Florida “epidemic” strains) in 
this envelope region. However, conservation of cytosine (C) at position 2458 likely 
allowed for detection of FLS569 and FLS650 by the SLEB primer set.  It is not clear why 
BR64 was detected by the SLEB primer-probe set, when this strain was identical to other 
strains (except TR58) over the probe annealing region.  In this situation, mutations at 
binding sites of the forward and reverse primers for TR58, TR62, and BR69 appear to be 
responsible for non-detection of these strains. This possibility (altered binding sites in the 
sense and anti-sense primers) was mentioned but not deemed relevant or further 
investigated for WNV strains (Papin, Vahrson and Dittmer, 2004).  
These findings are significant in the public health setting, where public health diagnostic 
laboratories frequently screen suspected clinical and surveillance samples for arboviruses 
with the primer sets developed by the CDC (Lanciotti and Kerst, 2001).  The  
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Figure 5-1 Multiple Sequence Alignment of the 3’ Envelope Region Targeted by 
Real-Time RT-PCR (TaqMan) Primer-Probe Set  
 The sense primer binds at position 2420 (first base in this figure). The 
probe anneals to the region encompassing nucleotide positions 2444-2466 
(boxed sections). The anti-sense primer binds over the region from 2487-
2468. Multiple sequence alignment of North American (Florida) and 
South American strains of SLEV indicated several nucleotide substitutions 
(transition mutations) in Florida “South American” strains and isolates 
from South American countries (Trinidad and Brazil). South American 
strains have 3 nucleotide substitutions in the probe annealing region.  
 
              
#FL52    CTG GCT ATC GGA GGG ATT CTC ATC TTT CTG GCA  [2452]
#TBH-28  ... ... G.. ... ... ... ... ..T ... ... ...  [2452]
#FL72    ... ... G.T ... ... ... ..A ... ... ..A ..G  [2452]
#FL85a   ... ... G.. ... ... ... ... ... ... ... ...  [2452]
#FL85b   ... ... G.. ... ... ... ... ... ... ... ...  [2452]
#FL89    ... ... G.. ... ..A ... ... ... ... ... ...  [2452]
#FL90a   ... ... G.. ... ..A ... ... ... ... ... ...  [2452]
#FL90b   ... ... G.. ... ..A ... ... ... ... ... ...  [2452]
#FL90c   ... ... G.. ... ..A ... ... ... ... ... ...  [2452]
#FL90d   ... ... G.. ... ..A ... ... ... ... ... ...  [2452]
#FLS569  ... ... G.T ... ... ... ..G ... ... ..A ..G  [2452]
#FLS650  ... ... G.T ... ... ... ..G ... ... ..A ..G  [2452]
#TR58    ... ... G.T ... ... ... ..A ... ..C ..A ..G  [2452]
#TR62    ... ... G.T ... ... ... ..A ... ... ..A ..G  [2452]
#BR64    ... ... G.T ... ... ... ..A ... ... ..A ..G  [2452]
#BR69    ... ..C G.T ... ... ... T.A ... ... ..A ..G  [2452]
#Kern217 ... ... G.T ... ... ... ..T ... ... ... ...  [2452]
#WNNY99  ..C ..A G.T ... ..A G.. ..G C.. ..C ..C T.C  [2452]
#WNEgypt ..C ..A G.T ... ... G.. T.G C.. ... ..C T.C  [2452]
 
              
#FL52    ACC AGC GTG CAA GCC GAT TCG GGA TGT GCA ATT GAC [2488]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... [2488]
#FL72    ... ... ... ... ..T ... ... ... ... ... ... ... [2488]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... [2488]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... [2488]
#FL89    ... ... ..A ... ... ..C ... ... ... ... ... ... [2488]
#FL90a   ... ... ..A ... ... ..C ... ... ... ... ... ... [2488]
#FL90b   ... ... ..A ... ... ..C ... ... ... ... ... ... [2488]
#FL90c   ... ... ..A ... ... ..C ... ... ... ... ... ... [2488]
#FL90d   ... ... ..A ... ... ..C ... ... ... ... ... ... [2488]
#FLS569  ... ... ... ... ..T ... ... ... ... ... ... ... [2488]
#FLS650  ... ... ... ... ..T ... ... ... ... ... ... ... [2488]
#TR58    ... ..T ... ... ..T ... ... ... ... ... ... ... [2488]
#TR62    ... ..T ... ... ..T ..C ... ... ... ... ... ... [2488]
#BR64    ... ..T ... ... ..T ... ... ... ... ... ... ... [2488]
#BR69    ... ..T ... ... ..T ... ... ... ... ... ... ... [2488]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... [2488]
#WNNY99  GTG .A. ... ..C ..T ..C A.T ..G ... ..C ..A ... [2488]
#WNEgypt GTG .A. ... ..C ..T ..C A.T ... ... ..C ..A ... [2488]  
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current diagnostic testing algorithm used by the BOL-Tampa would report a negative 
result for a sample detected only with a single TaqMan primer-probe set (e.g. SLEA).  
Confirmation of a “screening” result with a second TaqMan primer-probe set (SLEB) is 
required to report a positive result by molecular RT-PCR assays, per CDC guidelines 
[CDC, 2003A].   
A false-negative could result in misdiagnosis of a patient and/or impair mosquito 
control agencies that utilize surveillance results to implement control measures. As a 
result of this study, modifications have been made to the BOL-Tampa algorithm to 
include confirmation of SLEA positive screening assays with gel-based RT-PCR (if also 
negative by SLEB primer set) prior to reporting of a result. Thus far, false-negative 
samples have not been identified (or reported) due to the low prevalence of SLEV over 
the last decade. The two South American strains of SLEV isolated from sentinel chickens 
(FLS569 and FLS650) represent the first detection of North American SLEV since the 
1997 outbreak in Florida. Future studies are planned to develop new TaqMan primer-
probe sets that detect a complete battery of known South American strains of St. Louis 
encephalitis virus, which would provide more rapid results than confirmation by 
traditional RT-PCR methods (see End-Point RT-PCR below). 
 In Florida, this study has shown the introduction and re-introduction of South 
American strains of SLEV in the last 35 years. A previous phylogenetic analysis of the 
envelope region (Kramer and Chandler, 2001) had shown clustering of South American 
strains (Brazil, Mexico, and Panama) into Lineage IIA and IID, predominately North 
American clades (refer to Table 2-2). Southeastern states appear to be most affected by 
these findings, especially Florida and Texas, where phylogenetic analysis places South 
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American strains into clusters of isolates from these two states. In fact, Florida strains 
isolated in 1962 (TBH-28 and P-15) cluster with strains isolated in Mexico and Panama 
[Kramer and Chandler, 2001]. Consequently, diagnostic laboratories and public health 
agencies should be aware of potential false-negative results in real-time (TaqMan) RT-
PCR assays (Lanciotti and Kerst, 2001) for South American strains of SLEV circulating 
in the United States. Traditional RT-PCR methods are recommended for addition to the 
real-time (TaqMan) testing algorithm to confirm SLEA (screening primers) positive 
results, providing a second TaqMan primer set does not detect the virus.   
End-Point RT-PCR  
Several end-point RT-PCR primer sets designed for flaviviruses, as well as 
specifically for WNV and SLEV, were used for confirmation of real-time (TaqMan) 
results (Tables 3-7, 3-8 and 3-9).  The traditional gel-based RT-PCR method was not 
used to screen blood or cloacal swabs for detection of arboviruses, due to the lower 
reported sensitivity of the assay (1 PFU) compared to a real-time RT-PCR (TaqMan) 
assay (<1 PFU) for West Nile virus [Lanciotti et al 2000]. Sensitivities were identical for 
gel-based and real-time RT-PCR assays for St. Louis encephalitis virus (1 PFU) 
(Lanciotti and Kerst, 2001). Consequently, these more laborious, slower assays were 
performed for confirmation and sequencing reactions on positive real-time RT-PCR 
samples, including RNA extracted from cloacal swabs and cell culture supernatants.  
With the exception of WN and EEE viral RNA detected on cloacal swabs (virus 
not culturable) in 2005, TaqMan positive results (n=9) were confirmed with end-point 
RT-PCR primer sets.  Reference strains were also tested (SLEV, n=14; WNV, n=8). 
These strains either confirmed with the SLEC (membrane/envelope region) or WNAE 
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(capsid/prM region) primer sets depending on the strain of virus. The SLEC primer set 
amplified a subset of South American (and North American) strains studied (Figures 4-
10, 4-28). West Nile virus did not cross-react with this primer set. Instead, West Nile 
virus strains were successfully amplified with the WNAE primer set (Figure 4-29), which 
did not cross-react with SLEV. Novel flavivirus strains confirmed in both assays (Figures 
4-33 and 4-36). Based on this study, both gel-based primer sets would serve to confirm 
suspected SLEV or WNV positive samples by real-time RT-PCR assays, as previously 
reported (Lanciotti et al, 2000; Lanciotti and Kerst, 2001). 
In addition, several larger fragments of the viral genome were amplified for 
sequencing and phylogenetic analysis of reference and recent circulating strains of SLEV 
and WNV.  The complete envelope region of St. Louis encephalitis virus strains was 
amplified (1700bp PCR product) [Figure 4-27] and sequenced. The F880/B2586 primer 
set detected both North American and South American strains of SLEV (Kramer and 
Chandler, 2001), with successful amplification of all South American strains studied. 
West Nile virus did not cross-react with this primer set. The novel flavivirus strains also 
were not detected by this primer set (Figure 4-34) despite detection with both SLEV 
TaqMan primer sets. However, the complete envelope reverse primer (B2586) anneals to 
the genome approximately 100 bases downstream of the TaqMan SLEB primer set (3’ 
envelope region).  In contrast, the SLEA primer set targets the membrane region 
approximately ~70 bases upstream of the forward envelope primer (F880). This results in 
no overlapping regions with these primer sets (Figure 3-14).  
The RNA-dependent RNA polymerase (RdRp) domain is located at the carboxy 
(3’) terminus of the NS5 region, encoded from nucleotide positions 8997 to 9233 (based 
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on the yellow fever genome). The RdRp region in the NS5 gene is also the most 
conserved coding sequence in the flavivirus genome and important to transcription and 
replication of the virus [Chao, Davis, and Chang, 2006]. A portion of this NS5 region 
was amplified (larger 1000bp PCR product) [Figure 4-30] and sequenced. The Fu1/cfd3 
primer set (Kuno et al, 1998) detected both WNV and SLEV strains and amplified a 
portion of the RdRp domain [starting at positions 9070 (SLEV) and 9080 (WNV)].  
Interestingly, South American SLEV strains included in this study produced three 
amplicons (1000bp, 750bp, and ~300bp) with this primer set, as shown for FLS569 
(Figure 4-30).  North American SLEV and WNV strains produced a single 1000bp PCR 
product. However, the novel flavivirus strains were not detected by this primer set 
(Figure 4-35). 
A second primer set (WNBE) was used to amplify an internal portion of the NS5 
region described above.  However, this primer set was provided to the BOL-Tampa by 
the CDC following the introduction of WNV to the United States and was not fully 
validated nor published (personal communication, R. Lanciotti). Unlike the WNAE 
primer set, RT-PCR assays with these primers were non-specific and detected both WNV 
and SLEV (Figure 4-31). In addition, most sequencing reactions with these primers 
failed, as performed at two different facilities (BOL-Tampa and H. Lee Moffitt Cancer 
Center). Nevertheless, three recent strains isolated from sentinel chickens were 
successfully amplified and sequenced (FLS504, FLS649 and FLS694).  Notably, this 300 
bp region was detected and sequenced for the novel flavivirus strains despite non-
amplification of the larger NS5 product (1000bp). Nonetheless, this primer set is not 
recommended for confirmation or sequencing of West Nile virus isolates. 
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 Finally, a second universal flavivirus primer set (YF1/YF2) was used for 
amplification of 600-700 bases of the 3’ non-coding region (Tanaka, 1993).  This primer 
set detected both SLEV (600bp amplicon) and WNV (700bp amplicon) [Figures 4-32 and 
4-35]. Novel flavivirus strains were not amplified by this primer set (Figures 4-35). A 
subset of SLEV strains were assayed and sequenced in this region. Few nucleotide 
mutations were noted (Tables 4-10, 4-11). BLASTN results (Appendix I) were 
indistinguishable between strains, due to the limited number of St. Louis encephalitis 
virus sequences available in GenBank for this region. Consequently, the use of this 
primer set was discontinued at the BOL-Tampa and is not recommended for analysis of 
SLEV (at this time).  
 In conclusion, several primer sets were evaluated for detection and sequencing of 
SLEV and WNV strains collected in Florida, or SLEV strains acquired from South 
America (Table 4-10). These primer sets produced the expected amplicon sizes, as 
previously published, and distinguished between West Nile virus and St. Louis 
encephalitis virus after sequencing. One universal primer set for the detection of WNV, 
SLEV and the novel flavivirus strains was not identified (the WNBE primers produced 
poor sequence data for most strains). However, the primer set targeting the NS5 region 
(Fu1/cfd3) was able to rapidly distinguish between North American and South American 
strains of SLEV without sequencing. A characteristic banding pattern for South American 
strains (3 amplicon sizes) was visualized by gel electrophoresis, and confirmed with 
sequencing. The WNAE and SLEC primers are recommended for the detection of WNV 
and SLEV, respectively, as well as identification of novel flavivirus strains with paired 
analysis of these primer sets. 
 352
Sample Collection Methods 
In 2005, whole blood samples were added to lysis buffer (for molecular detection 
assays) and biological field diluent (for cell culture assays) during the weekly scheduled 
sampling of chickens at targeted sites. Concurrently, cloacal swabs were collected from 
these birds. Periodically, cloacal swabs were collected twice in one week from targeted 
birds at each agency’s discretion; however, blood was not collected again. 
Arboviral RNA was detected on a total of seven cloacal swabs from two counties 
(3 WNV+ and 4 EEEV+). However, real-time (TaqMan) RT-PCR assays performed on 
six corresponding blood samples were negative (note: FLM42-2 was a second swab, 
without a matching blood sample). Virus isolation in cell culture was attempted for each 
sample. BFD samples were filtered prior to inoculation into Vero cells and monitored for 
cytopathic effect for two weeks. All cell cultures were negative. Consequently, these 
results indicate that viremia was absent or below the threshold of detection by TaqMan 
RT-PCR on these collection dates, despite shedding of the virus in the feces.    
A further evaluation of blood samples collected from sentinel chickens was 
performed, where 194 specimens were screened by molecular detection and cell culture 
assays (200 total). A subset of these blood samples (n=20) were collected from 13 birds 
prior to and on the date of seroconversion in Manatee County. The remaining samples 
were tested from both Orange and Manatee counties from birds that did not seroconvert, 
as detected by the HAI assay. No virus was detected or isolated. These results further 
support the conclusion that viremia in naturally exposed chickens is very transient and/or 
at levels that are too low for detection, as performed in this experimental design.  
Consequently, the detection of arboviruses from blood samples was not practicable and 
 353
was discontinued during targeted sample collection by Sarasota County in 2005. Whole 
blood samples were not collected in 2006. 
These results were not surprising based on previous laboratory studies that 
identified transient, low titered viremias in chickens for SLEV or WNV (Reisen et al, 
1994; Senne et al, 2000; Langevin et al, 2001; Patiris et al, 2008). Experimentally 
infected chickens (needle inoculated) were viremic between two to three days post-
inoculation.  These studies also indicated that neutralizing antibody titers developed 
within two weeks of infection (Senne et al, 2000; Langevin et al, 2001). One study on 
SLEV identified that young chickens (19 weeks) developed a low titer, transient viremia 
for 1 day post-inoculation, which was not observed for older birds (38 weeks). These 
birds developed IgG antibodies to SLEV after 14 days post-inoculation (Reisen et al, 
1994). A recent study found that WNV and SLEV viremia in chickens subsided after 5 
days and the viremic response had significantly lower titers for SLEV (Patiris et al, 
2008).  
These studies were performed in controlled environments, where sample 
collection allowed for the immediate preservation of viremic blood (placed on ice or 
frozen) for later detection and quantification of the virus. In contrast, blood and cloacal 
swab collection from chickens was performed in the field during the warm summer 
months in Florida. Blood samples and cloacal swabs were placed in coolers with gel ice 
packs following collection. Consequently, it is possible that a low-level viremia was 
present for birds that later seroconverted but that environmental conditions and transport 
to the laboratory may have allowed for specimen degradation. Nevertheless, these birds 
did not appear to contribute to the local arbovirus transmission cycle and support earlier 
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studies indicating that viremia was well below the threshold required to infect mosquitoes 
(Langevin et al, 2001; Reisen, Fang and Martinez, 2005; Patiris et al, 2008).  
Several studies of West Nile virus and St. Louis encephalitis virus in wild birds 
(experimental infections) identified transient, high titered viremias capable of infecting 
mosquitoes (Komar et al, 2003; Reisen et al, 2003; Fang and Reisen, 2006). Fang and 
Reisen (2006) found that house finches infected with SLEV developed a lower titered 
viremia than birds infected with WNV.  Immune responses following inoculation of 
WNV and SLEV for wild bird species were also assessed, where two studies identified 
birds that failed to produce detectable antibody. For WNV, two birds out of 67 did not 
produce antibodies after 14 days post-inoculation, where detectable viremia was preset at 
24 hours post-inoculation and a persistent infection in the heart tissue was found for one 
bird. The second bird did not develop detectable viremia (Komar et al, 2003).  SLEV-
inoculated wild birds were sampled for six weeks and 58 birds (out of 163) failed to 
develop detectable antibodies (Reisen et al, 2003).  These experimental results in wild 
birds may in part explain the finding of six sentinel chickens that failed to seroconvert in 
the HAI assay following detection of the viral RNA on cloacal swabs (3 WNV+, 2 
Flavi+, and 1 EEEV+), either by escape of systemic infection or a low-level viremia 
resulted in the development of detectable titers of neutralizing antibodies. 
West Nile virus has been extensively isolated from over one hundred bird species 
in North America, following invasion of the virus and subsequent widespread bird 
mortality (CDC, 2007b, g). In contrast, St. Louis encephalitis has rarely been isolated 
from birds (Reisen, 2003).  Following the introduction of WNV to the United States, 
cloacal swabs were a sensitive, low-resource method for virus detection and isolation 
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from dead wild birds without necropsy (Komar et al, 2002; Brennan, 2003). In addition, 
experimental studies detected West Nile virus shed in the feces from live, laboratory-
infected chickens on cloacal swabs (Senne et al, 2000; Langevin et al, 2001). In young 
chickens (seven weeks old), shedding was only detected on cloacal swabs four  and five 
days post-inoculation (DPI) [Senne et al, 2000].  Another study using older chickens (17-
60 weeks) found that WNV shed in the feces from two to six DPI. However, peak 
detection of the virus occurred between days three through five post-inoculation. 
Interestingly, virus was not detected (shed) in the majority of mosquito-inoculated 
younger birds aged 17 weeks (9 of 11). However, West Nile virus was detected in the 
feces of all mosquito-inoculated chickens aged 60 weeks (n=5), as well as needle-
inoculated birds aged 20 weeks (n=5) [Langevin et al, 2001]. In this case, the age of the 
birds positively influenced the outcome of this study, such that virus was detected in the 
feces (but not blood) of sentinel chickens over 40 weeks of age. Table 5-6 provides a 
comparison of the detection of arboviruses from whole blood samples compared to 
cloacal swabs during the study period. 
Langevin et al. (2001) reported very low titers of West Nile virus detected on 
cloacal swabs (1-200 PFU/0.5ml). In Florida, these findings were supported in naturally 
infected sentinel chickens (Table 4-18), where three chickens shed an average 34 
PFU/0.1ml (range 32-36 PFU/0.1ml) of WNV or SLEV, as detected by cloacal swabs. 
Two other birds shed very low levels of virus in the feces, such that 3 PFU/0.1ml of 
WNV was detected on one cloacal swab (FLM38), whereas another bird shed SLEV 
(FLS650) below the level of detection (< 2 PFU/0.1ml) in the plaque assay. In contrast to 
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experimental studies, a single chicken shed a higher titer (816 PFU/0.1ml) of West Nile 
virus (FLS502) in the feces, as detected by plaque assay on cloacal swab eluate.  
Additional experimental studies measured the titer of West Nile virus directly 
shed in the feces (measured by gram) of wild birds, which indicated that titers were 
actually two to three fold higher than reported for cloacal swabs (Komar et al, 2003; Kipp 
et al, 2006). However, the WNV titers detected in sentinel chickens during this study 
were well below the approximate range of 103 through 109 PFU/g detected in wild bird 
species and likely do not represent as high of a risk to handlers of sentinel chickens 
compared to those that work with sick or dead wild birds (Komar et al, 2003; Kipp et al, 
2006).    
Characterization of Primary Immune Response in Sentinel Chickens 
The current study provided a unique opportunity to characterize arbovirus 
infections and development of the primary immune response in adult chickens following 
natural exposure. Transmission of the virus by mosquito bite is an ideal model that 
experimental studies may use to mimic a “natural” arbovirus infection of a vertebrate 
host in the laboratory, which also have had quantification and debate over the titer of 
virus delivered by mosquito bite (Reisen et al, 2000a). This method has previously been 
described in adult chickens for West Nile virus (Langevin et al, 2001). The timing and 
titer of viremia are important measures that influence the ability of the vertebrate host to 
infect mosquito populations and contribute to the amplification cycle (Reisen et al, 
2000a; Langevin et al, 2001; Reisen et al, 2002; Reisen, 2003; CDC, 2003A, 2004b, 
2005c, 2007b).  In addition, the development of virus-specific antibodies, both IgM and  
 357
Table 5-6 Comparison of Sample Collection Methods for the Detection of 
Arboviruses 
In 2005, two sample types were collected from sentinel chickens, whole 
blood and cloacal swabs. Cloacal swabs were a more successful sample 
type for the detection of arboviruses than whole blood samples. 
Consequently, the collection of whole blood samples from sentinel 
chickens for virus detection/isolation assays was discontinued in 2006. 
 
 
Comparison of Cloacal Swab and Whole Blood Sample Types 
Collected for Arbovirus Detection/Isolation 
Year 
Total 
Number 
Cloacal 
Swabs 
Total 
Number 
Processed 
Cloacal 
Swabs 
Number 
Positive 
Cloacal 
Swabs 
Total 
Number 
of Blood 
Samples 
Total 
Number 
Processed 
Blood 
Samples 
Number 
Positive 
Blood 
Samples 
2005 623 259 7 445 200 0 
2006 1338 529 8 NA NA NA 
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IgG, are important to assess vertebrate recovery from infection and susceptibility to re-
infection (Calisher et al, 1986b & c).  
From a public health perspective, several arbovirus surveillance programs in the 
United States utilize sentinel chicken seroconversions for detection of transmission 
activity and as an early warning system for potential epidemics/epizootics of disease 
(Komar, 2001; Blackmore et al, 2003; Reisen et al, 2004b; Butler and Stark, 2005; Patiris 
et al, 2008). For the first time in Florida, this study used the sentinel chicken program to 
collect samples that were tested for detection/isolation of the virus, as well as for sentinel 
seroconversions.  Arboviruses were detected/isolated from six naturally infected birds 
that also seroconverted to antibody positive for the infecting agent. The development of 
the primary immune response differed by arbovirus strain and location (county) of 
collection. Vendor (local chicken farms), type and approximate age of chickens at the 
time of transmission activity differed for each county where virus was detected (Table 5-
7). 
 In Orange County, Eastern equine encephalitis viral RNA was detected by 
TaqMan RT-PCR on two cloacal swabs collected from Bird 846 in August 2005. 
However, a serum sample collected from this chicken at the same time was negative for 
the presence of alphavirus total antibody, as measured by the HAI assay (Figure 4-10). 
Although the exact date of infection is unknown for this chicken, it is likely that it either 
coincided or occurred within one to two days of viral RNA detection on the cloacal swab. 
This finding is supported by the detection of alphavirus total antibody (seroconversion) 
six to eight days later in the HAI assay, which corresponds to the seven days post-
inoculation previously reported by experimental studies of chickens (Ogata and Byrne, 
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Table 5-7 Characteristics of Adult Sentinel Chickens Placed at Enzootic Transmission Sites By County 
Chickens were purchased from different vendors for the 2005 and 2006 seasons. Manatee, Orange and Sarasota 
counties purchased female, white leghorns for use at enzootic arbovirus transmission sites.  Age of sentinel chickens 
are shown as an estimate of age (in weeks) at the time of virus detection/isolation in each county.  
 
 
 
 
 
 
 
 
 
           
 
 
 
Characteristics of Adult Sentinel Chickens Placed at Enzootic Arbovirus Transmission Sites 
 
 
County 
 
Year 
 
Type 
 
 
Age (weeks) 
 
 
Vendor 
 
Manatee  2005 White leghorn 40 – 156  Port Manatee Inmate Farm (bred in Alabama) 
2005 White leghorn 40 
 
Hillandale LLC Farms (FL) 
 
 
Orange 
 
2006 White leghorn 36 
 
Hillandale LLC Farms (FL) 
 
 
2005 
 
White leghorn 52 Hillandale LLC Farms (FL) 
 
Sarasota 
2006 White leghorn 52 
 
Tampa Farms (FL) 
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1961; Calisher et al, 1986b). However, experimental inoculation of chickens with EEEV 
detected virus-specific IgM antibodies four days post-inoculation (Calisher et al, 1986b; 
Olson et al, 1991).  This experimental finding was not replicated by this naturally 
infected chicken. An IgM antibody capture ELISA did not detect EEEV-specific 
antibodies in the first HAI positive serum. It was assumed that IgM antibodies had 
already declined since cross-reactive neutralizing antibody was detected in the PRNT, 
such that further sera samples were not assayed in the MAC-ELISA (Figure 4-10).  
Consequently, it is unknown if the IgM response remained negative (P/N value < 2.0) or 
increased over the next 14 days that the bird was sampled.  
As a result, infection may have occurred earlier than first detected by cloacal 
swabs, with a corresponding elevated IgM response that was not detected by the HAI 
assay. Or this chicken may have had a poor immune response to the virus resulting in an 
initial low titered, cross-reactive total antibody produced, followed by a rise in IgM more 
than six days post-infection. A previous infection with HJV may also have led to a low 
level cross-reactive antibody, with a depressed IgM and early strong IgG response. Future 
targeted studies for the detection of EEEV in sentinel chickens would be beneficial to 
resolve these questions and to describe the natural course of infection and development of 
the primary immune response in several birds. Overall, the HAI assay detected total 
antibody for this bird soon after infection, which allowed for rapid detection of arbovirus 
transmission activity based on this seroconversion.  
In contrast to the EEEV seroconversion, the development of antibodies in a 
sentinel chicken following natural West Nile virus infection in Manatee County was quite 
different (Figure 4-14). For Bird 1773, isolation of infectious WNV from a cloacal swab 
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occurred on the first day of targeted sampling. A serum sample collected at the same time 
point was negative in the HAI assay for flavivirus total antibodies. However, this serum 
sample was assayed in the MAC-ELISA and WNV-specific IgM antibodies were 
detected (P/N = 6.3). The agency was notified that the bird had seroconverted to WNV, 
so that it could be removed from the field. However, the BOL-Tampa requested for the 
agency to continue sampling the bird until detectable total antibody developed in the HAI 
assay. Unlike the EEEV seroconversion, the next serum sample and cloacal swab 
collected seven days later were also negative.  This serum sample was also tested in the 
MAC-ELISA, which detected that the peak IgM response occurred at day seven post-
isolation (P/N = 21.9).  Bird 1773 first developed detectable HAI total antibodies 28 days 
post-isolation of West Nile virus. This unusual antibody profile has not been reported 
previously for chickens, where total antibody titer failed to develop despite elevated 
virus-specific IgM antibodies for 28 day period.   
It should be noted that this chicken is likely an exception to the rule and may not 
represent the primary immune response following natural WNV infection. In fact, most 
chickens develop an IgM response that rises and decays within one to two weeks 
(Calisher et al, 1986c; Martin et al, 2000). In contrast, this chicken had elevated IgM 
antibody until 28 days post-isolation of the virus and likely for longer, as the P/N value 
(5.2) was still elevated on the last time point collected. The chicken was 64 weeks old 
when virus was first detected and this may have influenced its subsequent immune 
response. The success of the sentinel chicken program for early warning of transmission 
activity in Florida through the detection of seroconversions in the HAI assay has been 
established (Blackmore et al, 2003; Butler and Stark, 2005). Sentinel seroconversions to 
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West Nile virus infections were likely detected much earlier than shown in Manatee 
County, and have played a role in limiting the number of human cases in Florida. 
However, a month delay until initial identification of transmission activity in a sentinel 
chicken flock is not an effective surveillance tool. If this were the norm, public health in 
the region could be jeopardized, as this may allow virus amplification to occur without 
early warning and hamper immediate vector control efforts. Interestingly, the slow 
antibody response in these chickens may have allowed for the extensive transmission of 
arboviruses to sentinel chicken flocks throughout Manatee County in 2005 (Figure 3-3), 
where 11 out of 13 sites experienced activity. Despite these active sentinel sites, no 
human cases of arboviral disease were reported in the county. Nonetheless, it is 
recommended that sentinel chickens be replaced each year so that advanced age does not 
impact detection of seroconversions in the following transmission season. 
In 2006, St. Louis encephalitis virus was isolated from two sentinel chickens in 
Sarasota County. The primary immune response will be described for each chicken 
separately. West Nile virus and St. Louis encephalitis virus was isolated from Bird 8-003-
R in October. WNV was isolated from the first cloacal swab collected from this chicken. 
On the same collection date, the matching serum sample was strongly positive in the HAI 
assay, with total antibody titer ≥ 40 (Figure 4-23).  This serum sample confirmed positive 
for St. Louis encephalitis virus in the MAC-ELISA, an experimental MIA test, and the 
PRNT (titer ≥ 40), with negative values in all assays for West Nile virus. In this situation, 
it appears that high neutralizing antibody titers to SLEV (as detected by the PRNT) did 
not prevent a dual infection of this bird with WNV. 
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The second cloacal swab and serum sample collected seven days later were tested 
and with identical results; WNV was isolated from the swab and the serum was 
confirmed SLEV positive in the MAC-ELISA, MIA, and PRNT assays.  Then, two days 
later a third swab was collected from this bird (no matching serum sample). Infectious 
SLEV was isolated. Based on the serology profile from sera collected over 14 days, it 
appears that SLEV was not isolated from these birds when IgM antibodies were highest.  
Instead, the virus was isolated two days after WN virus titers also declined, which 
corresponded to a decline in SLEV-specific IgM. Neutralizing antibody titers in the sera 
were measured by the PRNT and remained elevated over the entire time course, so they 
did not appear to modulate shedding of SLEV or WNV from the cloaca.  
No conclusive evidence has proven that mixed SLEV and WNV populations were 
present in these swabs.  However, challenge of these virus strains (Vero passage 1) with 
homologous polyclonal antibodies (WN antibodies to FLS502, FLS545; SLE antibodies 
to FLS569) revealed several clones that were cross-reactive to both viruses by TaqMan 
RT-PCR assays (Table 4-4). The significance of these results is unknown. Unfortunately, 
none of the original swab diluent was left for challenge with these polyclonal antibodies, 
which may have identified a mixed population prior to first passage in Vero cell culture.  
A recent study by Fang and Reisen (2006) may partly explain the isolation of 
WNV from a chicken previously infected with SLEV (based on its confirmed serology 
profile) in Sarasota County.  Experimental inoculation of house finches with either SLEV 
or WNV was performed, followed by challenge six weeks later with either the 
homologous (same) or heterologous (different) virus.  Initial infection with West Nile 
virus resulted in sterilizing immunity in house finches against both viruses upon 
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challenge.  In contrast, previous infection with SLEV only provided protection against 
subsequent challenge with a homologous virus (SLEV). When these SLEV birds were 
challenged with the heterologous virus instead, WNV was still able to infect and 
significant viremias developed (range from 102.7-6.4 pfu/ml) [Fang and Reisen, 2006].   
A second study performed a similar experiment in adult chickens, with similar 
results (Patiris et al, 2008).  This study also included co-infection of chickens with WNV 
and SLEV, but found that PRNT titers to WNV were significantly greater than those 
detected for SLEV (Patiris et al, 2008).  If these results are comparable to this natural 
dual infection, it may be inferred that SLEV and WNV did not concurrently infect Bird 8-
003-R based on the high PRNT titers to SLEV in the serology profile. However, the 
experimentally infected chickens were given a higher dose of West Nile virus than St. 
Louis encephalitis virus and developed a significantly higher viremia titer, which may 
have biased the PRNT association. It is also unknown the WNV and SLEV titers 
naturally inoculated by mosquito into Bird 8-003-R, so the experimental conclusions may 
be valid (although a natural dual infection in one chicken did not produce detectable IgM 
or PRNT antibodies to WNV through 14 days post-isolation).  
However, heterologous challenge with WNV significantly boosted antibody 
levels in house finches and chickens against SLEV (concept of original antigenic sin) 
[Fang and Reisen, 2006; Patiris et al, 2008]. This experimental finding was not supported 
by MAC-ELISA serology results for Bird 8-003-R following isolation of WNV, where a 
decline in SLEV-specific IgM antibodies was noted over a 14-day period. Perhaps 
secondary infection with WNV quickly boosted HAI and PRNT neutralizing antibodies 
(titer ≥ 40 for all time points) to SLEV in this bird, instead. As a result, the second 
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infection with WNV supports the concept of original antigenic sin to SLEV in this 
naturally infected bird, where the high titers of IgG were non-neutralizing to WNV.  This 
hypothesis for subsequent natural WNV infection boosting SLEV antibody titers is 
supported by serology results for the first three sentinel chickens that seroconverted to 
SLEV in Sarasota County during the previous 6 weeks.  In contrast to the strong SLEV 
antibody titers noted for the first positive serum on Bird 8-003-R, the earlier confirmed 
seroconversions were weakly positive in the HAI assay (reactive, reactive and 1:10, 
respectively) [Table 4-3]. 
Since cloacal swabs were processed retrospectively, no additional sera samples 
were drawn on this bird to investigate if WNV-specific IgM antibodies developed at a 
later time point. The BOL-Tampa requested that the agency re-sample this bird following 
detection of virus on the swabs; however, the chicken had been relocated to another state, 
and was lost to follow-up [personal communication, N. Osborn (SCMCD)]. In summary, 
virus isolation and serology results for Bird 8-003-R indicate that this bird had a dual 
infection of West Nile virus and St. Louis encephalitis virus. The sentinel chicken was 
likely naturally infected with SLEV prior to a second infection with West Nile virus 
(within a six day time frame). Based on previous experimental studies, it is probable that 
this bird was not co-infected at the exact same time, although co-infection by both virus 
strains may have occurred in vivo over a nine day period.  However, recombination was 
not identified in either the FLS569 (SLEV) or FLS545 (WNV) isolates. Further 
vertebrate bird studies would elucidate the competence of adult chickens and wild birds 
to serve as a mixing vessel for arboviruses, where challenge with heterologous strains 
occur within a few days instead of weeks (Fang and Reisen, 2006; Patiris et al, 2008). 
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A second strain (FLS650) of St. Louis encephalitis virus was isolated in Sarasota 
County. Bird 9-005-B also developed high titered antibodies (titer ≥ 40) in the HAI and 
PRNT to SLEV on the first positive serum collected. A second serum sample collected 
seven days later also had an antibody titer ≥40 in the HAI assay. Both sera were 
confirmed SLEV in the MAC-ELISA and MIA tests (Figure 4-25). Unlike Bird 8-003-R, 
only SLEV was isolated from this chicken. No virus was isolated on the second swab 
collected. These serology results closely approximated experimental findings, where IgM 
and total antibody (primarily IgG) titers were elevated early in the infection and then 
quickly decayed (Olson et al, 1991; Reisen, 1994; Martin, 2000; Patiris et al, 2008). 
Finally, three novel flavivirus strains were identified on cloacal swabs collected 
from two chickens (Figure 4-20).  Similar to the West Nile virus strain (FLS504) isolated 
in Sarasota County, these birds also failed to develop detectable HAI antibody following 
infection (Figure 5-2). Molecular RT-PCR assays of these strains failed to amplify the 
envelope region of the virus, indicating that this part of the genome may be altered. The 
envelope protein has been shown to be a major determinant of neutralizing antibody 
development [Chambers et al, 1990] which may partially explain these findings.  
For Bird 9-000-W, a real-time RT-PCR assay first detected the virus on November 6. The 
next detection of the virus occurred 21 days later on a cloacal swab collected on 
November 27. Swabs collected on November 13 and 20 were negative. This finding may 
indicate that the bird did develop flavivirus- specific IgM antibody that limited shedding 
of the virus until the IgM decayed two weeks later. However, sera samples from this 
chicken were HAI antibody negative, as detected by SLEV-group antigen, and discarded. 
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Figure 5-2 Development of the Primary Immune Response Following Natural 
Flavivirus Infection in a Sentinel Chicken  
Serum samples were collected from Bird 9-000-W (Site 001) and 
submitted to the BOL-Tampa for arbovirus screening in the HAI assay. 
Flavivirus (SLEV)-group antibody (pink dotted line) was not detected in 
samples submitted from October 30 to November 27. SLE viral RNA 
(triangles) and WN viral RNA (circles) were detected on cloacal swabs 
collected on November 6 & 27 (TaqMan CT values). Serum had been 
previously discarded and since the chicken was HAI antibody negative; 
MAC-ELISA and PRNT assays were not performed.  
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Development of the Primary Immune Response Following Natural 
Flavivirus Infection in a Sentinel Chicken 
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Consequently, a complete evaluation of the development of the primary immune response 
(MAC-ELISA, PRNT) for Bird 9-000-W was not performed.  Future studies on the viral 
genome are planned to sequence the envelope and NS1 regions (most immunogenic) to 
see if mutations (or recombination) prevented this bird from producing detectable 
antibody. 
 In conclusion, these results have provided new insights into the development of 
the primary immune response following natural arbovirus infection in adult chickens. 
Further studies are needed to elucidate the natural immune response to EEEV infection, 
as well as West Nile virus in Florida. Based on previous laboratory studies of inoculated 
chickens, a natural dual infected (SLEV & WNV) chicken in this study was likely not co- 
infected at the same time (Fang and Reisen, 2006; Patiris et al, 2008). However, it is 
possible that a secondary WNV infection following SLEV resulted in a boost of HAI and 
PRNT antibodies in early serum samples (concept of original antigenic sin). Chickens 
infected with novel flavivirus strains also did not develop antibodies detected by the SLE-
group antigen used in the HAI assay to identify flavivirus infection. Consequently, the 
birds may have developed SLEV or WNV-specific IgM antibodies and seroconverted; 
however, these HAI-negative sera were not saved due to retrospective processing of 
cloacal swabs. Based on limited RT-PCR assays of these flavivirus strains, the envelope 
protein may be altered which may have resulted in modified antibodies that would escape 
detection in the HAI assay.  
In summary, these findings have important implications to sentinel chicken 
programs for the surveillance of arboviruses, especially in regions where West Nile virus 
and St. Louis encephalitis virus co-exist. The development of the primary immune 
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response following natural arboviral infection in adult chickens occurred as previously 
described for St. Louis encephalitis virus, when isolated from a sentinel chicken alone or 
dually-infected with West Nile virus (Fang and Reisen, 2006; Patiris et al, 2008). In 
contrast, the isolation of West Nile virus identified concurrent production of IgM, but an 
extensive time delay until the development of detectable HAI antibody (IgM + IgG), 
likely as a result of the chicken’s advanced age during 2005.  Despite the isolation of 
West Nile virus in 2006, total antibody (HAI) or WNV-specific IgM antibody was not 
detected in the chickens located at sites with confirmed transmission of SLEV.  
These findings have demonstrated that natural arbovirus infections in adult 
chickens do not entirely compare to laboratory studies. Further targeted studies are 
needed to investigate these concerns and improve understanding of the immune response 
following natural infection. This research will have a direct impact on arbovirus 
surveillance systems that utilize sentinel seroconversions to detect transmission activity. 
Consequently, a variety of diagnostic assays are needed for accurate interpretation 
of cross-reactive flavivirus antibodies in regions where WNV and SLEV co-circulate, for 
both humans and sentinel animals. Research to improve diagnostic techniques for these 
pathogenic viruses is currently in progress at the BOL-Tampa (development of an MIA 
for detection of arbovirus-specific IgM in chicken sera). Rapid, sensitive and specific 
antibody-based assays for arboviruses are in high demand, as they are frequently used to 
detect arbovirus transmission activity (Day and Stark, 1999 & 2000; Reisen et al, 2000b; 
Komar, 2001; Blackmore et al, 2003; Patiris et al, 2008). As the technology improves, 
these diagnostic assays may soon approach “real-time” detection of arbovirus 
transmission and acute infections. 
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Aim Four 
Assessment of Arboviral Strain Differences in Florida 
Three pathogenic arboviruses have established enzootic transmission foci in 
Florida, including St. Louis encephalitis virus, Eastern Equine Encephalitis virus, and the 
recently introduced West Nile virus (Blackmore et al, 2003; Stark and Kazanis, 2001-
2007).  Consequently, a statewide surveillance program for the detection of these 
arboviruses operates year-round. The purpose of this project was to investigate and 
characterize genotypic and phenotypic differences in St. Louis encephalitis virus strains 
prior to and following the introduction of West Nile virus.  Several isolations of West 
Nile virus from sentinel birds during the study period resulted in the inclusion of WNV 
reference strains for genotypic comparison to recent circulating strains of the virus. 
Despite the detection of EEE viral RNA on cloacal swabs from two chickens, these 
strains were not further analyzed. 
The Epidemiology Research Center (ERC) was established following epidemics 
of St. Louis encephalitis virus in the late 1950s and located in Tampa, Florida.  This 
center conducted extensive vertebrate and vector studies in the field to determine the 
primary vector and avian amplifying hosts in Florida during the 1960s through 1970s 
(Dow et al, 1964; Lewis, Jennings and Schneider, 1964; Bond et al, 1966; Jennings, 
Allen and Lewis, 1966; Jennings et al, 1967; Jennings et al, 1970; Sather et al, 1970; 
Bigler et al, 1974 & 1975).  The ERC was merged with the Florida Department of Health 
and evolved into what is now the Bureau of Laboratories, Tampa (BOL-Tampa) Virology 
facility, which still provides testing for arbovirus surveillance programs in Florida (and 
neighboring states). 
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Currently, the BOL-Tampa holds an extensive collection of arboviruses isolated 
in Florida from these early ERC field studies, as well as strains resulting from 
collaborative projects conducted with other institutions over the last 50 years. The recent 
introduction of West Nile virus to the state prompted enhanced surveillance for the virus 
and the collection of more than 2000 isolates of WNV during the last seven years. 
Several of these arbovirus strains have been provided to the Centers for Disease Control 
and other institutions to add to their reference collections (Trent et al, 1980 & 1981; 
Monath et al, 1980; Kramer and Chandler, 2001; Davis et al, 2005; etc.). Consequently, 
this study investigated SLEV reference strains collected in Florida that were not included 
in the large phylogenetic analysis of St. Louis encephalitis virus conducted by Kramer 
and Chandler (2001), with the exception of the 1962 human strain TBH-28.  
Florida reference strains included in this study were isolated from a variety of 
sources, including humans, mosquitoes, wild birds, and sentinel chickens. The FL52 
strain represents the first isolation of SLEV from a human in Florida, a resident of 
Miami. Several strains of SLEV were collected in 1962 during a large outbreak of the 
virus (Chamberlain et al, 1964), although they have previously been studied (TBH-28, 
Pinellas 15, GHA-3, TBM-229G, TBM-163E, T349-62, etc) [Monath et al, 1980] and a 
few are no longer in the BOL-Tampa reference collection. However, TBH-28 is one of 
the most commonly used reference strains and was included in this study as a positive 
control, and as a representative 1962 strain.  Additional interepidemic strains of SLEV 
were isolated in 1969 (L695121.05 and 69-M-1143), but were not included in this study 
due to previous analysis elsewhere (Trent et al, 1980 & 1981; Monath et al, 1980; 
Kramer and Chandler, 2001). 
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An ERC project conducted during the early 1970s investigated strain differences 
of SLEV with kinetic HAI assays (personal communication, L. Stark).  At this time, the 
ERC acquired several South American strains of St. Louis encephalitis virus for analysis, 
including TR52, TR58, BR64, and BR69 strains used for this project. However, these 
early studies were unable to identify significant strain differences or relatedness between 
these North and South American SLEV isolates, as detected in the HAI assay. 
Interestingly, FL72 was collected from an opossum in the panhandle region of Florida 
and was not identified for nearly two years due to inconclusive results in HAI and 
complement-fixation assays (unpublished data, BOL-Tampa). This strain has been 
included for genotypic and phenotypic analysis.  
 Vector and wild bird ecology studies were conducted in Indian River County from 
the early 1980s through the 1990-1991 epidemic of St. Louis encephalitis virus in 
Florida, with collaborators at the University of Florida.  Mosquito pools and blood  
collected from wild birds were submitted to the BOL-Tampa for virus isolation and 
serology testing (wild bird sera only). SLEV was isolated during an interepidemic year 
from pools of Culex nigripalpus collected in 1985 (strains FL85a & b).  During 1989 
through 1990, several “epidemic” strains of SLEV were isolated during the last large 
outbreak of the disease in Florida (223 confirmed cases, see Figure 2-9). These strains 
(FL85 a & b, FL89, FL90 a-d) have also been included in the study to investigate 
potential epidemic strain differences from other Florida reference and recent isolates of 
SLEV.  In addition, these strains were not included in previous phylogenetic analysis of 
SLEV (Kramer and Chandler, 2001). Table 4-9 provides strain, designation, and virus 
identity of the flaviviruses sequenced and analyzed. 
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Phylogeny of St. Louis Encephalitis Virus in Florida 
 An analysis of the genetic evolutionary relationships (phylogeny) between strains 
of St. Louis encephalitis virus was performed in this study by comparing virus isolates 
from Florida and South America. These genomes were not completely sequenced (with 
the exception of FLS569); instead fragments of the viral genome were analyzed for 
comparison.  
As performed in MEGA4.0.1, the ClustalW 1.6 algorithm was used to align 
sequences. This program performed multiple sequence alignment by initially computing 
similarity in a pair-wise comparison of taxa (i.e. virus strains in this study), followed by a 
second computation (multiple alignment) that tested the pair-wise results over the entire 
set of taxa to ensure accuracy [Tamura et al, 2007].  Next, three types of phylogenetic 
tree construction methods were used, neighbor-joining, maximum parsimony, and 
unweighted paired group means arithmetic (UPGMA) to create phylograms, each tree 
with 1000 bootstrap replicates.  
Neighbor-joining analysis is a step-wise method that prefers a tree topology 
where the least total branch length (minimum evolution criterion) is chosen during pair-
wise calculations for the taxa. A constant rate of evolution is not assumed to produce an 
unrooted tree. However, the addition of outgroups to the analysis can be used to root the 
tree [Saitou and Nei, 1987]. Maximum parsimony analysis also does not assume a 
constant rate of evolution. This method calculates tree topology based on a requirement 
for the fewest number of evolutionary transitions to develop the most parsimonious tree, 
which can also be rooted with outgroups (Johnson, 2007). In contrast, the UPGMA 
method assumes a constant rate of evolution to produce a rooted tree. It is the simplest 
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method of tree construction, where the taxa are clustered according to similarity in a pair-
wise calculation (Tamura et al, 2007).  
Envelope Region 
The largest fragment (~1700bp) studied was the complete envelope region of 
SLEV. This region codes for the major structural and surface protein of the virion 
(Chambers et al, 1990; Lindenbach and Rice, 2001), and is the main target for 
neutralizing antibodies (Chambers et al, 1990). Consequently, changes in this highly 
conserved region of the virus may impact the host immune response and viral biology 
leading to extensive study of this gene in flaviviruses (Twiddy and Holmes, 2003).   
The consensus tree was chosen for both the neighbor-joining (Figure 4-37) and 
maximum parsimony (Figure 4-38) methods.  The maximum parsimony tree had the 
highest bootstrap values (95 or higher considered most accurate).  A previous 
phylogenetic analysis of the complete envelope region of North and South American 
strains of SLEV identified a monophyletic tree, with seven lineages. SLEV strains 
predominately clustered according to geographic origin (Kramer and Chandler, 2001).  
Both tree topologies also indicated that SLEV strains isolated in Florida grouped into a 
monophyletic tree, within North and South American clades.  Four strains isolated in 
1952, 1962 and 1985 grouped together to form one cluster of Florida strains.  A second 
cluster appeared to emerge during 1989 through 1990, where five strains isolated during 
these “epidemic” years grouped together. These isolates were collected from wild birds 
and one mosquito pool during the last large outbreak of SLEV in the state, with 223 
confirmed human cases.  
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Thirty-four years following the isolation of FL72 in the panhandle region of 
Florida, SLEV strains FLS569 and FLS650 were isolated in the southern region of the 
state during 2006. Interestingly, all three strains grouped into the South American clade. 
However, it is not clear from this inferred phylogeny (Figures 4-37, 4-38), which lineage 
should be assigned to these strains. Consequently, the majority of SLEV envelope 
sequences, originally submitted for publication by Kramer and Chandler (2001), were 
downloaded from GenBank (Appendix R). Please refer to Table 2-2 for strain names and 
locations for the sequences downloaded from GenBank (Kramer and Chandler, 2001). 
Neighbor-joining and maximum parsimony methods were performed on these strains, 
with the inclusion of additional strains from Brazil (dos Santos et al, 2006), Argentina 
(Diaz et al, 2006), and the Florida “South American” isolates (Figures 5-2 and 5-3, 
respectively). Appendix R also includes the strain names and GenBank Accession 
numbers of the included strains. 
Based on these updated phylogenetic trees (Figures 5-3 and 5-4), FLS569 and 
FLS650 cluster into Lineage VA and FL72 groups into Lineage VB, which 
predominately contain Brazilian isolates.  These are the first strains isolated in North 
America shown to cluster into these lineages and are highlighted in red in the figures. 
South American reference strains (TR52, TR58, BR64, BR69) also cluster in Lineage V. 
This finding is significant because it provides the first conclusive evidence for a 
previously suggested hypothesis that SLEV may be periodically reintroduced to the 
United States from South America with consequent cycles of amplification (Kramer and 
Chandler, 2001; Reisen, 2003). Although a mechanism is not necessarily needed for 
successful overwintering of the virus in south Florida (where mosquito populations often 
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Figure 5-3 Phylogenetic Relationships of North & South American SLEV, 
Neighbor-Joining Method 
Phylogram of the complete envelope region for SLEV strains was inferred 
using the neighbor-joining method in MEGA4.0.1, where the consensus 
tree (1000 bootstrap replicates, value shown on branches) was chosen. 
Branch lengths represent the amount of genetic divergence. 
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Figure 5-4 Phylogenetic Relationships of North & South American SLEV, 
Maximum Parsimony Method 
Phylogram of the complete envelope region for SLEV strains was inferred 
using the maximum parsimony method in MEGA4.0.1, where the 
consensus tree (1000 bootstrap replicates, value shown on branches) was 
chosen. Branch lengths represent the amount of genetic divergence, with 
the scale bar corresponding to number of base changes in the sequence.  
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survive year-round), the introduction of SLEV from South America has the potential to 
impact northern states. In addition, the molecular methods (RT-PCR, sequencing) for 
strain identification have finally clarified studies in the early 1970s by the Florida 
Epidemiology Research Center (ERC) that did not find significant differences in kinetic 
HAI assays conducted on South American and Florida strains of SLEV.  As a result of 
those studies, investigators at the ERC hypothesized that South American SLEV strains 
were closely related to Florida isolates (personal communication, L. Stark). This finding 
was further supported by the detection of South American strains of SLEV in the 
hemagglutination inhibition assay routinely performed at the BOL-Tampa during 2006. 
The introduction of South American strains of SLEV to the United States has 
been supported indirectly by earlier phylogenetic analysis (Kramer and Chandler, 2001) 
that identified the clustering of South American (SA) strains into Lineage II, a 
predominately North American (NA) clade. In addition, the GMO94 isolate was 
identified as a recombinant virus of Tennessee and Argentina strains (Twiddy and 
Holmes, 2003), which was isolated in Guatemala in 1969.  However, the isolation of a 
South American strain of SLEV has never been reported in the United States. SA strains 
with close homology to NA isolates [e.g. strains 65V310 (Mexico), PanAn902604 
(Panama), Span9398 (Brazil)] have only been isolated south of the border. This result has 
not been from a lack of research, as several investigators over the last 50 years have 
attempted to isolate the virus from migratory birds returning to North America (BOL-
Tampa, unpublished data 1964-1966; Calisher et al, 1971; Reisen et al, 2000b).  
It is not clear from this analysis if the reintroduction of SA strains has occurred 
frequently (i.e. annually) but was not detected, or if reintroduction is limited to 
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southeastern states only, where some SA strains share close homology to Florida, Texas, 
and Tennessee (recombinant) viruses. The spread of West Nile virus across North 
America and into the Caribbean and South America (Gubler, 2007) predicts that 
migratory birds are not as discriminatory, but local ecologic conditions (habitat, vector) 
may suggest a larger role in the annual arbovirus recrudescence, amplification and 
transmission cycles of SA SLEV strains in North America. Further virus isolation studies 
are recommended to investigate the frequency of this occurrence and its potential impact 
on SLEV strains in Florida that have more “North American” characteristics.  
Membrane/Envelope Region (SLEC) 
 The membrane protein is necessary for the maturation of an immature virus 
particle into an infectious form (Lindenbach and Rice, 2001) and the function of the 
envelope protein was discussed above. A second phylogenetic analysis was performed on 
a subset of SLEV reference strains for comparison to recent isolates of SLEV on 
sequences from the partial membrane/envelope region.  In particular, this region was also 
sequenced for the novel flavivirus strains. 
 The UPGMA method provided the highest level of branch support on the 
consensus tree, not the neighbor-joining or maximum parsimony trees, which may be an 
indication of the high conservation seen in the membrane and start of the envelope region 
(Tables 4-11, 4-12).  As shown for the envelope region, North American and South 
American strains clustered into two clades, where FLS569, FLS650 and FL72 remained 
associated with SA strains.  In contrast, the novel flavivirus isolates clustered with the 
North American clade of Florida reference strains (Figures 4-39, 4-40 and 4-41) despite 
isolation from the same site as FLS650.  
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Interestingly, multiple amplicons were produced for these two strains that were 
not seen for either North or South American strains of SLEV (Figure 4-33), and the RT-
PCR product fragments were also different between the two strains (individual chickens). 
Although one band was sequenced for each virus, differences within this region are 
shown in the placement of these strains within the Florida NA clade. It is unlikely that 
these strains resulted from contamination in the laboratory, as swabs collected from these 
chickens were processed by different technicians and at different times (the second 
positive swab from one chicken was initially processed seven months prior, with the 
same RT-PCR results). 
 The significance of these results is unknown without sequencing the complete 
genome.  Multiple hypotheses could be suggested to explain these findings and may 
include the co-circulation of both Florida enzootic and South American strains of SLEV 
during peak transmission months in Florida, inter-genotypic recombinants (as shown for 
dengue 1 virus, Aaskov et al [2007]), or a genetic shift from South American to a North 
American strain. Brazilian strains of SLEV appear to be highly promiscuous and have 
been reported to infect hosts concurrently infected with other flaviviruses. A recent study 
identified a patient simultaneously infected with SLEV and dengue 3 virus, which did not 
appear to increase disease severity, although minor hemorrhagic symptoms were noted 
(Mondini et al, 2007).  Consequently, further studies are needed to investigate these 
Florida strains of SLEV, as well as research the newly isolated strains of Brazilian SLEV.  
3’NC Region 
 The 3’non-coding region in flaviviruses has been shown to serve an enhancer 
function for viral RNA replication (Gritsun and Gould, 2007) and its interactions with the 
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NS5 region have also been shown to affect phenotype of West Nile virus (Davis et al, 
2007).  A subset of SLEV reference strains was sequenced in this region, but the lack of 
submitted GenBank sequences at the 3’ terminus for SLEV limited interpretation and 
comparison to other North and South American strains. The novel flavivirus strains failed 
to amplify in RT-PCR assays targeting this region.   
As shown for earlier phylogenetic analysis of the membrane and envelope 
regions, the 3’ untranslated region also separated North American and South American 
strains into two clades, where FLS569, FLS650 and FL72 remained associated with SA 
strains. Neither the maximum parsimony nor UPGMA methods (Figures 4-49, 4-50) 
resulted in robust bootstrap values on the consensus tree for the untranslated region. Few 
mutations were identified in this region (Tables 4-11, 4-13) and the limited number of 
strains analyzed contributed to this finding.   
NS5 Region 
 Nonstructural protein 5 is the largest and most highly conserved flaviviral protein 
(Chambers et al, 1990). The region sequenced for phylogenetic analysis in this study 
included a portion of the RNA-dependent RNA polymerase (RdRp) domain that is 
critical for RNA replication (Lindenbach and Rice, 2003). Current circulating and 
reference strains of both SLEV and WNV were sequenced in this region and combined 
phylogenetic trees were generated. Novel flavivirus strains failed to amplify in RT-PCR 
assays for this region.  St. Louis encephalitis virus and West Nile virus clustered 
according to species, forming monophyletic trees. Maximum parsimony analysis resulted 
in more robust bootstrap support values for both SLEV and WNV than found in the 
neighbor-joining method (Figures 4-45, 4-46).  
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 Analysis of the NS5 region of St. Louis encephalitis virus isolates resulted in the 
same phylogenetic tree previously noted, two clades segregated into North and South 
American strains.  The most parsimonious tree generated a longer branch length for the 
FLS569 and FLS650 cluster in the South American clade, as compared to reference 
strains of SLEV. However, North American strains of SLEV were still grouped into two 
clusters, with the most recent epidemic (1990) strains forming one cluster (Figure 4-46). 
Limited diversity in West Nile virus strains isolated in Florida over six years 
(Tables 4-14, 4-15) resulted in shorter branch lengths in the NS5 region than in 
comparison to SLEV strains isolated over 50 years. FLWN01b and FLWN05a had the 
longest branch lengths of the studied West Nile virus isolates collected in Florida. The 
FLWN01b strain was collected from a blue jay during the first year that WNV was 
introduced to Florida. The number of base changes in this isolate exceeded those found in 
FLWN01a isolated from a crow during the same year or from later reference strains. It is 
unknown if this anomaly may be found in other Florida strains from 2001.  Several 
studies have reported the existence of diverse quasispecies of WNV isolated from a 
relatively homogenous genetic population of viruses (Ebel et al, 2004; Jerzak et al, 2005; 
Ciota et al, 2007), which have higher mutation rates than found in the consensus 
population strains identified in the same year (Jerzak et al, 2005).  
The FLWN05a strain was isolated from an alligator in 2005 and several mutations 
were noted in the NS5 region than identified for the crow (FLWN05b) and sentinel 
chicken (FLM38) isolates from the same year. For this isolate, these changes are likely 
strain specific for reptilian hosts, where poor replication of WNV has been identified 
experimentally (Klenk and Komar, 2003). 
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A second multiple sequence alignment resulted in more robust bootstrap values 
and the accurate placement of Ilheus and Rocio viruses grouped togther, as the SLEV 
outgroup viruses (Figure 5-5). 
Phylogeny of West Nile Virus 
An analysis of the genetic evolutionary relationships (phylogeny) between strains 
of West Nile virus collected in Florida were compared for this project following the 
isolation of WNV from sentinel chickens (FLM38, FLS502, FLS504, FLS545). These 
genomes were not completely sequenced (with the exception of FLS545).  
Reference strains of West Nile virus were either purchased from ATCC (NY99) 
or obtained from the Center for Disease Control, Fort Collins (Egypt101). Lineage 2 
strains of West Nile virus (prototypical Ugandan, Madagascar, and South African strains) 
were not included in this analysis. Consequently, only Lineage 1 strains were studied. 
Kunjin (Accession # AY274505), Japanese encephalitis (Accession # EF571853), and 
Murray valley encephalitis (Accession # AF161266) viral genomes were downloaded 
from GenBank to root the phylogenetic trees. 
The NS5 region was analyzed for these WNV strains and discussed above. 
Mutations in the nonstructural proteins have been shown to significantly impact virus 
replication and virulence (Davis et al, 2004; Beasley DWC, 2005). A recent study has 
also identified that the NS5 region was the most variable with impacts on viral replication 
in Lineage 2 strains of WNV (Botha et al, 2008). 
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Figure 5-5 Phylogenetic Relationships of SLEV & WNV Strains (NS5 Region), 
Second Multiple Sequence Alignment 
Phylogram of the partial NS5 region for SLEV and WNV isolates was 
inferred following a second multiple sequence alignment and using the 
maximum parsimony method, where the consensus tree (1000 bootstrap 
replicates) was chosen. Branch lengths represent the amount of genetic 
divergence, with the scale bar corresponding to number of base changes in 
the entire sequence. Bootstrap values are shown on branches.  
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Capsid/preMembrane Region (WNAE) 
 Capsid proteins are assembled to form the structural nucleocapsid of the virion 
(Lindenbach and Rice, 2001) and the glycoprotein precursor of the membrane protein, 
prM, has chaperone-like properties needed for proper folding of the envelope protein 
(Lindenbach and Rice, 2003). These structural proteins are highly conserved in 
flaviviruses.  
 West Nile virus strains isolated in Florida clustered into four groups with the 
neighbor-joining and maximum parsimony methods, forming a monophyletic tree. 
Neighbor-joining analysis resulted in the highest bootstrap values of the three methods, 
with robust support of subtrees for Old World and North American clusters (Figures 4-
42, 4-43, 4-44). The recent strains of WNV isolated from sentinel chickens (FLM38, 
FLS502, 504, and 545) consistently clustered with the FLWN02b strain, isolated from a 
mosquito pool (Oc. taeniorhynchus) during 2002. In contrast, a second strain (FLWN02a) 
isolated from mosquitoes (same species) in Florida (same county) during 2002 clustered 
together with FLWN01a (crow) and FLWN05a (alligator) strains. These results support 
previous studies that found that WNV strains exhibited greater diversity between 
mosquito strains compared to strains isolated from avian hosts. The authors also 
suggested that inter-host quasispecies, especially in mosquitoes, may contribute to 
evolution of the virus in an overall homogenous population of the dominant genotype 
(i.e. NY99 and WN02) [Ebel et al, 2004; Jerzak et al, 2005]. 
Unexpectedly, the two novel flavivirus strains (FLS649 and FLS694) clustered 
together with an Old World strain, Egypt101. Laboratory contamination of the samples 
was considered, but all RT-PCR and sequencing assays were conducted with the NY99 
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strain of the virus as a positive control. Egypt101 was not in use at the time these samples 
were extracted and amplified, suggesting that this was not a laboratory artifact. While this 
may indicate a second introduction of an Old World strain of West Nile virus to North 
America, these results should be interpreted with caution due to the small region of the 
genome analyzed (400 bp).  Complete sequencing of these strains is needed for 
confirmation of this result.  
NS5 Region (WNBE) 
Nonstructural protein 5 is the largest and most highly conserved flaviviral protein, 
with important transcription and replication elements (Chambers et al, 1990). Mutations 
in the NS5 region have been shown to alter phenotype and virulence of naturally 
occurring West Nile virus strains (Davis et al, 2007; Botha et al, 2008).  After WNV was 
introduced to New York City in 1999, the Centers for Disease Control initially confirmed 
suspected cases of West Nile virus.  However, the overwhelming number of samples 
submitted for testing in the next year required supplementation by state public health 
agencies to confirm cases (human and animal). As a result, public health laboratories that 
met appropriate biosafety containment requirements for this agent were trained by the 
CDC and provided with RT-PCR primer set sequences for confirmation of West Nile 
virus. An experimental primer set (personal communication, RS. Lanciotti) targeting the 
3’ terminus of the NS5 gene was provided to the BOL-Tampa for gel-based confirmation 
of WNV. However, this primer set was cross-reactive with SLEV (as shown in this study) 
and was not later published (Lanciotti et al, 2000).  
The 3’ region of the NS5 gene did not sequence well for most of the recent 
Florida WNV strains analyzed in this study. Only two recent isolates were successfully 
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sequenced, FLS504 and FLS694, and both clustered in the same group. A monophyletic 
tree was generated, with high bootstrap confidence (99) on this branch of the consensus 
maximum parsimony tree (Figure 4-48). Interestingly, the novel flavivirus strain clustered 
with North American isolates of WNV, rather than Egypt101, in this region of the viral 
genome. As a result, it is hypothesized that this strain will likely have closer homology to 
North American than to Old World strains of West Nile virus once the complete sequence 
is known, due to its isolation in Florida and similarity to the NY99 strain in the 3’ NS5 
region. Although the novel flavivirus strain FLS694 did not produce an amplicon for the 
larger NS5 fragment, these results suggest that a portion of the NS5 gene is intact, which 
may or may not be sufficient for viral replication. Future studies are planned to 
investigate these findings. 
In summary, phylogenetic analysis of St. Louis encephalitis virus has revealed 
that strains isolated in Florida belong to North and South American lineages, as proposed 
by Kramer and Chandler (2001) [see Figures 5-3, 5-4). For the first time, strains of SLEV 
collected in the continental United States are placed into Lineage V in the South 
American clade.  From a public health standpoint, this complicates surveillance and 
prevention strategies for SLEV in Florida as reintroduction of South American strains 
may occur periodically in the state (both north and south regions). As a result, future St. 
Louis encephalitis virus epidemics in Florida will be difficult to prevent/eradicate without 
the elimination of the virus reservoir in South America. 
Real-time RT-PCR and sequence analysis of several South American strains also 
identified mutations in Brazilian and Trinidadian viral genomes that complicated 
confirmation of these South American strains of SLEV by RT-PCR assays. Surveillance 
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programs should be aware of the limitation of one real-time RT-PCR (TaqMan) primer-
probe set (Lanciotti and Kerst, 2001) and alternative gel-based confirmation strategies 
added to the testing algorithm to confirm these atypical strains. Additional arbovirus 
surveillance techniques and the development of a new real-time RT-PCR primer-probe 
set are recommended to detect these strains that may periodically circulate in North 
America.  
South American strains of SLEV isolated in Florida were from sentinel chickens 
in 2006 and an opossum in 1972, not from migratory birds, so the route of introduction 
remains unknown. However, migratory birds have been implicated in the spread of West 
Nile virus throughout the Americas and likely play a role in the dispersal of St. Louis 
encephalitis virus along bird migration routes. Florida is directly situated in the Atlantic 
Coast Route and Tributaries West migration pathway (Gubler, 2007). In fact, the 
migration pattern of birds from the New York and New England region to Florida 
introduced WNV to the state in 2001, but bypassed several mid-Atlantic states (Deardorff 
et al, 2006). Based on this information, it can be assumed that migratory birds transfer 
West Nile virus and potentially St. Louis encephalitis virus bidirectionally. This study 
provides the first report that South American strains of SLEV were transported 
northward, likely by migrating birds. Consequently, the potential of northward transport 
of West Nile virus also exists from South America, where migrating birds may re-
introduce and seed the virus throughout North America in the future (Gubler, 2007).  
Several questions require further study to investigate this North-South American 
connection for SLEV:  How often are SA strains of SLEV introduced or circulating in 
Florida? What ecologic conditions allow for this to occur in southeastern states?  Have 
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South American strains circulated in other regions of the United States, but escaped 
detection?  Does mixing occur between NA and SA strains of SLEV?  Can these strains 
cause epizootics/epidemics in North America? Will reintroductions of West Nile virus 
from South America also occur periodically? 
 Phylogenetic analysis of West Nile strains isolated in Florida identified that recent 
strains of West Nile virus collected in 2006 (the only WNV strains isolated by the BOL-
Tampa that year) clustered with strains collected in previous years. Overall, branch 
lengths for these strains were short and all strains clustered into a monophyletic tree, 
indicating limited divergence in these strains over a six year time period. Unusually, the 
two novel flavivirus strains isolated in 2006 shared homology with Old World strains of 
WNV (Egypt101) in the capsid/prM region of the viral genome, but one strain (FLS694) 
also clustered with North American isolates sequenced in the NS5 region. Additional 
experiments are planned to resolve this discrepancy. 
Mutation Analysis 
Sequences were aligned using the ClustalW 1.6 algorithm in MEGA4.0.1 and 
each strain was analyzed for nucleotide and amino acid changes, based on its relationship 
to other sequences in the multiple sequence alignment. Multiple sequence alignments for 
the capsid/prM region (WNV), 3’NS5 region (WNV),  envelope region (SLEV), 
membrane/envelope region (SLEV), NS5 region (WNV and SLEV), and 3’NC region 
(SLEV) are provided in Appendices L-Q, respectively. 
St. Louis Encephalitis Virus 
 SLEV-specific mutation analysis studies have been limited and rarely performed 
with modern nucleotide sequence analysis. For example, a previous SLEV study 
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identified epitopes and cross-reactive residues on the envelope protein with monoclonal 
antibodies (Roehrig, Mathews and Trent, 1983). One study identified highly conserved 
amino acid residues located at positions 104 (Glycine), 106 (Glycine), and 107 (Leucine) 
of SLEV recombinant virus-like particles in the E glycoprotein that influenced cross-
reactive monoclonal antibody reactivity; however, wild type viruses were not described 
(Trainor et al, 2007).  Another study performed cell culture adaptation of West Nile virus 
and St. Louis encephalitis virus to evaluate phenotype and subsequent nucleotide changes 
over repeated passage in mosquito and avian cell lines (Ciota et al, 2007b).  The 
complete genome for these virus strains were sequenced, and 8 nucleotides changes were 
noted for SLEV after repeated passage compared to the wild type virus (Kern217).  
It should be noted that a limited number of complete coding sequences (cds) have 
been submitted to GenBank for SLEV, with only seven complete cds published (as of 
March 25, 2008).  Without a large subset of published sequences for SLEV, it is difficult 
to perform accurate mutation analysis as “unique” differences identified in a few strains 
may match other strains when aligned. As a result, the 14 reference strains analyzed in 
the study may not provide a true reflection of non-conserved changes in these genomes, 
as the analytical power is decreased without a large sample size. These strains have also 
been passaged in mice and/or Vero and other cell culture lines, which may introduce 
mutations. Finally, these strains were not sequenced over the entire coding region and 
only fragments of the genome were analyzed, which may later impact mutation analysis 
results. 
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Evaluation of FL52 
Genotype 
 The nucleotide and amino acid sequence of FL52 (isolated from a Miami resident) 
had the greatest sequence diversity of the North American strains of SLEV analyzed in 
this study (Table 4-11). The complete envelope region of FL52 was sequenced and 
aligned to 16 other SLEV strains. This alignment identified 20 nucleotide changes, with a 
single insertion. Although this was the highest number of substitutions in the envelope 
region for Florida isolates studied, it is not significant compared to the 160 and 161 
nucleotide differences noted for Argentina strains in the envelope region (Kramer and 
Chandler, 2001).  
 A second analysis of the envelope region was performed to further validate these 
results for the Florida strains. A majority of envelope sequences (n=47) submitted by 
Kramer and Chandler (2001) and recent SLEV isolates (n=3) in South America from 
Argentina (Diaz et al, 2006) and Brazil (dos Santos et al, 2006) were downloaded from 
GenBank for multiple sequence alignment analysis (Appendix T) and phylogenetic 
relationships (Figures 5-3, 5-4). This larger sample size invalidated many of the “unique” 
nucleotide differences noted for FL52.  The second analysis identified 10 nucleotide 
substitutions not shared by other SLEV isolates, all non-synonymous mutations resulting 
in the insertion of one amino insertion (valine) and nine predicted amino acid 
substitutions (see Appendix T).  
 Very few nucleotide substitutions were noted in the membrane/envelope region or 
3’NC region (Table 4-11).  For the NS5 region, 5 nucleotide differences were noted 
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resulting in four predicted amino acid changes.  In addition, two insertions were 
identified in both the nucleotide and amino acid sequences (Appendix U).  
Phenotype 
The number of mutations in the envelope and NS5 regions appeared to alter the 
phenotype of this SLEV strain.  The strain grew very slowly after extraction from 
suckling mouse brain and did not adapt well in cell-culture. Weak cytopathic effect was 
observed after six days post-inoculation in Vero cell culture (Table 4-17). In addition, the 
plaque phenotype of FL52 consisted of several large, diffuse plaques without sharp 
borders nine days post-inoculation. Plaques were difficult to visualize or count due to 
their size and weakly defined borders (Figure 4-52).  This phenotype may be directly 
related to mutations in the NS5 and 3’NC regions that are important to virus replication 
and may alter phenotype, as shown for WNV (Davis et al, 2007).  
Evaluation of TBH-28 
Genotype 
 In contrast to FL52, the nucleotide and amino acid sequence of TBH-28 (collected 
in Tampa Bay, 1962) was highly conserved, with minimal sequence changes (Table 4-
11). The complete envelope region of TBH-28 was sequenced and aligned to 16 other 
SLEV strains. This alignment identified 11 nucleotide changes, with the majority of 
mutations silent and four predicted amino acid changes. However, the second analysis of 
the envelope region with additional SLEV strains did not detect any nucleotide changes 
that were unique. Most of the mutations previously noted were shared by the Pinellas 15 
strain of the virus, also isolated in the Tampa Bay area during 1962. Consequently, no 
amino acid substitutions were predicted for TBH-28 (Appendix T).  
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Very few nucleotide substitutions were noted in the membrane/envelope region or 
3’NC region. For the NS5 region, three nucleotide differences were noted in both the first 
(Table 4-11, Appendix P) and second multiple sequence alignments (Appendix U).  
However, in the second alignment three amino acid changes were predicted, instead of 
two in the first alignment.  
Phenotype 
The BOL-Tampa routinely uses the TBH-28 strain of the virus for plaque-
reduction neutralization tests (PRNT). Consequently, this strain had already been cultured 
in Vero cells.  As shown in this study, Florida isolates of SLEV grow more slowly than 
other strains in plaque assays. For example, the Kern217 strain (California) often forms 
plaques between 4-5 DPI in Vero cell culture (Payne et al, 2006).  In contrast to the FL52 
strain, TBH-28 formed both small and large plaques, with distinct borders nine days post-
inoculation (Figure 4-52). 
Evaluation of FL72 
Genotype 
 The nucleotide and predicted amino acid sequence of FL72 (collected in 
Escambia County, 1972) was less conserved than corresponding Florida isolates of SLEV 
(Table 4-11). Nine unique nucleotide substitutions were identified, with one insertion that 
differed from both North and South American strains, which resulted in seven predicted 
amino acid changes in the envelope region. However, this strain was most closely related 
to South American strains of the virus, where a characteristic pattern of nucleotide 
substitutions was noted for SA strains that segregated them from their North American 
counterparts (Table 4-12). The second analysis of the envelope region with additional 
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SLEV strains detected only three nucleotide changes that were unique, with two 
predicted amino acid substitutions. Interestingly, this isolate most closely matched a 
South American strain also isolated from an opossum in 1972 from Brazil (BeAn246262) 
[Kramer and Chandler, 2001].  Between the two strains, 21 nucleotide changes were 
noted in the envelope region (Appendix T).  
Very few nucleotide substitutions were noted in the membrane/envelope region or 
3’NC region. For the NS5 region, eight nucleotide differences were noted in the first 
alignment (Table 4-11, Appendix P) with five amino acid substitutions. A second 
alignment was performed, which identified four unique nucleotide changes and predicted 
four amino acid substitutions (Appendix U).   
Phenotype 
Unlike FL52, the FL72 strain quickly adapted to cell culture with the strongest 
cytopathic effect noted for any of the reference strains on day seven post-inoculation 
(Table 4-17).  As a result, FL72 quickly replicated in Vero cell culture and formed 
distinct, large plaques within five days post-inoculation (Figure 4-52). Consequently, 
nucleotide substitutions likely contributed to improved relative fitness of South American 
strains allowing them to quickly replicate in cell culture. This phenomenon has also been 
described for the Kern217 strain in adaptation studies (Ciota et al, 2007b).   
Evaluation of FL85 a &b 
Genotype 
 The first multiple sequence alignment did not identify unique nucleotide or 
predicted amino acid differences in the envelope region. However, a second analysis of 
this region with a larger sample size of SLEV strains identified two unique nucleotide 
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mutations shared by these strains, at positions 1440 and 1518.  These were synonymous 
mutations that did not alter the consensus predicted amino acid sequence (Appendix T).  
Very few nucleotide substitutions were noted in the membrane/envelope region or 
3’NC region for FL85a.  For the NS5 region, two nucleotide differences were noted in 
the first (Table 4-11, Appendix P) alignment, which predicted one amino acid 
substitution. In contrast, the second multiple sequence alignment detected four unique 
nucleotide substitutions, with three predicted amino acid changes (Appendix U).   
Phenotype 
Interestingly, these strains replicated very poorly in Vero cell culture. FL85a 
resulted in equivocal cytopathic effect seven DPI.  This strain required a second passage 
for cpe to be detectable (1+) after ten DPI in Vero culture. Similar results were found for 
FL85b, which produced no cytopathic effect 14 DPI on first passage.  Second passage of 
this strain resulted in detectable cpe (also 1+) after ten DPI (Table 4-17).  Consequently, 
these virus strains did not perform well in the plaque assay, as plaques were not detected 
after 14 DPI, with the plaque method used at the BOL-Tampa (data not shown).  For all 
of the Florida strains studied, only FL85a and FL85b had two nucleotide substitutions 
identified in the partial RdRp domain analyzed in the second alignment of the NS5 
region. It is suggested that the combination of these changes may have negatively 
affected replication of the virus, which resulted in the slow growing phenotype observed 
in this study (Appendix V). 
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Evaluation of Florida Epidemic Strains (FL89, FL90 a-d) 
Genotype 
 The first multiple sequence alignment identified 13-15 conserved mutations in the 
envelope region of Florida epidemic strains that were not present in other Florida or SA 
strains analyzed. This resulted in four predicted amino acid differences for FL89 and 
seven predicted changes to the protein sequence for FL90a-d (Appendix N). However, a 
second analysis of this region with a larger sample size of SLEV strains identified only 
one unique nucleotide mutation shared by these strains, a predicted non-synonymous 
mutation that substituted aspartic acid for asparagine at position 671 of the protein 
sequence. An additional nucleotide substitution for FL90a, c & d was noted, but it was 
silent with no predicted amino acid change (Appendix T). Consequently, the addition of a 
larger sample size of SLEV strains resulted in matching of many “unique” nucleotide 
changes noted for Florida epidemic strains that were conserved in other North (and 
South) American strains.  
 Although Kramer and Chandler (2001) found no clear evidence relating epidemic 
strains to nucleotide/amino acid substitutions, the initial alignment performed in this 
Florida study identified several differences in the epidemic strains from inter-epidemic 
and SA strains of SLEV circulating in Florida (Appendix T). A characteristic pattern of 
nucleotide/amino acid substitutions for these strains still emerged following the second 
alignment, where Florida epidemic strains consistently matched those collected either 
during an SLEV epidemic or the year preceding one in Texas and Tennessee (TNM4-
711K, Texas: 83V4953, 98V3181; PVI-2419). This pattern matches the isolation of FL89 
prior to the FL90a-d strains of SLEV collected during the last large outbreak in the state. 
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These strains were not analyzed in the membrane/envelope region as very few 
nucleotide differences had previously been noted for other Florida or South American 
strains. A future study to investigate strain differences over the entire genome would be 
recommended for these isolates for comparison to other North American “epidemic” 
strains of SLEV.  FL90a & d were, however, sequenced in the 3’ non-coding region but 
only four nucleotide differences were detected (Table 4-11).  For the NS5 region, 13-14 
nucleotide differences were noted in the first alignment (Table 4-11, Appendix P) for 
FL90a-d and FL89, respectively, which predicted seven amino acid substitutions. As 
shown above for the envelope region, the second multiple sequence alignment abrogated 
many unique differences and detected only six unique nucleotide substitutions, which 
resulted in six non-synonymous predicted amino acid changes in the NS5 region 
(Appendix V). Again, an epidemic pattern emerged, such that many of the “unique” 
changes noted in the first alignment for FL89 and FL90a-d strains matched with the 
Tennessee strain (TNM4-711K) included in this analysis. 
Phenotype 
FL89 first exhibited a weak equivocal (+/-) cytopathic effect seven DPI, whereas 
FL90a & 90d produced a stronger cpe at the same time point (1 & 1+, respectively) on 
first passage. Second passage of the FL89 strain resulted in the same equivocal result 
seven DPI, not a stronger cpe as expected. In contrast, FL90a & d both produced an 
equivocal (+/-) cytopathic effect three DPI in the second passage (Table 4-17).   
As a result, FL89 did not perform as well in the plaque assay similar to FL85a & 
b.  Plaques were detected after nine DPI but were very indistinct and did not photograph 
well (data not shown). Both FL90a & d formed distinct large and small plaques nine DPI 
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(Figure 4-52).  FL90a produced larger individual plaques than FL90d, whereas the plaque 
phenotype for FL90d resulted in smaller plaque sizes. 
The two viral genomic regions analyzed for both the FL89 and FL90 strains 
shared several conserved mutations. However, FL89 did not have as many nucleotide 
substitutions (13) in the envelope region, with less predicted amino acid changes (four) 
than found for FL90a-d strains (15 nucleotides and seven amin o acids). Multiple 
sequence analysis also identified two nucleotide differences in the NS5 region between 
FL89 & FL90 strains, resulting in one different amino acid substitution predicted 
between these closely related strains. Consequently, these changes may have adversely 
impacted the phenotype of FL89, as compared to FL90 strains. 
Evaluation of South American SLEV Strains (TR58, TR62, BR64 and BR69) 
Genotype 
 The South American reference strains included in this study exhibited a 
characteristic genotype, such that TR58, TR62, BR64, BR69 shared conserved nucleotide 
and predicted amino acid substitutions in the envelope, NS5, and membrane/envelope 
regions (Table 4-12).  However, each strain had ≤ 5 nucleotide substitutions that were not 
conserved in each region and differed from the consensus presented (Appendix N).  
Nonetheless, multiple sequence alignment indicated a characteristic pattern shared by 
South American strains of SLEV that can be used to distinguish them from North 
American strains of the virus. In addition, SA strains collected in Florida (FL72, FLS569, 
FLS650) also had these conserved nucleotide and predicted amino acid changes at the 
same positions.  
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The highest number of nucleotide substitutions was noted in the envelope region, 
where 59 changes from the North American consensus sequence were identified (with 23 
predicted amino acid differences).  The C ↔ T transition mutation was frequently noted, 
which were synonymous (silent) mutations. Interestingly, four nucleotide substitutions in 
the NS5 region resulted in early termination (*) of translation, a pattern not seen in North 
American strains of SLEV at these positions. The altered genotype of these strains may 
play a role in the phenotype and lower pathogenicity exhibited by some SA strains. 
Phenotype (TR62, BR69) 
As previously noted for FL72, these SA strains quickly adapted to cell culture 
following extraction from suckling mouse brain tissue. TR62 first exhibited a weak 
equivocal (+/-) cytopathic effect six DPI, whereas BR69 produced equivocal cpe one day 
later (seven DPI) on first passage. However, TR62 and BR69 cultures produced a strong 
cpe (3) by 11 DPI and were frozen at that time. A second passage was not required (Table 
4-17). Unlike FL72 that formed large plaques, TR62 and BR69 produced much smaller 
plaques within five days post-inoculation in the plaque assay (Figure 4-52).  Differences 
in phenotype were also noted between these two strains, such that TR62 formed small but 
distinct plaques whereas the BR69 strain formed smaller plaques without distinct edges. 
Evaluation of FLS569 
Genotype 
 The nucleotide and predicted amino acid changes found in reference SA strains 
were also detected in FLS569 (Table 4-12).  In addition, several unique differences were 
noted for this strain that differed from both SA and NA strains. In the envelope region, 13 
nucleotide substitutions were noted, with eight predicted amino acid changes (including 
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one early termination of translation) [Table 4-13].  In striking contrast, the second 
multiple sequence alignment only identified one unique nucleotide substitution (G → A), 
which resulted in an amino acid change (D → N) in the predicted protein sequence 
(Appendix T). The substitutions noted on the first alignment were predominately shared 
by other SA strains of SLEV.  
Unique nucleotide substitutions were noted in the membrane/envelope region 
(n=9, with 8 amino acid changes) or 3’NC region (n=5) on the first alignment. A second 
alignment of the membrane/envelope region identified a single nucleotide change and 
one amino acid difference for FLS569 (Appendix U). For the NS5 region, 19 nucleotide 
differences were noted in the first (Table 4-13) alignment, which predicted 12 amino acid 
substitutions. In contrast, the second multiple sequence alignment detected six unique 
nucleotide substitutions, with six predicted amino acid changes (Appendix V) shared by 
these strains.  
Phenotype  
As previously noted for SA strains, FLS569 quickly adapted to Vero cell culture 
following the initial culture of the processed cloacal swab diluent (32 PFU/0.1ml).  The 
first passage of FLS569 exhibited a weak equivocal (+/-) cytopathic effect 11 DPI. 
However, the second passage of the virus replicated much faster and produced stronger 
cpe (2+) after five DPI (Table 4-18). The plaque phenotype of FLS569 produced a 
variety of plaque sizes: pinpoint, medium and large, within five DPI (Figure 4-53, Table 
4-19). The unusual variety of different sized plaques was not noted for other reference or 
recent strains, with the closest appearance to SLEV FL90a and WNV NY99 (Figures 4-
53 and 4-24, respectively). However, larger plaque sizes were found in FLS569 as 
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compared to FL90a, but FLS569 plaque sizes were not as large as the plaques formed for 
NY99. Consequently, clones were picked from this “mixed” size population of plaques. 
Real-time RT-PCR detected SLEV alone in several clones, as well as clones that cross-
reacted with both SLEV and WNV. However, WNV was not detected alone from any of 
the plaques selected, even following challenge with homologous polyclonal antibody (i.e. 
SLE+ ab) [Table 4-19, Figure 4-24]. 
Evaluation of FLS650 
Genotype 
 The nucleotide and predicted amino acid changes found in reference SA strains 
were also detected in FLS650 (Table 4-12).  In addition, several unique shared 
differences were noted for this strain and FLS569 that differed from both SA and NA 
strains (Table 4-13). In the envelope region, one nucleotide substitution differed from 
FLS569; in the NS5 region, two nucleotides were not conserved between the strains. 
However, compared to eight predicted amino acid changes for FLS569, only six were 
identified for FLS650 [Table 4-13] in the first alignment of the envelope region. In 
striking contrast, the second multiple sequence alignment only identified one unique 
nucleotide substitution (G → A), which resulted in an amino acid change (D → N) in the 
predicted protein sequence (Appendix T). The substitutions noted on the first alignment 
were predominately shared by other SA strains of SLEV.  
Unique nucleotide substitutions were noted in the membrane/envelope region 
(n=7, with six amino acid changes) on the first alignment. A second alignment of the 
membrane/envelope region identified a single nucleotide change and one amino acid 
difference for FLS650 (Appendix U). For the NS5 region, 20 nucleotide differences were 
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noted in the first (Table 4-13) alignment, which predicted 12 amino acid substitutions. In 
contrast, the second multiple sequence alignment detected six unique nucleotide 
substitutions, with six predicted amino acid changes (Appendix V) shared by these 
strains.  
Phenotype  
Unlike previous SA strains, FLS650 did not adapt well to Vero cell culture. The 
slow replication noted for the first passage may have been a result of the low titer of 
infectious virus particles on the cloacal swab (< 2 PFU/0.1 ml), which were below 
detection of the plaque assay performed at the BOL-Tampa (Table 4-18). In fact, most 
cultures are discarded 14 days post-inoculation, if no cytopathic effect is observed. 
However, this sample was confirmed SLEV positive by real-time RT-PCR prior to 
inoculation into cell culture. As a result, this culture was not discarded after 14 days even 
though no cpe had been detected. The first identification of cpe (3) occurred 17 DPI 
following continued culture incubation over a weekend.  Interestingly, second passage of 
this strain did not replicate as quickly as the other SA strains of SLEV.  The first 
observation of low cytopathic effect (1+) occurred seven DPI of the second passage. In 
contrast to the plaque phenotypes shown for other SLEV strains, FLS650 produced 
hundreds of pinpoint plaques (Figure 4-53, Table 4-19), when the Vero 1 passage of the 
strain was diluted and tested in the plaque assay.  Computer generated contrast was 
applied to the image for enhanced visualization of the plaques (Figure 4-53).   
Despite a nearly identical genotype to FLS569 in the regions sequenced, the 
phenotype of this strain was dramatically different. Two hypotheses may explain this 
discrepancy: i) mixed population of viruses present in FLS569 sample, including SLEV, 
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WNV, and hybrid SLEV/WNV that resulted in multiple plaque phenotypes (as suggested 
by TaqMan RT-PCR results), ii) additional mutations in region(s) of the genome that are 
not shared by the strains. Complete sequencing of the FLS650 genome is planned, 
including additional sequencing of WNV and SLEV cross-reactive clones to resolve the 
discrepancy. 
West Nile Virus 
 For the purpose of this study, Florida reference strains of WNV were sequenced 
following the collection of West Nile virus strains from sentinel chickens in 2005 and 
2006. However, reference strains were not phenotyped, as they were not re-cultured in 
Vero cells. RNA was extracted from these reference strains only. However, NY99 and 
Egypt101 strains were phenotyped, due to their use as positive controls in plaque 
reduction neutralization assays (data not shown for Egypt101). Recently isolated strains 
of WNV from sentinel chickens were phenotyped in the plaque assay. 
Evaluation of FLWN01a 
 Many of the nucleotide and predicted amino acid changes found in FLWN01a 
were shared by the other WNV reference and recent strains sequenced (Tables 4-9, 4-10), 
but were unique when compared to WNNY99 and WNEgypt101. In the capsid/prM 
region, three nucleotide substitutions were noted, but were synonymous (silent) mutations 
with no predicted changes to the amino acid sequence [Table 4-14].  The cytosine at 
position 483 was conserved, as has previously been noted for North American strains of 
WNV (NY99) [Estrada-Franco et al, 2003; Beasley et al, 2004]. Additional West Nile 
virus sequences were downloaded from GenBank to perform a second multiple sequence 
alignment, with a larger sample size of strains for comparative purposes. The second 
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multiple sequence alignment of this region identified two nucleotide substitutions, both 
shared by FLWN02a (Appendix W).  
Two unique nucleotide substitutions were noted in the NS5 region, resulting in 
one amino acid change to the predicted protein sequence on the first alignment (Table 4-
14). A second alignment of the NS5 region produced identical results (Appendix V). 
Evaluation of FLWN01b 
 In the capsid/prM region, two nucleotide substitutions were noted, with one 
predicted change to the amino acid sequence [Table 4-14].  The cytosine at position 483 
was conserved, as has previously been noted for North American strains of WNV (NY99) 
[Estrada-Franco et al, 2003; Beasley et al, 2004]. The second multiple sequence 
alignment of this region identified one unique nucleotide substitution, a T → C transition 
mutation that resulted in the substitution of isoleucine for threonine in the predicted 
protein sequence (Appendix W).  
Twelve nucleotide substitutions were noted in the NS5 region, including one 
insertion, resulting in eight changes to the predicted protein sequence on the first 
alignment (Table 4-14). Two early termination of translation codons were observed, as 
well as the insertion of an amino acid. A second alignment of the NS5 region identified 
ten nucleotide changes, including one insertion, and seven amino acid differences for 
FLWN01b (Appendix V). These changes represent the highest sequence diversity of the 
WNV isolates studied from Florida. Curiously, this isolate was collected the first year 
that WNV was introduced to the state. Further sequence analysis on other regions (e.g. 
the envelope) of the viral genome should be performed to characterize this strain. 
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Evaluation of FLWN02a 
 For the capsid/prM region, three nucleotide substitutions were noted, but were 
shared with FLWN01a and were synonymous (silent) mutations with no predicted 
changes to the amino acid sequence [Table 4-14].  The cytosine at position 483 was 
conserved, as has previously been noted for North American strains of WNV (NY99) 
[Estrada-Franco et al, 2003; Beasley et al, 2004]. A second multiple sequence alignment 
identified these two 2 shared nucleotide differences (Appendix W).  
No unique nucleotide or predicted amino acid substitutions were noted in the NS5 
region on the first (Table 4-14) or second (Appendix V) alignments of the NS5 region for 
FLWN02a. 
Evaluation of FLWN02b 
 In the capsid/prM region, a single nucleotide substitution was noted. The C → T 
transition mutation (synonymous) at position 483 did not result in a predicted change to 
the amino acid sequence [Table 4-14].  However, this substitution was not conserved, as 
previously demonstrated for North American strains of WNV (NY99) [Estrada-Franco et 
al, 2003; Beasley et al, 2004; Deardorff et al, 2006]. This mutation was first reported in 
the New World for West Nile virus strain TM171-03 collected in Mexico from a dead 
common raven (May 2003). Interestingly, this strain of WNV was collected in St. John’s 
County (northern region of Florida) on July 23, 2002, which predates the Mexican isolate 
by nearly a year.  Ten additional WNV strains collected in Florida (2001-2002) were 
provided to another group in Texas to add to its reference collection. A later study by this 
group suggested that the spread of this virus (one of the most divergent from the parental 
NY99 strain identified in 2003) entered Mexico from migratory birds flying south from 
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Florida, Louisiana or indirectly through the Caribbean, and likely not from Texas 
(Deardorff et al, 2006).  Consequently, FLWN02b is not the only Florida isolate from 
that year with these characteristic mutations. 
TM171-03 was the first strain of WNV isolated in Mexico despite later studies 
that identified WNV positive IgG antibodies in horse sera collected during 2002 through 
2003 (Estrada-Franco et al, 2003). In addition, this strain has an attenuating mutation in 
the envelope region, at position 156, where proline had been substituted for serine. This 
residue removes the N-linked glycosylation site found in most North American strains, 
which is a putative virulence determinant that, when removed, results in an attenuated 
phenotype (likely in conjunction with nonstructural mutations) [Beasley et al, 2004].  
Interestingly, this residue has only been otherwise reported from WNV isolates in China 
and Egypt (Deardorff et al, 2006). Further sequencing studies are needed on FLWN02b 
(and other reference WNV strains in Florida) to identify if the E-156 Pro residue is 
present in Florida isolates.  
The second multiple sequence alignment of the capsid/prM region identified the 
same transition mutation at position 483. In addition, nucleotides at positions 459 and 
624 matched Old World strains of the virus. These transition mutations were not noted in 
Florida isolates from 2001, 2002 (a), or 2005 (except FLM38) nor in other isolates from 
the United States (Appendix W).  
Two unique nucleotide substitutions were noted in the NS5 region, also shared by 
FLWN01b and WN Egypt101, which did not result in a change to the predicted protein 
sequence on the first alignment (Table 4-14). A second alignment of the NS5 region 
identified two silent nucleotide mutations that matched to FLWN01b (Appendix V). 
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Evaluation of FLWN05a 
 FLWN05a was isolated from an alligator in Clermont, Florida. In the capsid/prM 
region, no unique nucleotide substitutions were noted [Table 4-14]. The adenine (position 
459) and cytosine (position 483) were conserved, as has previously been noted for 
position 483 in North American strains of WNV (NY99) [Estrada-Franco et al, 2003; 
Beasley et al, 2004]. A second multiple sequence alignment corroborated these findings 
(Appendix W).  
Seven nucleotide substitutions were noted in the NS5 region, resulting in five 
changes to the predicted protein sequence on the first alignment (Table 4-14). A second 
alignment of the NS5 region identified five nucleotide changes and four amino acid 
differences for FLWN05a (Appendix V). 
Evaluation of FLWN05b 
No unique nucleotide substitutions were noted in the capsid/prM region [Table 4-
14].  The adenine (position 459) and cytosine (position 483) were conserved, as has 
previously been noted for position 483 in North American strains of WNV (NY99) 
[Estrada-Franco et al, 2003; Beasley et al, 2004]. A second multiple sequence alignment 
supported these findings (Appendix W).  The C → T transition mutation (synonymous) at 
position 624 was shared in Florida strains collected in 2001, 2002, 2005 and 2006, but 
not in 2003. The thymine at this position is also found in Old World strains of the virus. 
Three nucleotide substitutions were noted in the NS5 region, resulting in two 
amino acid changes to the predicted protein sequence on the first alignment (Table 4-14). 
A second alignment of the NS5 region identified a single nucleotide change and one 
amino acid difference for FLWN05b (Appendix V). 
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Evaluation of FLM38 
Genotype 
 WNV strain FLM38 was collected in 2005 from a sentinel chicken in Manatee 
County, Florida. In the capsid/prM region, a single nucleotide substitution was noted. The 
non-conserved C → T transition mutation (synonymous) at position 483 did not result in 
a predicted change to the amino acid sequence [Table 4-15].  The second multiple 
sequence alignment of this region identified the same substitution, as well as identified 
substitutions at positions 459 and 624 that were shared by Old World Strains of the virus 
(Appendix W).  
Three synonymous nucleotide substitutions were noted in the NS5 region that 
were shared by FLM38, FLS502 and FLS504, as well as Egypt101, on the first (Table 4-
15) and second (Appendix V) alignments.  
Phenotype  
As previously noted for WNV strains, FLM38 quickly adapted to Vero cell 
culture following the initial culture of the processed cloacal swab diluent (3 PFU/0.1ml).  
The first passage of FLM38 exhibited a weak equivocal (+/-) cytopathic effect three DPI. 
This weak positive result was likely due to the low titer of virus present on the swab. 
Consequently, the second passage of the virus replicated much faster and produced 
stronger cpe (2+) after three DPI (Table 4-18). FLM38 produced medium sized plaques 
five DPI that were not as large as NY99 (Figure 4-24) or the WNV strains isolated from 
sentinel chickens in 2006 (Figure 4-53).   
 
 
 409
Evaluation of FLS502 
Genotype 
 WNV strain FLS502 was collected in 2006 from a sentinel chicken in Sarasota 
County, Florida. In the capsid/prM region, a single nucleotide substitution was noted. The 
non-conserved C → T transition mutation (synonymous) at position 483 did not result in 
a predicted change to the amino acid sequence [Table 4-15].  The second multiple 
sequence alignment of this region identified the same substitution, as well as identified 
substitutions at positions 459 and 624 that were shared by Old World Strains of the virus 
(Appendix W).  
Three synonymous nucleotide substitutions were noted in the NS5 region that 
were shared by FLM38, FLS502 and FLS504, as well as Egypt101, on the first (Table 4-
15) and second (Appendix V) alignments.  
Phenotype  
FLS502 also quickly adapted to Vero cell culture following the initial passage of 
the processed cloacal swab diluent (816 PFU/0.1ml).  The first passage exhibited a strong 
positive (2+) cytopathic effect at four DPI. The second passage of the virus also produced 
the same cpe (2+) after three DPI (Table 4-18). FLS502 produced large plaques, with 
diffuse borders after an incubation period of five DPI (Figure 4-53).    
Evaluation of FLS504 
Genotype 
 WNV strain FLS504 was collected in 2006 from another sentinel chicken in 
Sarasota County, Florida. In the capsid/prM region, a single nucleotide substitution was 
noted. The non-conserved C → T transition mutation (synonymous) at position 483 did 
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not result in a predicted change to the amino acid sequence [Table 4-15].  The second 
multiple sequence alignment of this region identified the same substitution, as well as 
identified that substitutions at positions 459 and 624 were shared by Old World Strains of 
the virus (Appendix W).  
Three synonymous nucleotide substitutions were noted in the NS5 region that 
were shared by FLM38, FLS502 and FLS504, as well as Egypt101, on the first (Table 4-
15) and second (Appendix V) alignments.  
Phenotype  
FLS504 also quickly adapted to Vero cell culture following the initial passage of 
the processed cloacal swab diluent (32 PFU/0.1ml).  The first passage of FLS504 
exhibited a weak equivocal (+/-) cytopathic effect four DPI. This weak positive result 
was likely due to the low titer of virus present on the swab. Consequently, the second 
passage of the virus replicated much faster and produced stronger cpe (1+) after three 
DPI (Table 4-18). FLS504 produced large plaques five DPI. These plaques were 
characterized by the halo appearance encircling each plaque (Figure 4-53).   
Evaluation of FLS545 
Genotype 
 WNV strain FLS545 was collected in 2006 from a sentinel chicken in Sarasota 
County, Florida (FLS502 also isolated from this bird). In the capsid/prM region, three 
nucleotide substitutions were noted, in contrast to the other WNV strains isolated from 
chickens. The non-conserved C → T transition mutation (synonymous) at position 483 
did not result in a predicted change to the amino acid sequence. Two additional mutations 
were noted at position 237 (transversion mutation) and position 591 (transition mutation) 
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[Table 4-15]. The transversion mutation at position 237 altered the predicted amino acid 
sequence, with the substitution of valine (instead of leucine). The synonymous 
substitution at 591 also matched Old World strains of West Nile virus. The second 
multiple sequence alignment of this region identified the same substitutions, as well as 
identified that substitutions at positions 459 and 624 were also shared by Old World 
Strains of the virus (Appendix W).  
One nucleotide insertion was noted in the NS5 region, resulting in one amino acid 
inserted into the predicted protein sequence on the first alignment. In addition, one other 
shared mutation was identified for FLWN05b that matched FLM38, FLS502, and 
FLS504 (Table 4-15). A second alignment of the NS5 region identified three shared 
nucleotide substitutions that matched Egypt101 and not NY99 strains of the virus. In 
addition, one amino acid was inserted into the predicted protein sequence for FLS545 
(Appendix V).   
It should be noted that the only other conserved mutation identified for North 
American isolates (that was also in regions of the genome sequenced by this study) 
collected during 2002-2005 was position 9352 (thymine) that was the same as Egypt101, 
instead of the NY99 strain of West Nile virus. (Grinev et al, 2008). 
Phenotype  
FLS545 also quickly adapted to Vero cell culture following the initial passage of 
the processed cloacal swab diluent (36 PFU/0.1ml).  The first passage of FLS545 
exhibited a weak equivocal (+/-) cytopathic effect four DPI. This weak positive result 
was likely due to the low titer of virus present on the swab. Consequently, the second 
passage of the virus replicated much faster and produced stronger cpe (3+) after three 
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DPI (Table 4-18). FLS545 also formed large plaques five DPI, with distinct borders 
(Figure 4-53).   
Molecular Epidemiology Analysis 
Molecular epidemiology has been defined as a science that investigates the 
contribution of potential genetic and environmental risk factors, identified at the 
molecular level, to the etiology, distribution and prevention of disease (Dorman, 1998).  
For arboviruses, widespread use of molecular epidemiology principles have been applied 
in the study of global dengue virus infections (Aquino et al, 2006; Aaskov et al, 2007; 
Tung et al, 2008), including molecular identification of the country of origin for travel-
imported cases (Ito et al, 2007).  The emergence of WNV in North America has 
prompted extensive molecular epidemiology studies on flaviviruses in the continental 
United States, as these techniques have also been useful in tracing the geographic and 
temporal spread of the virus (Davis et al, 2003; Estrada-Franco et al, 2003; Ebel et al, 
2004). Consequently, these studies have become highly effective in efforts to discover the 
etiology of novel agents and identify the distribution of disease and trace its movement, 
not only in the United States but across national borders. As these techniques approach 
real-time monitoring of disease trends, molecular epidemiology studies may be used to 
limit or prevent outbreaks of disease and can improve public health, as globalization 
creates one global community.  
The utility of molecular epidemiology studies to identification of the geographic 
movement of St. Louis encephalitis virus in Florida has also been demonstrated by this 
study. The introduction of South American strains into the continental United States has 
previously been suggested by phylogenetic analysis of SLEV strains from North and 
 413
South America (Kramer and Chandler, 2001). However, the isolation of South American 
SLEV strains in North America has not been reported, despite the distribution of SLEV 
throughout the Americas. In particular, all South American strains of the virus have been 
isolated south of the border. Conversely, a strain isolated in Guatemala in 1969 is 
currently the only successful isolation of a North American SLEV strain outside of the 
continental US (except Canada); although this virus has been identified as a recombinant 
strain (Tennessee-Guatemala) in the envelope region [Twiddy and Holmes, 2003], which 
may be a spurious result as the sequence was recently removed from GenBank (personal 
communication, L. Kramer). 
From 1963 to 1970, investigators at the Epidemiology Research Center in Tampa 
performed extensive field studies in the state and collected nearly 700 arbovirus strains. 
During that time period, SLEV was isolated four times, only in 1969. The authors 
concluded that SLEV was an “exotic agent” that must be introduced to Florida (Wellings, 
Lewis and Pierce, 1972). More than thirty five years later, the results of this molecular 
epidemiology study has finally provided natural biologic evidence that SLEV is 
reintroduced periodically from South America. Phylogenetic analysis of the 
membrane/envelope, complete envelope, and NS5 regions of the viral genome identified 
the recent introduction of SLEV from South America (Brazil) into Sarasota County 
during 2006, as well as a historical introduction of a different Brazilian strain collected in 
Escambia County in 1972.  
An extensive phylogenetic analysis of SLEV was performed in 2001 by Kramer 
and Chandler.  The authors sequenced the complete envelope region of 62 SLEV strains 
and proposed seven lineages based on homologous sequence identity between strains and 
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their geographic origin. North American strains of SLEV were grouped into Lineages I 
and II, whereas South American strains were separated into Lineages III through VII.  
Florida isolates clustered into Lineage II, A, B, C and D clades. However, three South 
American strains were also grouped into Lineage A and D clades, including a strain from 
Brazil, Mexico, and Panama (Kramer and Chandler, 2001). Based on these results, it can 
be inferred that Florida strains of the virus share homology to strains isolated throughout 
eastern and central states, where the strains may be transported by migratory birds. In 
addition, SA strains from three different countries have likely circulated in Florida during 
the last century.  
Phylogenetic analysis of the complete envelope (see Figures 5-3 and 5-4) and a 
portion of the NS5 (Figure 5-5, second alignment tree) regions have identified that two 
strains of SLEV isolated during an interepidemic year of transmission in Florida share the 
highest homology to the Mexico (65V310) strain. The relationship of a Panama 
(PanAn902604) strain is also shown to these strains in the Lineage II (D) clade for the 
envelope region (complete coding sequence not available). Although bootstrap support 
for these branches is not high, the known transmission of Brazilian strains in Florida 
provides potential evidence for their accuracy. 
Another potential use of molecular epidemiology analysis is the prediction or 
“forecasting” of epidemics based on patterns encoded in the nucleotide or amino acid 
sequences of microbes. In Florida, several epidemics of SLEV have occurred since its 
first recognition in a Miami resident in 1952 (Sanders et al, 1953). More recently, the last 
large outbreak of SLEV in the state happened in 1990-1991, with 223 laboratory 
confirmed cases, which also impacted tourism and Florida’s economy (Meehan et al, 
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2000).  Consequently, knowledge of the current circulating arbovirus strains could assist 
public health and vector control agencies implement prevention strategies based on 
surveillance for agents that have caused outbreaks in the past, “epidemic” strains.  
In this study, four strains isolated during 1989-1990 were sequenced to 
characterize a potential “epidemic” profile for SLEV strains in Florida.  The earlier 
phylogenetic study by Kramer and Chandler (2001) did not identify a pattern associated 
with epidemic SLEV strains or particular host specific differences. However, these 1989-
1990 strains were not included in the 2001 study, so they were investigated with other 
Florida strains to evaluate if a pattern could be detected. With the exception of TBH-28, 
FL89, and FL90a-d, all other Florida strains analyzed in this study were not collected 
during epizootic/epidemic transmission of SLEV. Although no consensus could be drawn 
from the 1962 (TBH-28) or 1989/1990 strains, patterns were noted that may be used as 
potential epidemic indicators in Florida. Two strains (TBH-28, Pinellas15) isolated in 
1962 from an epidemic in the Tampa Bay area were found to exhibit a characteristic 
paired pattern in the complete envelope region (15 nucleotide substitutions) [Appendix 
T].  Some of these positions were shared by other North and/or South American strains of 
SLEV; however, no other strain included in this analysis characteristically shared more 
than three of the same substitutions in the complete envelope coding sequence.  
For the most recent widespread epidemic of SLEV in Florida, a pattern emerged 
for the five analyzed strains where nucleotide bases were identical and shared for each 
strain.  Twenty bases were shared for FL89, FL90a-d in the complete envelope coding 
region of SLEV [Appendix T] that were unique from the majority of strains included for 
multiple sequence alignment.  Unlike the relatively unique pattern observed for the 1962 
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strains, most of these “epidemic” mutations were shared by four additional strains 
analyzed from Tennessee (TNM4-711K) and Texas (83V4953, 98V3181, and PVI-2419). 
Four or more human cases of SLEV were reported in the same year or in the year 
preceding the epidemic (as shown for FL89) from Tennessee and Texas [CDC, 2007l]. 
Notably, these mutations were rarely shared by South American strains of the virus (less 
than three nucleotides per any SA strain). 
Caution should be used when applying these criteria in real-world practice. As 
new SLEV sequences are uploaded to GenBank, the alignment should be repeated to 
verify that these nucleotide substitutions truly reflect epidemic/epizootic transmission.  
Kuno and Change (2005) proposed that the envelope region is under selective pressure to 
evolve since that may allow for the virus to avoid the host immune response. 
Consequently, new strains with additional diversity (mutations) could arise in Florida that 
do not share these twenty nucleotide substitutions and may still result in an outbreak. Due 
to the relatively tight constraints placed on arbovirus evolution (Scott and Weaver, 1989; 
Weaver et al, 1992; Weaver et al, 1997; Gould et al, 2003; Kuno and Chang, 2005), this 
may not rapidly occur as the virus must still be able to replicate in both the arthropod 
vector and vertebrate amplifying host. Of course, additional recombination events may 
suddenly arise, producing an altered genotype.  
Interestingly, a study on vesicular stomatitis virus (VSV) [negative-sense RNA 
virus] found that rapid evolution in RNA viruses was possible, as evidenced by an isolate 
with a significant number of nucleotide mutations (n=221 nt) collected 26 years prior to 
another strain (n=23 nt) with a common ancestor (Nichol et al, 1993). VSV is an 
important animal pathogen and surveillance programs for the disease had collected these 
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strains from cattle in Alabama and Costa Rica, respectively. Consequently, the authors 
concluded that quasispecies of the virus could become established in a region (tropics, 
Panama or Costa Rica in this case), where the most fit virus quasispecies could 
predominate and undergo rapid evolution. In addition, vector-borne transmission of this 
virus may also have increased genetic diversity in the strain as the virus adapted to the 
insect vector and was then transported to the temperate zone (United States) [Nichol et al, 
1993].   
This theory was hypothesized as a potential mechanism to explain the sudden 
appearance of a new genotype of SLEV in California around 1972 (Kramer et al, 1997). 
From 1933 through 1972, SLEV strains appeared to be variants of the same genotype by 
parsimony analysis. In 1972, the virus either entered a period of rapid evolution or a new 
strain of SLEV (not South American in origin) was introduced into the Sacramento area 
and the earlier strains died out. The role of migratory birds was also evaluated and avian 
species banded in California were observed to travel in the Mississippi and Pacific 
flyways and migrate to Gulf States and Mexico in the winter, which may have introduced 
the new virus variant from other states (Kramer et al, 1997).   
As shown in our Florida study, a combination of these possibilities (quasispecies 
development through mutation vs. importation of a new strain and hybridization) could 
explain the introduction of South American strains of SLEV in 1972 and 2006, as well as 
a potential rapid evolution of the FL85 strains into the epidemic/epizootic strains isolated 
4 years later (FL89, FL90a-d). However, these Florida SLEV strains are markedly 
different from each other and cluster in different clades (Figures 5-3, 5-4, 5-5). It is 
unknown what impact South American strains of SLEV have on North American 
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genotypes of the virus in Florida, where several SA strains cluster genetically with North 
American isolates. In addition, novel flaviviruses were isolated from the same site as one 
South American strain of SLEV (FLS650) in 2006, but the portion of the flavivirus 
genome that amplified was not South American in origin. Instead, it shared 98% 
sequence homology to the 1962 genotype of isolates in the Tampa Bay region. Future 
studies are needed to investigate this relationship.  
The emergence of a new genotype of WNV in 2002 was first detected in Texas 
and has now become the dominant genotype of the virus in North America. Several 
factors allowed this genotype to rapidly spread, including viral mutations and apparent 
increased fitness for replication in mosquitoes over the NY99 strain. A combination of 
these factors allowed the WN02 strain to rapidly spread across the United States in 2002-
2003, with record WNV human case numbers. As a result, the earlier NY99 strain of 
WNV appeared to die out or was out-competed by the new variant (Davis et al, 2004 & 
2005; Kilpatrick et al, 2006; Snappin et al, 2007).  
Several nucleotide mutations have been identified and become “fixed” in the 
North American clade of WNV strains isolated from 2002-2004 (note: Florida strains 
from 2001 and 2002 have been placed in the Eastern States clade) [Davis et al, 2005]. A 
few WNV reference strains collected in Florida from 2001, 2002, and 2005 were studied 
in this project. One conserved mutation at position 9352 (C → T) in the NS5 region was 
first detected in the Florida strains isolated during 2005 and 2006, which had reverted to 
the nucleotide shared by the Old World strains of the virus. This had previously been 
reported for other WNV strains earlier in 2002 (Davis et al, 2005; Grinev et al, 2008). 
However, one complete coding genome sequence of WNV strain (03-113FL) collected in 
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Florida from 2003 also had the mutation, so this variant position may have become fixed 
in Florida strains starting in 2003 (Appendix V). Several mutations noted for individual 
strains studied here may not become fixed in the WNV population, but may represent 
quasispecies of the dominant virus population in Florida. Additional Florida WNV strains 
should be sequenced to continue to study the accumulation of mutations and evolution of 
the virus in the state, as routinely performed in Texas and New York (Davis et al, 2003, 
2004 & 2005; Ebel et al, 2004). 
Previous studies on SLEV strains assessed virulence characteristics in isolates 
collected from different geographic locations through 1977 (Trent et al, 1980 & 1981; 
Monath et al, 1980; Bowen et al, 1980, 1981). Strains were placed into three categories: 
high, intermediate and low virulence based on neuroinvasiveness of the disease in mice 
and monkeys (Trent et al, 1980; Monath et al, 1980).  90% of North American epidemic 
strains were highly virulent (including Florida strains isolated in 1962, 1977, which were 
not studied as part of this project), as compared to interepidemic years that resulted in an 
attenuated (low virulence) phenotype. Low virulence phenotypes were noted for two 
SLEV strains collected in Polk County, Florida in 1969 (Table 5-8).   
Molecular epidemiology analysis of the three SLEV isolates collected in Florida 
placed these strains in South American lineages. Consequently, it is hypothesized that the 
potential virulence of these recent Florida strains may be similar to the estimated 
virulence for closely related South American isolates that have previously been examined 
in a mouse model (Monath et al, 1980). Unlike the majority of isolates studied from the 
United States, South American strains were considered endemic (or enzootic) since they 
were either associated with sporadic human cases or were obtained in absence of human 
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clinical illness during field studies.  Despite low levels or absent human cases in South 
America, 52% of SA strains were highly virulent (n=12) whereas 48% were completely 
or partially attenuated in mice (n=11) [Monath et al, 1980]. Phylogenetic analysis of 
FLS569 and FLS650 place these strains in Lineage VA, with closest homology to 
BeAn242587, a high virulence phenotype. In Lineage VA, only TR9464 was of 
intermediate virulence, but it was placed in a sister cluster. In contrast, FL72 was placed 
in Lineage VB, with closest homology to BeAn246262, also a high virulence phenotype. 
However, other strains in the cluster had low or intermediate virulence characteristics in 
mice (Monath et al, 1980).  
FLS569 and FLS650 had the highest nucleotide sequence homology to Brazilian 
and one Peruvian strain that demonstrated high virulence in animal models. FL72 also had 
the highest homology to a strain collected in the same year (1972) from the same host 
species (opossum) in Brazil.  BeAn246262 also was categorized with high virulence in a 
mouse model (Monath et al, 1980).  However, two other strains in Lineage VB were 
more attenuated, with low and intermediate virulence, than those grouped into Lineage 
VA. Although these virulence characteristics may not directly relate to epidemics of 
SLEV and/or pathogenicity of the strain for humans (Kramer et al, 1997), it is important 
to note that “virulent” South American strains may have been introduced to Florida.  
Virulence characteristics for these strains should be assessed with animal models to 
confirm this hypothesis.  
 Epidemics of SLEV are uncommon in South America (Sabattini et al, 1985; 
Spinsanti et al, 2003; Rocco et al, 2005), where high seroprevalence rates to dengue (and 
other endemic flaviviruses that circulate in South America) may provide cross-protective 
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immunity to the population from high virulence SLEV strains.  Recently, cross-reactive 
antibodies to dengue virus in amplifying and dead-end hosts have been proposed to 
explain the apparent attenuation/absence of severe WNV disease in humans, as well as 
several other circulating flaviviruses with avian-mosquito cycles that provided protective 
immunity for the primary amplifying host (birds) in Central and South America (Gubler, 
2007). Likely, the same scenario limits outbreaks and epizootic amplification of SLEV.   
Several flaviviruses circulate in South America, which can significantly impact 
disease diagnosis. Two outbreaks of SLEV were recorded in Argentina and Brazil in 
2005 (47 confirmed human cases, nine fatalities) and 2006 (six confirmed human cases), 
respectively (Diaz et al, 2006; Rocco et al, 2005; Mondini et al, 2007a).  Molecular 
epidemiology analysis on the envelope region (Diaz et al, 2006) and a small portion of 
the NS5 region (Mondini et al, 2007a) identified that the outbreaks were related.  SLEV 
strains isolated from both epidemics shared nucleotide sequence homology to 
Argentinean strains of the virus, placing them in Lineage III (Figure 5-4). Despite initial 
misdiagnosis as dengue infections, the six patients in Brazil were later confirmed SLEV 
positive after dengue and yellow fever etiologies were ruled out. Notably, three of these 
cases had clinical symptoms of hemorrhagic disease, which is the first time that 
hemorrhagic signs have been linked to SLEV infections.  Yet, dengue virus is endemic in 
the region and previous infections with dengue may confound this association (Mondini 
et al, 2007a). A recent report from Brazil identified one patient that was co-infected with 
St. Louis encephalitis and dengue type 3 viruses, which did not result in severe disease 
(Mondini et al, 2007b).  
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Recent outbreaks of SLEV in tropical regions have raised concerns that the mild 
illness typically associated with the virus in South America may have become more 
severe. The potential introduction (or reintroduction) of these SA strains to the United 
States should be carefully monitored, where the potential attenuation of virulence from 
cross-protective dengue antibodies in South America may not protect an immunologically 
naïve population in the US from disease. 
In conclusion, St. Louis encephalitis virus strains collected in Florida during 1972 
and 2006 were identified as South American in origin; molecular epidemiology and 
phylogenetic analysis of the envelope region classified these strains into Lineages VA 
and VB, as proposed by Kramer and Chandler (2001). These strains, FLS569 and 
FLS650, may be highly virulent, as found in animal models for other SLEV strains that 
are grouped into the same lineages (Monath et al, 1980). Phylogenetic analysis is an 
important surveillance tool for the study of arboviruses, where avian amplifying hosts can 
travel long distances and transport “exotic agents”, such as strains of SLEV or West Nile 
virus into (or out of) the United States (Wellings, Lewis, and Pierce, 1972; Gubler, 2007).  
 
Discovery of a Novel Arbovirus 
In 2006, targeted sampling of sentinel chicken flocks located at Site 004 in 
Sarasota County resulted in the detection, of St. Louis encephalitis virus and West Nile 
virus from a single confirmed SLE antibody positive bird. This finding was unexpected 
because confirmed WNV transmission activity (seroconversions) had not been detected 
in sentinel chicken flocks in Sarasota County since April 2006, six months earlier. An 
experimental MIA test identified WN activity at Site 003 in June, which indicated that 
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the virus was likely still circulating in the rural, wild bird-mosquito populations. 
Beginning October 9 and over the next nine days, cloacal swabs were collected from this 
sentinel chicken three times; virus was isolated from each swab (WNV on the first two 
specimens and SLEV on the third).  Interestingly, West Nile antibodies were not detected 
in any of the birds located at Site 004.   
The county mosquito control district was contacted to verify submitted paperwork 
and accuracy of sample collection on those dates. It was concluded that samples were not 
switched in the field (e.g. with other SLE positive chickens). Targeted sample collection 
at the second positive location (Site 001) did not begin until five days later on October 
23, following reported HAI results on October 20 (see Figure 4-20).  CDC light traps 
baited with CO2 were also operated for three hours every other night at Site 001 from 
August through November. Mosquito collection results made at Site 004 during the 
months when sentinel seroconversions were detected illustrates the importance of Culex 
nigripalpus to the transmission cycle of SLEV (Figure 5-6) [unpublished data, W. 
Brennan (Sarasota County Mosquito Control District)].   
Ground and aerial spraying are routinely triggered by an increase in pest 
mosquitoes (Psorophora sp.) or when Culex sp. numbers reached over 3000. Due to the 
low mosquito numbers collected each week in September and October, ground and aerial 
spraying was only initiated on September 15 near Site 004. Once sentinels seroconverted 
in October, larvaciding efforts were intensified and neighboring woodlots were treated by 
hand application of insecticide [personal communication, W. Brennan (SCMCD)]. Culex 
nigripalpus was the primary mosquito vector collected, although Culex melanoconion 
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Figure 5-6 Mosquito Surveillance Results Conducted at Site 004 (Sarasota County, 2006) 
In 2006, Sarasota County Mosquito Control District trapped mosquitoes located at Site 004 every other day, using CDC 
light traps baited with CO2 and operated for three hours. The date ground and aerial pesticide treatment was decided 
(blue) and dates of chicken sera collection (green) indicates the time that a bird first developed SLE+ antibodies. Culex 
nigripalpus was the mosquito species predominately trapped during this time period, although Cx. melanoconion was 
also collected in low levels. 
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was also detected in mosquito traps (less than 40 collected in a single night preceding and 
at time of sentinel seroconversions) throughout September and October.         
At Site 004, West Nile virus was collected on October 9 and October 16, whereas 
St. Louis encephalitis virus was isolated on October 18. However, retrospective 
processing of these samples was performed in November once the seroconversion was 
confirmed SLE positive. Targeted sample collection at Site 001 was initiated by the 
county on October 23 following a second SLE+ sentinel seroconversion in the HAI 
assay. The BOL-Tampa performed molecular detection, cell culture, and serology assays 
on samples collected from Site 004 for the next several months to investigate the dually 
infected sentinel chicken. Complete genome sequencing of FLS545 and FLS569 was 
performed to investigate if these strains of the virus had recombined. However, 
recombination was not detected.   
During this time period, samples were also processed from each site targeted by 
Sarasota County where a seroconversion had been detected.  The first evidence for the 
cross-reaction of WNV and SLEV by real-time (TaqMan) RT-PCR was noted for 
FLS853 (the first novel flavivirus detected) at Site 001. The test was repeated following a 
second RNA extraction and RT-PCR assay, with the same results. However, this sample 
did not replicate in culture and was not further investigated.  
Additional specimens collected at this time were examined retrospectively.  
Consequently, samples collected from the second SLE+ at site (001) were only extracted 
several months later, after the sentinel chicken program in Sarasota County had 
discontinued for the winter months. Cloacal swabs were processed, extracted and tested 
by molecular assay prior to inoculation in cell culture. Three additional arbovirus strains 
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were detected on swabs collected at Site 001: FLS650 (SLEV+), FLS649 and FLS694 
(novel flavivirus +).  
Sarasota County Mosquito Control District has provided the results of mosquito 
collections that were made at Site 001 in the months that sentinel seroconversions 
occurred (Figure 5-7) [unpublished data, W. Brennan (SCMCD)].  November data is not 
shown, but low numbers of Culex nigripalpus were reported trapped every other day 
Collections from November 29 included 151 Culex sp., but every other collection in 
November had 50 or less. In addition, the distance between the locations of Site 001 and 
Site 004 is 12 Km (7.5 miles). It has been well-established that Culex nigripalpus is the 
primary epidemic and enzootic mosquito vector for SLEV and WNV in Florida (Burke 
and Monath, 2001; Reisen, 2003; Stark and Kazanis, 2001-2005). 
Evaluation of FLS649 
Genotype 
FLS649 was detected by real-time RT-PCR for SLEV (screened and confirmed), 
but it was a weak positive with high CT values (38.37 on screening). This cloacal swab 
was also screened with the WNA TaqMan primer-probe set, but was not detected (unlike 
FLS853). However, the gel-based primers for the membrane/envelope (SLEC) and 
capsid/prM (WNAE) regions amplified RNA from this strain. Gel-electrophoresis of the 
PCR products identified a multiple banding pattern for FLS649 (Figure 4-33). Strain 
identity was confirmed by sequencing. FLS649 shared 97% homology with Tampa Bay 
strains of SLEV (TBH-28 and GHA-3) in the membrane/envelope region. Sequencing of 
the capsid/prM region identified that FLS649 shared 98% sequence identity with Old 
World strains of WNV, although several amino acids were missing in the multiple 
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Figure 5-7 Mosquito Surveillance Results Conducted at Site 001 (Sarasota County, 2006) 
In 2006, Sarasota County Mosquito Control District trapped mosquitoes located at Site 001 every other day, with CDC 
light traps baited with CO2 and operated for 3 hours. The dates ground and aerial pesticide treatment was decided (blue) 
and dates of chicken sera collection (green) indicates the time that a bird first developed SLE+ antibodies. Culex 
nigripalpus was the mosquito species predominately trapped during this time period, although Cx. melanoconion was 
also collected in low levels. 
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sequence alignment due to inconclusive base calls between the sense and anti-sense 
sequences for some nucleotide positions (Appendix L, Table 4-16).   
Confirmation of this homology to Old World strains was not possible, as RT-PCR 
with the WNBE primer set (3’ NS5 region) generated an amplicon, but sequencing failed 
(Figure 4-36, Table 4-16).  In addition, RT-PCR assays targeting the SLEV envelope, 
flavivirus NS5, and flavivirus 3’non-coding regions did not produce amplicons. 
Consequently, results indicate that this strain has homology to SLEV and WNV in one 
region each, but the fragments do not overlap and are less than 400 base pairs in size (7% 
of the genome collectively). Complete genome sequencing was attempted on this strain, 
but the primer sets [Ciota et al, 2007c] used were designed to amplify large portions of 
the genome (overlapping fragments ~1.5kb in size) and non-specific amplicons of smaller 
sizes resulted. Additional studies are needed to resolve these findings. 
The first multiple sequence alignment identified six unique nucleotide and five 
predicted amino acid differences in the membrane/envelope region (SLEC) (Table 4-16, 
Appendix O). However, a second analysis of this region with a larger sample size of 
SLEV strains identified five unique nucleotide mutations (non-synonymous) that resulted 
in five amino acid changes to the predicted protein sequence (Appendix U). In contrast, 
the first and second alignments identified ten conserved nucleotides that matched the Old 
World strains of West Nile virus in the capsid/prM region (Appendix L and W, 
respectively).  
Phenotype 
Similar to FLS853, these extracted novel flavivirus samples (FLS649) also did not 
replicate in cell culture or produce detectable cytopathic effect after two passages (Table 
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4-18). As a result, FLS649 did not produce plaques in assays with two different 
incubation periods (three DPI and seven DPI) before media-agarose overlays 
(supplemented with neutral red) were added and plaques counted, if present.  In addition, 
FLS649 was inoculated into human pulmonary endothelial cells (HPMEC), an in vitro 
system that collaborators with the BOL-Tampa have developed to study cytokine 
production following dengue virus infection (Azizan et al, 2006). However, cytopathic 
effect was not observed in this system (data not shown). Real-time RT-PCR assays also 
did not detect replication of the virus during a 14 day time course experiment in this cell 
line. Additional in vivo (mouse) and in vitro (mosquito and avian cell lines) studies are 
planned to evaluate the phenotype of this virus and to assess its ability to replicate. 
Evaluation of FLS694 
Genotype 
FLS694 was detected by real-time RT-PCR for SLEV (screened and confirmed), 
but it was a weak positive with high CT values (36.20 on screening). This cloacal swab 
was also screened with the WNA TaqMan primer-probe set, but was not detected (unlike 
FLS853). However, cell culture supernatant from the first passage of this strain was 
extracted and tested by real-time RT-PCR and was positive with the WNA and WNB 
TaqMan primer sets. In addition, the gel-based primers for the membrane/envelope 
(SLEC) and the capsid/prM (WNAE) regions were amplified for this strain. FLS694 
produced a double band at the expected size with the SLEC primer set (Figure 4-33) and 
a single band with the WNAE primer set (Figure 4-36). The PCR products were 
extracted, purified and sequenced as described above for FLS649.  
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BLASTN search results on the membrane/envelope sequence identified 98% 
homology with strains from Tampa Bay (TBH-28 and GHA-3), as well as a Guatemala 
strain (78 A 28).  St. Louis encephalitis virus strains from Mexico strain (65 V 310) and 
Missouri (Parton) were also matched to the FLS694 query sequence at 97% identity 
(Appendix K).  As shown for FLS649, the capsid/prM region identified that FLS694 also 
shared 99% sequence identity with Old World strains of WNV (Appendix L, Table 4-16).   
In addition, the FLS694 viral genome did not amplify with the complete envelope 
primer set, the larger NS5 primer set (Fu1/cfd3) or the 3’NC primer set (YF1/2) [Figures 
4-34 and 4-35], as previously shown for FLS649. However, the RT-PCR product 
targeting the carboxy terminus of the NS5 gene did sequence for FLS694 (Figure 4-48). 
These WNBE primers targeted a small, internal region of the larger NS5 fragment (300 
bp).  BLASTN search results found 100% sequence identity to Oklahoma (OKO3), New 
York (385-99, 3356K VP2), and Florida (FL03-FL2-3) strains of WNV. 100% sequence 
identity was also found for a California WNV strain cultured from a blood donor 
[Appendix K]. The discrepancy between the BLASTN results for this region (homology 
to North American strains) compared to the capsid/prM region (homology to Old World 
strains) will be analyzed in future studies. Complete genome sequencing was attempted 
to resolve this contradiction, but the primer sets failed to produce amplicons of the 
correct size, as described above for FLS649.  
Multiple sequence alignment was performed on the sequenced PCR product that 
targeted the M/E region. Analysis of the membrane/envelope alignment identified a 
single nucleotide mutation that resulted in one predicted amino acid substitution (Table 4-
16). A second alignment of this region found no unique differences since the nucleotide 
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substitution at position 834 matched South American strains of SLEV (including FLS569 
and FLS650).  As a result, no unique amino acid substitutions were predicted.  Finally, 
the alignment of the carboxy NS5 region (WNBE) found no unique differences in either 
the nucleotide or predicted amino acid sequence, with closest homology to North 
American strains of WNV. 
Phenotype 
As found for FLS649 and FLS853, this extracted novel flavivirus sample 
(FLS694) did not replicate in cell culture or produce detectable cytopathic effect after 
two passages (Table 4-18). As a result, FLS694 did not produce plaques in assays with 
two different incubation periods (three DPI and seven DPI) before media-agarose 
overlays (supplemented with neutral red) were added and plaques counted, if present.  In 
addition, FLS649 was also inoculated into human pulmonary endothelial cells (HPMEC), 
a second mammalian in vitro system. Cytopathic effect was not observed in this system 
(data not shown). Real-time RT-PCR assays also did not detect replication of the virus 
during a 14 day time course experiment in this cell line. Additional in vivo (mouse) and 
in vitro (mosquito and avian cell lines) studies are planned to evaluate the phenotype of 
this virus and to assess its ability to replicate.  
 In summary, the genotypes of FLS649 and FLS694 were unusual. These strains 
were identified as SLEV+ by TaqMan RT-PCR with SLEV primers, but FLS694 also 
exhibited cross-reactivity with WNV primers in this real-time nucleic acid amplification 
assay. Despite these results, FLS649 and FLS694 did not produce an amplicon for the 
SLEV complete (or partial) envelope region in gel-based RT-PCR assays. The only 
SLEV-specific region that was detected and sequenced was the partial 
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membrane/envelope (SLEC), but these viruses produced amplicon banding patterns that 
differed from that of the control viruses. After sequencing, phylogenetic analysis did not 
group these strains with each other. In fact, all other North American strains of SLEV 
shared FLS694 as a common ancestor. However, bootstrap values were low indicating 
that these branches may not be accurately drawn, as shown in the maximum parsimony 
method, with additional reference strains (Figure 5-8). In contrast, the UPGMA method 
resulted in more robust bootstrap support (Figure 5-9) although FLS694 grouped close to 
two other North American strains (FL 79-411 and Kern217). These results suggest that 
the novel flavivirus strains were quasispecies of a virus that was transmitted to sentinel 
chickens from the mosquito-wild bird cycle (quasispecies have been identified for WNV 
in naturally infected mosquitoes, Jerzak et al, 2005), or that may have developed in the 
chicken following infection with “prototype” of the virus.  
Specific primer sets for the detection of West Nile virus were also used to 
characterize these strains based on real-time RT-PCR results. Both strains produced a 
single amplicon size for the capsid/prM region of WNV. In contrast to the SLEV 
membrane/envelope region, sequencing results and phylogenetic analysis grouped these 
strains together in the maximum parsimony method, as shown with additional reference 
strains (Figure 5-10). In addition, only FLS694 was successfully sequenced in the 3’ 
terminal region of the NS5 gene, which indicated that the virus shared homology with 
North American WNV strains (Figure 4-48).  
Unlike neutralized plaque variant clones (picked for FLS502, FLS545 and 
FLS569) that were cross-reactive in the TaqMan assays, these strains did not amplify 
with several gel-based primer sets that were previously able to confirm identifty of cross- 
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Figure 5-8 Phylogenetic Relationships of SLEV & Flaviviruses (Partial 
Membrane/Envelope Region), Second Alignment 
Phylogram of the partial membrane/envelope region (bases 728-112) was 
inferred using the maximum parsimony method in MEGA4.0.1, where the 
consensus tree (1000 bootstrap replicates) was chosen. Branch lengths 
represent the amount of genetic divergence, with the scale bar 
corresponding to number of base changes in the entire sequence. Bootstrap 
values are shown on branches. 
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Figure 5-9 Phylogenetic Relationships of SLEV & Flavivirus Strains (Partial 
Membrane/Envelope Region), UPGMA Second Alignment  
Phylogram of the partial membrane/envelope region (bases 728-112) was 
inferred using the unweighted-paired group means arithmetic (UPGMA) 
method in MEGA4.0.1, where the consensus tree (1000 bootstrap 
replicates) was chosen. UPGMA method produced a rooted tree and 
assumed a constant rate of evolution. Branch lengths represent the amount 
of genetic divergence, with the scale bar corresponding to number of base 
changes per site (maximum composite likelihood method). Bootstrap 
values are shown on branches. 
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Figure 5-10 Phylogenetic Relationships of WNV & Flaviviruses (Capsid/prM 
Region), Second Alignment 
Phylogram of the partial membrane/envelope region (bases 728-112) was 
inferred using the maximum parsimony method in MEGA4.0.1, where the 
consensus tree (1000 bootstrap replicates, value shown on branches) was 
chosen. Branch lengths represent the amount of genetic divergence, with 
the scale bar corresponding to number of base changes in the sequence.  
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reactive clones. Since infectious virus was isolated from a WNV and SLEV dually 
infected chicken, the cross-reactive results may be explained by a mixture of the viruses 
on the swab (further studies are needed). However, infectious virus was not detected by 
traditional cell culture or plaque assays for the novel flavivirus strains. Consequently, 
mutations in the genome may have negatively impacted the phenotype of these strains 
(potential lethal mutations) and/or prevented replication.  
This hypothesis is supported by RT-PCR assays that failed to produce an 
amplicon for longer contiguous sequences of the genome, including the SLEV complete 
envelope, flavivirus NS5 and 3’non-coding regions. As a result, these genotypic 
differences may have prevented the detection of these strains in traditional serology 
assays, especially if replication was altered/defective, which may have caused an aborted 
infection and little or no antibody production. Consequently, further studies are needed to 
assess genotypic and phenotypic differences found for these novel strains and their 
impact on surveillance methods used for the detection of arboviruses.  
Impact on Surveillance Methods 
The Arbovirus Isolation Network was successful in targeting regions where 
arbovirus activity was present, which improved arbovirus isolation from field collected 
samples with a systematic approach used by several local agencies. However, the 
detection and isolation of South American SLEV and novel flavivirus strains required the 
use of additional molecular methods (gel-based assays and sequence analysis), as well as 
modified plaque assays for the identification and characterization of these strains. The 
current surveillance systems (mosquito pools, dead birds, sentinel chicken 
seroconversions) for detection of arbovirus transmission activity in Florida failed to 
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identify these novel flavivirus strains; yet, sentinel chicken seroconversions did detect 
South American strains of SLEV. As discussed above, novel flavivirus strains may have 
been missed by the traditional serology assays performed on chicken sera due to an 
altered genotype (atypical envelope region) resulting in development of antibodies of 
different specificity.  
No one surveillance method exists that can concurrently detect seroconversions 
(antibody development) and capture virus strains for molecular epidemiology analysis. 
Several surveillance techniques are recommended for an effective arbovirus surveillance 
program (CDC, 2003A) to detect enzootic/epizootic transmission activity. As shown in 
this study, natural arbovirus infections resulted in transient and low level viremias that 
would not be adequate for surveillance purposes. In addition, detection of infection by 
arbovirus shedding in the feces appeared to be impacted by the age of the chicken, rarely 
identified infections prior to the development of antibodies, and was a more expensive 
test to perform than traditional antibody-based assays. Consequently, serological assays 
are still the gold standard for detection of arbovirus transmission in Florida, where 
sentinel seroconversions have been shown to provide early warning for human cases of 
WNV (Blackmore et al, 2003; Butler and Stark, 2005). The Arbovirus Isolation Network 
has created another tool that can be used to track the evolution and distribution of 
arboviruses in Florida. As discussed previously, arbovirus strains may rapidly evolve 
where variant quasispecies exist in an otherwise homogenous population of a dominant 
genotype (e.g. WNV) or mixing of strains (quasispecies) in mosquito and/or avian 
amplifying hosts may provide a mechanism for these RNA viruses to evolve.  
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Homologous recombination was demonstrated in the Flaviviridae for all four 
serotypes of dengue virus (Holmes et al, 1999; Tolou et al, 2001). The impact of 
recombination on the evolution of virus taxa will largely depend on the level of 
difference between the viruses that undergo a recombination event. Currently, 
recombination in flaviviruses has been identified only in very closely related viruses, 
leading to low level sequence divergence (Calisher and Gould, 2003). Despite the 
isolation of WNV and SLEV strains from a dually infected sentinel chicken, 
recombination was not identified in either isolate. However, recombination between 
WNV and SLEV strains would not be a homologous event as they belong to separate 
taxa. This may result in a high level of sequence divergence in a hypothetical recombined 
WNV/SLEV strain that is lethal to replication of the virus. Nonetheless, there are still 
conserved regions within the viral genome that are shared by all flaviviruses including 
residues in the 5’UTR, envelope and NS5 regions that may allow for such an event to 
occur (McMinn, 1997; Kuno et al, 1998; Twiddy and Holmes, 2003). This type of 
recombination event may negatively impact both the molecular and serological methods 
currently in use for detection of West Nile virus and St. Louis encephalitis virus. 
Molecular Detection Methods 
The novel flavivirus strains were detected with the SLEV-specific primer-probe 
sets in real-time RT-PCR (TaqMan) assays and FLS694 tested positive with the WNV-
specific primer-probe sets. The low titer of virus/viral RNA present on cloacal swabs 
often resulted in samples that were weakly positive by TaqMan RT-PCR, where the 
strains were not detected by the instrument until later in the RT-PCR cycle (cycle 
numbers greater than 30). It is recommended that all samples that screen positive in real-
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time RT-PCR assays with weak CT values (greater than 37) be confirmed with additional 
real-time and traditional gel-based RT-PCR assays. Consequently, novel flavivirus strains 
are not likely to be missed during molecular testing, as long as samples are run in parallel 
with both SLE and WN specific RT-PCR assays when collected from sites with 
confirmed SLEV seroconversions. The application of this principle to routine testing of 
mosquito pools and tissues submitted to the BOL-Tampa for arbovirus molecular 
detection assays would require additional study, as this would significantly add to the 
cost of the assay. Perhaps this method could be implemented only at certain times of the 
year, i.e. during peak transmission season when samples are routinely screened for WNV 
only.  
Although these novel flavivirus strains were detected by real-time RT-PCR 
methods, they were difficult to amplify with the majority of gel-based RT-PCR methods 
used in this study. One end-point primer set for SLEV and WNV worked for both strains, 
and an additional WNV primer set amplified FLS694 only.  However, these primer sets 
amplified 300-400 nucleotide bases of the viral genome, whereas primer sets that targeted 
a longer contiguous sequence (600-1700 bases) failed. Complete genome sequencing is 
planned to elucidate the reason(s) why these molecular detection methods were 
unsuccessful.  
Virus Isolation Methods 
Another arbovirus surveillance method that will be impacted by these novel 
flaviviruses is the use of Vero cell cultures for arbovirus isolation assays. At this time, 
this is the only cell line used by the BOL-Tampa for inoculation of field collected 
samples for virus isolation. The failure of these strains to produce cytopathic effect in 
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Vero cells may limit the future detection of these novel strains with this in vitro system. 
This finding was unusual as cell culture systems are often useful for the isolation of novel 
viruses, whereas molecular methods can be employed only for previously recognized 
viruses and those of suspected etiology for a diagnostic sample (Oglivie, 2001). 
However, it is likely that genotypic differences may have influenced the ability or 
efficiency of these strains to replicate in culture and not the methods used in this study. 
Real-time RT-PCR CT values were also high, which may indicate that intact infectious 
virus on the swab was also low, if present. Additional in vitro systems should be assessed 
with these strains and enzootic arboviruses (EEEV, HJV, CAL) in Florida to determine if 
an alternative culture system would produce cytopathic effect for all viruses.  
Serological Methods 
The hemagglutination inhibition assay is an antigen-antibody based test that can 
be used for the detection of arbovirus-specific antibodies (Casals and Brown, 1954). As 
performed at the BOL-Tampa, this assay is highly sensitive for the detection of flavivirus 
and alphavirus antibodies in chicken sera. Nonetheless, this assay may also be impacted 
by novel arbovirus strains in that the group antigens used in the test (SLEV for 
flaviviruses and EEEV for alphaviruses) may not be capable of detecting “novel” 
antibodies generated to a virus with altered envelope and/or NS1 epitopes to which most 
host antibodies are formed (Chambers et al, 1990). The results of molecular RT-PCR 
assays on the novel flavivirus strains indicated that the envelope and NS1 (overlapping 
bases at the 5’ terminus) regions may be significantly different at the genomic level, 
which may correlate to insertions, deletions or base substitutions that are non-
synonymous.  
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A new predicted protein sequence in the envelope region may have serious 
consequences not only for the host, but also for serology assays that rely on the detection 
of antibodies generated to envelope epitopes. Consequently, it was not unexpected that 
these novel flavivirus infections in sentinel chickens were missed by the HAI assay, 
based on genotypic characteristics of these strains. Unfortunately, the HAI-negative sera 
from these birds were discarded, due to the retrospective processing strategy used in this 
study. As a result, these and later sera samples were not tested in additional assays that 
may have detected SLEV or WNV-specific IgM and neutralizing antibodies and thus no 
assessment of the immune response to these viruses in naturally infected chickens could 
be made. 
However, the detection of these novel flaviviruses only occurred because other 
chickens at Site 001 were identified by the HAI assay following seroconversion to SLEV. 
It is unlikely that these strains would have been discovered with the retrospective 
processing strategy used by the BOL-Tampa, if no evidence of infection was detected at a 
site (seroconversion). In particular, a retrospective processing strategy that only 
processed cloacal samples collected from birds with confirmed seroconversions would 
have missed these infections. As shown in this study, it is important to process samples 
collected from the entire flock at a suspected site based on a single confirmed 
seroconversion, as virus was detected and/or isolated from other birds in these flocks that 
did not seroconvert. Based on these findings, it is possible that these strains may be 
present in cloacal swabs collected from HAI-antibody negative birds located at sites 
without confirmed seroconversions in Sarasota County, or even in other counties. In 
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addition, it is unknown if these novel flaviviruses were circulating in Florida prior to 
2006 but were undetected. 
 
Aim Five 
Assessment of Virus Isolation/Detection Methods as a Surveillance Tool in Florida 
This study has clearly shown the importance of serological assays for the 
detection of arbovirus transmission activity in naturally exposed sentinel chickens. 
Serosurveys have frequently been used to detect arbovirus transmission activity, where 
exposure rates for humans or other animals are based on seroprevalence estimates in 
populations studied in the United States and South America (Calisher, 1994; Sabbatini et 
al, 1985; Burke and Monath, 2001; Reisen, 2003; Mondini et al, 2007a).  In essence, a 
serosurvey was conducted each week on approximately 3,000 – 4,000 sentinel chickens 
naturally exposed to arboviruses throughout Florida during 2005 and 2006. Positive 
seroconversions detected by the HAI assay are usually indicative of a recent infection 
(due to weekly or biweekly sample submittal) and can be used to assess risk of 
epizootic/epidemic transmission resulting in implementation of prevention strategies by 
public health and mosquito control agencies (FDOH-BCEH, 2007).  
However, the sentinel chicken program in Florida relies on serological testing for 
detection of antibodies to the viruses. This program does not attempt to isolate 
arboviruses for molecular characterization studies from samples routinely collected from 
live chickens; instead arboviruses are usually cultured from mosquito pools or tissues 
from birds/mammals. The major disadvantage of this approach is that when prevalence of 
the disease is low during interepidemic years (as seen for SLEV since 1997), natural 
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evolution or alterations of these viruses may be missed until an outbreak of disease 
occurs. Consequently, an Arbovirus Isolation Network was implemented to collect 
arboviruses in Florida with a targeted sampling strategy in order to analyze molecular 
epidemiology trends. 
Evaluation of Virus Isolation/Molecular Detection Compared to Serological Assays 
Assays performed by the BOL-Tampa were sensitive for the isolation and 
detection of low titered arbovirus shedding in the feces (≥ 2 PFU/0.1ml) processed from 
cloacal swabs by Vero cell culture and real-time RT-PCR, respectively. However, culture 
and molecular methods were not successful for the detection of viremia from whole 
blood samples (Table 5-6). Viremia in adult chickens appears to be transient (consistent 
with previous reports: Reisen et al, 1994; Langevin et al, 200; Patiris et al, 2008) and/or 
below the detection threshold of the TaqMan assay routinely used at the BOL-Tampa. 
Consequently, this sampling strategy was discontinued for the 2006 transmission season 
and is not recommend for future targeted studies of sentinel chickens. 
In 2005, three counties performed targeted sample collection at sentinel chicken 
sites.  Manatee County had a total of 49 birds seroconvert during 2005, with 29 chickens 
that seroconverted during the county’s active participation in the Arbovirus Isolation 
Network. However, only 14 of these birds were targeted for sample collection at the time 
of seroconversion. West Nile virus was isolated from a single bird. In addition, WNV 
was detected (but not cultured) from two additional birds in Manatee County that failed 
to seroconvert in the HAI assay (Tables 5-1, 5-2). As previously discussed, the advanced 
age of chickens in these flocks may have contributed to an altered immune response 
following infection. In particular, the chicken where WNV was cultured from the cloacal 
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swab did not seroconvert in the HAI assay until 28 days post isolation. The extensive 
time delay for this chicken to develop detectable antibody may have contributed to the 
decreased recovery of virus from confirmed sentinel seroconversions in Manatee County, 
as targeting of the site did not occur until well after infection.  As a result, this was likely 
the single largest factor that contributed to the poor recovery of virus from the 13 other 
birds that seroconverted but virus was not isolated/detected. 
Orange County had a total of 21 birds seroconvert during 2005, with seven 
chickens that seroconverted during the county’s active participation in the Arbovirus 
Isolation Network. However, only one of these birds was targeted for sample collection at 
the time of seroconversion.  Eastern Equine Encephalitis viral RNA was detected (but not 
cultured) on cloacal swabs from this bird, at two different time points. In contrast to 
Manatee County, Bird 846 seroconverted within eight days post detection of the initial 
positive cloacal swab.  In addition, EEE viral RNA was detected (but not cultured) from 
one additional bird in Orange County that failed to seroconvert in the HAI assay (Tables 
5-1, 5-2).  
Sarasota County had a total of 17 chickens seroconvert during 2005, with eight 
birds that seroconverted during the county’s active participation in the Arbovirus 
Isolation Network. None of these seroconversions were detected at targeted sites. 
Consequently, evaluation of the effectiveness of virus isolation/detection from confirmed 
sentinel chicken seroconversions could not be assessed.  However, no virus was detected 
or isolated from 38 processed swabs collected from sero-negative birds (Tables 5-1, 5-2). 
These results suggested that confirmed seroconversions were either not effective at 
predicting the location of “hot zones” of arbovirus transmission activity or the time delay 
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until confirmed results were reported was too late for arbovirus isolation/detection in this 
county. As a result, routine serological testing of sentinel chicken sera was a much more 
reliable indicator of previous arbovirus infection than detection of the virus on cloacal 
swabs in 2005.  
During 2006, five counties participated in the Arbovirus Isolation Network and 
performed targeted sample collection from sentinel chicken sites. Lee County had a total 
of 15 chickens seroconvert during 2006. However, none of these birds seroconverted 
during the two week time period of the county’s active participation in the Arbovirus 
Isolation Network. Consequently, evaluation of the effectiveness of virus 
isolation/detection from confirmed sentinel chicken seroconversions could not be 
assessed.  However, no virus was detected or isolated from 22 processed swabs collected 
from sero-negative birds (Tables 5-1, 5-3).  For Lee County, the limited collection time 
(two weeks) and the biweekly sample collection of the flocks contributed to the poor 
success of the targeted strategy in this county. Notably, 11 sentinels seroconverted to 
SLEV following the discontinuation of targeting. 
In contrast to Lee County, the BOL-Tampa requested that Orange County collect 
cloacal swabs over a two week period based on transmission activity in a neighboring 
mosquito control district. Orange County had a total of five sentinel seroconversions in 
2006, including three chickens that seroconverted during the county’s active participation 
and collection of cloacal swabs. However, none of these conversions occurred at targeted 
sites. It is interesting that activity in a neighboring district was useful for targeting sample 
collection in Orange County; however, this strategy was not adequate for the precision 
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that appears to be required for specific targeting of chicken flocks at fixed locations 
(Tables 5-1, 5-3).  
In Pasco County, the opposite scenario occurred and no new sentinel chicken 
seroconversions were detected after the BOL-Tampa requested the agency to initiate 
targeted sample collection. Consequently, evaluation of the effectiveness of virus 
isolation/detection from confirmed sentinel chicken seroconversions could not be 
assessed.  However, no virus was detected or isolated from 20 processed swabs collected 
from sero-negative birds (Tables 5-1, 5-3). Arbovirus transmission activity was thus 
highly focal and sporadic in Pasco County during 2006, with only two confirmed 
seroconversions. For future studies it is recommended for cloacal swab collection be 
discontinued after two months, if no new seroconversions are detected in a county. 
Volusia County collected samples for one month at four sites, but similar to Pasco 
County, no new seroconversions were detected during targeted sampling. Despite six 
seroconversions prior to targeted sampling, the only other confirmed seroconversion in 
Volusia County that year occurred three months after sampling was discontinued. 
However, sentinel chicken flocks in Volusia County were targeted based on experimental 
MIA results for the detection of virus-specific IgM antibodies in chicken sera. The MIA 
is currently in development at the BOL-Tampa for the detection of seroconversions to 
both flaviviruses (WNV, SLEV) and alphaviruses (EEEV). Based on the results from 
Volusia County, the detection threshold was set too low and was not a true measure of 
transmission activity. The assay was far too sensitive and MIA-positive sera were not 
confirmed in the MAC-ELISA (i.e. false-positives).  Consequently, evaluation of the 
effectiveness of virus isolation/detection from confirmed sentinel chicken 
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seroconversions could not be assessed.  However, no virus was detected or isolated from 
48 processed swabs collected from sero-negative birds (Tables 5-1, 5-3). 
During 2006, Sarasota County participated in the Arbovirus Isolation Network for 
a second year. Sarasota County had a total of eight chickens seroconvert during the year, 
with seven chickens that seroconverted during the county’s active participation in this 
study. However, only four of these birds were targeted for sample collection at the time 
of seroconversion.  In contrast to the county’s earlier targeted approach in 2005, virus 
was isolated from all four of these birds during 2006.  In addition, West Nile virus was 
cultured and novel flavivirus viral RNA was detected (but not cultured) from three 
additional birds. Interestingly, West Nile virus was not detected in any of the sentinels in 
Sarasota County after April of that year, and the birds infected with a novel flavivirus 
also failed to seroconvert in the HAI assay (Tables 5-1, 5-4).  
The Sarasota County Mosquito Control District only altered two components of 
its targeted sample collection in 2006.  The most important factor that increased arbovirus 
isolation success appeared to be timing of sample collection at the sites. Instead of 
waiting for a seroconversion to be confirmed prior to targeted collection, the agency 
immediately initiated sample collection at sites based on sentinel chickens that were 
reported positive in the HAI assay. In less than one week, samples were collected from 
other birds at a positive site based on a non-confirmed seroconversion for one bird in the 
flock. As a result, timing of targeted sample collection appeared to be an extremely 
important component for successful arbovirus isolation from sentinel chicken sites with 
recent evidence of transmission activity. MAC-ELISA confirmed test results were often 
not reported until samples had already been collected from sentinel chicken sites during 
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the next week, so targeted sample collection began after seven days from the first 
indication of activity (at the earliest).   
The second change to the procedure used by Sarasota County was that the agency 
did not discontinue sample collection at targeted sites.  In 2005, the county had collected 
samples from several sites for one month, but no new seroconversions were detected at 
those sites and sampling was discontinued. Four days later a chicken seroconverted at one 
of the sites. This experience prompted the agency to continuously target a site for sample 
collection after it was confirmed positive.  However, all of the arbovirus isolates were 
collected at sites that were immediately targeted following a positive sentinel 
seroconversion detected in the HAI assay. Consequently, it is recommended that future 
studies target sites based on consistent positive results in the HAI assay.  
For Sarasota County, targeted sample collection and virus isolation from these 
chickens was as effective at the detection of arbovirus infections as serological methods,. 
At Site 001, a novel flavivirus was discovered that was not detected with the traditional 
HAI assay. However, these sites would not have been targeted without the use of 
serology assays to first identify “hot zones” of transmission activity. The success of this 
agency’s targeted strategy for collection of samples has provided a blue print for future 
arbovirus isolation studies in Florida and other states with active sentinel chicken 
programs.  
It should be noted that the routine collection of cloacal swabs from sentinel 
chickens for the surveillance of arbovirus transmission activity is not recommended 
based on this limited study, where sera and cloacal swabs were not tested in parallel for 
detection of arboviruses. Previous experimental studies indicate that viremia and 
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shedding of arboviruses in the feces occurs over a short time period (fecal shedding: 
range 2-6 days post-inoculation) in chickens [Senne et al, 2000; Langevin et al, 2001]. 
Consequently, this short window of opportunity for the detection of infection is not 
preferable over the detection of antibodies to the virus, which remain elevated for at least 
two weeks or longer following infection (Calisher et al, 1986a, b, & c; Martin et al, 
2000). These finding are supported by this study that also detected fecal shedding of 
arboviruses over a short time period. Since these birds were exposed to the virus 
naturally, the exact date of infection is unknown and a true estimate of the duration of 
fecal shedding could not be determined.  
Cloacal shedding of the arboviruses for a period longer than two days was only 
detected in two birds. One of these birds was dually infected with WNV and SLEV. West 
Nile virus was isolated from cloacal swabs collected seven days apart, slightly extending 
the range noted above from experimental studies. In addition, St. Louis encephalitis virus 
was isolated nine days following the initial isolation of WNV (Day 0) in the same bird. 
Interestingly, it is posited that SLEV was the first infection for this bird based on 
serology results (Fang and Reisen, 2006; Patiris et al, 2008). Consequently, this bird may 
have experienced an acute infection lasting from 9 to 15 days (Table 5-8), with no 
clinical symptoms and full recovery (healthy when relocated at the end of the season).  
A second bird shed flaviviral RNA at two time points, separated by 21 days, but 
infectious virus was not cultured from these swabs. In addition, cloacal swabs collected 
seven and 14 days post-isolation were negative for viral RNA and infectious virus. This 
finding may is similar to the WN/SLE dually infected bird discussed above, where
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Table 5-8 Duration of Arbovirus Shedding from the Cloacae of Naturally Infected Chickens 
During 2005-2006, cloacal swabs were collected from sentinel chickens naturally exposed to arboviruses. The duration 
of arbovirus shedding in the feces is shown in the time course below (exact date of infection is unknown). Day 0 
indicates the first date of arbovirus detection/isolation for each chicken, where dates are relative to the time of isolation 
(pre or post-isolation). The time to seroconversion (HAI+) from isolation/detection of the virus has also been provided. 
 
 Duration of Arbovirus Shedding in the Feces of Sentinel Chickens (Cloacal Swabs)  
 Days  
County Bird # Age (weeks) -6 0 2 4 6 7 9 14 21 
Virus 
Cultured? 
Time to 
Seroconvert 
Orange 846 40 neg EEE EEE n/c neg n/c neg n/c n/c No 8 DPI 
 870 40 neg EEE EEE n/c n/c n/c n/c n/c n/c No Negative 
Manatee 1773 64 n/c WNV n/c neg n/c n/c n/c n/c n/c Yes 28 DPI 
 1714 65 neg WN n/c n/c neg n/c n/c neg n/c No Negative 
 1695 65 n/c WN n/c n/c neg n/c n/c neg n/c No Negative 
Sarasota 8-003-R 52 n/c WNV n/c n/c n/c WNV SLEV neg n/c Yes 0 – 14 DPI 
 8-005-B 52 n/c WNV n/c n/c n/c neg n/c neg neg Yes Negative 
 9-005-B 55 n/c SLEV n/c n/c n/c neg n/c neg neg Yes 0 – 7 DPI 
 9-004-G 55 neg FLAVI n/c n/c n/c neg n/c neg neg No Negative 
 9-000-W 56 neg FLAVI n/c n/c n/c neg n/c neg FLAVI No Negative 
Abbreviations:  neg = negative, n/c = not collected, DPI = day post virus detection/isolation.  
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a decline in IgM antibody titers may have corresponded to late shedding of SLEV in the 
feces. Perhaps the flavivirus positive bird also developed an IgM immune response that 
decayed after two weeks, allowing for the viral RNA to be detected in the feces 21 days 
after the first detection (Table 5-8).   
Interestingly, WNV infection in a mouse model deficient in CD4+ T helper cells 
found that mice produced IgM antibodies by 5 days post-infection, as found for wild type 
(control) mice infected with the virus. However, virus-specific IgG antibody production 
was significantly blunted throughout the course of infection, unlike control mice. 
Notably, the neutralizing activity of serum antibodies was not affected by the depletion of 
CD4+ T cells (Siati and Diamond, 2006). This study may partially explain the similar 
pattern observed for the absence of total antibody (IgG + IgM) production (HAI negative) 
in sentinel chickens following infection with the novel flavivirus strains. In addition, the 
early IgM production but late rising total antibody produced in Bird 1773 (a nearly 
identical immune response to WNV, Manatee County) may be linked to the old age of 
these chickens and impaired T cell function. While this does not explain the lack of total 
antibody production for all of the birds that virus was detected/isolated, one hypothesis 
may propose that other factors (smaller amount of virus inoculated, limited viremic 
phase) were also involved plus the age of the chicken prevented total antibody production 
(Table 5-8).  
Impact of Retrospective Processing on Arbovirus Characterization 
A targeted testing strategy was implemented by the BOL-Tampa to process and 
perform molecular detection/virus isolation assays on submitted cloacal swabs to 
conserve resources.  Samples were retrospectively processed based on presumptive 
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seroconversions in the HAI assay for sentinel chickens (Figures 4-11 and 4-12). Since 
wild bird sera were not collected for evaluation in the HAI assay, all wild bird cloacal 
swabs were immediately processed and tested.  Although this strategy for sentinel 
chicken cloacal swabs efficiently conserved resources, it was not effective as a 
surveillance tool. Earlier detection of arboviruses prior to confirmation of serology results 
may have been possible in Sarasota County in 2006 (Figure 4-20), if swabs were 
processed upon arrival at the laboratory. Consequently, the retrospective processing 
method was only effective for later identification and molecular epidemiology analysis of 
circulating arbovirus strains and not for immediate surveillance of arbovirus activity.  
Prospective processing of cloacal swab samples would have triggered more 
intensive surveillance efforts for the novel flavivirus strain identified at Site 001 in 
Sarasota County (Figures 3-9 and 4-20). For example, the BOL-Tampa requested 
additional sera samples from chickens located at Site 004 in December to re-assess 
serology profiles from birds that had not seroconverted at the end of 2006. Despite the 
isolation of WNV three times from two birds, none of the birds in this flock developed 
detectable antibody to West Nile virus. One bird was dually infected with WNV and 
SLEV and developed detectable antibody to SLEV. 
Cloacal swabs collected from Site 001 were not processed until 2007, when 
Sarasota’s sentinel chicken program had stopped for the year and the chickens removed 
from the program (lost to follow-up). If these samples had been processed before the end 
of 2006, additional sera and cloacal swab samples would have been requested from the 
flock. Unfortunately, the initial sera samples collected on the same dates as the cloacal 
swabs had been discarded because the birds failed to produce antibodies detected by the 
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SLEV-group antigen in the HAI assay. It is unknown if the two chickens with novel 
flavivirus strains produced detectable antibodies later during the course of infection. 
Prospective processing and early identification of these strains would also have allowed 
for preservation of the trapped mosquitoes collected at Site 001 and 004 (Figures 5-6 and 
5-7) for virus detection/isolation studies in the mosquito vector. The agency would have 
been requested to maintain a cold chain for these trapped mosquitoes from collection to 
arrival at the laboratory.  
This novel flavivirus strain may have also infected chickens in other targeted 
flocks (or non-targeted sites elsewhere) but may not have been detected, if the birds also 
failed to seroconvert. The retrospective processing strategy did not process swabs from 
negative sites, a strategy that was implemented in 2005 following testing of one hundred 
(negative) samples; sites were only assayed if HAI positive seroconversions were 
detected. Currently, there are 364 and 809 cloacal swabs that have not been tested for 
2005 and 2006, respectively. A future project is planned to analyze swabs collected at 
some of these sites without seroconversions to identify if other arbovirus strains were 
missed. 
It is interesting to note that Lee County is near Sarasota County to the south and 
had extensive sentinel seroconversions to SLEV during the same time period (Figure 4-
16). These chickens may also have been infected with a South American strain of SLEV, 
as detected in Sarasota County. It is unknown if co-circulation of the novel flavivirus 
strains also occurred at these sites in Lee County (as seen at Site 001 in Sarasota) due to 
the retrospective processing strategy and the discontinuation of targeted sampling by the 
agency prior to these seroconversions. 
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Recommendations for Arbovirus Surveillance Methods 
Recommendations for future studies have frequently been made throughout this 
discussion. However, this section will summarize what has been learned during the 
implementation of an Arbovirus Isolation Network for the targeted collection of 
arboviruses from sentinel chickens and wild (rehabilitated) birds in Florida. This study 
focused on the natural history of St. Louis encephalitis virus and attempted to isolate the 
virus in its natural setting from avian (primarily chicken) hosts to model the wild bird 
amplification cycle. Wild birds admitted to wildlife rehabilitation centers were also 
sampled based on symptoms characteristic of WNV arbovirus infections. SLEV has not 
been cultured in Florida since the introduction of West Nile virus to the state in 2001 
(Stark & Kazanis, 2002-2007). Diagnosis of animal infection (including sentinel chicken) 
is usually identified by the presence of virus-specific antibodies in serum and is rarely 
diagnosed by virus isolation (Reisen, 2003). Consequently, this was not going to be a 
simple task in the absence of human cases and/or epizootic activity, a pattern that is seen 
most years, when St. Louis encephalitis virus is maintained in an enzootic mosquito-wild 
bird cycle in Florida (Day, 2001).  
Although serological testing is the most utilized method for the surveillance of 
arboviruses and detection of transmission activity, the molecular epidemiology of 
circulating strains cannot be assessed without isolation of the arboviral genome. Unlike 
previous studies that have performed targeted collection for St. Louis encephalitis virus 
during or following the identification of human cases (Rocco et al, 2005; Diaz et al, 
2006), this study attempted to isolate the virus in avian hosts during enzootic 
transmission activity in Florida. First, local agencies that participated in the Sentinel 
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Chicken Program were invited to participate in the Arbovirus Isolation Network for the 
targeted collection of samples from sentinel flocks. The success in recruiting these 
agencies (10 out of 14) to participate in the project was likely due to the long-standing 
success of the Sentinel Chicken Arbovirus Surveillance Program and collaboration with 
the BOL-Tampa. Wildlife rehabilitation centers were also receptive to the program and 
submitted samples from certain species (known amplifying hosts) and birds with 
encephalitic symptoms (Appendix H) for virus isolation/detection assays. Overall, the 
enthusiastic response of the partner agencies and the level of participation exceeded 
expectations. 
The targeted strategy used in this study relied heavily on serology testing of 
sentinel chicken sera to identify “hot zones” of arbovirus transmission based on 
seroconversions, detected by the HAI, MAC-ELISA and PRNT assays. During the study 
period, targeted sampling of sites with each method was used. Confirmation of a SLEV 
seroconversion in the PRNT often required up to 22 days following the original 
collection date of the sample. As a result, SLEV was not isolated from three sites in 2005 
that were targeted with this method. In addition, MAC-ELISA results were routinely used 
to target active transmission sites in both 2005 and 2006, with a shorter turn around time 
than the PRNT for initiation of targeted sampling at a “hot zone”. Results for the MAC-
ELISA were reported 7-9 days following the collection date of a serum sample that 
screened positive in the HAI assay (Table 5-4). This introduced an unavoidable time 
delay from the first evidence of transmission activity (HAI positive result) until targeted 
sample collection was started at the site. Nevertheless, arbovirus isolations and/or 
detections were made with this method, including WNV and EEE viral RNA. 
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In contrast, Sarasota County used positive seroconversions detected in the HAI 
(screening) assay to target sentinel chicken flocks in 2006. This method limited the time 
delay needed for confirmation of HAI results, so that targeted collection of samples from 
chickens occurred at two sites within one week of the original sera collection date. A 
single SLEV isolate was cultured from each site. One SLEV isolate from Site 004 was 
collected from a dually infected WNV and SLEV chicken. Interestingly, WNV 
seroconversions had not been detected in this region for six months, nor did two birds 
develop WNV-specific IgM antibodies following isolation of the virus, as tested at the 
end of the transmission season. Complete genome sequencing of these WNV strains is 
planned to identify if mutations in the genome (especially the envelope) may have 
encoded for an altered envelope protein, which is the major antigenic determinant in 
eliciting host neutralizing antibodies (McMinn, 1997).  
The second SLEV isolate was collected at a different site 12 days later following 
the initial detection of a sentinel seroconversion in the HAI assay.  In addition, targeted 
sample collection at Site 001 resulted in the detection of two novel flavivirus strains. 
Although these flavivirus infections were not detected by the HAI assay, the site was first 
targeted based on a positive HAI serology result for another bird. Therefore, the HAI 
assay is recommended for targeted sample collection at sites with transmission activity to 
maximize arbovirus isolation recovery while controlling cost. As shown in this study, 
these sites may also have co-circulation of other flavivirus strains that are not detected by 
the HAI assay. These findings require additional study to assess the frequency of co-
circulating Flaviviridae viruses in Florida, including WNV, SLEV and a novel flavivirus. 
Both SLEV strains shared the highest nucleotide sequence homology to South American 
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strains of the virus, which may play an important role in the transmission and 
maintenance of SLEV in Florida. 
Nonetheless, a weak HAI positive result (R, reactive, or 1:10) does not always 
confirm and may be a “false” positive due to non-specific reactive factors in the serum, 
variability in blood collection techniques, etc. Consequently, initiation of targeted 
sampling at a site based on weak HAI results should be implemented with care, 
especially during the low season when prevalence of the disease is extremely low. 
However, during peak SLEV transmission months, it is recommended that cloacal swab 
samples be collected from all chickens in the flock as quickly as possible following 
detection of a sentinel seroconversion (1:20, 1:40) in the HAI assay.  In addition, 
retrospective processing of cloacal swabs is recommended during months with low 
transmission activity. However, prospective processing is recommended during peak 
transmission months, as co-circulating arboviruses may be present at a targeted site. Early 
detection of these arboviruses could then allow for additional ecological investigations at 
or near the site, including the collection of trapped mosquitoes and/or wild birds for sera 
and cloacal swab collection for virus isolation assays.  
The recommendation for inclusion of sentinel chickens with positive 
seroconversions for cloacal swab collection is based on the fact that SLE virus was 
isolated from birds that had strong total antibody (HAI), IgM antibody (MAC-ELISA) 
and strong serum neutralizing antibody (PRNT) titers to SLEV. Consequently, it may be 
possible to isolate virus from birds with recent HAI seroconversions. Although virus was 
not isolated in Hillsborough County from birds that were confirmed positive by MAC-
ELISA, the pilot sites did not have chickens that had recently seroconverted in the HAI 
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assay (but were not yet confirmed) to evaluate this hypothesis. Additional studies are 
needed to evaluate the efficiency of recovery of arboviruses from sentinel chickens that 
screen positive in the HAI assay.  
Wild birds admitted to rehabilitation centers were also triaged based on symptoms 
(Komar et al, 2003; Brault et al, 2004) and known amplifying host species (CDC, 2007g) 
for inclusion in the study. A total of 87 swabs were collected from five centers located 
throughout Florida, as well as from the Florida Fish and Wildlife Conservation 
Commission that investigated wild bird mortality events. Despite targeted sampling of 
these birds, no virus was detected or isolated.  Although sampling of clinic admitted birds 
was successful in one study for WNV (Nemeth et al, 2007a), the sample size included in 
this study was not adequate to detect SLEV or WNV, where prevalence was low in 
Florida during 2006 (as compared to high prevalence in Colorado when the study was 
conducted). Recommendations for future wild bird studies would suggest that rehab 
centers swab all birds that are admitted, especially since SLEV infection does not usually 
cause clinical signs of illness (Reisen, 2003). In addition, the ecology of wild bird 
transmission cycle that occurs at or near active sentinel chickens sites would also be 
interesting to study. These studies would be able to evaluate flavivirus strains present in 
the avian amplifying host and correlate these findings to strains detected in sentinel 
chickens.  
Based on the results of this study, cloacal swabs are the recommended sample 
collection method for detection of viruses from adult chickens. They are a low resource, 
effective method for arbovirus isolation from birds (Komar et al, 2002; Brennan, 2003). 
However, processing techniques and molecular detection methods, including choice of 
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primers/probes for viral amplification, should be validated prior to testing of field 
collected samples. For example, a panel of North and South American reference and two 
recent strains of St. Louis encephalitis virus were detected with the standard SLEA 
TaqMan primer-probe set (n=20) [Lanciotti and Kerst, 2001]. However, the SLEB 
primer-probe set failed to detect six South American strains of the virus (30%) due to 
nucleotide substitutions in both the probe and forward/reverse primer annealing sites (as 
shown for three strains) [Figure 5-1].  
These base substitutions had an important impact on molecular detection methods 
of South American strains of SLEV, which required additional gel-based RT-PCR assays 
and sequencing for confirmation. Prior to this study, a sample that did not confirm with 
the SLEB primer-probe set would be considered negative; such false-negative molecular 
surveillance results have not been previously reported due to the low prevalence of SLEV 
since the introduction of WNV. South American strains of SLEV have indirectly been 
shown to circulate periodically in the southeastern United States, based on their 
phylogenetic placement in North American lineages. Consequently, other states with 
arbovirus surveillance programs in the southeast may also need to modify their current 
molecular detection testing algorithm for the confirmation of St. Louis encephalitis virus 
strains with the gel-based membrane/envelope and complete envelope primers developed 
specifically to detect SLEV strains (Lanciotti and Kerst, 2001; Kramer and Chandler, 
2001, respectively).  
A successful arbovirus surveillance program incorporates several tools for the 
detection of transmission activity and no one method has been found to be superior for all 
regions of the United States (CDC, 2003Aa). Consequently, some states perform 
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surveillance on infection rates in mosquito populations instead of seroconversion rates in 
sentinel chickens (CDC, 1993; CDC, 2003Aa). In Florida, early warning of transmission 
activity has been detected by sentinel chicken seroconversions (Blackmore et al, 2003; 
Butler and Stark, 2005). As a result, this serological method was chosen for targeting of 
active arbovirus transmission. Then, local agencies performed sample collection for the 
isolation of arboviruses during the weekly scheduled sampling of the flock resulting in 
the isolation and/or detection of several arboviruses, including two South American 
strains of SLEV and two novel flavivirus strains. 
This arbovirus isolation study was funded by a grant to develop a pilot program 
for the isolation of arboviruses (especially SLEV) in Florida for molecular epidemiology 
analysis. The project lasted for two years and successfully isolated several arbovirus 
strains, but should be evaluated for continued use as a molecular epidemiology 
surveillance tool due to its expense. Several new questions were raised about the natural 
history of SLEV and WNV in Florida that will require additional arbovirus isolation 
attempts on a larger scale and from the mosquito-wild bird amplifying hosts in future 
studies. Currently, this network is not actively targeting sites due to decreased funding at 
the BOL-Tampa for the surveillance and study of West Nile virus and other pathogenic 
arboviruses in Florida. Additional funding support would be required to offer testing of 
field collected samples at no cost to local agencies for diagnosis of infection and/or 
isolation of arboviruses for phylogenetic analysis.  
Conclusions of the Impact of WNV on the Natural History of SLEV in Florida 
Recently, extensive arbovirus studies in the United States, conducted in the field 
and in the laboratory, have focused on several aspects of West Nile virus infections, 
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including epidemiology, ecology (bird and mosquito), abiotic environmental factors 
(temperature, rainfall), surveillance systems, and virus pathogenesis (genotypic and 
phenotypic determinants) to describe the rapid spread and virulence associated with the 
virus once introduced into a naïve geographic territory. Yet, the majority of these studies 
have largely ignored the impact or potential influence that the introduction of this closely 
related virus may have on St. Louis encephalitis virus in the United States. Two other 
states (Texas and California) have reported concerns about WNV and SLEV coexisting in 
the same region (Lillibridge et al, 2004; Fang and Reisen, 2006), with a report of the 
noted “disappearance” of SLEV following introduction of WNV in California (Fang and 
Reisen, 2006). The same phenomenon was noted in Florida, where SLEV virtually 
disappeared in 2002 following the introduction of WNV (Stark and Kazanis, 2001). 
These concerns motivated the inception of this project to assess the impact of West Nile 
virus on the natural history of SLEV in Florida. 
Will the viruses peacefully co-exist or will one virus dominate the other as they 
both compete for shared mosquito vectors, habitat and amplifying hosts?  While this 
study was not ecology based, the Florida Sentinel Chicken Program has served as a 
model of natural arbovirus amplification and disease transmission in the wild bird-
mosquito populations since 1978 (Nelson et al, 1983). This system has successfully 
detected epizootic amplification of West Nile virus and provided early warning of 
transmission activity prior to clinical cases of the disease (Blackmore et al, 2003; Butler 
and Stark, 2005). During this study period, the rate of sentinel chicken seroconversions to 
West Nile virus and St. Louis encephalitis virus were evaluated in 2005 and 2006. These 
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rates indicated that the amplification of West Nile virus has a considerable impact on the 
subsequent amplification cycle and transmission of St. Louis encephalitis virus.  
Early season transmission of WNV, during June through August, modulates the 
rate of SLEV transmission late in the season from September through October. WNV 
activity predominated in 2005 with over 400 sentinel seroconversions; however, only five 
confirmed SLEV seroconversions were detected in nearly 4,000 sentinel birds. In 
contrast, WNV transmission activity to sentinel chickens was very low in 2006, which 
resulted in more sentinel seroconversions (n=40) to SLEV than detected for WNV (n=30) 
that year. For the first time since the introduction of WNV into Florida, the rate of SLEV 
seroconversions exceeded WNV (Figures 4-7 and 4-8). Consequently, the sentinel 
chicken program provides indirect evidence for the influence of WNV on SLEV, as these 
viruses compete for shared avian amplifying hosts.  
These findings are supported by experimental evidence, where WNV infections 
appear to prevent subsequent SLEV infections in wild birds (house finches) by inducing 
sterilizing immunity in the avian host. In contrast, previous infection with SLEV did not 
result in sterilizing immunity, which allowed for a subsequent WNV infection in the wild  
bird host with high titered viremia capable of infecting mosquitoes (Fang and Reisen, 
2006).  As a result, Fang and Reisen (2006) concluded that prior infection with WNV in 
wild bird primary amplifying hosts may significantly impact and decrease St. Louis 
encephalitis virus amplification and transmission cycles, where these viruses coexist.   
The long term impact of West Nile virus transmission in Florida is unknown, 
where enzootic circulation of several arboviruses (SLEV, EEEV, HJV, and California-
group) occurs each year. However, surveillance data indicates that WNV has established 
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enzootic transmission foci and will continue to be a public health concern in the state 
(Stark and Kazanis, 2001-2007).  Genetic and phenotypic studies of these viruses, 
especially St. Louis encephalitis virus, are critically necessary because they can identify 
variations in a virus that may impact its virulence, mosquito infectivity, and disease 
potential.   As a result, this study aimed to investigate SLEV strain differences prior to 
and following the introduction of West Nile virus in 2001. However, SLEV has not been 
isolated in culture since the introduction of WNV in Florida. An Arbovirus Isolation 
Network was formed and local agencies in the central and southern region of the state 
were recruited to participate, as SLEV transmission is historically the most active in these 
regions of Florida (Figure 3-1). 
During the study period, eight county agencies actively targeted sentinel chicken 
flocks for arbovirus isolation studies. Six strains of West Nile virus were detected (n=2) 
or cultured (n=4) from cloacal swabs, two strains of St. Louis encephalitis virus were 
cultured from a site with concurrent WNV transmission in 2006, three novel flavivirus 
strains were detected (but not cultured) at one site with concurrent SLEV transmission 
(Sarasota), and four strains of Eastern Equine Encephalitis virus were detected (but not 
cultured) from one county (Orange) in 2005. Flavivirus strains were then characterized in 
genotypic and phenotypic studies. Molecular epidemiology analysis of these strains 
served two purposes: i) identification of the origin and potential virulence of arbovirus 
strains as a surveillance tool in Florida, and ii) study the accumulation of mutations 
(evolution) of SLEV in Florida over five decades. The isolation of strains of West Nile 
virus from sentinel chickens in 2005 and 2006 were also compared to a small number of 
reference strains collected in Florida during 2001, 2002, and 2005.  
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For this study, the impact of West Nile virus on the natural history of St. Louis 
encephalitis virus was investigated at the genomic level. Selective and competitive 
pressures on these closely related viruses that coexist in the same primary amplifying 
mosquito and avian host populations were hypothesized to potentially enhance the rate of 
evolution in SLEV from strains isolated prior to the introduction and widespread 
transmission of West Nile virus in Florida. The complete envelope region was chosen for 
analysis due to its important biological functions and the “extensive” number (n=90) of 
envelope sequences submitted to GenBank [McMinn, 1997; Kramer and Chandler, 2001; 
Twiddy and Holmes, 2003]. In fact, the total number of sequences submitted for SLEV is 
approximately ten times less (n=225) when compared to West Nile virus, its more 
intensely studied counterpart with 2395 submitted sequences [as of March 25, 2008]. 
Nevertheless, nucleotide sequence analysis on two SLEV strains isolated in Sarasota 
County in 2006 indicated the viruses were of South American (Brazil) origin.  
Prior to this study, no biologic evidence existed for the circulation of South 
American strains in the United States despite indirect evidence for the introduction of 
strains from Brazil, Mexico, and Panama that share close nucleotide sequence homology 
to North American clades (Table 2-2). Interestingly, this study has not only shown the 
introduction of a Brazilian strain of SLEV in 2006, but also an earlier introduction of 
another Brazilian strain collected in 1972 from the panhandle region of Florida. These 
strains represent the first reported detection of South American strains of SLEV in North 
America. Phylogenetic analysis of different regions of the viral genomes also confirmed 
the BLASTN results (Appendix I). Three methods were used to draw phylogenetic trees, 
with all trees placing the 2006 strains within Lineage VA or Lineage VB for the 1972 
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isolate (maximum parsimony method shown in Figure 5-4). In addition, all three of the 
introduced strains share highest sequence identity to Brazilian isolates that have been 
characterized as highly virulent in mouse models (Monath et al, 1980).   
These results confirm that the introduction of SLEV from Brazil in 2006 was not 
an isolated event, as one strain was also collected during field studies in 1972. 
Consequently, the 2006 isolates do not represent a recent extension of the geographic 
range of Brazilian strains of SLEV.  Instead, these findings have more significance for 
the periodic re-introduction and maintenance of SLE virus in Florida and other 
southeastern states. Recent outbreaks of severe disease in Argentina and Brazil suggest 
that the prevalence and apparent attenuation of SLEV in the tropics may be under-
reported due to differential diagnosis of dengue virus for most cases (Diaz et al, 2006; 
Mondini et al, 2007a). As a result, these outbreaks should not be ignored by Florida and 
the continental United States as migratory birds could transport the disease north during 
spring migration, which occurs during peak transmission of arboviruses in Central and 
South America (January through March) [Dupuis et al, 2003, 2005]. Conversely, fall bird 
migration southward occurs during peak SLEV transmission activity in Florida (October 
– November) that likely carries and seeds the virus into Central and South America 
(Kramer and Chandler, 2001), as shown for WNV (Deardorff et al, 2006). Therefore, 
outbreaks of SLEV and WNV transcend geographic and national boundaries to spread 
these viruses throughout the Americas. However, a larger impact may be felt in Florida 
(and North America) due to a largely non-immune population to flaviviruses unlike the 
population found in South America, where dengue antibodies may provide cross-
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protection and prevent SLEV (Bond, 1969; Bond and Hammon, 1970) or WNV infection 
(Gubler, 2007). 
The impact of West Nile virus on the rate of evolution of these South American 
strains of SLEV has been thought to be minimal, due to the fact that WNV has not been 
detected in Brazil through March 2008. In addition, multiple sequence alignment of the 
FLS569 and FLS650 strains with other North and South American SLEV envelope 
sequences only identified one unique nucleotide base substitution, a non-synonymous 
mutation that resulted in a single predicted amino acid change. However, the most direct 
impact of West Nile virus on the natural history of St. Louis encephalitis virus in Florida 
may be the potential for recombination and rapid evolutionary change, as both viruses are 
now co-circulating in the region. It is recommended that arbovirus isolation and 
molecular epidemiology studies become a vital part of arbovirus surveillance programs in 
Florida to monitor such a trend and implement appropriate prevention and control 
measures should it occur. While recombination was not detected in either the FLS545 
(WNV) or FLS569 (SLEV) strains, the identification of a sentinel chicken with a dual 
infection of SLEV and WNV in Sarasota County indicates that it may only be a matter of 
time before a “West Louis virus” is detected.  
Based on these results, the three strains (two WNV, one SLEV) collected from 
this chicken were challenged with homologous polyclonal neutralizing antibodies and 
several plaque “clones” were picked to identify if mixed populations of WNV and SLEV 
were present on a single swab. The results were inconclusive, as real-time RT-PCR 
(TaqMan) assays detected two clonal population types. The dominant genotype was 
detected (i.e. WNV for FLS545) for the majority of clones picked, but several clones 
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were also cross-reactive to both WNV and SLEV. Cross-reactive detection and 
confirmation of WNV and SLEV in the TaqMan assay (as shown for FLS502 clones, 
Table 4-4) had not previously been noted at the BOL-Tampa in seven years of real-time 
RT-PCR testing for both viruses. While SLEV was not detected alone from a WNV 
positive swab (or vice versa), these cross-reactive findings suggest the possibility of a 
mixed population or perhaps a combined virus. Additional sequencing of these cross-
reactive clonal viruses is recommended to fully evaluate these results. While 
recombination between WNV and SLEV has not been proven in this study, the detection 
of a chicken with a dual infection raises the concern that these viruses may be mixing in 
the wild bird-mosquito populations and recombination may occur in the future. 
Interestingly, WNV was isolated from another chicken at this site but the bird 
failed to raise detectable antibody titers to the virus. Consequently, there was no serologic 
evidence of WNV co-circulation in the region based on sentinel chicken seroconversions. 
In addition, no confirmed WNV seroconversions were detected in counties bordering 
Sarasota County to the north or south despite seroconversions to SLEV late in the season, 
in Manatee and Lee counties, respectively. A single WNV seroconversion was detected 
in Sarasota and Manatee counties in April and single seroconversion on August 21 in Lee 
County. The seroconversion in Lee County was the closest time point to the RT-PCR 
detection of the virus on cloacal swabs in Sarasota County ~45 days later. These results 
indicate that the virus was present during the early season amplification in Manatee and 
Sarasota Counties, but was not detected much later in the season in Sarasota County 
despite its isolation from cloacal swabs. Further studies are needed to address these 
findings in both the wild bird amplifying hosts and sentinel chickens, where the impact of 
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co-circulation of WNV and SLEV during early and late season transmission can be 
compared.  
Additional questions for future study were also raised in the detection of a novel 
flavivirus in Sarasota County that also co-circulated with South American SLEV and 
WNV in the region. Unlike the other arboviruses collected from Sarasota County, this 
strain did not replicate (produce detectable cpe) in Vero cell culture. Several RT-PCR 
primer sets failed to amplify regions of this virus, including the full envelope and NS5 
fragments. However, three gel-based primer sets did produce an amplicon for sequencing. 
Interestingly, the strain was identified as SLEV in the membrane/envelope region, but as 
WNV in the capsid/prM and 3’NS5 regions. None of these primer sets overlapped. 
Primer sets that targeted 1500bp segments of the virus failed to produce amplicons. The 
SLEV region of the virus closely matched other Tampa Bay SLEV strains despite the 
detection of Brazilian SLEV circulating at the site. The WNV region was identified as 
homologous to Old World strains in the capsid region, but North American strains in the 
3’NS5 region. The inoculation of the novel flavivirus strains into susceptible hosts is 
planned for virus isolation and subsequent complete genome sequencing to resolve the 
exact phenotype and genotype of this strain, as well as to confirm the current molecular 
results. 
Little is known on the specific molecular determinants of SLEV that contribute to 
its epidemiology, where enzootic strains are markedly different from those isolated 
during epidemics (Trent et al, 1980; Kramer & Chandler, 2001). This study has identified 
the possibility that South American strains of SLEV introduced to Florida may co-
circulate with enzootic North American strains, as well as with West Nile virus. The 
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SpAn9398 strain of SLEV was isolated in January 1968 from a wild rodent (Akodon 
arviculoides) in Brazil. Phylogenetic analysis of the envelope region placed it in Lineage 
IIA, which also contains isolates made in Texas, Kentucky and Florida (Kramer and 
Chandler, 2001). One year later, four strains of SLEV were isolated from Cx. nigripalpus 
(n=3) and one raccoon (n=1) in Polk County, Florida where 3 human cases were reported 
in a sporadic outbreak. 
Based on the molecular results of this study, it appears that the SpAn9398 
Brazilian strain was introduced into Florida where it may have rapidly evolved or co-
circulated with North American enzootic strains, producing the new 1969 Florida strain 
genotype (69M1143 and L695121.05). (Figure 5-4).  In fact, the researchers at the ERC 
in Tampa proposed that this outbreak resulted from the introduction of an “exotic agent” 
(Wellings, Lewis and Pierce, 1972). Sequencing of additional regions of the SpAn9398 
strain (only the envelope gene has been submitted to GenBank as of March 25, 2008: 
http://www.ncbi.nlm.nih.gov/sites/entrez?db=nuccore&cmd=search&term=SpAn9398)  
and the Florida 1969 strains may provide insight into the relationship between these 
isolates of SLEV.  
In summary, the natural history of St. Louis encephalitis virus in Florida appears 
to be closely tied to South American strains of the virus. Further research is needed to 
elucidate the mechanisms that contribute to the shift from an enzootic cycle (and 
genotype) into epidemic transmission of North American strains of the virus. The role of 
the distinct genotypes of South American strains in either of these cycles is unknown, but 
the proven introduction (and re-introduction) of SLEV proposes a mechanism for the 
continued maintenance of the virus. The diverse ecosystem in South America and 
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particularly the Amazon region of Brazil allows for evolution of the virus with periodic 
seeding (by migrating birds) of these strains into the United States, where a large 
proportion of the population has no immunity to the virus.  
The recent introduction of West Nile virus to Florida in 2001 also has had a 
tremendous impact on the natural history of SLEV, where SLEV virtually disappeared 
for two years following the widespread distribution of WNV in the state. Experimental 
wild bird studies by Fang and Reisen (2006) and surveillance data in Florida supports the 
hypothesis of early season transmission of West Nile virus, with resulting sterilizing 
immunity in primary avian amplifying hosts, as an important factor in preventing the 
subsequent amplification and transmission of St. Louis encephalitis virus. Consequently, 
these closely related flaviviruses must compete for shared resources as they co-exist in 
the same region. As a result, dual infection of avian and mosquito hosts is possible (as 
shown in this study for chickens).  Further studies in wild bird and mosquito populations 
are recommended to identify the frequency of this occurrence that may promote the 
recombination of these highly pathogenic arboviruses. Surveillance programs are critical 
for early detection of arbovirus transmission activity to protect public health and virus 
isolation strategies can be used to detect genotypic changes in the virus that may impact 
its virulence, mosquito infectivity, and disease potential.  
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Summary of Study Findings 
Aim One 
• The study resulted in the successful establishment of an Arbovirus Isolation 
Network for the field collection of samples for arbovirus detection and/or 
isolation. Collaborators included ten county mosquito control districts, five 
wildlife rehabilitation centers and six state agencies. 
• The BOL-Tampa requested nine county mosquito control agencies to target 
sentinel chicken sites based on results of routine weekly surveillance activity; 
eight agencies implemented sample collection within one week of request. Five 
wildlife rehabilitation centers also submitted samples based on bird species 
(amplifying host) and/or symptoms indicative of an arbovirus infection during 
2006. 
Aim Two 
• Three serology assays (HAI, MAC-ELISA, PRNT) were utilized to target 
sampling of active sentinel chicken flocks based on seroconversion surveillance 
data. This strategy for collection of cloacal swabs at sites with recent arbovirus 
transmission activity (“hot zones”) enabled the isolation of WNV, SLEV, and 
EEE viral RNA from adult chickens. Fifteen arboviruses were detected and/or 
isolated by molecular and cell culture assays, including two SLEV isolates, 
identification of a dual infection (WNV and SLEV) in a single bird, and detection 
of a novel flavivirus. 
• The HAI test used for screening sentinel chicken sera for arbovirus-specific 
antibodies resulted in the shortest time delay (3 days) for initiation of targeted 
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sample collection and the highest number of arbovirus isolations from sentinel 
chickens. Initiation of cloacal swab sampling after a single positive 
seroconversion at a site in Sarasota County, 2006, resulted in detection of both 
virus and concurrent seroconversion in other birds of that flock. 
• Confirmation of HAI results in the MAC-ELISA or PRNT resulted in an 
additional 7 or 22 days from the date of seroconversion until targeted sample 
collection began at an active site, respectively. MAC-ELISA targeted collection 
resulted in detection and/or isolation of WNV and EEE viral RNA. However, 
targeted sample collection based on PRNT results for SLEV did not isolate/detect 
virus in cloacal swabs from confirmed “active” sites (due to sporadic transmission 
and/or effective vector control efforts).  
• Despite the collection of cloacal swabs (n=84) from wild birds, no virus was 
detected/isolated. Targeted sampling of wild bird species was not effective at 
wildlife rehabilitation centers based on known amplifying host species and/or 
symptoms indicative of arbovirus infection, such as weakness. A larger sample 
size of rehabilitated birds is recommended for future studies to improve virus 
isolation and surveillance for arboviruses in this statewide resource of naturally 
exposed wild bird populations, as shown in Colorado (Nemeth et al, 2007).  
• Seasonal timing of WNV transmission had an important impact on the subsequent 
transmission of SLEV in Florida. In 2005, early season amplification of WNV 
appeared to prevent the later amplification of SLEV in the late summer to early 
fall months, when SLEV tends to reach peak transmission activity (CDC, 1993). 
In contrast, the relative absence of WNV activity in 2006 may have allowed for 
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the subsequent amplification of SLEV, which resulted in a higher number of 
SLEV sentinel chicken seroconversions than detected for WNV.  
Aim Three 
• Serologic methods for the detection of virus-specific antibodies in sentinel 
chicken sera were highly effective for targeting active sites of arbovirus 
transmission. Delayed production of total antibody (detected by the HAI assay) 
following WNV infection was noted for one chicken, aged 64 weeks at the time 
of virus isolation. In addition, six chickens failed to seroconvert in three counties 
(including Manatee) as detected by the HAI assay despite the isolation and/or 
detection of arboviruses on cloacal swabs. It is suggested that advanced age 
and/or altered immune response of these chickens may have influenced the 
primary immune response (production of total antibodies) following arbovirus 
infection in these birds may have allowed them to escape detection in the HAI 
assay  . 
• Dual infection of SLEV and WNV was detected in one sentinel chicken. 
Serologic assays indicated that the bird’s primary immune response produced 
SLEV-specific antibodies only following these infections. The concept of original 
antigenic sin suggests that the bird was likely not co-infected with WNV; instead, 
the WNV infection followed the SLEV infection, which resulted in a boosted 
immune response (total antibody titers) to SLEV and no elevation of WNV-
specific antibodies over 14 days. Interestingly, molecular detection of WNV from 
cloacal swabs was the only evidence of co-circulation of WNV in Sarasota 
County during October 2006 (not detected by serology). 
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• Real-time RT-PCR (TaqMan) detection of six South American strains of SLEV 
(Brazil and Trinidad) was impacted by nucleotide substitutions in the forward and 
reverse primer and probe annealing sites in the envelope/NS1 region. The current 
molecular testing algorithm would have reported these strains negative, as they 
were only confirmed by end-point RT-PCR, sequencing of the PCR product and 
virus isolation in cell culture. Recommendations include the re-design of a second 
SLEV-specific TaqMan RT-PCR primer-probe set for the detection of all known 
South American strains of SLEV, as well as confirmation of SLEV strains with 
the NS5 gel-based primer set to identify origin of the virus as North or South 
American. 
• Cloacal swabs were shown to be more effective than blood samples collected 
from sentinel chickens in 2005 for the detection of arboviruses. Low level, 
transient viremia in birds lasts from only one to five days following infection 
(Reisen et al, 1994; Patiris et al, 2008) and viremia was not detected with the 
experimental design (targeted sample collection based on seroconversions) 
employed for blood collection in the current study. 
Aim Four 
• Three strains of SLEV isolated in Florida (including two strains during 2006) 
were identified as South American in origin (Brazil). These strains represent the 
first reported isolation of South American SLEV in North America, which 
corroborates indirect evidence of SA SLEV circulation in the United States by 
phylogenetic analysis (Kramer and Chandler, 2001). 
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• Interestingly, the phenotypes of the FLS569 and FLS650 South American strains 
of SLEV were different from each other despite a nearly identical genotype in the 
regions of the viral genome analyzed for this study. Large and small pinpoint 
plaques were identified in FLS569 (from a chicken with a dual infection of 
WNV), whereas only small pinpoint plaques were identified in FLS650. Plaques 
were picked from both strains; however, only FLS569 produced cross-reactive 
results in TaqMan RT-PCR for SLEV and WNV in some of the clones picked for 
FLS569 (larger plaque sizes). TaqMan RT-PCR of plaques picked for FLS650 
only detected SLEV (pinpoint plaques). 
• Strain differences were identified in SLEV isolated from the last five decades. A 
pattern of nucleotide substitutions in the envelope region (n=15) was detected in 
the 1990 epidemic strains of SLEV that were not shared by other Florida isolates. 
However, this pattern was also present in strains of SLEV that coincided with 
human cases in Texas and Tennessee based on multiple sequence alignment of the 
envelope region.  
• Phylogenetic analysis of the envelope and partial NS5 regions of Florida isolates 
identified that two SLEV strains (FLS569 and FLS650) collected from sentinel 
chickens in 2006 were placed in Lineage VA, whereas the FL72 strain collected 
from an opossum in 1972 was placed in Lineage VB. The detection of these South 
American strains indicates that Brazilian strains of SLEV were introduced and re-
introduced to Florida during the last 30 years. In addition, the 1989-1990 
“epidemic” strains of SLEV collected during the last large outbreak in the United 
States clustered separately from the other Florida strains of SLEV analyzed in this 
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study. Novel flavivirus strains were isolated from one site with circulation of the 
FLS650 SA strain of SLEV.  However, phylogenetic analysis revealed that these 
novel strains clustered with the North American strains of SLEV and not in the 
South American lineages. 
• In contrast to SLEV, phylogenetic analysis of WNV strains indicated limited 
divergence of Florida isolates since the introduction of the virus to the state in 
2001 (capsid/prM and partial NS5 regions). The novel flavivirus strains clustered 
with Old World isolates in the capsid/prM region, with a low bootstrap support 
value (92%). However, analysis of an internal portion of the WNV genome in the 
3’ NS5 region indicated the FL694 clustered with North American strains of 
WNV (bootstrap support 99%). Complete genome sequencing of these strains is 
recommended to elucidate both the SLEV and WNV components of this virus.  
Aim Five 
• In this study, serological methods proved to be the most effective surveillance 
tool for identification of arbovirus transmission activity in sentinel chickens as 
compared to virus isolation/detection from cloacal swabs. For example, WNV 
was isolated from only one out of 14 chickens in Manatee County that 
seroconverted and were targeted during 2005. However, in Sarasota County 
during 2006, virus was isolated from all four birds that seroconverted that were 
also targeted for cloacal swab collection. In addition, the virus isolation strategy 
identified the co-circulation of WNV (not detected serologically) and novel 
flaviviruses. Consequently, detection of seroconversions in sentinel chicken 
flocks remains the gold standard for detection of arbovirus transmission activity 
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in Florida, but virus isolation is a valuable technique to enhance arbovirus 
surveillance and identification of the origin and potential virulence of circulating 
strains. 
• The impact of WNV on SLEV has been demonstrated with sentinel chicken 
seroconversion rates during this study period. Seroconversion rates to WNV early 
in the year (June through August) appeared to influence subsequent amplification 
and transmission of SLEV during the late summer to early fall months during 
2005 in Florida. In 2006, the number of seroconversions to WNV (n=30) were 
lower than the number of chickens that seroconverted to SLEV (n=40) for the first 
time since the introduction of the WN virus in 2001. Consequently, limited early 
season WNV activity appeared to allow for the later amplification and 
transmission of SLEV.  
• In conclusion, WNV also has the potential to directly impact the natural history of 
SLEV through recombination and rapid evolutionary change as both viruses now 
co-circulate in the same region. The identification of a sentinel chicken with a 
dual infection of SLEV and WNV indicates that it may only be a matter of time 
before “West Louis virus” is detected. Virus isolation and molecular 
epidemiology studies are recommended to enhance arbovirus surveillance in 
Florida to monitor such a trend and implement appropriate prevention and control 
measures should it occur. 
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APPENDIX A 
 
Media Components 
 
Abbreviations    Description  
BSA     Bovine Serum Albumin 
EMEM     Minimal Eagle Media, Earle’s Salts 
FCS      Fetal Calf Serum 
HEPES    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HMEM    Minimal Eagle Media, Hank’s Salts 
L15     Leibowitz Media 
NCS     Newborn Calf Serum 
 
 
Outgrowth Media to Passage Vero Cells 
 
Reagent ml Vendor Catalog Number 
1X HMEM 
1X L15 
NCS (inactivated) 
Penicillin (200,000 U/ml) 
Streptomycin (200 mg/ml) 
Amphotericin B (2.5 mg/ml) 
Kanamycin (50 mg/ml) 
45.0 
45.0 
10.0 
0.1 
0.1 
0.1 
0.1 
Sigma 
Sigma 
HyClone 
Sigma 
Sigma 
Sigma 
Sigma 
M-1018 
L-4386 
SH30118.03 
P-7794 
S-9137 
A-9258 
K-1377 
 
 
Liquid Maintenance Media to Maintain Vero Cells After Inoculation  
 
Reagent ml Vendor Catalog Number 
1X EMEM 
NCS (inactivated) 
Penicillin (200,000 U/ml) 
Streptomycin (200 mg/ml) 
Amphotericin B (2.5 mg/ml) 
Kanamycin (50 mg/ml) 
HEPES (1 M) 
100.0 
2.0 
0.1 
0.1 
0.1 
0.1 
1.0 
Sigma 
HyClone 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
M-1018 
SH30118.03 
P-7794 
S-9137 
A-9258 
K-1377 
H-4034 
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APPENDIX A: (CONTINUED) 
 
Media-Agar Overlay for Plaque Assay and PRNT (First Overlay) 
Reagent ml Vendor Catalog Number 
10X EMEM 
Sterile Reagent Grade H2O 
L-glutamine (200 mM) 
NaHCO3 (8.8%) 
FCS (inactivated) 
HEPES (1 M) 
Penicillin (200,000 U/ml) 
Streptomycin (200 mg/ml) 
Amphotericin B (2.5 mg/ml) 
Kanamycin (50 mg/ml) 
10.0 
32.9 
1.0 
2.5 
2.0 
1.2 
0.1 
0.1 
0.1 
0.1 
Sigma 
--- 
Sigma 
Sigma 
HyClone 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
M-0275 
----- 
G-7513 
S233-500 
SH30070.03 
H-4034 
P-7794 
S-9137 
A-9258 
K-1377 
Warm media to 37°C.  Prepare agarose overlay (below) in a 2x larger flask. 
Autoclave agarose/H2O mixture below for 15 min, 121 PSI. Remove from 
autoclave and cool gel in a 37°C water bath until warm to the touch.  
Aseptically combine media into the flask with agarose overlay.  
SeaKem Agarose  
Sterile Reagent Grade H2O 
2.0 g 
50.0 ml 
Cambrex 
------- 
50004 
------ 
 
Media-Agar Overlay for Plaque Assay and PRNT (Second Overlay) 
Reagent ml Vendor Catalog Number 
10X EMEM 
Sterile Reagent Grade H2O 
L-glutamine (200 mM) 
NaHCO3 (8.8%) 
FCS (inactivated) 
HEPES (1 M) 
Penicillin (200,000 U/ml) 
Streptomycin (200 mg/ml) 
Amphotericin B (2.5 mg/ml) 
Kanamycin (50 mg/ml) 
Neutral Red (0.33 mg/ml) 
10.0 
32.5 
1.0 
2.5 
2.0 
1.2 
0.1 
0.1 
0.1 
0.1 
0.4 
Sigma 
--- 
Sigma 
Sigma 
HyClone 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
M-0275 
----- 
G-7513 
S233-500 
SH30070.03 
H-4034 
P-7794 
S-9137 
A-9258 
K-1377 
N-2889 
Warm media to 37°C.  Prepare agarose overlay (below) in a 2x larger flask. 
Autoclave agarose/H2O mixture below for 15 min, 121 PSI. Remove from 
autoclave and cool gel in a 37°C water bath until warm to the touch. 
Aseptically combine media into the flask with agarose overlay. 
SeaKem Agarose  
Sterile Reagent Grade H2O 
1.0 g 
50.0 ml 
Cambrex 
------- 
50004 
------ 
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APPENDIX A: (CONTINUED) 
 
Biology Field Diluent (BFD) 
Reagent ml Vendor Catalog Number 
1X HMEM 
FCS (inactivated) 
Penicillin (200,000 U/ml) 
Streptomycin (200 mg/ml) 
Amphotericin B (2.5 mg/ml) 
Kanamycin (50 mg/ml) 
90 
10 
0.1 
0.1 
0.1 
0.1 
Sigma 
HyClone 
Sigma 
Sigma 
Sigma 
Sigma 
M-1018 
SH30070.03 
P7794 
S9137 
A9258 
K1377 
 
Bovine Serum Albumin (BSA) Stock Solution (10%) 
Reagent g/ml Vendor Catalog Number 
BSA 
1X EMEM 
10.0 g 
90.0 ml 
Millipore 
Sigma 
81-066-4 
M-0275 
Dissolve BSA in 1X EMEM, 
filter sterilize. 
QS to 
 
 
100.0 ml 
 
Serum Virus Diluent (SVD) 
Reagent ml Vendor Catalog Number 
1X EMEM 
BSA Stock Solution (10%) 
FCS (non-inactivated) 
HEPES (1 M) 
Penicillin (200,000 U/ml) 
Streptomycin (200 mg/ml) 
Amphotericin B (2.5 mg/ml) 
Kanamycin (50 mg/ml) 
81.0 
10.0 
8.0 
1.0 
0.1 
0.1 
0.1 
0.1 
Sigma 
Millipore 
HyClone 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
M-0275 
81-066-4 
SH30070.03 
H-4034 
P7794 
S9137 
A9258 
K1377 
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Serologic Assay and Virus Specific Reagents 
 
Hemagglutination Inhibition Assay 
 
Antigens Strain Date Prepared 
SLEV Antigen 
EEEV Antigen 
SLEV TBH 28 
EEEV D64-837 
 
11/04, 04/06 
11/04 
 
Note: Antigens prepared at the Florida Department of Health, Tampa Laboratory. 
 
 
IgM Antibody Capture ELISA (Chicken) 
 
Virus & Negative Antigens Strain Date Prepared Vendor 
Catalog 
Number 
WNV Mouse Brain Antigen 
SLEV Mouse Brain Antigen 
EEEV Mouse Brain Antigen 
Normal Mouse Brain Antigen 
WN Eg101 SMB 
SLE TBH 28 
EEE D64-837 
NMB 
 
02/06/03 
----- 
11/05/04 
----- 
 
FDOH-TL 
CDC 
FDOH-TL 
CDC 
 
NA 
M29797 
NA 
M29714 
 
Antibodies Strain Vendor Catalog Number 
 
Capture Antibody (goat anti-chicken) 
 
Conjugate Antibody 6B6C-1 (Flavivirus group 
peroxidase conjugated monoclonal antibody) 
 
Conjugate Antibody 2A2C-3 (Alphavirus group 
peroxidase conjugated monoclonal antibody) 
 
 
------ 
 
SLE MSI-7 
 
 
WEE 
McMillian 
 
MP Biomedicals 
 
CDC 
 
 
CDC 
 
64395 
 
VS2338 
 
 
VS2371 
Vendors: CDC antigens obtained from the Centers for Disease Control and Prevention, Fort 
Collins, Colorado.  FDOH-TL antigens prepared at the Florida Department of Health, 
Tampa Laboratory. 
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Plaque Reduction Neutralization Test 
 
Virus Strain Passage Date Prepared 
WNV 
 
SLEV  
 
EEEV 
HJV 
Eg101 
 
TBH 28 
 
D64-837 
64A-1519 
 
SM2, Vero 2 
SM2, Vero 3 
SM11, Vero 1 
SM11, Vero 2 
SM8, BGM 2, Vero 1 
SM4, BGM 1, Vero 1 
 
 
10/21/04 
04/11/06 
10/21/04 
04/11/06 
01/15/05 
01/15/05 
Note: Viruses prepared at the Florida Department of Health, Tampa Laboratory. See 
Appendix I for all media reagents needed for the PRNT assay. 
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Cloacal Swab Sampling Criteria & Protocol for Wild Rehabilitated Birds 
 
The swab samples will be screened for WNV and SLEV.  Additional viruses (such 
as Eastern Equine Encephalitis, California & Highlands J) may also be added to the 
panel based on other types of surveillance data (e.g. dead bird, sentinel chicken) in 
the sampling region. Please note that this project is experimental and results will be 
returned as quickly as possible.   
 
Packing List 
 
1. Each box contains 2 coolers, 2 room temperature gel packs, 40 swabs, ziplock 
bags, 1 copy of the submittal form, the sample protocol, and 2 shipping 
address labels. 
2. The cloacal swab culture tubes may remain at room temperature until the 
sample is collected.  Freeze provided gel packs until needed for shipment to 
lab. 
 
Sample Criteria 
 
1. Please do NOT swab all birds that are admitted to the facility.  Do NOT swab 
birds that are at the facility only as a result of accidental/intentional human-
induced trauma.  
2. Targeted species include: raptors, wading & water birds, and blue 
jays/mourning doves/grackles. Please swab these bird species, if they meet 
criteria #1.   
3. Also, swab birds with potential arbovirus infections based on the following 
symptoms: 
a. CNS symptoms (i.e. encephalitis) regardless of species (indicate CNS on 
paperwork).   
b. Weakness, lethargy, shaking and convulsions, anorexia, weight loss, 
unusual posture, ruffled feathers, inability to hold head upright, ataxia. 
4. Swab each bird only ONCE as soon as possible after admittance.  
 
Sample Protocol 
1. Wear appropriate PPE while swabbing the birds (gloves & gown, mask if 
possible). 
2. Each pre-sterilized culture swab pack contains: 2 cotton-tipped applicators & 
a single culture tube.  Only one applicator is necessary per bird (you may 
discard the second). 
3. Label swab culture tube with the Swab Collection Date, Bird # and Facility 
Name in the space provided on the tube for each bird that is swabbed.   
4. Locate and swab cloacae with one applicator. Wet most of cotton tip! 
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5. Sheath the swab in the separate culture tube and return the bird to its cage. 
6. Immediately freeze the culture tubes (+swab) after sample collection in 
provided ziplock bags for storage.  Keep tubes frozen at -70°C until shipment 
to the laboratory. 
7. Please return tubes (in ziplock bags) to lab in provided cooler boxes with 
frozen gel packs within 2 weeks of collection date. Ship overnight.  The 
samples must remain cold at all times in order to preserve the virus. 
8. Please enter Swab Collection Date, Bird #, and Site (where bird was found, if 
available) on the form provided for each bird & submit with each box.  If 
submitting more than one sample at a time, multiple entries per page are 
recommended. 
9. Results for samples will be emailed once molecular and culture assays are 
completed. 
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Arbovirus Surveillance: Detection and Virus Isolation (Submittal Form)  
Arbovirus Surveillance of Rehab Birds from Cloacal Swabs 
County  Reported http://wld.fwc.state.fl.us/bird/  
__yes ___no 
Contact  
Name  E-mail:  
Organization  Phone: (             ) 
Address  Fax: (             ) 
Address  For DoH Tampa Laboratory Use Only 
City/State/zip  Date Received  
Specimen Collection Data  
 
Collecti
on date Bird # 
Site/Address of 
Collection OR GPS 
Coordinates 
Species 
of bird 
DoH LAB 
# 
Molecular 
Assay 
Results 
Virus 
Isolation 
Result 
       
       
       
       
       
       
 
Please send cloacal swabs to: 
Florida Department of Health, Bureau of Laboratories, 3602 Spectrum Blvd.,  
Tampa, FL  33612-9401, Attention: Virology (B) 
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Cloacal Swab Sampling Criteria and Protocol for Arbovirus Isolation  
from Sentinel Chickens 
 
Sample Criteria 
 
1. Do not sample all sites in the county- please only swab sentinel chickens at 
sites where arboviral activity has recently been detected (within 1-2 weeks). 
2. Swab all chickens that have not yet seroconverted at that positive site. 
3. Do not swab any confirmed positive sentinels at the site. 
4. Please swab the negative chickens when they are bled for the HAI assay.   
5. Continue to swab the negative sentinels at the site for 4-8 weeks. 
6. If possible, swab the sentinels twice a week to improve probability of 
arbovirus isolation.  
7. This project is experimental and results will be returned as quickly as 
possible.  
 
Swab Protocol 
 
3. Enter the Bird #, Site, and Date in the space provided on the swab culture 
label for each sentinel that is swabbed. Also, enter this information for each 
swab on virus isolation/detection paperwork to be submitted to laboratory. 
4. On the Arbovirus Surveillance Serology submittal paperwork for the HAI test, 
enter the letter ‘S’ in the Comments section if a swab is also submitted for 
testing on that bird.   
5. Wear appropriate PPE while swabbing the birds (gloves & gown, mask if 
possible). 
6. Collect the blood for serology testing prior to swabbing the sentinel. 
7. Next, locate and swab the cloacae with the viral culturette swab provided.  
Attempt to wet most of the cotton applicator. 
8. Re-sheath the swab and return the sentinel chicken to its cage. 
9. For swabs with a green top (Cat. No. 261514), use both hands to apply 
pressure to the bottom of the culturette and crack the amber liquid at the base. 
This will release the media to preserve the sample.  For swabs with a red top 
(Cat. No. 220221), sheathe applicators in viral culture tube by immersing 
cotton swabs in the media, break base of plastic applicator at score lines, and 
cap tube. 
10. Keep swabs as cold as possible in the field (on ice packs) and freeze them     
@ -70°C until shipment to the laboratory. Ship overnight on dry ice. 
11. Results for the swabs will be emailed once molecular and cell culture assays 
are completed. 
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Arbovirus Surveillance: Detection and Virus Isolation (Submittal Form)  
 
 
     Bureau of Laboratories phone:   
    Tampa Branch Laboratory fax:   
    3602 Spectrum Boulevard   
    
Tampa, FL  
33612    
    email:         
 Arbovirus Surveillance of Sentinel Chickens from Blood & Swabs 
County       page _____ of________ 
Contact 
Name          
Address          
           
Telephone      For Laboratory use only 
Fax:        
Date 
Received:     
e-mail        
MA Date 
Reported:     
       
VI Date 
Reported:     
Specimen Collection Data        
  
Coll. 
date Bird # Site New 
LAB 
Number MA Result 
VI 
Result Comments 
1                 
2                 
3                 
4                 
5                 
6                 
7                 
8                 
9                 
10                 
11                 
12                 
         
This form must accompany all blood & cloacal swab specimens submitted for virus detection/isolation. 
Submitter should fill out left side of form completely.  DO NOT SKIP LINES when listing collected specimens   
If bird is new to the flock or first time  bled, place an X in the “New” column.  Please  Do not write below this line 
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Master Mix Components for RT-PCR and Sequencing 
 
 
Real Time One-Step RT-PCR (TaqMan) for ABI 7000 System 
Component [Final Conc] Volume Stock Concentration 
RNase/DNase-free H20 
2X Universal PCR Master Mix 
50 pmol Primer (forward) 
50 pmol Primer (reverse) 
7.5 pmol Probe 
10X Multiscribe & RNase Inhibitor Mix 
Template  
17.7 µl  
25.0 µl 
  0.5 µl 
  0.5 µl 
  0.3 µl 
  1.0 µl 
  5.0 µl  
n/a 
Proprietary 
100 µM (100 pmol/µl) 
100 µM (100 pmol/µl) 
  25 µM (25 pmol/µl) 
Proprietary 
n/a 
Total 50.0 µl  
 
 
 
Real Time One-Step RT-PCR (TaqMan) for ABI 7500 System 
Component [Final Conc] Volume Stock Concentration 
RNase/DNase-free H20 
2X Universal PCR Master Mix 
25 pmol Primer (forward) 
25 pmol Primer (reverse) 
3.75 pmol Probe 
10X Multiscribe & RNase Inhibitor Mix 
Template  
6.35 µl  
12.5 µl 
0.25 µl 
0.25 µl 
0.15 µl 
  0.5 µl 
  5.0 µl  
n/a 
Proprietary 
100 µM (100 pmol/µl) 
100 µM (100 pmol/µl) 
  25 µM (25 pmol/µl) 
Proprietary 
n/a 
Total 25.0 µl  
 
 
 
SuperScript III One-Step RT-PCR System with Platinum Taq High Fidelity 
Component [Final Conc] Volume Stock Concentration 
RNase/DNase-free H20 
2X Reaction Mix 
100 pmol Primer (forward) 
100 pmol Primer (reverse) 
SS III RT-PCR Platinum Taq HiFi Mix 
16U RNasin (RNase Inhibitor) 
Template  
20.6 µl  
25.0 µl 
  0.5 µl 
  0.5 µl 
  1.0 µl 
  0.4 µl 
  2.0 µl  
n/a 
Proprietary 
200 µM (200 pmol/µl) 
200 µM (200 pmol/µl) 
Proprietary 
40 units/µl 
n/a 
Total 50.0 µl  
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Nucleotide Sequencing Reaction 
Component  [Final Conc] Volume Stock Concentration 
RNase/DNase-free H20 
40 pmol Primer 
DTCS Master Mix 
Template (variable) 
(8.0 - x)µl  
2.0 µl 
8.0 µl 
x µl 
n/a 
20 µM (20 pmol/µl) 
Proprietary 
n/a 
Total 20.0 µl  
 
 
 
Thermal Cycler Parameters 
 
Real Time One-Step RT-PCR (TaqMan) for ABI 7000/7500 Systems 
Stage 1 Stage 2 Stage 3 
1 cycle 1 cycle Step 1:  45 cycles 
95°C             15 seconds  
Step 2:  1 cycle 
48°C      30 minutes
 
95°C             10 minutes 
60°C               1  minute 
Run Mode: 9600 Emulation 
 
 
 
SuperScript III One-Step RT-PCR System with Platinum Taq High Fidelity 
1 cycle 40 cycles 1 cycle 
50°C      30 minutes
95°C               5 minutes 
94°C             20 seconds 
55°C             30 seconds 
68°C               3 minutes 
72°C             20 minutes 
  4°C              ∞ 
 
 
Nucleotide Sequencing Reaction 
35 cycles 
96°C                                  20 seconds 
42°C                                  20 seconds 
60°C                                  3 minutes 
  4°C                                  ∞ 
 
 517
APPENDIX E 
 
COMPREHENSIVE ARBOVIRUS SURVEILLANCE MAPS (2005) 
 
 
EEEV Comprehensive Surveillance (2005) 
 
 
 
Map appears courtesy of the DOH-BCEH. Open access is available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-arboviral.html#2005 
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WNV Comprehensive Surveillance (2005) 
 
 
 
Map appears courtesy of the DOH-BCEH. Open access is available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-arboviral.html#2005 
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SLEV WEEKLY SURVEILLANCE ACTIVITY (2005) 
 
Note: A comprehensive map was not generated for SLEV in 2005. 
 
 
August 21 – August 27  
 
Map appears courtesy of the DOH-BCEH. Open access is available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-sentinel.htm#2005 
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SLEV WEEKLY SENTINEL SURVEILLANCE ACTIVITY (2005), Continued 
 
 
September 25 – October 1 
 
Map appears courtesy of the DOH-BCEH. Open access is available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-sentinel.htm#2005 
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SLEV WEEKLY SENTINEL SURVEILLANCE ACTIVITY (2005), Continued 
 
 
October 9 – October 15 
 
Map appears courtesy of the DOH-BCEH. Open access is available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-sentinel.htm#2005 
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SLEV WEEKLY SENTINEL SURVEILLANCE ACTIVITY (2005), Continued 
 
 
October 23 – October 29 
 
Map appears courtesy of the DOH-BCEH. Open access is available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-sentinel.htm#2005 
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COMPREHENSIVE ARBOVIRUS SURVEILLANCE MAPS (2006) 
 
 
EEEV Comprehensive Surveillance (2006) 
 
 
 
Map appears courtesy of the DOH-BCEH. Open access is available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-arboviral.html#2006 
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WNV Comprehensive Surveillance (2006) 
 
 
 
Map appears courtesy of the DOH-BCEH. Open access is available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-arboviral.html#2006 
 
 
 
 
 
 
 
 
 525
APPENDIX F: (CONTINUED) 
 
 
SLEV Comprehensive Surveillance (2006) 
 
 
 
Map appears courtesy of the DOH-BCEH. Open access is available at 
http://www.doh.state.fl.us/environment/community/arboviral/maps-arboviral.html#2006 
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SENTINEL CHICKEN ARBOSEROLOGY RESULTS 
 
 
BIRD 8-003-R (Sarasota County, Site 004) 
 
 
 
Arboserology Test Results for Sera Collected from Bird 8-003-R 
 
 
Assay Type 
 
Day 0 (Serum 1) Day 7 (Serum 2) Day 14 (Serum 3) 
 
HAI ≥40 ≥40 ≥40 
 
 WN SLE WN SLE WN SLE 
 
MAC-ELISA 
 
MIA Screen (Adj) 
MIA Confirm (Adj) 
 
PRNT 
 
1.0 
 
3.69 
0.43 
 
<10 
 
3.9 
 
32.5 
2.71 
 
≥40 
 
0.9 
 
2.73 
0.42 
 
<10 
 
2.40 
 
15.6 
1.54 
 
≥40 
 
0.79 
 
1.91 
QNS* 
 
QNS 
 
1.46 
 
11.5 
QNS 
 
QNS 
*QNS= quantity not sufficient. 
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BIRD 9-005-B (Sarasota County, Site 001) 
 
 
 
Arboserology Test Results for Sera Collected from Bird 9-005-B 
 
Assay Type 
 
Day 0 (Serum #1) 
 
Day 7 (Serum #2) 
 
HAI 
 
≥40 ≥40 
 
WN SLE WN SLE 
 
MAC-ELISA  
 
MIA Screen (Adjusted) 
 
MIA Confirm (Adjusted) 
 
PRNT* 
 
2.15 
 
2.28 
 
NT 
 
<10 
 
17.0 
 
27.26 
 
NT 
 
≥40 
 
1.40 
 
1.55 
 
NT 
 
NT 
 
5.86 
 
11.07 
 
NT 
 
NT 
 
*NT = Not Tested 
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WILD BIRD SPECIES 
 
Number of Cloacal Swabs Submitted for Each Bird Species  
by Wildlife Rehabilitation Centers and the  
Florida Fish & Wildlife Conservation Commission 
SPECIES NUMBER 
Anhinga 1 
Bald Eagle 1 
Barred Owl 9 
Black Vulture 3 
Brown Pelican 1 
Chicken 1 
Cooper’s Hawk 3 
Common Grackle 1 
Common Loon 1 
Double Crested Cormorant 4 
Duck 1 
Eastern Screech Owl 4 
Feral Pigeon 4 
Great Horned Owl 3 
Great American Egret 1 
Great Blue Heron 1 
Great White Heron 1 
Green Heron 1 
Ibis 2 
Laughing Gull 9 
Magnificent Frigate Bird 1 
Mockingbird 1 
Osprey 6 
Pelican 1 
Permanent Ring Collar Dove 1 
Red Hawk 1 
Ringed-Turtle Dove 6 
Ring-neck Duck 1 
Red-shouldered Hawk 7 
Red-tailed Hawk 3 
Ruddy Turnstone 1 
Sora 2 
Tern 1 
Turkey Vulture 1 
Wurde-Mann’s Heron 1 
Yellow Crown Night Heron 1 
Total Species = 36 Total Swabs = 87 
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BLASTN Results for St. Louis Encephalitis Virus Strains 
 
 
FL52 
 
FL52 Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158066.1 St. Louis encephalitis virus strain GHA-3  2796 100% 0.0 97% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  2780 100% 0.0 97% 
AF205509.1 St. Louis encephalitis virus strain Parton  2776 98% 0.0 97% 
AF205505.1 St. Louis encephalitis virus strain GHA-3  2765 98% 0.0 97% 
EF158065.1 St. Louis encephalitis virus strain TNM 4-711  2763 100% 0.0 97% 
 
FL52 NS5 
Accession Description Max score Query coverage E value Max ident 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  1748 99% 0.0 97% 
EF158055.1 St. Louis encephalitis virus strain TBH 28  1748 99% 0.0 97% 
EF158049.1 St. Louis encephalitis virus strain 904.3  1736 99% 0.0 97% 
EF158070.1 St. Louis encephalitis virus strain Parton  1725 99% 0.0 97% 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  1725 99% 0.0 97% 
 
FL52 SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158055.1 St. Louis encephalitis virus strain TBH 28  645 99% 0.0 99% 
EF158066.1 St. Louis encephalitis virus strain GHA-3  636 100% 2e-179 98% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  636 100% 2e-179 98% 
EF158070.1 St. Louis encephalitis virus strain Parton  630 100% 9e-178 98% 
EF158065.1 St. Louis encephalitis virus strain TNM 4-711  630 100% 9e-178 98% 
 
FL52 3’NC 
Accession Description Max score Query coverage E value Max ident 
DQ525916.1 St. Louis encephalitis virus strain Kern217 1011 100% 0.0 96% 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  981 96% 0.0 96% 
AF242895.1 St. Louis encephalitis virus polyprotein gene 503 49% 4e-139 96% 
AF246796.1 St. Louis encephalitis virus Be H 355964 NS5  455 45% 1e-124 96% 
AY632544.1 St. Louis encephalitis virus polyprotein gene 448 49% 2e-122 93% 
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TBH-28 
 
TBH-28 Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158055.1 St. Louis encephalitis virus strain TBH28  3001 100% 0.0 99% 
AF205469.1 St. Louis encephalitis virus strain Tbh28  2985 99% 0.0 99% 
AF205468.1 St. Louis encephalitis virus strain P15  2968 99% 0.0 99% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  2863 100% 0.0 98% 
AF205470.1 St. Louis encephalitis virus strain 65v310  2852 99% 0.0 98% 
 
TBH-28 NS5 
Accession Description Max score Query coverage E value Max ident 
EF158055.1 St. Louis encephalitis virus strain TBH 28  1810 100% 0.0 99% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  1766 100% 0.0 98% 
EF158050.1 St. Louis encephalitis virus strain MSI 7  1727 100% 0.0 97% 
EF158049.1 St. Louis encephalitis virus strain 904.3  1727 100% 0.0 97% 
AF013416.1 St. Louis encephalitis virus strain MSI-7 NS5  1727 100% 0.0 97% 
 
TBH-28 SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158055.1 St. Louis encephalitis virus strain TBH 28  651 99% 0.0 99% 
EF158066.1 St. Louis encephalitis virus strain GHA-3  641 100% 0.0 99% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  641 100% 0.0 99% 
EF158070.1 St. Louis encephalitis virus strain Parton  636 100% 2e-179 98% 
EF158065.1 St. Louis encephalitis virus strain TNM 4-711  636 100% 2e-179 98% 
 
TBH-28 3’NC 
Accession Description Max score Query coverage E value Max ident 
DQ525916.1 St. Louis encephalitis virus strain Kern217 1011 99% 0.0 97% 
DQ359217.1 St. Louis encephalitis virus isolate MSI- 965 97% 0.0 96% 
AF242895.1 St. Louis encephalitis virus polyprotein gene 520 49% 4e-144 97% 
AY632544.1 St. Louis encephalitis virus polyprotein gene 464 49% 2e-127 94% 
AF246796.1 St. Louis encephalitis virus Be H 355964 NS5  444 45% 2e-121 96% 
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FL72 
 
FL72 Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 2904 100% 0.0 98% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  2865     100% 0.0 97% 
AF205483.1 St. Louis encephalitis virus strain bean246262  2854 98% 0.0 98% 
AF205484.1 St. Louis encephalitis virus strain beh203235  2843 98% 0.0 98% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  2782 100% 0.0 96% 
 
FL72 NS5 
Accession Description Max score Query coverage E value Max ident 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 1792 100% 0.0 98% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  1705 100% 0.0 96% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  1703 100% 0.0 96% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  1642 100% 0.0 95% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 1631 100% 0.0 95% 
      
FL72 SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  616 99% 3e-173 98% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 610 99% 1e-171 98% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  593 99% 1e-166 97% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 571 99% 6e-160 96% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  560 99% 1e-156 95% 
 
FL72 3’NC 
Accession Description Max score Query coverage E value Max ident 
DQ525916.1 St. Louis encephalitis virus strain Kern217 985 99% 0.0 96% 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  922 95% 0.0 95% 
AF246796.1 St. Louis encephalitis virus Be H 355964 NS5  484 46% 1e-133 98% 
AF242895.1 St. Louis encephalitis virus polyprotein gene 468 47% 1e-128 95% 
AY632544.1 St. Louis encephalitis virus polyprotein gene 457 47% 3e-125 95% 
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FL85a 
 
FL85a Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  1836 100% 0.0 99% 
EF158055.1 St. Louis encephalitis virus strain TBH 28  1808 100% 0.0 98% 
AF205470.1 St. Louis encephalitis virus strain 65v310  1796 97% 0.0 99% 
EF158066.1 St. Louis encephalitis virus strain GHA-3  1792 100% 0.0 98% 
M16614.1 St. Louis encephalitis virus viral polyprotein  1786 100% 0.0 98% 
 
FL85a NS5 
Accession Description Max score Query coverage E value Max ident 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  1792 100% 0.0 98% 
EF158055.1 St. Louis encephalitis virus strain TBH 28  1770 100% 0.0 97% 
EF158050.1 St. Louis encephalitis virus strain MSI 7  1742 100% 0.0 97% 
AF013416.1 Saint Louis encephalitis virus strain MSI-7 NS5 1742 100% 0.0 97% 
EF158070.1 St. Louis encephalitis virus strain Parton  1720 100% 0.0 96% 
 
FL85a SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158055.1 St. Louis encephalitis virus strain TBH 28  699 100% 0.0 99% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  688 100% 0.0 98% 
EF158070.1 St. Louis encephalitis virus strain Parton  682 100% 0.0 98% 
EF158066.1 St. Louis encephalitis virus strain GHA-3  682 100% 0.0 98% 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  682 100% 0.0 98% 
 
FL85a 3’NC 
Accession Description Max score Query coverage E value Max ident 
DQ525916.1 St. Louis encephalitis virus strain Kern217 1007 99% 0.0 97% 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  944 95% 0.0 96% 
AF242895.1 St. Louis encephalitis virus polyprotein gene 497 48% 2e-137 97% 
AY632544.1 St. Louis encephalitis virus polyprotein gene 442 48% 8e-121 94% 
AF246796.1 St. Louis encephalitis virus Be H 355964 NS5  427 45% 2e-116 95% 
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APPENDIX I: (CONTINUED) 
 
 
FL85b 
 
FL85b Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  2961 100% 0.0 99% 
AF205470.1 St. Louis encephalitis virus strain 65v310  2913 98% 0.0 99% 
EF158055.1 St. Louis encephalitis virus strain TBH 28  2889 100% 0.0 98% 
EF158050.1 St. Louis encephalitis virus strain MSI 7  2883 100% 0.0 98% 
AY289618.1 St. Louis encephalitis virus strain MSI7  2883 100% 0.0 98% 
 
FL85b NS5 
Accession Description Max score Query coverage E value Max ident 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  1783 99% 0.0 98% 
EF158055.1 St. Louis encephalitis virus strain TBH 28  1760 99% 0.0 98% 
EF158050.1 St. Louis encephalitis virus strain MSI 7  1733 99% 0.0 97% 
AF013416.1 Saint Louis encephalitis virus strain MSI-7  1733 99% 0.0 97% 
EF158070.1 St. Louis encephalitis virus strain Parton  1705 99% 0.0 97% 
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APPENDIX I: (CONTINUED) 
 
 
FL90a 
 
FL90a Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158052.1 St. Louis encephalitis virus strain V 2380-42  2916 100% 0.0 98% 
EF158057.1 St. Louis encephalitis virus strain 78 A 28  2900 100% 0.0 98% 
AF205498.1 St. Louis encephalitis virus strain 83V4953  2881 98% 0.0 98% 
AF205499.1 St. Louis encephalitis virus strain PV1-2419  2880 98% 0.0 98% 
AF205500.1 St. Louis encephalitis virus strain 98V3181  2870 98% 0.0 98% 
 
FL90a NS5 
Accession Description Max score Query coverage E value Max ident 
EF158052.1 St. Louis encephalitis virus strain V 2380-42  1705 100% 0.0 98% 
EF158057.1 St. Louis encephalitis virus strain 78 A 28  1694 100% 0.0 98% 
EF158065.1 St. Louis encephalitis virus strain TNM 4-711  1683 100% 0.0 98% 
EF158051.1 St. Louis encephalitis virus strain GMO 94  1655 100% 0.0 98% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  1628 100% 0.0 97% 
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APPENDIX I: (CONTINUED) 
 
 
FL90b 
 
FL90b Envelope 
Accession Description Max score Query coverage E value Max ident 
AF205498.1 St. Louis encephalitis virus strain 83V4953  2881 100% 0.0 98% 
AF205499.1 St. Louis encephalitis virus strain PV1-2419  2880 99% 0.0 98% 
EF158052.1 St. Louis encephalitis virus strain V 2380-42 2876 100% 0.0 98% 
AF205500.1 St. Louis encephalitis virus strain 98V3181  2870 100% 0.0 98% 
EF158057.1 St. Louis encephalitis virus strain 78 A 28  2859 100% 0.0 98% 
 
FL90b NS5 
Accession Description Max score Query coverage E value Max ident 
EF158052.1 St. Louis encephalitis virus strain V 2380-42  1781 100% 0.0 97% 
EF158057.1 St. Louis encephalitis virus strain 78 A 28  1770 100% 0.0 97% 
EF158065.1 St. Louis encephalitis virus strain TNM 4-711  1748 100% 0.0 97% 
EF158051.1 St. Louis encephalitis virus strain GMO 94  1725 100% 0.0 96% 
EF158055.1 St. Louis encephalitis virus strain TBH 28  1692 100% 0.0 96% 
 
FL90b 3’NC 
Accession Description Max score Query coverage E value Max ident 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  961 99% 0.0 97% 
DQ525916.1 St. Louis encephalitis virus strain Kern217 950 99% 0.0 96% 
AF242895.1 St. Louis encephalitis virus polyprotein gene 499 52% 5e-138 96% 
AF246796.1 St. Louis encephalitis virus Be H 355964 NS5  462 47% 6e-127 97% 
AY632544.1 St. Louis encephalitis virus polyprotein gene cds 449 52% 5e-123 93% 
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APPENDIX I: (CONTINUED) 
 
 
FL90c 
 
FL90c Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158052.1 St. Louis encephalitis virus strain V 2380-42  2918 100% 0.0 98% 
EF158057.1 St. Louis encephalitis virus strain 78 A 28  2902 100% 0.0 98% 
AF205498.1 St. Louis encephalitis virus strain 83V4953  2881 98% 0.0 98% 
AF205499.1 St. Louis encephalitis virus strain PV1-2419  2880 98% 0.0 98% 
AF205500.1 St. Louis encephalitis virus strain 98V3181  2870 98% 0.0 98% 
 
FL90c NS5 
Accession Description Max score Query coverage E value Max ident 
EF158052.1 St. Louis encephalitis virus strain V 2380-42  1759 100% 0.0 98% 
EF158057.1 St. Louis encephalitis virus strain 78 A 28  1748 100% 0.0 98% 
EF158065.1 St. Louis encephalitis virus strain TNM 4-711  1731 100% 0.0 98% 
EF158051.1 St. Louis encephalitis virus strain GMO 94  1703 100% 0.0 97% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  1670 100% 0.0 97% 
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APPENDIX I: (CONTINUED) 
 
 
FL90d 
 
FL90d Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158052.1 St. Louis encephalitis virus strain V 2380-42  2911 99% 0.0 98% 
EF158057.1 St. Louis encephalitis virus strain 78 A 28  2889 99% 0.0 98% 
AF205499.1 St. Louis encephalitis virus strain PV1-2419  2878 98% 0.0 98% 
AF205498.1 St. Louis encephalitis virus strain 83V4953  2868 98% 0.0 98% 
EF158065.1 St. Louis encephalitis virus strain TNM 4-711  2857 99% 0.0 97% 
 
FL90d NS5 
Accession Description Max score Query coverage E value Max ident 
EF158052.1 St. Louis encephalitis virus strain V 2380-42  1790 100% 0.0 98% 
EF158057.1 St. Louis encephalitis virus strain 78 A 28  1773 100% 0.0 98% 
EF158065.1 St. Louis encephalitis virus strain TNM 4-711  1751 100% 0.0 97% 
EF158051.1 St. Louis encephalitis virus strain GMO 94  1729 100% 0.0 97% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  1696 100% 0.0 96% 
 
FL90d 3’NC 
Accession Description Max score Query coverage E value Max ident 
DQ525916.1 St. Louis encephalitis virus strain Kern217 1002 99% 0.0 96% 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  972 95% 0.0 97% 
AF242895.1 St. Louis encephalitis virus polyprotein gene 488 48% 1e-134 97% 
AF246796.1 St. Louis encephalitis virus Be H 355964 NS5 462 45% 6e-127 97% 
AY632544.1 St. Louis encephalitis virus polyprotein gene 438 48% 1e-119 94% 
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APPENDIX I: (CONTINUED) 
 
 
BR64 
 
BR64 Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 2876 99% 0.0 97% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  2870 99% 0.0 97% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 2854 99% 0.0 96% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  2837 99% 0.0 96% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  2837 99% 0.0 96% 
 
BR64 NS5 
Accession Description Max score Query coverage E value Max ident 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 1668 100% 0.0 96% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  1663 100% 0.0 96% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 1646 100% 0.0 96% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  1646 100% 0.0 96% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  1626 99% 0.0 96% 
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APPENDIX I: (CONTINUED) 
 
 
BR69 
 
BR69 Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  2730 100% 0.0 96% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 2724 100% 0.0 96% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  2719 100% 0.0 96% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 2697 100% 0.0 96% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  2693 100% 0.0 96% 
 
BR69 NS5 
Accession Description Max score Query coverage E value Max ident 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 1637 100% 0.0 95% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  1624 100% 0.0 95% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  1618 100% 0.0 95% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 1613 100% 0.0 95% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  1607 100% 0.0 94% 
 
BR69 SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  617 99% 7e-174 98% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  617 99% 7e-174 98% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 612 99% 3e-172 97% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 595 99% 3e-167 96% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  584 99% 7e-164 96% 
      
BR69 3’NC 
Accession Description Max score Query coverage E value Max ident 
DQ525916.1 St. Louis encephalitis virus strain Kern217 881 98% 0.0 95% 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  870 98% 0.0 95% 
AF242895.1 St. Louis encephalitis virus polyprotein gene 470 51% 3e-129 96% 
AF246796.1 St. Louis encephalitis virus Be H 355964 NS5  464 50% 2e-127 97% 
AY632544.1 St. Louis encephalitis virus polyprotein gene 448 51% 2e-122 94% 
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APPENDIX I: (CONTINUED) 
 
 
TR58 
 
TR58 Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  2784 100% 0.0 97% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  2767 99% 0.0 96% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  2761 100% 0.0 96% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 2756 100% 0.0 96% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 2750 99% 0.0 96% 
 
TR58 NS5 
Accession Description Max score Query coverage E value Max ident 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 1746 100% 0.0 98% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  1718 100% 0.0 97% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  1718 99% 0.0 97% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  1679 100% 0.0 97% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 1668 100% 0.0 96% 
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APPENDIX I: (CONTINUED) 
 
 
TR62 
 
TR62 Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  2719 86% 0.0 96% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 2713 86% 0.0 96% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 2708 86% 0.0 96% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  2708 86% 0.0 96% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  2697 86% 0.0 95% 
 
TR62 NS5 
Accession Description Max score Query coverage E value Max ident 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 1727 99% 0.0 97% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  1716 99% 0.0 97% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  1700 99% 0.0 96% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  1650 99% 0.0 96% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 1639 99% 0.0 95% 
 
TR62 SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  614 100% 9e-173 97% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 608 100% 4e-171 97% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  603 100% 2e-169 97% 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 569 100% 2e-159 95% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  558 100% 5e-156 94% 
 
TR62 3’NC  
Accession Description Max score Query coverage E value Max ident 
DQ525916.1 St. Louis encephalitis virus strain Kern217 929 99% 0.0 94% 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  900 95% 0.0 94% 
AF246796.1 St. Louis encephalitis virus Be H 355964 NS5  464 45% 2e-127 97% 
AF242895.1 St. Louis encephalitis virus polyprotein gene 429 47% 6e-117 93% 
AY632544.1 St. Louis encephalitis virus polyprotein gene 418 47% 1e-113 92% 
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APPENDIX I: (CONTINUED) 
 
 
FLS569 
 
FLS569 Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 2885 100% 0.0 98% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  2880 100% 0.0 98% 
AF205478.1 St. Louis encephalitis virus strain bean242587  2854 98% 0.0 98% 
AF205479.1 St. Louis encephalitis virus strain 75d90  2832 98% 0.0 98% 
AY135514.1 St. Louis encephalitis virus strain Coav 405  2820 98% 0.0 98% 
 
FLS569 NS5 
Accession Description Max score Query coverage E value Max ident 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 1718 100% 0.0 97% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  1718 100% 0.0 97% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 1591 100% 0.0 95% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  1576 100% 0.0 95% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  1563 100% 0.0 94% 
 
FLS569 SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 641 100% 0.0 99% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  630 100% 9e-178 98% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  597 100% 1e-167 96% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 592 100% 4e-166 96% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  586 100% 2e-164 96% 
 
FLS569 3’NC 
Accession Description Max score Query coverage E value Max ident 
DQ525916.1 St. Louis encephalitis virus strain Kern217 929 100% 0.0 95% 
DQ359217.1 St. Louis encephalitis virus isolate MSI-7  918 100% 0.0 95% 
AF242895.1 St. Louis encephalitis virus polyprotein gene 479 51% 6e-132 95% 
AF246796.1 St. Louis encephalitis virus Be H 355964 NS5  470 48% 4e-129 97% 
AY632544.1 St. Louis encephalitis virus polyprotein gene cds 457 51% 3e-125 93% 
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APPENDIX I: (CONTINUED) 
 
 
FLS650 
 
FLS650 Envelope 
Accession Description Max score Query coverage E value Max ident 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 2902 100% 0.0 98% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  2896 100% 0.0 98% 
AF205478.1 St. Louis encephalitis virus strain bean242587  2867 98% 0.0 98% 
AF205479.1 St. Louis encephalitis virus strain 75d90  2844 98% 0.0 98% 
AY135514.1 St. Louis encephalitis virus strain Coav 405  2828 98% 0.0 98% 
 
FLS650 NS5 
Accession Description Max score Query coverage E value Max ident 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 1738 100% 0.0 98% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  1738 100% 0.0 98% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 1605 100% 0.0 95% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  1589 100% 0.0 95% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  1585 99% 0.0 95% 
 
FLS650 SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158067.1 St. Louis encephalitis virus strain BeAn 247377 619 56% 4e-174 98% 
EF158054.1 St. Louis encephalitis virus strain 75 D 90  608 56% 8e-171 97% 
EF158056.1 St. Louis encephalitis virus strain TRVL 9464  575 56% 8e-161 96% 
EF158053.1 St. Louis encephalitis virus strain BeAn 246262 569 56% 4e-159 95% 
EF158048.1 St. Louis encephalitis virus strain BeAr 23379  564 56% 2e-157 95% 
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APPENDIX J 
 
BLASTN Results for West Nile Virus Strains 
 
 
 
FLWN01a 
 
FLWN01a WNA 
Accession Description Max score Query coverage E value Max ident 
AY289214.1 West Nile virus strain TVP 8533  562 100% 3e-157 99% 
EU155484.1 West Nile virus strain OK03 556 100% 1e-155 99% 
EF657887.1 West Nile virus strain 3356K VP2 556 100% 1e-155 99% 
DQ983578.1 West Nile virus strain FLO3-FL2-3 556 100% 1e-155 99% 
EF530047.1 West Nile virus strain 3356.2.1.1 556 100% 1e-155 99% 
 
FLWN01a NS5 
Accession Description Max score Query coverage E value Max ident 
EF657887.1 West Nile virus strain 3356K VP2 1748 100% 0.0 98% 
EF571854.1 West Nile virus strain 385-99 1748 100% 0.0 98% 
AY848696.2 West Nile virus strain 385-99  1748 100% 0.0 98% 
AY848695.2 West Nile virus strain 385-99  1748 100% 0.0 98% 
AY848697.2 West Nile virus strain 385-99  1748 100% 0.0 98% 
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APPENDIX J: (CONTINUED) 
 
 
FLWN01b 
 
FLW01bWNA 
Accession Description Max score Query coverage E value Max ident 
DQ291155.1 West Nile virus from crow envelope protein  749 99% 0.0 99% 
EF657887.1 West Nile virus strain 3356K VP2 745 100% 0.0 99% 
DQ666451.1 West Nile virus isolate BSL13-2005 745 100% 0.0 99% 
DQ666448.1 West Nile virus isolate BSL5-2004 745 100% 0.0 99% 
DQ666472.1 West Nile virus isolate BSL6-2005  745 100% 0.0 99% 
 
FLWN01b NS5 
Accession Description Max score Query coverage E value Max ident 
DQ080072.1 West Nile virus isolate FL232  1712 99% 0.0 96% 
DQ431697.1 West Nile virus isolate 03-113FL  1707 99% 0.0 96% 
AF533540.1 West Nile virus polyprotein precursor 1707 99% 0.0 96% 
EF657887.1 West Nile virus strain 3356K VP2  1701 99% 0.0 96% 
EF571854.1 West Nile virus strain 385-99 1701 99% 0.0 96% 
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APPENDIX J: (CONTINUED) 
 
 
FLWN02a 
 
FLWN02a WNA 
Accession Description Max score Query coverage E value Max ident 
AY289214.1 West Nile virus strain TVP 8533  745 100% 0.0 99% 
DQ291155.1 West Nile virus from crow envelope  743 99% 0.0 99% 
EF657887.1 West Nile virus strain 3356K VP2 739 100% 0.0 99% 
DQ666451.1 West Nile virus isolate BSL13-2005 739 100% 0.0 99% 
DQ666448.1 West Nile virus isolate BSL5-2004 739 100% 0.0 99% 
 
FLWN02a NS5 
Accession Description Max score Query coverage E value Max ident 
EF657887.1 West Nile virus strain 3356K VP2  1844 100% 0.0 99% 
EF571854.1 West Nile virus strain 385-99 1844 100% 0.0 99% 
AY848696.2 West Nile virus strain 385-99  1844 100% 0.0 99% 
AY848695.2 West Nile virus strain 385-99  1844 100% 0.0 99% 
AY848697.2 West Nile virus strain 385-99  1844 100% 0.0 99% 
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APPENDIX J: (CONTINUED) 
 
 
FLWN02b 
 
FLWN02b WNA 
Accession Description Max score Query coverage E value Max ident 
DQ005530.1 West Nile virus isolate FDA-BSL5-2003  745 100% 0.0 99% 
AF375044.1 West Nile virus isolate WN_0247  745 100% 0.0 99% 
AF375042.1 West Nile virus isolate WN_0043  745 100% 0.0 99% 
DQ291155.1 West Nile virus from crow envelope protein  743 99% 0.0 99% 
EF657887.1 West Nile virus strain 3356K VP2  739 100% 0.0 99% 
 
FLWN02b NS5 
Accession Description Max score Query coverage E value Max ident 
DQ080072.1 West Nile virus isolate FL232  1857 100% 0.0 99% 
DQ431697.1 West Nile virus isolate 03-113FL  1851 100% 0.0 99% 
AF533540.1 West Nile virus polyprotein precursor 1851 100% 0.0 99% 
EF657887.1 West Nile virus strain 3356K VP2  1845 100% 0.0 99% 
EF571854.1 West Nile virus strain 385-99  1845 100% 0.0 99% 
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APPENDIX J: (CONTINUED) 
 
 
FLWN05a 
 
FLWN05a WNA 
Accession Description Max score Query coverage E value Max ident 
AY289214.1 West Nile virus strain TVP 8533  684 100% 0.0 99% 
EF657887.1 West Nile virus strain 3356K VP2 678 100% 0.0 99% 
DQ983578.1 West Nile virus strain FLO3-FL2-3 678 100% 0.0 99% 
EF530047.1 West Nile virus strain 3356.2.1.1 678 100% 0.0 99% 
DQ666451.1 West Nile virus isolate BSL13-2005 678 100% 0.0 99% 
 
FLWN05a NS5 
Accession Description Max score Query coverage E value Max ident 
DQ431707.1 West Nile virus isolate 04-237NM  1808 100% 0.0 98% 
DQ431706.1 West Nile virus isolate 04-236NM  1808 100% 0.0 98% 
DQ431704.1 West Nile virus isolate 04-219CO  1808 100% 0.0 98% 
DQ431702.1 West Nile virus isolate 04-216CO  1808 100% 0.0 98% 
DQ080070.1 West Nile virus isolate TVP9115  1808 100% 0.0 98% 
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APPENDIX J: (CONTINUED) 
 
 
FLWN05b 
 
FLWN05b WNA 
Accession Description Max score Query coverage E value Max ident 
DQ291155.1 West Nile virus from crow envelope protein  754 99% 0.0 100% 
EF657887.1 West Nile virus strain 3356K VP2 750 100% 0.0 99% 
DQ666451.1 West Nile virus isolate BSL13-2005 750 100% 0.0 99% 
DQ666448.1 West Nile virus isolate BSL5-2004 750 100% 0.0 99% 
DQ666472.1 West Nile virus isolate BSL6-2005  750 100% 0.0 99% 
 
FLWN05b NS5 
Accession Description Max score Query coverage E value Max ident 
DQ431705.1 West Nile virus isolate 04-233ND  1812 100% 0.0 98% 
DQ431701.1 West Nile virus isolate 04-214CO  1812 100% 0.0 98% 
DQ431694.1 West Nile virus isolate 03-22TX  1812 100% 0.0 98% 
DQ080061.1 West Nile virus isolate TWN496  1812 100% 0.0 98% 
AY646354.1 West Nile virus from USA 1812 100% 0.0 98% 
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APPENDIX J: (CONTINUED) 
 
 
FLM38 
 
FLM38 WNA 
Accession Description Max score Query coverage E value Max ident 
DQ005530.1 West Nile virus isolate FDA-BSL5-2003  745 100% 0.0 99% 
AF375044.1 West Nile virus isolate WN_0247  745 100% 0.0 99% 
AF375042.1 West Nile virus isolate WN_0043 745 100% 0.0 99% 
DQ291155.1 West Nile virus from crow envelope  743 99% 0.0 99% 
EF657887.1 West Nile virus strain 3356K VP2  739 100% 0.0 99% 
 
FLM38 NS5 
Accession Description Max score Query coverage E value Max ident 
DQ431698.1 West Nile virus isolate 03-120FL   1823 100% 0.0 98% 
DQ431705.1 West Nile virus isolate 04-233ND  1820 100% 0.0 98% 
DQ431701.1 West Nile virus isolate 04-214CO  1820 100% 0.0 98% 
DQ431694.1 West Nile virus isolate 03-22TX  1820 100% 0.0 98% 
DQ080061.1 West Nile virus isolate TWN496  1820 100% 0.0 98% 
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APPENDIX J: (CONTINUED) 
 
 
FLS502 
 
FLS502 WNA 
Accession Description Max score Query coverage E value Max ident 
DQ005530.1 West Nile virus isolate FDA-BSL5-2003 745 100% 0.0 99% 
AF375044.1 West Nile virus isolate WN_0247  745 100% 0.0 99% 
AF375042.1 West Nile virus isolate WN_0043  745 100% 0.0 99% 
DQ291155.1 West Nile virus from crow envelope protein  743 99% 0.0 99% 
EF657887.1 West Nile virus strain 3356K VP2 739 100% 0.0 99% 
 
FLS502 NS5 
Accession Description Max score Query coverage E value Max ident 
DQ431698.1 West Nile virus isolate 03-120FL  1849 100% 0.0 99% 
DQ431705.1 West Nile virus isolate 04-233ND  1845 100% 0.0 99% 
DQ431701.1 West Nile virus isolate 04-214CO  1845 100% 0.0 99% 
DQ431694.1 West Nile virus isolate 03-22TX  1845 100% 0.0 99% 
DQ080061.1 West Nile virus isolate TWN496  1845 100% 0.0 99% 
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APPENDIX J: (CONTINUED) 
 
 
FLS504 
 
 
FLS504 WNA 
Accession Description Max score Query coverage E value Max ident 
DQ005530.1 West Nile virus isolate FDA-BSL5-2003  745 100% 0.0 99% 
AF375044.1 West Nile virus isolate WN_0247  745 100% 0.0 99% 
AF375042.1 West Nile virus isolate WN_0043  745 100% 0.0 99% 
DQ291155.1 West Nile virus from crow envelope protein  743 99% 0.0 99% 
EF657887.1 West Nile virus strain 3356K VP2  739 100% 0.0 99% 
 
FLS504 NS5 
Accession Description Max score Query coverage E value Max ident 
DQ431698.1 West Nile virus isolate 03-120FL  1842 100% 0.0 99% 
DQ431705.1 West Nile virus isolate 04-233ND  1838 100% 0.0 99% 
DQ431701.1 West Nile virus isolate 04-214CO  1838 100% 0.0 99% 
DQ431694.1 West Nile virus isolate 03-22TX  1838 100% 0.0 99% 
DQ080061.1 West Nile virus isolate TWN496  1838 100% 0.0 99% 
 
      
FLS504 WNB 
Accession Description Max score Query coverage E value Max ident 
EU155484.1 West Nile virus strain OK03 501 100% 6e-139 100% 
EF657887.1 West Nile virus strain 3356K VP2 501 100% 6e-139 100% 
DQ983578.1 West Nile virus strain FLO3-FL2-3 501 100% 6e-139 100% 
EF571854.1 West Nile virus strain 385-99 501 100% 6e-139 100% 
DQ431705.1 West Nile virus isolate 04-233ND  501 100% 6e-139 100% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 553
APPENDIX J: (CONTINUED) 
 
 
FLS545 
 
FLS545 WNA 
Accession Description Max score Query coverage E value Max ident 
DQ005530.1 West Nile virus isolate FDA-BSL5-2003  734 100% 0.0 99% 
AF375044.1 West Nile virus isolate WN_0247  734 100% 0.0 99% 
AF375042.1 West Nile virus isolate WN_0043  734 100% 0.0 99% 
DQ291155.1 West Nile virus from crow envelope protein  732 99% 0.0 99% 
EF657887.1 West Nile virus strain 3356K VP2 728 100% 0.0 98% 
 
FLS545 NS5 
Accession Description Max score Query coverage E value Max ident 
DQ431698.1 West Nile virus isolate 03-120FL  1825 100% 0.0 98% 
DQ431705.1 West Nile virus isolate 04-233ND  1821 100% 0.0 98% 
DQ431701.1 West Nile virus isolate 04-214CO  1821 100% 0.0 98% 
DQ431694.1 West Nile virus isolate 03-22TX  1821 100% 0.0 98% 
DQ080061.1 West Nile virus isolate TWN496  1821 100% 0.0 98% 
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APPENDIX K 
 
BLASTN Results for Novel Flavivirus Virus Strains 
 
 
FLS649 
 
FLS649 WNA 
Accession Description Max score Query coverage E value Max ident 
AM404308.1 West Nile virus strain PTRoxo  669 100% 0.0 98% 
EU081844.1 West Nile virus strain Egypt 101 669 100% 0.0 98% 
AY944239.1 West Nile virus isolate WNI68856B  669 100% 0.0 98% 
AF260968.1 West Nile virus strain Eg101 669 100% 0.0 98% 
AF130363.1 West Nile virus strain 96-1030  664 100% 0.0 98% 
      
 
FLS649 SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158055.1 St. Louis encephalitis virus strain TBH 28  564 100% 9e-158 97% 
EF158066.1 St. Louis encephalitis virus strain GHA-3  553 100% 2e-154 97% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  553 100% 2e-154 97% 
EF158070.1 St. Louis encephalitis virus strain Parton  547 100% 9e-153 96% 
EF158065.1 St. Louis encephalitis virus strain TNM 4-711 547 100% 9e-153 96% 
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APPENDIX K: (CONTINUED) 
 
 
FLS694 
 
FLS694 WNA 
Accession Description Max score Query coverage E value Max ident 
AM404308.1 West Nile virus strain PTRoxo ete genome 725 100% 0.0 99% 
EU081844.1 West Nile virus strain Egypt 101 725 100% 0.0 99% 
AY944239.1 West Nile virus isolate WNI68856B  725 100% 0.0 99% 
AF260968.1 West Nile virus strain Eg101 725 100% 0.0 99% 
AF130363.1 West Nile virus strain 96-1030  719 100% 0.0 99% 
 
FLS694 WNB 
Accession Description Max score Query coverage E value Max ident 
EU155484.1 West Nile virus strain OK03 501 100% 6e-139 100% 
EF657887.1 West Nile virus strain 3356K VP2 501 100% 6e-139 100% 
DQ983578.1 West Nile virus strain FLO3-FL2-3  501 100% 6e-139 100% 
EF571854.1 West Nile virus strain 385-99 501 100% 6e-139 100% 
DQ431710.1 West Nile virus isolate 04-244CA  501 100% 6e-139 100% 
 
FLS694 SLEC 
Accession Description Max score Query coverage E value Max ident 
EF158066.1 St. Louis encephalitis virus strain GHA-3  628 99% 3e-177 98% 
EF158055.1 St. Louis encephalitis virus strain TBH 28  625 99% 4e-176 98% 
EF158057.1 St. Louis encephalitis virus strain 78 A 28  623 99% 2e-175 98% 
EF158059.1 St. Louis encephalitis virus strain 65 V 310  617 99% 7e-174 97% 
EF158070.1 St. Louis encephalitis virus strain Parton  612 99% 3e-172 97% 
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APPENDIX L 
 
Multiple Sequence Alignment: WNV Capsid/prM Region 
 
West Nile Virus Strains 
Capsid/prM Region: WNAE Primer Set 
 
Nucleotide Alignment 
 
#MEGA
!Title WNA ClustalW 1.6;
!Format
   DataType=Nucleotide CodeTable=Standard
   NSeqs=18 NSites=409
   Identical=. Missing=? Indel=-;
!Domain=Data property=Coding CodonStart=1;
#FLM38   TTT GTG TTG GCT CTC TTG GCG TTC TTC AGG TTC ACA GCA ATT GCT CCG  [279]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLS545  ... ... G.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLS649  --- --- --- --- --- --- --- --- --- --- --- --- --- -.. ... ...  [279]
#FLS694  --- --- --- ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#Kunjin  ... ... ... ... ... ... ... ..T ..T ... ... ..G ... ... ... ...  [279]
#MVE     ... ... ... ... ... ..A ..T ... ... ... ..T ... ... C.. ..C ...  [279]
#JE      ..C ... C.. ... ..T A.C A.. ... ... .A. ... ... ... T.A ..C ...  [279]
#Kern217 ..C A.A C.A ..C A.. C.. A.A ... ... C.A ..T ... ..T C.A CAG ..A  [279]
 
#FLM38   ACC CGA GCA GTG CTG GAT CGA TGG AGA GGT GTG AAC AAA CAA ACA GCG  [327]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLS649  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLS694  ... ... ... ... ... ... ... ... ... K.. ... ... ... ... ... ...  [327]
#FLWN01a ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ...  [327]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLWN02a ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ...  [327]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLWN05a ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ...  [327]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#Kunjin  ... ..G ... ... ... ... ... ... ... A.. ... ... ... ... ... ...  [327]
#MVE     ... AAG ..C T.. A.. AGG ..C ... .AG A.C ... ... ..G AC. ..G ..C  [327]
#JE      ... AAG ..G C.T T.A .GC ... ... .A. .CA ... G.A ..G AGT GTG ..A  [327]
#Kern217 ..T GAG ..G C.. AA. CGC A.. ... ..G .C. ... G.. ... AG. ..G ..A  [327]
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APPENDIX L: (CONTINUED) 
 
#FLM38   ATG AAA CAC CTT CTG AGT TTT AAG AAG GAA CTA GGG ACC TTG ACC AGT  [375]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLS649  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLS694  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLWN01a ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ...  [375]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLWN02a ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ...  [375]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLWN05a ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ...  [375]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#Kunjin  ... ... ..T ..C ... ... ..C ... ... ... ... ..A ... ... ... ...  [375]
#MVE     ... ... ..T ..G ACC ... ... ... ..A ... T.. ..A ..A C.. .TT GA.  [375]
#JE      ... ... ..T ... ACT ... ..C ..A CGA ... ..T ..A ..A C.C .TT GAC  [375]
#Kern217 T.. ... ... ..G AAC G.A ... ..A CGT ..C ..C ..A T.. A.. CTA GAC  [375]  
#FLM38   GCT ATC AAT CGG CGG AGC TCA AAA CAA AAG AAA AGA GGA GGA AAG ACC  [423]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLS649  ... ... ... ... ... ... ... ... ... ... W.. ... ... ... ... ...  [423]
#FLS694  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#Kunjin  ... ... ..C ... ... ... ... ... ..G ... ..G ... ... ... ... ...  [423]
#MVE     .TG G.G ..C AAA A.. G.. AA. ... ... ... ... ... ..T ..C .G. CTT  [423]
#JE      ..C G.G ..C AA. ... G.. AG. ..G ... ..C ... ... ... ... ..C .TG  [423]
#Kern217 A.C ... ..C ... ... --- C.. .GC A.G ... .G. G.. ..G ACC .GA T.G  [423]
 
#FLM38   GGA ATT GCA GTC ATG ATT GGC CTG ATC GCC AGC GTG GGA GCA GTT ACC  [471]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [471]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [471]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [471]
#FLS649  ... ... ... ... ... ... R.. T.. ... ... ... ... ... ... ... ...  [471]
#FLS694  ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ...  [471]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#FLWN01b ... .C. ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [471]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#WNEgypt ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ...  [471]
#Kunjin  ... ... ... T.. ... ... ... T.. ..T ..T G.. ... ... ... ..C ..T  [471]
#MVE     ATG C.C ATT T.. ... C.G ATT GGA T.T ... --- --- .CT ..C T.A .AG  [471]
#JE      T.G C.C ..G AG. T.. GCA .TT A.C ..A ... T.. .CA ... ..C A.G .AG  [471]
#Kern217 TTG C.C .G. T-- -.. GC. .CG ..A ..T .GA CTG .C. A.T T.. T.G CAG  [471]
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APPENDIX L: (CONTINUED) 
 
#FLM38   CTC TCT AAC TTT CAA GGG AAG GTG ATG ATG ACG GTA AAT GCT ACT GAC  [519]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLS649  ... ... ... ..C ... ... ... ... ... ... ..T ... ... ..C ... ...  [519]
#FLS694  ... ... ... ..C ... ... ... ... ... ... ..T ... ... ..C ... ...  [519]
#FLWN01a ... ... ... ..C ... ... ... ... ... ... ... ... .R. ... ... ...  [519]
#FLWN01b ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLWN02a ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLWN05a ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLWN05b ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#WNNY99  ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#WNEgypt ... ... ... ..C ... ... ... ... ... ... ..T ... ... ..C ... ...  [519]
#Kunjin  ... ..C ... ... ... ... ... ... ... ... ... ..G ..C ... ... ...  [519]
#MVE     ..T ..C .C. ..C ..G ..C ... A.A ... ... ..T ..G ..C ... ..G ...  [519]
#JE      T.G ..A ..T ..C ..G ... ... C.T T.. ... ..C ..C ..C AA. ..G ..T  [519]
#Kern217 T.A ..A .C. .A. ..G ... ..A ... T.A ... T.A A.C ..C AAG ... ...  [519]
 
#FLM38   GTC ACA GAT GTC ATC ACG ATT CCA ACA GCT GCT GGA AAG AAC CTA TGC  [567]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLS649  ... ... ..C ... ... ... ... ... ... ... ... ... ... M.T ... ...  [567]
#FLS694  ... ... ..C ... ... ... ... ... ... ... ... ... ... ..T ... ...  [567]
#FLWN01a ... ... ... ... ... ... ..- --- --- --- --- --- --- --- --- ---  [567]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#WNEgypt ... ... ..C ... ... ... ... ... ... ... ... ... ... ..T ... ...  [567]
#Kunjin  ... ... ..C A.T ... ... ..A ... ..G ..C ... ... ... ... ..G ...  [567]
#MVE     A.T G.T ... ..G ... G.C ... ... ..C C.G AAG ... CCC ..T .A. ...  [567]
#JE      A.T G.. ..C ..T ... GT. ... ..C ..C T.A AAA ... G.. ... AG. ..T  [567]
#Kern217 .CT CA. AGC .C. ..A .AC ... ..T .GT ..C AAC ... GCA ... ACT ...  [567]  
#FLM38   ATT GTC AGA GCA ATG GAT GTG GGA TAC ATG TGC GAT GAT ACT ATC ACT  [615]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLS545  ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ...  [615]
#FLS649  ... ... ... ... ... ..C ... .KG ... ... ..T ... ... ... ... ..C  [615]
#FLS694  ... ... ... ... ... ..C ... ..G ... ... ..T ... ... ... ... ..C  [615]
#FLWN01a --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---  [615]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... .-- --- --- ---  [615]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#WNEgypt ... ... ... ... ... ..C ... ..G ... ... ..T ... ... ... ... ..C  [615]
#Kunjin  ... ... ... ..T ... ... ... ..G C.. ... ..T ... ... ... ... ..C  [615]
#MVE     TGG A.T C.. ..C ..T ..C A.T ... .TT ... ..T ... ..C ..C ... ...  [615]
#JE      TGG ... C.G ... ..C ..C ..C ..C ..T ... ..T ..G ..C ... ... ..G  [615]
#Kern217 ... ..G ..G ..T C.A ... ... ..G GT. ... ... A.A ... GAC ... ..A  [615]  
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APPENDIX L: (CONTINUED) 
 
#FLM38   TAT GAA TGT CCA GTG CTG TCG GCT G [640]
#FLS502  ... ... ... ... ... ... ... ... . [640]
#FLS504  ... ... ... ... ... ... ... ... . [640]
#FLS545  ... ... ... ... ... ... ... ... . [640]
#FLS649  ... ... ... ... ... ... ... .-- - [640]
#FLS694  ... A.. ... ... ... ... ... --- - [640]
#FLWN01a --- --- --- --- --- --- --- --- - [640]
#FLWN01b ... ... ... ... ... ... ... ... . [640]
#FLWN02a ... ... ... ... ... ... ... ... . [640]
#FLWN02b ... ... ... ... ... ... ... ... . [640]
#FLWN05a --- --- --- --- --- --- --- --- - [640]
#FLWN05b ... ... ... ... ... ... ... ... . [640]
#WNNY99  ... ... ..C ... ..A ... ... ... . [640]
#WNEgypt ... ... ... ... ... ... ... ... . [640]
#Kunjin  ... ... ... ... ... T.. ... ..C . [640]
#MVE     ... ... ..C ..G AAA T.. GAA AG. . [640]
#JE      ..C ... ... ..T AA. ..C A.C ATG . [640]
#Kern217 ..C CTG ..C ... ... ..T ..A ..G . [640]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 560
APPENDIX L: (CONTINUED) 
 
West Nile Virus Strains 
Capsid/prM Region: WNAE Primer Set 
 
Amino Acid Alignment 
 
!Domain=Data;
#FLM38   FVLALLAFFR FTAIAPTRAV LDRWRGVNKQ TAMKHLLSFK KELGTLTSAI  [128]
#FLS502  .......... .......... .......... .......... ..........  [128]
#FLS504  .......... .......... .......... .......... ..........  [128]
#FLS545  ..V....... .......... .......... .......... ..........  [128]
#FLS649  ---------- ----...... .......... .......... ..........  [128]
#FLS694  ---....... .......... .....?.... .......... ..........  [128]
#FLWN01a .......... .......... .......... .......... ..........  [128]
#FLWN01b .......... .......... .......... .......... ..........  [128]
#FLWN02a .......... .......... .......... .......... ..........  [128]
#FLWN02b .......... .......... .......... .......... ..........  [128]
#FLWN05a .......... .......... .......... .......... ..........  [128]
#FLWN05b .......... .......... .......... .......... ..........  [128]
#WNNY99  .......... .......... .......... .......... ..........  [128]
#WNEgypt .......... .......... .......... .......... ..........  [128]
#Kunjin  .......... .......... .....S.... .......... ..........  [128]
#MVE     .......... ...L...K.L MR..KS...T ......T... ......IDVV  [128]
#JE      .....IT..K ...L...K.L .G..KA.E.S V.....T... R.....ID.V  [128]
#Kern217 .I..I.T... ...LQ..E.L KR...A.D.R ..L...NG.. RD..SMLDT.  [128]  
#FLM38   NRRSSKQKKR GGKTGIAVMI GLIASVGAVT LSNFQGKVMM TVNATDVTDV  [178]
#FLS502  .......... .......... .......... .......... ..........  [178]
#FLS504  .......... .......... .......... .......... ..........  [178]
#FLS545  .......... .......... .......... .......... ..........  [178]
#FLS649  ........?. .......... ?......... .......... ..........  [178]
#FLS694  .......... .......... .......... .......... ..........  [178]
#FLWN01a .......... .......... .......... .......... ..?.......  [178]
#FLWN01b .......... .....T.... .......... .......... ..........  [178]
#FLWN02a .......... .......... .......... .......... ..........  [178]
#FLWN02b .......... .......... .......... .......... ..........  [178]
#FLWN05a .......... .......... .......... .......... ..........  [178]
#FLWN05b .......... .......... .......... .......... ..........  [178]
#WNNY99  .......... .......... .......... .......... ..........  [178]
#WNEgypt .......... .......... .......... .......... ..........  [178]
#Kunjin  .......... .......F.. ....G..... .......... .........I  [178]
#MVE     .K.GK..... ..RLMLIF.L IGF.--A.LK ..T....I.. ......IA..  [178]
#JE      .K.GR..N.. ..NMWL.SLA VI..CA..MK .......LL. ...N..IA..  [178]
#Kern217 ...-PSK.RG .TRSLLG--A A..GLASSLQ ..TY....L. SI.K..AQSA  [178]
#FLM38   ITIPTAAGKN LCIVRAMDVG YMCDDTITYE CPVLSA [214]
#FLS502  .......... .......... .......... ...... [214]
#FLS504  .......... .......... .......... ...... [214]
#FLS545  .......... .......... .......... ...... [214]
#FLS649  .........? .........? .......... .....- [214]
#FLS694  .......... .......... .........K .....- [214]
#FLWN01a ..-------- ---------- ---------- ------ [214]
#FLWN01b .......... .......... .......... ...... [214]
#FLWN02a .......... .......... .......... ...... [214]
#FLWN02b .......... .......... .......... ...... [214]
#FLWN05a .......... .......... ....------ ------ [214]
#FLWN05b .......... .......... .......... ...... [214]
#WNNY99  .......... .......... .......... ...... [214]
#WNEgypt .......... .......... .......... ...... [214]
#Kunjin  .......... .......... H......... ...... [214]
#MVE     .A...PK.P. Q.WI..I.I. F......... ..K.ES [214]
#JE      .V...SK.E. R.W...I... ...E...... ..K.TM [214]
#Kern217 .N..S.N.A. T.....L... V..K.D...L ...... [214]  
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APPENDIX M 
 
Multiple Sequence Alignment: WNV NS5 (3’) Region 
 
West Nile Virus Strains 
NS5 (3’): WNBE Primer Set 
 
Nucleotide Alignment 
 
#MEGA
!Title WNB ClustalW 1.6;
!Format
   DataType=Nucleotide CodeTable=Standard
   NSeqs=9 NSites=271
   Identical=. Missing=? Indel=-;
!Domain=Data property=Coding CodonStart=1;
#FLS694    ACC TAC GCC CTA AAC ACT TTC ACC AAC CTG GCC GTC CAG CTG GTG AGG [9553]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9553]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9553]
#WNEgypt   ... ... ..T ... ... ..C ... ... ... ... ... ... ... T.. ... ... [9553]
#WNTX02    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9553]
#WNFL03    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9553]
#WNMexico  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9553]
#WNHungary ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9553]
#Kern217   ..A ..T ... ..G ... ..C ... ... ... ... ... ..T ..A ... A.A ..A [9553]
#FLS694    ATG ATG GAA GGG GAA GGA GTG ATT GGC CCA GAT GAT GTG GAG AAA CTC [9601]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9601]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9601]
#WNEgypt   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9601]
#WNTX02    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9601]
#WNFL03    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9601]
#WNMexico  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9601]
#WNHungary ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9601]
#Kern217   TGC ... ..G .CT ... ..G ... G.A .AT GAG ... ..C A.T AC. .G. G.G [9601]
#FLS694    ACA AAA GGG AAA GGA CCC AAA GTC AGG ACC TGG CTG TTT GAG AAT GGG [9649]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9649]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9649]
#WNEgypt   ... ..G ..A ... ... ..T ... ... ... ... ... ... ... ... ... ... [9649]
#WNTX02    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9649]
#WNFL03    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9649]
#WNMexico  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9649]
#WNHungary ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9649]
#Kern217   .G. CTT ..A CGG TTG G.. ... .CG GTC GAG ... ... AGG A.. ... ..A [9649]  
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#FLS694    GAA GAA AGA CTC AGC CGC ATG GCT GTC AGT GGA GAT GAC TGT GTG GTA [9697]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9697]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9697]
#WNEgypt   ..G ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... [9697]
#WNTX02    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9697]
#WNFL03    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9697]
#WNMexico  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9697]
#WNHungary ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... [9697]
#Kern217   CCT ... C.. T.G ... A.A ... ..A ..G ... ..G ..C ... ... ..T ..G [9697]  
#FLS694    AAG CCC CTG GAC GAT CGC TTT GCC ACC TCG CTC CAC TTC CTC AAT GCT [9745]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9745]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9745]
#WNEgypt   ... ... ..A ..T ..C ... ..C ... ... ..T ... ... ... ... ..C ..C [9745]
#WNTX02    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9745]
#WNFL03    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9745]
#WNMexico  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9745]
#WNHungary ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... [9745]
#Kern217   ..A ..A A.T ..T ..C A.A ... ... ..T G.A ... ... ..T ... ..C AAC [9745]
#FLS694    ATG TCA AAG GTT CGC AAA GAC ATC CAA GAG T [9776]
#FLS504    ... ... ... ... ... ... ... ... ... ..- - [9776]
#WNNY99    ... ... ... ... ... ... ... ... ... ... . [9776]
#WNEgypt   ... ... ... ... ... ... ..T ... ..G ... . [9776]
#WNTX02    ... ... ... ... ... ... ... ... ... ... . [9776]
#WNFL03    ... ... ... ... ... ... ... ... ... ... . [9776]
#WNMexico  ... ... ... ... ... ... ... ... ... ... . [9776]
#WNHungary ... ... ... ... ... ... ... ... ... ... . [9776]
#Kern217   ... ... ... A.C A.A ..G ... ..T ..G ... . [9776]
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West Nile Virus Strains 
NS5 (3’): WNBE Primer Set 
 
Amino Acid Alignment 
 
#MEGA
!Title Translated WNB ClustalW 1.6;
!Format
   DataType=Protein
   NSeqs=9 NSites=90
   Identical=. Missing=? Indel=-;
!Domain=Data;
#FLS694    TYALNTFTNL AVQLVRMMEG EGVIGPDDVE KLTKGKGPKV RTWLFENGEE  [3219]
#FLS504    .......... .......... .......... .......... ..........  [3219]
#WNNY99    .......... .......... .......... .......... ..........  [3219]
#WNEgypt   .......... .......... .......... .......... ..........  [3219]
#WNTX02    .......... .......... .......... .......... ..........  [3219]
#WNFL03    .......... .......... .......... .......... ..........  [3219]
#WNMexico  .......... .......... .......... .......... ..........  [3219]
#WNHungary .......... .......... .......... .......... ..........  [3219]
#Kern217   .......... ....I.C..A ...VDE..IT RVRL.RLA.A VE..RK..P.  [3219]
#FLS694    RLSRMAVSGD DCVVKPLDDR FATSLHFLNA MSKVRKDIQE  [3259]
#FLS504    .......... .......... .......... .........-  [3259]
#WNNY99    .......... .......... .......... ..........  [3259]
#WNEgypt   .......... .......... .......... ..........  [3259]
#WNTX02    .......... .......... .......... ..........  [3259]
#WNFL03    .......... .......... .......... ..........  [3259]
#WNMexico  .......... .......... .......... ..........  [3259]
#WNHungary .......... .......... .......... ..........  [3259]
#Kern217   .......... ......I... ...A.....N ...I......  [3259]
 
 
 
 
 
 
 
 
 
  
 564
APPENDIX N 
 
Multiple Sequence Alignments: SLEV Envelope Region 
 
St. Louis Encephalitis Virus Strains 
Envelope Region: F880/B2586 Primer Set 
 
Nucleotide Alignment 
#MEGA
!Title Envelope ClustalW 1.6;
!Format
   DataType=Nucleotide CodeTable=Standard
   NSeqs=19 NSites=1633
   Identical=. Missing=? Indel=-;
!Domain=Data property=Coding CodonStart=1;
#FL52    AGA GTG GTC TTT GTG ATC ATG CTG ATG CTG ATT GCT CCG GCA TAC AGC  [ 963]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL72    ... .K. T.. ... ... ... ... ... ... T.. ... ..C ..A ... ... ...  [ 963]
#FL85a   ... ... T.. ... ... ... ... ... ... ... ..G ... ... ... ... ...  [ 963]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... .S. ... ...  [ 963]
#FL89    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL90b   --- --- --- ... ..S ... ... ... ... ... ..G ... ... ... ... ...  [ 963]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL90d   ... ... T.. ... ... ... ... ... ... ... ..G ... ... ... ... ...  [ 963]
#FLS569  ... ... ... ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#FLS650  ... ... ... ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#TR58    ... ... ... ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#TR62    ... ... ... ... ... ... ... ... ... A.. ..G ..C ... K.. ... ...  [ 963]
#BR64    ... ... ... ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#BR69    ... ... ... ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#Kern217 ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#WNNY99  ... ..T ..G ... ..C G.G C.A T.. C.T T.. G.G ..C ..A ..T ... ...  [ 963]
#WNEgypt C.. ..T ..G ..C ..T G.G C.A ... C.C T.. G.G ... ..A ..C ... ...  [ 963]
 
#FL52    TTC AAC TGT TTG GGA ACA TCA AAC AGG GAC TTT GTC GAG GGA ACC AGC  [1011]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ...  [1011]
#FL72    ..T ..T ... C.. ... ... ... ... ... ... ..C ... ..A ..G G.. ...  [1011]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ...  [1011]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ...  [1011]
#FL89    ... ..T ... ... ... ... ... ... ... ... ... ... ... ..R G.. ...  [1011]
#FL90a   ... ..T ... ... ... ... ... ... ... ... ... ... ... ... G.. ...  [1011]
#FL90b   ... ..T ... ... ... ... ... ... ... R.. ... ... ... ... G.. ...  [1011]
#FL90c   ... ..T ... ... ... ... ... ... ... ... ... ... ... ... G.. ...  [1011]
#FL90d   ... ..T ... ... ... ... ... ... ... ... ... ... ... ... G.. ...  [1011]
#FLS569  ... ..T ... ... ... ... ... ... ... ..T ..C ..T ..A ..G G.. ...  [1011]
#FLS650  ... ..T ... ... ... ... ... ... ... ..T ..C ..T ..A ..G G.. ...  [1011]
#TR58    ..T ..T ... C.. ... ... ... ... ... ... ..C ... ..A ..G G.. ...  [1011]
#TR62    ..T ..T ... C.. ... ... ... ... ... ... ..C ... A.R ..G G.. ...  [1011]
#BR64    ..T ..T ... ... ... ... ... ... ... ... ..C ... ..A ..G G.. ..T  [1011]
#BR69    ..T ..T ... C.A ... ... ... ... ... ... ..C ... A.A ..G G.. ...  [1011]
#Kern217 ... ... ... C.. ... ... ... ... ... ... ... ... ... ... G.. ..T  [1011]
#WNNY99  ... ... ..C C.T ... .TG AGC ... ..A ... ..C T.G ..A ... GTG TCT  [1011]
#WNEgypt ..T ... ..C C.T ... .TG AGC ... ..A ... ..C T.A ... ... GTG TCT  [1011]
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#FL52    GGG GCA ACA TGG ATT GAC TTG GTA CTT GAA GGG GGA AGC TGT GTT ACA  [1059]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1059]
#FL72    ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ..C ...  [1059]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1059]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1059]
#FL89    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ...  [1059]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ...  [1059]
#FL90b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ...  [1059]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ...  [1059]
#FL90d   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ...  [1059]
#FLS569  ... ... ... ... ..C ... ... ... ... ... ..A ... ... ... ..C ...  [1059]
#FLS650  ... ... ... ... ..C ... ... ... ... ... ..A ... ... ... ..C ...  [1059]
#TR58    ... ... ... ... ... ..T ... ... ... ... ..A ... ... ... ..C ...  [1059]
#TR62    ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ..C ...  [1059]
#BR64    ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ..C ...  [1059]
#BR69    ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ..C ...  [1059]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1059]
#WNNY99  ..A ... ... ... G.G ..T ... ..T ..C ... ..C .AC ... ..C ..G ..T  [1059]
#WNEgypt ..A ... ... ... G.G ..T ... ..T ..C ... ..C .AC ... ... ..G ..C  [1059]
 
#FL52    GTG ATG GCA CCA GAG AAA CCA ACA CTG GAC TTC AAA GTG ACG AAG ATG  [1107]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... .T. ... ...  [1107]
#FL72    ... ... ... ... ... ... ... ... T.. ... ... ... ... .T. ... ...  [1107]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... .T. ... ...  [1107]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... .T. ... ...  [1107]
#FL89    ... ... ... ... ... ... ... ... ... ... ..T ... ... .T. ... ...  [1107]
#FL90a   ... ... ..G ... ... ... ... ... ... ... ..T ... ... .T. ... ...  [1107]
#FL90b   ... ... ... ... ... ... ... ... ... ... ..T ... ... .T. ... ...  [1107]
#FL90c   ... ... ..G ... ... ... ... ... ... ... ..T ... ... .T. ... ...  [1107]
#FL90d   ... ... ..G ... ... ... ... ... ... ... ..T ... ... .T. ... ...  [1107]
#FLS569  ... ... ... ... ... ... ... ... T.A ... ... ... ..A .T. ... ...  [1107]
#FLS650  ... ... ... ... ... ... ... ... T.. ... ... ... ..A .T. ... ...  [1107]
#TR58    ... ... ... ... ... ... ... ... T.. ... ... ... ... .T. ... ...  [1107]
#TR62    ..A ... ... ... ... ... ... ... T.. ... ... ... ... .T. ... ...  [1107]
#BR64    ... ... ... ... ... ... ... ... T.. ... ... ... ... .T. ... ...  [1107]
#BR69    ... ... ... ... ... ... ... ... T.. ... ... ... ... .T. ... ...  [1107]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ..G ... .T. ... ...  [1107]
#WNNY99  A.C ... T.T AAG ..C ..G ..T ..C A.C ..T G.G ..G A.. .T. ..T ...  [1107]
#WNEgypt A.C ... T.T AAG ..C ..G ..T ..C A.C ..T G.G ..G A.. .T. ..T ...  [1107]
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#FL52    GAG GCT ACC GAG TTA GCC ACT GTG CGT GAG TAT TGT TAC AAA GCA ACC  [1155]
#TBH-28  ... ... ... ... ... ... ... ... ... A.. ... ... ..T G.. ... ...  [1155]
#FL72    ... ..C ..G ... ... ..T ..C ... ... ... ... ..C ... G.. ... ...  [1155]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ...  [1155]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ...  [1155]
#FL89    ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ...  [1155]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ...  [1155]
#FL90b   ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ...  [1155]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ...  [1155]
#FL90d   ... ... ... ... ... ... ... ... ... ... ... ... ... R.. ... ...  [1155]
#FLS569  ... ..C ..G ... ... ..T ... ... ... ... ... ..C ... G.. ... ...  [1155]
#FLS650  ... ..C ..G ... ... ..T ... ... ... ... ... ..C ... G.. ... ...  [1155]
#TR58    ... ..C ..G ... ... ..T ... ... ... ... ..C ..C ... G.. ... ...  [1155]
#TR62    ... ... ..G ... ... ..T ... ... ... ... ... ..C ... R.. ... ...  [1155]
#BR64    ... ..C ..G ... ... ..T ... ... ... ... ... ..C ... G.. ... ...  [1155]
#BR69    ... ..C ..G ... ..G ..T ... ... ..C ... ... ..C ... ... ... ...  [1155]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ...  [1155]
#WNNY99  ... ..G G.. A.C C.G ..A GAG ..C ..C AGT ... ..C ..T TTG ..T ...  [1155]
#WNEgypt ... ..C G.. A.C C.G ..A GAG ..C ..C AGT ... ..C ..T CTG ..C ...  [1155]
 
#FL52    TTG GAC ACG CTG TCA ACA GTG GCA AGA TGC CCC ACA ACA GGA GAG GCG  [1203]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T  [1203]
#FL72    ... ... ... ... ... ... ... ... ... ..T ... ... ..G ... ..A ..C  [1203]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T  [1203]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T  [1203]
#FL89    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T  [1203]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T  [1203]
#FL90b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T  [1203]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T  [1203]
#FL90d   ... ... ... ... ... ... ... ... ... ... ... ..M ... ... ..A ..T  [1203]
#FLS569  ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ..T  [1203]
#FLS650  ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ..T  [1203]
#TR58    ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ..T  [1203]
#TR62    ... ... ... ... ..G ... ... ... ... ..T ... ... ... ... ..A ..T  [1203]
#BR64    ... ... ..A ... ... ... ... ... ... ..T ... ... ..G ... ..A ..T  [1203]
#BR69    ... ... ... ... ... ... ... ... ... ..T ... ... ..G ... ..A ..T  [1203]
#Kern217 ... ... ... ... ... ... ... ... ..G ... ..T ... ... ... ... ..T  [1203]
#WNNY99  G.C AG. GAT ..C ..C ..C AAA ..T GCG ... ..G ..C .TG ... ..A ..T  [1203]
#WNEgypt G.C AG. GAT ..C ..C ..C AAA ..T GCG ... ..G ..T .TG ... ..A ..T  [1203]
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#FL52    CAC AAC ACC AGA AGG AGT GAC CCA ACA TTT GTC TGC AAA AGA GAT GTT  [1251]
#TBH-28  ... ... ... .A. ... ... ... ... ... ... ... ... ... ... ... ...  [1251]
#FL72    ... ... ... .AG ... ... ... ... ... ..C ... ... ... ... ... ...  [1251]
#FL85a   ... ... ... .A. ... ... ... ... ... ... ... ... ... ... ... ...  [1251]
#FL85b   ... ... ... .A. ... ... ... ... ... ... ... ... ... ... ... ...  [1251]
#FL89    ... ... ... .A. ... ... ... ... ... ... ... ..T ... ... ... ...  [1251]
#FL90a   ... ... ... .A. ... ... ... ... ... ... ... ..T ... ... ... ...  [1251]
#FL90b   ... ... ... .A. ... ... ... ... ... ... ... ..T ... ... ... ...  [1251]
#FL90c   ... ... ... .A. ... ... ... ... ... ... ... ..T ... ... ... ...  [1251]
#FL90d   ... ... ... .A. ... ... ... ... ... ... ... ..T ... ... ... ...  [1251]
#FLS569  ... ... ... .AG ... ... ... ... ... ... ... ... ... ... ... ...  [1251]
#FLS650  ... ... ... .AG ... ... ... ... ... ... ... ... ... ... ... ...  [1251]
#TR58    ... ... ... .AG ... ... ... ... ... ..C ... ... ... ... ... ...  [1251]
#TR62    ... ... ... .AG ... ... ..T ... ... ..Y ... ... ... ... ... ...  [1251]
#BR64    ... ... ... .AG ... ... ... ... ... ..C ... ... ... ... ... ...  [1251]
#BR69    ... ... ... .AG ... ... ... ... ... ... ... ... ... ... ... ...  [1251]
#Kern217 ... ... ... .A. ... ... ... ... ... ... ... ... ... ... ... ...  [1251]
#WNNY99  ... ..T GA. .A. C.T GC. ... ... G.T ... ..G ... .G. CA. .GA ..G  [1251]
#WNEgypt ... ..T GA. .A. C.T GC. ... ... G.T ... ..G ..T ... CA. .GA ..A  [1251]
 
#FL52    GTA GAC CGC GGA TGG GGC AAC GGA TGT GGT CTG TTT GGA AAA GGG AGC  [1299]
#TBH-28  ..G ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ...  [1299]
#FL72    ... ... ..T ... ... ..T ... ... ... ... ... ... ... ... ..A ...  [1299]
#FL85a   ..G ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ...  [1299]
#FL85b   ..G ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ...  [1299]
#FL89    ..G ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ...  [1299]
#FL90a   ..G ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ...  [1299]
#FL90b   ..G ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ...  [1299]
#FL90c   ..G ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ...  [1299]
#FL90d   ..G ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ...  [1299]
#FLS569  ..G ... ..T ... ... ... ... ... ... ..C ... ... ... ... ..A ...  [1299]
#FLS650  ..G ... ..T ... ... ... ... ... ... ..C ... ... ... ... ..A ...  [1299]
#TR58    ..G ..T ..T ... ... ... ... ... ... ... ... ... ... ... ..A ...  [1299]
#TR62    ..G ... ..T ... ... ..T ... ... ... ... ... ... ... ..G ..A ...  [1299]
#BR64    ..G ... ..T ... ... ..T ... ... ... ... ... ... ... ... ..A ...  [1299]
#BR69    ..G ... ..T ... ... ..T ... ... ... ... ... ... ... ... ..A ...  [1299]
#Kern217 ..G ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ...  [1299]
#WNNY99  ..G ... A.G ..C ... ... ... ..C ..C ..A ..A ... ..C ... ..A ...  [1299]
#WNEgypt ..G ... A.G ..T ... ... ... ..C ... ..A ..A ... ..T ... ..A ...  [1299]
#FL52 ATT GAC ACA TGC GCA AAG TTC ACA TGC AAA AAC AAG GCA ACA GGG AAG [1347]   
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#FL52    ATT GAC ACA TGC GCA AAG TTC ACA TGC AAA AAC AAG GCA ACA GGG AAG  [1347]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1347]
#FL72    ... ... ... ... ..G ... ..T .T. ... ..G ... ... ... ... ... ...  [1347]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1347]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1347]
#FL89    ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [1347]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [1347]
#FL90b   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [1347]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [1347]
#FL90d   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [1347]
#FLS569  ... ... ... ... ..G ... ... ... ... ..G ... ... ... ... ... ...  [1347]
#FLS650  ... ... ... ... ..G ... ... ... ... ..G ... ... ... ... ... ...  [1347]
#TR58    ... ... ... ... ..G ... ..T ... ... ..G ... ... ... ... ... ...  [1347]
#TR62    ... ... ... ... ..G ... ..T ... ... ..G ... ... ... ... ... ...  [1347]
#BR64    ... ... ... ... ..G ... ... ... ... ..G ... ... ... ... ... ...  [1347]
#BR69    ... ... ... ... ..G ... ... ... ... ..G .G. ... ... ... ... ...  [1347]
#Kern217 ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ...  [1347]
#WNNY99  ... ... ... ... ..C ..A ..T G.C ... TCT .C. ... ... .T. ..A .GA  [1347]
#WNEgypt ... ... ... ... ..C ..A ..T G.C ..T TCT .C. ... ... ... ..A .GA  [1347]
 
#FL52    ACA ATC TTG AGA GAA AAC ATC AAG TAC GAG GTT GCA ATT TCT GTG CAT  [1395]
#TBH-28  ..G ... ... ... ... ... ... ... ..T ... ... ... ..C .T. ... ...  [1395]
#FL72    ... ... C.. ..G ... ... ... ... ... ... ..C ... ... .T. ... ...  [1395]
#FL85a   ..G ... ... ... ... ... ... ... ..T ... ... ... ..C .T. ... ...  [1395]
#FL85b   ..G ... ... ... ... ... ... ... ..T ... ... ... ..C .T. ... ...  [1395]
#FL89    ... ... ... ... ... ... ... ... ... ... ..C ... ... .T. ... ...  [1395]
#FL90a   ... ... ... ... ... ... ... ... ... ... ..C ... ... .T. ... ...  [1395]
#FL90b   ... ... ... ... ... ... ... ... ... ... ..C ... ... .T. ... ...  [1395]
#FL90c   ... ... ... ... ... ... ... ... ... ... ..C ... ... .T. ... ...  [1395]
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#TR62    ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ...  [2019]
#BR64    ... ... ... ... ... ... ..A ... ... ... ... ... ... ..G ... ...  [2019]
#BR69    ... ... ... ... ... ... ..A ... ... ... ... ... ... ..G ... ...  [2019]
#Kern217 ..A ... ... ..C ... ... ... ... ... ... ... ..T ... ... ... ...  [2019]
#WNNY99  AAA ... ..T ..C ..G TCA GTG ..T TCA T.G .AC ... C.A ..G ..A ..G  [2019]
#WNEgypt AAA ... ... ..C ..G TCA GTG ..T TCA T.G .AC ... C.A ..G ..A ..G  [2019]  
#FL52    GGA AGA TTG GTC ACG GTC AAT CCC CTT ATA AGC ACA GGG GGA GCG AAC  [2067]
#TBH-28  ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#FL72    ... ... ... ..T ... ... ... ... T.. ... ... ..G ... ... ... ...  [2067]
#FL85a   ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#FL85b   ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#FL89    ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#FL90a   ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#FL90b   ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#FL90c   ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#FL90d   ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#FLS569  ... ... ... ..T ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#FLS650  ... ... ... ..T ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#TR58    ... ... ... ..T ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#TR62    ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#BR64    ... ... ... ..T ... ... ... ... T.. ... ... ... ... ... ... ...  [2067]
#BR69    ... ... ... ..T ... ... ... ... T.C ... ... ... ... ... ... ...  [2067]
#Kern217 ... ... C.. ... ... ... ... ..T T.. ... ... ... ... ... ... ...  [2067]
#WNNY99  ..C ... ... ... ..T ... ..C ..T T.. G.T TCA GTG .CC ACG ..C ...  [2067]
#WNEgypt ..C ..G ... ... ..T ... ..C ... T.. G.T TCA GT. .CC ACG ..C ..T  [2067]
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APPENDIX N: (CONTINUED) 
 
#FL52    AAC AAG GTC ATG ATT GAA GTT GAA CCA CCC TTC GGC GAT TCT TAC ATC  [2115]
#TBH-28  ... ... ... ... ..C ... ... ... ... ..T ... ... ... ... ... ...  [2115]
#FL72    ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ...  [2115]
#FL85a   ... ... ... ... ..C ... ..C ... ... ... ... ... ..C ... ..T ...  [2115]
#FL85b   ... ... ... ... ..C ... ..C ... ... ... ... ... ..C ... ..T ...  [2115]
#FL89    ... ... ..T ... ..C ... ... ... ... ... ... ... ... ... ... ...  [2115]
#FL90a   ... ... ..T ... ..C ... ... ... ... ... ... ... ... ... ... ...  [2115]
#FL90b   ... ... ..T ... ..C ... ... ... ... ... ... ... ... ... ... ...  [2115]
#FL90c   ... ... ..T ... ..C ... ... ... ... ... ... ... ... ... ... ...  [2115]
#FL90d   ... ... ..T ... ..C ... ... ... ... ... ... ... ... ... ... ...  [2115]
#FLS569  ... ... ... ... ..C ... ... ... ... ... ... ..T ..C ... ... ...  [2115]
#FLS650  ... ... ... ... ..C ... ... ... ... ... ... ..T ..C ... ... ...  [2115]
#TR58    ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ...  [2115]
#TR62    ... ... ... ... ..C ... ... ... ... ..T ... ... ... ... ... ...  [2115]
#BR64    ... ... ... ... ..C ... ..C ... ... ... ... ... ... ... ... ...  [2115]
#BR69    ... ... ... ... ..C ... ..C ... ... ... ... ... ... ... ... ...  [2115]
#Kern217 ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ...  [2115]
#WNNY99  GCT ... ... C.. ... ... T.G ... ... ... ..T ..A ..C ..A ... ..A  [2115]
#WNEgypt GC. ... ... C.. ... ... T.G ... ... ... ..T ..A ..C ..A ... ..A  [2115]
 
#FL52    GTC GTC GGA AGA GGC ACC GCC CAG ATT AAC TAC CAC TGG CAC AAA GGG  [2163]
#TBH-28  ... ... ... ... ... ... A.. ... ... ... ... ... ... ..T ... .A.  [2163]
#FL72    ... ... ... ... ..T ... A.. ..A ..C ... ... ... ... ... ... .A.  [2163]
#FL85a   ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... .A.  [2163]
#FL85b   ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... .A.  [2163]
#FL89    ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... .AA  [2163]
#FL90a   ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... .AA  [2163]
#FL90b   ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... .AA  [2163]
#FL90c   ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... .AA  [2163]
#FL90d   ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... .AA  [2163]
#FLS569  ... ... ... ... ... ... A.. ..A ..C ... ... ... ... ... ... .A.  [2163]
#FLS650  ... ... ... ... ... ... A.. ..A ..C ... ... ... ... ... ... .A.  [2163]
#TR58    ... ... ... ... ... ... A.. ..A ..C ... ... ... ... ... ... .A.  [2163]
#TR62    ... ... ... ... ..T ... A.. ..A ..C ... ... ... ... ... ... .A.  [2163]
#BR64    ... ... ... ... ... ... A.. ..A ..C ..T ... ... ... ... ... .A.  [2163]
#BR69    ... ... ... ... ... ... A.. ..A ..C ... ... ... ... ... ... .A.  [2163]
#Kern217 ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... .AA  [2163]
#WNNY99  ..G ..G ..C ... ..A GAA CAA ... ..C ..T C.. ..T ... ... ..G TCT  [2163]
#WNEgypt ..G ..G ..C ... ..A GAA CAA ... ... ..T C.. ..T ... ... ..G TCT  [2163]
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APPENDIX N: (CONTINUED) 
 
#FL52    GGA AGC AGC ATT GGG AAG GCT TTG GCG ACC ACA TGG AAA GGA GCC CAA  [2211]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [2211]
#FL72    ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ...  [2211]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [2211]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [2211]
#FL89    ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ...  [2211]
#FL90a   ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ...  [2211]
#FL90b   ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ...  [2211]
#FL90c   ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ...  [2211]
#FL90d   ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ...  [2211]
#FLS569  ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ...  [2211]
#FLS650  ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ...  [2211]
#TR58    ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ...  [2211]
#TR62    ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ...  [2211]
#BR64    ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ...  [2211]
#BR69    ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ...  [2211]
#Kern217 ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ...  [2211]
#WNNY99  ... ... ... ... ..C ..A ..C ..T A.A ... ..C CTC ... ... ..G ..G  [2211]
#WNEgypt ... ... ... ... ..C ..A ..C ..C A.A ... ..C CTC ... ..G ..G ..G  [2211]  
 
#FL52    CGG CTA GCC GTC TTA GGG GAT ACA GCG TGG GAC TTT GGA TCT GTT GGA  [2259]
#TBH-28  ... ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ...  [2259]
#FL72    ... ... ... ... ..G ... ..C ... ... ... ... ..C ... ..C A.. ...  [2259]
#FL85a   ... ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ...  [2259]
#FL85b   ... ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ...  [2259]
#FL89    ..A ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ...  [2259]
#FL90a   ..A ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ...  [2259]
#FL90b   ..A ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ...  [2259]
#FL90c   ..A ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ...  [2259]
#FL90d   ..A ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ...  [2259]
#FLS569  ..A ... ... ... ..G ... ..C ... ... ... ... ..C ... ..C A.. ...  [2259]
#FLS650  ..A ... ... ... ..G ... ..C ... ... ... ... ..C ... ..C A.. ...  [2259]
#TR58    ... ... ... ... ..G ... ..C ... ... ... ... ... ... ..C A.. ...  [2259]
#TR62    ... T.. ... ... ..G ..A ..C ... ... ... ... ..C ... ..C A.. ...  [2259]
#BR64    ... ... ... ... ..G ... ..C ... ... ... ... ..C ... ..C A.. ...  [2259]
#BR69    ... ... ... ... ..G ... ..C ... ... ... ... ..C ... ..C A.. ...  [2259]
#Kern217 ... ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ...  [2259]
#WNNY99  A.A ... ... .CT C.. ..A ..C ... ..T ... ... ... ... ..A ... ...  [2259]
#WNEgypt A.A T.. ... .C. C.. ..A ... ... ..T ... ... ... ... ..A ... ...  [2259]
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APPENDIX N: (CONTINUED) 
 
#FL52    GGA GTT TTC AAT TCA ATT GGC AAA GCT GTC CAC CAA GTC TTC GGA GGA  [2307]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ..T ..Y ... ...  [2307]
#FL72    ... ..C ... ... ... ..C ... ... ... ... ... ... ... ..T ... ..G  [2307]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ...  [2307]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ...  [2307]
#FL89    ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ...  [2307]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ...  [2307]
#FL90b   ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ...  [2307]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ...  [2307]
#FL90d   ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ...  [2307]
#FLS569  ... ..C ..T ... ... ..C ... ... ... ... ... ... ..T ..T ... ..G  [2307]
#FLS650  ... ..C ..T ... ... ..C ... ... ... ... ... ... ..T ..T ... ..G  [2307]
#TR58    ... ..C ... ... ... ..C ... ... ... ... ... ... ..T ..T ... ..G  [2307]
#TR62    ... ..C ... ... ... ..C ... ..G ... ... ... ... ..T ..T ... ..G  [2307]
#BR64    ... ..C ..T ... ... ..C ... ... ... ..G ... ... ..T ..T ... ..G  [2307]
#BR69    ... ..C ... ... ... ... ... ... ... ..G ... ... .YT ..T ... ..G  [2307]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ...  [2307]
#WNNY99  ..G ..G ... .CC ... G.. ..G ..G ... ... ..T ... ..G ... ... ...  [2307]
#WNEgypt ..G ..G ... .CC ... G.G ..G ..G ... ... ..T ... ..G ..T ..T ...  [2307]
 
#FL52    GCG TTC AGG ACT CTG TTC GGG GGA ATG TCC TGG ATC ACA CAG GGA CTA  [2355]
#TBH-28  ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ...  [2355]
#FL72    ..A ... ... ..C ... ... ... ... ... ... ... ... ... ... ... T.G  [2355]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [2355]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [2355]
#FL89    ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..G  [2355]
#FL90a   ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..G  [2355]
#FL90b   ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..G  [2355]
#FL90c   ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..G  [2355]
#FL90d   ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..G  [2355]
#FLS569  ..A ... ... ... ... ... ..A ... ... ... ... ... ... ... ... T..  [2355]
#FLS650  ..A ... ... ... ... ... ..A ... ... ... ... ... ... ... ... T..  [2355]
#TR58    ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... T..  [2355]
#TR62    ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... T..  [2355]
#BR64    ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... T..  [2355]
#BR69    ..A ... ... ... ... ... ... ... ... ..T ... ... ... ... ... T..  [2355]
#Kern217 ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [2355]
#WNNY99  ..A ... C.C T.A ... ... ..A ..C ... ... ... ..A ..G ..A ... T.G  [2355]
#WNEgypt ..A ... C.C T.A ... ... ..A ..C ... ..T ... ..A ..G ..A ... T.G  [2355]  
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APPENDIX N: (CONTINUED) 
 
#FL52    CTT GGA GCC CTT CTC CTG TGG ATG GGG TTG CAG GCC CAC GAC AGG AGC  [2403]
#TBH-28  ... ... ..T ... ... ... ... ... ... ... ... ... .G. ... ... ...  [2403]
#FL72    ... ... ... ... ... T.. ... ... ... ... ... ... .G. ... ... ...  [2403]
#FL85a   ... ... ..T ... ... ... ... ... ... ... ... ... .G. ... ... ...  [2403]
#FL85b   ... ... ..T ... ... ... ... ... ... ... ... ... .G. ... ... ...  [2403]
#FL89    ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ...  [2403]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ...  [2403]
#FL90b   ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ...  [2403]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ...  [2403]
#FL90d   ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ...  [2403]
#FLS569  ... ... ..T ... ... T.. ... ... ... ... ... ... .GT ... ... ...  [2403]
#FLS650  ... ... ..T ... ... T.. ... ... ... ... ... ... .GT ... ... ...  [2403]
#TR58    ... ... ... ... ... T.. ... ... ... ... ... ... .G. ... ... ...  [2403]
#TR62    ... ... ... ... ... T.. ... ... ... ... ... ... .G. ... ... ...  [2403]
#BR64    ... ... ... ... ... T.. ... ... ... ... ... ... .G. ... ... ...  [2403]
#BR69    ... ... ... ... ... T.. ... ... ... ... ... ... .G. ... ... ...  [2403]
#Kern217 ... ... ..T ... ... ... ... ... ... ... ... ... .G. ... ... ...  [2403]
#WNNY99  ..G ..G ..T ..C ..G T.. ... ... ..C A.C A.T ..T .GT ..T ... TC.  [2403]
#WNEgypt ..G ..G ..T ..G ..G T.. ... ... ..C A.C A.T ..T .GT ... ... TC.  [2403]
 
#FL52    ATC TCG CTG ACT CTA CTG GCT ATC GGA GGG ATT CTC ATC TTT CTG GCA  [2451]
#TBH-28  ... ... ... ... ... ... ... G.. ... ... ... ... ..T ... ... ...  [2451]
#FL72    ... ... T.. ..C ... ... ... G.T ... ... ... ..A ... ... ..A ..G  [2451]
#FL85a   ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ... ...  [2451]
#FL85b   ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ... ...  [2451]
#FL89    ..T ... T.. ... ... ... ... G.. ... ..A ... ... ... ... ... ...  [2451]
#FL90a   ..T ... T.. ... ... ... ... G.. ... ..A ... ... ... ... ... ...  [2451]
#FL90b   ..T ... T.. ... ... ... ... G.. ... ..A ... ... ... ... ... ...  [2451]
#FL90c   ..T ... T.. ... ... ... ... G.. ... ..A ... ... ... ... ... ...  [2451]
#FL90d   ..T ... T.. ... ... ... ... G.. ... ..A ... ... ... ... ... ...  [2451]
#FLS569  ..T ... ... ... ... ... ... G.T ... ... ... ..G ... ... ..A ..G  [2451]
#FLS650  ..T ... ... ... ... ... ... G.T ... ... ... ..G ... ... ..A ..G  [2451]
#TR58    ... ... ... ..C ... ... ... G.T ... ... ... ..A ... ..C ..A ..G  [2451]
#TR62    ... ... ... ..C ... ... ... G.T ... ... ... ..A ... ... ..A ..G  [2451]
#BR64    ... ... T.. ... ... ... ... G.T ... ... ... ..A ... ... ..A ..G  [2451]
#BR69    ... ... T.. ... ... ... ..C G.T ... ... ... T.A ... ... ..A ..G  [2451]
#Kern217 ... ... ... ... ... ... ... G.T ... ... ... ..T ... ... ... ...  [2451]
#WNNY99  ..A G.T ..C ..G T.T ..C ..A G.T ... ..A G.. ..G C.. ..C ..C T.C  [2451]
#WNEgypt ..A G.T ..C ..G T.T ..C ..A G.T ... ... G.. T.G C.. ... ..C T.C  [2451]
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APPENDIX N: (CONTINUED) 
 
#FL52    ACC AGC GTG CAA GCC GAT TCG GGA TGT GCA ATT GAC CTA CAA CGA CGT  [2499]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [2499]
#FL72    ... ... ... ... ..T ... ... ... ... ... ... ... ..G ... ... ...  [2499]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ...  [2499]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ...  [2499]
#FL89    ... ... ..A ... ... ..C ... ... ... ... ... ... ... ... ... ...  [2499]
#FL90a   ... ... ..A ... ... ..C ... ... ... ... ... ... ... ... ... ...  [2499]
#FL90b   ... ... ..A ... ... ..C ... ... ... ... ... ... ... ... M.. ...  [2499]
#FL90c   ... ... ..A ... ... ..C ... ... ... ... ... ... ... ... ... ...  [2499]
#FL90d   ... ... ..A ... ... ..C ... ... ... ... ... ... ... ... ... ...  [2499]
#FLS569  ... ... ... ... ..T ... ... ... ... ... ... ... T.. ... ... ...  [2499]
#FLS650  ... ... ... ... ..T ... ... ... ... ... ... ... T.. ... ... ...  [2499]
#TR58    ... ..T ... ... ..T ... ... ... ... ... ... ... ... ... ... ...  [2499]
#TR62    ... ..T ... ... ..T ..C ... ... ... ... ... ... ... ... ... ...  [2499]
#BR64    ... ..T ... ... ..T ... ... ... ... ... ... ... ... ... ... ...  [2499]
#BR69    ... ..T ... ... ..T ... ... ... ... ... ... ... ... ... ... ...  [2499]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [2499]
#WNNY99  GTG .A. ... ..C ..T ..C A.T ..G ... ..C ..A ... A.C AGC ..G .AA  [2499]
#WNEgypt GTG .A. ... ..C ..T ..C A.T ... ... ..C ..A ... A.C AGC ..G .AG  [2499]
 
#FL52    GAA TTG AAA TGT GGA GGA GGC ATC TTC GTG TAC AAC GAC GTT GAG AAG  [2547]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [2547]
#FL72    ... ... ... ... ... ... ... ... ... ... ... ..T ... ..C ... ...  [2547]
#FL85a   ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [2547]
#FL85b   ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [2547]
#FL89    ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [2547]
#FL90a   ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [2547]
#FL90b   ... ... ... ... ... ... ..T ... ... ... ... ... ... ... --- ---  [2547]
#FL90c   ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [2547]
#FL90d   ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ..-  [2547]
#FLS569  ... ... ... ... ... ... ... ... ... ... ... ..T ... ..C ... ...  [2547]
#FLS650  ... ... ... ... ... ... ... ... ... ... ... ..T ... ..C ... ...  [2547]
#TR58    ... ... ... ... ... ... ... ... ... ... ... ..T ..T ..C K.. ..-  [2547]
#TR62    ... ... ... ... ... ... ... ... ... ... ... ..T ... ..C ... ..C  [2547]
#BR64    ... ... ... ... ... ... ... ... ..T ... ... ..T ..T ..C ... ...  [2547]
#BR69    ... ... ... ... ... ... ... ... ... ... ... ..T ..T ..C ... ...  [2547]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [2547]
#WNNY99  ..G C.. .G. ... ... A.T ..A G.G ... A.A C.. ..T ..T ..G ... GCT  [2547]
#WNEgypt ..G C.. .G. ... ... A.T ..A G.G ... A.A C.. ..T ..T ..G ... GCT  [2547]
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APPENDIX N: (CONTINUED) 
 
#FL52    T [2548]
#TBH-28  - [2548]
#FL72    . [2548]
#FL85a   . [2548]
#FL85b   . [2548]
#FL89    . [2548]
#FL90a   . [2548]
#FL90b   - [2548]
#FL90c   . [2548]
#FL90d   - [2548]
#FLS569  . [2548]
#FLS650  . [2548]
#TR58    - [2548]
#TR62    A [2548]
#BR64    . [2548]
#BR69    . [2548]
#Kern217 . [2548]
#WNNY99  . [2548]
#WNEgypt . [2548]
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APPENDIX N: (CONTINUED) 
 
St. Louis Encephalitis Virus Strains 
Envelope Region: F880/B2586 Primer Set 
 
Amino Acid Alignment 
 
#MEGA
!Title Translated Envelope ClustalW 1.6;
!Format
   DataType=Protein
   NSeqs=19 NSites=544
   Identical=. Missing=? Indel=-;
!Domain=Data;
#FL52    RVVFVIMLML IAPAYSFNCL GTSNRDFVEG TSGATWIDLV LEGGSCVTVM  [356]
#TBH-28  .......... .......... .......... A......... ..........  [356]
#FL72    .?F....... .......... .......... A......... ..........  [356]
#FL85a   ..F....... M......... .......... A......... ..........  [356]
#FL85b   .......... ...?...... .......... A......... ..........  [356]
#FL89    .......... .......... .........? A......... ..........  [356]
#FL90a   .......... .......... .......... A......... ..........  [356]
#FL90b   ---.?..... M......... .....?.... A......... ..........  [356]
#FL90c   .......... .......... .......... A......... ..........  [356]
#FL90d   ..F....... M......... .......... A......... ..........  [356]
#FLS569  .......... .......... .......... A......... ..........  [356]
#FLS650  .......... .......... .......... A......... ..........  [356]
#TR58    .......... .......... .......... A......... ..........  [356]
#TR62    .........M M..?...... ........?. A......... ..........  [356]
#BR64    .......... .......... .......... A......... ..........  [356]
#BR69    .......... .......... ........K. A......... ..........  [356]
#Kern217 .......... .......... .......... A......... ..........  [356]
#WNNY99  .....VL.L. V......... .M.....L.. V.....V... ...D....I.  [356]
#WNEgypt .....VL.L. V......... .M.....L.. V.....V... ...D....I.  [356]
 
#FL52    APEKPTLDFK VTKMEATELA TVREYCYKAT LDTLSTVARC PTTGEAHNTR  [406]
#TBH-28  .......... .M........ ...K...E.. .......... .........K  [406]
#FL72    .......... .M........ .......E.. .......... .........K  [406]
#FL85a   .......... .M........ .......E.. .......... .........K  [406]
#FL85b   .......... .M........ .......E.. .......... .........K  [406]
#FL89    .......... .M........ .......E.. .......... .........K  [406]
#FL90a   .......... .M........ .......E.. .......... .........K  [406]
#FL90b   .......... .M........ .......E.. .......... .........K  [406]
#FL90c   .......... .M........ .......E.. .......... .........K  [406]
#FL90d   .......... .M........ .......?.. .......... .?.......K  [406]
#FLS569  .......... .M........ .......E.. .......... .........K  [406]
#FLS650  .......... .M........ .......E.. .......... .........K  [406]
#TR58    .......... .M........ .......E.. .......... .........K  [406]
#TR62    .......... .M........ .......?.. .......... .........K  [406]
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#Kern217 .......... .M........ .......E.. .......... .........K  [406]
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#WNEgypt SKD...I.V. MMN...AN.. E..S...L.. VSD...K.A. ..M.....DK  [406]  
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Multiple Sequence Alignment: SLEV Membrane/Envelope 
 
St. Louis Encephalitis Virus Strains 
Membrane/Envelope Region: SLEC Primer Set 
 
Nucleotide Alignment 
 
#MEGA
!Title SLEC ClustalW 1.6;
!Format
   DataType=Nucleotide CodeTable=Standard
   NSeqs=13 NSites=356
   Identical=. Missing=? Indel=-;
!Domain=Data property=Coding CodonStart=1;
#FL52    TAG CCG ACG GTC AAT CTC TGT GCA GCA TCA TGG AGA TTC CAC ACT GGC  [776]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [776]
#FL72    ... ... ... ... ... ... ... ... ... ... C.. ... YYM ... ... ...  [776]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... YYM ... ... ...  [776]
#FLS569  ... T.. G.. ... ... T.. ... ... ... ... C.. ... C.. ... ... ...  [776]
#FLS649  --- --. ... ... ... ... ... ... ... .T. .T. G.. ... ... .A. ...  [776]
#FLS650  .T. ... ... ... ... ... ... ... ... ... C.. ... C.. ... ... ...  [776]
#FLS694  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [776]
#TR62    ... ... ... ... ... ... ... ... ... ... ... ... C.. ... ... ...  [776]
#BR69    ... ... ... ... ... ... ... ... ... ... C.. ... C.. ... ... ...  [776]
#Kern217 ... ... ... ... ... T.. ... ... ... C.. ... ... ... ... ... ...  [776]
#WNNY99  C.. T.. GA. ... .C. GA. A.. ... .AC A.. C.. ... AAG ... T.. A..  [776]
#WNEgypt ... ... GA. ... .C. GA. A.. ... .AC A.. ... ... AAG ... T.. A..  [776]
#FL52    AAC AAA GAA CAC GCC ATG GTT GGA CAC CGT GAA AAC CAC CAA ATA CTT  [824]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [824]
#FL72    ... ... ... ... ... ... .C. A.. ... ... ... ... ... T.. G.. ...  [824]
#FL85a   ... ... ... ... ... ... .C. ... ... ... ... ... ... ... ... ...  [824]
#FLS569  ... ... ... ... ... ... .C. ... ... ... A.. ... ... ... G.. ...  [824]
#FLS649  ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ...  [824]
#FLS650  ... ... ... ... ... ... .C. ... ... ... A.. ... ... ... G.. ...  [824]
#FLS694  ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ...  [824]
#TR62    ... ... ... ... ... ... .C. A.. ... T.. ... ... ... T.. G.. ...  [824]
#BR69    ... ... ... ... ... ... .C. ... ... ... ... ... ... ... G.. ...  [824]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [824]
#WNNY99  G.A C.. ... GGG .G. T.. .A. ... ..G .AC C.. GG. ... A.G G.. T..  [824]
#WNEgypt G.A C.. ... GGG .G. T.. .A. ... ..G .AC C.. GG. T.. A.G G.. T..  [824]
#FL52    GAC AAA AGT CGA AAA CTG GGT TTT GCG CAA TCC TGG ATA TGC CCT AGT  [872]  #TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [872]
#FL72    ... ... ... ... ... ... ... .C. ... ... ... C.. ... ... ... ...  [872]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... C.. ... ...  [872]
#FLS569  ... ... ... T.. ... ... ... CC. ... ... ... ... ... ... ... ...  [872]
#FLS649  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [872]
#FLS650  ... ... ... T.. ... ... ... CC. ... ... ... ... ... ... ... ...  [872]
#FLS694  ... ... ... T.. ... ... ... .C. ... ... ... ... ... ... ... ...  [872]
#TR62    ... ... ... ... ... ... ... .C. ... ... ... C.. ... ... ... ...  [872]
#BR69    ... ... ... ... ... ... ... .C. ... ... ... C.. ... ... ... ...  [872]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [872]
#WNNY99  .GT ... .AC A.. .TC A.. .A. C.. .A. G.. C.. ... ... ... ... G..  [872]
#WNEgypt .GT ... .AC A.. .TC A.. .A. C.. .A. G.. C.. C.. ... ... ... G..  [872]  
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#FL52    TGC GCT GGC GAT TGG ATG GAT GCT AGG TAG CAA CAA CAC ACA GAG AGT  [920]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [920]
#FL72    ... ... ... ... ... ... ... ... G.. C.. ... ... ... ... ... ...  [920]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [920]
#FLS569  ... A.. ... ... ... ... ... ... ... C.. ... ... ... ... ... ...  [920]
#FLS649  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [920]
#FLS650  ... A.. ... ... ... ... ... ... ... C.. ... ... ... ... ... ...  [920]
#FLS694  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [920]
#TR62    ... ... ... ... ... ... ... ... ... C.. T.. ... ... ... ... ...  [920]
#BR69    ... ... ... ... ... ... ... ... ... C.. ... ... ... ... ... ...  [920]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [920]
#WNNY99  G.. AGC C.T C.. ... T.. ... ... T.. G.. ... ..C ..T G.. ... ...  [920]
#WNEgypt G.. AGC C.T C.. ... T.. ... ... T.. A.. ... ..C ..T G.. .C. ...  [920]
#FL52    GGT CTT TGT GAT CAT GCT GAT GCT GAT TGC TCC GGC ATA CAG CTT CAA  [968]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [968]
#FL72    ... ... ... ... ... ... ... .T. ... ... C.. A.. ... ... ... T..  [968]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [968]
#FLS569  ... ... ... ... ... ... ... .T. ... ... C.. ... ... ... ... ...  [968]
#FLS649  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [968]
#FLS650  ... ... ... ... ... ... ... .T. ... ... C.. ... ... ... ... ...  [968]
#FLS694  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [968]
#TR62    ... ... ... ... ... ... ... .T. ... ... C.. ... ... ... ... T..  [968]
#BR69    ... ... ... ... ... ... ... .T. ... ... C.. ... ... ... ... T..  [968]
#Kern217 ... T.. ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [968]
#WNNY99  T.. G.. ... CG. GC. AT. .C. TT. .G. G.. C.. A.. T.. ... ... ...  [968]
#WNEgypt T.. G.. C.. TG. GC. A.. .C. CT. .G. G.. ... A.. C.. ... ... T..  [968]
 
#FL52    CTG TTT GGG AAC ATC AAA CAG GGA CTT TGT CGA GGG AAC CAG CGG GGC  [1016]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ...  [1016]
#FL72    T.. .C. ... ... ... ... ... ... ... C.. ... A.. GG. ... ... ...  [1016]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ...  [1016]
#FLS569  T.. ... ... ... ... ... ... ... T.. C.. T.. A.. GG. ... ... ...  [1016]
#FLS649  ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ...  [1016]
#FLS650  T.. ... ... ... ... ... ... ... T.. Y.. T.. A.. GG. ... ... ...  [1016]
#FLS694  T.. ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ...  [1016]
#TR62    T.. .C. ... ... ... ... ... ... ... C.. ... A.. GG. ... ... ...  [1016]
#BR69    T.. .C. A.. ... ... ... ... ... ... C.. ... A.. GG. ... ... ...  [1016]
#Kern217 ... .C. ... ... ... ... ... ... ... ... ... ... .G. ... T.. ...  [1016]
#WNNY99  ... CC. T.. ..T GAG C.. ... A.. ... CT. G.. A.. .GT GTC T.. A..  [1016]
#WNEgypt ... CC. T.. ..T GAG C.. ... A.. ... CT. A.. ... .GT GTC T.. A..  [1016]
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#FL52    AAC ATG GAT TGA CTT GGT ACT TGA AGG GGG AAG CTG TGT TAC AGT GAT  [1064]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1064]
#FL72    ... ... ... ... ... ... ... ... ... A.. ... ... ... C.. ... ...  [1064]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1064]
#FLS569  ... ... ... C.. ... ... ... ... ... A.. ... ... ... C.. ... ...  [1064]
#FLS649  ... ... ... ... ... ... ... ... ... ... ... G.. ... ... .-- ---  [1064]
#FLS650  ... ... ... C.. ... ... ... ... ... A.. ... ... ... C.. ... ...  [1064]
#FLS694  ... ... ... ... ... ... ... ... ... ... ... ... ... Y.. ... ...  [1064]
#TR62    ... ... ... ... ... ... ... ... ... A.. ... ... ... C.. ... A..  [1064]
#BR69    ... ... ... ... ... ... ... ... ... A.. ... ... ... C.. ... ...  [1064]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [1064]
#WNNY99  ... ... .G. G.. T.. ... T.. C.. ... C.A C.. ... C.. G.. TA. C..  [1064]
#WNEgypt ... ... .G. G.. T.. ... T.. C.. ... C.A C.. ... ... G.. CA. C..  [1064]
#FL52    GGC ACC AGA GAA ACC AAC AC [1112]
#TBH-28  ... ... ... ... ... ... .. [1112]
#FL72    ... ... ... ... ... ... .T [1112]
#FL85a   ... ... ... ... ... ... .. [1112]
#FLS569  ... ... ... ... ... ... .T [1112]
#FLS649  --- --- --- --- --- --- -- [1112]
#FLS650  ... ... ... ... ... ... .. [1112]
#FLS694  ... ... ... ... ... ... .- [1112]
#TR62    ... ... ... ... ... ... .T [1112]
#BR69    ... ... ... ... ... ... -- [1112]
#Kern217 ... ... ... ... ... ... .. [1112]
#WNNY99  .T. TAA G.. C.. G.. T.. CA [1112]
#WNEgypt .T. TAA G.. C.. G.. T.. CA [1112]
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St. Louis Encephalitis Virus Strains 
Membrane/Envelope Region: SLEC Primer Set 
 
Amino Acid Alignment 
#MEGA
!Title Translated SLEC ClustalW 1.6;
!Format
   DataType=Protein
   NSeqs=13 NSites=118
   Identical=. Missing=? Indel=-;
!Domain=Data;
#FL52    *PTVNLCAAS WRFHTGNKEH AMVGHRENHQ ILDKSRKLGF AQSWICPSCA  [293]
#TBH-28  .......... .......... .......... .......... ..........  [293]
#FL72    .......... R.?....... ..AR.....* V........S ...R......  [293]
#FL85a   .......... ..?....... ..A....... .......... .....R....  [293]
#FLS569  .SA..F.... R.L....... ..A...K... V....*...P .........T  [293]
#FLS649  --.......L LG..N....Q .......... .......... ..........  [293]
#FLS650  L......... R.L....... ..A...K... V....*...P .........T  [293]
#FLS694  .......... .......... .......... V....*...S ..........  [293]
#TR62    .......... ..L....... ..AR.C...* V........S ...R......  [293]
#BR69    .......... R.L....... ..A....... V........S ...R......  [293]
#Kern217 .....F...P .......... .......... .......... ..........  [293]
#WNNY99  QSE.TDS.DT R.K.SSEQ.G GLD.QHQG.K VFG.N.IMDL EEP....GGS  [293]
#WNEgypt ..E.TDS.DT ..K.SSEQ.G GLD.QHQGYK VFG.N.IMDL EEPR...GGS  [293]
#FL52    GDWMDAR*QQ HTESGLCDHA DADCSGIQLQ LFGNIKQGLC RGNQRGNMD*  [343]
#TBH-28  .......... .......... .......... .......... ..S.......  [343]
#FL72    ......GQ.. .......... .V..PS...* .S.......R .RG.......  [343]
#FL85a   .......... .......... .......... .......... ..S.......  [343]
#FLS569  .......Q.. .......... .V..P..... ........FR *RG......R  [343]
#FLS649  .......... .......... .......... .......... ..S.......  [343]
#FLS650  .......Q.. .......... .V..P..... ........F? *RG......R  [343]
#FLS694  .......... .......... .......... .......... ..S.......  [343]
#TR62    .......Q*. .......... .V..P....* .S.......R .RG.......  [343]
#BR69    .......Q.. .......... .V..P....* .SR......R .RG.......  [343]
#Kern217 .......... .....F.... .......... .S........ ..S.W.....  [343]
#WNNY99  RH.L..WE.H .A..CV.RAI AFGGPSL... .PW.EQ.R.L GRSVWS..GG  [343]
#WNEgypt RH.L..WK.H .AA.CVRCAT ALGG.SL..* .PW.EQ.R.L ..SVWS..GG  [343]  
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#FL52    LGT*RGKLCY SDGTRETN [361]
#TBH-28  .......... ........ [361]
#FL72    .....R...H ........ [361]
#FL85a   .......... ........ [361]
#FLS569  .....R...H ........ [361]
#FLS649  .......V.. -------- [361]
#FLS650  .....R...H ........ [361]
#FLS694  .........? ........ [361]
#TR62    .....R...H .N...... [361]
#BR69    .....R...H ........ [361]
#Kern217 .......... ........ [361]
#WNNY99  F.SR.RQ.RD YHV*GQAY [361]
#WNEgypt F.SR.RQ..D HHV*GQAY [361]  
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Multiple Sequence Alignment: Flavivirus NS5 Region 
 
West Nile Virus Strains 
NS5 Region: Fu1/cfd3 Primer Set 
 
Nucleotide Alignment 
#MEGA
!Title NS5 ClustalW 1.6 WN;
!Format
   DataType=Nucleotide CodeTable=Standard
   NSeqs=15 NSites=1006
   Identical=. Missing=? Indel=-;
!Domain=Data property=Coding CodonStart=1;
#FLM38   --- --- -CA AGG GAA GCA GAG CCA TTT GGT TCA TGT GGC TCG GAG CTC  [9130]
#FLS502  --- --- -.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [9130]
#FLS504  --- --- -.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [9130]
#FLS545  GAA AGG C.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [9130]
#FLWN01a GAA AGG C.. ... ... ... ..A ... ... ... ... ... ... ... ... ...  [9130]
#FLWN01b --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---  [9130]
#FLWN02a --- --- -.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [9130]
#FLWN02b --- --- -.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [9130]
#FLWN05a -AA AGG C.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [9130]
#FLWN05b -AA AGG C.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [9130]
#WNNY99  GAA AGG C.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [9130]
#WNEgypt GAA AGG CT. ... ... ... ... ... .A. ... ... ... ... ... ... ...  [9130]
#Kunjin  GGA AAG C.. ... ... ... .G. ... .C. ... .T. ... ... .G. ... ...  [9130]
#JE      GAA AAG C.. ... ... ... .G. ... ... ... ... ... ... .T. ... .A.  [9130]
#MVE     GAA AGG C.. ... ... ... ... ... .C. ... ... ... ... .G. ... .CA  [9130]  
#FLM38   GCT TTC TGG AGT TCG AGG CTC TGG GTT TTC TCA ATG AAG ACC ACT GGC  [9178]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9178]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9178]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9178]
#FLWN01a ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ... ...  [9178]
#FLWN01b --- --- --- --- --- --- --- --. ... ... ..T C.C ... ... ... ...  [9178]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9178]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9178]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9178]
#FLWN05b ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9178]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9178]
#WNEgypt ... ... ... ... ... .A. ... ... .C. ... .T. .C. ... ... ... ...  [9178]
#Kunjin  ... .C. .A. ... .T. ... ... ... .C. ... .T. ... .G. ... ... ...  [9178]
#JE      .G. A.. .A. ... .T. .A. ..T ... .G. .C. .G. ... ... ... .T. ...  [9178]
#MVE     .A. .CT ... ... .T. .A. ... .A. .A. .C. ... ... ... ... .T. ..A  [9178]
#FLM38   TTG GAA GAA AGA ACT CAG GAG GAG GTG TCG AGG GCT TGG GCC TCC AAA  [9226]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#FLWN01b .A. T.. ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9226]
#WNEgypt ... ... ... ... ... ... ... .C. .G. ... ... ... ... ... ... ...  [9226]
#Kunjin  ... ... ... ... ... .G. .G. .C. .G. ... ... .TC ... ... ... .G.  [9226]
#JE      .GA .CC ..G ... .T. ... ... .T. .A. .G. .A. ... C.. ..G ... ...  [9226]
#MVE     .GA .T. ..G ... .T. ... ... ... .A. .T. .A. .AG CT. .TA .T. .G.  [9226]
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#FLM38   AAC TGG GTT ACA TCC TGC GTG AAG TTG GCA CCC GGC CTG GGG GCA AGA  [9274]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9274]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9274]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9274]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9274]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9274]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9274]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9274]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... .C. ... ... ...  [9274]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9274]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9274]
#WNEgypt ... ... ... .T. .T. ... ... ... ... ... ... .A. ... .A. ... ...  [9274]
#Kunjin  ..T .A. .C. ... ... ... ... ... ... ... ... .A. .C. .A. ... GA.  [9274]
#JE      .G. .A. .A. ... ... .C. ... .CA .A. CAG GAA A.. AA. .A. .G. .A.  [9274]
#MVE     .G. ... .A. ... ..T ..A .A. .T. .G. CTC AAA A.. ... .A. .G. .A.  [9274]
#FLM38   TCT ATG CTG ATG ACA CAG CTG GCT GGG ACA CCC GCA TCA CGA GAG CTG  [9322]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9322]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9322]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9322]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9322]
#FLWN01b .T. ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ...  [9322]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9322]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9322]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9322]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9322]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9322]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... .T. ... ... ...  [9322]
#Kunjin  ... .C. ... ... ... ... .C. .T. ... ... ... ... ... .A. ... ...  [9322]
#JE      .G. .C. ... ... .T. .C. .C. .G. ... ... .TA .A. .T. .C. ..A ...  [9322]
#MVE     .T. ... .C. ... ... ... ... .T. ... ... ... ... ... .AC A.. ...  [9322]
 
#FLM38   ACT TGG AAA ATG AAG CTA AGG TGC TTG AGT TGC TTG ATG GGG AAC ATC  [9370]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9370]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9370]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9370]
#FLWN01a ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ...  [9370]
#FLWN01b ... ... ... ... .G. ... ... ... ... ..C ... ... ... ... ... ...  [9370]
#FLWN02a ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ...  [9370]
#FLWN02b ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ...  [9370]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... .G. ...  [9370]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9370]
#WNNY99  ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ...  [9370]
#WNEgypt ..C ... ... ... ... ... ... .T. ... ... ... .G. ... ... ... ...  [9370]
#Kunjin  ..C ... .G. ... ... .C. ... .T. ... ... ..T .G. .C. ... .G. .C.  [9370]
#JE      ... .A. ... ... ... ... ... ... .G. ..C .C. .A. .C. .T. ... .C.  [9370]
#MVE     ..C .T. .G. .C. ... ... .A. .T. .G. ... ..A .G. .A. .T. .G. .G.  [9370]
#FLM38   GGC GTC TTG CCA GGG CCA TCA TTG AGC TCA CCT ATC GTC ACA AAG TTG  [9418]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#WNEgypt ... ... ... .T. ... ... ... ... ... ... ... ... ... ... ... ...  [9418]
#Kunjin  ... .C. .G. ... ... ... ... ... ... ... ... ... .C. ... ... .A.  [9418]
#JE      .CA TG. .C. ..C .A. ... .A. ... .A. .G. .T. .CA .G. ... ... .G.  [9418]
#MVE     ..A C.T .G. .A. .A. .A. ... ... ... .G. .A. .CA .G. ... ... .G.  [9418]  
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#FLM38   TGA AAG TGA TGC GCC CGG CTG CTG ATG GAA GAA CCG TCA TGG ATG TTA  [9466]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9466]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9466]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9466]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9466]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9466]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9466]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9466]
#FLWN05a .A. ... ... ... ... ... ... ... ... ... ... ... .T. ... ... ...  [9466]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9466]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9466]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .C.  [9466]
#Kunjin  ... .G. .A. ... ... ... ... ... ... ... ... ... ... ... .C. .C.  [9466]
#JE      .C. .G. .C. ..A .A. .T. .A. .A. .A. ... AG. ... .G. ... .C. .G.  [9466]
#MVE     .C. .G. .C. ... ... ... .A. ... GA. ... AG. .T. .G. ... ... .C.  [9466]
#FLM38   TCT CCA GAG AAG ATC AGA GGG GGA GTG GAC AAG TTG TCA CCT ACG CCC  [9514]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#FLWN05a .T. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9514]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .T.  [9514]
#Kunjin  ... ... .G. ... .C. ... .A. .A. ... .G. ... ... ... ... ... .T.  [9514]
#JE      .A. .A. ... ... ... .A. ... ... ... ... .G. .G. ... .T. .T. .T.  [9514]
#MVE     .T. .AC .C. ... ... .A. .A. .A. ... ... ... .A. .G. ... .T. .TT  [9514]
 
#FLM38   TAA ACA CTT TCA CCA ACC TGG CCG TCC AGC TGG TGA GGA TGA TGG AAG  [9562]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9562]
#WNEgypt ... ... .C. ... ... ... ... ... ... ..T ... ... ... ... ... ...  [9562]
#Kunjin  ... ... .C. .T. ... ... ... .T. ... .AT ... ... .A. ... ... ...  [9562]
#JE      .T. ... ... ... .G. ..A .T. .T. ... ... .C. .C. ..C ... ... .G.  [9562]
#MVE     ... ... .A. ... ... ..A .C. .T. .G. .AT ... .T. .AC .C. ... ...  [9562]
#FLM38   GGG AAG GAG TGA TTG GCC CAG ATG ATG TGG AGA AAC TCA CAA AAG GGA  [9610]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9610]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... ... ... .G. .A.  [9610]
#Kunjin  .A. .G. .T. ... .C. ... ... ... ... ... ... ... ... ... .G. ...  [9610]
#JE      CT. .G. .G. .C. ... .A. ..C .GC .CT ... .AC .G. .AC .C. G.A AA.  [9610]
#MVE     CC. ... CG. .C. .A. .T. ... ... .CA .T. .A. GCA .TG A.. GGA AA.  [9610]
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#FLM38   AAG GAC CCA AAG TCA GGA CCT GGC TGT TTG AGA ATG GGG AAG AAA GAC  [9658]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9658]
#WNEgypt ... ... .T. ... ... ... ... ... ... ... ... ... ... .G. ... ...  [9658]
#Kunjin  ... .G. ... .G. .T. .A. ... ... ... C.. ... ... ... .G. ... ...  [9658]
#JE      .CA AGA TAG CT. ... ... ... ... .C. ... ... ... .A. .G. .G. ..G  [9658]
#MVE     .GA A.T TTG C.. ..C .C. .A. ... .T. ... ... .C. CA. ... ... ..G  [9658]
#FLM38   TCA GCC GCA TGG CTG TCA GTG GAG ATG -AC TGT GTG GTA AAG CCC CTG  [9706]
#FLS502  ... ... ... ... ... ... ... ... ... -.. ... ... ... ... ... ...  [9706]
#FLS504  ... ... ... ... ... ... ... ... ... -.. ... ... ... ... ... ...  [9706]
#FLS545  ... ... ... ... ... ... ... ... ... -.. ... ... ... ... ... ...  [9706]
#FLWN01a ... ... ... ... ... ... ... ... ... -.. ... ... ... ... ... ...  [9706]
#FLWN01b ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ...  [9706]
#FLWN02a ... ... ... ... ... ... ... ... ... -.. ... ... ... ... ... ...  [9706]
#FLWN02b ... ... ... ... ... ... ... ... ... -.. ... ... ... ... ... ...  [9706]
#FLWN05a .T. ... ... ... ... ... ... ... ... -.. ... ... ... ... ... ...  [9706]
#FLWN05b ... ... ... ... ... ... ... ... ... -.. ... ... ... ... ... T..  [9706]
#WNNY99  ... ... ... ... ... ... ... ... ... -.. ... ... ... ... ... ...  [9706]
#WNEgypt ... ... ... ... ... ... .C. ... ... -.. ... ... ... ... ... ..A  [9706]
#Kunjin  ... ... ... ... ... ... ... ... ... -.. ... ... ... ... ... T..  [9706]
#JE      .G. C.A .G. ... .GA ... .C. ... .C. -.. ... ..C ..C ... ..G ...  [9706]
#MVE     .GC AG. ... ... ... .T. ... .T. ... -.. ... ..T ..C ..A ..A T..  [9706]  
#FLM38   GAC GAT CGC TTT GCC ACC TCG CTC CAC TTC CTC AAT GCT ATG TCA AAG  [9754]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9754]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9754]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9754]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9754]
#FLWN01b C.. ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ...  [9754]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9754]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ...  [9754]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9754]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9754]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9754]
#WNEgypt ..T ..C ... ..C ... ... ..T ... ... ... ... ..C ..C ... ... ...  [9754]
#Kunjin  ..T ... ... ... ... ... ..T ... ... ..T ... ..C ..C ... ... ...  [9754]
#JE      ..T ..C A.A ..C ... ..G G.C ... ... ... ... ..C ..A ... ... ...  [9754]
#MVE     ..T ... A.A ... T.. ..T G.T T.G ..T ... T.G ..C ..C ... ... ...  [9754]
#FLM38   GTT CGC AAA GAC ATC CAA GAG TGG AAA CCG TCA ACT GGA TGG TAT GAT  [9802]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9802]
#WNEgypt ... ... ... ..T ... ..G ... ... ... ... ... ... ... ... ... ..C  [9802]
#Kunjin  ..G ... ..G ... ... ... ... ... ... ..A ... ..C ... ... ... ...  [9802]
#JE      ..C A.A ... ... ... ... ..A ... ..G ..T ..G CA. ..C ... C.C ..C  [9802]
#MVE     ..G A.A ... ... ... ..G ... ... ... ..C ... CAA ..C ... ... ..C  [9802]
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#FLM38   TGG CAG CAG GTT CCA TTT TGC TCA AAC CAT TTC ACT GAA TTG ATC ATG  [9850]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9850]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9850]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9850]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9850]
#FLWN01b ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ...  [9850]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9850]
#FLWN02b ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ...  [9850]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9850]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9850]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9850]
#WNEgypt ... ... ... ... ... ..C ... ..G ... ... ... ... ... ..A ... ...  [9850]
#Kunjin  ... ... ..A ... ... ..C ..T ... ... ..C ... ... ... C.. ... ...  [9850]
#JE      ... ... ..A ... ..C ..C ... ..T ... ... ..T CAG ..G A.T G.G ...  [9850]
#MVE     ... ..A ..A ..C ..C ..C ..T ..G ..T ... ... CAG ... G.C ... ...  [9850]
#FLM38   AAA GAT GGA AGA ACA CTG GTG GTT CCA TGC CGA GGA CAG GAT GAA TTG  [9898]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9898]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... C..  [9898]
#Kunjin  ... ... ... ... ... ... ... AC. ... ... ... ..G ... ... ..G ..A  [9898]
#JE      ... ... ... ..G .GT A.A ..C ..C ..G ..T A.. ... ... ... ..G ...  [9898]
#MVE     ... ... ..G ..G ..C T.. ... ..G ..C ... A.. ... ... ..C ..G C..  [9898]
 
#FLM38   GTA GGC AGA GCT CGT ATA TCT CCA GGG GCC GGA TGG AAC GTC CGC GAC  [9946]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9946]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9946]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9946]
#FLWN01a ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ...  [9946]
#FLWN01b ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ...  [9946]
#FLWN02a ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ...  [9946]
#FLWN02b ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ...  [9946]
#FLWN05a ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ...  [9946]
#FLWN05b ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ...  [9946]
#WNNY99  ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ...  [9946]
#WNEgypt ... ... ... ... ..C ..T ... ... ... ... ... ... ... ... ..T ...  [9946]
#Kunjin  ..G ... ... ... ..C ..C ..C ... ... ..T ... ... ..T ..T ..A ...  [9946]
#JE      A.. ... ..G ... ..C ..C ..C ... ..A ..T ... ... ..T ..G AAG ...  [9946]
#MVE     A.T ..A ... ..A ..A ... ..C ..T ..C T.A ... ... ... ... A.G ...  [9946]
#FLM38   ACT GCT TGT CTG GCT AAG TCC TAT GCC CAG ATG TGG CTG CTT CTG TAC  [9994]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9994]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9994]
#FLS545  ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9994]
#FLWN01a ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9994]
#FLWN01b ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9994]
#FLWN02a ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9994]
#FLWN02b ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9994]
#FLWN05a ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9994]
#FLWN05b ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9994]
#WNNY99  ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9994]
#WNEgypt ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9994]
#Kunjin  ... ... ..C T.A ..C ..A ..T ... ..T ... ... ... T.. ..C ... ...  [9994]
#JE      ..A ... ..C T.. ..C ..A G.A ... ..A ... ... ... ..A ..C ..A ...  [9994]
#MVE     ..G ..A ..C T.A ..A ..A G.A ... ..A ... ... ... ..T G.G T.. ...  [9994]
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#FLM38   TTC CAC AGA AGA GAC CTG CGG CTC ATG GCC AAC GCC ATT TGC TCC GCT  [10042]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10042]
#WNEgypt ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ...  [10042]
#Kunjin  ... ... ... ... ..T ... ... T.G ... ... ... ... ..C ... ..T ..C  [10042]
#JE      ... ..T C.T ..G ... T.. ..T ... ... ..A ..T ..G ... ... ..A ..A  [10042]
#MVE     ... ..T C.. C.G ..T ... ..C ..G ... ... ... ... ..A ... ..T T.A  [10042]
#FLM38   GTC CCT GTG AAT TGG GTC CCT ACC GGA AGA ACC ACG TGG TCC ATC C [10088]
#FLS502  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#FLS504  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#FLS545  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#FLWN01a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#FLWN01b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#FLWN02a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#FLWN02b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#FLWN05a ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#FLWN05b ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#WNNY99  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#WNEgypt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... . [10088]
#Kunjin  ..A ... ..A ..C ... ... ... ..T ... ... ... ..A ... ... ... . [10088]
#JE      ..G ..A ... G.. ... ..G ..C ..A ..C ..G ..A T.C ... ..A ..A . [10088]
#MVE     ... ..A ..T G.C ... ..T ..A ... ..C ..G ..T ..T ... ... ... . [10088]
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West Nile Virus Strains 
NS5 Region: Fu1/cfd3 Primer Set 
 
Amino Acid Alignment 
#MEGA
!Title Translated NS5 ClustalW 1.6 WN;
!Format
   DataType=Protein
   NSeqs=15 NSites=335
   Identical=. Missing=? Indel=-;
!Domain=Data;
#FLM38   ---REAEPFG SCGSELAFWS SRLWVFSMKT TGLEERTQEE VSRAWASKNW  [3080]
#FLS502  ---....... .......... .......... .......... ..........  [3080]
#FLS504  ---....... .......... .......... .......... ..........  [3080]
#FLS545  ERP....... .......... .......... .......... ..........  [3080]
#FLWN01a ERP....... .......... ...G...... .......... ..........  [3080]
#FLWN01b ---------- ---------- ----...L.. ..**...... ..........  [3080]
#FLWN02a ---....... .......... .......... .......... ..........  [3080]
#FLWN02b ---....... .......... .......... .......... ..........  [3080]
#FLWN05a -RP....... .......... .......... .......... ..........  [3080]
#FLWN05b -RP....... .......... .......... .......... ..........  [3080]
#WNNY99  ERP....... .......... .......... .......... ..........  [3080]
#WNEgypt ERL.....Y. .......... .K..A.LT.. .........A G.........  [3080]
#Kunjin  GKP...G.S. L..W...S*. L...A.L.R. .......RGA G..V...R.*  [3080]
#JE      EKP...G... ...L.HGI*. LK..GS*... I.*A..I..V EWK.R...S*  [3080]
#MVE     ERP.....S. ...W.PDS.. LK.*DS.... I.*V..I... ELKELVFRS.  [3080]
 
#FLM38   VTSCVKLAPG LGARSMLMTQ LAGTPASREL TWKMKLRCLS CLMGNIGVLP  [3130]
#FLS502  .......... .......... .......... .......... ..........  [3130]
#FLS504  .......... .......... .......... .......... ..........  [3130]
#FLS545  .......... .......... .......... .......... ..........  [3130]
#FLWN01a .......... .......... .......... .......... ..........  [3130]
#FLWN01b .......... ....F..... .G........ ....R..... ..........  [3130]
#FLWN02a .......... .......... .......... .......... ..........  [3130]
#FLWN02b .......... .......... .......... .......... ..........  [3130]
#FLWN05a .......... P......... .......... .......... ....S.....  [3130]
#FLWN05b .......... .......... .......... .......... ..........  [3130]
#WNNY99  .......... .......... .......... .......... ..........  [3130]
#WNEgypt .IF......D .E........ ......L... .......F.. .W.......L  [3130]
#Kunjin  A........D PE.E.T.... PV.....Q.. ..R..P.F.. .WT.ST.AW.  [3130]
#JE      D..S.T*QES KEGKCT..IP PG..LELP.. .*......W. S*TV.TACS.  [3130]
#MVE     D..*EMWLKS .EGKF.P... .V.....HK. .LRT..KFW. *WKVSS.LWQ  [3130]
#FLM38   GPSLSSPIVT KL*K*CARLL MEEPSWMLSP EKIRGGVDKL SPTP*TLSPT  [3180]
#FLS502  .......... .......... .......... .......... ..........  [3180]
#FLS504  .......... .......... .......... .......... ..........  [3180]
#FLS545  .......... .......... .......... .......... ..........  [3180]
#FLWN01a .......... .......... .......... .......... ..........  [3180]
#FLWN01b .......... .......... .......... .......... ..........  [3180]
#FLWN02a .......... .......... .......... .......... ..........  [3180]
#FLWN02b .......... .......... .......... .......... ..........  [3180]
#FLWN05a .......... .......... ....L...F. .......... ..........  [3180]
#FLWN05b .......... .......... .......... .......... ..........  [3180]
#WNNY99  .......... .......... .......... .......... ..........  [3180]
#WNEgypt .......... .......... .......S.. .......... ...L..P...  [3180]
#Kunjin  ........A. .*.R...... ......TS.. G.T.EE.G.. ...L..PL..  [3180]
#JE      E.*.N*LTG. .WSRS*DLQQ K.R.*.T*YQ ...K....RW .LMLL...R.  [3180]
#MVE     EQ...*HTG. .WSRS...Q. E.RL*..SFH A..KEE...* *.ML..H...  [3180]
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#FLM38   WPSSW*G*WK GKE*LAQMMW RNSQKGKDPK SGPGCLRMGK KDSAAWLSVE  [3230]
#FLS502  .......... .......... .......... .......... ..........  [3230]
#FLS504  .......... .......... .......... .......... ..........  [3230]
#FLS545  .......... .......... .......... .......... ..........  [3230]
#FLWN01a .......... .......... .......... .......... ..........  [3230]
#FLWN01b .......... .......... .......... .......... ..........  [3230]
#FLWN02a .......... .......... .......... .......... ..........  [3230]
#FLWN02b .......... .......... .......... .......... ..........  [3230]
#FLWN05a .......... .......... .......... .......... ..L.......  [3230]
#FLWN05b .......... .......... .......... .......... ..........  [3230]
#WNNY99  .......... .......... .......... .......... ..........  [3230]
#WNEgypt .......... .......... ....RE..L. .........R ........A.  [3230]
#Kunjin  .L.N..E... ERV.S..... ....R..G.R LE.......R ..........  [3230]
#JE      LL..SS...R LRGS.DHST. NSYPEKTR*L ....S...ER RE*PG.R.A.  [3230]
#MVE     SLCN.LDS.. P.RS*V..TL KALKGKRNLQ .AH.F..TQ. .ECS...L.V  [3230]
#FLM38   M-CVVKPLDD RFATSLHFLN AMSKVRKDIQ EWKPSTGWYD WQQVPFCSNH  [3280]
#FLS502  .-........ .......... .......... .......... ..........  [3280]
#FLS504  .-........ .......... .......... .......... ..........  [3280]
#FLS545  .-........ .......... .......... .......... ..........  [3280]
#FLWN01a .-........ .......... .......... .......... ..........  [3280]
#FLWN01b .Y......H. .......... .......... .......... ..........  [3280]
#FLWN02a .-........ .......... .......... .......... ..........  [3280]
#FLWN02b .-........ .......... .......... .......... ..........  [3280]
#FLWN05a .-........ .......... .......... .......... ..........  [3280]
#FLWN05b .-........ .......... .......... .......... ..........  [3280]
#WNNY99  .-........ .......... .......... .......... ..........  [3280]
#WNEgypt .-........ .......... .......... .......... ..........  [3280]
#Kunjin  .-........ .......... .......... .......... ..........  [3280]
#JE      T-........ ....A..... .......... .....H..H. ..........  [3280]
#MVE     .-........ ..S.A..... .......... .....Q.... ..........  [3280]  
#FLM38   FTELIMKDGR TLVVPCRGQD ELVGRARISP GAGWNVRDTA CLAKSYAQMW  [3330]
#FLS502  .......... .......... .......... .......... ..........  [3330]
#FLS504  .......... .......... .......... .......... ..........  [3330]
#FLS545  .......... .......... .......... .......... ..........  [3330]
#FLWN01a .......... .......... .......... .......... ..........  [3330]
#FLWN01b .......... .......... .......... .......... ..........  [3330]
#FLWN02a .......... .......... .......... .......... ..........  [3330]
#FLWN02b .......... .......... .......... .......... ..........  [3330]
#FLWN05a .......... .......... .......... .......... ..........  [3330]
#FLWN05b .......... .......... .......... .......... ..........  [3330]
#WNNY99  .......... .......... .......... .......... ..........  [3330]
#WNEgypt .......... .......... .......... .......... ..........  [3330]
#Kunjin  .......... ...T...... .......... .......... ..........  [3330]
#JE      .Q.IV..... SI........ ..I....... ......K... ....A.....  [3330]
#MVE     .Q.V...... .......... ..I....... .S........ ....A.....  [3330]
#FLM38   LLLYFHRRDL RLMANAICSA VPVNWVPTGR TTWSI [3365]
#FLS502  .......... .......... .......... ..... [3365]
#FLS504  .......... .......... .......... ..... [3365]
#FLS545  .......... .......... .......... ..... [3365]
#FLWN01a .......... .......... .......... ..... [3365]
#FLWN01b .......... .......... .......... ..... [3365]
#FLWN02a .......... .......... .......... ..... [3365]
#FLWN02b .......... .......... .......... ..... [3365]
#FLWN05a .......... .......... .......... ..... [3365]
#FLWN05b .......... .......... .......... ..... [3365]
#WNNY99  .......... .......... .......... ..... [3365]
#WNEgypt .......... .......... .......... ..... [3365]
#Kunjin  .......... .......... .......... ..... [3365]
#JE      .......... .......... ...D...... .S... [3365]
#MVE     .V........ .........S ...D...... ..... [3365]
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St. Louis Encephalitis Virus Strains 
NS5 Region: Fu1/cfd3 Primer Set 
 
Nucleotide Alignment 
 
#MEGA
!Title NS5 ClustalW 1.6 SLE;
!Format
   DataType=Nucleotide CodeTable=Standard
   NSeqs=19 NSites=1006
   Identical=. Missing=? Indel=-;
!Domain=Data property=Coding CodonStart=1;
#FL52    GAA AGG CTA AAG GAA GCA GAG CCA TTT GGT ACA TGT GGT TGG GAG CTC  [9120]
#TBH-28  .G. ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9120]
#FL72    .G. ... .C. ... ... ... ... .T. .C. ... .T. ... ..C .A. ... ...  [9120]
#FL85a   .G. ... ... ... .C. ... ... ... ... ... ... ... ... ... ... ...  [9120]
#FL85b   .GG ... ... .-. .C. ... ... ... ... ... ... ... ... ... ... ...  [9120]
#FL89    .GG ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9120]
#FL90a   .GG ... ... .G. --. ... ... ... ... ... ... ... ... ... ... ...  [9120]
#FL90b   .G. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9120]
#FL90c   .GG ... ... .G. --. ... ... ... ... ... ... ... ... ... ... ...  [9120]
#FL90d   .G. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9120]
#FLS569  .G. ... .C. ... ... ... .G. .T. .C. ... ... ... ..C .A. ... ...  [9120]
#FLS650  .GG ... .C. .-. ... ... .G. .T. .C. ... ... ... ..C .A. ... ...  [9120]
#TR58    .GG ... .C. ... ... ... ... .T. .C. ... ... ... ..C .A. ... ...  [9120]
#TR62    .G. ... .A. ... ... ... ... .T. .C. ... ... ... ..C .A. ... ...  [9120]
#BR64    .GG ... .C. .-. ... ... ... ... .C. ... ... ... ..C ... ... .C.  [9120]
#BR69    .G. ... .C. ... ... ... ... ... .C. ... ... ... ..C .A. ... .C.  [9120]
#Kern217 .G. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9120]
#Rocio   .G. .A. ... .G. .C. ..C .C. ... ... ... .T. ... ..C ... .G. .AA  [9120]
#Ilheus  .G. ... .A. .G. ... ... ... ... .C. ... ... ... ..C .T. ... ..A  [9120]  
#FL52    GGT TTT TGG AGT TTG AAG CCC TCG GGT TCC TAA ATG AAG ACC ATT GGA  [9168]
#TBH-28  ... .C. ... ... ... ... ... ... ... ... ... ... ... ... .C. ...  [9168]
#FL72    ... ... ... ... ... .G. .T. ... ... .T. ... ... ... .T. .C. ...  [9168]
#FL85a   ... .C. ... ... ... ... ... ... ... ... ... ... ... ... .C. ...  [9168]
#FL85b   ... .C. ... ... ... ... ... ... ... ... ... ... ... ... .C. ...  [9168]
#FL89    ... .C. ... ... ... ... ... ... ... ... ... ... ... .T. .C. ...  [9168]
#FL90a   ... .C. ... ... ... ... ... ... ... ... ... ... ... .T. .C. ...  [9168]
#FL90b   ... .C. ... ... ... ... ... ... ... ... ... ... ... .T. .C. ...  [9168]
#FL90c   ... .C. ... ... ... ... ... ... ... ... ... ... ... .T. .C. ...  [9168]
#FL90d   ... .C. ... ... ... ... ... ... ... ... ... ... ... .T. .C. ...  [9168]
#FLS569  ... ..C ... ... ... .G. ... ... ... .T. ... ... ... .T. .C. ...  [9168]
#FLS650  ... ..C ... ... ... .G. ... ... ... .T. ... ... ... .T. .C. ...  [9168]
#TR58    ... ... ... ... ... .G. .T. ... ... .T. ... ... ... .T. .C. ...  [9168]
#TR62    ... ... ... ... ... .G. .T. ... ... ... ... ... ... .T. .C. ...  [9168]
#BR64    ... ... ... ... ... .G. ... ... ... .T. ... ... ... .T. .C. ...  [9168]
#BR69    ... ..C ... ... ... .G. ... ... ... .T. ... ... ... .T. .C. ...  [9168]
#Kern217 ... .C. ... ... ... ... ... .T. ... ... ... ... ... ... .C. ...  [9168]
#Rocio   ... ..C .T. ... .C. ... .G. ... .A. .T. .C. ... ... ... .C. ...  [9168]
#Ilheus  .A. .C. ... .A. ... ... .A. .G. .C. .T. ... ... ... ... ... ...  [9168]
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#FL52    TGA GCC GCG AGA ACT CCT ATG GAG GAG TTG AGG GGA AAG GAC TCC AGA  [9216]
#TBH-28  ... ... ... ... ... ... ... ... ... .C. ... ... ... ... ... ...  [9216]
#FL72    ... ... ... ... ... .AC ... ... ... ... ... ... ... ... ... .A.  [9216]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9216]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9216]
#FL89    ... ... ... ... ... ... .C. ... ... ... ... ... ... ... ... ...  [9216]
#FL90a   ... ... ... ... ... ... .C. ... ... ... ... ... ... ... ... ...  [9216]
#FL90b   ... ... ... ... ... ... .C. ... ... ... ... ... ... ... ... ...  [9216]
#FL90c   ... ... ... ... ... ... .C. ... ... ... ... ... ... ... ... ...  [9216]
#FL90d   ... ... ... ... ... ... .C. ... ... ... ... ... ... ... ... ...  [9216]
#FLS569  ... ... ... ... ... .AC ... ... ... ... ... .A. ... ... ... ...  [9216]
#FLS650  ... ... ... ... .T. .AC ... ... ... ... ... .A. ... ... ... ...  [9216]
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#FL89    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9840]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9840]
#FL90b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9840]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9840]
#FL90d   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9840]
#FLS569  ... ..G ... ... ..T ... ... ... ..C ... ... ... ... ... ... ...  [9840]
#FLS650  ... ..G ... ... ..T ... ... ... ..C ... ... ... ... ... ... ...  [9840]
#TR58    ... ..G ... ... ..T ... ... ... ..C ... ... ..C ... ... ... ...  [9840]
#TR62    ... ..G ... ... ..T ... ... ... ..C ... ... ..C ... ... G.. ...  [9840]
#BR64    ... ..G ... ... ..T ... ... ... ..C ... ... ... ... ... ... T..  [9840]
#BR69    ... ..G ... ... ..T ... ... ... ..C ... ..T ... ... ... ... ...  [9840]
#Kern217 ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ...  [9840]
#Rocio   AAT TGG C.. .A. GT. CCA .T. .GC TCC ..T CAT TT. A.T GAG C.. G.C  [9840]
#Ilheus  ... ..G ..A ... ..A ..T G.. ..C ..C ..T ... ... ..G ..G C.. A..  [9840]  
#FL52    AAG GAT GGG CGG ACC ATC GTG GTG CCA TGC AGG AGC CAG GAT GAG CTG  [9888]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9888]
#FL72    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ...  [9888]
#FL85a   ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9888]
#FL85b   ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9888]
#FL89    ... ... ... ... ... ... ... ..A ... ... ... ..T ... ... ... ...  [9888]
#FL90a   ... ... ... ... ... ... ... ..A ... ... ... ..T ... ... ... ...  [9888]
#FL90b   ... ... ... ... ... ... ... ..A ... ... ... ..T ... ... ... ...  [9888]
#FL90c   ... ... ... ... ... ... ... ..A ... ... ... ..T ... ... ... ...  [9888]
#FL90d   ... ... ... ... ... ... ... ..A ... ... ... ..T ... ... ... ...  [9888]
#FLS569  ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ..A ...  [9888]
#FLS650  ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ..A ...  [9888]
#TR58    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ...  [9888]
#TR62    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A T..  [9888]
#BR64    ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ..A ...  [9888]
#BR69    ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ..A ...  [9888]
#Kern217 ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ...  [9888]
#Rocio   .T. CG. .AT G.C .GG .AA A.C ..C GTG CC. T.T ..G GCC C.A ..T GAA  [9888]
#Ilheus  ..A ... ..A ..C ... ... ..A ..T ... ... C.T TC. ..A ... ..A ..A  [9888]
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#FL52    ATT GGC AGA GCC AGA ATT TCA CCA GGA GCA GGA TGG AAT GTG AAA GAG  [9936]
#TBH-28  ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ...  [9936]
#FL72    ..C ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ...  [9936]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ...  [9936]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ..S ... ... ...  [9936]
#FL89    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#FL90b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#FL90d   ... ... ... ... ... ..Y ... ... ... ... ... ... ... ... ... ...  [9936]
#FLS569  ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#FLS650  ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#TR58    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#TR62    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#BR64    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#BR69    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [9936]
#Kern217 ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ...  [9936]
#Rocio   C.A ATT G.. AGA GCC CGG GTG T.C CC. .GG A.T G.A TGG AGC CTG CGA  [9936]
#Ilheus  G.G ..A ... ..A C.G G.G ... ..T ..T AGC ... ... .GC C.. CG. ...  [9936]
 
#FL52    ACA GCC TGC CTG AGC AAA TCC TAT GCT CAG ATG TGG TTG CTT ATG TAC  [9984]
#TBH-28  ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ...  [9984]
#FL72    ... ..T ... ... ... ... ... ... ... ... ... ... ... ..C ... ...  [9984]
#FL85a   ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ...  [9984]
#FL85b   ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ...  [9984]
#FL89    ... ... ... ... ... ... ..T ..C ... ... ... ... ... ... ... ...  [9984]
#FL90a   ... ... ... ... ... ... ..T ..C ... ... ... ... ... ... ... ...  [9984]
#FL90b   ... ... ... ... ... ... ..T ..C ... ... ... ... ... ... ... ...  [9984]
#FL90c   ... ... ... ... ... ... ..T ..C ... ... ... ... ... ... ... ...  [9984]
#FL90d   ... ... ... ... ... ... ..T ..C ... ... ... ... ... ... ... ...  [9984]
#FLS569  ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..T  [9984]
#FLS650  ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..T  [9984]
#TR58    ... ..T ... ... ... ... ... ... ... ... ... ... ... ..C ... ...  [9984]
#TR62    ... ..T ... ... ... ... ... ..C ... ... ... ... ... ..C ... ...  [9984]
#BR64    ... ..T ... ... ... ... ... ... ... ... ... ... ... ..C ... ...  [9984]
#BR69    ... ..T ... ... ... ... ... ... ... ... ... ... ... ..C ... ...  [9984]
#Kern217 ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ...  [9984]
#Rocio   GA. A.T GC. TGT CTG GG. AAA GC. TAC GCT CA. AT. .G. ..G C.C ATG  [9984]
#Ilheus  ... ..T ..T ... ... ... G.. ... ..C ... ... ... ... ..C ... ..T  [9984]
 #FL52    TTC CAC AGG CGG GAT CTC AGA ATG ATG GCA AAT GCC ATT TGT TCA GCT  [10032]
#TBH-28  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10032]
#FL72    ... ... ... ... ... ... ..G ... ... ... ... ... ..C ..C ..T ..C  [10032]
#FL85a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10032]
#FL85b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10032]
#FL89    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10032]
#FL90a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10032]
#FL90b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10032]
#FL90c   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10032]
#FL90d   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [10032]
#FLS569  ... ... ..A ... ... ... ..G ... ... ... ... ..T ..C ... ... ..C  [10032]
#FLS650  ... ... ..A ... ... ... ..G ... ... ... ... ..T ..C ... ... ..C  [10032]
#TR58    ... ... ... ... ... ... ..G ... ... ... ... ... ..C ..C ..T ..C  [10032]
#TR62    ... ... ... ... ... ... ..G ... ... ... ... ... ..C ... ..T ..C  [10032]
#BR64    ... ... ... ... ... ... ..G ... ... ... ... ... ..C ... ... ..C  [10032]
#BR69    ... ... ... ... ... ..T ..G ... ... ... ... ... ..C ... ... ..C  [10032]
#Kern217 ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ...  [10032]
#Rocio   .A. TT. CAC A.A CGG GAT CT. CGC T.A ATG GCC AA. GCC AT. .GC T.G  [10032]
#Ilheus  ... ... C.C ..T ..C ... C.T C.C ... ..C ..C ... ..C ... ... ..A  [10032]
 
 
 
 
 
 608
APPENDIX P: (CONTINUED) 
 
#FL52    GTC CCA GTC AAC TGG GTC CCA ACT GGA CGT ACC ACA TGG TCA A-- - [10078]
#TBH-28  ... ... ... ... ... ... ... ... ... ..- --- --- --- --- --- - [10078]
#FL72    ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... .TT C [10078]
#FL85a   ..T ... ... ... ... ... ... ... ... ... ... ... ... ... .TT C [10078]
#FL85b   ..T ... ... ... ... ... ... ... ... ... ... ... ... ... .T- - [10078]
#FL89    ... ..G ..T ... ... ... ... ..C ... ... ... ... ... ... .T- - [10078]
#FL90a   ... ... ..T ... ... ... ... ..C ... ... ... ... ..- --- --- - [10078]
#FL90b   ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... .TT C [10078]
#FL90c   ... ... ..T ... ... ... ... ..C ... ... ... ... ..- --- --- - [10078]
#FL90d   ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... .TT C [10078]
#FLS569  ... ... ... ... ... ... ..C ... ... --- --- --- --- --- --- - [10078]
#FLS650  ... ... ... ... ... ... ..C ... ... ..C ..T ... ... ... .TC - [10078]
#TR58    ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... .T- C [10078]
#TR62    ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... .TT C [10078]
#BR64    ... ... ... ..T ... ... ..C ... ... ... ..T ..C ... ... .T- - [10078]
#BR69    ... ... ... ..T ... ... ... ... ... ... ... ... ... ... .TT C [10078]
#Kern217 ... ... ... ... ... ... ... ... ... ... ... ... ... ... .TT C [10078]
#Rocio   .C. GTG CC. .TT GAC TGG GTT C.G ACT G.A .GA ... ACC .GG TCG A [10078]
#Ilheus  ..G ..T ..G G.T ... ... ..G ... ... ..A ... ... ... ..C .TC C [10078]
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St. Louis Encephalitis Virus Strains 
NS5 Region: Fu1/cfd3 Primer Set 
 
Amino Acid Alignment 
#MEGA
!Title NS5 ClustalW 1.6;
!Format
   DataType=Protein
   NSeqs=19 NSites=335
   Identical=. Missing=? Indel=-;
!Domain=Data;
#FL52    ERLKEAEPFG TCGWELGFWS LKPSGS*MKT IG*AARTPME ELRGKDSRNS  [3077]
#TBH-28  G.....D... .......S.. .......... T......... .S........  [3077]
#FL72    G.P....LS. I..*...... .RL..F...I T......H.. .......K..  [3077]
#FL85a   G...A..... .......S.. .......... T......... ..........  [3077]
#FL85b   G..-A..... .......S.. .......... T......... ..........  [3077]
#FL89    G......... .......S.. .........I T.......T. ..........  [3077]
#FL90a   G..R-..... .......S.. .........I T.......T. ..........  [3077]
#FL90b   G......... .......S.. .........I T.......T. .........?  [3077]
#FL90c   G..R-..... .......S.. .........I T.......T. ..........  [3077]
#FL90d   G......... .......S.. .........I T.......T. ..........  [3077]
#FLS569  G.P...GLS. ...*...... .R...F...I T......H.. ...E......  [3077]
#FLS650  G.P-..GLS. ...*...... .R...F...I T.....IH.. ...E......  [3077]
#TR58    G.P....LS. ...*...... .RL..F...I T......H.G ..........  [3077]
#TR62    G.Q....LS. ...*...... .RL......I T......H.. ......F...  [3077]
#BR64    G.P-....S. .....P.... .R...F...I T......H.. ...E......  [3077]
#BR69    G.P.....S. ...*.P.... .R...F...I T......H.. ...E.....?  [3077]
#Kern217 G......... .......S.. ...L...... T......... .........L  [3077]
#Rocio   GK.RA.A... I...GQ..L. S.R.DFS... T..VE.IH.G .*KER...SW  [3077]
#Ilheus  G.QR....S. ...L..DS.N ..HWAF.... ....E..HWV .SK......L  [3077]  
#FL52    DTFCKK?PKF QEERCTQMIQ PAGTPGSQKK T*RMKQK*QR EWKKGIESLQ  [3127]
#TBH-28  ..S...S... ........T. .V........ ..K....... ..........  [3127]
#FL72    ..SY..S... .....M..T. .....A.... ..K......K ..M..T..S.  [3127]
#FL85a   ..S...?... ........T. .......... ..K....... .....T....  [3127]
#FL85b   ..S...S... ........T. .......... ..K....... .....T....  [3127]
#FL89    .IS...S... R.......T. ....L..... ..K....... .....T....  [3127]
#FL90a   .IS...S... R.......T. ....L..... ..K....... .....T....  [3127]
#FL90b   .IS...?... R.......T. ....L..... ..K....... .....T....  [3127]
#FL90c   .IS...S... R.......T. ....L..... ..K....... .....T....  [3127]
#FL90d   .IS...S... R.......T. ....L..... ..K....... .....T....  [3127]
#FLS569  .IS...S..S .....M.... .....A.... ..K.R....K ..??.T.?..  [3127]
#FLS650  .IS...S..S .....M.... .....A.... ..K.R....K ..M..T....  [3127]
#TR58    ..SY..S..S .....M..T. .....A.... ..K......K ..M..T....  [3127]
#TR62    ..SY..?..S .....M..T. .....AL... I.K......K ..M..T....  [3127]
#BR64    ..S...S..S .....M..T. .....AL... ..K......K ..M..TG...  [3127]
#BR69    ..S...S..S .....M..T. .V...A.... ..K......K ..M..T....  [3127]
#Kern217 ..S...S... ........T. .......... ..K....... .........R  [3127]
#Rocio   ..SS.RF.GK KVDT.LR.TL ...IQE.H*R .WK.RPR..D G.NRS.GNW.  [3127]
#Ilheus  G..*GTSHTW RV.T.LL.TL Q..I.E.RGL ILKT.P..*T *.MEN.NNSP  [3127]
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#FL52    RQSLI*PTAI RW*KS*DQGL MGKPTWMLSP EKTKGAVDKW SHMP*TPSPT  [3177]
#TBH-28  .......... .......... .......S.L ........R. ..........  [3177]
#FL72    .R.......T .......... ...L...S.L .....V..R* ..T.......  [3177]
#FL85a   .......... .......... .......S.. .....V..R. ..........  [3177]
#FL85b   .......... .......... .......S.. .....V..R. ..........  [3177]
#FL89    ....S....T .......... ....I..S.. ......A.R. ..........  [3177]
#FL90a   ....S....T .......... .......S.. ......A.R. ..........  [3177]
#FL90b   ....S....T .......... .......S.. ......A.R. ..........  [3177]
#FL90c   ....S....T .......... .......S.. ......A.R. ..........  [3177]
#FL90d   ....S....T .......... .......S.. ......A.R. ..........  [3177]
#FLS569  .R..T...VT ?......... ...L...SFL ..I?..A.R* L.T......I  [3177]
#FLS650  .R..T...VT .......... ...L...SFL ......A.R* L.T......I  [3177]
#TR58    .R..T...VT .......... ...L...S.L .....V..R* .........I  [3177]
#TR62    .R..T...VT .......... ...L...S.L .....V..R* ..T.....L.  [3177]
#BR64    .R..T...VT .......... ..RL.....L ......A.R* ..TL......  [3177]
#BR69    .R..T...VT .......... ..RL.....L ........R* ..TL......  [3177]
#Kern217 .R........ .......... .V.....S.. ........R. ..........  [3177]
#Rocio   KP*.SSH.RT K.S..RG.EK R.RR*.TSFH .T.REG.GRL *R.....T.I  [3177]
#Ilheus  .L*SN...G. K*SR.CGLRG E.RQS.TS.. GR.REG.A.* .P.HL.....  [3177]  
#FL52    WPFN**DAWK LKGW*MRMTS RE*DSDDWPK RLSG*GRMDL ND*VEWQ*VG  [3227]
#TBH-28  .......... .......... ....L..... .......... ..........  [3227]
#FL72    .......... ...*W..... *......... .....E...P .G........  [3227]
#FL85a   .......... .......... ....L..... .......... ..........  [3227]
#FL85b   .......... .......... ....L..... .......... ..........  [3227]
#FL89    .......... .......... .......... .......... ...A......  [3227]
#FL90a   .......... .......... .......... .......... ...A......  [3227]
#FL90b   .......... .......... .......... .......... ...A......  [3227]
#FL90c   .......... .......... .......... .......... ...A......  [3227]
#FL90d   .......... .......... .......... .......... ...A......  [3227]
#FLS569  .LC....V.. ...*...... *......... Q......... .G........  [3227]
#FLS650  .LC....V.. ...*...... *......... Q......... .G........  [3227]
#TR58    .......... ...*W..... *......... ....L..... .G........  [3227]
#TR62    .......... ...*W..... *......... .......... .G.....L..  [3227]
#BR64    .......... ...*W..... *......... .......... .G........  [3227]
#BR69    .......... ...*W..... *......... .*........ .G....R...  [3227]
#Kern217 .........R .........L ....L.G... .S........ ...A......  [3227]
#Rocio   .L..SSG..R V.AFWR.KRP CGSLMPNG-- QCKPGLTPMG LKGSLRWQ*V  [3227]
#Ilheus  .RL......R GRNC.R.V.C TA.ARRRSKQ SGT..SK.EE RGFRA.LS.E  [3227]
 
#FL52    TTVL*NQLTT DLPLHSTFSI TCQQIRKDIQ EWKPSTGWHN WQEVPFCSHH  [3277]
#TBH-28  ........M. .......... ...-...... .......... ..........  [3277]
#FL72    MI......M. ...P...S.T ...-...... .......... ..........  [3277]
#FL85a   ........M. .......... ...-...... .......... ..........  [3277]
#FL85b   ........M. .......... ...-...... .......... ..........  [3277]
#FL89    ........M. ..L....... ...-...... .......... ..........  [3277]
#FL90a   ........MI ..L....... ...-...... .......... ..........  [3277]
#FL90b   ........MI ..L....... ...-...... .......... ..........  [3277]
#FL90c   ........MI ..L....... ...-...... .......... ..........  [3277]
#FL90d   ........MI ..L....... ...-...... .......... ..........  [3277]
#FLS569  MI........ .S.P..IS.T ...-...... .?....?... ..........  [3277]
#FLS650  MI........ .S.P..IS.T ...-...... .......... ..........  [3277]
#TR58    MI........ ...P...S.T ...-...... .......... ..........  [3277]
#TR62    MI......M. ...P...S.T ...-...... .......... ..........  [3277]
#BR64    MI.....SM. ...P.F.S.T ...-...... .......... ..........  [3277]
#BR69    M..S...SM. ...P...S.T ...-...... .......... ..........  [3277]
#Kern217 ........M. .........T ...-...... .......... ..........  [3277]
#Rocio   G-IAWSSPL. TDSQLLSIF* MEC.-VRKDI QEWKPSTGWT NWQEVPFCS.  [3277]
#Ilheus  M.AW..P.M. .SRAPFIS.M AW.-....T. .....V..S. ......G...  [3277]
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#FL52    FNELMLKDGR TIVVPCRSQD ELIGRARISP GAGWNVKETA CLSKSYAQMW  [3327]
#TBH-28  .......... .......... .......... .......... ..........  [3327]
#FL72    .......... .......... .......... .......... ..........  [3327]
#FL85a   .......... .......... .......... .......... ..........  [3327]
#FL85b   .......... .......... .......... ....?..... ..........  [3327]
#FL89    .......... .......... .......... .......... ..........  [3327]
#FL90a   .......... .......... .......... .......... ..........  [3327]
#FL90b   .......... .......... .......... .......... ..........  [3327]
#FL90c   .......... .......... .......... .......... ..........  [3327]
#FL90d   .......... .......... .......?.. .......... ..........  [3327]
#FLS569  .......... .......... .......... .......... ..........  [3327]
#FLS650  .......... .......... .......... .......... ..........  [3327]
#TR58    .......... .......... .......... .......... ..........  [3327]
#TR62    ....V..... .......... .......... .......... ..........  [3327]
#BR64    .......... .......... .......... .......... ..........  [3327]
#BR69    .......... .......... .......... .......... ..........  [3327]
#Kern217 .......... .......... .......... .......... ..........  [3327]
#Rocio   HFNELVMRDG RKI.VPCRAQ DELIGRARVS PGSGWSLRET ACLGKAYAQM  [3327]
#Ilheus  ....LM.... .......... ..V....V.. .S..SLR... ....A.....  [3327]  
#FL52    LLMYFHRRDL RMMANAICSA VPVNWVPTGR TTWS- [3362]
#TBH-28  .......... .......... .........- ----- [3362]
#FL72    .......... .......... .......... ....I [3362]
#FL85a   .......... .......... .......... ....I [3362]
#FL85b   .......... .......... .......... ....- [3362]
#FL89    .......... .......... .......... ....- [3362]
#FL90a   .......... .......... .......... ..--- [3362]
#FL90b   .......... .......... .......... ....I [3362]
#FL90c   .......... .......... .......... ..--- [3362]
#FL90d   .......... .......... .......... ....I [3362]
#FLS569  .......... .......... .........- ----- [3362]
#FLS650  .......... .......... .......... ....I [3362]
#TR58    .......... .......... .......... ....- [3362]
#TR62    .......... .......... .......... ....I [3362]
#BR64    .......... .......... .......... ....- [3362]
#BR69    .......... .......... .......... ....I [3362]
#Kern217 .......... .......... .......... ....I [3362]
#Rocio   W.LMYFH.RD LRLMANAICS AVPIDWVPTG R.TWS [3362]
#Ilheus  .......... .L........ ...D...... ....I [3362]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 612
APPENDIX Q 
 
Multiple Sequence Alignment: SLEV 3’NC Region 
 
St. Louis Encephalitis Virus Strains 
3’NC Region: YF1/YF2 Primer Set 
 
Nucleotide Alignment 
 
#MEGA
!Title 3'NC Region ClustalW 1.6;
!Format
   DataType=Nucleotide
   NSeqs=12 NSites=602
   Identical=. Missing=? Indel=-;
!Domain=Data;
#FL52    ACCACGGAAG ACATGCTGAG TGTCTGKTAC YGTGTGTGGA TTGAAGAAAA  [10154]
#TBH-28  .......... .......... ......GA.. T.C.....R. ..........  [10154]
#FL72    .......... .......... ......GA.. C......... .......G..  [10154]
#FL85a   .......... .......... ......G... T......... ..........  [10154]
#FL90b   .......... .......... ......GA.. C......... ..........  [10154]
#FL90d   .......... .......... ......GA.. T......... ..........  [10154]
#FLS569  .......... .......... ......GW.. C.......R. .......G..  [10154]
#TR62    .......... .......... ......TA.. T......... .K.....G..  [10154]
#BR69    ------.... .......... ......GA.. C......... .......G..  [10154]
#Kern217 ..A..A.... .....T.... ......GA.. C......... .......G..  [10154]
#WNNY99  ..A..A..G. .....T..GA G.....GA.. C....T.... .A..G..G..  [10154]
#WNEgypt ..A..A.... ........GA G.....GA.. C....T.... .A..G..G..  [10154]
#FL52    TGAATATATG AAAGACAAAA CACCATTGGC GGCTTGGAAC GACATTCCAT  [10204]
#TBH-28  ......C... .......... .......... .......... ..........  [10204]
#FL72    ......C... ..G....... .......... ...C...... ..........  [10204]
#FL85a   ......C... G......... ......K... .......... ..........  [10204]
#FL90b   .......... .......... .C........ .......... ..........  [10204]
#FL90d   .......... .......... .C........ .......... ..........  [10204]
#FLS569  ......C... ..G....... .......... .........T ..........  [10204]
#TR62    .......... C.G....... .......... A......... ..........  [10204]
#BR69    ......C... ..G....... .......... .......... ..........  [10204]
#Kern217 ......C... .......... .......... .......... ..........  [10204]
#WNNY99  .....GG... G......... .C...G...A .AAA....GT ...G.C....  [10204]
#WNEgypt .....GG... G......... .C...G...A .AAA....GT ...G.C....  [10204]  
#FL52    ACCTAGGAAA GAGAGAGGAC ATCTGGTGTG GAAGCCTTAT CGGAACAAGG  [10254]
#TBH-28  .......... .......... .......... .......... ..........  [10254]
#FL72    .......... .......... ........C. .......A.. T.........  [10254]
#FL85a   .......... .......... .......... .......... ..........  [10254]
#FL90b   .......... .......... .......... .......C.. .......C..  [10254]
#FL90d   .......... .......... .......... .......C.. .......C..  [10254]
#FLS569  .......T.. .......... .......... .......A.. T.........  [10254]
#TR62    .......... .......... ........C. .......A.. T.....G...  [10254]
#BR69    .T........ ......A... ........C. .......A.. ..........  [10254]
#Kern217 .......... .......... .......... .......... ..........  [10254]
#WNNY99  .TTC...... AC........ .......... .C.....G.. T..C.....A  [10254]
#WNEgypt ..TC...... AC.G...... .......... .C...T.G.. T..C.....A  [10254]
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#FL52    ACCAGAGCCA CCTGGGCTGA GAACATCTAC GCTCCAATCA TGCAGATCCG  [10304]
#TBH-28  .......... .......... .......... .......... ..........  [10304]
#FL72    .......... .......... .........T .......... ..........  [10304]
#FL85a   ..T....... .......... .......... .......... ..........  [10304]
#FL90b   .......... .......... .........T .......... ..........  [10304]
#FL90d   .......... .......... .........T .......... ..........  [10304]
#FLS569  .......... .......... .........T .......... ..........  [10304]
#TR62    .......... .......... .........T .......... ..........  [10304]
#BR69    .......... .......... .........T .......... ..........  [10304]
#Kern217 .......... .......... .......... .......... ..........  [10304]
#WNNY99  G..C...... .G.....A.. A......C.G .TGG.T.... AC..AG..A.  [10304]
#WNEgypt ...C...... .G.....A.. A......C.G .TAG.C.... AC..AG..A.  [10304]
 
#FL52    CAACCTCATC GGGGAAGAAG AGTACAGAGA CTACATGGTT GCCCAAAATA  [10354]
#TBH-28  .......... .......... .......... .......... ........C.  [10354]
#FL72    .........Y ........G. .......... .......... ........C.  [10354]
#FL85a   .......... .......... G......... .......... ........C.  [10354]
#FL90b   .......... .......... .......... .......... ........C.  [10354]
#FL90d   .......... .......... .......... .......... ........C.  [10354]
#FLS569  .......... .......... .......... .......A.. ........C.  [10354]
#TR62    .......... .......... .......... ...T...A.C ........C.  [10354]
#BR69    .......... .......... .......... .......A.. ........C.  [10354]
#Kern217 .......... ........G. .......... .......... ........C.  [10354]
#WNNY99  AGCAA..... ..A..T..GA ....TGTG.. .......AG. T.A.T...G.  [10354]
#WNEgypt AGCAA....T ..A..T..GA ....TGTG.. T......AG. T.ATT...G.  [10354]
#FL52    GATTTGGTAG GGAAGAAACT CATGTGGTAG GAGGAGTGTT GTAGATTAAA  [10404]
#TBH-28  .......... .......... .......... ........C. ..........  [10404]
#FL72    .......C.. .......... .......... .......... ...A......  [10404]
#FL85a   .......... .......... .......... ........C. .....C....  [10404]
#FL90b   .......... .......... .......... .......... ..........  [10404]
#FL90d   .......... .......... .......... .......... ..........  [10404]
#FLS569  .......... ...G...... .......... ........C. ...A......  [10404]
#TR62    .......C.. .......... .......... .......... ...A......  [10404]
#BR69    .......C.. .........C .......... ........C. ...AG.....  [10404]
#Kern217 .......... .......... .......... ........C. .......G..  [10404]
#WNNY99  ........T. A.G.C.C.G. AC...A...A A..TGTA... T..T.G..GT  [10404]
#WNEgypt ........T. A.G.C.C.G. AC...AA..A A..T.TA... T..T.G..GC  [10404]
 
#FL52    ATGTAAATAG TGTAAATAAA TAAAA-CAGG TAAGTCAGGC CAATTAGTTT  [10454]
#TBH-28  ...C...... .......... ..G..-.... .......... ..........  [10454]
#FL72    .......... .......... .....-.... .......... .......G..  [10454]
#FL85a   .......... ..C....... .....-T... .......... ..........  [10454]
#FL90b   .......... .......... .....-.... A......... ..........  [10454]
#FL90d   .......... .......... .....-.... A......... ..........  [10454]
#FLS569  .......... .......... .....-.... .......... ..........  [10454]
#TR62    .......... .......... .....-.... .......... ..........  [10454]
#BR69    .......C.. .......... .....-.... .......... ..........  [10454]
#Kern217 .......... .......... .....A.... .......... ....C.....  [10454]
#WNNY99  ..T..GT... ........GT ...G.AGGA. A......... .GGGA....C  [10454]
#WNEgypt ..T..GT... ........GT ...G.AGGA. G......... .GGAA.....  [10454]  
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#FL52    TGCCACCGGA TGTCAGGTAA ACGGTGCTGT CTGTAACCTG GCCCCAGGTG  [10504]
#TBH-28  .......... .......... .......... .......... ..........  [10504]
#FL72    .......... .......... .......... .......... ..........  [10504]
#FL85a   .......... .......... .......... .......... ..........  [10504]
#FL90b   .......... .......... .......... .......... ..........  [10504]
#FL90d   .......... .......... .......... .......... ..........  [10504]
#FLS569  .......... .......... .......... .......... ..........  [10504]
#TR62    .......... .......... .......... .......... ..........  [10504]
#BR69    .......... .......... .......... .......... ..........  [10504]
#Kern217 .......... .......... .......... .......... ........C.  [10504]
#WNNY99  C......... A..TGA...G .........C ...CG..TCA A.......A.  [10504]
#WNEgypt C......... A..TGA...G .........C ...CG..TCA A.......A.  [10504]  
#FL52    ACTGGGTTAT CAAAGCCTAT CTGGCTGGGT GCAAAGCCCC TCATTCCGAC  [10554]
#TBH-28  .......... .......A.C .C........ .......... ..........  [10554]
#FL72    .......... .......A.. ..A....A.. .......... ..........  [10554]
#FL85a   .......... .......A.C .C........ .......... ..........  [10554]
#FL90b   .......... .......A.. .......... .......... ..........  [10554]
#FL90d   .......... .......A.. .......... .......... ..........  [10554]
#FLS569  .......... .......A.. ..A....A.. ..G....... ..........  [10554]
#TR62    .......... .......G.. .......A.. .......... ..........  [10554]
#BR69    .......... .......A.. ..A....A.. .......... ..........  [10554]
#Kern217 .......... .......A.C .C........ .......... ..........  [10554]
#WNNY99  .......G.A .......GCG AA..A.CCA. .T-......T CAGAA...T.  [10554]
#WNEgypt .......G.A ......TGCG AA..A.CCA. .T-......T CAGAA...T.  [10554]
 
#FL52    TCGGGAGGGT CCCTGGCACG TAGGCTGGAG AGGACGCACA AGTCAGACCA  [10604]
#TBH-28  .......... .......... .....C.... .......... ..........  [10604]
#FL72    .......... .......... .......... ........A. ..........  [10604]
#FL85a   .......... .......... .......... .......... ..........  [10604]
#FL90b   .......... .......... .......... .......... ..........  [10604]
#FL90d   .......... .......... .......... .......... ..........  [10604]
#FLS569  .......... .......... .......... ........A. ..........  [10604]
#TR62    .......... ......T... .......... ........AG ..........  [10604]
#BR69    .......... .......... .......... ........A. ..........  [10604]
#Kern217 .......... .......... .......... .......... ..........  [10604]
#WNNY99  ....A....G A..CCA..T. .T.TAACTTC .AAG.C..-. T.........  [10604]
#WNEgypt ....A....G A..CCA..T. .T.TAACTTC .AAG.C..-. T.........  [10604]
#FL52    GAAATGCCAC CTRAAAGCAT GCTAGAGGTG CTGTCTGTAC ATGCCCCAGG  [10654]
#TBH-28  ........M. ..G....... ....A..... .......... ..........  [10654]
#FL72    .......... ..G....... ....A..... .......... ..........  [10654]
#FL85a   .......... ..G....... ....A..... .......... ..........  [10654]
#FL90b   .......... ..G....... ....A..... .......... ..........  [10654]
#FL90d   .......... .......... ....A..... .......... ..........  [10654]
#FLS569  .......... ..G....... ...GA..... .......... ..........  [10654]
#TR62    .......... ..G....... ....A..... .......... ..........  [10654]
#BR69    .......... ..G....... ....A..... .......... ..........  [10654]
#Kern217 .......... ..G....... ....A..... .......... ..........  [10654]
#WNNY99  CGC-.A.GG. G.GCT.CTC. ..GGAGA... .A.....CGA G.........  [10654]
#WNEgypt CGC-.A.GG. G.GCC.CTC. ..GGAGA... .A.....CGA G.........  [10654]
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#FL52    AGGA-CTGGG TTAACAAAGC TTAACAGCCC CAGCGGCCCA AACCATGGAG  [10704]
#TBH-28  ....T..... .......... .......... .......... ..--------  [10704]
#FL72    ....-..... .......... .......... .......... ..........  [10704]
#FL85a   ....-..... .......... .C........ .......... ..........  [10704]
#FL90b   ....-..... .......C.- ---------- ---------- ----------  [10704]
#FL90d   ....-..... .......... .......... .......... ..........  [10704]
#FLS569  ....-..... .......... .....----- ---------- ----------  [10704]
#TR62    ....-..... .......... .......... .......... ..........  [10704]
#BR69    ...C-A..A. .--------- ---------- ---------- ----------  [10704]
#Kern217 ....-..... .......... .......... .......... ..........  [10704]
#WNNY99  ....-..... .........G CC...GC... AC.......T .G..CC..TA  [10704]
#WNEgypt ....-..... .........G .C...GC... AC.......T .G..C...TA  [10704]
#FL52    TG [10706]
#TBH-28  -- [10706]
#FL72    .. [10706]
#FL85a   .. [10706]
#FL90b   -- [10706]
#FL90d   .. [10706]
#FLS569  -- [10706]
#TR62    .. [10706]
#BR69    -- [10706]
#Kern217 .. [10706]
#WNNY99  AT [10706]
#WNEgypt AT [10706]
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Arbovirus Strain Sequences Downloaded from GenBank 
 
 
 
St. Louis Encephalitis Virus 
 
 
West Nile Virus 
 
Arbovirus Outgroups 
Envelope Coding Sequence Complete CDS Complete CDS 
Strain  Accession # Strain Accession # Strain Accession # 
CorAn 9124 
CorAn 9275 
79V-2533 
BeAr 23379 
BeAn 246262 
Beh 203235 
BeAn 248398 
BeAn 246407 
BeAn 242587 
Span 9398 
75D90 
GMO94 
GML 900968 
PanAn 902604 
PanAn 902745 
GML 902612 
GML 902981 
GML 903797 
TR9464 
65V310 
BFS 1750 
BFS 4772 
E22924 
SOUE 135 
Kern 217 
Chlv 374 
Coav 750 
72V4749 
72V1165 
GHA 3 
Pinellas 15 
69M-1143 
L695121.05 
FL79-411 
Ft.Washington 
AF205473 
AF205474 
AF205490 
AF205485 
AF205483 
AF205484 
AF205480 
AF205482 
AF205478 
AF205472 
AF205479 
AF205513 
AF205488 
AF205471 
AF205476 
AF205475 
AF205489 
AF205487 
AF205486 
AF205470 
AF205455 
AF205454 
AF205453 
AF205458 
AF205465 
AF205464 
AF205456 
AF205497 
AF205494 
AF205505 
AF205468 
AF205460 
AF205459 
AF205467 
AF205504 
AnMg798 
Tx2004Harris4 
CO 2003 
AZ 2004 
PaAn001 
03-124 FL 
03-113 FL 
GA 2002-1 
Hungary03 
Egypt101 
TM171-03-Mx 
TX 2002 
FLO3-FL2-3┼ 
DQ176636 
DQ164206 
DQ164204 
DQ164201 
EU074023 
DQ431699 
DQ431697 
DQ164196 
DQ118127 
AF260968 
AY660002 
DQ176637 
DQ983578 
JE (Naka.) 
Rocio 
Kunjin 
MVE.1.51 
Ilheus 
EF571853 
AY632542 
AY274505 
AF161266 
NC 009028 
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┼Partial coding sequence. 
 
 
 
 
 
St. Louis Encephalitis Virus 
 
 
West Nile Virus 
 
Arbovirus Outgroups 
Envelope Coding Sequence Complete CDS Complete CDS 
Strain  Accession # Strain Accession # Strain Accession # 
VP34 
904 
MSI-7 
Parton 
Hubbard 
TNM4-711K 
75V14868 
Texas 1955 
P17797 
83V4953 
PV7-3389 
PV0-620 
PV1-2419 
98V3181 
CbaAr4005 
CbaAr4006 
SPH 253157 
AF205503 
AF205506 
M16614 
AF205509 
AF205508 
AF205501 
AF205466 
AF205512 
AF205493 
AF205498 
AF205491 
AF205492 
AF205499 
AF205500 
DQ385451 
DQ385450 
DQ22950 
 
Complete & Partial CDS 
Kern 217c 
MSI-7c 
GHA-3c 
TNM4-711Kc 
GML 902612c 
FL79-411c 
65 V 310c 
TRVL 9464c 
TBH-28c 
75 D 90c 
BeAn 246262c 
Partonc 
69M-1143c┼ 
NC 07580 
DQ359217 
EF158066 
EF158065 
EF158064 
EF158062 
EF158059 
EF158056 
EF158055 
EF158054 
EF158053 
EF158070 
EU088426 
    
 618
APPENDIX S 
 
 Amino Acid Abbreviations
One Letter Abbreviations for Amino Acids 
Symbol Amino Acid 
A Alanine 
C Cysteine 
D Aspartic Acid 
E Glutamic Acid 
F Phenylalanine 
G Glycine 
H Histidine 
I Isoleucine 
K Lysine 
L Leucine 
M Methionine 
N Asparagine 
P Proline 
Q Glutamine 
R Arginine 
S Serine 
T Threonine 
V Valine 
W Tryptophan 
Y Tyrosine 
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Second Multiple Sequence Alignments: SLEV Envelope Region 
 
St. Louis Encephalitis Virus 
Envelope Region: F880/B2586 Primer Set 
Nucleotide Alignment 
 #Kern217     TTT GTG ATC ATG CTG ATG CTG ATT GCT CCG GCA TAC AGC  [ 963]
#Chlv374     ... ... ..T ... ... ... ... ... ... ... ... ... ...  [ 963]
#Coav750     ... ... ... ... ..T ... ... ... ..C ... ... ..T ...  [ 963]
#Soue135     ... ... ... ... ..T ... ... ... ..C ... ... ..T ...  [ 963]
#BFS1750     ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#BFS4772     ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#E22924      ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#72V1165     ... ... ... ... ..T ... ... ... ..C ... ... ..T ...  [ 963]
#72V4749     ... ... ... ... ..T ... ... ... ..C ... ... ..T ...  [ 963]
#FortWash    ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#VP34        ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#Parton      ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#Hubbard     ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#MSI-7       ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#904         ..C ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#75V14868    ..C ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#TNM4-711K   ... ... ... ... ... ... ... ..A ... ... ... ... ...  [ 963]
#83V4953     ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#98V3181     ... ... ... ... ... ... T.. ... ... ... ... ... ...  [ 963]
#PV7-3389    ... ... ... ... ..T ... ... ... ..C ... ... ..T ...  [ 963]
#PV0-620     ... ... ... ... ..T ... ... ... ..C ... ... ..T ...  [ 963]
#P17797      ... ... ... ... ..T ... ... ... ..C ... ... ..T ...  [ 963]
#PVI-2419    ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#Tex1955     ... ... .C. ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL52        ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#GHA-3       ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#Pinellas15  ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#69M-1143    ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]  #L695121.05  ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL79-411    ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL85a       ... ... ... ... ... ... ... ..G ... ... ... ... ...  [ 963]
#FL85b       ... ... ... ... ... ... ... ... ... ... .S. ... ...  [ 963]
#FL89        ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL90a       ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL90b       ... ..S ... ... ... ... ... ..G ... ... ... ... ...  [ 963]
#FL90c       ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#FL90d       ... ... ... ... ... ... ... ..G ... ... ... ... ...  [ 963]
#FLS569      ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#FLS650      ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#FL72        ... ... ... ... ... ... T.. ... ..C ..A ... ... ...  [ 963]
#TR58        ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#TR62        ... ... ... ... ... ... A.. ..G ..C ... K.. ... ...  [ 963]
#TR9464      ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#75D90       ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#BR64        ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#BR69        ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#BeAr23379   ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#BeAn246407  ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#BeAn242587  ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#BeAn246262  ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#BeH203235   ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#BeAn248398  ... ... ... ... ... ... T.. ... ... ... ... ... ...  [ 963]
#SPH253157   --- --- --- --- --- --- --- --- --- --- --- --- ---  [ 963]
#Span9398    ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#65V310      ... ... ... ... ..A ... ... ... ... ... ... ... ...  [ 963]
#PanAn902604 ... ... ... ... ... ... ... ... ... ... ... ... ...  [ 963]
#PanAn902745 ... ... ... ... ... ... T.. ... ..C ... ... ... ..T  [ 963]
#GML903797   ... ... ... ... ... ... T.. ... ..C ..A ... ... ...  [ 963]
#GML902981   ... ... ... ... ... ... T.. ... ..C ..T ... ... ..T  [ 963]
#GMO94       ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#79V2533     ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#CbaAr4005   --- --- --- --- --- --- --- --- --- --- --- --- ---  [ 963]
#CbaAr4006   --- --- --- --- --- --- --- --- --- --- --- --- ---  [ 963]
#CorAn9124   ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#CorAn9275   ... ... ... ... ... ... T.. ... ..C ... ... ... ...  [ 963]
#WNNY99      ... ..C G.G C.A T.. C.T T.. G.G ..C ..A ..T ... ...  [ 963]  #WNEgypt     ..C ..T G.G C.A ... C.C T.. G.G ... ..A ..C ... ...  [ 963]
#Kunjin      ... .CC G.G T.A ... C.T T.. G.A ... ..A ..T ... ...  [ 963]
#JE          ..C ACC ... C.C ... C.. T.. G.C ... ... ..T ... ..T  [ 963]
#MVE         ... ACA G.G C.T T.. C.C ..C G.. ... ..T ..C ... ..T  [ 963]  
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#Kern217     TTC AAC TGT CTG GGA ACA TCA AAC AGG GAC TTT GTC GAG  [1002]
#Chlv374     ... ... ... ... ... ... ... ... ... ... ... ... ...  [1002]
#Coav750     ..T ... ... T.A ... ... ... ... ..A ... ... ... ...  [1002]
#Soue135     ..T ... ... T.A ... ... ... ... ..A ... ... ... ...  [1002]
#BFS1750     ..T ... ... ... ... ... ... ... ..A ... ..C ... ..A  [1002]
#BFS4772     ..T ... ... ... ... ... ..G ... ..A ... ..C ... ..A  [1002]
#E22924      ..T ... ... ... ... ... ..G ... ..A ... ..C ... ..A  [1002]
#72V1165     ..T ... ... T.A ... ... ... ... ..A ... ... ... ...  [1002]
#72V4749     ... ... ... T.A ... ... ... ... ..A ... ... ... ...  [1002]
#FortWash    ... ... ... ... ... ... ... ... ... ... ... ... ...  [1002]
#VP34        ... ... ... ... ... ... ... ... ... ... ... ... ...  [1002]
#Parton      ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#Hubbard     ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#MSI-7       ... ... ... ... ... ... ... ... ... ... ... ... ...  [1002]
#904         ..T ... ... T.. ... ... ... ... ... ..T ... ... ...  [1002]
#75V14868    ... ... ... ... ... ... ... ... ... ... ... ... ...  [1002]
#TNM4-711K   ... ... ... T.A ... ... ... ... ... ... ... ... ...  [1002]
#83V4953     ... ..T ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#98V3181     ... ..T ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#PV7-3389    ..T ... ... T.A ... ... ... ... ..A ... ... ... ...  [1002]
#PV0-620     ..T ... ... T.A ... ... ... ... ..A ... ... ... ...  [1002]
#P17797      ..T ... ... ..A ... ... ... ... ..A ... ... ... ...  [1002]
#PVI-2419    ... ..T ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#Tex1955     ... ..T ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#FL52        ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#GHA-3       ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#Pinellas15  ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#TBH-28      ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#69M-1143    ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#L695121.05  ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#FL79-411    ... ... ... ... ..G ... ... ... ... ... ... ... ...  [1002]
#FL85a       ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
#FL85b       ... ... ... T.. ... ... ... ... ... ... ... ... ...  [1002]
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#E22924      .....NQ... ...G....E. S......... ..C.GR.... ...H......  [758]
#72V1165     ..Y..NQ... ...G....E. .........A ..C.GR.... ..........  [758]
#72V4749     ..Y..NQ... ...G....E. .........A ..C.GR.... ...H......  [758]
#FortWash    .......... ...G....E. .......... .......... ..........  [758]
#VP34        .......... ...G....E. .......... .......... ..........  [758]
#Parton      .......... ..KG....E. .......... .......... ..........  [758]
#Hubbard     .......... ..KG....E. .......... .......... ..........  [758]
#MSI-7       .......... ...G....E. .......... P......... ..........  [758]
#904         .......... ...G....E. .......... ...PG.Y... ..........  [758]
#75V14868    .......... ...G...... .......G.. .......... ..........  [758]
#TNM4-711K   .......... ...G.*Y.E. .......... .......... ...H....*.  [758]
#83V4953     .......... ...G....E. ....L..... .......... ..........  [758]
#98V3181     .......... ...G...RE. ....L..... I......... ...H......  [758]
#PV7-3389    ..Y..NQ... ...G....E. .........A ..C.GR.... ..........  [758]
#PV0-620     ..Y..NQ... ...G....E. .........A ..C.GR.... ..........  [758]
#P17797      ..Y..NQ... ...G....E. .........A ..C.GR.... .......S..  [758]
#PVI-2419    ..Y....... ...G....E. ....L..... V......... ..........  [758]
#Tex1955     .......... ...G....E. .......... .......... ..........  [758]
#FL52        ...R...... ...G....E. .......... ......Y... ...C......  [758]
#GHA-3       .......... ...G....K. .......... .G....Y... ..........  [758]
#Pinellas15  .......... .*.G....E. .......... ..H....... ..........  [758]
#TBH-28      .......... .*.G....E. .......... .......... ..........  [758]
#69M-1143    ...Y...... ...G...RE. ......G... .......... ..........  [758]
#L695121.05  ...Y...... ...G...RE. ......G... .......... ..........  [758]
#FL79-411    .......... ...G...RE. .......... .......... .........L  [758]
#FL85a       .......... ...G....E. .......... .......... ..........  [758]
#FL85b       .......... ...G....E. .......... .......... ..........  [758]
#FL89        .......... ........E. ....L..... T......... ..........  [758]
#FL90a       .......... ........E. ....L..... T......... ..........  [758]
#FL90b       .......... ........E. ....L..... T......... ..........  [758]
#FL90c       .......... ........E. ....L..... T......... ..........  [758]  #FL90d       .......... ........E. ....L..... T......... ..........  [758]
#FLS569      .....NQ... ...G....E. ...Y....T. T...G..... .R.H...L*.  [758]
#FLS650      .....NQ... ...G....E. ...Y....T. T...G..... .R.H...L*.  [758]
#FL72        ..Y..NQ... ...G....E. ...Y....T. ....G..... .R.H...L..  [758]
#TR58        .....NQ... ...G....E. ...Y....T. ....G..... ...H...L..  [758]
#TR62        ..Y..NQ... ...G....E. ...Y....T. V...GR.... .R.H...L..  [758]
#TR9464      ......Q... ...G....E. ...N....T. ....G..... F.VH...L..  [758]
#75D90       .....NQ... ...G....E. ...Y..G.T. ....G..... .R.H...L..  [758]
#BR64        .....NQ... ...G....E. ...Y....T. ....G..... .R.H...L*.  [758]
#BR69        .....NQ... ...G....E. ...Y....T. ....G..... .R.H...L..  [758]
#BeAr23379   .....NQ... ...G....E. ...Y....T. ...PG.Y... .R.H...L..  [758]
#BeAn246407  .....NQ... ...G....E. ...Y....T. ....G..... .R.HR..L..  [758]
#BeAn242587  .....NQ... ...G....E. ...Y....T. ....G..... .R.H...L..  [758]
#BeAn246262  .....NQ... ...G...RE. ...Y....T. ....G..... .R.H...L..  [758]
#BeH203235   .....NQ... ...G....E. S..Y....T. ....G..... .R.H...L..  [758]
#BeAn248398  .....NQ... ...G....E. ...Y....T. ....G..... ...H...L..  [758]
#SPH253157   ......Q... ...G....E. .S........ ...FG...M. FR........  [758]
#Span9398    ..Y...Q.S. ...G....E. S......... .......C.. ..........  [758]
#65V310      ........S. ...G....E. .......... .......... ..........  [758]
#PanAn902604 .......... ...G....E. .......... .......... ..........  [758]
#PanAn902745 .GYR..Q... ...G...RK. ......G... .GHPG..... ...H...L..  [758]
#GML903797   .....NQ... ...G....E. L..Y....S. ...FG..C.. F..H......  [758]
#GML902981   .GYR..Q... ...G....K. .......... ....G..... ...H.....L  [758]
#GMO94       .......... ...G..Y.E. .......... .......... F........L  [758]
#79V2533     ......Q... ...G....E. ..N....... ...FG..... .R.H......  [758]
#CbaAr4005   ......Q... ...G....ES ..N....... ...FG..... .R........  [758]
#CbaAr4006   ......Q... ...G....ES ..N....... ...FG..... .R........  [758]
#CorAn9124   .G..SNQ... ...G....E. .......... ...FG..... .....G....  [758]
#CorAn9275   .G..SNQ... ...G....E. .......... ...FG..... .....G....  [758]
#WNNY99      Q.RTT.QS.. ..VW....QS LYN.PQ..AE T..S.R..L. ...S..GVHL  [758]
#WNEgypt     Q.RTT..S.. ..VW....QS LHN.PQ.GAE I..P.RY.L. ...S..GVHL  [758]
#Kunjin      ..RAT.QPS. ..VW.*..QS .HS.PQG.SE T.SSGR..L. ...G...VYL  [758]
#JE          .GRQA..P.. ..GW.HAGQS LFNDF.G.SK TGSVGR..L. ..L...G..L  [758]
#MVE         QGRQA.QS.. .*GG*FN.QS LQHNL.G.TE IGSSWR.G.. ...SR..L..  [758]
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#Kern217     NWQSCPPSFR RSVQDPVRGN VLDHTGTTWS SSPVDGVAGP RQEHLADSTG  [808]
#Chlv374     .......... .......... .......... .......... ..........  [808]
#Coav750     .R..YSS.VW .G.*.S.... .......... P..L..A... ..........  [808]
#Soue135     .R..YSS.VW .G.*.S.... .......... P.....A... ..........  [808]
#BFS1750     .R..S.S..W ...*.S.... .......A.. P......... ..........  [808]
#BFS4772     .R..S.S..W ...*.S.... .......A.. P......... ..........  [808]
#E22924      .R..S.S..W ...*.S.... .......A.. P......... ..........  [808]
#72V1165     .R..YSS.VW .G.*.S.... .......... P.....A... ..........  [808]
#72V4749     .R..YSS.VW .G.*.S.... .......... P.....A... ..........  [808]
#FortWash    .......... .....S.... .......... .......... ..........  [808]
#VP34        .......... .....S.... .......... .......... ..........  [808]
#Parton      .C..R..... .....S.... .......... P.L....... ..........  [808]
#Hubbard     ....R..... .....S.... .......... P.L....... ..........  [808]
#MSI-7       .......... .....S.... ......A... .......... ..........  [808]
#904         .......... ..I*.F.W.. .......... PP.....T.. .....T....  [808]
#75V14868    .....S.... .......... .......... .......... ..........  [808]
#TNM4-711K   .......... .....S.... .......A.. P......... ....FV....  [808]
#83V4953     .......... ...*.S.... .......A.. P......... .....V....  [808]
#98V3181     .......... ...*.S.... .......A.. P......... .....V....  [808]
#PV7-3389    .R..YSS.VW .G.*.S.... .......... P..L..A... ..........  [808]
#PV0-620     .R..YSS.VW .G.*.S.... .......... P..L..A... ..........  [808]
#P17797      .R..YSS.VW .G.*.S.... .......... P.....A... ..........  [808]
#PVI-2419    .......... ...*.S.... .......A.. P......... .....V....  [808]
#Tex1955     .......... ..I..F.... .......... P......... ..........  [808]
#FL52        ........L. .....S.... .......... P......... ..........  [808]
#GHA-3       .......... ...*.S.... .......... P......... ........ID  [808]
#Pinellas15  .......... .....SI... .......... .......... ..........  [808]
#TBH-28      .........? .....SI... .......... .......... ..........  [808]
#69M-1143    ..*....... ...*.F...D ...Y.....G P.S....... ...C......  [808]
#L695121.05  ..*....... ...*.F...D ...Y.....G P.S....... ...C......  [808]
#FL79-411    .......... .....S.... .......... .......... ..........  [808]
#FL85a       .......... .....S.... .......... .......... ..........  [808]
#FL85b       .......... .....S.... .......... .......... ..........  [808]
#FL89        .......... ...*.S.... .......A.. P......... ....FV....  [808]
#FL90a       .......... ...*.S.... .......A.. P......... ....FV....  [808]
#FL90b       .......... ...*.S.... .......A.. P......... ....FV....  [808]
#FL90c       .......... ...*.S.... .......A.. P......... ....FV....  [808]  #FL90d       .......... ...*.S.... .......A.. P......... ....FV....  [808]
#FLS569      .R.......W .GI..S..R. ......I... ..L....... *...F.....  [808]
#FLS650      .R.......W .GI..S..R. ......I... ..L....... *...F.....  [808]
#FL72        .R......LW .GI....... ......IA.. P.L....... .....V.P..  [808]
#TR58        .R.......W .GI..S.... ......I... P.L....... .......P..  [808]
#TR62        .R.G.....W .GI..S.... ......I... P.L....... .......P..  [808]
#TR9464      .R.......W .GI..S.W.. .......... P.L....... ..........  [808]
#75D90       .R.......W .GI..S..R. ......I... ..L....... *.........  [808]
#BR64        .R...A...W .GI..S.... ......I... P.L....... .....V....  [808]
#BR69        .....A.?.W .GI..S.... ......I... P.L....... .....V....  [808]
#BeAr23379   .........W .GI....... ......IA.. P.L....... .....V.P..  [808]
#BeAn246407  .R.......W .GI..S..R. ......I... P.L....... *..Y......  [808]
#BeAn242587  .R.......W .GI..S..R. ......I... ..L....... **........  [808]
#BeAn246262  .R.......W .GI....... ......IA.. P.L....... .....V.P..  [808]
#BeH203235   .R.......W .GI....... .......A.. P.L....... .....V.P..  [808]
#BeAn248398  .R.......W .GI..F..R. ......I... ..L....... *.........  [808]
#SPH253157   ........LW .G.....W.. .......... P........S ...Y......  [808]
#Span9398    .........W ..I*.F.... .......... P......... ..........  [808]
#65V310      .......... .....S.... .......... .......... .........D  [808]
#PanAn902604 .........W .....S.... .......... .......... .....V..I.  [808]
#PanAn902745 .........W .G........ ......I... P.L....... .*...V....  [808]
#GML903797   .R*...S..W .G..NS.... ......I... .PV....... ..K.F....S  [808]
#GML902981   .R...A...W .G........ ......I... P.L....... .....V....  [808]
#GMO94       .......... .....S.... .......A.. P......... ..........  [808]
#79V2533     .R......LW .G........ ...Y...... P.L....... ....F.....  [808]
#CbaAr4005   .R......LW .G........ ...Y...... P......... ....F.....  [808]
#CbaAr4006   .R......LW .G........ ...Y...... P......... ....F.....  [808]
#CorAn9124   .R......VW .....L.W.. ......I... P.L....... ........I.  [808]
#CorAn9275   .R......VW .....L.W.. ......I... P.L....... ........I.  [808]
#WNNY99      S.EG..S.V. ..IPLT..RH ...NARIAGG .PV...HQCS **V.SSHVSR  [808]
#WNEgypt     SGEG..S.VW W.IPLT..RH ...NARIAGG .AV...HQCS *.V.SSHVSR  [808]
#Kunjin      RGKG..S.IW W.IPLI.WRH ...NS.SAGG PPI...Y*RS **I.SPHVPR  [808]
#JE          HRE.RS..VW WCL.NTL... .....RANGG PTTL..RQRT .PINCSGLLS  [808]
#MVE         .RKGST..LW ..I*N.LWR. .M.QPRSAGG VTAM..GQC* .*INCFGFPS  [808]
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#Kern217     CWRDSYLSGN QRASRFGMCN *PTTT*IEMW RRHLRVQRR [847]
#Chlv374     .......... .......... .......... ........C [847]
#Coav750     R....H...D .C......R. R......K.. ......*.. [847]
#Soue135     R....H...D ........R. R...A..K.. ......*.. [847]
#BFS1750     R....HF..D ....*..... .......... ......... [847]
#BFS4772     R....HF..D ....*..... .......... ......... [847]
#E22924      R....HF..D ....*..... .......... ......... [847]
#72V1165     R....H...D ........R. R......K.. ......*.. [847]
#72V4749     R....H...D ........R. R......K.. ......*.. [847]
#FortWash    .....H.... .......... .......... ......... [847]
#VP34        .....H.... .......... .......... ......... [847]
#Parton      .R...H.... .......... .......... ......... [847]
#Hubbard     .R...H.... .......... .......... .....---- [847]
#MSI-7       .R...H.... .......... .......... ......*.. [847]
#904         .R...H.... .......... .......... ......... [847]
#75V14868    .R...H.... .......... .......... ......... [847]
#TNM4-711K   .R...H.... .....L.... .......... ..Y...... [847]
#83V4953     .R.N.H.... ..T..L.... .......... ..Y...... [847]
#98V3181     .R.N.R.... ..T..L.... .......... ..Y...*.. [847]
#PV7-3389    R....H...D .C......R. R......K.. ......*.. [847]
#PV0-620     R....H...D .C......R. R......K.. .....?*.. [847]
#P17797      R....H...D ........R. R......K.. ......*.. [847]
#PVI-2419    .R.N.HF... ..T..L.... .......... ..Y...... [847]
#Tex1955     .R...H...Y .......... .......... .......*. [847]
#FL52        YR...H.... .......... .......... ......... [847]
#GHA-3       .R...H.... ..T....... .......... ..Y...... [847]
#Pinellas15  .R...HF... .......... .......... ......... [847]
#TBH-28      .R...HF... .......... .......... ......... [847]
#69M-1143    .R.N.H.... .......... ...A....V. ......... [847]
#L695121.05  .R.N.H.... .......... ...A....V. ......... [847]
#FL79-411    .R...H.... .......... .......... ......... [847]
#FL85a       .R...H.... .......... .L........ ..Y...... [847]
#FL85b       .R...H.... .......... .L........ ..Y...... [847]
#FL89        .R.N.H.... ..T..L.... .......... ..Y...... [847]
#FL90a       .R.N.H.... ..T..L.... .......... ..Y...... [847]
#FL90b       .R.N.H.... ..T..L.... ...?...... ..Y...... [847]
#FL90c       .R.N.H.... ..T..L.... .......... ..Y...... [847]  #FL90d       .R.N.H.... ..T..L.... .......... ..Y...... [847]
#FLS569      .....D..SD ....*..... .L........ .......*. [847]
#FLS650      .....D..SD ....*..... .L........ .......*. [847]
#FL72        .....N..SD ....*..... ..A....... .......*. [847]
#TR58        .....N.PSD .C..*..... .......... .......*C [847]
#TR62        .....N..SD .C..*L.... .......... .......*. [847]
#TR9464      .....N..SD ....*..... .......... .......*. [847]
#75D90       .....N..SD ....*..... .......... .......*. [847]
#BR64        .....N..SD .C..*..... .......... ....C..*C [847]
#BR69        R...FN..SD .C..*..... .......... .......*C [847]
#BeAr23379   .....N..SD ....G..... .L........ .......*. [847]
#BeAn246407  .....N..SD ....*....H .......... ....C..*C [847]
#BeAn242587  .....N..SD ....*..... .L........ .......*. [847]
#BeAn246262  .....N..SD ....*..... ..A....... .......*. [847]
#BeH203235   .....N..SD ....*..... ..A....... .......*. [847]
#BeAn248398  .....N..SD ....*..... ......T... .......*. [847]
#SPH253157   .........D ....------ ---------- --------- [847]
#Span9398    .R...H.... .......... .......... ......... [847]
#65V310      .R...H.... .......... .L........ ......... [847]
#PanAn902604 .R...H.... .......... ...A...... ........C [847]
#PanAn902745 .....N..SD ....*..V.. .......... ..Y....*. [847]
#GML903797   .G..FD.FS. ....*L.... .......... ...F...*. [847]
#GML902981   .....N..SD ....*..VR. .SA....... .......*. [847]
#GMO94       .R...H.... ....*.R... .........R ..Y...... [847]
#79V2533     .........D ....*..... ..A....... ......... [847]
#CbaAr4005   .........D ....------ ---------- --------- [847]
#CbaAr4006   .........D ....------ ---------- --------- [847]
#CorAn9124   H...FN..SD *...*..... .S.A...... .......*. [847]
#CorAn9275   H...FN..SD *...*..... .S.A...... .......*. [847]
#WNNY99      S..S.A.PLR E..R*HWV.H RHQPARA... KWSVHT.*C [847]
#WNEgypt     S..GFA..LR E..R*HW..H RHQPAGA... KWSVHT.*C [847]
#Kunjin      G..S.A..LR E..C*YW..H RYKSARV.V. Q.SIYT.*C [847]
#JE          HR.CARVLSD .C.C*HW..H .RHKKRD.V. KW...A... [847]
#MVE         NR.RFVVP.H KCPC*HWLRD .HHQEGAQV. Q.NIHT.*C [847]  
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Second Multiple Sequence Alignment: SLEV M/E Region 
 
St. Louis Encephalitis Virus 
Membrane/Envelope Region: SLEC primer set 
 
Nucleotide Alignment 
#MEGA
!Title Membrane/Envelope Region SLEV;
!Format
   DataType=Nucleotide CodeTable=Standard
   NSeqs=23 NSites=352
   Identical=. Missing=? Indel=-;
!Domain=Data property=Coding CodonStart=1;
#FL52        GAC GGT CAA TCT CTG TGC AGC ATC ATG GAG ATT CCA CAC  [772]
#GHA-3c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [772]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [772]
#FL72        ... ... ... ... ... ... ... ... .C. ... ... ... ...  [772]
#FL79-411c   ... ... ... .T. ... ... ... ... ... ... ... ... ...  [772]
#FL85a       ... ... ... ... ... ... ... ... ... ... ... ... ...  [772]
#FLS569      .G. ... ... .T. ... ... ... ... .C. ... .C. ... ...  [772]
#FLS649      ... ... ... ... ... ... ... ..T ..T .G. ... ... ..A  [772]
#FLS650      ... ... ... ... ... ... ... ... .C. ... .C. ... ...  [772]
#FLS694      ... ... ... ... ... ... ... ... ... ... ... ... ...  [772]
#Partonc     ... ... ... ... ... ... ... ... ... ... ... ... ...  [772]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [772]
#TNM4-711Kc  ... ... ... ... ... ... ... ... .C. ... ... ... ...  [772]
#Kern217     ... ... ... .T. ... ... ... .C. ... ... ... ... ...  [772]
#TR62        ... ... ... ... ... ... ... ... ... ... .C. ... ...  [772]
#BR69        ... ... ... ... ... ... ... ... .C. ... .C. ... ...  [772]
#65V310c     ... ... ... .T. ... ... ... ... ... ... ... ... ...  [772]
#75D90c      .G. ... ... .T. ... ... ... ... .C. ... .C. ... ...  [772]
#BeAn246262c .G. ... ... .T. ... ... ... ... .C. ... .C. ... ...  [772]
#GML902612c  .G. .A. ... .T. ... ... ... .C. .C. ... .C. ... ..T  [772]
#TRVL9464c   .G. ... ... .T. ... ... ... ... ... ... .C. ... ...  [772]
#WNNY99      .GA ... ..C .GA .A. ... ..A CA. .C. ... .AA G.. .T.  [772]
#WNEgypt     .GA ... ..C .GA .A. ... ..A CA. ... ... .AA G.. .T.  [772]
 
#FL52        TGG CAA CAA AGA ACA CGC CAT GGT TGG ACA CCG TGA AAA  [811]
#GHA-3c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [811]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [811]
#FL72        ... ... ... ... ... ... ... ..C .A. ... ... ... ...  [811]
#FL79-411c   ... ... ... ... ... ... ... ... ... ... ... ... ...  [811]
#FL85a       ... ... ... ... ... ... ... ..C ... ... ... ... ...  [811]
#FLS569      ... ... ... ... ... ... ... ..C ... ... ... .A. ...  [811]
#FLS649      ... ... ... ... ... A.. ... ... ... ... ... ... ...  [811]
#FLS650      ... ... ... ... ... ... ... ..C ... ... ... .A. ...  [811]
#FLS694      ... ... ... ... ... ... ... ... ... ... ... ... ...  [811]
#Partonc     ... ... ... ... ... ... ... ... ... ... ... ... ...  [811]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [811]
#TNM4-711Kc  ... ... ... ... ... ... ... ... ... ... ... ... ...  [811]
#Kern217     ... ... ... ... ... ... ... ... ... ... ... ... ...  [811]
#TR62        ... ... ... ... ... ... ... ..C .A. ... .T. ... ...  [811]
#BR69        ... ... ... ... ... ... ... ..C ... ... ... ... ...  [811]
#65V310c     ... ... ... ... ... ... ... ... ... ... ... ... ...  [811]
#75D90c      ... ... ... ... .T. ... ... ..C ... ... ... ... .G.  [811]
#BeAn246262c ... ... ... ... ... ... ... ..C .A. ... ... .A. ...  [811]
#GML902612c  ... ... .G. ... ... ... ... ... ... ... ... ... ...  [811]
#TRVL9464c   ... ... ... ... ... ... ... ..C ... ... ... ... ...  [811]
#WNNY99      .A. .G. AC. ... .GG G.G .T. ..A ... ... G.A CC. .GG  [811]
#WNEgypt     .A. .G. AC. ... .GG G.G .T. ..A ... ... G.A CC. .GG  [811]  
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#FL52        CCA CCA AAT ACT TGA CAA AAG TCG AAA ACT GGG TTT TGC  [850]
#GHA-3c      ... ... ... ... ... ... ... ... ... ... ... ..C ...  [850]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [850]
#FL72        ... .T. .G. ... ... ... ... ... ... ... ... ..C ...  [850]
#FL79-411c   ... ... ... ... ... ... ... ... ... ... ... ... ...  [850]
#FL85a       ... ... ... ... ... ... ... ... ... ... ... ... ...  [850]
#FLS569      ... ... .G. ... ... ... ... .T. ... ... ... .CC ...  [850]
#FLS649      ... ... ... ... ... ... ... ... ... ... ... ... ...  [850]
#FLS650      ... ... .G. ... ... ... ... .T. ... ... ... .CC ...  [850]
#FLS694      ... ... .G. ... ... ... ... .T. ... ... ... ..C ...  [850]
#Partonc     ... ... ... ... ... ... ... ... ... ... ... ... ...  [850]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [850]
#TNM4-711Kc  ... ... ... ... ... ... ... ... ... ... ... ... ...  [850]
#Kern217     ... ... ... ... ... ... ... ... ... ... ... ... ...  [850]
#TR62        ... .T. .G. ... ... ... ... ... ... ... ... ..C ...  [850]
#BR69        ... ... .G. ... ... ... ... ... ... ... ... ..C ...  [850]
#65V310c     ... ... ... ... ... ... ... ... ... ... ... ... ...  [850]
#75D90c      ... ... .G. ... ... ... ... .T. ... ... ... ..C ...  [850]
#BeAn246262c ... .T. .G. ... ... ... ... ... ... ... ... ..C ...  [850]
#GML902612c  ... ... .G. ... ... ... ... ... ... ... ... ..C ...  [850]
#TRVL9464c   ... ... .G. ... ... ... ... ... ... ... ... ..C ...  [850]
#WNNY99      ... .A. GG. .T. ..G T.. ..A CA. ..T CA. ..A .C. ..A  [850]
#WNEgypt     .T. .A. GG. .T. ..G T.. ..A CA. ..T CA. ..A .C. ..A  [850]
 
#FL52        GCA ATC CTG GAT ATG CCC TAG TTG CGC TGG CGA TTG GAT  [889]
#GHA-3c      ... ... ... ... ... ... ... ... ... ... ... .C. ...  [889]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [889]
#FL72        ... ... .C. ... ... ... ... ... ... ... ... ... ...  [889]
#FL79-411c   ... ... ... ... ... ... ... ... ... ... ... ... ...  [889]
#FL85a       ... ... ... ... .C. ... ... ... ... ... ... ... ...  [889]
#FLS569      ... ... ... ... ... ... ... ... .A. ... ... ... ...  [889]
#FLS649      ... ... ... ... ... ... ... ... ... ... ... ... ...  [889]
#FLS650      ... ... ... ... ... ... ... ... .A. ... ... ... ...  [889]
#FLS694      ... ... ... ... ... ... ... ... ... ... ... ... ...  [889]
#Partonc     .T. ... ... ... ... ... ... ... ... ... ... ... ...  [889]
#MSI-7c      .T. ... ... ... ... ... ... ... ... ... ... ... ...  [889]
#TNM4-711Kc  ... ... ... ... ... ... ... ... ... ... ... ... ...  [889]
#Kern217     ... ... ... ... ... ... ... ... ... ... ... ... ...  [889]
#TR62        ... ... .C. ... ... ... ... ... ... ... ... ... ...  [889]
#BR69        ... ... .C. ... ... ... ... ... ... ... ... ... ...  [889]
#65V310c     ... ... ... ... ... ... .G. ... ... ... ... ... ...  [889]
#75D90c      ... ... ... ... ... ... ... ... .A. ... ... ... ...  [889]
#BeAn246262c ... ... .C. ... ... ... ... ... ... ... ... ... ...  [889]
#GML902612c  ... ... ... ... ... ... ... ... ..T ... ... ... .G.  [889]
#TRVL9464c   ... ... .C. ... ... ... ... ... ... ... ... ... ...  [889]
#WNNY99      .G. .C. ... ... ... ... .G. .G. .AG CC. TC. ... .T.  [889]
#WNEgypt     .G. .C. .C. ... ... ... .G. .G. .AG CC. TC. ... .T.  [889]  
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#FL52        GGA TGC TAG GTA GCA ACA ACA CAC AGA GAG TGG TCT TTG  [928]
#GHA-3c      ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [928]
#FL72        ... ... .G. .C. ... ... ... ... ... ... ... ... ...  [928]
#FL79-411c   ... ... ... ... ... ... ... ... ... ... ... .T. ...  [928]
#FL85a       ... ... ... ... ... ... ... ... ... ... ... ... ...  [928]
#FLS569      ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#FLS649      ... ... ... ... ... ... ... ... ... ... ... ... ...  [928]
#FLS650      ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#FLS694      ... ... ... ... ... ... ... ... ... ... ... ... ...  [928]
#Partonc     ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#MSI-7c      ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#TNM4-711Kc  ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#Kern217     ... ... ... ... ... ... ... ... ... ... ... .T. ...  [928]
#TR62        ... ... ... .C. .T. ... ... ... ... ... ... ... ...  [928]
#BR69        ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#65V310c     ... ... ... ... ... ... ... ... ... ... ... ... ...  [928]
#75D90c      ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#BeAn246262c ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#GML902612c  ... ... .G. ... ... ... ... ... ... ... ... ... ...  [928]
#TRVL9464c   ... ... ... .C. ... ... ... ... ... ... ... ... ...  [928]
#WNNY99      ... ... .T. .G. ... ... C.. TG. ... ... .T. .G. ...  [928]
#WNEgypt     ... ... .T. .A. ... ... C.. TG. ..C ... .T. .G. .C.  [928]  
#FL52        TGA TCA TGC TGA TGC TGA TTG CTC CGG CAT ACA GCT TCA  [967]
#GHA-3c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [967]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [967]
#FL72        ... ... ... ... ..T ... ... .C. .A. ... ... ... .T.  [967]
#FL79-411c   ... ... ... ... ... ... ... ... ... ... ... ... ...  [967]
#FL85a       ... ... ... ... ... ... ... ... ... ... ... ... ...  [967]
#FLS569      ... ... ... ... ..T ... ... .C. ... ... ... ... ...  [967]
#FLS649      ... ... ... ... ... ... ... ... ... ... ... ... ...  [967]
#FLS650      ... ... ... ... ..T ... ... .C. ... ... ... ... ...  [967]
#FLS694      ... ... ... ... ... ... ... ... ... ... ... ... ...  [967]
#Partonc     ... ... ... ... ... ... ... ... ... ... ... ... ...  [967]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [967]
#TNM4-711Kc  ... ... ... ... ... ... .A. ... ... ... ... ... ...  [967]
#Kern217     ... ... ... ... ... ... ... ... ... ... ... ... ...  [967]
#TR62        ... ... ... ... ..T ... ... .C. ... ... ... ... .T.  [967]
#BR69        ... ... ... ... ..T ... ... .C. ... ... ... ... .T.  [967]
#65V310c     ... ... ... .A. ... ... ... ... ... ... ... ... ...  [967]
#75D90c      ... ... ... ... ..T ... ... .C. ... ... ... ... ...  [967]
#BeAn246262c ... ... ... ... ..T ... ... .C. ... ... ... ... .T.  [967]
#GML902612c  ... ... ... ... ..T ... ... .C. ... ... ... .T. .T.  [967]
#TRVL9464c   ... ... ... ... ..T ... ... .C. ... ... ... ... ...  [967]
#WNNY99      .CG .GC .AT ..C .TT ..G .G. .C. .A. .T. ... ... ...  [967]
#WNEgypt     .TG .GC .A. ..C .CT ..G .G. ... .A. .C. ... ... .T.  [967]
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#FL52        ACT GTT TGG GAA CAT CAA ACA GGG ACT TTG TCG AGG GAA  [1006]
#GHA-3c      ... ... ... ... ... ... ... ... ... ... ... ... ..G  [1006]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ..G  [1006]
#FL72        .T. ..C ... ... ... ... ... ... ... .C. ... .A. .GG  [1006]
#FL79-411c   ... ..C ... .G. ... ... ... ... ... ... ... ... ..G  [1006]
#FL85a       ... ... ... ... ... ... ... ... ... ... ... ... ..G  [1006]
#FLS569      .T. ... ... ... ... ... ... ... .T. .C. .T. .A. .GG  [1006]
#FLS649      ... ... ... ... ... ... ... ... ... ... ... ... ..G  [1006]
#FLS650      .T. ... ... ... ... ... ... ... .T. .Y. .T. .A. .GG  [1006]
#FLS694      .T. ... ... ... ... ... ... ... ... ... ... ... ..G  [1006]
#Partonc     ... ... ... ... ... ... ... ... ... ... ... ... .GG  [1006]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... ... ... .GG  [1006]
#TNM4-711Kc  ... ... .A. ... ... ... ... ... ... ... ... ... ..G  [1006]
#Kern217     ... ..C ... ... ... ... ... ... ... ... ... ... ..G  [1006]
#TR62        .T. ..C ... ... ... ... ... ... ... .C. ... .A. .GG  [1006]
#BR69        .T. ..C .A. ... ... ... ... ... ... .C. ... .A. .GG  [1006]
#65V310c     ... ... ... ... ... ... ... ... ... ... ... ... ..G  [1006]
#75D90c      .T. ... ... ... ... ... ... ... .T. .C. ... .A. .GG  [1006]
#BeAn246262c .T. ..C ... ... ... ... ... .A. ... .C. ... .A. .GG  [1006]
#GML902612c  ... ..C ... ... ... ... ... ... ... .C. ... .A. .GG  [1006]
#TRVL9464c   .T. ..C ... ... ... ... ... ... ... .C. ... .A. .GG  [1006]
#WNNY99      ... .CC .T. ... TGA GC. ... .A. ... .CT .G. .A. ..G  [1006]
#WNEgypt     ... .CC .T. ... TGA GC. ... .A. ... .CT .A. ... ..G  [1006]  
#FL52        CCA GCG GGG CAA CAT GGA TTG ACT TGG TAC TTG AAG GGG  [1045]
#GHA-3c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [1045]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [1045]
#FL72        ... ... ... ... ... ... ... ... ... ... ... ... .A.  [1045]
#FL79-411c   .T. .T. ... ... ... ... ... ... ... ... ... ... ...  [1045]
#FL85a       ... ... ... ... ... ... ... ... ... ... ... ... ...  [1045]
#FLS569      ... ... ... ... ... ... .C. ... ... ... ... ... .A.  [1045]
#FLS649      ... ... ... ... ... ... ... ... ... ... ... ... ...  [1045]
#FLS650      ... ... ... ... ... ... .C. ... ... ... ... ... .A.  [1045]
#FLS694      ... ... ... ... ... ... ... ... ... ... ... ... ...  [1045]
#Partonc     ... ... ... ... ... ... ... ... ... ... .C. ... ...  [1045]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... .C. ... ...  [1045]
#TNM4-711Kc  ... ... ... ... ... ... ... ... ... ... ... ... ...  [1045]
#Kern217     ... .T. ... ... ... ... ... ... ... ... ... ... ...  [1045]
#TR62        ... ... ... ... ... ... ... ... ... ... ... ... .A.  [1045]
#BR69        ... ... ... ... ... ... ... ... ... ... ... ... .A.  [1045]
#65V310c     ... ... ... ... ... ... ... ... ... ... ... ... ...  [1045]
#75D90c      ... ... ... ... ... ... .C. ... ... ... ... ... .A.  [1045]
#BeAn246262c ... ... ... ... ... ... ... ... ... ... ... ... .A.  [1045]
#GML902612c  ... ... ... ... ... ... ... ... ... .G. ... .G. .A.  [1045]
#TRVL9464c   ... ... ... ... ... ... ... ... ... ... .C. ... .A.  [1045]
#WNNY99      TGT CT. .A. ... ... ..G .G. .T. ... .T. .C. ... .C.  [1045]
#WNEgypt     TGT CT. .A. ... ... ..G .G. .T. ... .T. .C. ... .C.  [1045]  
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#FL52        GAA GCT GTG TTA CAG TGA TGG CAC CAG AGA AAC CAA CAC  [1084]
#GHA-3c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [1084]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [1084]
#FL72        ... ... ... .C. ... ... ... ... ... ... ... ... ..-  [1084]
#FL79-411c   ... ... ... ... ... ... ... ... ... .A. ... ... ...  [1084]
#FL85a       ... ... ... ... ... ... ... ... ... ... ... ... ...  [1084]
#FLS569      ... ... ... .C. ... ... ... ... ... ... ... ... ..T  [1084]
#FLS649      ... .G. ... ... ..- --- --- --- --- --- --- --- ---  [1084]
#FLS650      ... ... ... .C. ... ... ... ... ... ... ... ... ...  [1084]
#FLS694      ... ... ... .Y. ... ... ... ... ... ... ... ... ..-  [1084]
#Partonc     ... ... ... ... ... ... ... ... ... ... ... ... ...  [1084]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [1084]
#TNM4-711Kc  ... ... ... ... ... ... ... ... ... ... ... ... ...  [1084]
#Kern217     ... ... ... ... ... ... ... ... ... ... ... ... ...  [1084]
#TR62        ... ... ... .C. ... .A. ... ... ... ... ... ... ..T  [1084]
#BR69        ... ... ... .C. ... ... ... ... ... ... ... ... .--  [1084]
#65V310c     ... ... ... ... ... ... ... ... ... ... ... ... ...  [1084]
#75D90c      ... ... ... .C. ... ... ... ... ... ... ... ... ..T  [1084]
#BeAn246262c ... ... ... .C. ... ... ... ... ... ... ... ... ..T  [1084]
#GML902612c  ... ... ... ... ... ... ... ... ... ... ... ... ...  [1084]
#TRVL9464c   ... ... ... .C. ... ... ... ... ... ... ... ... ..T  [1084]
#WNNY99      AC. ... .C. .G. .TA .C. ..T .TA AG. .C. .G. .T. .CA  [1084]
#WNEgypt     AC. ... ... .G. .CA .C. ..T .TA AG. .C. .G. .T. .CA  [1084]  
#FL52        - [1085]
#GHA-3c      T [1085]
#TBH-28      - [1085]
#FL72        - [1085]
#FL79-411c   T [1085]
#FL85a       T [1085]
#FLS569      - [1085]
#FLS649      - [1085]
#FLS650      A [1085]
#FLS694      - [1085]
#Partonc     T [1085]
#MSI-7c      T [1085]
#TNM4-711Kc  T [1085]
#Kern217     T [1085]
#TR62        - [1085]
#BR69        - [1085]
#65V310c     T [1085]
#75D90c      T [1085]
#BeAn246262c T [1085]
#GML902612c  T [1085]
#TRVL9464c   T [1085]
#WNNY99      T [1085]
#WNEgypt     T [1085]  
 
 
 
 
 
 
 
 
 
 
 
 
 677
 
 
APPENDIX U (CONTINUED) 
 
 
Amino Acid Alignment 
#MEGA
!Title Membrane/Envelope Region SLEV;
!Format
   DataType=Protein
   NSeqs=23 NSites=117
   Identical=. Missing=? Indel=-;
!Domain=Data;
#FL52        DGQSLCSIME IPHWQQRTRH GWTP*KPPNT *QKSKTGFCA ILDMP*LRWR  [295]
#GHA-3c      .......... .......... .......... .......... ..........  [295]
#TBH-28      .......... .......... .......... .......... ..........  [295]
#FL72        ........T. .......... .*.....LS. .......... .P........  [295]
#FL79-411c   ...F...... .......... .......... .......... ..........  [295]
#FL85a       .......... .......... .......... .......... ...T......  [295]
#FLS569      G..F....T. T......... ........S. ...L...S.. .......H..  [295]
#FLS649      ........IG ..Q.....S. .......... .......... ..........  [295]
#FLS650      ........T. T......... ........S. ...L...S.. .......H..  [295]
#FLS694      .......... .......... ........S. ...L...... ..........  [295]
#Partonc     .......... .......... .......... .........V ..........  [295]
#MSI-7c      .......... .......... .......... .........V ..........  [295]
#TNM4-711Kc  ........T. .......... .......... .......... ..........  [295]
#Kern217     ...F...T.. .......... .......... .......... ..........  [295]
#TR62        .......... T......... .*.L...LS. .......... .P........  [295]
#BR69        ........T. T......... ........S. .......... .P........  [295]
#65V310c     ...F...... .......... .......... .......... .....W....  [295]
#75D90c      G..F....T. T......I.. .....R..S. ...L...... .......H..  [295]
#BeAn246262c G..F....T. T......... .*.....LS. .......... .P........  [295]
#GML902612c  GD.F...TT. T....R.... ........S. .......... ..........  [295]
#TRVL9464c   G..F...... T......... ........S. .......... .P........  [295]
#WNNY99      G.H*Q.RHT. KAL*RT.RGL ...APR.QGI W*.QNH.S*G T....WWQPS  [295]
#WNEgypt     G.H*Q.RH.. KAL*RT.RGL ...APRLQGI W*.QNH.S*G TP...WWQPS  [295]  
#FL52        LDGC*VATTH REWSL*SC*C *LLRHTASTV WEHQTGTLSR EPAGQHGLTW  [345]
#GHA-3c      S....A.... .......... .......... .......... ..........  [345]
#TBH-28      .......... .......... .......... .......... ..........  [345]
#FL72        ....WA.... .......... ..PQ...LI. .......S.K G.........  [345]
#FL79-411c   .......... ...F...... .......... .G........ .LV.......  [345]
#FL85a       .......... .......... .......... .......... ..........  [345]
#FLS569      .....A.... .......... ..P.....I. ......ISLK G......S..  [345]
#FLS649      .......... .......... .......... .......... ..........  [345]
#FLS650      .....A.... .......... ..P.....I. ......I?LK G......S..  [345]
#FLS694      .......... .......... ........I. .......... ..........  [345]
#Partonc     .....A.... .......... .......... .......... G.........  [345]
#MSI-7c      .....A.... .......... .......... .......... G.........  [345]
#TNM4-711Kc  .....A.... .......... .*........ *......... ..........  [345]
#Kern217     .......... ...F...... .......... .......... ..V.......  [345]
#TR62        .....AV... .......... ..P....LI. .......S.K G.........  [345]
#BR69        .....A.... .......... ..P....LI. *......S.K G.........  [345]
#65V310c     .......... .......... .......... .......... ..........  [345]
#75D90c      .....A.... .......... ..P.....I. ......IS.K G......S..  [345]
#BeAn246262c .....A.... .......... ..P....LI. .....E.S.K G.........  [345]
#GML902612c  .G..W..... .......... ..P...VL.. .......S.K G.........  [345]
#TRVL9464c   .....A.... .......... ..P.....I. .......S.K G.........  [345]
#WNNY99      .V..LG..PC ..LC.SCYCF WWPQL....A L.*A.E.SWK .CLE...WI.  [345]
#WNEgypt     .V..LE..PC S.LCSLCYCS WW.QP..L.A L.*A.E.S*. .CLE...WI.  [345]
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#FL52        YLKGEAVLQ* WHQRNQH [362]
#GHA-3c      .......... ....... [362]
#TBH-28      .......... ....... [362]
#FL72        ...E...S.. ......- [362]
#FL79-411c   .......... ...K... [362]
#FL85a       .......... ....... [362]
#FLS569      ...E...S.. ....... [362]
#FLS649      .....G..-- ------- [362]
#FLS650      ...E...S.. ....... [362]
#FLS694      .......?.. ......- [362]
#Partonc     .S........ ....... [362]
#MSI-7c      .S........ ....... [362]
#TNM4-711Kc  .......... ....... [362]
#Kern217     .......... ....... [362]
#TR62        ...E...S.. ....... [362]
#BR69        ...E...S.. ......- [362]
#65V310c     .......... ....... [362]
#75D90c      ...E...S.. ....... [362]
#BeAn246262c ...E...S.. ....... [362]
#GML902612c  C.RE...... ....... [362]
#TRVL9464c   .S.E...S.. ....... [362]
#WNNY99      FS.AT.A*LS CLRTSLP [362]
#WNEgypt     FS.AT..*PS CLRTSLP [362]
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Second Multiple Sequence Alignment: Flavivirus NS5 Region 
 
West Nile Virus    NS5 Region: Fu1/cfd3 primer set 
 
Nucleotide Alignment 
!Domain=Data property=Coding CodonStart=1;
#FLM38     CAA GGG AAG CAG AGC CAT TTG GTT CAT GTG GCT CGG AGC  [9128]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#FLS545    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#FLWN01a   ... ... ... ... .A. ... ... ... ... ... ... ... ...  [9128]
#FLWN01b   --- --- --- --- --- --- --- --- --- --- --- --- ---  [9128]
#FLWN02a   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#FLWN05a   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#FLWN05b   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#03-124FL  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#AZ-2004   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#CO-2003-1 ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#GA-2002-1 ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#TX-2004H  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#WNFL03    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#WNTX02    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#WNHungary ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#WNMexico  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9128]
#WNEgypt   T.. ... ... ... ... ... A.. ... ... ... ... ... ...  [9128]
#Kunjin    ... ... ... ... G.. ... C.. ... T.. ... ... G.. ...  [9128]
#AnMg798   ... ... T.. T.. ... ... ... ... T.. ... ... A.. ...  [9128]
#MVE       ... ... ... ... ... ... C.. ... ... ... ... G.. ...  [9128]
#JE        ... ... ... ... G.. ... ... ... ... ... ... T.. ...  [9128]
 
#FLM38     TCG CTT TCT GGA GTT CGA GGC TCT GGG TTT TCT CAA TGA  [9167]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#FLS545    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#FLWN01a   ... ... ... ... ... ... ... ..G ... ... ... ... ...  [9167]
#FLWN01b   --- --- --- --- --- --- --- --- -.. ... ... .TC .C.  [9167]
#FLWN02a   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#FLWN05a   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#FLWN05b   ... ... .T. ... ... ... ... ... ... ... ... ... ...  [9167]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#03-124FL  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#AZ-2004   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#CO-2003-1 ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#GA-2002-1 ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#TX-2004H  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#WNFL03    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#WNTX02    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#WNHungary ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#WNMexico  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9167]
#WNEgypt   ... ... ... ... ... ... A.. ... ... C.. ... T.. C..  [9167]
#Kunjin    ... ... C.. A.. ... T.. ... ... ... C.. ... T.. ...  [9167]
#AnMg798   ... G.. ... T.. ... T.. ... ... C.. G.. ... ... C..  [9167]
#MVE       CA. A.. CT. ... ... T.. A.. ... A.. A.. C.. ... ...  [9167]
#JE        A.. G.A ... A.. ... T.. A.. .T. ... G.. C.. G.. ...  [9167]
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#FLM38     AGA CCA CTG GCT TGG AAG AAA GAA CTC AGG AGG AGG TGT  [9206]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9206]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9206]
#FLS545    ... ... ... ... ... ... ... ... ... ... ... ... ...  [9206]
#FLWN01a   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9206]
#FLWN01b   ... ... ... ... A.T ... ... ... ... ... ... ... ...  [9206]
#FLWN02a   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9206]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9206]
#FLWN05a   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9206]
#FLWN05b   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9206]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9206]
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#03-113FL  ... ... ... ... ... ... ... ... ... .C- -- [10099]
#03-124FL  ... ... ... ... ... ... ... ... ... .C- -- [10099]
#AZ-2004   ... ... ... ... ... ... ... ... ... .C- -- [10099]
#CO-2003-1 ... ... ... ... ... ... ... ... ... .C- -- [10099]
#GA-2002-1 ... ... ... ... ... ... ... ... ... .C- -- [10099]
#TX-2004H  ... ... ... ... ... ... ... ... ... .C- -- [10099]
#WNFL03    ... ... ... ... ... ... ... ... ... .C- -- [10099]
#WNTX02    ... ... ... ... ... ... ... ... ... .C- -- [10099]
#WNNY99    ... ... ... ... ... ... ... ... ... .C- -- [10099]
#WNHungary ... ... ... ... ... ... ... ... ... .C- -- [10099]
#WNMexico  ... ... ... ... ... ... ... ... ... .C- -- [10099]
#WNEgypt   ... ... ... ... ... ... ... ... ... .C- -- [10099]
#Kunjin    ..T ... ... ... ..A ... ... ... ..C .C- -- [10099]
#AnMg798   ..A ..T C.C ... ..T ... ..G ... ..C .C- -- [10099]
#MVE       ... ..C ..G ..T ..T ... ... ... ... .G- -- [10099]
#JE        ..A ..C ..G ..A T.C ... ..A ..A ..C TC- -- [10099]  
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West Nile Virus 
NS5 Region 
 
Amino Acid Alignment 
 
#MEGA
!Title Translated NS5 v2 WNV;
!Format
   DataType=Protein
   NSeqs=26 NSites=335
   Identical=. Missing=? Indel=-;
!Domain=Data;
#FLM38     QGKQSHLVHV ARSSLSGVRG SGFSQ*RPLA WKKELRRRCR GLGPPKTGLH  [3083]
#FLS502    .......... .......... .......... .......... ..........  [3083]
#FLS504    .......... .......... .......... .......... ..........  [3083]
#FLS545    .......... .......... .......... .......... ..........  [3083]
#FLWN01a   ....N..... .......... .......... .......... ..........  [3083]
#FLWN01b   ---------- ---------- --..LS.... S......... ..........  [3083]
#FLWN02a   .......... .......... .......... .......... ..........  [3083]
#FLWN02b   .......... .......... .......... .......... ..........  [3083]
#FLWN05a   .......... .......... .......... .......... ..........  [3083]
#FLWN05b   .......... .....F.... .......... .......... ..........  [3083]
#03-113FL  .......... .......... .......... .......... ..........  [3083]
#03-124FL  .......... .......... .......... .......... ..........  [3083]
#AZ-2004   .......... .......... .......... .......... ..........  [3083]
#CO-2003-1 .......... .......... .......... .......... .........Y  [3083]
#GA-2002-1 .......... .......... .......... .......... ..........  [3083]
#TX-2004H  .......... .......... .......... .......... ..........  [3083]
#WNFL03    .......... .......... .......... .......... ..........  [3083]
#WNTX02    .......... .......... .......... *......... ..........  [3083]
#WNNY99    .......... .......... .......... .......... ..........  [3083]
#WNHungary .......... .......... .......... .......... ..........  [3083]
#WNMexico  .......... .......... .......... .......... ..........  [3083]
#WNEgypt   *.....M... .........S ..L.*R.... ........G. .........Y  [3083]
#Kunjin    ....G...Y. .G...PR.*. ..L.*.G... .....GG.G. .S...EIR..  [3083]
#AnMg798   ..**....Y. ....V.*.*. .RV..RG..V RQ.....GG* RP...EARV.  [3083]
#MVE       .......... .G.QIL..*S .RIP.....D E*R.F...S* RSWYSEA.I.  [3083]
#JE        ....G..... .W.TV.R.*S F.VPE..... EPR.F..WSG R..R..ARI.  [3083]
 
#FLM38     PA*SWHPAWG QDLC**HSWL GHPHHES*LG K*S*GA*VA* WGTSASCQGH  [3133]
#FLS502    .......... .......... .......... .......... ..........  [3133]
#FLS504    .......... .......... .......... .......... ..........  [3133]
#FLS545    .......... .......... .......... .......... ..........  [3133]
#FLWN01a   .......... .......... .......... .......A.. ..........  [3133]
#FLWN01b   .......... .........V .......... ..G....A.. ..........  [3133]
#FLWN02a   .......... .......... .......... .......A.. ..........  [3133]
#FLWN02b   .......... .......... .......... .......A.. ..........  [3133]
#FLWN05a   ........R. .......... .......... .......... ..A.......  [3133]
#FLWN05b   .......... .......... .......... .......... ..........  [3133]
#03-113FL  .......... .......... .......... .......A.. ..........  [3133]
#03-124FL  .......... .......... .......... .......... ..........  [3133]
#AZ-2004   ........R. .......... .......... .......... ..........  [3133]
#CO-2003-1 .......... .......... .......... .......... ..........  [3133]
#GA-2002-1 .......... .......... .......... .......... .R........  [3133]
#TX-2004H  .......... .......... ....Y..... .......... ..........  [3133]
#WNFL03    .......... .......... .......... .......A.. ..........  [3133]
#WNTX02    .......... .......... .......... .......... ..........  [3133]
#WNNY99    .......... .......... .......... .......A.. ..........  [3133]
#WNHungary ..R....... .......... .......... .......A.. ..........  [3133]
#WNMexico  .......... .......... .......... .......A.. ......R...  [3133]
#WNEgypt   S......T.R .......... ....Y...P. .....S...G .......*..  [3133]
#Kunjin    .......TRR .N.R....R. .....K..P. E..Q.S..VG R.AP.PG...  [3133]
#AnMg798   .EVG.GE..W K..R...... .YT.....P. E..K.PRATR .RA..PSAI.  [3133]
#MVE       LERCGSK..R EN..R..... .....T..P* ER..SSG.DG R*AADFGKSN  [3133]
#JE        .P.HSRK.RR ENVR..YRRV ..*NYQN..R ......GAPR R*.PHARPS.  [3133]  
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#FLM38     H*AHLSSQSC ESDAPGC*WK NRHGCYLQRR SEGEWTSCHL RPKHFHQPGR  [3183]
#FLS502    .......... .......... .......... .......... ..........  [3183]
#FLS504    .......... .......... .......... .......... ..........  [3183]
#FLS545    .......... .......... .......... .......... ..........  [3183]
#FLWN01a   .......... .......... .......... .......... ..........  [3183]
#FLWN01b   .......... .......... .......... .......... ..........  [3183]
#FLWN02a   .......... .......... .......... .......... ..........  [3183]
#FLWN02b   .......... .......... .......... .......... ..........  [3183]
#FLWN05a   .......... K......... ..Y...F... .......... ..........  [3183]
#FLWN05b   .......... .......... .......... .......... ..........  [3183]
#03-113FL  .......... .......... .......... .......... ..........  [3183]
#03-124FL  .......... .......... .......... .......... ..........  [3183]
#AZ-2004   .......... .......... .......... .......... ..........  [3183]
#CO-2003-1 .......... ........R. .......*.. .......... ..........  [3183]
#GA-2002-1 .......... .......... .......... .......... ..........  [3183]
#TX-2004H  .......... .......... .......... .......... ........V.  [3183]
#WNFL03    .......... .......... .C........ .......... ..........  [3183]
#WNTX02    .......... .......... .......*.. .......... ..........  [3183]
#WNNY99    .......... .......... .......... .......... ..........  [3183]
#WNHungary .......... .......... .......... .......... ..........  [3183]
#WNMexico  ......P... .......... .C........ .......... ..........  [3183]
#WNEgypt   .......... .......... .....H.... .......... .S..L.....  [3183]
#Kunjin    ......P..S .GN....... ....RH..G. P.RK.A.... .S..LY...C  [3183]
#AnMg798   .R..IPA... ...ET.RR.. DCN..DI*.G ...KR...D. CAE..Y...G  [3183]
#MVE       ...DIQA..G QGH...SWR. DCD..HFT.. .KRK...SD. CF..I..HRC  [3183]
#JE        N.TD.QA..G QGHETCSRR. D.D.RDIK.. .K....GG.. CS*...EHCC  [3183]
 
#FLM38     PAGEDDGRGR SDWPR*CGET HKRERTQSQD LAV*EWGRKT QPHGCQWR-T  [3233]
#FLS502    .......... .......... .......... .......... ........-.  [3233]
#FLS504    .......... .......... .......... .......... ........-.  [3233]
#FLS545    .......... .......... .......... .......... ........-.  [3233]
#FLWN01a   .......... .......... .......... .......... ........-.  [3233]
#FLWN01b   .......... .......... .......... .......... ........C.  [3233]
#FLWN02a   .......... .......... .......... .......... ........-.  [3233]
#FLWN02b   .......... .......... .......... .......... ........-.  [3233]
#FLWN05a   .......... .......... .......... .......... *.......-.  [3233]
#FLWN05b   .......... .......... .......... .......... ........-.  [3233]
#03-113FL  .......... .......... .......... .......... ........-.  [3233]
#03-124FL  .......... .......... .......... .......... ........-.  [3233]
#AZ-2004   .......... .......... .......... .......... *.......-.  [3233]
#CO-2003-1 .......... .......... .......... .......... ........-.  [3233]
#GA-2002-1 .......... .......... .......... .......... ........-.  [3233]
#TX-2004H  .......... .......... .......... .......... ........-.  [3233]
#WNFL03    .......... .......... .......... .......... ........-.  [3233]
#WNTX02    .......... .......... .......... .......... ........-.  [3233]
#WNNY99    .......... .......... .......... .......... ........-.  [3233]
#WNHungary .......... .......... .......... .......... ........-I  [3233]
#WNMexico  .......... .......... .......... .......... ........-.  [3233]
#WNEgypt   .V........ .......... ..GK..*... .......G.. ......R.-.  [3233]
#Kunjin    .I..N...RG C.R....... ..G..A.G*N .......G.. ........-.  [3233]
#AnMg798   S...N..... .H.T*..*KI RE....K... ....K.RGAP *S......-I  [3233]
#MVE       AI.*TH.SRS GHRS..H*KH *.EKEIC.PH M.F..RR..S AA...*.*-.  [3233]
#JE        ..RQA..G*G GH.TTAL.TA TQKKQDSC.. ..L...RGES DQD.D.R.-.  [3233]
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#FLM38     VW*SPWTIAL PPRS-FLNAM SKVRKDIQEW KPSTGWYDWQ QVPFCSNHFT  [3283]
#FLS502    .......... ....-..... .......... .......... ..........  [3283]
#FLS504    .......... ....-..... .......... .......... ..........  [3283]
#FLS545    .......... ....T..... .......... .......... ..........  [3283]
#FLWN01a   .......... ....-..... .......... .......... ..........  [3283]
#FLWN01b   .....C.... ....-..... .......... .......... ..........  [3283]
#FLWN02a   .......... ....-..... .......... .......... ..........  [3283]
#FLWN02b   .......... ....-..... .......... .......... ..........  [3283]
#FLWN05a   .......... ....-..... .......... .......... ..........  [3283]
#FLWN05b   .......... ....-..... .......... .......... ..........  [3283]
#03-113FL  .......... ....-..... .......... .......... ..........  [3283]
#03-124FL  .......... ....-..... .......... .......... ..........  [3283]
#AZ-2004   .......... ....-..... .......... .......... ..........  [3283]
#CO-2003-1 .......... ....-..... .......... .......... ..........  [3283]
#GA-2002-1 .......... ....-..... .......... .......... ..........  [3283]
#TX-2004H  .......... ....-..... .......... .......... ..........  [3283]
#WNFL03    .......... ....-..... .......... .......... ..........  [3283]
#WNTX02    .......... ....-..... .......... .......... ..........  [3283]
#WNNY99    .......... ....-..... .......... .......... ..........  [3283]
#WNHungary .......... ....-..... .......... .......... ..........  [3283]
#WNMexico  .......... ....-..... .......... .......... ..........  [3283]
#WNEgypt   .....*MT.S ..L.-..... .......... .......... ..........  [3283]
#Kunjin    ......M... ..L.-..... .......... .......... ..........  [3283]
#AnMg798   .*LN...TGS .H.C-..... .......... ...V...... ..........  [3283]
#MVE       .LSNH.M.DF .LLC-..... .......... ...Q...... .........Q  [3283]
#JE        .SS.R.MTDS .RP.-..... .......... ...H..H... .........Q  [3283]  
#FLM38     ELIMKDGRTL VVPCRGQDEL VGRARISPGA GWNVRDTACL AKSYAQMWLL  [3333]
#FLS502    .......... .......... .......... .......... ..........  [3333]
#FLS504    .......... .......... .......... .......... ..........  [3333]
#FLS545    .......... .......... .......... .......... ..........  [3333]
#FLWN01a   .......... .......... .......... .......... ..........  [3333]
#FLWN01b   .......... .......... .......... .......... ..........  [3333]
#FLWN02a   .......... .......... .......... .......... ..........  [3333]
#FLWN02b   .......... .......... .......... .......... ..........  [3333]
#FLWN05a   .......... .......... .......... .......... ..........  [3333]
#FLWN05b   .......... .......... .......... .......... ..........  [3333]
#03-113FL  .......... .......... .......... .......... ..........  [3333]
#03-124FL  .......... .......... .......... .......... ..........  [3333]
#AZ-2004   .......... .......... .......... .......... ..........  [3333]
#CO-2003-1 .......... .......... .......... .......... ..........  [3333]
#GA-2002-1 .......... .......... .......... .......... ..........  [3333]
#TX-2004H  .......... .......... .......... .......... ..........  [3333]
#WNFL03    .......... .......... .......... .......... ..........  [3333]
#WNTX02    .......... .......... .......... .......... ..........  [3333]
#WNNY99    .......... .......... .......... .......... ..........  [3333]
#WNHungary .......... .......... .......... .......... ..........  [3333]
#WNMexico  .......... .......... .......... .......... ..........  [3333]
#WNEgypt   .......... .......... .......... .......... ..........  [3333]
#Kunjin    .......... .T........ .......... .......... ..........  [3333]
#AnMg798   .......... .......... I......... .......... ..........  [3333]
#MVE       .V........ .......... I........S .......... ..A......V  [3333]
#JE        .IV.....SI .......... I......... ....K..... ..A.......  [3333]  
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#FLM38     LYFHRRDLRL MANAICSAVP VNWVPTGRTT WSIH- [3368]
#FLS502    .......... .......... .......... ....- [3368]
#FLS504    .......... .......... .......... ....- [3368]
#FLS545    .......... .......... .......... ....- [3368]
#FLWN01a   .......... .......... .......... ...-- [3368]
#FLWN01b   .......... .......... .......... ....- [3368]
#FLWN02a   .......... .......... .......... ....- [3368]
#FLWN02b   .......... .......... .......... ....- [3368]
#FLWN05a   .......... .......... .......... ...-- [3368]
#FLWN05b   .......... .......... .......... ....- [3368]
#03-113FL  .......... .......... .......... ....- [3368]
#03-124FL  .......... .......... .......... ....- [3368]
#AZ-2004   .......... .......... .......... ....- [3368]
#CO-2003-1 .......... .......... .......... ....- [3368]
#GA-2002-1 .......... .......... .......... ....- [3368]
#TX-2004H  .......... .......... .......... ....- [3368]
#WNFL03    .......... .......... .......... ....- [3368]
#WNTX02    .......... .......... .......... ....- [3368]
#WNNY99    .......... .......... .......... ....- [3368]
#WNHungary .......... .......... .......... ....- [3368]
#WNMexico  .......... .......... .......... ....- [3368]
#WNEgypt   .......... .......... .......... ....- [3368]
#Kunjin    .......... .......... .......... ....- [3368]
#AnMg798   .......... .......... .......... ....- [3368]
#MVE       .......... .......S.. .D........ ....- [3368]
#JE        .......... .......... .D.......S ....- [3368]
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St. Louis Encephalitis Virus 
NS5 Region: Fu1/cfd3 primer set 
 
Nucleotide Alignment 
!Domain=Data property=Coding CodonStart=1;
#FL52        TAA AGG AAG CAG AGC CAT TTG GTA CAT GTG GTT GGG AGC  [9119]
#GHA-3c      C.. ... ... ... ... ... ... ... ... ... ... ... G..  [9119]
#TBH-28      ... ... ... ... .T. ... ... ... ... ... ... ... ...  [9119]
#FL79-411c   ... ... ... ... ... ... ... ... ... ... ... ... ...  [9119]
#FL85a       ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9119]
#FL85b       -T. ... C.. ... ... ... ... ... ... ... ... ... ...  [9119]
#FL89        ... ... ... ... ... ... ... ... ... ... ... ... ...  [9119]
#FL90a       --T .A. G.. ... ... ... ... ... ... ... ... ... ...  [9119]
#FL90b       ... ... ... ... ... ... ... ... ... ... ... ... ...  [9119]
#FL90c       --T .A. G.. ... ... ... ... ... ... ... ... ... ...  [9119]
#FL90d       ... ... ... ... ... ... ... ... ... ... ... ... ...  [9119]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [9119]
#TNM4-711Kc  ... ... ... ... ... ... ... ... ... ... ... ... ...  [9119]
#Kern217     ... ... ... ... ... ... ... ... ... ... ... ... ...  [9119]
#Partonc     ... ... ... ... ... ... ... ... ... ... ... ... ...  [9119]
#FL72        C.. ... ... ... ... T.. C.. ... T.. ... .C. A.. ...  [9119]
#FLS569      C.. ... ... ... G.. T.. C.. ... ... ... .C. A.. ...  [9119]
#FLS650      -C. ... ... ... G.. T.. C.. ... ... ... .C. A.. ...  [9119]
#TR58        C.. ... ... ... ... T.. C.. ... ... ... .C. A.. ...  [9119]
#TR62        A.. ... ... ... ... T.. C.. ... ... ... .C. A.. ...  [9119]
#BR64        -C. ... ... ... ... ... C.. ... ... ... .C. ... ...  [9119]
#BR69        C.. ... ... ... ... ... C.. ... ... ... .C. A.. ...  [9119]
#75D90c      C.. ... ... ... G.. T.. C.. ... ... ... .C. A.. ...  [9119]
#GML902612c  C.. ... ... ... ... ... C.. ... ... ... .C. ... ...  [9119]
#BeAn246262c C.. ... ... ... ... T.. C.. ... ... ... .C. A.. ...  [9119]
#65V310c     ... ... ... ... ... ... ... ... ... ... ... ... ...  [9119]
#TRVL9464c   C.. ... ... ... ... T.. C.. ... ... ... .C. A.. ...  [9119]
#Ilheus      A.. G.. ... ... ... ... C.. ... ... ... .C. T.. ...  [9119]
#Rocio       ... G.. C.. .C. C.. ... ... ... T.. ... .C. ... G..  [9119]  
#FL52        TCG GTT TTT GGA GTT TGA AGC CCT CGG GTT CCT AAA TGA  [9158]
#GHA-3c      ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#TBH-28      ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#FL79-411c   ... ... C.. ... ... ... ... ... T.. ... ... ... ...  [9158]
#FL85a       ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#FL85b       ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#FL89        ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#FL90a       ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#FL90b       ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#FL90c       ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#FL90d       ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#MSI-7c      ... ... C.. ... ... C.. ... ... ... ... ... ... ...  [9158]
#TNM4-711Kc  ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9158]
#Kern217     ... ... C.. ... ... ... ... ... T.. ... ... ... ...  [9158]
#Partonc     ... ... C.. ... ... C.. ... ... ... ... ... ... ...  [9158]
#FL72        ... ... ... ... ... ... G.. T.. ... ... T.. ... ...  [9158]
#FLS569      ... ... .C. ... ... ... G.. ... ... ... T.. ... ...  [9158]
#FLS650      ... ... .C. ... ... ... G.. ... ... ... T.. ... ...  [9158]
#TR58        ... ... ... ... ... ... G.. T.. ... ... T.. ... ...  [9158]
#TR62        ... ... ... ... ... ... G.. T.. ... ... ... ... ...  [9158]
#BR64        C.. ... ... ... ... ... G.. ... ... ... T.. ... ...  [9158]
#BR69        C.. ... .C. ... ... ... G.. ... ... ... T.. ... ...  [9158]
#75D90c      ... ... ... ... ... ... G.. ... ... ... T.. ... ...  [9158]
#GML902612c  ... ... ... ... ... ... G.. T.. ... ... ... ... ...  [9158]
#BeAn246262c ... ... ... ... ... ... G.. T.. ... ... T.. ... ...  [9158]
#65V310c     ... ... C.. ... ... ... ... T.. ... ... ... ... ...  [9158]
#TRVL9464c   ... ... ... A.. ... ... G.. T.. ... A.. T.. ... ...  [9158]
#Ilheus      .A. A.. C.. ... A.. ... ... A.. G.. C.. T.. ... ...  [9158]
#Rocio       AA. ... .C. T.. ... C.. ... G.. ... A.. T.. C.. ...  [9158]
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#FL52        AGA CCA TTG GAT GAG CCG CGA GAA CTC CTA TGG AGG AGT  [9197]
#GHA-3c      G.. ... C.. ... ... ... T.. ... ... ... ... ... ...  [9197]
#TBH-28      ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9197]
#FL79-411c   ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9197]
#FL85a       ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9197]
#FL85b       ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9197]
#FL89        ... T.. C.. ... ... ... ... ... ... ... C.. ... ...  [9197]
#FL90a       ... T.. C.. ... ... ... ... ... ... ... C.. ... ...  [9197]
#FL90b       ... T.. C.. ... ... ... ... ... ... ... C.. ... ...  [9197]
#FL90c       ... T.. C.. ... ... ... ... ... ... ... C.. ... ...  [9197]
#FL90d       ... T.. C.. ... ... ... ... ... ... ... C.. ... ...  [9197]
#MSI-7c      ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9197]
#TNM4-711Kc  ... ... C.. ... ... ... ... ... ... ... C.. ... ...  [9197]
#Kern217     ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9197]
#Partonc     ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9197]
#FL72        ... T.. C.. ... ... ... ... ... ... AC. ... ... ...  [9197]
#FLS569      ... T.. C.. ... ... ... ... ... ... AC. ... ... ...  [9197]
#FLS650      ... T.. C.. ... ... ... ... ... T.. AC. ... ... ...  [9197]
#TR58        ... T.. C.. ... ... ... ... ... ... AC. ... G.. ...  [9197]
#TR62        ... T.. C.. ... ... ... ... ... ... AC. ... ... ...  [9197]
#BR64        ... T.. C.. ... ... ... ... ... ... AC. ... ... ...  [9197]
#BR69        ... T.. C.. ... ... ... ... ... ... A.. ... ... ...  [9197]
#75D90c      ... T.. C.. ... ... ... ... ... ... AC. ... ... ...  [9197]
#GML902612c  ... T.. C.. ... ... T.. ... ..G ... AC. ... ... ...  [9197]
#BeAn246262c ... T.. C.. ... ... ... ... ... ... AC. ... ... ...  [9197]
#65V310c     ... ... C.. ... ... ... ... ... ... ... ... ... ...  [9197]
#TRVL9464c   ... T.. ... ... ... ... ... ... ... AC. ... ... ...  [9197]
#Ilheus      ... ... ... ... ... .A. A.. ... ... ACT G.. T.. ...  [9197]
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#FL72        ... ... .T. ... ... ... ... ... ... ... ... ... ...  [9977]
#FLS569      ... ... ... ... ... ... ... ... ... ... ... ... ...  [9977]
#FLS650      ... ... ... ... ... ... ... ... ... ... ... ... ...  [9977]
#TR58        ... ... .T. ... ... ... ... ... ... ... ... ... ...  [9977]
#TR62        ... ... .T. ... ... ... ... ... .C. ... ... ... ...  [9977]
#BR64        ... ... .T. ... ... ... ... ... ... ... ... ... ...  [9977]
#BR69        ... ... .T. ... ... ... ... ... ... ... ... ... ...  [9977]
#75D90c      ... ... .T. ... ... ... ... ... ... .C. ... ... ...  [9977]
#GML902612c  .A. ... .T. ... ... ... ... .T. ... ... ... ... ...  [9977]
#BeAn246262c ... ... .T. ... ... ... ... ... ... ... ... ... ...  [9977]
#65V310c     ... ... ... ..T ... ... ... ... ... ... ... ... ...  [9977]
#TRVL9464c   ... ... .T. ... ... ... .G. .T. ... ... ... ... ...  [9977]
#Ilheus      ... ... .T. .T. ... ... ..G ... ... .C. ... ... ...  [9977]
#Rocio       .A. .T. ... .T. ..G .A. ..G .T. .C. ... ... ... ..C  [9977]
 
#FL52        TGC TTA TGT ACT TCC ACA GGC GGG ATC TCA GAA TGA TGG  [10016]
#GHA-3c      ... ... ... ... ... .T. ... ... ... ... ... ... ...  [10016]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#FL79-411c   ... .C. ... ... ... ... ... ... .C. ... ... ... ...  [10016]
#FL85a       ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#FL85b       ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#FL89        ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#FL90a       ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#FL90b       ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#FL90c       ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#FL90d       ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#TNM4-711Kc  ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#Kern217     ... ... ... ... ... ... ... ... .C. ... ... ... ...  [10016]
#Partonc     ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#FL72        ... .C. ... ... ... ... ... ... ... ... .G. ... ...  [10016]
#FLS569      ... .C. ... .T. ... ... .A. ... ... ... .G. ... ...  [10016]
#FLS650      ... .C. ... .T. ... ... .A. ... ... ... .G. ... ...  [10016]
#TR58        ... .C. ... ... ... ... ... ... ... ... .G. ... ...  [10016]
#TR62        ... .C. ... ... ... ... ... ... ... ... .G. ... ...  [10016]
#BR64        ... .C. ... ... ... ... ... ... ... ... .G. ... ...  [10016]
#BR69        ... .C. ... ... ... ... ... ... ... .T. .G. ... ...  [10016]
#75D90c      ... .C. ... .T. ... ... ... ... ... .T. .G. ... ...  [10016]
#GML902612c  ... .C. ... .T. ... ... ... ... ... .T. .G. ... ...  [10016]
#BeAn246262c ... .C. ... ... ... ... ... ... ... ... .G. ... ...  [10016]
#65V310c     ... ... ... ... ... ... ... ... ... ... ... ... ...  [10016]
#TRVL9464c   ... .C. ... ... ... ... ... .A. ... ... .G. ... ...  [10016]
#Ilheus      ... .C. ... .T. ... ..C .C. .T. .C. ..C .TC .C. ...  [10016]
#Rocio       ... .C. ... ... ... ... .A. ... ... .AC .CT .A. ...  [10016]
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#FL52        CAA ATG CCA TTT GTT CAG CTG TCC CAG TCA ACT GG- GTC  [10055]
#GHA-3c      ... ... ... ... ... ... ... ... ... ... ... ..- ...  [10055]
#TBH-28      ... ... ... ... ... ... ... ... ... ... ... ..- ...  [10055]
#FL79-411c   ... ... ... ... ... ... ... ... ... ... ... ..- ...  [10055]
#FL85a       ... ... ... ... ... ... ... .T. ... ... ... ..- ...  [10055]
#FL85b       ... ... ... ... ... ... ... .T. ... ... ... ..- ...  [10055]
#FL89        ... ... ... ... ... ... ... ... .G. .T. ... ..- ...  [10055]
#FL90a       ... ... ... ... ... ... ... ... ... .T. ... ..- ...  [10055]
#FL90b       ... ... ... ... ... ... ... ... ... .T. ... ..- ...  [10055]
#FL90c       ... ... ... ... ... ... ... ... ... .T. ... ..- ...  [10055]
#FL90d       ... ... ... ... ... ... ... ... ... .T. ... ..- ...  [10055]
#MSI-7c      ... ... ... ... ... ... ... ... ... ... ... ..- ...  [10055]
#TNM4-711Kc  ... ... ... ... ... ... ... ... ... ... ... ..- ...  [10055]
#Kern217     ... ... ... ... ... ... ... ... ... ... ... ..- ...  [10055]
#Partonc     ... ... ... ... ... ... ... ... ... ... ... ..- ...  [10055]
#FL72        ... ... ... .C. .C. .T. .C. ... ... ... ... ..- ...  [10055]
#FLS569      ... ... .T. .C. ... ... .C. ... ... ... ... ..- ...  [10055]
#FLS650      ... ... .T. .C. ... ... .C. ... ... ... ... ..- ...  [10055]
#TR58        ... ... ... .C. .C. .T. .C. ... ... ... ... ..- ...  [10055]
#TR62        ... ... ... .C. ... .T. .C. ... ... ... ... ..- ...  [10055]
#BR64        ... ... ... .C. ... ... .C. ... ... ... .T. ..- ...  [10055]
#BR69        ... ... ... .C. ... ... .C. ... ... ... .T. ..- ...  [10055]
#75D90c      ... ... .T. .C. ... ... .C. ... ... ... ... ..- ...  [10055]
#GML902612c  ... ... ... .C. ... ... .C. ... ... ... ... ..- ...  [10055]
#BeAn246262c ... ... ... .C. ... ... .C. ... ... ... ... ..- ...  [10055]
#65V310c     ... ... ... ... ... ... ... ... ... ... ... ..- ...  [10055]
#TRVL9464c   ... ... ... .C. ... ... .C. ... ... ... ... ..- ...  [10055]
#Ilheus      .C. .C. ... .C. ... ... .A. .G. .T. .GG .T. ..- ...  [10055]
#Rocio       .C. .C. ... ... .C. .G. .C. .G. .CA .TG ... ..- ..T  [10055]
 
#FL52        CCA ACT GG- --A CGT ACC ACA TGG TCA ATC CGT TA [10090]
#GHA-3c      ... ..C ..- --. ... ... ... ... ... ..T .A. GG [10090]
#TBH-28      ... ... .-- --- --- --- --- --- --- --- --- -- [10090]
#FL79-411c   ... ... ..- --. ... ..T ... ... ... ..T .A. GG [10090]
#FL85a       ... ... ..- --. ... ... ... ... ... ..T .A. -- [10090]
#FL85b       ... ... ..- --. ... ... ... ... ... ..- --- -- [10090]
#FL89        ... ..C ..- --. ... ... ... ... ... ..- --- -- [10090]
#FL90a       ... ..C ..- --. ... ... ... ..- --- --- --- -- [10090]
#FL90b       ... ..C ..- --. ... ... ... ... ... ..T .A. -- [10090]
#FL90c       ... ..C ..- --. ... ... ... ..- --- --- --- -- [10090]
#FL90d       ... ..C ..- --. ... ... ... ... ... ..T .A. G- [10090]
#MSI-7c      ... ... ..- --. ..C ... ... ... ... ..T .A. GG [10090]
#TNM4-711Kc  ... ..C ..- --. ... ... ... ... ... ..T .A. GG [10090]
#Kern217     ... ... ..- --. ... ... ... ... ... ..T .A. GG [10090]
#Partonc     ... ... ..- --. ..C ... ... ... ... ..T .A. GG [10090]
#FL72        ..C ... ..- --. ... ..T ... ... ... ..T .A. -- [10090]
#FLS569      ..C ... ..- --. --- --- --- --- --- --- --- -- [10090]
#FLS650      ..C ... ..- --. ..C ..T ... ... ... ... --- -- [10090]
#TR58        ..C ... ..- --. ... ..T ... ... ... ..- .A. -- [10090]
#TR62        ..C ... ..- --. ... ..T ... ... ... ..T .A. .- [10090]
#BR64        ..C ... ..- --. ... ..T ..C ... ... ..- --- -- [10090]
#BR69        ... ... ..- --. ... ... ... ... ... ..T ... -- [10090]
#75D90c      ..C ... ..- --. ..C ..T ... ... ... ..T .A. GG [10090]
#GML902612c  ..C ... ..- --. ..C ... ... ... ... ... .AC GG [10090]
#BeAn246262c ..C ... ..- --. ... ..T ... ... ... ..T .A. GG [10090]
#65V310c     ... ... ..- --. ... ... ... ... ... ..T .A. GG [10090]
#TRVL9464c   ..C ... ..- --. ... ..T ... ... ... ..T .A. GG [10090]
#Ilheus      ..G ... ..- --. ..A ... ... ... ..C ... .AC GG [10090]
#Rocio       ..G ... ..- --. A.A ..A ..C ... ..G ..A .A. GG [10090]
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St. Louis Encephalitis Virus 
NS5 Region 
 
Amino Acid 
!Domain=Data;
#FL52        *RKQSHLVHV VGSSVFGV*S PRVPK*RPLD EPRELLWRS* GERTPETRIH  [3081]
#GHA-3c      Q......... ..G..L.... ......G... ..*....... ..........  [3081]
#TBH-28      ....I..... .....L.... .......... .........R ..........  [3081]
#FL79-411c   .......... .....L.... .W........ .......... ..........  [3081]
#FL85a       ..Q....... .....L.... .......... .......... ..........  [3081]
#FL85b       -.Q....... .....L.... .......... .......... ..........  [3081]
#FL89        .......... .....L.... .......S.. ......R... .........Y  [3081]
#FL90a       -KE....... .....L.... .......S.. ......R... .........Y  [3081]
#FL90b       .......... .....L.... .......S.. ......R... .......?.Y  [3081]
#FL90c       -KE....... .....L.... .......S.. ......R... .........Y  [3081]
#FL90d       .......... .....L.... .......S.. ......R... .........Y  [3081]
#MSI-7c      .......... .....L..R. .......... .......... ..........  [3081]
#TNM4-711Kc  .......... .....L.... .......... ......R... .........Y  [3081]
#Kern217     .......... .....L.... .W........ .......... .......W..  [3081]
#Partonc     .......... .....L..R. .......... .......... ..........  [3081]
#FL72        Q....Y..Y. AR.......G S..S...S.. .....T.... .....K....  [3081]
#FLS569      Q...GY.... AR...S...G ...S...S.. .....T.... .K.......Y  [3081]
#FLS650      -...GY.... AR...S...G ...S...S.. ....FT.... .K.......Y  [3081]
#TR58        Q....Y.... AR.......G S..S...S.. .....T.G.. ..........  [3081]
#TR62        K....Y.... AR.......G S......S.. .....T.... ....S.....  [3081]
#BR64        -......... A..P.....G ...S...S.. .....T.... .K........  [3081]
#BR69        Q......... AR.P.S...G ...S...S.. .....I.... .K.....?..  [3081]
#75D90c      Q...GY.... AR.......G ...S...S.. .....T.... .K........  [3081]
#GML902612c  Q......... A........G S......S.. .S...T.... .......W.Y  [3081]
#BeAn246262c Q....Y.... AR.......G S..S...S.. .....T.... .....K....  [3081]
#65V310c     .......... .....L.... S......... .......... ..........  [3081]
#TRVL9464c   Q....Y.... AR....R..G S.IS...S.. .....T.... .....K....  [3081]
#Ilheus      KG........ AW.*IL.I.. TGLS...... .Q...TGW.R RA.....WV.  [3081]
#Rocio       .GQPR...Y. A.GK.S*.R. A.ISQ..... .*..FI.G.R RKG...AG..  [3081]  
#FL52        SARN?PNSRR KDVRR*YSRL GHPDHKRRPE E*SKNNKENG RKA*KACRGN  [3131]
#GHA-3c      P...L..... ......H... ........L. K......... ..........  [3131]
#TBH-28      P...L..... ......H... ........L. K.?....... ..........  [3131]
#FL79-411c   P...L..F.. ......H... ........L. K......... .......G..  [3131]
#FL85a       L...?..... ......H... ........L. K......... ...Q......  [3131]
#FL85b       L...L..... ......H... ........L. K......... ...Q......  [3131]
#FL89        P...L...G. ......H... ..S.....L. K......... ...Q......  [3131]
#FL90a       P...L...G. ......H... ..S.....L. K......... ...Q......  [3131]
#FL90b       P...?...G. ......H... ..S.....L. K......... ...Q......  [3131]
#FL90c       P...L...G. ......H... ..S.....L. K......... ...Q......  [3131]
#FL90d       P...L...G. ......H... ..S.....L. K......... ...Q......  [3131]
#MSI-7c      P...F..... ......H... ...Y...GL. K......... ..........  [3131]
#TNM4-711Kc  P...L..... ......H... ........L. K......... ..........  [3131]
#Kern217     P...L..... ......H... ........L. K......... .......G.D  [3131]
#Partonc     P...F..... ......H... ...Y...GL. K......... ..........  [3131]
#FL72        PT..L..... ...C..H... ...H....L. K......K.. *..Q..R..G  [3131]
#FLS569      P...L..P.. ...C...... ...H....L. K.G....K.. ??.Q?....D  [3131]
#FLS650      P...L..P.. ...C...... ...H....L. K.G....K.. *..Q.....D  [3131]
#TR58        PT..L..P.. ...C..H... ...H....L. K......K.. *..Q.....D  [3131]
#TR62        PT..?..P.. ...C..H... ...HY...F. K......K.. *..Q.....D  [3131]
#BR64        P...L..P.. ...C..H... ...HY...L. K......K.. *..QE....D  [3131]
#BR69        P...L..P.. ...C..H... ...H....L. K......K.. *..Q.....D  [3131]
#75D90c      P...L..P.. ...C*.H... ...H....L. K......K.. *..Q.....D  [3131]
#GML902612c  P...L..P.. ...C..H... ...H..G.L. KR........ *..Q......  [3131]
#BeAn246262c PT..L..... ...C..H... ...H....L. K......K.. *..Q.....G  [3131]
#65V310c     P...L..... ......H... ........L. K......... ..........  [3131]
#TRVL9464c   P...L..P.. ...C..H... ...H....L. K......K.. *..Q.....D  [3131]
#Ilheus      .EGHLTPGGW .H.C*.HC.. .YQN.EG*S* KR.QSDEHD. WRT.TTRQ.Y  [3131]
#Rocio       PP.DFQER.W TH.CG.HC.. .YKS.TNG.G K.GQD..MD. TG.SETG.SH  [3131]
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#FL52        H*SNLPP*GG ESHETRA*WE NLHGCYLQRR PKGQWTSGHI CPEHLHQPGR  [3181]
#GHA-3c      .......... .......... ..Y..H...G S.....G... ..........  [3181]
#TBH-28      .......... .......... .....H.*.. ......G... ..........  [3181]
#FL79-411c   ...D...... K........* .....H.... ......G... ..........  [3181]
#FL85a       .......... .......... .....H.... ...*..G... ..........  [3181]
#FL85b       .......... .......... .....H.... ...*..G... ..........  [3181]
#FL89        ..A....Q.. .......... ..Y..H.... ....R.G... ..........  [3181]
#FL90a       ..A....Q.. .......... .....H.... ....R.G... ..........  [3181]
#FL90b       ..A....Q.. .......... .....H.... ....R.G... ..........  [3181]
#FL90c       ..A....Q.. .......... .....H.... ....R.G... ..........  [3181]
#FL90d       ..A....Q.. .......... .....H.... ....R.G... ..........  [3181]
#MSI-7c      .......... .......... .....H.... ......G... ..........  [3181]
#TNM4-711Kc  .......... .......... .....H.... ....R.G... ..........  [3181]
#Kern217     .......... .........* .....H.... ......G... ..........  [3181]
#Partonc     .......... .......... .....H.... ......G... ..........  [3181]
#FL72        ..FD...Q.. .......... .....H.*.. ...*..GS.. R.........  [3181]
#FLS569      ..LD..S?.. .......... .....HF*.. S?..R.GSY. R......F.C  [3181]
#FLS650      ..LD..SQ.. .......... .....HF*.. ....R.GSY. R......F.C  [3181]
#TR58        ..PD..SQ.. .......... .....H.*.. ...*..GS.. .......S..  [3181]
#TR62        ..LD..SQ.. .......... .....H.*.. ...*..GS.. R.....*...  [3181]
#BR64        ..LD..SQ.. .......... D......*.. ....R.GS.. RS........  [3181]
#BR69        ..LD..SQ.. .......... D......*.. ......GS.. RS........  [3181]
#75D90c      ..LD..SQ.. .......... .....HF*.. ......GSY. R......S.C  [3181]
#GML902612c  ..LD..SQ.. .......... .....H.... ......G... .S........  [3181]
#BeAn246262c ..LD...Q.. .......... .....H.*.. ...*..GS.. R.........  [3181]
#65V310c     .......... .......... .....H.... ...*..G... ..........  [3181]
#TRVL9464c   ..FD..SQ.S .......... .....H.*.. ...*..GS.. R.........  [3181]
#Ilheus      NRID.QA.SS QG.AAC.GR. DS..HH..GG .ERE.P.S.L .T*......G  [3181]
#Rocio       D.AHIQEQS. Q...A.KRG. DGD.HHFTK. .ERE.AGCDV ..K....S.C  [3181]
 
#FL52        STDKMHGS*R GGR*G*-SRE *DSDDWPKRL SG*GRMDLND *VEWQ*VGTT  [3231]
#GHA-3c      P......... ......-... .......... .......... ..........  [3231]
#TBH-28      .......... ......-... ..L....... ...??..... ..........  [3231]
#FL79-411c   .......... ..G...-L.. ..L....... .........G ..........  [3231]
#FL85a       .......... ......-... ..L....... .......... ..........  [3231]
#FL85b       .......... ......-... ..L....... .......... ..........  [3231]
#FL89        .......... ......-... .......... .......... .A........  [3231]
#FL90a       .......... ......-... .......... .......... .A........  [3231]
#FL90b       .......... ......-... .......... .......... .A........  [3231]
#FL90c       .......... ......-... .......... .......... .A........  [3231]
#FL90d       .......... ......-... .......... .......... .A........  [3231]
#MSI-7c      .......... ......-... .......... .......... ..........  [3231]
#TNM4-711Kc  .......... ......-... .......... .......... W.........  [3231]
#Kern217     .......G.. ......-L.. ..L.G....S .......... .A........  [3231]
#Partonc     .......... ......-... .......... .......... ..........  [3231]
#FL72        .......... .SG...-.*. .......... ...E...P.G ........MI  [3231]
#FLS569      A....Y.... .N....-.*. ........Q. .........G ........MI  [3231]
#FLS650      A....Y.... .N....-.*. ........Q. .........G ........MI  [3231]
#TR58        .......... .SG...-.*. .......... ..L......G ........MI  [3231]
#TR62        .......... .SG...-.*. .......... .........G .....L..MI  [3231]
#BR64        .......... .SG...-.*. .......... .........G ........MI  [3231]
#BR69        .......... .SG...-.*. .........* .........G ....R...M.  [3231]
#75D90c      A......... .S....-.*. .......... .........G ........MI  [3231]
#GML902612c  .I........ SSG.R.-.*. ....G..... ........SG .A......MI  [3231]
#BeAn246262c .......... .SG...-.*. .......... .......P.G L.......MI  [3231]
#65V310c     .......... ......-... ..L....... .......... ..........  [3231]
#TRVL9464c   .......... .SG...-.*. .......... .........G ........MI  [3231]
#Ilheus      ..SE...GGG TVDGE.RA.. PEEEA---SG T..SK.EERG FRA.LS.EM.  [3231]
#Rocio       ..HQV..G.. PSGG.R-PCG LMPNGG--CK P.LTP.G.KG SLR.....MI  [3231]
 
 
 
 
 
 
 711
APPENDIX V: (CONTINUED) 
 
#FL52        VL*NQLTTDL PLHS-FLNNM STDQKGHSGM ETFNRLAHIG KRCPSAHITS  [3281]
#GHA-3c      ......MI.. ....-..... .-..E..... ...Y...-.. ..........  [3281]
#TBH-28      ......M... ....-..... .-........ .......-.. .......T..  [3281]
#FL79-411c   ......M... ....-..... .-..E..... .......-T. .......T..  [3281]
#FL85a       ......M... ....-..... .-........ ...D...-T. .......T..  [3281]
#FL85b       ......M... ....-..... .-........ ...D...-T. .......T..  [3281]
#FL89        ......M... L...-..... .-...R.... .......-.. ..........  [3281]
#FL90a       ......MI.. L...-..... .-...R.... .......-.. ..........  [3281]
#FL90b       ......MI.. L...-..... .-...R.... .......-.. ..........  [3281]
#FL90c       ......MI.. L...-..... .-...R.... .......-.. ..........  [3281]
#FL90d       ......MI.. L...-..... .-...R.... .......-.. ..........  [3281]
#MSI-7c      ......M... ....-..... .-........ .......-.. ..........  [3281]
#TNM4-711Kc  ......M... ....-..... .-N....... .......-.. ..........  [3281]
#Kern217     ......M... ....-..... .-.......V .......-T. .......T..  [3281]
#Partonc     ......M... ....-..... .-........ .......-.. ..........  [3281]
#FL72        ......M... .P..-..... .-N.....R. .....?.-.. R..H...T..  [3281]
#FLS569      .........S .P..-..... .-N.E...R. ?....?.-.. R..L...T..  [3281]
#FLS650      .........S .P..-..... .-N.E...R. .......-.. R..L...T..  [3281]
#TR58        .......... .P..-..... .-N.....R. .......-.. R..L...T..  [3281]
#TR62        ......M... .P..-..... .-N.....R. .......-.. R..L...T..  [3281]
#BR64        .....SM... .P.F-..... .-N.....R. .......-T. R..L...T..  [3281]
#BR69        .S...SM... .P..-..... .-N.....R. .......-T. R..L...T.L  [3281]
#75D90c      ......M..S .P..-..... .-N.E...R. .......-.. R..L...T..  [3281]
#GML902612c  ......M... QP..-..... .-N.....R. .......-.. ....F..T..  [3281]
#BeAn246262c ......M... .P..-..... .-N....PR. .......-.. R..H...T..  [3281]
#65V310c     ......M... ....-..... .-........ .......-T. .......T..  [3281]
#TRVL9464c   ......M... .P..-..... .-N.....R. .......-.. R..L...T..  [3281]
#Ilheus      AW..P.M..S RAPF-...G. A-..ERYP.. ..IRG.E-T. RK.HL.PTI.  [3281]
#Rocio       AWSSP....S Q.L.-...G. .-GEERYT.. .A.HW.D-.. R.SH..P.IL  [3281]
 
#FL52        MN*C*RMGGP SWCHAGARMS *LAEPEFHQE QDGM*KRQPA *ANPMLRCGC  [3331]
#GHA-3c      .S........ .........N .......... .......... ..S.......  [3331]
#TBH-28      .......... .......... ......Y... .......... ...?......  [3331]
#FL79-411c   .......... .......... .......... ....L..... ..........  [3331]
#FL85a       .....K.... .......... .......... ...T...... ..........  [3331]
#FL85b       .....K.... .......... .......... ...?...... ..........  [3331]
#FL89        .......... ..Y...V... .......... .......... ...LT.....  [3331]
#FL90a       .......... ..Y...V... .......... .......... ...LT.....  [3331]
#FL90b       .......... ..Y...V... .......... .......... ...LT.....  [3331]
#FL90c       .......... ..Y...V... .......... .......... ...LT.....  [3331]
#FL90d       .......... ..Y...V... ......?... .......... ...LT.....  [3331]
#MSI-7c      .......... .......... .......... R......... ....T.....  [3331]
#TNM4-711Kc  .......... ..Y...V... .S........ .......... ...LT.....  [3331]
#Kern217     .......... ....V..... ......S... .......... ..........  [3331]
#Partonc     .......... .......... .......... R......... ....T.....  [3331]
#FL72        T......... .........N .S.......G ........L. ..........  [3331]
#FLS569      ........E. .........N ....L..... .......... ..........  [3331]
#FLS650      ........E. .........N ....L..... .......... ..........  [3331]
#TR58        T......... .........N .......... ........L. ..........  [3331]
#TR62        T......... .........N .......... ........L. ....T.....  [3331]
#BR64        .......... L........N .......... ........L. ..........  [3331]
#BR69        .......... L........N .......... ........L. ..........  [3331]
#75D90c      ........E. .........N .......... ........L. .....P....  [3331]
#GML902612c  ......T... ..Y......N ......S... ...T..K.L. ...L......  [3331]
#BeAn246262c T......... .........N .......... ........L. ..........  [3331]
#65V310c     .......... .......... .......... .......... ..........  [3331]
#TRVL9464c   .......... .........N .......... .G......L. ..SL......  [3331]
#Ilheus      .SC*.K.DA. .*F..VPK.N .WE.HGC.LV A..ACE..LV ..K..P....  [3331]
#Rocio       .SWSCV.A.K .S.PV.PK.N ..E..GCP.G V..ACEKL.V WEKLT.....  [3331]
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APPENDIX V: (CONTINUED) 
 
#FL52        LCTSTGGISE *WQMPFVQLS QST-VPT--R TTWSIR [3367]
#GHA-3c      ....I..... .......... ...-...--. .....H [3367]
#TBH-28      .......... .......... ...-...--- ------ [3367]
#FL79-411c   S......T.. .......... ...-...--. .....H [3367]
#FL85a       .......... .........F ...-...--. .....H [3367]
#FL85b       .......... .........F ...-...--. ....-- [3367]
#FL89        .......... .......... RL.-...--. ....-- [3367]
#FL90a       .......... .......... .L.-...--. ..---- [3367]
#FL90b       .......... .......... .L.-...--. .....H [3367]
#FL90c       .......... .......... .L.-...--. ..---- [3367]
#FL90d       .......... .......... .L.-...--. .....H [3367]
#MSI-7c      .......... .......... ...-...--. .....H [3367]
#TNM4-711Kc  .......... .......... ...-...--. .....H [3367]
#Kern217     .......T.. .......... ...-...--. .....H [3367]
#Partonc     .......... .......... ...-...--. .....H [3367]
#FL72        S........G .....SALP. ...-...--. .....H [3367]
#FLS569      S.I..D...G ....LS..P. ...-...--- ------ [3367]
#FLS650      S.I..D...G ....LS..P. ...-...--. .....- [3367]
#TR58        S........G .....SALP. ...-...--. ....-H [3367]
#TR62        S........G .....S.LP. ...-...--. .....H [3367]
#BR64        S........G .....S..P. ..I-...--. ....-- [3367]
#BR69        S.......LG .....S..P. ..I-...--. ...... [3367]
#75D90c      S.I.....LG ....LS..P. ...-...--. .....H [3367]
#GML902612c  S.I.....LG .....S..P. ...-...--. .....H [3367]
#BeAn246262c S........G .....S..P. ...-...--. .....H [3367]
#65V310c     .......... .......... ...-...--. .....H [3367]
#TRVL9464c   S.....E..G .....S..P. ...-...--. .....H [3367]
#Ilheus      S.I..AVT.V S.PT.S..QC LWI-...--. .....H [3367]
#Rocio       S....D..YA ..PT..ARPC PL.-...--. .....H [3367]
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APPENDIX W 
 
Second Multiple Sequence Alignment: WNV Capsid/prM 
 
West Nile Virus 
Capsid/prM Region: WNAE primer set 
 
Nucleotide Alignment 
!Domain=Data property=Coding CodonStart=1;
#FLM38     TTT GTG TTG GCT CTC TTG GCG TTC TTC AGG TTC ACA GCA ATT GCT CCG  [279]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLS545    ... ... G.. ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLS649    --- --- --- --- --- --- --- --- --- --- --- --- --- -.. ... ...  [279]
#FLS694    --- --- --- ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN01a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN01b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN02a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN05a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FLWN05b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#FL03-03-2 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#03-124FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#TX2002    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#TX-2004H  ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ...  [279]
#TM171Mx   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#AZ-2004   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#CO-2003-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#GA-2002-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#Hungary03 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#India     ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#WNEgypt   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [279]
#Kunjin    ... ... ... ... ... ... ... ..T ..T ... ... ..G ... ... ... ...  [279]
#AnMg798   ... ... ... ..C ..G ... ... ... ..T ..A ... ..T ... ... ... ...  [279]
#MVE       ... ... ... ... ... ..A ..T ... ... ... ..T ... ... C.. ..C ...  [279]
#JE        ..C ... C.. ... ..T A.C A.. ... ... .A. ... ... ... T.A ..C ...  [279]
#Kern217   ..C A.A C.A ..C A.. C.. A.A ... ... C.A ..T ... ..T C.A CAG ..A  [279]  
#FLM38     ACC CGA GCA GTG CTG GAT CGA TGG AGA GGT GTG AAC AAA CAA ACA GCG  [327]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLS545    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLS649    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLS694    ... ... ... ... ... ... ... ... ... K.. ... ... ... ... ... ...  [327]
#FLWN01a   ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ...  [327]
#FLWN01b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLWN02a   ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ...  [327]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FLWN05a   ... ... ... ... ... ... ..R ... ... ... ... ... ... ... ... ...  [327]
#FLWN05b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#FL03-03-2 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#03-124FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#TX2002    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#TX-2004H  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#TM171Mx   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#AZ-2004   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#CO-2003-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#GA-2002-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#Hungary03 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#India     ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#WNEgypt   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [327]
#Kunjin    ... ..G ... ... ... ... ... ... ... A.. ... ... ... ... ... ...  [327]
#AnMg798   ..T ..T ..G ..A T.. ..C A.G ... ... ..C ..T ... ... ... ... ..A  [327]
#MVE       ... AAG ..C T.. A.. AGG ..C ... .AG A.C ... ... ..G AC. ..G ..C  [327]
#JE        ... AAG ..G C.T T.A .GC ... ... .A. .CA ... G.A ..G AGT GTG ..A  [327]
#Kern217   ..T GAG ..G C.. AA. CGC A.. ... ..G .C. ... G.. ... AG. ..G ..A  [327]  
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APPENDIX W: (CONTINUED) 
 
#FLM38     ATG AAA CAC CTT CTG AGT TTT AAG AAG GAA CTA GGG ACC TTG ACC AGT  [375]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLS545    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLS649    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLS694    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLWN01a   ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ...  [375]
#FLWN01b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLWN02a   ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ...  [375]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FLWN05a   ... ... ... ... ... ... ..Y ... ... ... ... ... ... ... ... ...  [375]
#FLWN05b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#FL03-03-2 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#03-124FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#TX2002    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#TX-2004H  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#TM171Mx   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#AZ-2004   ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ...  [375]
#CO-2003-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#GA-2002-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#Hungary03 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#India     ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#WNEgypt   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [375]
#Kunjin    ... ... ..T ..C ... ... ..C ... ... ... ... ..A ... ... ... ...  [375]
#AnMg798   ... ..G ..T ..C T.. ... ..C ... ... ... T.G ..A ..T C.T ... ...  [375]
#MVE       ... ... ..T ..G ACC ... ... ... ..A ... T.. ..A ..A C.. .TT GA.  [375]
#JE        ... ... ..T ... ACT ... ..C ..A CGA ... ..T ..A ..A C.C .TT GAC  [375]
#Kern217   T.. ... ... ..G AAC G.A ... ..A CGT ..C ..C ..A T.. A.. CTA GAC  [375]
 
#FLM38     GCT ATC AAT CGG CGG AGC TCA AAA CAA AAG AAA AGA GGA GGA AAG ACC  [423]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLS545    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLS649    ... ... ... ... ... ... ... ... ... ... W.. ... ... ... ... ...  [423]
#FLS694    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN01a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN01b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN02a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN05a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FLWN05b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#FL03-03-2 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#03-124FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#TX2002    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#TX-2004H  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#TM171Mx   ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#AZ-2004   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#CO-2003-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#GA-2002-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#Hungary03 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#India     ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#WNEgypt   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [423]
#Kunjin    ... ... ..C ... ... ... ... ... ..G ... ..G ... ... ... ... ...  [423]
#AnMg798   ..C ... ..C ..T ... ... G.. ... ... ... ... ... ... ..T .CA G.G  [423]
#MVE       .TG G.G ..C AAA A.. G.. AA. ... ... ... ... ... ..T ... .CA T..  [423]
#JE        ..C G.G ..C AA. ... G.. AG. ..G ... ..C ... ... ... ... .TC .TG  [423]
#Kern217   A.C ... ..C ... ... --- -.C ..G .-- ... ..G ... ... ..G .CC .GA  [423]  
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APPENDIX W: (CONTINUED) 
#FLM38     GGA ATT GCA GTC ATG ATT GGC CTG ATC GCC AGC GTG GGA GCA GTT ACC  [471]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [471]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [471]
#FLS545    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [471]
#FLS649    ... ... ... ... ... ... R.. T.. ... ... ... ... ... ... ... ...  [471]
#FLS694    ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ...  [471]
#FLWN01a   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#FLWN01b   ... .C. ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#FLWN02a   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [471]
#FLWN05a   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#FLWN05b   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#FL03-03-2 ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#03-124FL  ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#TX2002    ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#TX-2004H  ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#TM171Mx   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#AZ-2004   ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#CO-2003-1 ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#GA-2002-1 ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#Hungary03 ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ...  [471]
#India     ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ...  [471]
#WNEgypt   ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ...  [471]
#Kunjin    ... ... ... T.. ... ... ... T.. ..T ..T G.. ... ... ... ..C ..T  [471]
#AnMg798   ..G T.. T.C A.. T.. C.. ..G ... ... ... T.. .CA ..C ..T ... ..T  [471]
#MVE       .TG C.. ATG C.. ..T T.C ATG ... ..T .GA TTT .CC .CT ..C T.A .AG  [471]
#JE        T.G C.C ..G AG. T.. GCA .TT A.C ..A ... T.. .CA ... ..C A.G .AG  [471]
#Kern217   TCG T.G CTC .GA T.. GC. .CG ..A ..T .GA CTG .C. A.T T.. T.G CAG  [471]
 
#FLM38     CTC TCT AAC TTT CAA GGG AAG GTG ATG ATG ACG GTA AAT GCT ACT GAC  [519]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLS545    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLS649    ... ... ... ..C ... ... ... ... ... ... ..T ... ... ..C ... ...  [519]
#FLS694    ... ... ... ..C ... ... ... ... ... ... ..T ... ... ..C ... ...  [519]
#FLWN01a   ... ... ... ..C ... ... ... ... ... ... ... ... .R. ... ... ...  [519]
#FLWN01b   ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLWN02a   ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLWN05a   ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FLWN05b   ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#FL03-03-2 ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#03-113FL  ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#03-124FL  ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#TX2002    ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#TX-2004H  ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#TM171Mx   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#AZ-2004   ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#CO-2003-1 ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#GA-2002-1 ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#WNNY99    ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#Hungary03 ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ...  [519]
#India     ... ... ... ..C ... ... ... ... ... ... ..T ... ... ..C ... ...  [519]
#WNEgypt   ... ... ... ..C ... ... ... ... ... ... ..T ... ... ..C ... ...  [519]
#Kunjin    ... ..C ... ... ... ... ... ... ... ... ... ..G ..C ... ... ...  [519]
#AnMg798   ... ..A ... ... ... ..C ... ... ... ... ..T ..C ... ..A ..C ...  [519]
#MVE       ..T ..C .C. ..C ..G ..C ... A.A ... ... ..T ..G ..C ... ..G ...  [519]
#JE        T.G ..A ..T ..C ..G ... ... C.T T.. ... ..C ..C ..C AA. ..G ..T  [519]
#Kern217   T.A ..A .C. .A. ..G ... ..A ... T.A ... T.A A.C ..C AAG ... ...  [519]
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APPENDIX W: (CONTINUED) 
 
#FLM38     GTC ACA GAT GTC ATC ACG ATT CCA ACA GCT GCT GGA AAG AAC CTA TGC  [567]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLS545    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLS649    ... ... ..C ... ... ... ... ... ... ... ... ... ... M.T ... ...  [567]
#FLS694    ... ... ..C ... ... ... ... ... ... ... ... ... ... ..T ... ...  [567]
#FLWN01a   ... ... ... ... ... ... ..- --- --- --- --- --- --- --- --- ---  [567]
#FLWN01b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLWN02a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLWN05a   ... -.. ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FLWN05b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#FL03-03-2 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#03-124FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#TX2002    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#TX-2004H  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#TM171Mx   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#AZ-2004   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#CO-2003-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#GA-2002-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#Hungary03 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [567]
#India     ... ... ..C ... ... ... ... ... ... ... ... ... ... ..T ... ...  [567]
#WNEgypt   ... ... ..C ... ... ... ... ... ... ... ... ... ... ..T ... ...  [567]
#Kunjin    ... ... ..C A.T ... ... ..A ... ..G ..C ... ... ... ... ..G ...  [567]
#AnMg798   A.. ..T ... ..G ..A ..C ... ... ... ..C ..C ..G ..A ... ... ...  [567]
#MVE       A.T G.T ... ..G ... G.C ... ... ..C C.G AAG ... CCC ..T .A. ...  [567]
#JE        A.T G.. ..C ..T ... GT. ... ..C ..C T.A AAA ... G.. ... AG. ..T  [567]
#Kern217   .CT CA. AGC .C. ..A .AC ... ..T .GT ..C AAC ... GCA ... ACT ...  [567]  
#FLM38     ATT GTC AGA GCA ATG GAT GTG GGA TAC ATG TGC GAT GAT ACT ATC ACT  [615]
#FLS502    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLS504    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLS545    ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ...  [615]
#FLS649    ... ... ... ... ... ..C ... .KG ... ... ..T ... ... ... ... ..C  [615]
#FLS694    ... ... ... ... ... ..C ... ..G ... ... ..T ... ... ... ... ..C  [615]
#FLWN01a   --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---  [615]
#FLWN01b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLWN02a   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLWN02b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FLWN05a   ... ... ... ... ... ... ... ... ... ... ... ... .-- --- --- ---  [615]
#FLWN05b   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#FL03-03-2 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#03-113FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#03-124FL  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#TX2002    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#TX-2004H  ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ...  [615]
#TM171Mx   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#AZ-2004   ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#CO-2003-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#GA-2002-1 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#WNNY99    ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#Hungary03 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  [615]
#India     ... ... ... ... ... ..C ... ..G ... ... ..T ... ... ... ... ..C  [615]
#WNEgypt   ... ... ... ... ... ..C ... ..G ... ... ..T ... ... ... ... ..C  [615]
#Kunjin    ... ... ... ..T ... ... ... ..G C.. ... ..T ... ... ... ... ..C  [615]
#AnMg798   ..C ..G ..G ..C ... ..C ... ... ... C.C ..T ..G ..C ... ... ..C  [615]
#MVE       TGG A.T C.. ..C ..T ..C A.T ... .TT ... ..T ... ..C ..C ... ...  [615]
#JE        TGG ... C.G ... ..C ..C ..C ..C ..T ... ..T ..G ..C ... ... ..G  [615]
#Kern217   ... ..G ..G ..T C.A ... ... ..G GT. ... ... A.A ... GAC ... ..A  [615]
 
 
 
 
 
 717
APPENDIX W: (CONTINUED) 
 
#FLM38     TAT GAA TGT CCA GTG CTG TCG GCT G [640]
#FLS502    ... ... ... ... ... ... ... ... . [640]
#FLS504    ... ... ... ... ... ... ... ... . [640]
#FLS545    ... ... ... ... ... ... ... ... . [640]
#FLS649    ... ... ... ... ... ... ... .-- - [640]
#FLS694    ... A.. ... ... ... ... ... --- - [640]
#FLWN01a   --- --- --- --- --- --- --- --- - [640]
#FLWN01b   ... ... ... ... ... ... ... ... . [640]
#FLWN02a   ... ... ... ... ... ... ... ... . [640]
#FLWN02b   ... ... ... ... ... ... ... ... . [640]
#FLWN05a   --- --- --- --- --- --- --- --- - [640]
#FLWN05b   ... ... ... ... ... ... ... ... . [640]
#FL03-03-2 ... ... ..C ... ..A ... ... ... . [640]
#03-113FL  ... ..G ..C ... ... ... ... ... . [640]
#03-124FL  ... ... ..C ... ... ... ... ... . [640]
#TX2002    ... ... ..C ... ... ... ... ... . [640]
#TX-2004H  ... ... ..C ... ... ... ... ... . [640]
#TM171Mx   ... ... ..C ... ... ... ... ... . [640]
#AZ-2004   ... ... ..C ... ... ... ... ... . [640]
#CO-2003-1 ... ... ..C ... ... ... ... ... . [640]
#GA-2002-1 ... ... ..C ... ... ... ... ... . [640]
#WNNY99    ... ... ..C ... ... ... ... ... . [640]
#Hungary03 ... ... ..C ... ... ... ... ... . [640]
#India     ... ... ... ... ... ... ... ... . [640]
#WNEgypt   ... ... ... ... ... ... ... ... . [640]
#Kunjin    ... ... ... ... ... T.. ... ..C . [640]
#AnMg798   ... ..G ... ..T ..C T.. G.T ... . [640]
#MVE       ... ... ..C ..G AAA T.. GAA AG. . [640]
#JE        ..C ... ... ..T AA. ..C A.C ATG . [640]
#Kern217   ..C CTG ..C ... ... ..T ..A ..G . [640]
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West Nile Virus 
Capsid/prM Region 
 
Amino Acid Alignment 
!Title Translated WNA;
!Format
   DataType=Protein
   NSeqs=30 NSites=136
   Identical=. Missing=? Indel=-;
!Domain=Data;
#FLM38     FVLALLAFFR FTAIAPTRAV LDRWRGVNKQ TAMKHLLSFK KELGTLTSAI  [128]
#FLS502    .......... .......... .......... .......... ..........  [128]
#FLS504    .......... .......... .......... .......... ..........  [128]
#FLS545    ..V....... .......... .......... .......... ..........  [128]
#FLS649    ---------- ----...... .......... .......... ..........  [128]
#FLS694    ---....... .......... .....?.... .......... ..........  [128]
#FLWN01a   .......... .......... .......... .......... ..........  [128]
#FLWN01b   .......... .......... .......... .......... ..........  [128]
#FLWN02a   .......... .......... .......... .......... ..........  [128]
#FLWN02b   .......... .......... .......... .......... ..........  [128]
#FLWN05a   .......... .......... ..?....... ........?. ..........  [128]
#FLWN05b   .......... .......... .......... .......... ..........  [128]
#FL03-03-2 .......... .......... .......... .......... ..........  [128]
#03-113FL  .......... .......... .......... .......... ..........  [128]
#03-124FL  .......... .......... .......... .......... ..........  [128]
#TX2002    .......... .......... .......... .......... ..........  [128]
#TX-2004H  .......... .......... .......... .......... ..........  [128]
#TM171Mx   .......... .......... .......... .......... ..........  [128]
#AZ-2004   .......... .......... .......... .......... ....A.....  [128]
#CO-2003-1 .......... .......... .......... .......... ..........  [128]
#GA-2002-1 .......... .......... .......... .......... ..........  [128]
#WNNY99    .......... .......... .......... .......... ..........  [128]
#Hungary03 .......... .......... .......... .......... ..........  [128]
#India     .......... .......... .......... .......... ..........  [128]
#WNEgypt   .......... .......... .......... .......... ..........  [128]
#Kunjin    .......... .......... .....S.... .......... ..........  [128]
#AnMg798   .......... .......... .......... .......... ..........  [128]
#MVE       .......... ...L...K.L MR..KS...T ......T... ......IDVV  [128]
#JE        .....IT..K ...L...K.L .G..KA.E.S V.....T... R.....ID.V  [128]
#Kern217   .I..I.T... ...LQ..E.L KR...A.D.R ..L...NG.. RD..SMLDT.  [128]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 719
APPENDIX W: (CONTINUED) 
 
#FLM38     NRRSSKQKKR GGKTGIAVMI GLIASVGAVT LSNFQGKVMM TVNATDVTDV  [178]
#FLS502    .......... .......... .......... .......... ..........  [178]
#FLS504    .......... .......... .......... .......... ..........  [178]
#FLS545    .......... .......... .......... .......... ..........  [178]
#FLS649    ........?. .......... ?......... .......... ..........  [178]
#FLS694    .......... .......... .......... .......... ..........  [178]
#FLWN01a   .......... .......... .......... .......... ..?.......  [178]
#FLWN01b   .......... .....T.... .......... .......... ..........  [178]
#FLWN02a   .......... .......... .......... .......... ..........  [178]
#FLWN02b   .......... .......... .......... .......... ..........  [178]
#FLWN05a   .......... .......... .......... .......... .......-..  [178]
#FLWN05b   .......... .......... .......... .......... ..........  [178]
#FL03-03-2 .......... .......... .......... .......... ..........  [178]
#03-113FL  .......... .......... .......... .......... ..........  [178]
#03-124FL  .......... .......... .......... .......... ..........  [178]
#TX2002    .......... .......... .......... .......... ..........  [178]
#TX-2004H  .......... .......... .......... .......... ..........  [178]
#TM171Mx   .......... .......... .......... .......... ..........  [178]
#AZ-2004   .......... .......... .......... .......... ..........  [178]
#CO-2003-1 .......... .......... .......... .......... ..........  [178]
#GA-2002-1 .......... .......... .......... .......... ..........  [178]
#WNNY99    .......... .......... .......... .......... ..........  [178]
#Hungary03 .......... .......... .......... .......... ..........  [178]
#India     .......... .......... .......... .......... ..........  [178]
#WNEgypt   .......... .......... .......... .......... ..........  [178]
#Kunjin    .......... .......F.. ....G..... .......... .........I  [178]
#AnMg798   ....A..... ..TA.FSILL ....CA.... .......... ......I...  [178]
#MVE       .K.GK..... ..TSVLMLIF M..GFAA.LK ..T....I.. ......IA..  [178]
#JE        .K.GR..N.. ..IMWL.SLA VI..CA..MK .......LL. ...N..IA..  [178]
#Kern217   ...--.-... ..TRSLLGLA A..GLASSLQ ..TY....L. SI.K..AQSA  [178]  
#FLM38     ITIPTAAGKN LCIVRAMDVG YMCDDTITYE CPVLSA [214]
#FLS502    .......... .......... .......... ...... [214]
#FLS504    .......... .......... .......... ...... [214]
#FLS545    .......... .......... .......... ...... [214]
#FLS649    .........? .........? .......... .....- [214]
#FLS694    .......... .......... .........K .....- [214]
#FLWN01a   ..-------- ---------- ---------- ------ [214]
#FLWN01b   .......... .......... .......... ...... [214]
#FLWN02a   .......... .......... .......... ...... [214]
#FLWN02b   .......... .......... .......... ...... [214]
#FLWN05a   .......... .......... ....------ ------ [214]
#FLWN05b   .......... .......... .......... ...... [214]
#FL03-03-2 .......... .......... .......... ...... [214]
#03-113FL  .......... .......... .......... ...... [214]
#03-124FL  .......... .......... .......... ...... [214]
#TX2002    .......... .......... .......... ...... [214]
#TX-2004H  .......... .......... .......... ...... [214]
#TM171Mx   .......... .......... .......... ...... [214]
#AZ-2004   .......... .......... .......... ...... [214]
#CO-2003-1 .......... .......... .......... ...... [214]
#GA-2002-1 .......... .......... .......... ...... [214]
#WNNY99    .......... .......... .......... ...... [214]
#Hungary03 .......... .......... .......... ...... [214]
#India     .......... .......... .......... ...... [214]
#WNEgypt   .......... .......... .......... ...... [214]
#Kunjin    .......... .......... H......... ...... [214]
#AnMg798   .......... .......... .L.E...... ....A. [214]
#MVE       .A...PK.P. Q.WI..I.I. F......... ..K.ES [214]
#JE        .V...SK.E. R.W...I... ...E...... ..K.TM [214]
#Kern217   .N..S.N.A. T.....L... V..K.D...L ...... [214]
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